activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	34280	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		220.0	CHEMBL3650	Homo sapiens	Selectivity		220.0
	34280	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		220.0	CHEMBL3650	Homo sapiens	Selectivity		220.0
	37866	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1ccnc(Nc2ncc(-c3ccccc3)s2)c1		CHEMBL319065	=	Selectivity		220.0	CHEMBL3650	Homo sapiens	Selectivity		220.0
	40261	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL98385	=	Selectivity		600.0	CHEMBL3650	Homo sapiens	Selectivity		600.0
	42686	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	O=C(Nc1ncc(-c2ccccc2)s1)c1ccccc1		CHEMBL98633	=	Selectivity		72.0	CHEMBL3650	Homo sapiens	Selectivity		72.0
	46272	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1cccnc1Nc1ncc(-c2ccccc2)s1		CHEMBL329713	=	Selectivity		820.0	CHEMBL3650	Homo sapiens	Selectivity		820.0
	48771	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	CCCCN(C)c1ccc(/N=N/c2ncc([N+](=O)[O-])s2)c(C)c1		CHEMBL100174	>	Selectivity		130.0	CHEMBL3650	Homo sapiens	Selectivity		130.0
	50206	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	c1ccc(-c2cnc(Nc3ccccn3)s2)cc1		CHEMBL98538	=	Selectivity		164.0	CHEMBL3650	Homo sapiens	Selectivity		164.0
	53971	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Brc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL101464	=	Selectivity		1620.0	CHEMBL3650	Homo sapiens	Selectivity		1620.0
	55134	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Clc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL319789	>	Selectivity		580.0	CHEMBL3650	Homo sapiens	Selectivity		580.0
	66860	CHEMBL678678	Selectivity for Fibroblast growth factor receptor 1 over (KDR) kinase insert domain receptor	B	N#Cc1cnc(Nc2ccccn2)s1		CHEMBL101544	=	Selectivity		214.0	CHEMBL3650	Homo sapiens	Selectivity		214.0
	78009	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)c1		CHEMBL432941	=	IC50	nM	1350.0	CHEMBL3650	Homo sapiens	IC50	uM	1.35
	79178	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c2c(c1CCC(=O)O)CCCC2		CHEMBL420609	=	IC50	nM	1080.0	CHEMBL3650	Homo sapiens	IC50	uM	1.08
	80320	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2cc3c([nH]2)CCCC3)c1		CHEMBL419682	=	IC50	nM	17500.0	CHEMBL3650	Homo sapiens	IC50	uM	17.5
	83549	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1cc2c([nH]1)CCCC2		CHEMBL88462	=	IC50	nM	17700.0	CHEMBL3650	Homo sapiens	IC50	uM	17.7
	84546	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)[nH]c2c1CCCC2		CHEMBL431996	=	IC50	nM	220.0	CHEMBL3650	Homo sapiens	IC50	uM	0.22
	85632	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	COc1ccc2c(c1)NC(=O)/C2=C\c1cc2c([nH]1)CCCC2		CHEMBL91250	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	85641	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)[nH]c2c1CCCC2		CHEMBL88771	=	IC50	nM	1270.0	CHEMBL3650	Homo sapiens	IC50	uM	1.27
	87620	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)cc1		CHEMBL91815	=	IC50	nM	880.0	CHEMBL3650	Homo sapiens	IC50	uM	0.88
	88631	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL328029	=	IC50	nM	10500.0	CHEMBL3650	Homo sapiens	IC50	uM	10.5
	88640	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(Br)cc32)[nH]c2c1CCCC2		CHEMBL314995	=	IC50	nM	270.0	CHEMBL3650	Homo sapiens	IC50	uM	0.27
	91570	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL88483	=	IC50	nM	220.0	CHEMBL3650	Homo sapiens	IC50	uM	0.22
	91579	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	O=C1Nc2cc(-c3ccccc3)ccc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL313746	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	91588	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	92600	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	7080.0	CHEMBL3650	Homo sapiens	IC50	uM	7.08
	96619	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2cc3c([nH]2)CCCC3)cc1		CHEMBL313500	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	98655	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL89010	=	IC50	nM	310.0	CHEMBL3650	Homo sapiens	IC50	uM	0.31
	98664	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)CCCC3)C(=O)N2		CHEMBL86531	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	uM	0.2
	99527	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c2c1CCCC2		CHEMBL315753	=	IC50	nM	270.0	CHEMBL3650	Homo sapiens	IC50	uM	0.27
	104504	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	O=C1Nc2ccc(Br)cc2/C1=C/c1cc2c([nH]1)CCCC2		CHEMBL88606	=	IC50	nM	13300.0	CHEMBL3650	Homo sapiens	IC50	uM	13.3
	104513	CHEMBL678670	Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c2c(c1CCC(=O)O)CCCC2		CHEMBL313821	=	IC50	nM	80.0	CHEMBL3650	Homo sapiens	IC50	uM	0.08
	106108	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CN1CCN(c2ccc(Nc3ncc4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL51283	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	uM	0.028
	107292	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CC(=O)Nc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL111913	=	IC50	nM	5800.0	CHEMBL3650	Homo sapiens	IC50	uM	5.8
	107296	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21		CHEMBL322298	=	IC50	nM	210.0	CHEMBL3650	Homo sapiens	IC50	uM	0.21
	107300	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(Br)c3)nc21		CHEMBL111434	=	IC50	nM	2400.0	CHEMBL3650	Homo sapiens	IC50	uM	2.4
	107304	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	COc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL111197	=	IC50	nM	370.0	CHEMBL3650	Homo sapiens	IC50	uM	0.37
	108285	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NC3CCCCC3)nc21		CHEMBL113128	=	IC50	nM	6800.0	CHEMBL3650	Homo sapiens	IC50	uM	6.8
	108289	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCOC(=O)c1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL109547	=	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	uM	1.5
	109637	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(OCCN4CCCCC4)cc3)nc21		CHEMBL323775	=	IC50	nM	39.0	CHEMBL3650	Homo sapiens	IC50	uM	0.039
	111012	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	COc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cn1		CHEMBL111365	=	IC50	nM	540.0	CHEMBL3650	Homo sapiens	IC50	uM	0.54
	111016	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCNCCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL113521	=	IC50	nM	66.0	CHEMBL3650	Homo sapiens	IC50	uM	0.066
	112442	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL51573	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	112446	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCc3cccnc3)nc21		CHEMBL110034	=	IC50	nM	3150.0	CHEMBL3650	Homo sapiens	IC50	uM	3.15
	112450	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	COc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1C		CHEMBL113023	=	IC50	nM	450.0	CHEMBL3650	Homo sapiens	IC50	uM	0.45
	113787	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CN1CCN(CCCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL106232	=	IC50	nM	240.0	CHEMBL3650	Homo sapiens	IC50	uM	0.24
	113791	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21		CHEMBL327127	=	IC50	nM	80.0	CHEMBL3650	Homo sapiens	IC50	uM	0.08
	114999	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(O)cc3)nc21		CHEMBL323405	=	IC50	nM	150.0	CHEMBL3650	Homo sapiens	IC50	uM	0.15
	115003	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(OCCN)cc3)nc21		CHEMBL331366	=	IC50	nM	55.0	CHEMBL3650	Homo sapiens	IC50	uM	0.055
	116314	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCc3ccccc3)nc21		CHEMBL113356	=	IC50	nM	14000.0	CHEMBL3650	Homo sapiens	IC50	uM	14.0
	118829	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CN(C)c1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL299347	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	118833	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	COc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc(OC)c1		CHEMBL324926	=	IC50	nM	430.0	CHEMBL3650	Homo sapiens	IC50	uM	0.43
	119920	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CC(C)Nc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL109759	=	IC50	nM	700.0	CHEMBL3650	Homo sapiens	IC50	uM	0.7
	121234	CHEMBL676878	Inhibition of fibroblast growth factor receptor (FGFr)	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(CC)c3n2)cc1		CHEMBL112914	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	121281	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CN(C)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL112080	=	IC50	nM	34.0	CHEMBL3650	Homo sapiens	IC50	uM	0.034
	122503	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CN1CCN(Cc2ccc(Nc3ncc4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL112706	=	IC50	nM	49.0	CHEMBL3650	Homo sapiens	IC50	uM	0.049
	122507	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(O)c3)nc21		CHEMBL321193	=	IC50	nM	180.0	CHEMBL3650	Homo sapiens	IC50	uM	0.18
	122511	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCOC(=O)CCCc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL419022	=	IC50	nM	2600.0	CHEMBL3650	Homo sapiens	IC50	uM	2.6
	123749	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CC[N+]([O-])(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL320339	=	IC50	nM	46.0	CHEMBL3650	Homo sapiens	IC50	uM	0.046
	125061	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	COc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL104153	=	IC50	nM	410.0	CHEMBL3650	Homo sapiens	IC50	uM	0.41
	127734	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(CC(=O)O)cc3)nc21		CHEMBL50647	=	IC50	nM	61.0	CHEMBL3650	Homo sapiens	IC50	uM	0.061
	127738	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	COc1ccccc1Nc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL320705	=	IC50	nM	3200.0	CHEMBL3650	Homo sapiens	IC50	uM	3.2
	128841	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCN3CCOCC3)nc21		CHEMBL48172	=	IC50	nM	1410.0	CHEMBL3650	Homo sapiens	IC50	uM	1.41
	128845	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCCCC(=O)O)nc21		CHEMBL113863	=	IC50	nM	580.0	CHEMBL3650	Homo sapiens	IC50	uM	0.58
	130154	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(C(=O)O)c3)nc21		CHEMBL109631	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	131439	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCO)nc21		CHEMBL111618	=	IC50	nM	1660.0	CHEMBL3650	Homo sapiens	IC50	uM	1.66
	131443	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccnc3)nc21		CHEMBL325589	=	IC50	nM	150.0	CHEMBL3650	Homo sapiens	IC50	uM	0.15
	132777	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)nc21		CHEMBL49596	=	IC50	nM	1300.0	CHEMBL3650	Homo sapiens	IC50	uM	1.3
	133939	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCN(CC)CCOc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL297523	=	IC50	nM	32.0	CHEMBL3650	Homo sapiens	IC50	uM	0.032
	133948	CHEMBL676963	Inhibition of fibroblast growth factor receptor (FGFr) tyrosine kinase	B	CCN(CC)CCOc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL297523	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	133982	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccncc3)nc21		CHEMBL448154	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	135129	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL50470	=	IC50	nM	13900.0	CHEMBL3650	Homo sapiens	IC50	uM	13.9
	135133	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CN1CCN(CCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL104244	=	IC50	nM	320.0	CHEMBL3650	Homo sapiens	IC50	uM	0.32
	136423	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL107472	=	IC50	nM	2500.0	CHEMBL3650	Homo sapiens	IC50	uM	2.5
	136427	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCc3ccccn3)nc21		CHEMBL326041	=	IC50	nM	3210.0	CHEMBL3650	Homo sapiens	IC50	uM	3.21
	136431	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(Cl)cc3)nc21		CHEMBL111247	=	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	137438	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CC[N+](C)(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1.[I-]		CHEMBL324543	=	IC50	nM	40.0	CHEMBL3650	Homo sapiens	IC50	uM	0.04
	137442	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(CCCC(=O)O)cc3)nc21		CHEMBL113070	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	137446	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(O)nc21		CHEMBL109725	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	137453	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccncc3)nc21		CHEMBL104779	=	IC50	nM	190.0	CHEMBL3650	Homo sapiens	IC50	uM	0.19
	138900	CHEMBL676878	Inhibition of fibroblast growth factor receptor (FGFr)	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	IC50	nM	43.0	CHEMBL3650	Homo sapiens	IC50	uM	0.043
	138951	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21		CHEMBL301612	=	IC50	nM	460.0	CHEMBL3650	Homo sapiens	IC50	uM	0.46
	138963	CHEMBL678594	Inhibition of fibroblast growth factor receptor (FGFr)	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21		CHEMBL301612	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	139959	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL299194	=	IC50	nM	380.0	CHEMBL3650	Homo sapiens	IC50	uM	0.38
	139963	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCc3ccccn3)nc21		CHEMBL323699	=	IC50	nM	6530.0	CHEMBL3650	Homo sapiens	IC50	uM	6.53
	141069	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL109296	=	IC50	nM	960.0	CHEMBL3650	Homo sapiens	IC50	uM	0.96
	141077	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	Cc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL111339	=	IC50	nM	910.0	CHEMBL3650	Homo sapiens	IC50	uM	0.91
	142381	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCOC(=O)c1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL109525	=	IC50	nM	33600.0	CHEMBL3650	Homo sapiens	IC50	uM	33.6
	143685	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CN(C)CCCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL110905	=	IC50	nM	33.0	CHEMBL3650	Homo sapiens	IC50	uM	0.033
	144665	CHEMBL678675	Inhibitory concentration evaluated against fibroblast growth factor receptor 1.	B	CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL332269	=	IC50	nM	4480.0	CHEMBL3650	Homo sapiens	IC50	uM	4.48
	184549	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCCN3CCOCC3)cc21		CHEMBL320382	=	IC50	nM	230.0	CHEMBL3650	Homo sapiens	IC50	uM	0.23
	186095	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL299194	=	IC50	nM	380.0	CHEMBL3650	Homo sapiens	IC50	uM	0.38
	187192	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL107071	=	IC50	nM	210.0	CHEMBL3650	Homo sapiens	IC50	uM	0.21
	188500	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL420477	=	IC50	nM	150.0	CHEMBL3650	Homo sapiens	IC50	uM	0.15
	189686	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)cc21		CHEMBL108004	=	IC50	nM	380.0	CHEMBL3650	Homo sapiens	IC50	uM	0.38
	189691	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	COc1ccc(Nc2ccc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL323017	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	191002	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	COc1ccc(Nc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)cc1		CHEMBL318519	=	IC50	nM	2200.0	CHEMBL3650	Homo sapiens	IC50	uM	2.2
	191005	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2ccc(N)nc21		CHEMBL107372	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	192128	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ccc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL107247	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	193246	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)C(=O)c1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL104357	=	IC50	nM	180.0	CHEMBL3650	Homo sapiens	IC50	uM	0.18
	194461	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccncc3)cc21		CHEMBL106839	=	IC50	nM	3500.0	CHEMBL3650	Homo sapiens	IC50	uM	3.5
	194467	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21		CHEMBL301612	=	IC50	nM	460.0	CHEMBL3650	Homo sapiens	IC50	uM	0.46
	195593	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)cc21		CHEMBL323453	=	IC50	nM	2200.0	CHEMBL3650	Homo sapiens	IC50	uM	2.2
	195596	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCOc2ccc(Nc3cc4c(cn3)cc(-c3c(Cl)cccc3Cl)c(=O)n4C)cc2)CC1		CHEMBL110403	=	IC50	nM	210.0	CHEMBL3650	Homo sapiens	IC50	uM	0.21
	196767	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL106232	=	IC50	nM	240.0	CHEMBL3650	Homo sapiens	IC50	uM	0.24
	198998	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCN3CCOCC3)nc21		CHEMBL48172	=	IC50	nM	1400.0	CHEMBL3650	Homo sapiens	IC50	uM	1.4
	200322	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCOc2ccc(Nc3cc4c(cn3)cc(-c3c(Cl)cccc3Cl)c(=O)n4C)cc2)CC1		CHEMBL104071	=	IC50	nM	120.0	CHEMBL3650	Homo sapiens	IC50	uM	0.12
	200325	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(N4CCOCC4)cc3)cc21		CHEMBL106992	=	IC50	nM	8700.0	CHEMBL3650	Homo sapiens	IC50	uM	8.7
	200328	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1cc2nc(O)c(-c3c(Cl)cccc3Cl)cc2cn1		CHEMBL104322	=	IC50	nM	170.0	CHEMBL3650	Homo sapiens	IC50	uM	0.17
	200331	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCOc1ccc(Nc2ccc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL106379	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	202774	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)CC1		CHEMBL108013	=	IC50	nM	170.0	CHEMBL3650	Homo sapiens	IC50	uM	0.17
	202780	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(c2ccc(Nc3ncc4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL51283	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	uM	0.028
	203952	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL107676	=	IC50	nM	80.0	CHEMBL3650	Homo sapiens	IC50	uM	0.08
	203955	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ccc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL104532	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	203958	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2ccc(Nc3ccccc3)nc21		CHEMBL420473	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	203961	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL50470	=	IC50	nM	14000.0	CHEMBL3650	Homo sapiens	IC50	uM	14.0
	205162	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCn3ccnc3)cc21		CHEMBL106953	=	IC50	nM	210.0	CHEMBL3650	Homo sapiens	IC50	uM	0.21
	205165	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(c2ccc(Nc3cc4c(cn3)cc(-c3c(Cl)cccc3Cl)c(=O)n4C)cc2)CC1		CHEMBL104414	=	IC50	nM	42.0	CHEMBL3650	Homo sapiens	IC50	uM	0.042
	205171	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL107177	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	205174	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1		CHEMBL104244	=	IC50	nM	320.0	CHEMBL3650	Homo sapiens	IC50	uM	0.32
	206411	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN(C)c1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL108170	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	206414	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1		CHEMBL107472	=	IC50	nM	2500.0	CHEMBL3650	Homo sapiens	IC50	uM	2.5
	206420	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccncc3)nc21		CHEMBL104779	=	IC50	nM	190.0	CHEMBL3650	Homo sapiens	IC50	uM	0.19
	207589	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCCCNc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)CC1		CHEMBL108332	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	208761	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)nc21		CHEMBL49596	=	IC50	nM	1300.0	CHEMBL3650	Homo sapiens	IC50	uM	1.3
	209935	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCCNc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)CC1		CHEMBL108333	=	IC50	nM	170.0	CHEMBL3650	Homo sapiens	IC50	uM	0.17
	209941	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2cc3nc(O)c(-c4c(Cl)cccc4Cl)cc3cn2)CC1		CHEMBL104304	=	IC50	nM	72.0	CHEMBL3650	Homo sapiens	IC50	uM	0.072
	209944	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	IC50	nM	43.0	CHEMBL3650	Homo sapiens	IC50	uM	0.043
	213399	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)C(=O)c1ccc(Nc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)cc1		CHEMBL322005	=	IC50	nM	1900.0	CHEMBL3650	Homo sapiens	IC50	uM	1.9
	214556	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCCOc1ccc(Nc2cc3nc(O)c(-c4c(Cl)cccc4Cl)cc3cn2)cc1		CHEMBL419914	=	IC50	nM	440.0	CHEMBL3650	Homo sapiens	IC50	uM	0.44
	215719	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCOc1ccc(Nc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)cc1		CHEMBL107277	=	IC50	nM	130.0	CHEMBL3650	Homo sapiens	IC50	uM	0.13
	218211	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCCOc1ccc(Nc2cc3c(cn2)cc(-c2c(Cl)cccc2Cl)c(=O)n3C)cc1		CHEMBL107458	=	IC50	nM	250.0	CHEMBL3650	Homo sapiens	IC50	uM	0.25
	218214	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	COc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL104153	=	IC50	nM	410.0	CHEMBL3650	Homo sapiens	IC50	uM	0.41
	220586	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCCCCNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL107423	=	IC50	nM	80.0	CHEMBL3650	Homo sapiens	IC50	uM	0.08
	220589	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCN3CCOCC3)cc21		CHEMBL106295	=	IC50	nM	570.0	CHEMBL3650	Homo sapiens	IC50	uM	0.57
	220592	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(N4CCOCC4)cc3)nc21		CHEMBL106772	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	uM	0.1
	221681	CHEMBL678672	Inhibitory activity against fibroblast growth factor receptor 1	B	CCN(CC)CCNc1cc2c(cn1)cc(-c1c(Cl)cccc1Cl)c(=O)n2C		CHEMBL107418	=	IC50	nM	33000.0	CHEMBL3650	Homo sapiens	IC50	uM	33.0
	305183	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	Oc1cc2ncn(-c3ccccc3)c2cc1O		CHEMBL311449	=	IC50	nM	11000.0	CHEMBL3650	Homo sapiens	IC50	uM	11.0
	305186	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1cc2ncn(-c3ccccc3)c2cc1C		CHEMBL77712	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	305199	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CC(C)Oc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL79328	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	306472	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	OCCCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL77261	=	IC50	nM	25000.0	CHEMBL3650	Homo sapiens	IC50	uM	25.0
	307772	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3cc4c(cc32)OCO4)cc1		CHEMBL80651	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	uM	27.0
	307775	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CN(C)CCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL75969	=	IC50	nM	45000.0	CHEMBL3650	Homo sapiens	IC50	uM	45.0
	307793	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL76202	=	IC50	nM	22000.0	CHEMBL3650	Homo sapiens	IC50	uM	22.0
	307797	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1ccc2c(ncn2-c2ccccc2)c1O		CHEMBL77412	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	307858	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCNCC1.Cl		CHEMBL2448064	=	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	309241	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CN(C)CCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL312269	=	IC50	nM	4100.0	CHEMBL3650	Homo sapiens	IC50	uM	4.1
	309256	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	Oc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL80873	=	IC50	nM	6400.0	CHEMBL3650	Homo sapiens	IC50	uM	6.4
	309260	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1ccc2c(ncn2-c2ccccc2)c1OC		CHEMBL80558	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	309316	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN(C)c1ccncc1		CHEMBL25579	=	IC50	nM	1600.0	CHEMBL3650	Homo sapiens	IC50	uM	1.6
	309325	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(C#N)cc3F)ncnc2cc1OC/C=C/CN1CCCC1		CHEMBL24026	=	IC50	nM	19000.0	CHEMBL3650	Homo sapiens	IC50	uM	19.0
	309332	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC1CCN(C)CC1		CHEMBL26050	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	310463	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	C=CCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL311318	=	IC50	nM	35000.0	CHEMBL3650	Homo sapiens	IC50	uM	35.0
	310466	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1cc2ncn(-c3ccccc3)c2cc1CO		CHEMBL306184	=	IC50	nM	11000.0	CHEMBL3650	Homo sapiens	IC50	uM	11.0
	311836	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	Oc1cccc2c1ncn2-c1ccccc1		CHEMBL75964	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	314571	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(C)cc3F)ncnc2cc1OCC1CCNCC1		CHEMBL428534	=	IC50	nM	12300.0	CHEMBL3650	Homo sapiens	IC50	uM	12.3
	316939	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL281872	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	316967	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(C)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL281990	=	IC50	nM	13500.0	CHEMBL3650	Homo sapiens	IC50	uM	13.5
	316974	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3c(F)cc(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL422758	=	IC50	nM	1700.0	CHEMBL3650	Homo sapiens	IC50	uM	1.7
	316981	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3c(F)cc(Cl)cc3F)ncnc2cc1OCC1CCNCC1		CHEMBL25450	=	IC50	nM	2500.0	CHEMBL3650	Homo sapiens	IC50	uM	2.5
	316988	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC[C@@H]1CCCN(C)C1		CHEMBL1907763	=	IC50	nM	1800.0	CHEMBL3650	Homo sapiens	IC50	uM	1.8
	316995	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCOCC1		CHEMBL24137	=	IC50	nM	6700.0	CHEMBL3650	Homo sapiens	IC50	uM	6.7
	318196	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3cc(OCCCCN4CCOCC4)ccc32)cc1		CHEMBL308245	=	IC50	nM	12000.0	CHEMBL3650	Homo sapiens	IC50	uM	12.0
	318225	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	C=CCOc1ccc2c(ncn2-c2ccccc2)c1Br		CHEMBL310243	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	318228	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	Cc1cc2c(cc1O)ncn2-c1ccccc1		CHEMBL311913	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	318308	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	6000.0	CHEMBL3650	Homo sapiens	IC50	uM	6.0
	319396	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CCCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL80510	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	321764	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3cc(OCC4CO4)ccc32)cc1		CHEMBL310726	=	IC50	nM	18000.0	CHEMBL3650	Homo sapiens	IC50	uM	18.0
	321767	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3cc(OCCCN4CCOCC4)ccc32)cc1		CHEMBL80915	=	IC50	nM	9800.0	CHEMBL3650	Homo sapiens	IC50	uM	9.8
	321820	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	OCC(O)COc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL310137	=	IC50	nM	15000.0	CHEMBL3650	Homo sapiens	IC50	uM	15.0
	321870	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC/C=C/CN1CCCC1.Cl		CHEMBL1744349	=	IC50	nM	1900.0	CHEMBL3650	Homo sapiens	IC50	uM	1.9
	321878	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCC1CCN(C)CC1		CHEMBL24979	=	IC50	nM	2100.0	CHEMBL3650	Homo sapiens	IC50	uM	2.1
	321887	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL2448065	=	IC50	nM	4300.0	CHEMBL3650	Homo sapiens	IC50	uM	4.3
	323301	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL77407	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	323303	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3cc(SCCCN4CCOCC4)ccc32)cc1		CHEMBL443800	=	IC50	nM	24000.0	CHEMBL3650	Homo sapiens	IC50	uM	24.0
	323342	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC[C@@H]1CCCN(C)C1		CHEMBL1907764	=	IC50	nM	1800.0	CHEMBL3650	Homo sapiens	IC50	uM	1.8
	324334	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1ccc2c(c1)ncn2-c1ccc(N)cc1		CHEMBL309035	=	IC50	nM	18000.0	CHEMBL3650	Homo sapiens	IC50	uM	18.0
	324428	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCN(C)CC1		CHEMBL283088	=	IC50	nM	8000.0	CHEMBL3650	Homo sapiens	IC50	uM	8.0
	324435	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCCC1.Cl		CHEMBL2448067	=	IC50	nM	4200.0	CHEMBL3650	Homo sapiens	IC50	uM	4.2
	325525	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CN(C)CCCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL78698	=	IC50	nM	6800.0	CHEMBL3650	Homo sapiens	IC50	uM	6.8
	325574	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCN1CCN(C)CC1.Cl		CHEMBL1202477	=	IC50	nM	2000.0	CHEMBL3650	Homo sapiens	IC50	uM	2.0
	326804	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL416191	=	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	uM	1.5
	328167	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	C=CCc1c(O)ccc2c1ncn2-c1ccccc1		CHEMBL307817	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	328341	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL533849	=	IC50	nM	3600.0	CHEMBL3650	Homo sapiens	IC50	uM	3.6
	328372	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC[C@H]1CCCN(C)C1		CHEMBL1907944	=	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	329531	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CN(C)C(=S)Oc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL309270	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	330722	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	Sc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL419653	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	330725	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1cc2ncn(-c3ccccc3)c2cc1C=O		CHEMBL76962	=	IC50	nM	25000.0	CHEMBL3650	Homo sapiens	IC50	uM	25.0
	330762	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL78444	=	IC50	nM	35000.0	CHEMBL3650	Homo sapiens	IC50	uM	35.0
	330765	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	Oc1ccc2c(ncn2-c2ccccc2)c1Br		CHEMBL76839	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	330835	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCN(C)CC1.Cl		CHEMBL1744347	=	IC50	nM	2100.0	CHEMBL3650	Homo sapiens	IC50	uM	2.1
	332170	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCOCC1		CHEMBL25610	=	IC50	nM	19000.0	CHEMBL3650	Homo sapiens	IC50	uM	19.0
	333551	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3cc(OCCN4CCOCC4)ccc32)cc1		CHEMBL77242	=	IC50	nM	28000.0	CHEMBL3650	Homo sapiens	IC50	uM	28.0
	334839	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3ccccc32)cc1		CHEMBL310080	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	334916	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCC1CCNCC1		CHEMBL26641	=	IC50	nM	2700.0	CHEMBL3650	Homo sapiens	IC50	uM	2.7
	336026	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CC1Cc2c(ccc3c2ncn3-c2ccccc2)O1		CHEMBL75637	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	337356	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1c(O)ccc2c1ncn2-c1ccccc1		CHEMBL308385	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	337411	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCC1CCNCC1		CHEMBL279459	=	IC50	nM	1900.0	CHEMBL3650	Homo sapiens	IC50	uM	1.9
	338668	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3cc(O)c(C)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL1202473	=	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	uM	1.5
	338675	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCC1CCN(C)CC1		CHEMBL25425	=	IC50	nM	4100.0	CHEMBL3650	Homo sapiens	IC50	uM	4.1
	340067	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	NCCOc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL311777	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	uM	27.0
	340070	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	O=C(O)c1cc2c(cc1O)ncn2-c1ccccc1		CHEMBL77032	=	IC50	nM	22000.0	CHEMBL3650	Homo sapiens	IC50	uM	22.0
	340147	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COCCOc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL286160	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	uM	27.0
	340162	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3cc(O)c(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL2448066	=	IC50	nM	900.0	CHEMBL3650	Homo sapiens	IC50	uM	0.9
	342415	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1cc2ncn(-c3ccccc3)c2cc1C(=O)O		CHEMBL80171	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	342468	CHEMBL676971	Inhibition fibroblast growth factor receptor TK kinase activity at a concentration of 2 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC/C=C/CN1CCCC1.Cl		CHEMBL1202478	=	IC50	nM	2100.0	CHEMBL3650	Homo sapiens	IC50	uM	2.1
	343579	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	CSc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL80810	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	uM	27.0
	343582	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COc1cc2ncn(-c3ccccc3)c2cc1OC		CHEMBL79177	=	IC50	nM	25000.0	CHEMBL3650	Homo sapiens	IC50	uM	25.0
	345023	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	Oc1ccc2c(ncn2-c2ccccc2)c1O		CHEMBL77303	=	IC50	nM	1900.0	CHEMBL3650	Homo sapiens	IC50	uM	1.9
	345061	CHEMBL678503	Inhibition of [32P]ATP incorporated (phosphorylation) into glutamate-tyrosine copolymer substrate by human fibroblast growth factor receptor 1	B	COC(=O)c1cc2c(cc1OC)ncn2-c1ccccc1		CHEMBL311574	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	430433	CHEMBL676970	Inhibition of Fibroblast growth factor receptor in NIH 3T3 cells	B	COc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)cc1OC		CHEMBL327300	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
Not Determined	474201	CHEMBL678677	Inhibition of human fibroblast growth factor receptor 1 phosphorylation (Not tested)	B	CN(C)CCCN(C)c1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL60917		NT			CHEMBL3650	Homo sapiens	NT		
	474235	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CC(C)(C)NC(=O)Nc1nc2cc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL132358	=	IC50	nM	120.0	CHEMBL3650	Homo sapiens	IC50	uM	0.12
	475336	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	Cc1cccc(C)c1-c1cc2cnc(N)nc2nc1N		CHEMBL58628	=	IC50	nM	13000.0	CHEMBL3650	Homo sapiens	IC50	uM	13.0
	475339	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(/N=C(/S)Nc4ccccc4)nc3n2)CC1		CHEMBL417208	=	IC50	nM	320.0	CHEMBL3650	Homo sapiens	IC50	uM	0.32
	477652	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(NC(=O)C(F)(F)F)cc3nc2N)c1		CHEMBL134334	=	IC50	nM	61.0	CHEMBL3650	Homo sapiens	IC50	uM	0.061
	479014	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)Nc4ccc(Br)cc4)nc3n2)CC1		CHEMBL444829	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	479017	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CC/N=C(\N)Nc1nc2nc(NCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL58937	=	IC50	nM	2700.0	CHEMBL3650	Homo sapiens	IC50	uM	2.7
	480221	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Br)cccc1Br		CHEMBL300171	=	IC50	nM	290.0	CHEMBL3650	Homo sapiens	IC50	uM	0.29
	480224	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL299763	=	IC50	nM	48.0	CHEMBL3650	Homo sapiens	IC50	uM	0.048
	480227	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2nc(NCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL301273	=	IC50	nM	130.0	CHEMBL3650	Homo sapiens	IC50	uM	0.13
	480230	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	COc1ccc(NC(=O)Nc2nc3nc(NCCCN4CCN(C)CC4)ncc3cc2-c2c(Cl)cccc2Cl)cc1		CHEMBL298679	=	IC50	nM	74.0	CHEMBL3650	Homo sapiens	IC50	uM	0.074
Not Determined	480233	CHEMBL678677	Inhibition of human fibroblast growth factor receptor 1 phosphorylation (Not tested)	B	CCN(CC)CCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL291899		NT			CHEMBL3650	Homo sapiens	NT		
	480334	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(N)cc3nc2NC(=O)Nc2ccccc2)c1		CHEMBL134066	=	IC50	nM	510.0	CHEMBL3650	Homo sapiens	IC50	uM	0.51
	480337	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL422797	=	IC50	nM	150.0	CHEMBL3650	Homo sapiens	IC50	uM	0.15
	480340	CHEMBL678589	Inhibition of bFGF-mediated tyrosine phosphorylation	F	Cn1c(SSc2c(C(=O)Nc3ccccc3)c3ccccc3n2C)c(C(=O)Nc2ccccc2)c2ccccc21		CHEMBL304414	=	IC50	nM	4500.0	CHEMBL3650	Homo sapiens	IC50	uM	4.5
	481532	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(C)cccc3C)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL291777	=	IC50	nM	340.0	CHEMBL3650	Homo sapiens	IC50	uM	0.34
	481535	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2nc(NCCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL301483	=	IC50	nM	49.0	CHEMBL3650	Homo sapiens	IC50	uM	0.049
	481549	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NCCNC(=O)OC(C)(C)C)nc3n2)CC1		CHEMBL57451	=	IC50	nM	67.0	CHEMBL3650	Homo sapiens	IC50	uM	0.067
	481552	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)C(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL292701	=	IC50	nM	5500.0	CHEMBL3650	Homo sapiens	IC50	uM	5.5
	482706	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL57475	=	IC50	nM	1800.0	CHEMBL3650	Homo sapiens	IC50	uM	1.8
	482709	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN(C)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL294438	=	IC50	nM	75.0	CHEMBL3650	Homo sapiens	IC50	uM	0.075
	482747	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(NC(=O)NC(C)(C)C)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL135074	=	IC50	nM	160.0	CHEMBL3650	Homo sapiens	IC50	uM	0.16
	482754	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CC(C)(C)NC(=O)Nc1nc2cc(N)ncc2cc1-c1ccccc1		CHEMBL133436	=	IC50	nM	1900.0	CHEMBL3650	Homo sapiens	IC50	uM	1.9
	483970	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL56958	=	IC50	nM	8300.0	CHEMBL3650	Homo sapiens	IC50	uM	8.3
	483973	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(N)=O)nc3n2)CC1		CHEMBL264280	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	uM	0.14
	483976	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)Nc4ccc(Cl)cc4)nc3n2)CC1		CHEMBL58652	=	IC50	nM	120.0	CHEMBL3650	Homo sapiens	IC50	uM	0.12
	483979	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)Nc4cccc5ccccc45)nc3n2)CC1		CHEMBL443262	=	IC50	nM	300.0	CHEMBL3650	Homo sapiens	IC50	uM	0.3
Not Determined	483982	CHEMBL678677	Inhibition of human fibroblast growth factor receptor 1 phosphorylation (Not tested)	B	CN1CCN(CCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(N)nc3n2)CC1		CHEMBL294639		NT			CHEMBL3650	Homo sapiens	NT		
	484021	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CCNC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL432738	=	IC50	nM	130.0	CHEMBL3650	Homo sapiens	IC50	uM	0.13
	484024	CHEMBL678589	Inhibition of bFGF-mediated tyrosine phosphorylation	F	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	485152	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CC(C)(C)NC(=O)Nc1nc2nc(NCCCN3CCOCC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL432708	=	IC50	nM	72.0	CHEMBL3650	Homo sapiens	IC50	uM	0.072
	486243	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	Cc1cccc(C)c1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL57323	=	IC50	nM	400.0	CHEMBL3650	Homo sapiens	IC50	uM	0.4
	486246	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	Cc1cc(C)c(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL56236	=	IC50	nM	710.0	CHEMBL3650	Homo sapiens	IC50	uM	0.71
	487429	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)C)nc2n1		CHEMBL57022	=	IC50	nM	77.0	CHEMBL3650	Homo sapiens	IC50	uM	0.077
	487432	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(/N=C\N(C)C)nc2n1		CHEMBL57035	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	487465	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	Nc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL58627	=	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	487468	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	Nc1cc2nc(N)c(-c3c(Cl)cccc3Cl)cc2cn1		CHEMBL132089	=	IC50	nM	2800.0	CHEMBL3650	Homo sapiens	IC50	uM	2.8
	488616	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	IC50	nM	13000.0	CHEMBL3650	Homo sapiens	IC50	uM	13.0
	488619	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NCc4ccccc4)nc3n2)CC1		CHEMBL51485	=	IC50	nM	62.0	CHEMBL3650	Homo sapiens	IC50	uM	0.062
	488652	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL299763	=	IC50	nM	600.0	CHEMBL3650	Homo sapiens	IC50	uM	0.6
Not Determined	489798	CHEMBL678677	Inhibition of human fibroblast growth factor receptor 1 phosphorylation (Not tested)	B	CN(C)CC(C)(C)CNc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL300561		NT			CHEMBL3650	Homo sapiens	NT		
	489834	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(NC(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL135889	=	IC50	nM	25.0	CHEMBL3650	Homo sapiens	IC50	uM	0.025
	490966	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)Nc3ccccc3)nc2n1		CHEMBL56983	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	490979	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC(C)(C)C)nc3n2)CC1		CHEMBL431942	=	IC50	nM	35.0	CHEMBL3650	Homo sapiens	IC50	uM	0.035
	490982	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCCC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL300992	=	IC50	nM	3700.0	CHEMBL3650	Homo sapiens	IC50	uM	3.7
	490985	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NS(=O)(=O)c4ccccc4)nc3n2)CC1		CHEMBL368189	=	IC50	nM	68.0	CHEMBL3650	Homo sapiens	IC50	uM	0.068
	491032	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL422625	=	IC50	nM	29.0	CHEMBL3650	Homo sapiens	IC50	uM	0.029
	492166	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	uM	0.14
	492203	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	Nc1cc2nc(N)c(-c3ccccc3)cc2cn1		CHEMBL135061	=	IC50	nM	17000.0	CHEMBL3650	Homo sapiens	IC50	uM	17.0
	493388	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	Nc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL58627	=	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	493391	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2nc(NCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57761	=	IC50	nM	1300.0	CHEMBL3650	Homo sapiens	IC50	uM	1.3
	493394	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CC1CCCCN1CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL418284	=	IC50	nM	60.0	CHEMBL3650	Homo sapiens	IC50	uM	0.06
	493397	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	C=CCNC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL292146	=	IC50	nM	35.0	CHEMBL3650	Homo sapiens	IC50	uM	0.035
	493400	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC45C[C@H]6C[C@@H](C4)C[C@@H](C5)C6)nc3n2)CC1		CHEMBL57585	=	IC50	nM	120.0	CHEMBL3650	Homo sapiens	IC50	uM	0.12
Not Determined	493403	CHEMBL678677	Inhibition of human fibroblast growth factor receptor 1 phosphorylation (Not tested)	B	Nc1nc2nc(NCCCN3CCOCC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL301905		NT			CHEMBL3650	Homo sapiens	NT		
	494493	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	Cc1ccc(NC(=O)Nc2nc3nc(NCCCN4CCN(C)CC4)ncc3cc2-c2c(Cl)cccc2Cl)cc1		CHEMBL293322	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	495602	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCCCCCCCNC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL416501	=	IC50	nM	420.0	CHEMBL3650	Homo sapiens	IC50	uM	0.42
	495639	CHEMBL678589	Inhibition of bFGF-mediated tyrosine phosphorylation	F	COC(=O)C1=C(c2ccccc2)c2ccccc2C1=O		CHEMBL317768	=	IC50	nM	5100.0	CHEMBL3650	Homo sapiens	IC50	uM	5.1
	496687	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL300784	=	IC50	nM	2400.0	CHEMBL3650	Homo sapiens	IC50	uM	2.4
	496690	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(/N=C(\S)NCCCN3CCOCC3)nc2n1		CHEMBL56184	=	IC50	nM	130.0	CHEMBL3650	Homo sapiens	IC50	uM	0.13
	497834	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL299026	=	IC50	nM	82.0	CHEMBL3650	Homo sapiens	IC50	uM	0.082
	497837	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CC(C)/N=C(/Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl)NC(C)C		CHEMBL299270	=	IC50	nM	2500.0	CHEMBL3650	Homo sapiens	IC50	uM	2.5
	497868	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(N)cc3nc2N)c1		CHEMBL133604	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	uM	0.2
	499028	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC4CCCCC4)nc3n2)CC1		CHEMBL51028	=	IC50	nM	29.0	CHEMBL3650	Homo sapiens	IC50	uM	0.029
	499031	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)Nc4ccc(C(F)(F)F)cc4)nc3n2)CC1		CHEMBL294711	=	IC50	nM	610.0	CHEMBL3650	Homo sapiens	IC50	uM	0.61
	499034	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	COc1ccccc1NC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL301641	=	IC50	nM	67.0	CHEMBL3650	Homo sapiens	IC50	uM	0.067
Not Determined	499037	CHEMBL678677	Inhibition of human fibroblast growth factor receptor 1 phosphorylation (Not tested)	B	CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL61089		NT			CHEMBL3650	Homo sapiens	NT		
	499098	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CNC(=O)Nc1nc2cc(N)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL134801	=	IC50	nM	95.0	CHEMBL3650	Homo sapiens	IC50	uM	0.095
	499101	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL339856	=	IC50	nM	31.0	CHEMBL3650	Homo sapiens	IC50	uM	0.031
	499108	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	130.0	CHEMBL3650	Homo sapiens	IC50	uM	0.13
	500324	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN(C)CCCN(C)c1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL56380	=	IC50	nM	2000.0	CHEMBL3650	Homo sapiens	IC50	uM	2.0
	500327	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC(C)(C)C)nc3n2)CC1		CHEMBL57347	=	IC50	nM	51.0	CHEMBL3650	Homo sapiens	IC50	uM	0.051
	500341	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)Nc4ccccc4)nc3n2)CC1		CHEMBL418111	=	IC50	nM	84.0	CHEMBL3650	Homo sapiens	IC50	uM	0.084
	500349	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(/N=C(/N)Nc4ccccc4)nc3n2)CC1		CHEMBL300335	=	IC50	nM	2800.0	CHEMBL3650	Homo sapiens	IC50	uM	2.8
	501607	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC3CCCCC3)nc2n1		CHEMBL293132	=	IC50	nM	43.0	CHEMBL3650	Homo sapiens	IC50	uM	0.043
	502771	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	Cc1cc(C)c(C)c(-c2cc3cnc(N)nc3nc2N)c1C		CHEMBL293592	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	502774	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL45827	=	IC50	nM	48.0	CHEMBL3650	Homo sapiens	IC50	uM	0.048
Not Determined	502787	CHEMBL678677	Inhibition of human fibroblast growth factor receptor 1 phosphorylation (Not tested)	B	CN(C)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL57130		NT			CHEMBL3650	Homo sapiens	NT		
Not Determined	502790	CHEMBL678677	Inhibition of human fibroblast growth factor receptor 1 phosphorylation (Not tested)	B	CC1CNCCN1CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(N)nc2n1		CHEMBL60865		NT			CHEMBL3650	Homo sapiens	NT		
	504084	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)Nc4ccc(Cl)c(Cl)c4)nc3n2)CC1		CHEMBL299687	=	IC50	nM	600.0	CHEMBL3650	Homo sapiens	IC50	uM	0.6
	504087	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)Cc4ccccc4)nc3n2)CC1		CHEMBL58936	=	IC50	nM	6800.0	CHEMBL3650	Homo sapiens	IC50	uM	6.8
	505266	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(C)cccc3C)c(N)nc2n1		CHEMBL57229	=	IC50	nM	18000.0	CHEMBL3650	Homo sapiens	IC50	uM	18.0
	505269	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL61257	=	IC50	nM	53.0	CHEMBL3650	Homo sapiens	IC50	uM	0.053
	505276	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)CC(C)(C)C)nc2n1		CHEMBL417950	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	uM	27.0
	505341	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(N)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL134354	=	IC50	nM	42.0	CHEMBL3650	Homo sapiens	IC50	uM	0.042
	505349	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2N)c1		CHEMBL56942	=	IC50	nM	230.0	CHEMBL3650	Homo sapiens	IC50	uM	0.23
	505352	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1ccccc1		CHEMBL135267	=	IC50	nM	1300.0	CHEMBL3650	Homo sapiens	IC50	uM	1.3
	506458	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2N)c1		CHEMBL56942	=	IC50	nM	230.0	CHEMBL3650	Homo sapiens	IC50	uM	0.23
	506461	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	COc1cccc(NC(=O)Nc2nc3nc(NCCCN4CCN(C)CC4)ncc3cc2-c2c(Cl)cccc2Cl)c1		CHEMBL60979	=	IC50	nM	63.0	CHEMBL3650	Homo sapiens	IC50	uM	0.063
	507774	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1ncc2cc(-c3c(Br)cccc3Br)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL57803	=	IC50	nM	190.0	CHEMBL3650	Homo sapiens	IC50	uM	0.19
	510181	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN(C)CCNC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL417961	=	IC50	nM	75.0	CHEMBL3650	Homo sapiens	IC50	uM	0.075
	510184	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CC/N=C(\S)Nc1nc2nc(NCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL60690	=	IC50	nM	260.0	CHEMBL3650	Homo sapiens	IC50	uM	0.26
	510187	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)CC(C)(C)C)nc3n2)CC1		CHEMBL60635	=	IC50	nM	8000.0	CHEMBL3650	Homo sapiens	IC50	uM	8.0
	510256	CHEMBL678504	Inhibition of the phosphorylation of a random glutamate-tyrosine (4:1) copolymer by isolated Fibroblast growth factor receptor 1.	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1ccccc1		CHEMBL76599	=	IC50	nM	3700.0	CHEMBL3650	Homo sapiens	IC50	uM	3.7
	511338	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN(C)CC(C)(C)CNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL58684	=	IC50	nM	210.0	CHEMBL3650	Homo sapiens	IC50	uM	0.21
	511341	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(N)nc3n2)CC1		CHEMBL298620	=	IC50	nM	450.0	CHEMBL3650	Homo sapiens	IC50	uM	0.45
	511344	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CC(C)NC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57207	=	IC50	nM	34.0	CHEMBL3650	Homo sapiens	IC50	uM	0.034
	511347	CHEMBL678501	Ability to prevent phosphorylation of human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(/N=C(/S)NC(C)(C)C)nc3n2)CC1		CHEMBL57947	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	uM	0.1
	512672	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(C(=O)O)cc21		CHEMBL435227	=	IC50	nM	770.0	CHEMBL3650	Homo sapiens	IC50	uM	0.77
	512676	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(C(=O)O)cc21		CHEMBL435227	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	512707	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1c[nH]c(/C=C2\C(=O)Nc3cccc(C)c32)c1CCC(=O)O		CHEMBL147761	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	512711	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1c[nH]c(/C=C2\C(=O)Nc3cccc(C)c32)c1CCC(=O)O		CHEMBL147761	=	IC50	nM	250.0	CHEMBL3650	Homo sapiens	IC50	uM	0.25
	514074	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1		CHEMBL450622	=	IC50	nM	1200.0	CHEMBL3650	Homo sapiens	IC50	uM	1.2
	514078	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1		CHEMBL450622	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	uM	0.14
	514082	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	3040.0	CHEMBL3650	Homo sapiens	IC50	uM	3.04
	514086	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	9300.0	CHEMBL3650	Homo sapiens	IC50	uM	9.3
	520421	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c(C)c1CCC(=O)O		CHEMBL357803	=	IC50	nM	2050.0	CHEMBL3650	Homo sapiens	IC50	uM	2.05
	520425	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c(C)c1CCC(=O)O		CHEMBL357803	=	IC50	nM	3600.0	CHEMBL3650	Homo sapiens	IC50	uM	3.6
	523089	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(S(N)(=O)=O)cc21		CHEMBL146697	=	IC50	nM	460.0	CHEMBL3650	Homo sapiens	IC50	uM	0.46
	523093	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(S(N)(=O)=O)cc21		CHEMBL146697	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	523097	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C		CHEMBL146694	=	IC50	nM	7330.0	CHEMBL3650	Homo sapiens	IC50	uM	7.33
	523101	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C		CHEMBL146694	=	IC50	nM	4000.0	CHEMBL3650	Homo sapiens	IC50	uM	4.0
	524402	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)c1		CHEMBL148514	=	IC50	nM	360.0	CHEMBL3650	Homo sapiens	IC50	uM	0.36
	524406	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)c1		CHEMBL148514	=	IC50	nM	130.0	CHEMBL3650	Homo sapiens	IC50	uM	0.13
	526966	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	7080.0	CHEMBL3650	Homo sapiens	IC50	uM	7.08
	526970	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	529802	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	CCOc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1		CHEMBL443296	=	IC50	nM	4500.0	CHEMBL3650	Homo sapiens	IC50	uM	4.5
	529806	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	CCOc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C)c2CCC(=O)O)c1		CHEMBL443296	=	IC50	nM	270.0	CHEMBL3650	Homo sapiens	IC50	uM	0.27
	529810	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C		CHEMBL149243	=	IC50	nM	3890.0	CHEMBL3650	Homo sapiens	IC50	uM	3.89
	529814	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C		CHEMBL149243	=	IC50	nM	31600.0	CHEMBL3650	Homo sapiens	IC50	uM	31.6
	531100	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)c(C)c1CCC(=O)O		CHEMBL149073	=	IC50	nM	280.0	CHEMBL3650	Homo sapiens	IC50	uM	0.28
	531104	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)c(C)c1CCC(=O)O		CHEMBL149073	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	533734	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)cc1		CHEMBL148984	=	IC50	nM	1540.0	CHEMBL3650	Homo sapiens	IC50	uM	1.54
	533738	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(CCC(=O)O)c2C)cc1		CHEMBL148984	=	IC50	nM	1600.0	CHEMBL3650	Homo sapiens	IC50	uM	1.6
	536422	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2cc(-c3ccccc3)ccc21		CHEMBL347074	=	IC50	nM	1050.0	CHEMBL3650	Homo sapiens	IC50	uM	1.05
	536426	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2cc(-c3ccccc3)ccc21		CHEMBL347074	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	uM	1.0
	537815	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	537819	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	2800.0	CHEMBL3650	Homo sapiens	IC50	uM	2.8
	537823	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccccc21		CHEMBL344319	=	IC50	nM	3680.0	CHEMBL3650	Homo sapiens	IC50	uM	3.68
	537827	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccccc21		CHEMBL344319	=	IC50	nM	10100.0	CHEMBL3650	Homo sapiens	IC50	uM	10.1
	541592	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C		CHEMBL356245	=	IC50	nM	5400.0	CHEMBL3650	Homo sapiens	IC50	uM	5.4
	541596	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)c(CCC(=O)O)c1C		CHEMBL356245	=	IC50	nM	25100.0	CHEMBL3650	Homo sapiens	IC50	uM	25.1
	543020	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)cc1		CHEMBL150151	=	IC50	nM	5760.0	CHEMBL3650	Homo sapiens	IC50	uM	5.76
	543024	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1ccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)cc1		CHEMBL150151	=	IC50	nM	5640.0	CHEMBL3650	Homo sapiens	IC50	uM	5.64
	544198	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL358728	=	IC50	nM	1400.0	CHEMBL3650	Homo sapiens	IC50	uM	1.4
	544202	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL358728	=	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	uM	1.5
	546998	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O		CHEMBL149201	=	IC50	nM	2290.0	CHEMBL3650	Homo sapiens	IC50	uM	2.29
	547002	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O		CHEMBL149201	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	548225	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c1CCC(=O)O		CHEMBL148744	=	IC50	nM	80.0	CHEMBL3650	Homo sapiens	IC50	uM	0.08
	548229	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1c[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c1CCC(=O)O		CHEMBL148744	=	IC50	nM	490.0	CHEMBL3650	Homo sapiens	IC50	uM	0.49
	548233	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c(C)c1CCC(=O)O		CHEMBL150177	=	IC50	nM	280.0	CHEMBL3650	Homo sapiens	IC50	uM	0.28
	548237	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c(C)c1CCC(=O)O		CHEMBL150177	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	550329	CHEMBL678671	Inhibitory activity against Fibroblast growth factor receptor 1	B	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C		CHEMBL147112	=	IC50	nM	2130.0	CHEMBL3650	Homo sapiens	IC50	uM	2.13
	550333	CHEMBL696130	Inhibitory activity of compound against FGF induced cell proliferation	F	COc1ccccc1-c1ccc2c(c1)NC(=O)/C2=C\c1[nH]cc(CCC(=O)O)c1C		CHEMBL147112	=	IC50	nM	40.0	CHEMBL3650	Homo sapiens	IC50	uM	0.04
	572162	CHEMBL772801	Inhibition of Protein kinase fibroblast growth factor receptor 1 at 10 uM	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Inhibition	%	32.0	CHEMBL3650	Homo sapiens	Inhibition	%	32.0
	714092	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL293712	=	IC50	nM	1200.0	CHEMBL3650	Homo sapiens	IC50	uM	1.2
	714100	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CCOC(=O)CN1CCN(CCCc2c(/C=C3\C(=O)Nc4ccc(S(=O)(=O)NC)cc43)[nH]c3c2CCCC3)CC1		CHEMBL291759	=	IC50	nM	80.0	CHEMBL3650	Homo sapiens	IC50	uM	0.08
	714962	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	716119	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCc1ccncc1		CHEMBL268731	=	IC50	nM	3100.0	CHEMBL3650	Homo sapiens	IC50	uM	3.1
	716442	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2		CHEMBL56109	=	IC50	nM	600.0	CHEMBL3650	Homo sapiens	IC50	uM	0.6
	717800	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2		CHEMBL56569	=	IC50	nM	70.0	CHEMBL3650	Homo sapiens	IC50	uM	0.07
	719758	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCCN1CCN(C)CC1		CHEMBL430155	=	IC50	nM	4200.0	CHEMBL3650	Homo sapiens	IC50	uM	4.2
	719768	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCOCC1		CHEMBL13354	=	IC50	nM	2600.0	CHEMBL3650	Homo sapiens	IC50	uM	2.6
	721880	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	IC50	nM	170.0	CHEMBL3650	Homo sapiens	IC50	uM	0.17
	722193	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL59042	=	IC50	nM	400.0	CHEMBL3650	Homo sapiens	IC50	uM	0.4
	723024	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	724251	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCn1cncn1		CHEMBL267293	=	IC50	nM	17100.0	CHEMBL3650	Homo sapiens	IC50	uM	17.1
	724590	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2		CHEMBL292930	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	uM	0.2
	726660	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c1C		CHEMBL13629	=	IC50	nM	730.0	CHEMBL3650	Homo sapiens	IC50	uM	0.73
	726670	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN1CCCC1		CHEMBL13608	=	IC50	nM	3900.0	CHEMBL3650	Homo sapiens	IC50	uM	3.9
	727035	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2		CHEMBL55496	=	IC50	nM	3400.0	CHEMBL3650	Homo sapiens	IC50	uM	3.4
	732859	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCOCC1)CCCC3)C(=O)N2		CHEMBL296185	=	IC50	nM	1700.0	CHEMBL3650	Homo sapiens	IC50	uM	1.7
	735352	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CC(=O)O)CC1)CCCC3)C(=O)N2		CHEMBL300853	=	IC50	nM	400.0	CHEMBL3650	Homo sapiens	IC50	uM	0.4
	735360	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(CCO)CC1)CCCC3)C(=O)N2		CHEMBL57143	=	IC50	nM	1100.0	CHEMBL3650	Homo sapiens	IC50	uM	1.1
	738132	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN(C)C)CCCC3)C(=O)N2		CHEMBL52513	=	IC50	nM	700.0	CHEMBL3650	Homo sapiens	IC50	uM	0.7
Not Determined	739284	CHEMBL678682	Inhibition of Fibroblast growth factor receptor 1 (Not tested)	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCN(C)CC1)CCCC3)C(=O)N2		CHEMBL54283		IC50	nM		CHEMBL3650	Homo sapiens	IC50	uM	
	740165	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCC1CCN(C)CC1		CHEMBL13983	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	uM	0.2
	741554	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NCCN(C)C		CHEMBL13976	=	IC50	nM	1600.0	CHEMBL3650	Homo sapiens	IC50	uM	1.6
	744625	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2		CHEMBL301143	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	uM	0.2
	745575	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL275117	=	IC50	nM	880.0	CHEMBL3650	Homo sapiens	IC50	uM	0.88
	745973	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCCN1CCC(O)CC1)CCCC3)C(=O)N2		CHEMBL298566	=	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	uM	0.5
	749669	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CN1CCOCC1)CCCC3)C(=O)N2		CHEMBL55594	=	IC50	nM	400.0	CHEMBL3650	Homo sapiens	IC50	uM	0.4
	750640	CHEMBL678683	Inhibition of Fibroblast growth factor receptor 1	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	751794	CHEMBL678687	Inhibition of Fibroblast growth factor receptor 1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	2900.0	CHEMBL3650	Homo sapiens	IC50	uM	2.9
	752113	CHEMBL678681	Inhibitory activity against Fibroblast growth factor receptor 1	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(N)=O)CCCC3)C(=O)N2		CHEMBL301271	=	IC50	nM	80.0	CHEMBL3650	Homo sapiens	IC50	uM	0.08
	789660	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(Cn2cnc3ccccc32)cc1		CHEMBL347547	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	789662	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Oc1cccc2c1ncn2-c1ccccc1		CHEMBL75964	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	791132	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=[N+]([O-])c1ccc(-n2cnc3ccccc32)cc1		CHEMBL345970	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	791134	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Cc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL152934	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	792469	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=[N+]([O-])c1cccc(-n2cnc3ccccc32)c1		CHEMBL435677	=	IC50	nM	35000.0	CHEMBL3650	Homo sapiens	IC50	uM	35.0
	792471	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	NC(=O)c1ccc(-n2cnc3ccccc32)cc1		CHEMBL345730	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	792473	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	CC(=O)c1ccc(-n2cnc3ccccc32)cc1		CHEMBL153682	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	792475	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL76202	=	IC50	nM	22000.0	CHEMBL3650	Homo sapiens	IC50	uM	22.0
	792478	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=C(O)c1cccc2ncn(-c3ccccc3)c12		CHEMBL347553	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	792480	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=[N+]([O-])c1cccc2ncn(-c3ccccc3)c12		CHEMBL150816	=	IC50	nM	40000.0	CHEMBL3650	Homo sapiens	IC50	uM	40.0
	793535	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	N#Cc1cccc(-n2cnc3ccccc32)c1		CHEMBL356027	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	793537	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	NC(=O)c1ccc2c(c1)ncn2-c1ccccc1		CHEMBL358446	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	795749	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(-n2nnc3ccccc32)cc1		CHEMBL153275	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	795751	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	N#Cc1ccccc1-n1cnc2ccccc21		CHEMBL359358	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	795753	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3ccccc32)nc1		CHEMBL155161	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	795755	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=C(O)c1cccc(-n2cnc3ccccc32)c1		CHEMBL150575	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	795757	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COC(=O)c1cccc2c1ncn2-c1ccccc1		CHEMBL154978	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	796904	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COC(=O)c1ccc(-n2cnc3ccccc32)cc1		CHEMBL434312	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	796906	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=[N+]([O-])c1cccc2c1ncn2-c1ccccc1		CHEMBL150579	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	798033	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=Cc1ccc(-n2cnc3ccccc32)cc1		CHEMBL153512	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	799298	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Nc1ccccc1-n1cnc2ccccc21		CHEMBL153365	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	799300	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=C(O)c1ccc(-n2cnc3ccccc32)cc1		CHEMBL345546	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	799302	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=C(O)c1ccc2ncn(-c3ccccc3)c2c1		CHEMBL149401	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	799304	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Nc1ccc2ncn(-c3ccccc3)c2c1		CHEMBL152995	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	799306	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Oc1cccc2ncn(-c3ccccc3)c12		CHEMBL357347	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	799329	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=Cc1cccc(-n2cnc3ccccc32)c1		CHEMBL151956	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	800426	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(-c2nc3ccccc3[nH]2)cc1		CHEMBL153535	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	800428	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Cc1ccccc1-n1cnc2ccccc21		CHEMBL153145	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	800430	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1cccc2ncn(-c3ccccc3)c12		CHEMBL153526	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	801663	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	CC(=O)c1cccc(-n2cnc3ccccc32)c1		CHEMBL155093	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	801665	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc2c(c1)ncn2-c1ccncc1		CHEMBL358429	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	801667	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COC(=O)c1ccc2ncn(-c3ccccc3)c2c1		CHEMBL359055	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	801705	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3ccccc32)cc1		CHEMBL310080	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	802872	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Clc1cccc2c1ncn2-c1ccccc1		CHEMBL348189	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	804130	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1ccccc1-n1cnc2ccccc21		CHEMBL345775	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	804132	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Oc1ccccc1-n1cnc2ccccc21		CHEMBL358240	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	804176	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(C2=Nc3ccccc3NCC2)cc1		CHEMBL358447	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	805442	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Clc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL436455	=	IC50	nM	51000.0	CHEMBL3650	Homo sapiens	IC50	uM	51.0
	805444	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COC(=O)c1ccc2c(c1)ncn2-c1ccccc1		CHEMBL153054	=	IC50	nM	6600.0	CHEMBL3650	Homo sapiens	IC50	uM	6.6
	805447	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=Cc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL358384	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	805485	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=Cc1ccccc1-n1cnc2ccccc21		CHEMBL150790	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	806762	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Nc1cccc(-n2cnc3ccccc32)c1		CHEMBL155505	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	806764	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Oc1ccc(-n2cnc3ccccc32)cc1		CHEMBL348242	=	IC50	nM	5800.0	CHEMBL3650	Homo sapiens	IC50	uM	5.8
	808162	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Oc1cccc(-n2cnc3ccccc32)c1		CHEMBL348706	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	808164	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Cc1cccc2ncn(-c3ccccc3)c12		CHEMBL153527	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	808166	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Nc1cccc2ncn(-c3ccccc3)c12		CHEMBL357368	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	809493	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	NC(=O)c1ccccc1-n1cnc2ccccc21		CHEMBL153812	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	810641	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(-n2ncc3ccccc32)cc1		CHEMBL151537	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	810643	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1ccc(-n2cnc3ccccc32)cc1		CHEMBL153101	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	810645	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=C(O)c1cccc2c1ncn2-c1ccccc1		CHEMBL150765	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	810647	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Nc1cccc2c1ncn2-c1ccccc1		CHEMBL405050	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	810649	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Oc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL80873	=	IC50	nM	6400.0	CHEMBL3650	Homo sapiens	IC50	uM	6.4
	810652	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Nc1ccc2c(c1)ncn2-c1ccccc1		CHEMBL150973	=	IC50	nM	36000.0	CHEMBL3650	Homo sapiens	IC50	uM	36.0
	811815	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=C(c1ccccc1)n1cnc2ccccc21		CHEMBL153600	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	811817	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	CCOC(=O)c1cccc(-n2cnc3ccccc32)c1		CHEMBL358241	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	811819	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Cc1cccc2c1ncn2-c1ccccc1		CHEMBL149635	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	811821	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	CC(=O)c1ccc2c(c1)ncn2-c1ccccc1		CHEMBL150568	=	IC50	nM	14000.0	CHEMBL3650	Homo sapiens	IC50	uM	14.0
	811823	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1ccc2c(c1)ncn2-c1ccsc1		CHEMBL358469	=	IC50	nM	6500.0	CHEMBL3650	Homo sapiens	IC50	uM	6.5
	813159	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Cc1cccc(-n2cnc3ccccc32)c1		CHEMBL346000	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	813161	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Cc1ccc(-n2cnc3ccccc32)cc1		CHEMBL347769	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	815549	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	NC(=O)c1cccc(-n2cnc3ccccc32)c1		CHEMBL358881	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	815551	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Clc1ccc(-n2cnc3ccccc32)cc1		CHEMBL153624	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	815553	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Cc1ccc2ncn(-c3ccccc3)c2c1		CHEMBL347777	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	815555	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Oc1ccc2ncn(-c3ccccc3)c2c1		CHEMBL153106	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	815584	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(-n2ccc3ccccc32)cc1		CHEMBL149746	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	816863	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Clc1ccccc1-n1cnc2ccccc21		CHEMBL153417	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	816865	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Clc1ccc2ncn(-c3ccccc3)c2c1		CHEMBL153328	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	817973	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	CCOC(=O)c1ccccc1-n1cnc2ccccc21		CHEMBL436465	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	817975	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	N#Cc1ccc(-n2cnc3ccccc32)cc1		CHEMBL356237	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	817977	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Nc1nc2ccccc2n1-c1ccccc1		CHEMBL356228	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	817979	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	NC(=O)c1cccc2c1ncn2-c1ccccc1		CHEMBL149573	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	819189	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	CC(=O)c1ccccc1-n1cnc2ccccc21		CHEMBL153477	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	819191	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1cccc(-n2cnc3ccccc32)c1		CHEMBL346611	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	819193	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1cncc(-n2cnc3ccccc32)c1		CHEMBL153571	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	819195	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1ccc2c(c1)ncn2-c1cccs1		CHEMBL153084	=	IC50	nM	5300.0	CHEMBL3650	Homo sapiens	IC50	uM	5.3
	820313	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Cc1nc2ccccc2n1-c1ccccc1		CHEMBL150809	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	820315	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=C(O)c1ccc2c(c1)ncn2-c1ccccc1		CHEMBL150504	=	IC50	nM	28000.0	CHEMBL3650	Homo sapiens	IC50	uM	28.0
	820317	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Clc1cccc2ncn(-c3ccccc3)c12		CHEMBL150899	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	820319	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	NC(=O)c1cccc2ncn(-c3ccccc3)c12		CHEMBL150934	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	821368	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Clc1cccc(-n2cnc3ccccc32)c1		CHEMBL150573	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	822457	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=C(O)c1ccccc1-n1cnc2ccccc21		CHEMBL152521	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	822459	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1cccc2c1ncn2-c1ccccc1		CHEMBL149458	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	823687	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Nc1ccc(-n2cnc3ccccc32)cc1		CHEMBL346870	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	823690	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=[N+]([O-])c1ccc2ncn(-c3ccccc3)c2c1		CHEMBL358243	=	IC50	nM	39000.0	CHEMBL3650	Homo sapiens	IC50	uM	39.0
	824992	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	Oc1nc2ccccc2n1-c1ccccc1		CHEMBL150912	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	826250	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=[N+]([O-])c1ccc2c(c1)ncn2-c1ccccc1		CHEMBL153208	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	826252	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3cnccc32)cc1		CHEMBL450929	=	IC50	nM	49000.0	CHEMBL3650	Homo sapiens	IC50	uM	49.0
	827409	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	O=[N+]([O-])c1ccccc1-n1cnc2ccccc21		CHEMBL355950	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	827411	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COc1ccc2ncn(-c3ccccc3)c2c1		CHEMBL356169	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	827414	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	NC(=O)c1ccc2ncn(-c3ccccc3)c2c1		CHEMBL356679	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	827416	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	COC(=O)c1cccc2ncn(-c3ccccc3)c12		CHEMBL154750	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	827418	CHEMBL678502	Inhibition of phosphorylation of a random glutamate/tyrosine copolymer in lysates of transfected Sf9 insect cells overexpressing human fibroblast growth factor receptor 1	B	c1ccc(-n2cnc3cccnc32)cc1		CHEMBL153110	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	828005	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CN(C)c1cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc(N(C)C)c1		CHEMBL50371	=	IC50	nM	16000.0	CHEMBL3650	Homo sapiens	IC50	uM	16.0
	829172	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	Cc1ccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc1		CHEMBL309470	=	IC50	nM	1670.0	CHEMBL3650	Homo sapiens	IC50	uM	1.67
	831446	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	COc1ccccc1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL79241	=	IC50	nM	11220.0	CHEMBL3650	Homo sapiens	IC50	uM	11.22
	832548	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	Cc1cc(C)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL81474	=	IC50	nM	1130.0	CHEMBL3650	Homo sapiens	IC50	uM	1.13
	838571	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CCOc1cc(OCC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL48809	=	IC50	nM	1650.0	CHEMBL3650	Homo sapiens	IC50	uM	1.65
	838580	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	uM	0.14
	838582	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	Cc1ccccc1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL78393	=	IC50	nM	1400.0	CHEMBL3650	Homo sapiens	IC50	uM	1.4
	839710	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	COc1ccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc1		CHEMBL312055	=	IC50	nM	3970.0	CHEMBL3650	Homo sapiens	IC50	uM	3.97
	843419	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	COc1ccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)cc1OC		CHEMBL78802	=	IC50	nM	20250.0	CHEMBL3650	Homo sapiens	IC50	uM	20.25
	843422	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	Cc1cc(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c(C)c1		CHEMBL81615	=	IC50	nM	270.0	CHEMBL3650	Homo sapiens	IC50	uM	0.27
	844713	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Br		CHEMBL312454	=	IC50	nM	180.0	CHEMBL3650	Homo sapiens	IC50	uM	0.18
	844716	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CCN(CC)CCOc1ccc(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL312148	=	IC50	nM	890.0	CHEMBL3650	Homo sapiens	IC50	uM	0.89
	845961	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CCOc1cccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL78485	=	IC50	nM	670.0	CHEMBL3650	Homo sapiens	IC50	uM	0.67
	847078	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	Cc1cccc(C)c1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL57323	=	IC50	nM	400.0	CHEMBL3650	Homo sapiens	IC50	uM	0.4
	848301	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	COc1cccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL81146	=	IC50	nM	360.0	CHEMBL3650	Homo sapiens	IC50	uM	0.36
	848310	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	Cc1cc(C)c(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL56236	=	IC50	nM	710.0	CHEMBL3650	Homo sapiens	IC50	uM	0.71
	850616	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL49658	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	850619	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	Cc1c(C)c(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c(C)c1C		CHEMBL78555	=	IC50	nM	1620.0	CHEMBL3650	Homo sapiens	IC50	uM	1.62
	851671	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1cccc(Cl)c1Cl		CHEMBL79274	=	IC50	nM	160.0	CHEMBL3650	Homo sapiens	IC50	uM	0.16
	856136	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL299763	=	IC50	nM	60.0	CHEMBL3650	Homo sapiens	IC50	uM	0.06
	857164	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)ccc(Cl)c1Cl		CHEMBL312048	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	857167	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Br)cccc1Br		CHEMBL300171	=	IC50	nM	290.0	CHEMBL3650	Homo sapiens	IC50	uM	0.29
	859658	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1cc(F)cc(F)c1		CHEMBL81975	=	IC50	nM	1100.0	CHEMBL3650	Homo sapiens	IC50	uM	1.1
	859661	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CCc1ccccc1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C		CHEMBL421145	=	IC50	nM	11220.0	CHEMBL3650	Homo sapiens	IC50	uM	11.22
	863055	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CCc1cc(CC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL445893	=	IC50	nM	7760.0	CHEMBL3650	Homo sapiens	IC50	uM	7.76
	863058	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(F)cccc1F		CHEMBL77781	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	863061	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	Cc1cccc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C		CHEMBL82431	=	IC50	nM	340.0	CHEMBL3650	Homo sapiens	IC50	uM	0.34
	864310	CHEMBL676884	Inhibition of the fibroblast growth factor receptor (FGFR1)	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1ccccc1		CHEMBL76599	=	IC50	nM	8000.0	CHEMBL3650	Homo sapiens	IC50	uM	8.0
	1006306	CHEMBL678673	Inhibition of fibroblast growth factor receptor 1	B	O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O		CHEMBL141247	=	IC50	nM	6700.0	CHEMBL3650	Homo sapiens	IC50	uM	6.7
	1038867	CHEMBL678674	Inhibition of Fibroblast growth factor receptor 1	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3		CHEMBL150894	=	IC50	nM	162.0	CHEMBL3650	Homo sapiens	IC50	nM	162.0
	1104969	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1cc2nccc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150817	=	IC50	nM	9300.0	CHEMBL3650	Homo sapiens	IC50	uM	9.3
	1107489	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	IC50	nM	11000.0	CHEMBL3650	Homo sapiens	IC50	uM	11.0
	1110887	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCc1ccncc1		CHEMBL345943	>	IC50	nM	33000.0	CHEMBL3650	Homo sapiens	IC50	uM	33.0
	1110906	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN(C)c1ccncc1		CHEMBL25579	=	IC50	nM	1600.0	CHEMBL3650	Homo sapiens	IC50	uM	1.6
	1111974	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL286160	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	uM	27.0
	1113208	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	7000.0	CHEMBL3650	Homo sapiens	IC50	uM	7.0
	1116826	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OCCOC		CHEMBL148869	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1118075	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2ncnc(Nc3ccccc3F)c2cc1OC		CHEMBL150581	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1119360	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCC(=O)Nc1cc2ncnc(Nc3cc(O)c(C)cc3F)c2cc1OC		CHEMBL151015	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1121549	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1cc2ncnc(Nc3cc(O)c(Cl)cc3F)c2cc1OC		CHEMBL347086	=	IC50	nM	7400.0	CHEMBL3650	Homo sapiens	IC50	uM	7.4
	1121621	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCC(=O)Nc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL151948	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1121624	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL281872	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1121633	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2ncnc(Nc3ccc(F)cc3F)c2cc1OC		CHEMBL346200	=	IC50	nM	58000.0	CHEMBL3650	Homo sapiens	IC50	uM	58.0
	1122750	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1ccc2c(Nc3ccc(Cl)cc3F)ncnc2c1		CHEMBL150657	=	IC50	nM	16000.0	CHEMBL3650	Homo sapiens	IC50	uM	16.0
	1122783	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL150187	=	IC50	nM	6100.0	CHEMBL3650	Homo sapiens	IC50	uM	6.1
	1123979	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC1CCN(C)CC1		CHEMBL26050	=	IC50	nM	40000.0	CHEMBL3650	Homo sapiens	IC50	uM	40.0
	1125130	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCOCCN1CCOCC1		CHEMBL356658	=	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	1125185	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL421961	=	IC50	nM	7000.0	CHEMBL3650	Homo sapiens	IC50	uM	7.0
	1127639	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1cc2nccc(Nc3cc(O)c(Cl)cc3F)c2cc1OC		CHEMBL433936	=	IC50	nM	1400.0	CHEMBL3650	Homo sapiens	IC50	uM	1.4
	1127644	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1cc2nncc(Nc3cc(O)c(Cl)cc3F)c2cc1OC		CHEMBL150826	>	IC50	nM	33000.0	CHEMBL3650	Homo sapiens	IC50	uM	33.0
	1127649	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCn1ccnc1		CHEMBL147192	=	IC50	nM	2600.0	CHEMBL3650	Homo sapiens	IC50	uM	2.6
	1130033	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COCCOc1cc2nncc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150825	=	IC50	nM	14000.0	CHEMBL3650	Homo sapiens	IC50	uM	14.0
	1135052	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2ncnc(Nc3ccc(Cl)cc3)c2cc1OC		CHEMBL147138	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1135081	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCOCC1		CHEMBL25610	=	IC50	nM	19000.0	CHEMBL3650	Homo sapiens	IC50	uM	19.0
	1135086	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL357815	=	IC50	nM	1800.0	CHEMBL3650	Homo sapiens	IC50	uM	1.8
	1135096	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(C#N)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL358672	=	IC50	nM	45000.0	CHEMBL3650	Homo sapiens	IC50	uM	45.0
	1135102	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC		CHEMBL301018	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1137565	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCn1cncn1		CHEMBL150606	=	IC50	nM	25000.0	CHEMBL3650	Homo sapiens	IC50	uM	25.0
	1137570	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2ncnc(Nc3cc(O)c(C)cc3F)c2cc1OC		CHEMBL440727	=	IC50	nM	2500.0	CHEMBL3650	Homo sapiens	IC50	uM	2.5
	1138816	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCCC1		CHEMBL147180	=	IC50	nM	9400.0	CHEMBL3650	Homo sapiens	IC50	uM	9.4
	1140149	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCc1ccsc1		CHEMBL151067	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1140178	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCCN1CCOCC1		CHEMBL434311	=	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	uM	1.5
	1141416	CHEMBL678320	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCOCC1		CHEMBL24137	=	IC50	nM	6700.0	CHEMBL3650	Homo sapiens	IC50	uM	6.7
	1144047	CHEMBL678321	In vitro inhibition of Fibroblast growth factor receptor (FTK)	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL369360	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1152816	CHEMBL678679	In vitro inhibition of Fibroblast growth factor receptor expressed in baculovirus	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	1152865	CHEMBL678321	In vitro inhibition of Fibroblast growth factor receptor (FTK)	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1175322	CHEMBL678679	In vitro inhibition of Fibroblast growth factor receptor expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	2310.0	CHEMBL3650	Homo sapiens	IC50	nM	2310.0
	1175339	CHEMBL678680	In vitro inhibition of Fibroblast growth factor receptor 1 expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	3600.0	CHEMBL3650	Homo sapiens	IC50	nM	3600.0
	1175347	CHEMBL678679	In vitro inhibition of Fibroblast growth factor receptor expressed in baculovirus	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	1175363	CHEMBL678680	In vitro inhibition of Fibroblast growth factor receptor 1 expressed in baculovirus	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	4200.0	CHEMBL3650	Homo sapiens	IC50	nM	4200.0
	1176719	CHEMBL678321	In vitro inhibition of Fibroblast growth factor receptor (FTK)	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCC1CCN(C)CC1		CHEMBL170984	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	1180536	CHEMBL678679	In vitro inhibition of Fibroblast growth factor receptor expressed in baculovirus	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O		CHEMBL75232	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	1183188	CHEMBL678679	In vitro inhibition of Fibroblast growth factor receptor expressed in baculovirus	B	O=C(Nc1cccc(-c2cncc3ccccc23)c1)c1ccccc1NCc1ccncc1		CHEMBL347537	=	IC50	nM	5100.0	CHEMBL3650	Homo sapiens	IC50	nM	5100.0
	1232527	CHEMBL678688	Inhibition of Fibroblast growth factor receptor 1 autophosphorylation in PAE cells	B	CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7572	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	uM	0.2
	1233670	CHEMBL678688	Inhibition of Fibroblast growth factor receptor 1 autophosphorylation in PAE cells	B	CN(C)CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7432	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	1246866	CHEMBL678688	Inhibition of Fibroblast growth factor receptor 1 autophosphorylation in PAE cells	B	O=C(c1cc2ccccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL7735	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	1248126	CHEMBL678688	Inhibition of Fibroblast growth factor receptor 1 autophosphorylation in PAE cells	B	COCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7600	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	1489632	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCO)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL425363	=	IC50	nM	52.0	CHEMBL3650	Homo sapiens	IC50	uM	0.052
	1489634	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCO)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL425363	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	uM	0.008
	1489642	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCCO)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL365727	=	IC50	nM	93.0	CHEMBL3650	Homo sapiens	IC50	uM	0.093
	1489644	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCCO)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL365727	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	uM	0.01
	1489652	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCOCc4ccccc4)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL188431	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1489653	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCOCc4ccccc4)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL188431	=	IC50	nM	9000.0	CHEMBL3650	Homo sapiens	IC50	uM	9.0
	1489657	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCCOCc4ccccc4)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL190210	=	IC50	nM	14000.0	CHEMBL3650	Homo sapiens	IC50	uM	14.0
	1489658	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCCOCc4ccccc4)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL190210	=	IC50	nM	1100.0	CHEMBL3650	Homo sapiens	IC50	uM	1.1
	1489761	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCCCOCc4ccccc4)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL190443	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1489762	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCCCOCc4ccccc4)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL190443	=	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	1489766	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCO)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL363304	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1489767	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCO)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL363304	=	IC50	nM	7900.0	CHEMBL3650	Homo sapiens	IC50	uM	7.9
	1489771	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCCO)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL191372	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1489772	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCCO)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL191372	=	IC50	nM	8700.0	CHEMBL3650	Homo sapiens	IC50	uM	8.7
	1489776	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCCCO)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL192668	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1489777	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(C2Cc3cnc(N(CCCCCO)C(C)=O)cc3N=C2NC(=O)NC(C)(C)C)c1		CHEMBL192668	=	IC50	nM	7700.0	CHEMBL3650	Homo sapiens	IC50	uM	7.7
	1489781	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL189851	=	IC50	nM	33.0	CHEMBL3650	Homo sapiens	IC50	uM	0.033
	1489783	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCNC(=O)Nc1nc2nc(NCCCN3CCN(C)CC3)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL189851	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	uM	0.018
	1489890	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCN(C)CC4)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189059	=	IC50	nM	19.0	CHEMBL3650	Homo sapiens	IC50	uM	0.019
	1489892	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCN(C)CC4)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189059	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	uM	0.011
	1489900	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2nc(NCCCCN(CC)CC)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL190783	=	IC50	nM	35.0	CHEMBL3650	Homo sapiens	IC50	uM	0.035
	1489902	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCNC(=O)Nc1nc2nc(NCCCCN(CC)CC)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL190783	=	IC50	nM	86.0	CHEMBL3650	Homo sapiens	IC50	uM	0.086
	1489910	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	uM	0.028
	1489912	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	19.0	CHEMBL3650	Homo sapiens	IC50	uM	0.019
	1490025	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCO)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL365140	=	IC50	nM	38.0	CHEMBL3650	Homo sapiens	IC50	uM	0.038
	1490027	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCO)nc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL365140	=	IC50	nM	49.0	CHEMBL3650	Homo sapiens	IC50	uM	0.049
	1490656	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL339856	=	IC50	nM	31.0	CHEMBL3650	Homo sapiens	IC50	uM	0.031
	1490658	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL339856	=	IC50	nM	12.0	CHEMBL3650	Homo sapiens	IC50	uM	0.012
	1490666	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCN(C)CC4)cc3nc2N)c1		CHEMBL191265	=	IC50	nM	44.0	CHEMBL3650	Homo sapiens	IC50	uM	0.044
	1490667	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCN(C)CC4)cc3nc2N)c1		CHEMBL191265	=	IC50	nM	83.0	CHEMBL3650	Homo sapiens	IC50	uM	0.083
	1490674	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2cc(NCCCN3CCN(C)CC3)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL188087	=	IC50	nM	21.0	CHEMBL3650	Homo sapiens	IC50	uM	0.021
	1490676	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCNC(=O)Nc1nc2cc(NCCCN3CCN(C)CC3)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL188087	=	IC50	nM	21.0	CHEMBL3650	Homo sapiens	IC50	uM	0.021
	1490684	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCN(C)CC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189995	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	uM	0.024
	1490793	CHEMBL832924	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCN(C)CC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189995	=	IC50	nM	5.0	CHEMBL3650	Homo sapiens	IC50	uM	0.005
	1490801	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3cc(OC)cc(OC)c3)cc2cn1		CHEMBL363551	=	IC50	nM	60.0	CHEMBL3650	Homo sapiens	IC50	uM	0.06
	1490803	CHEMBL832924	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3cc(OC)cc(OC)c3)cc2cn1		CHEMBL363551	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	uM	0.008
	1490811	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL187396	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	1490813	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL187396	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	uM	0.007
	1490821	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCN4CCN(C)CC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL190161	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	uM	0.024
	1490933	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCN4CCN(C)CC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL190161	=	IC50	nM	6.0	CHEMBL3650	Homo sapiens	IC50	uM	0.006
	1490941	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1cc2nc(N)c(-c3cc(OC)cc(OC)c3)cc2cn1		CHEMBL188978	=	IC50	nM	87.0	CHEMBL3650	Homo sapiens	IC50	uM	0.087
	1490942	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCCNc1cc2nc(N)c(-c3cc(OC)cc(OC)c3)cc2cn1		CHEMBL188978	=	IC50	nM	46.0	CHEMBL3650	Homo sapiens	IC50	uM	0.046
	1490949	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2cc(NCCCCN(CC)CC)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL190389	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	uM	0.024
	1490951	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCNC(=O)Nc1nc2cc(NCCCCN(CC)CC)ncc2cc1-c1cc(OC)cc(OC)c1		CHEMBL190389	=	IC50	nM	13.0	CHEMBL3650	Homo sapiens	IC50	uM	0.013
	1490959	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3cc(OC)cc(OC)c3)cc2cn1		CHEMBL191023	=	IC50	nM	25.0	CHEMBL3650	Homo sapiens	IC50	uM	0.025
	1491068	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3cc(OC)cc(OC)c3)cc2cn1		CHEMBL191023	=	IC50	nM	6.0	CHEMBL3650	Homo sapiens	IC50	uM	0.006
	1491076	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL191070	=	IC50	nM	33.0	CHEMBL3650	Homo sapiens	IC50	uM	0.033
	1491078	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL191070	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	uM	0.009
	1491086	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCCN4CCN(C)CC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189691	=	IC50	nM	70.0	CHEMBL3650	Homo sapiens	IC50	uM	0.07
	1491087	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCCN4CCN(C)CC4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189691	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	uM	0.01
	1491094	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3cc(OC)cc(OC)c3)cc2cn1		CHEMBL192856	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	uM	0.028
	1491096	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3cc(OC)cc(OC)c3)cc2cn1		CHEMBL192856	=	IC50	nM	6.0	CHEMBL3650	Homo sapiens	IC50	uM	0.006
	1491209	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2cc3nc(N)c(-c4ccccc4)cc3cn2)CC1		CHEMBL190132	=	IC50	nM	2200.0	CHEMBL3650	Homo sapiens	IC50	uM	2.2
	1491210	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CN1CCN(CCCNc2cc3nc(N)c(-c4ccccc4)cc3cn2)CC1		CHEMBL190132	=	IC50	nM	4600.0	CHEMBL3650	Homo sapiens	IC50	uM	4.6
	1491214	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2cc3nc(NC(=O)NC(C)(C)C)c(-c4ccccc4)cc3cn2)CC1		CHEMBL425552	=	IC50	nM	190.0	CHEMBL3650	Homo sapiens	IC50	uM	0.19
	1491215	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CN1CCN(CCCNc2cc3nc(NC(=O)NC(C)(C)C)c(-c4ccccc4)cc3cn2)CC1		CHEMBL425552	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	uM	0.14
	1491219	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2cc3nc(NCCCN4CCN(C)CC4)c(-c4ccccc4)cc3cn2)CC1		CHEMBL361886	=	IC50	nM	12000.0	CHEMBL3650	Homo sapiens	IC50	uM	12.0
	1491220	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CN1CCN(CCCNc2cc3nc(NCCCN4CCN(C)CC4)c(-c4ccccc4)cc3cn2)CC1		CHEMBL361886	=	IC50	nM	23000.0	CHEMBL3650	Homo sapiens	IC50	uM	23.0
	1491224	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1cc2nc(N)c(-c3ccccc3)cc2cn1		CHEMBL190351	=	IC50	nM	7300.0	CHEMBL3650	Homo sapiens	IC50	uM	7.3
	1491225	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCCNc1cc2nc(N)c(-c3ccccc3)cc2cn1		CHEMBL190351	=	IC50	nM	3100.0	CHEMBL3650	Homo sapiens	IC50	uM	3.1
	1491229	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3ccccc3)cc2cn1		CHEMBL189542	=	IC50	nM	300.0	CHEMBL3650	Homo sapiens	IC50	uM	0.3
	1491230	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3ccccc3)cc2cn1		CHEMBL189542	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	uM	0.2
	1491339	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2cc3nc(N)c(-c4c(Cl)cccc4Cl)cc3cn2)CC1		CHEMBL191189	=	IC50	nM	120.0	CHEMBL3650	Homo sapiens	IC50	uM	0.12
	1491340	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CN1CCN(CCCNc2cc3nc(N)c(-c4c(Cl)cccc4Cl)cc3cn2)CC1		CHEMBL191189	=	IC50	nM	220.0	CHEMBL3650	Homo sapiens	IC50	uM	0.22
	1491344	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2cc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL190188	=	IC50	nM	32.0	CHEMBL3650	Homo sapiens	IC50	uM	0.032
	1491345	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCNC(=O)Nc1nc2cc(NCCCN3CCN(C)CC3)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL190188	=	IC50	nM	16.0	CHEMBL3650	Homo sapiens	IC50	uM	0.016
	1491349	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CN1CCN(CCCNc2cc3nc(NC(=O)NC(C)(C)C)c(-c4c(Cl)cccc4Cl)cc3cn2)CC1		CHEMBL191389	=	IC50	nM	26.0	CHEMBL3650	Homo sapiens	IC50	uM	0.026
	1491350	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CN1CCN(CCCNc2cc3nc(NC(=O)NC(C)(C)C)c(-c4c(Cl)cccc4Cl)cc3cn2)CC1		CHEMBL191389	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	uM	0.007
	1491354	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1cc2nc(N)c(-c3c(Cl)cccc3Cl)cc2cn1		CHEMBL188648	=	IC50	nM	350.0	CHEMBL3650	Homo sapiens	IC50	uM	0.35
	1491355	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCCNc1cc2nc(N)c(-c3c(Cl)cccc3Cl)cc2cn1		CHEMBL188648	=	IC50	nM	630.0	CHEMBL3650	Homo sapiens	IC50	uM	0.63
	1491359	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCNC(=O)Nc1nc2cc(NCCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL190162	=	IC50	nM	29.0	CHEMBL3650	Homo sapiens	IC50	uM	0.029
	1491360	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCNC(=O)Nc1nc2cc(NCCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL190162	=	IC50	nM	16.0	CHEMBL3650	Homo sapiens	IC50	uM	0.016
	1491463	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	CCN(CC)CCCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3c(Cl)cccc3Cl)cc2cn1		CHEMBL365377	=	IC50	nM	25.0	CHEMBL3650	Homo sapiens	IC50	uM	0.025
	1491464	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	CCN(CC)CCCCNc1cc2nc(NC(=O)NC(C)(C)C)c(-c3c(Cl)cccc3Cl)cc2cn1		CHEMBL365377	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	uM	0.007
	1491468	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCOCc4ccccc4)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL190866	=	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	uM	1.5
	1491469	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCOCc4ccccc4)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL190866	=	IC50	nM	330.0	CHEMBL3650	Homo sapiens	IC50	uM	0.33
	1491473	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCCOCc4ccccc4)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189325	=	IC50	nM	5100.0	CHEMBL3650	Homo sapiens	IC50	uM	5.1
	1491474	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCCOCc4ccccc4)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189325	=	IC50	nM	2400.0	CHEMBL3650	Homo sapiens	IC50	uM	2.4
	1491478	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCO)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL362502	=	IC50	nM	28000.0	CHEMBL3650	Homo sapiens	IC50	uM	28.0
	1491479	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCO)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL362502	=	IC50	nM	1400.0	CHEMBL3650	Homo sapiens	IC50	uM	1.4
	1491483	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCCO)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189628	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1491484	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCCO)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189628	=	IC50	nM	8400.0	CHEMBL3650	Homo sapiens	IC50	uM	8.4
	1491585	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCCCO)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL365133	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1491586	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCCCO)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL365133	=	IC50	nM	7500.0	CHEMBL3650	Homo sapiens	IC50	uM	7.5
	1491590	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCOc4ccccc4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL190991	=	IC50	nM	910.0	CHEMBL3650	Homo sapiens	IC50	uM	0.91
	1491591	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCOc4ccccc4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL190991	=	IC50	nM	190.0	CHEMBL3650	Homo sapiens	IC50	uM	0.19
	1491595	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCOc4ccccc4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189322	=	IC50	nM	1100.0	CHEMBL3650	Homo sapiens	IC50	uM	1.1
	1491596	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCOc4ccccc4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL189322	=	IC50	nM	260.0	CHEMBL3650	Homo sapiens	IC50	uM	0.26
	1491600	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCCOc4ccccc4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL190405	=	IC50	nM	3300.0	CHEMBL3650	Homo sapiens	IC50	uM	3.3
	1491601	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCCCOc4ccccc4)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL190405	=	IC50	nM	330.0	CHEMBL3650	Homo sapiens	IC50	uM	0.33
	1491605	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(NCCCO)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL278472	=	IC50	nM	49.0	CHEMBL3650	Homo sapiens	IC50	uM	0.049
	1491607	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(NCCCO)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL278472	=	IC50	nM	4.0	CHEMBL3650	Homo sapiens	IC50	uM	0.004
	1512266	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCCCS(C)(=O)=O)c(C(C)C)c23)c(F)cc1F		CHEMBL195218	=	IC50	nM	58.0	CHEMBL3650	Homo sapiens	IC50	uM	0.058
	1512385	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCC4CCCO4)c(C(C)C)c23)c(F)cc1F		CHEMBL370266	=	IC50	nM	46.0	CHEMBL3650	Homo sapiens	IC50	uM	0.046
	1512396	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4ncc(C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL193306	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	nM	20.0
	1512403	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nc(C)no4)c(C(C)C)c23)c(F)cc1F		CHEMBL370515	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	nM	110.0
	1512407	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4noc(C)n4)c(C(C)C)c23)c(F)cc1F		CHEMBL194929	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	nM	140.0
	1512521	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL365318	=	IC50	nM	19.0	CHEMBL3650	Homo sapiens	IC50	nM	19.0
	1512530	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnco4)c(C(C)C)c23)c(F)cc1F		CHEMBL195771	=	IC50	nM	160.0	CHEMBL3650	Homo sapiens	IC50	nM	160.0
	1512534	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CCc1nnc(-c2cn3ncnc(Nc4cc(C(=O)NOC)c(F)cc4F)c3c2C(C)C)o1		CHEMBL371373	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	nM	28.0
	1512538	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(C)C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL373365	=	IC50	nM	39.0	CHEMBL3650	Homo sapiens	IC50	nM	39.0
	1512542	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(CC(C)C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL192101	=	IC50	nM	33.0	CHEMBL3650	Homo sapiens	IC50	nM	33.0
	1512546	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C5CC5)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL190980	=	IC50	nM	14.0	CHEMBL3650	Homo sapiens	IC50	nM	14.0
	1512653	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(CC5CC5)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL191913	=	IC50	nM	27.0	CHEMBL3650	Homo sapiens	IC50	nM	27.0
	1512668	CHEMBL832663	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)F)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL194498	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	uM	0.1
	1512674	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)(F)F)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL370023	=	IC50	nM	84.0	CHEMBL3650	Homo sapiens	IC50	nM	84.0
	1512678	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(CC(F)(F)F)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL194872	=	IC50	nM	68.0	CHEMBL3650	Homo sapiens	IC50	nM	68.0
	1512682	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(N(C)C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL195847	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
	1512686	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(CN(C)C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL372662	=	IC50	nM	149.0	CHEMBL3650	Homo sapiens	IC50	nM	149.0
	1512790	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(CS(C)(=O)=O)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL195398	=	IC50	nM	16.0	CHEMBL3650	Homo sapiens	IC50	nM	16.0
	1512808	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)(F)S(C)(=O)=O)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL195903	=	IC50	nM	220.0	CHEMBL3650	Homo sapiens	IC50	nM	220.0
	1512929	CHEMBL829448	Inhibition of human fibroblast growth factor receptor 1	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4n[nH]c(C)n4)c(C(C)C)c23)c(F)cc1F		CHEMBL193136	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	nM	50.0
	1516604	CHEMBL829923	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human fibroblast growth factor receptor 1	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCCCOCc4ccccc4)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL370328	=	IC50	nM	12000.0	CHEMBL3650	Homo sapiens	IC50	uM	12.0
	1516605	CHEMBL832920	Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human FGFR1 in DELFIA assay	B	COc1cc(OC)cc(-c2cc3cnc(N(CCCCCOCc4ccccc4)C(C)=O)cc3nc2NC(=O)NC(C)(C)C)c1		CHEMBL370328	=	IC50	nM	3300.0	CHEMBL3650	Homo sapiens	IC50	uM	3.3
Not Active	1650459	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1650460	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1650461	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3650	Homo sapiens	Kd		
	1650462	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1800.0	CHEMBL3650	Homo sapiens	Kd	uM	1.8
Not Active	1650463	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3650	Homo sapiens	Kd		
	1650464	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	5100.0	CHEMBL3650	Homo sapiens	Kd	uM	5.1
	1650465	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2500.0	CHEMBL3650	Homo sapiens	Kd	uM	2.5
Not Active	1650466	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1650467	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3650	Homo sapiens	Kd		
	1651588	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	60.0	CHEMBL3650	Homo sapiens	Kd	uM	0.06
Not Active	1651589	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1651590	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1651591	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1651592	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1651593	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1651594	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1651595	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3650	Homo sapiens	Kd		
Not Active	1651596	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL3650	Homo sapiens	Kd		
	1651597	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	5300.0	CHEMBL3650	Homo sapiens	Kd	uM	5.3
Not Active	1651598	CHEMBL860911	Average Binding Constant for FGFR1; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL3650	Homo sapiens	Kd		
	1653637	CHEMBL861479	Inhibitory activity against bFGFR1	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	45800.0	CHEMBL3650	Homo sapiens	IC50	uM	45.8
Not Active	1661757	CHEMBL868737	Inhibitory activity against FGF1R at 25 uM	B	O=C(Nc1ccc2c(c1)C=Nc1c(Cl)ncnc1O2)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL199886		Activity			CHEMBL3650	Homo sapiens	Activity		
	1677767	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(O)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383237	=	Inhibition	%	12.6	CHEMBL3650	Homo sapiens	Inhibition	%	12.6
	1677799	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCc2ccncc2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL370449	=	Inhibition	%	2.6	CHEMBL3650	Homo sapiens	Inhibition	%	2.6
	1677800	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCc2ccc(C(=O)OC(C)(C)C)cc2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL372798	=	Inhibition	%	50.8	CHEMBL3650	Homo sapiens	Inhibition	%	50.8
	1677801	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCc2ccc(C(F)(F)F)cc2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383280	=	Inhibition	%	44.5	CHEMBL3650	Homo sapiens	Inhibition	%	44.5
	1677802	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCc2ccc(OC)cc2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383008	=	Inhibition	%	46.0	CHEMBL3650	Homo sapiens	Inhibition	%	46.0
	1677803	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCCN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201830	=	Inhibition	%	48.2	CHEMBL3650	Homo sapiens	Inhibition	%	48.2
	1677804	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL382462	=	Inhibition	%	55.5	CHEMBL3650	Homo sapiens	Inhibition	%	55.5
	1677805	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCCN2CCOCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201089	=	Inhibition	%	41.4	CHEMBL3650	Homo sapiens	Inhibition	%	41.4
	1677806	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCCN2CCCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL200976	=	Inhibition	%	79.1	CHEMBL3650	Homo sapiens	Inhibition	%	79.1
	1677807	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCCN2CCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL202244	=	Inhibition	%	65.2	CHEMBL3650	Homo sapiens	Inhibition	%	65.2
	1677808	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383030	=	Inhibition	%	51.2	CHEMBL3650	Homo sapiens	Inhibition	%	51.2
	1677809	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	CCN(CC)CCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O		CHEMBL202162	=	Inhibition	%	61.1	CHEMBL3650	Homo sapiens	Inhibition	%	61.1
	1677810	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201865	=	Inhibition	%	51.0	CHEMBL3650	Homo sapiens	Inhibition	%	51.0
	1677811	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OC(C)=O)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL202158	=	Inhibition	%	-8.1	CHEMBL3650	Homo sapiens	Inhibition	%	-8.1
	1677812	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	CCCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O		CHEMBL202216	=	Inhibition	%	2.4	CHEMBL3650	Homo sapiens	Inhibition	%	2.4
	1677813	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	COC(=O)c1c(OC)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201840	=	Inhibition	%	10.5	CHEMBL3650	Homo sapiens	Inhibition	%	10.5
	1677835	CHEMBL862240	Inhibitory activity against FGFR1 kinase at 20 uM	B	N#CC(C#N)=C(N)/C(C#N)=C/c1cc(O)c(O)c(O)c1		CHEMBL78257	=	Inhibition	%	93.0	CHEMBL3650	Homo sapiens	Inhibition	%	93.0
	1677860	CHEMBL862244	Inhibitory activity against FGFR1 kinase	B	COC(=O)c1c(OC)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201840	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1677870	CHEMBL862244	Inhibitory activity against FGFR1 kinase	B	CCCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O		CHEMBL202216	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1677873	CHEMBL862244	Inhibitory activity against FGFR1 kinase	B	COC(=O)c1c(OCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL201865	=	IC50	nM	23600.0	CHEMBL3650	Homo sapiens	IC50	uM	23.6
	1677880	CHEMBL862244	Inhibitory activity against FGFR1 kinase	B	N#CC(C#N)=C(N)/C(C#N)=C/c1cc(O)c(O)c(O)c1		CHEMBL78257	=	IC50	nM	4900.0	CHEMBL3650	Homo sapiens	IC50	uM	4.9
	1677881	CHEMBL862244	Inhibitory activity against FGFR1 kinase	B	COC(=O)c1c(OCCN2CCCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL200976	=	IC50	nM	7100.0	CHEMBL3650	Homo sapiens	IC50	uM	7.1
	1677882	CHEMBL862244	Inhibitory activity against FGFR1 kinase	B	COC(=O)c1c(OCCN2CCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL202244	=	IC50	nM	23800.0	CHEMBL3650	Homo sapiens	IC50	uM	23.8
	1677883	CHEMBL862244	Inhibitory activity against FGFR1 kinase	B	COC(=O)c1c(OCCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O		CHEMBL383030	=	IC50	nM	38400.0	CHEMBL3650	Homo sapiens	IC50	uM	38.4
	1677884	CHEMBL862244	Inhibitory activity against FGFR1 kinase	B	CCN(CC)CCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O		CHEMBL202162	=	IC50	nM	8800.0	CHEMBL3650	Homo sapiens	IC50	uM	8.8
	1697676	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203056	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697740	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cc3ccccc3)cc2)o1		CHEMBL383126	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697741	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Oc3ccccc3)cc2)o1		CHEMBL206267	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697742	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(-c3ccccc3)cc2)o1		CHEMBL205464	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697743	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Br)cc2)o1		CHEMBL205463	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697744	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(NCc2ccc3c(c2)OCO3)o1		CHEMBL202892	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697745	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c(F)c1		CHEMBL379908	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697746	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(C(F)(F)F)c2)o1		CHEMBL205127	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697747	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	COc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1OC		CHEMBL378592	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697748	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(Cl)c2)o1		CHEMBL204874	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697749	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL379239	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697750	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	COc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL204312	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697751	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	COc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203796	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697752	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203789	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697753	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2cccc(OC(F)(F)F)c2)o1		CHEMBL206538	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697754	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(F)(F)F)cc2)o1		CHEMBL380131	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697755	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)F)cc2)o1		CHEMBL383255	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697756	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)Cl)cc2)o1		CHEMBL205884	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697757	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	CC(C)c1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1		CHEMBL203119	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697758	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(C)(C)C)cc2)o1		CHEMBL203731	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697759	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2cccc3ncccc23)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL378165	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697760	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc3ccccc3n2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL204718	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697761	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc3[nH]ncc3c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206118	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697762	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc(F)c(F)c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203394	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697763	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCCc2ccc3c(c2)OCO3)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL382672	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697764	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccccn2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL202904	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1697765	CHEMBL867752	Protective index against FGFR1 at 10 uM by HTRF method	B	Cn1cnc(NCc2cccnc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206742	<	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1699822	CHEMBL859794	Inhibitory activity against FGFR1	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	IC50	nM	148.0	CHEMBL3650	Homo sapiens	IC50	nM	148.0
	1707006	CHEMBL865654	Inhibitory activity against FGFR1	B	O=c1[nH]c2ccccc2c(O)c1-c1nc2ccccc2[nH]1		CHEMBL377345	=	IC50	nM	215.0	CHEMBL3650	Homo sapiens	IC50	uM	0.215
	1707062	CHEMBL865654	Inhibitory activity against FGFR1	B	Cn1ncc2c(N)c(-c3nc4ccccc4[nH]3)c(O)nc21		CHEMBL383261	=	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	1707063	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c2cnnc-2[nH]c(O)c1-c1nc2ccccc2[nH]1		CHEMBL205305	=	IC50	nM	3170.0	CHEMBL3650	Homo sapiens	IC50	uM	3.17
	1707064	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c2ncnc-2[nH]c(O)c1-c1nc2ccccc2[nH]1		CHEMBL383299	=	IC50	nM	2660.0	CHEMBL3650	Homo sapiens	IC50	uM	2.66
	1707065	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3ccccc3[nH]2)c(O)nc2sccc12		CHEMBL205406	=	IC50	nM	348.0	CHEMBL3650	Homo sapiens	IC50	uM	0.348
	1707066	CHEMBL865654	Inhibitory activity against FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(O)nc5ccccc5c4N)nc3n2)CC1		CHEMBL204524	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	uM	0.01
	1707067	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3ccc(N4CCOCC4)[nH]c-3n2)c(O)nc2ccccc12		CHEMBL380702	=	IC50	nM	47.0	CHEMBL3650	Homo sapiens	IC50	uM	0.047
	1707068	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3ccc[nH]c-3n2)c(O)nc2cnccc12		CHEMBL204985	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	1707069	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3ccc[nH]c-3n2)c(O)nc2ccccc12		CHEMBL204727	=	IC50	nM	51.0	CHEMBL3650	Homo sapiens	IC50	uM	0.051
	1707070	CHEMBL865654	Inhibitory activity against FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(O)nc5cccnc5c4N)nc3c2)CC1		CHEMBL205405	=	IC50	nM	43.0	CHEMBL3650	Homo sapiens	IC50	uM	0.043
	1707071	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3cc(N4CCOCC4)ccc3[nH]2)c(O)nc2ccncc12		CHEMBL381283	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	uM	0.1
	1707072	CHEMBL865654	Inhibitory activity against FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(O)nc5cnccc5c4N)nc3c2)CC1		CHEMBL205893	=	IC50	nM	4.0	CHEMBL3650	Homo sapiens	IC50	uM	0.004
	1707073	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3cc(N4CCOCC4)ccc3[nH]2)c(O)nc2cnccc12		CHEMBL205108	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	uM	0.01
	1707074	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3ccccc3[nH]2)c(O)nc2cnccc12		CHEMBL383618	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	uM	0.01
	1707075	CHEMBL865654	Inhibitory activity against FGFR1	B	Oc1nc2cnccc2c(O)c1-c1nc2ccccc2[nH]1		CHEMBL206410	=	IC50	nM	576.0	CHEMBL3650	Homo sapiens	IC50	uM	0.576
	1707076	CHEMBL865654	Inhibitory activity against FGFR1	B	Oc1nc2ncccc2c(O)c1-c1nc2ccccc2[nH]1		CHEMBL207061	=	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	1707077	CHEMBL865654	Inhibitory activity against FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL204427	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	uM	0.008
	1707078	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3cc(N4CCOCC4)ccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL204426	=	IC50	nM	21.0	CHEMBL3650	Homo sapiens	IC50	uM	0.021
	1707079	CHEMBL865654	Inhibitory activity against FGFR1	B	Nc1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL383417	=	IC50	nM	44.0	CHEMBL3650	Homo sapiens	IC50	uM	0.044
	1739486	CHEMBL862851	Inhibition of FGFR1	B	CC(C)(C)NC(=O)Nc1cccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc12		CHEMBL212262	>	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	1739500	CHEMBL862851	Inhibition of FGFR1	B	c1ccc(COc2cccc3c(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)[nH]nc23)cc1		CHEMBL379995	>	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	1739512	CHEMBL862851	Inhibition of FGFR1	B	Fc1cccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc12		CHEMBL211940	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	uM	0.2
	1739524	CHEMBL862851	Inhibition of FGFR1	B	FC(F)(F)c1ccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc2c1		CHEMBL377230	=	IC50	nM	2.0	CHEMBL3650	Homo sapiens	IC50	uM	0.002
	1739538	CHEMBL862851	Inhibition of FGFR1	B	c1ccc(COc2ccc3c(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)[nH]nc3c2)cc1		CHEMBL209704	=	IC50	nM	23.0	CHEMBL3650	Homo sapiens	IC50	uM	0.023
	1739553	CHEMBL862851	Inhibition of FGFR1	B	Fc1ccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc2c1		CHEMBL212054	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	uM	0.028
	1739570	CHEMBL862851	Inhibition of FGFR1	B	COC(=O)c1ccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c2c1		CHEMBL380372	=	IC50	nM	73.0	CHEMBL3650	Homo sapiens	IC50	uM	0.073
	1739586	CHEMBL862851	Inhibition of FGFR1	B	CC(C)(C)NC(=O)Nc1ccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c2c1		CHEMBL378024	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	uM	0.001
	1739602	CHEMBL862851	Inhibition of FGFR1	B	c1cc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c2cc1NCC1CCCCC1		CHEMBL379108	=	IC50	nM	16.0	CHEMBL3650	Homo sapiens	IC50	uM	0.016
	1739617	CHEMBL862851	Inhibition of FGFR1	B	c1ccc(Oc2ccc3n[nH]c(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)c3c2)cc1		CHEMBL211662	=	IC50	nM	15.0	CHEMBL3650	Homo sapiens	IC50	uM	0.015
	1739635	CHEMBL862851	Inhibition of FGFR1	B	c1ccc(COc2ccc3[nH]nc(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)c3c2)cc1		CHEMBL377346	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	uM	0.008
	1739654	CHEMBL862851	Inhibition of FGFR1	B	CC(C)(C)NC(=O)Nc1cccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c12		CHEMBL379740	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	uM	0.003
	1739672	CHEMBL862851	Inhibition of FGFR1	B	c1ccc(COc2cccc3[nH]nc(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)c23)cc1		CHEMBL425247	=	IC50	nM	94.0	CHEMBL3650	Homo sapiens	IC50	uM	0.094
	1739707	CHEMBL862851	Inhibition of FGFR1	B	CN1CCN(Cc2ccc3[nH]c(-c4[nH]nc5ccccc45)nc3c2)CC1		CHEMBL209265	=	IC50	nM	270.0	CHEMBL3650	Homo sapiens	IC50	uM	0.27
	1739726	CHEMBL862851	Inhibition of FGFR1	B	c1ccc2c(-c3nc4cc(OCCCN5CCCC5)ccc4[nH]3)[nH]nc2c1		CHEMBL208775	=	IC50	nM	98.0	CHEMBL3650	Homo sapiens	IC50	uM	0.098
	1739750	CHEMBL862851	Inhibition of FGFR1	B	c1ccc2c(-c3nc4cc(-n5ccnc5)ccc4[nH]3)[nH]nc2c1		CHEMBL378003	=	IC50	nM	210.0	CHEMBL3650	Homo sapiens	IC50	uM	0.21
	1739767	CHEMBL862851	Inhibition of FGFR1	B	CN1CCC(N(C)c2ccc3[nH]c(-c4[nH]nc5ccccc45)nc3c2)CC1		CHEMBL212429	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	uM	0.018
	1739785	CHEMBL862851	Inhibition of FGFR1	B	c1ccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc2c1		CHEMBL378299	=	IC50	nM	48.0	CHEMBL3650	Homo sapiens	IC50	uM	0.048
	1739797	CHEMBL862851	Inhibition of FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4[nH]nc5ccccc45)nc3c2)CC1		CHEMBL208600	=	IC50	nM	82.0	CHEMBL3650	Homo sapiens	IC50	uM	0.082
	1739813	CHEMBL862851	Inhibition of FGFR1	B	c1ccc2c(-c3nc4cc(N5CCOCC5)ccc4[nH]3)[nH]nc2c1		CHEMBL209783	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	uM	0.1
	1739833	CHEMBL862851	Inhibition of FGFR1	B	c1ccc2c(-c3nc4c(N5CCOCC5)cccc4[nH]3)[nH]nc2c1		CHEMBL211708	=	IC50	nM	830.0	CHEMBL3650	Homo sapiens	IC50	uM	0.83
	1739846	CHEMBL862851	Inhibition of FGFR1	B	c1ccc2[nH]c(-c3n[nH]c4ccccc34)nc2c1		CHEMBL383990	=	IC50	nM	1400.0	CHEMBL3650	Homo sapiens	IC50	uM	1.4
	1744631	CHEMBL866824	Inhibition of FGFR1	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	>	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	nM	5000.0
	1748678	CHEMBL870358	Inhibition of FGF1R	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL386760	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	1769391	CHEMBL910911	Inhibition of FGFR1	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	uM	1.0
	1778611	CHEMBL912346	Inhibition of FGFR1	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	1778615	CHEMBL912346	Inhibition of FGFR1	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	IC50	nM	880.0	CHEMBL3650	Homo sapiens	IC50	nM	880.0
	1779362	CHEMBL854972	Inhibition of recombinant FGFR1 by ELISA	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	=	IC50	nM	37000.0	CHEMBL3650	Homo sapiens	IC50	uM	37.0
	1779384	CHEMBL854972	Inhibition of recombinant FGFR1 by ELISA	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	1781990	CHEMBL911840	Inhibition of FGFR1	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	47.0	CHEMBL3650	Homo sapiens	IC50	uM	0.047
	1807172	CHEMBL908989	Inhibition of FGFR1	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	960.0	CHEMBL3650	Homo sapiens	IC50	uM	0.96
	1816519	CHEMBL911989	Inhibition of FGFR1 at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)Cc1ccccc1-3		CHEMBL148471	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	Inhibition	%	30.0
	1816534	CHEMBL911989	Inhibition of FGFR1 at 1 uM	B	O=C1NCc2c1c1c3ccccc3sc1c1[nH]c3ccccc3c21		CHEMBL221536	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	Inhibition	%	30.0
	1816535	CHEMBL911989	Inhibition of FGFR1 at 1 uM	B	O=C1NCc2c1c1c(c3[nH]c4ccccc4c23)Cc2ccccc2-1		CHEMBL357490	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	Inhibition	%	30.0
	1816536	CHEMBL911989	Inhibition of FGFR1 at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)CCc1ccccc1-3		CHEMBL374581	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	Inhibition	%	30.0
	1816537	CHEMBL911989	Inhibition of FGFR1 at 1 uM	B	O=C1NC(=O)c2c1c1c(c3[nH]c4ccccc4c23)CCc2ccccc2-1		CHEMBL386636	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	Inhibition	%	30.0
	1824546	CHEMBL913831	Inhibition of FGFR1	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL3650	Homo sapiens	Ki	uM	10.0
	1824719	CHEMBL913831	Inhibition of FGFR1	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL3650	Homo sapiens	Ki	uM	10.0
	1824794	CHEMBL913831	Inhibition of FGFR1	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL3650	Homo sapiens	Ki	uM	10.0
	1841818	CHEMBL914503	Inhibition of FGFR1 kinase	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	880.0	CHEMBL3650	Homo sapiens	IC50	nM	880.0
	1912506	CHEMBL889723	Inhibition of rhFGF2-induced cellular proliferation of HUVEC	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	MEC	uM	10.0	CHEMBL3650	Homo sapiens	MEC	uM	10.0
	1912507	CHEMBL889723	Inhibition of rhFGF2-induced cellular proliferation of HUVEC	F	Cc1[nH]c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O		CHEMBL149201	=	MEC	uM	10.0	CHEMBL3650	Homo sapiens	MEC	uM	10.0
	1912508	CHEMBL889723	Inhibition of rhFGF2-induced cellular proliferation of HUVEC	F	COc1cc(OC)cc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL231526	=	MEC	uM	0.4	CHEMBL3650	Homo sapiens	MEC	uM	0.4
	1912509	CHEMBL889723	Inhibition of rhFGF2-induced cellular proliferation of HUVEC	F	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL358728	=	MEC	uM	0.4	CHEMBL3650	Homo sapiens	MEC	uM	0.4
	1912510	CHEMBL889722	Inhibition of human FGFR1 kinase expressed in insect cell by HTRF detection method	B	COc1cc(OC)cc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL231526	=	IC50	nM	400.0	CHEMBL3650	Homo sapiens	IC50	uM	0.4
	1912511	CHEMBL889722	Inhibition of human FGFR1 kinase expressed in insect cell by HTRF detection method	B	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL358728	=	IC50	nM	1200.0	CHEMBL3650	Homo sapiens	IC50	uM	1.2
Dose-dependent effect	1912512	CHEMBL889724	Suppression of HUVEC tube formation	F	COc1cc(OC)cc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL231526		Activity			CHEMBL3650	Homo sapiens	Activity		
Active	1912513	CHEMBL889725	Effect on intracellular signaling in HUVEC assessed as inhibition of rhFGF2-induced ERK activation	F	COc1cc(OC)cc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL231526		Activity			CHEMBL3650	Homo sapiens	Activity		
	1912514	CHEMBL889723	Inhibition of rhFGF2-induced cellular proliferation of HUVEC	F	COc1cc(OC)cc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL231526	=	IC50	nM	18200.0	CHEMBL3650	Homo sapiens	IC50	uM	18.2
	1912515	CHEMBL889723	Inhibition of rhFGF2-induced cellular proliferation of HUVEC	F	COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL358728	=	IC50	nM	17900.0	CHEMBL3650	Homo sapiens	IC50	uM	17.9
	1912516	CHEMBL889723	Inhibition of rhFGF2-induced cellular proliferation of HUVEC	F	Cc1[nH]c(/C=C2\C(=O)Nc3cc(-c4ccccc4)ccc32)c(C)c1CCC(=O)O		CHEMBL149201	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1912517	CHEMBL889723	Inhibition of rhFGF2-induced cellular proliferation of HUVEC	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1916322	CHEMBL894172	Inhibition of recombinant FGFR1 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	1916375	CHEMBL894172	Inhibition of recombinant FGFR1 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	1966312	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nnnn1CCc1ccncc1		CHEMBL233829	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966313	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccccn1		CHEMBL232800	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966413	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2nnnn2CCc2ccncc2)cc1		CHEMBL233828	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966414	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL233827	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966415	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL234205	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966416	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nnnn1CCc1ccncc1		CHEMBL393001	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966417	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234013	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966418	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234012	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966419	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL233826	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966420	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nccn1CCc1ccncc1		CHEMBL233825	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966421	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2nccn2CCc2ccncc2)cc1		CHEMBL233824	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966422	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL391104	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966423	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL234203	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966424	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nccn1CCc1ccncc1		CHEMBL234202	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966425	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL391103	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966426	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL234201	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966427	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(OC(F)(F)F)cc2)c1C		CHEMBL234011	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966428	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(Cl)cc2)c1C		CHEMBL391102	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966429	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	Cc1cc(C(=O)Nc2ccc(OC(F)(F)F)cc2)n(CCc2ccncc2)n1		CHEMBL392331	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966430	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	Cc1cc(C(=O)Nc2ccc(Cl)cc2)n(CCc2ccncc2)n1		CHEMBL234010	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966431	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	COc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1OC		CHEMBL234009	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966432	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL392330	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966433	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL233823	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966434	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL233822	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966435	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc2cn[nH]c2c1)c1ccnn1CCc1ccncc1		CHEMBL392329	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966436	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc2[nH]ncc2c1)c1ccnn1CCc1ccncc1		CHEMBL233821	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966437	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1cnc2ccccc2c1)c1ccnn1CCc1ccncc1		CHEMBL391069	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966438	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(OCc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL233631	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966439	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Oc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL392313	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966440	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(-c2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL399606	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966441	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	CC(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL236420	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966442	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL399605	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966443	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1cccc(OC(F)(F)Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL236419	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966444	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL236206	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966445	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL236205	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966446	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	CCc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL392935	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966447	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL392934	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966448	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1c[nH]cn1		CHEMBL237680	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966449	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1noc2ccccc12		CHEMBL237679	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966450	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cnoc1		CHEMBL232802	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966451	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	COc1ccc(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)cc1OC		CHEMBL234864	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966452	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccc(F)c(F)c1		CHEMBL393006	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966453	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	CC1C=C2OCOC2=C(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)C1		CHEMBL234863	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966454	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccncc1		CHEMBL397323	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1966455	CHEMBL897512	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cccnc1		CHEMBL397322	>	Activity	%	30.0	CHEMBL3650	Homo sapiens	Activity	%	30.0
	1986214	CHEMBL899834	Inhibition of FGFR1	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	IC50	nM	9700.0	CHEMBL3650	Homo sapiens	IC50	nM	9700.0
	2000774	CHEMBL900485	Inhibition of FGFR1 at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	Inhibition	%	20.4	CHEMBL3650	Homo sapiens	Inhibition	%	20.4
	2000795	CHEMBL900485	Inhibition of FGFR1 at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	86.5	CHEMBL3650	Homo sapiens	Inhibition	%	86.5
	2051621	CHEMBL941759	Inhibition of FGFR	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	4737.0	CHEMBL3650	Homo sapiens	Ki	uM	4.737
	2080194	CHEMBL929549	Inhibition of FGFR1	B	CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL253292	=	IC50	nM	570.0	CHEMBL3650	Homo sapiens	IC50	uM	0.57
	2081789	CHEMBL928812	Inhibition of FGFR1 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL3650	Homo sapiens	Inhibition	%	20.0
	2137027	CHEMBL937651	Inhibition of bFGFR1	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	45800.0	CHEMBL3650	Homo sapiens	IC50	nM	45800.0
	2137050	CHEMBL937670	Inhibition of FGFR1	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	nM	5000.0
	2137138	CHEMBL937670	Inhibition of FGFR1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	IC50	nM	170.0	CHEMBL3650	Homo sapiens	IC50	nM	170.0
	2137258	CHEMBL937670	Inhibition of FGFR1	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	21.5	CHEMBL3650	Homo sapiens	IC50	nM	21.5
	2147261	CHEMBL921851	Activity of human FGFR1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	43.0	CHEMBL3650	Homo sapiens	Activity	%	43.0
Not Evaluated	2149618	CHEMBL931315	Inhibition of human FGFR1	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL3650	Homo sapiens	Activity		
	2158773	CHEMBL922536	Inhibition of FGFR1	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	2164860	CHEMBL929424	Inhibition of FGFR1	B	Cc1nnc(-c2cn3ncnc(Nc4cnc5[nH]ccc5c4)c3c2C(C)C)o1		CHEMBL258694	=	IC50	nM	61.0	CHEMBL3650	Homo sapiens	IC50	nM	61.0
	2164869	CHEMBL929424	Inhibition of FGFR1	B	Cc1cc2cc(Nc3ncnn4cc(-c5nnc(C)o5)c(C(C)C)c34)cnc2[nH]1		CHEMBL261592	=	IC50	nM	78.0	CHEMBL3650	Homo sapiens	IC50	nM	78.0
	2182858	CHEMBL945532	Inhibition of FGFR1 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2198004	CHEMBL1005546	Inhibition of Tel-fused FGFR1 kinase-mediated mouse BaF3 cell proliferation	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	1216.0	CHEMBL3650	Homo sapiens	IC50	uM	1.216
	2206772	CHEMBL977771	Inhibition of FGFR1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	2206801	CHEMBL977771	Inhibition of FGFR1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	170.0	CHEMBL3650	Homo sapiens	IC50	nM	170.0
	2206894	CHEMBL973091	Inhibition of FGFR1 by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	80.0	CHEMBL3650	Homo sapiens	EC50	nM	80.0
	2206943	CHEMBL973091	Inhibition of FGFR1 by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL3650	Homo sapiens	EC50	uM	1.0
	2206957	CHEMBL973091	Inhibition of FGFR1 by cellular assay	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	EC50	nM	21.0	CHEMBL3650	Homo sapiens	EC50	nM	21.0
	2206958	CHEMBL977771	Inhibition of FGFR1	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	nM	30.0
	2239385	CHEMBL980074	Inhibition of FGFR1 assessed as residual enzyme activity at 1 uM	B	Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1		CHEMBL462132	=	Activity	%	111.0	CHEMBL3650	Homo sapiens	Activity	%	111.0
	2248202	CHEMBL1012685	Inhibition of FGFR1 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	3.0	CHEMBL3650	Homo sapiens	INH	%	3.0
	2248232	CHEMBL1012685	Inhibition of FGFR1 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	2250171	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2cccc3[nH]c(=O)c(-c4nc5ccccc5[nH]4)c(N)c23)CC1		CHEMBL498551	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	uM	0.001
	2250172	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCCC(Oc2cccc3[nH]c(=O)c(-c4nc5ccccc5[nH]4)c(N)c23)C1		CHEMBL495749	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	uM	0.001
	2250173	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5c(Cl)cccc5[nH]c4=O)nc3c2)CC1		CHEMBL495762	=	IC50	nM	2.0	CHEMBL3650	Homo sapiens	IC50	uM	0.002
	2250174	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN(C)CC(=O)N(C)c1ccc2[nH]c(-c3c(N)c4ccccc4[nH]c3=O)nc2c1		CHEMBL495962	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	uM	0.003
	2250175	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Cc1cccc2[nH]c(=O)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(N)c12		CHEMBL495763	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	uM	0.003
	2250176	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5ccc(F)cc5[nH]c4=O)nc3c2)CC1		CHEMBL498013	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	uM	0.003
	2250177	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(N)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL496764	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	uM	0.007
	2250178	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(NCc6ccccc6)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL495735	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	uM	0.008
	2250179	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL204427	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	uM	0.009
	2250180	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(Cc2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL495961	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	uM	0.009
	2250181	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(C(=O)c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL498214	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	uM	0.01
	2250182	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(C(=O)NCc6ccccc6)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL526507	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	uM	0.01
	2250183	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	uM	0.011
	2250184	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CNc1cccc2[nH]c(=O)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(N)c12		CHEMBL496762	=	IC50	nM	15.0	CHEMBL3650	Homo sapiens	IC50	uM	0.015
	2250185	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCCN(c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL523071	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	uM	0.02
	2250186	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN(C)[C@H]1CCN(c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)C1		CHEMBL496150	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	uM	0.02
	2250187	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Nc1c(-c2nc3cc(OCCN4CCOCC4)ccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL526658	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	uM	0.02
	2250188	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(Cl)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL523745	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	uM	0.024
	2250189	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Nc1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL383417	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	2250190	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Nc1c(-c2nc3cc(N4CCOCC4)ccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL204426	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	2250191	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5c(F)cc(F)cc5[nH]c4=O)nc3c2)CC1		CHEMBL498347	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	uM	0.03
	2250192	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(F)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL496763	=	IC50	nM	40.0	CHEMBL3650	Homo sapiens	IC50	uM	0.04
	2250193	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Cc1cc2nc(-c3c(N)c4ccccc4[nH]c3=O)[nH]c2cc1C		CHEMBL498206	=	IC50	nM	70.0	CHEMBL3650	Homo sapiens	IC50	uM	0.07
	2250194	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Cc1ccc2[nH]c(-c3c(N)c4ccccc4[nH]c3=O)nc2c1		CHEMBL498205	=	IC50	nM	80.0	CHEMBL3650	Homo sapiens	IC50	uM	0.08
	2250195	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(N(C)C)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL495529	=	IC50	nM	83.0	CHEMBL3650	Homo sapiens	IC50	uM	0.083
	2250196	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	O=c1[nH]c2ccccc2c(O)c1-c1nc2ccccc2[nH]1		CHEMBL377345	=	IC50	nM	90.0	CHEMBL3650	Homo sapiens	IC50	uM	0.09
	2250197	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(F)c(F)cc5[nH]c4=O)nc3c2)CC1		CHEMBL522732	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	2250198	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CNc1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL521552	=	IC50	nM	120.0	CHEMBL3650	Homo sapiens	IC50	uM	0.12
	2250199	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CCC1CCN(C)C(Nc2c(-c3nc4ccccc4[nH]3)c(=O)[nH]c3ccccc23)C1		CHEMBL495984	=	IC50	nM	190.0	CHEMBL3650	Homo sapiens	IC50	uM	0.19
	2250200	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cccc(F)c5[nH]c4=O)nc3c2)CC1		CHEMBL526836	=	IC50	nM	190.0	CHEMBL3650	Homo sapiens	IC50	uM	0.19
	2250201	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CNc1ccc2c(N)c(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c(=O)[nH]c2c1		CHEMBL449593	=	IC50	nM	370.0	CHEMBL3650	Homo sapiens	IC50	uM	0.37
	2250202	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	O=c1[nH]c2ccccc2cc1-c1nc2ccccc2[nH]1		CHEMBL118440	=	IC50	nM	390.0	CHEMBL3650	Homo sapiens	IC50	uM	0.39
	2250203	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN(C)c1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL495983	=	IC50	nM	390.0	CHEMBL3650	Homo sapiens	IC50	uM	0.39
	2250204	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	O=c1[nH]c2ccccc2c(NCC2CCNCC2)c1-c1nc2ccccc2[nH]1		CHEMBL526285	=	IC50	nM	550.0	CHEMBL3650	Homo sapiens	IC50	uM	0.55
	2250205	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(NC(=O)c6ccccc6)ccc5[nH]c4=O)nc3c2)CC1		CHEMBL495530	=	IC50	nM	900.0	CHEMBL3650	Homo sapiens	IC50	uM	0.9
	2250206	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5cc(F)c(N(C)C)cc5[nH]c4=O)nc3c2)CC1		CHEMBL498348	=	IC50	nM	1800.0	CHEMBL3650	Homo sapiens	IC50	uM	1.8
	2250207	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	CN1CCN(c2ccc3[nH]c(=O)c(-c4nc5ccccc5[nH]4)c(N)c3c2)CC1		CHEMBL457985	=	IC50	nM	4100.0	CHEMBL3650	Homo sapiens	IC50	uM	4.1
	2250208	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Cn1c(-c2c(O)c3ccccc3[nH]c2=O)nc2ccccc21		CHEMBL496172	=	IC50	nM	7900.0	CHEMBL3650	Homo sapiens	IC50	uM	7.9
	2250209	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Cn1c(=O)c(-c2nc3ccccc3[nH]2)c(O)c2ccccc21		CHEMBL523571	>	IC50	nM	25000.0	CHEMBL3650	Homo sapiens	IC50	uM	25.0
	2250210	CHEMBL1010125	Inhibition of human recombinant FGFR1	B	Cn1c(-c2c(O)c3ccccc3n(C)c2=O)nc2ccccc21		CHEMBL496173	>	IC50	nM	25000.0	CHEMBL3650	Homo sapiens	IC50	uM	25.0
	2250292	CHEMBL1011981	Inhibition of FGFR1 phosphorylation expressed in human KM12L4A cells by Western blot analysis	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	EC50	nM	166.0	CHEMBL3650	Homo sapiens	EC50	uM	0.166
	2250934	CHEMBL1011028	Inhibition of FGFR1	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	>	IC50	nM	4000.0	CHEMBL3650	Homo sapiens	IC50	uM	4.0
	2251210	CHEMBL1009908	Inhibition of FGFR1	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
	2251211	CHEMBL1009909	Inhibition of FGFR1 V561M mutant	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
	2264733	CHEMBL963869	Binding affinity to FGFR1	B	CS(=O)(=O)c1ccc(CNCc2cc(C(=O)O)c(Nc3ccc(I)cc3F)c(F)c2F)cc1		CHEMBL465465	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	2264734	CHEMBL963869	Binding affinity to FGFR1	B	NC(=O)C[C@H](N)C(=O)NCc1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL517647	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	2264735	CHEMBL963869	Binding affinity to FGFR1	B	O=C(N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F)c1ccc(CO)o1		CHEMBL481968	=	IC50	nM	2000.0	CHEMBL3650	Homo sapiens	IC50	uM	2.0
	2264736	CHEMBL963869	Binding affinity to FGFR1	B	O=C(CS(=O)(=O)c1ccc(Cl)cc1)N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL481969	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	2268494	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3c[nH]cn3)nn2)c1		CHEMBL464619	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268495	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL517021	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268496	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL516635	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268497	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460959	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268498	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460958	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268499	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Fc1ccc(CNc2ccccc2-c2cn(-c3cccc(Cl)c3)nn2)cc1F		CHEMBL460751	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268500	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Cc1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1C(F)(F)F		CHEMBL454403	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268501	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Cc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1C(F)(F)F		CHEMBL523320	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268502	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491872	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268503	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491871	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268504	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)c1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1Cl		CHEMBL522133	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268505	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	c1ccc(-c2cn(-c3ccc4[nH]ncc4c3)nn2)c(NCc2ccncc2)c1		CHEMBL516645	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268506	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	c1ccc(-c2cn(-c3ccc4ccccc4n3)nn2)c(NCc2ccncc2)c1		CHEMBL461605	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268507	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	CC(C)(C)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL461392	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268508	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	CC(C)(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL461391	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268509	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	CC(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL518652	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268510	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)Oc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491681	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268511	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL522304	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268512	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491680	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268513	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)Oc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL491502	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268514	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523133	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268515	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL490969	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268516	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL490968	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268517	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523301	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2268518	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL489329	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2289043	CHEMBL960818	Inhibition of FGFR1 at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL522629	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2298380	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	nM	50.0
	2298381	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	38.0	CHEMBL3650	Homo sapiens	IC50	nM	38.0
	2298382	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049	=	IC50	nM	71.0	CHEMBL3650	Homo sapiens	IC50	nM	71.0
	2298383	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)Cn2ccnc2)cc1)c1ccccc1		CHEMBL524453	=	IC50	nM	66.0	CHEMBL3650	Homo sapiens	IC50	nM	66.0
	2298384	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CC(=O)N(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL498088	=	IC50	nM	54.0	CHEMBL3650	Homo sapiens	IC50	nM	54.0
	2298385	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL525909	=	IC50	nM	17.0	CHEMBL3650	Homo sapiens	IC50	nM	17.0
	2298386	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL498265	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
	2298387	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL498266	=	IC50	nM	25.0	CHEMBL3650	Homo sapiens	IC50	nM	25.0
	2298388	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)N(C)CCN(C)C)cc1)c1ccccc1		CHEMBL525550	=	IC50	nM	88.0	CHEMBL3650	Homo sapiens	IC50	nM	88.0
	2298389	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL498105	=	IC50	nM	82.0	CHEMBL3650	Homo sapiens	IC50	nM	82.0
	2298390	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL465015	=	IC50	nM	219.0	CHEMBL3650	Homo sapiens	IC50	nM	219.0
Not Determined	2298391	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN(C)C)cc1)c1ccccc1		CHEMBL465016		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	2298392	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL518867		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	2298393	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCC2=O)cc1)c1ccccc1		CHEMBL465217		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	2298394	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(C(=O)N(C)CCN(C)C)c1)c1ccccc1		CHEMBL485642		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	2298395	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccccc1)c1ccccc1		CHEMBL519213		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	2298396	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCN(C)CC1)c1ccccc1		CHEMBL485643		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	2298397	CHEMBL1017192	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCC(NC(=O)CN(C)C)CC1)c1ccccc1		CHEMBL483781		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	2302215	CHEMBL945708	Inhibition of human FGFR1 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	2341410	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	2341450	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	86.0	CHEMBL3650	Homo sapiens	INH	%	86.0
	2341491	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	15.0	CHEMBL3650	Homo sapiens	INH	%	15.0
	2341532	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	52.0	CHEMBL3650	Homo sapiens	INH	%	52.0
	2341573	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	14.0	CHEMBL3650	Homo sapiens	INH	%	14.0
	2341614	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	2341655	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	13.0	CHEMBL3650	Homo sapiens	INH	%	13.0
	2341696	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	2341737	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	3.0	CHEMBL3650	Homo sapiens	INH	%	3.0
	2341778	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	19.0	CHEMBL3650	Homo sapiens	INH	%	19.0
	2341819	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	16.0	CHEMBL3650	Homo sapiens	INH	%	16.0
	2341860	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	20.0	CHEMBL3650	Homo sapiens	INH	%	20.0
	2341901	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	49.0	CHEMBL3650	Homo sapiens	INH	%	49.0
	2341942	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2341983	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	2342024	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	82.0	CHEMBL3650	Homo sapiens	INH	%	82.0
	2342065	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2342106	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2342147	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	59.0	CHEMBL3650	Homo sapiens	INH	%	59.0
	2342188	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	2342231	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2342270	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	21.0	CHEMBL3650	Homo sapiens	INH	%	21.0
	2342311	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2342352	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	80.0	CHEMBL3650	Homo sapiens	INH	%	80.0
	2342393	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	2342434	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2342475	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2342516	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	16.0	CHEMBL3650	Homo sapiens	INH	%	16.0
	2342789	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	2342822	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	2343097	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343121	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	2343143	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343167	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343191	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343215	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343239	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343263	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343624	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	2343685	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	2343706	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343728	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343750	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	2343772	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	21.0	CHEMBL3650	Homo sapiens	INH	%	21.0
	2343794	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	2343815	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343837	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	19.0	CHEMBL3650	Homo sapiens	INH	%	19.0
	2343859	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343881	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343903	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343925	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	4.0	CHEMBL3650	Homo sapiens	INH	%	4.0
	2343947	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	4.0	CHEMBL3650	Homo sapiens	INH	%	4.0
	2343968	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2343990	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2344013	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2344720	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	2344743	CHEMBL953370	Inhibition of FGFR1 at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	2356984	CHEMBL958280	Inhibition of FGFR1 at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	2361601	CHEMBL980903	Inhibition of human recombinant FGFR1	B	Cc1cc(C2CCN(CCCF)CC2)cc2[nH]c(-c3c(NCCn4cc(Cl)cn4)cc[nH]c3=O)nc12		CHEMBL459729	<	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	2379763	CHEMBL996114	Inhibition of human FGFR1 expressed in baculovirus insect cell system	B	COc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460989	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	2379773	CHEMBL996114	Inhibition of human FGFR1 expressed in baculovirus insect cell system	B	CC(C)Oc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460990	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	2386913	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1	Non standard unit for type	CHEMBL382818	=	ED50	uM	0.035	CHEMBL3650	Homo sapiens	ED50	uM	0.035
	2386914	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1	Non standard unit for type	CHEMBL380316	=	ED50	uM	0.01	CHEMBL3650	Homo sapiens	ED50	uM	0.01
	2386915	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	CC(C)(C)c1ccc(Nc2nnc(-c3cccc(C(N)=O)c3)c3ccccc23)cc1	Non standard unit for type	CHEMBL196994	=	ED50	uM	0.9	CHEMBL3650	Homo sapiens	ED50	uM	0.9
	2386916	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	CNC(=O)c1ccc(-c2nnc(Nc3ccc(C(C)(C)C)cc3)c3ccccc23)cc1	Non standard unit for type	CHEMBL196609	=	ED50	uM	0.27	CHEMBL3650	Homo sapiens	ED50	uM	0.27
	2386917	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	NC(=O)c1ccc(-c2nnc(Nc3cccc(Cl)c3)c3ccccc23)cc1	Non standard unit for type	CHEMBL407008	=	ED50	uM	0.37	CHEMBL3650	Homo sapiens	ED50	uM	0.37
	2386918	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	NC(=O)c1ccc(-c2nnc(Nc3cccc(Br)c3)c3ccccc23)cc1	Non standard unit for type	CHEMBL370193	=	ED50	uM	0.25	CHEMBL3650	Homo sapiens	ED50	uM	0.25
	2386919	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	CC(C)(C)c1cccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)c1	Non standard unit for type	CHEMBL196668	=	ED50	uM	1.2	CHEMBL3650	Homo sapiens	ED50	uM	1.2
	2386920	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	COC(=O)c1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1	Non standard unit for type	CHEMBL196610	>	ED50	uM	10.0	CHEMBL3650	Homo sapiens	ED50	uM	10.0
	2386921	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	Cc1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1	Non standard unit for type	CHEMBL194747	=	ED50	uM	5.0	CHEMBL3650	Homo sapiens	ED50	uM	5.0
	2386922	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	COc1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1	Non standard unit for type	CHEMBL195917	>	ED50	uM	10.0	CHEMBL3650	Homo sapiens	ED50	uM	10.0
	2386923	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	NC(=O)c1ccc(-c2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc1	Non standard unit for type	CHEMBL194746	=	ED50	uM	1.3	CHEMBL3650	Homo sapiens	ED50	uM	1.3
	2386924	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	NC(=O)c1ccc(-c2nnc(Nc3ccc(Br)cc3)c3ccccc23)cc1	Non standard unit for type	CHEMBL197158	=	ED50	uM	3.9	CHEMBL3650	Homo sapiens	ED50	uM	3.9
	2386925	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	CC(C)(C)c1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1	Non standard unit for type	CHEMBL370586	=	ED50	uM	0.21	CHEMBL3650	Homo sapiens	ED50	uM	0.21
	2386932	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	Non standard unit for type	CHEMBL24828	=	ED50	uM	0.15	CHEMBL3650	Homo sapiens	ED50	uM	0.15
	2386937	CHEMBL1006971	Inhibition of FGFR1 at 10 uM	B	Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1		CHEMBL380316	=	Inhibition	%	38.0	CHEMBL3650	Homo sapiens	INH	%	38.0
	2389228	CHEMBL944261	Inhibition of FGFR1 at 10 uM	B	O=c1cc2oc3cc(O)c(O)cc3c(-c3cccc(Cl)c3Cl)c-2cc1O		CHEMBL473332	=	Inhibition	%	85.0	CHEMBL3650	Homo sapiens	INH	%	85.0
	2396045	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	NC(=O)c1ccc(-c2nnc(Nc3ccc(OC(F)(F)Cl)cc3)c3ccccc23)cc1	Non standard unit for type	CHEMBL193342	=	ED50	uM	1.6	CHEMBL3650	Homo sapiens	ED50	uM	1.6
	2396046	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	CC(C)(C)c1ccc(Nc2nnc(-c3cccc4ncccc34)c3ccccc23)cc1	Non standard unit for type	CHEMBL202950	=	ED50	uM	2.4	CHEMBL3650	Homo sapiens	ED50	uM	2.4
	2396047	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	Clc1ccc(Nc2nnc(-c3cccc4ncccc34)c3ccccc23)cc1	Non standard unit for type	CHEMBL206846	>	ED50	uM	10.0	CHEMBL3650	Homo sapiens	ED50	uM	10.0
	2396048	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	Cc1cc2cc(Nc3nnc(-c4cccc5cnccc45)c4ccccc34)ccc2[nH]1	Non standard unit for type	CHEMBL206658	=	ED50	uM	1.4	CHEMBL3650	Homo sapiens	ED50	uM	1.4
	2396049	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	Cc1cccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)c1	Non standard unit for type	CHEMBL202998	=	ED50	uM	0.016	CHEMBL3650	Homo sapiens	ED50	uM	0.016
	2396050	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	Cc1ccccc1Nc1nnc(-c2cccc3cnccc23)c2ccccc12	Non standard unit for type	CHEMBL204220	>	ED50	uM	10.0	CHEMBL3650	Homo sapiens	ED50	uM	10.0
	2396051	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	Cc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)c(F)c1	Non standard unit for type	CHEMBL380508	=	ED50	uM	0.35	CHEMBL3650	Homo sapiens	ED50	uM	0.35
	2396052	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	FC(F)(F)c1cc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)ccc1Cl	Non standard unit for type	CHEMBL383616	=	ED50	uM	0.28	CHEMBL3650	Homo sapiens	ED50	uM	0.28
	2396053	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1Cl	Non standard unit for type	CHEMBL205823	=	ED50	uM	0.07	CHEMBL3650	Homo sapiens	ED50	uM	0.07
	2396054	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	c1cc(-c2nnc(Nc3ccc(N4CCOCC4)cc3)c3ccccc23)c2ccncc2c1	Non standard unit for type	CHEMBL203438	=	ED50	uM	0.88	CHEMBL3650	Homo sapiens	ED50	uM	0.88
	2396055	CHEMBL1006965	Inhibition of FGFR1/VEGFR2 chimeric construct expressed in HEK293 cells by ELISA	B	CC(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1	Non standard unit for type	CHEMBL203346	=	ED50	uM	0.024	CHEMBL3650	Homo sapiens	ED50	uM	0.024
	2418043	CHEMBL1019613	Inhibition of FGFR1 at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	38.0	CHEMBL3650	Homo sapiens	INH	%	38.0
	2419038	CHEMBL964244	Inhibition of FGFR1K autophosphorylation activity assessed as [32P] incorporation	B	O=CN1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL315546	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	2419039	CHEMBL964244	Inhibition of FGFR1K autophosphorylation activity assessed as [32P] incorporation	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	2470219	CHEMBL983621	Inhibition of FGFR1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	2476622	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	8.7	CHEMBL3650	Homo sapiens	Activity	%	8.7
Not Evaluated	2476825	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2478664	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3650	Homo sapiens	Activity		
	2478867	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	13.9	CHEMBL3650	Homo sapiens	Activity	%	13.9
Not Evaluated	2479722	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3650	Homo sapiens	Activity		
Active	2480721	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL3650	Homo sapiens	Activity		
	2488846	CHEMBL1028053	Inhibition of human FGFR1 expressed in insect cells by HTRF method	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	1810.0	CHEMBL3650	Homo sapiens	IC50	uM	1.81
	2488857	CHEMBL1028053	Inhibition of human FGFR1 expressed in insect cells by HTRF method	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)NNc4ccccc4)cc32)c(C)c1CCC(=O)O		CHEMBL480356	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	uM	0.1
	2488858	CHEMBL1028053	Inhibition of human FGFR1 expressed in insect cells by HTRF method	B	COc1cc(OC)cc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(CCC(=O)O)c2C)c1		CHEMBL231526	=	IC50	nM	520.0	CHEMBL3650	Homo sapiens	IC50	uM	0.52
	2507114	CHEMBL947776	Inhibition of FGFR1	B	Nc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)cc1Cl		CHEMBL475817	=	IC50	nM	13000.0	CHEMBL3650	Homo sapiens	IC50	uM	13.0
	2511580	CHEMBL972538	Inhibition of FGFR1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	uM	0.009
	2513005	CHEMBL970590	Inhibition of FGFR1 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	16.0	CHEMBL3650	Homo sapiens	INH	%	16.0
	2526444	CHEMBL981440	Inhibition of FGFR1	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	93.0	CHEMBL3650	Homo sapiens	IC50	nM	93.0
	2560054	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@@H]2O)cc1O		CHEMBL445196	=	Inhibition	%	99.4	CHEMBL3650	Homo sapiens	INH	%	99.4
	2560055	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	=	Inhibition	%	100.0	CHEMBL3650	Homo sapiens	INH	%	100.0
	2560056	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	O=C1COc2c(ccc(O)c2O)-c2cc(O)c(O)cc2C1		CHEMBL475940	=	Inhibition	%	98.4	CHEMBL3650	Homo sapiens	INH	%	98.4
	2560057	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	O=C1COc2cc(O)ccc2-c2cc(O)c(O)cc2C1		CHEMBL447427	=	Inhibition	%	29.0	CHEMBL3650	Homo sapiens	INH	%	29.0
Not Determined	2560058	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	CC(C)=CCc1c(O)ccc(C(=O)/C=C/c2ccc(O)cc2)c1O		CHEMBL253467		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	2560059	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)cc1		CHEMBL253777	=	Inhibition	%	28.0	CHEMBL3650	Homo sapiens	INH	%	28.0
	2560060	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O		CHEMBL129795	=	Inhibition	%	13.1	CHEMBL3650	Homo sapiens	INH	%	13.1
	2560061	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)c(O)c1		CHEMBL476986	=	Inhibition	%	86.9	CHEMBL3650	Homo sapiens	INH	%	86.9
	2560062	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O		CHEMBL128000	=	Inhibition	%	68.5	CHEMBL3650	Homo sapiens	INH	%	68.5
	2560063	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	COc1ccc(/C=C2\COc3cc(O)cc(O)c3C2=O)cc1		CHEMBL476776	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	2560064	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	COc1ccc(/C=C2\COc3cc(O)ccc3C2=O)cc1		CHEMBL450675	=	Inhibition	%	6.7	CHEMBL3650	Homo sapiens	INH	%	6.7
	2560065	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	O=C1/C(=C/c2ccc(O)c(O)c2)COc2cc(O)ccc21		CHEMBL249002	=	Inhibition	%	69.5	CHEMBL3650	Homo sapiens	INH	%	69.5
	2560066	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	O=C1/C(=C/c2ccc(O)cc2)COc2cc(O)ccc21		CHEMBL250414	=	Inhibition	%	76.2	CHEMBL3650	Homo sapiens	INH	%	76.2
	2560067	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)cc1		CHEMBL518739	=	Inhibition	%	13.8	CHEMBL3650	Homo sapiens	INH	%	13.8
	2560068	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477780	=	Inhibition	%	24.2	CHEMBL3650	Homo sapiens	INH	%	24.2
Not Determined	2560069	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	Oc1ccc2c(c1)OC[C@](O)(Cc1ccc(O)c(O)c1)[C@H]2O		CHEMBL477779		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Determined	2560070	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	O=C1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477778		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	2560071	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	Oc1ccc2c(c1O)OC[C@]1(O)Cc3ccc(O)c(O)c3[C@H]21		CHEMBL447506	=	Inhibition	%	94.3	CHEMBL3650	Homo sapiens	INH	%	94.3
	2560072	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	CO[C@H]1C23C=CC(=O)C(O)=C2OC[C@]1(O)Cc1cc(O)c(O)cc13		CHEMBL477781	=	Inhibition	%	48.1	CHEMBL3650	Homo sapiens	INH	%	48.1
	2560073	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	CO[C@@H]1C23C=CC(=O)C(O)=C2OC[C@]1(O)Cc1cc(O)c(O)cc13		CHEMBL514559	=	Inhibition	%	27.9	CHEMBL3650	Homo sapiens	INH	%	27.9
	2560074	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	O=C1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477768	=	Inhibition	%	96.7	CHEMBL3650	Homo sapiens	INH	%	96.7
	2560075	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	Oc1ccc(CC2=Cc3ccc(O)c(O)c3OC2)cc1O		CHEMBL477560	=	Inhibition	%	99.4	CHEMBL3650	Homo sapiens	INH	%	99.4
	2560076	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	Oc1ccc(CC2=Cc3ccc(O)cc3OC2)cc1		CHEMBL477559	=	Inhibition	%	14.4	CHEMBL3650	Homo sapiens	INH	%	14.4
Not Determined	2560077	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	CO[C@@H]1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL518432		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	2560078	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477769	=	Inhibition	%	93.3	CHEMBL3650	Homo sapiens	INH	%	93.3
	2560079	CHEMBL986513	Inhibition of FGFR1 at 10 uM by ELISA	B	Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@H]2O)cc1O		CHEMBL478611	=	Inhibition	%	97.5	CHEMBL3650	Homo sapiens	INH	%	97.5
	2560134	CHEMBL986501	Inhibition of FGFR1 by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	=	IC50	nM	320.0	CHEMBL3650	Homo sapiens	IC50	uM	0.32
	2560155	CHEMBL986501	Inhibition of FGFR1 by ELISA	B	Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@H]2O)cc1O		CHEMBL478611	=	IC50	nM	560.0	CHEMBL3650	Homo sapiens	IC50	uM	0.56
	2560160	CHEMBL986501	Inhibition of FGFR1 by ELISA	B	O=C1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477768	=	IC50	nM	2900.0	CHEMBL3650	Homo sapiens	IC50	uM	2.9
	2560161	CHEMBL986501	Inhibition of FGFR1 by ELISA	B	Oc1ccc(CC2=Cc3ccc(O)c(O)c3OC2)cc1O		CHEMBL477560	=	IC50	nM	600.0	CHEMBL3650	Homo sapiens	IC50	uM	0.6
	2561554	CHEMBL981080	Inhibition of human FGFR1	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	nM	140.0
Not Evaluated	2577343	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2577546	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3650	Homo sapiens	Activity		
	2583233	CHEMBL1009271	Inhibition of FGFR1	B	CNC(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1F		CHEMBL455428	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	2593548	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	1.7	CHEMBL3650	Homo sapiens	Activity	%	1.7
Not Evaluated	2593751	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2594017	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2594960	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2595163	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2595229	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2596360	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2597629	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Evaluated	2597832	CHEMBL1035886	Binding affinity to human FGFR1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3650	Homo sapiens	Activity		
	2602474	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL515880	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602548	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccc2ccccc2n1		CHEMBL458532	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602549	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1		CHEMBL512380	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602550	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL458531	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602551	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL517399	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602552	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462528	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602553	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462527	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602554	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccc(F)c(F)c1		CHEMBL518204	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602555	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(NCc1ccc2c(c1)OCO2)c1nscc1NCc1ccncc1		CHEMBL462315	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602556	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)c(F)c1		CHEMBL460191	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602557	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	Cc1cc(NC(=O)c2nscc2NCc2ccncc2)ccc1C(F)(F)F		CHEMBL512863	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602558	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1C(F)(F)F		CHEMBL470441	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602559	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL470440	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602560	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL512862	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602561	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL473268	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602562	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(NC1=CC2C=NNC2C=C1)c1nscc1NCc1ccncc1		CHEMBL443921	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602563	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc2ccccc2n1)c1nscc1NCc1ccncc1		CHEMBL474709	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602564	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccccc1Br)c1nscc1NCc1ccncc1		CHEMBL509737	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602565	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1nscc1NCc1ccncc1		CHEMBL473288	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602566	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccncc1		CHEMBL473287	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602567	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1nscc1NCc1ccncc1		CHEMBL475709	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602568	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1		CHEMBL475708	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602569	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1		CHEMBL475510	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602570	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL516243	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602571	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL475509	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602572	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccccn1		CHEMBL474494	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602573	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1cccnc1		CHEMBL474293	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602574	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL475704	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602575	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccccn1		CHEMBL475703	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2602576	CHEMBL1034030	Inhibition of FGFR1 at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1cccnc1		CHEMBL514986	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	2603068	CHEMBL1023863	Inhibition of FGFR1	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	2661403	CHEMBL1058609	Inhibition of FGFR1	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	IC50	nM	1207.0	CHEMBL3650	Homo sapiens	IC50	uM	1.207
	2704632	CHEMBL1054867	Inhibition of FGFR1 at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	-8.05	CHEMBL3650	Homo sapiens	INH	%	-8.05
	2721606	CHEMBL1057435	Inhibition of FGFR1 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	2896157	CHEMBL1052124	Inhibition of bFGFR	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21		CHEMBL327127	=	IC50	nM	61.5	CHEMBL3650	Homo sapiens	IC50	M	6.15E-8
	2896158	CHEMBL1052124	Inhibition of bFGFR	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(N4CCOCC4)cc3)nc21		CHEMBL106772	=	IC50	nM	98.8	CHEMBL3650	Homo sapiens	IC50	M	9.88E-8
	2896159	CHEMBL1052124	Inhibition of bFGFR	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	IC50	nM	1250.0	CHEMBL3650	Homo sapiens	IC50	M	0.00000125
	2896160	CHEMBL1052124	Inhibition of bFGFR	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(F)cc3)nc21		CHEMBL574059	=	IC50	nM	933.0	CHEMBL3650	Homo sapiens	IC50	M	9.33E-7
	2896161	CHEMBL1052124	Inhibition of bFGFR	B	CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL578006	=	IC50	nM	451.0	CHEMBL3650	Homo sapiens	IC50	M	4.51E-7
	2896162	CHEMBL1052124	Inhibition of bFGFR	B	CCN(CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1)C(C)=O		CHEMBL573820	=	IC50	nM	244.0	CHEMBL3650	Homo sapiens	IC50	M	2.44E-7
	2896163	CHEMBL1052124	Inhibition of bFGFR	B	Cc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)ccc1F		CHEMBL574058	=	IC50	nM	934.0	CHEMBL3650	Homo sapiens	IC50	M	9.34E-7
	2897249	CHEMBL1051306	Percent residual FGFR1 activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	80.0	CHEMBL3650	Homo sapiens	Activity	%	80.0
	2907111	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907112	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	6200.0	CHEMBL3650	Homo sapiens	Kd	nM	6200.0
	2907113	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	620.0	CHEMBL3650	Homo sapiens	Kd	nM	620.0
	2907114	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907115	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	4300.0	CHEMBL3650	Homo sapiens	Kd	nM	4300.0
	2907116	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907117	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	150.0	CHEMBL3650	Homo sapiens	Kd	nM	150.0
	2907118	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	4700.0	CHEMBL3650	Homo sapiens	Kd	nM	4700.0
	2907119	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907120	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907121	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907122	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3700.0	CHEMBL3650	Homo sapiens	Kd	nM	3700.0
	2907123	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907124	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907125	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907126	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907127	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907128	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	990.0	CHEMBL3650	Homo sapiens	Kd	nM	990.0
	2907129	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907130	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	810.0	CHEMBL3650	Homo sapiens	Kd	nM	810.0
	2907131	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907132	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907133	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907134	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2400.0	CHEMBL3650	Homo sapiens	Kd	nM	2400.0
	2907135	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907136	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1600.0	CHEMBL3650	Homo sapiens	Kd	nM	1600.0
	2907137	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907138	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907139	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907140	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907141	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907142	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2800.0	CHEMBL3650	Homo sapiens	Kd	nM	2800.0
	2907143	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	90.0	CHEMBL3650	Homo sapiens	Kd	nM	90.0
	2907144	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1900.0	CHEMBL3650	Homo sapiens	Kd	nM	1900.0
	2907145	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	520.0	CHEMBL3650	Homo sapiens	Kd	nM	520.0
	2907146	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	550.0	CHEMBL3650	Homo sapiens	Kd	nM	550.0
	2907147	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	2907148	CHEMBL1062840	Binding constant for FGFR1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	560.0	CHEMBL3650	Homo sapiens	Kd	nM	560.0
	2921338	CHEMBL1053727	Inhibition of FGFR1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	80.0	CHEMBL3650	Homo sapiens	Activity	%	80.0
	2926250	CHEMBL1056923	Inhibition of FGF-R1 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	90.0	CHEMBL3650	Homo sapiens	Activity	%	90.0
	2928436	CHEMBL1055347	Inhibition of FGF-R1 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	62.0	CHEMBL3650	Homo sapiens	Activity	%	62.0
	2938507	CHEMBL1041358	Inhibition of FGFR1 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	3.0	CHEMBL3650	Homo sapiens	INH	%	3.0
	2938625	CHEMBL1041495	Inhibition of FGFR1	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	microM	10.0
	2943696	CHEMBL1044069	Inhibition of FGFR1	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	microM	10.0
	2943708	CHEMBL1044069	Inhibition of FGFR1	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	microM	10.0
	2944867	CHEMBL1049990	Inhibition of FGFR1 at 2 uM	B	c1cncc(CN2CCC(n3ncc4c(N5CCOCC5)nc(-c5ccc6[nH]ccc6c5)nc43)CC2)c1		CHEMBL583194	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	2947587	CHEMBL1047355	Inhibition of FGFR1 at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	2992207	CHEMBL1044510	Inhibition of human FGFR1 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	8.0	CHEMBL3650	Homo sapiens	INH	%	8.0
	2999048	CHEMBL1044624	Inhibition of FGFR1 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	81.0	CHEMBL3650	Homo sapiens	Activity	%	81.0
	2999838	CHEMBL1044624	Inhibition of FGFR1 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	95.0	CHEMBL3650	Homo sapiens	Activity	%	95.0
	2999909	CHEMBL1050751	Inhibition of FGFR1 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	50.0	CHEMBL3650	Homo sapiens	Activity	%	50.0
	2999985	CHEMBL1050751	Inhibition of FGFR1 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	50.0	CHEMBL3650	Homo sapiens	Activity	%	50.0
	3052608	CHEMBL1037584	Residual activity of FGFR1 V561M mutant at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL3650	Homo sapiens	Residual activity	%	93.0
	3052609	CHEMBL1037585	Residual activity of wild type FGF-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	115.0	CHEMBL3650	Homo sapiens	Residual activity	%	115.0
	3053917	CHEMBL1045127	Residual activity of FGFR1 V561M mutant at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	26.0	CHEMBL3650	Homo sapiens	Residual activity	%	26.0
	3053918	CHEMBL1045128	Residual activity of wild type FGF-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	47.0	CHEMBL3650	Homo sapiens	Residual activity	%	47.0
	3054169	CHEMBL1040637	Residual activity of FGFR1 V561M mutant at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	109.0	CHEMBL3650	Homo sapiens	Residual activity	%	109.0
	3054170	CHEMBL1040638	Residual activity of wild type FGF-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	103.0	CHEMBL3650	Homo sapiens	Residual activity	%	103.0
	3055456	CHEMBL1037584	Residual activity of FGFR1 V561M mutant at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	103.0	CHEMBL3650	Homo sapiens	Residual activity	%	103.0
	3055457	CHEMBL1037585	Residual activity of wild type FGF-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	123.0	CHEMBL3650	Homo sapiens	Residual activity	%	123.0
	3055708	CHEMBL1045127	Residual activity of FGFR1 V561M mutant at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	32.0	CHEMBL3650	Homo sapiens	Residual activity	%	32.0
	3055709	CHEMBL1045128	Residual activity of wild type FGF-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	157.0	CHEMBL3650	Homo sapiens	Residual activity	%	157.0
	3057013	CHEMBL1040637	Residual activity of FGFR1 V561M mutant at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	108.0	CHEMBL3650	Homo sapiens	Residual activity	%	108.0
	3057014	CHEMBL1040638	Residual activity of wild type FGF-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	101.0	CHEMBL3650	Homo sapiens	Residual activity	%	101.0
	3058333	CHEMBL1037584	Residual activity of FGFR1 V561M mutant at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	102.0	CHEMBL3650	Homo sapiens	Residual activity	%	102.0
	3058334	CHEMBL1037585	Residual activity of wild type FGF-R1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	126.0	CHEMBL3650	Homo sapiens	Residual activity	%	126.0
	3058585	CHEMBL1045127	Residual activity of FGFR1 V561M mutant at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	47.0	CHEMBL3650	Homo sapiens	Residual activity	%	47.0
	3058586	CHEMBL1045128	Residual activity of wild type FGF-R1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	124.0	CHEMBL3650	Homo sapiens	Residual activity	%	124.0
	3072931	CHEMBL1040637	Residual activity of FGFR1 V561M mutant at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL3650	Homo sapiens	Residual activity	%	93.0
	3072932	CHEMBL1040638	Residual activity of wild type FGF-R1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL3650	Homo sapiens	Residual activity	%	95.0
	3084435	CHEMBL1073298	Inhibition of FGFR1	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3117924	CHEMBL1072200	Inhibition of FGFR1	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3117977	CHEMBL1072200	Inhibition of FGFR1	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3118030	CHEMBL1072200	Inhibition of FGFR1	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3123262	CHEMBL1067542	Inhibition of FGFR1	B	CC(C)(C)c1cc(NC(=O)c2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL598626	=	IC50	nM	4250.0	CHEMBL3650	Homo sapiens	IC50	uM	4.25
	3123970	CHEMBL1067542	Inhibition of FGFR1	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL597592	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3123971	CHEMBL1067542	Inhibition of FGFR1	B	O=C(Nc1cc(Oc2cccc3[nH]c(=O)[nH]c23)c(F)c(F)c1F)c1cccc(OC(F)(F)F)c1		CHEMBL602123	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
Not Active	3124772	CHEMBL1069629	Inhibition of FGFR1	B	O=C(NCc1n[nH]c(=O)c2ccccc12)c1ccc(Br)o1		CHEMBL603828		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124773	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(C2C=C(Nc3ccccc3)C(=O)N2c2ccccc2)ccc1O		CHEMBL598997		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124774	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(/C=C2\NC(=S)NC2=O)ccc1OCCCOc1cc(C)cc(C)c1		CHEMBL600414		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124775	CHEMBL1069629	Inhibition of FGFR1	B	Cc1ccc(SCCNCC(=O)COC(=O)Cc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL604542		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124776	CHEMBL1069629	Inhibition of FGFR1	B	O=c1[nH]c2ccc(NCc3cccc(OCc4ccccc4)c3)cc2[nH]1		CHEMBL602689		IC50			CHEMBL3650	Homo sapiens	IC50		
	3124777	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(/C=C2\SC(=N)NC2=O)ccc1OCCCOc1cc(C)cc(C)c1		CHEMBL602890	=	IC50	nM	23000.0	CHEMBL3650	Homo sapiens	IC50	uM	23.0
Not Active	3124778	CHEMBL1069629	Inhibition of FGFR1	B	O=C(CC1NC(=O)c2ccccc21)NCc1ccco1		CHEMBL591461		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124779	CHEMBL1069629	Inhibition of FGFR1	B	CC(C)C(=O)Nc1nc2c(c3c1c(=O)oc1ccccc13)CCCC2		CHEMBL597789		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124780	CHEMBL1069629	Inhibition of FGFR1	B	CCc1ccc(OCCCOc2ccc(/C=C3\SC(=O)NC3=O)cc2)cc1		CHEMBL597790		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124781	CHEMBL1069629	Inhibition of FGFR1	B	C/C(=N\CC1CCCO1)C1C(=O)NC(=O)N(c2ccc(C)cc2)C1=O		CHEMBL607854		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124782	CHEMBL1069629	Inhibition of FGFR1	B	O=C1C(Nc2ccccc2)=CC(c2cccc([N+](=O)[O-])c2)N1c1ccccc1		CHEMBL597989		IC50			CHEMBL3650	Homo sapiens	IC50		
	3124783	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCC(C)C4)ccc1OCC(=O)O		CHEMBL597990	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
Not Active	3124784	CHEMBL1069629	Inhibition of FGFR1	B	Cc1ccc2[nH]c(=O)c(C3=NC4C=CC(Cl)=CN4C3NCC3CCCO3)cc2c1		CHEMBL596743		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124785	CHEMBL1069629	Inhibition of FGFR1	B	COc1ccc(C2=NC3=C4C=C(Cl)C=CC4OC(=O)C3C(NC(C)=O)=N2)cc1		CHEMBL603868		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124786	CHEMBL1069629	Inhibition of FGFR1	B	CC(=O)Nc1nc(-c2ccc(C(C)(C)C)cc2)nc2c1c(=O)oc1ccccc12		CHEMBL599198		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124787	CHEMBL1069629	Inhibition of FGFR1	B	COc1ccc2cc(C3(C)NC(=O)N(Cc4ccc(F)cc4Cl)C3=O)ccc2c1		CHEMBL599199		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124788	CHEMBL1069629	Inhibition of FGFR1	B	CCOC(=O)CNc1ccccc1-c1nc2ccccc2[nH]c1=O		CHEMBL599200		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124789	CHEMBL1069629	Inhibition of FGFR1	B	COc1ccc2cc(-c3nc4cccc(C)n4c3NC3CCCC3)c(=O)[nH]c2c1		CHEMBL597161		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124790	CHEMBL1069629	Inhibition of FGFR1	B	Cc1ccc(C2(C)NC(=O)N(Cc3ccc(F)cc3)C2=O)cc1		CHEMBL610210		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124791	CHEMBL1069629	Inhibition of FGFR1	B	CC(=O)Nc1nc(-c2ccc(Cl)c(Cl)c2)nc2c1c(=O)oc1ccccc12		CHEMBL597162		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124792	CHEMBL1069629	Inhibition of FGFR1	B	O=C(CSc1nc2c(c(=O)[nH]1)C1CCCCC1S2)NCc1ccco1		CHEMBL597364		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124793	CHEMBL1069629	Inhibition of FGFR1	B	Cc1ccc2[nH]c(=O)c3cc(C(=O)N4CCN(C5=CC=CCN5)CC4)sc3c2c1		CHEMBL599412		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124794	CHEMBL1069629	Inhibition of FGFR1	B	CC(CCc1ccccc1)NC(=O)COC(=O)CC1Sc2ccccc2NC1=O		CHEMBL598396		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124795	CHEMBL1069629	Inhibition of FGFR1	B	C=C1c2ccccc2NC(=O)N1c1cccc(Cl)c1		CHEMBL598593		IC50			CHEMBL3650	Homo sapiens	IC50		
	3124796	CHEMBL1069629	Inhibition of FGFR1	B	CCOc1cc(/C=C2\NC(=S)NC2=O)ccc1OCCCOc1cc(C)cc(C)c1	Outside typical range	CHEMBL598601	=	IC50	nM	250000.0	CHEMBL3650	Homo sapiens	IC50	uM	250.0
	3124797	CHEMBL1069629	Inhibition of FGFR1	B	COCc1cc(/C=C2\NC(=S)NC2=O)ccc1OCCCOc1cc(C)cc(C)c1	Outside typical range	CHEMBL597374	=	IC50	nM	3300000.0	CHEMBL3650	Homo sapiens	IC50	uM	3300.0
Not Active	3124798	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(/C=C2\NC(=S)NC2=O)ccc1OCCCOc1ccccc1Cl		CHEMBL597573		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124799	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(/C=C2\NC(=S)NC2=O)ccc1OCCCOc1cccc(Cl)c1		CHEMBL606048		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124800	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(/C=C2\NC(=S)NC2=O)ccc1OCCCOc1ccc(Cl)cc1		CHEMBL598815		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124801	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(/C=C2\NC(=S)NC2=O)ccc1OCCCOc1cccc(C)c1		CHEMBL597985		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124802	CHEMBL1069629	Inhibition of FGFR1	B	COc1ccc(-c2nc(=O)c3c4c(sc3[nH]2)CC(C)CC4)cc1OC		CHEMBL597986		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Active	3124803	CHEMBL1069629	Inhibition of FGFR1	B	COc1cccc(-c2nc(=O)c3c4c(sc3[nH]2)CC(C)CC4)c1		CHEMBL597987		IC50			CHEMBL3650	Homo sapiens	IC50		
	3124804	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(-c2nc(=O)c3c([nH]2)sc2cc(C)ccc23)ccc1OCC(=O)O		CHEMBL596972	=	IC50	nM	4000.0	CHEMBL3650	Homo sapiens	IC50	uM	4.0
	3124805	CHEMBL1069629	Inhibition of FGFR1	B	CCc1ccc2c(c1)sc1[nH]c(-c3ccc(OCC(=O)O)c(OC)c3)nc(=O)c12		CHEMBL596973	=	IC50	nM	5500.0	CHEMBL3650	Homo sapiens	IC50	uM	5.5
Not Active	3124806	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(-c2nc(=O)c3c([nH]2)sc2cc(C(F)(F)F)ccc23)ccc1OCC(=O)O		CHEMBL599187		IC50			CHEMBL3650	Homo sapiens	IC50		
	3124807	CHEMBL1069629	Inhibition of FGFR1	B	COc1cc(-c2nc(=O)c3c([nH]2)sc2ccc(C)cc23)ccc1OCC(=O)O		CHEMBL599388	=	IC50	nM	1900.0	CHEMBL3650	Homo sapiens	IC50	uM	1.9
	3127293	CHEMBL1074371	Inhibition of FGFR1 at 1 uM	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	3127312	CHEMBL1074371	Inhibition of FGFR1 at 1 uM	B	CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1		CHEMBL597211	=	Inhibition	%	3.0	CHEMBL3650	Homo sapiens	INH	%	3.0
	3127331	CHEMBL1074371	Inhibition of FGFR1 at 1 uM	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	3127430	CHEMBL1074437	Inhibition of FGFR1 by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3127464	CHEMBL1074437	Inhibition of FGFR1 by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3213810	CHEMBL1108397	Inhibition of FGFR1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	3224819	CHEMBL1099656	Inhibition of FGFR1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3225069	CHEMBL1099656	Inhibition of FGFR1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3251252	CHEMBL1107907	Inhibition of FGFR1	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	nM	50.0
	3260097	CHEMBL1108071	Inhibition of FGF-R1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	31.0	CHEMBL3650	Homo sapiens	Activity	%	31.0
	3261376	CHEMBL1108071	Inhibition of FGF-R1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	37.0	CHEMBL3650	Homo sapiens	Activity	%	37.0
Not Active	3271904	CHEMBL1112912	Inhibition of FGFR1	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271905	CHEMBL1112912	Inhibition of FGFR1	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271906	CHEMBL1112912	Inhibition of FGFR1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271907	CHEMBL1112912	Inhibition of FGFR1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271908	CHEMBL1112912	Inhibition of FGFR1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271909	CHEMBL1112912	Inhibition of FGFR1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271910	CHEMBL1112912	Inhibition of FGFR1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271911	CHEMBL1112912	Inhibition of FGFR1	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271912	CHEMBL1112912	Inhibition of FGFR1	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	3271913	CHEMBL1112912	Inhibition of FGFR1	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	3271914	CHEMBL1112912	Inhibition of FGFR1	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL3650	Homo sapiens	INH	%	20.0
Not Active	3271915	CHEMBL1112912	Inhibition of FGFR1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	3291454	CHEMBL1111953	Inhibition of FGFR1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3294247	CHEMBL1104803	Inhibition of FGFR1	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	76.0	CHEMBL3650	Homo sapiens	IC50	nM	76.0
	3302024	CHEMBL1118616	Inhibition of FGFR1 at 1 uM	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(N5CCN(C)CC5)nc34)CC2)no1		CHEMBL1086579	=	Inhibition	%	80.0	CHEMBL3650	Homo sapiens	INH	%	80.0
	3307955	CHEMBL1119358	Inhibition of human FGFR1	B	Cc1cn(-c2cc(NC(=O)Nc3ccc(-c4nc5[nH]ncc5[nH]4)c(C)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1084036	=	Inhibition	%	26.0	CHEMBL3650	Homo sapiens	INH	%	26.0
	3316779	CHEMBL1120338	Inhibition of FGFR1 at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	3327242	CHEMBL1168284	Inhibition of FGFR1 at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3331941	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3333356	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3334761	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3336181	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3337528	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3337778	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3339112	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3340414	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3340709	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3342125	CHEMBL1169231	Inhibition of FGFR1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	3344685	CHEMBL1168106	Inhibition of FGFR1 assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	83.0	CHEMBL3650	Homo sapiens	Activity	%	83.0
	3344686	CHEMBL1168107	Inhibition of FGFR1 assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	88.0	CHEMBL3650	Homo sapiens	Activity	%	88.0
	3358576	CHEMBL1174421	Inhibition of FGFR1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.25	CHEMBL3650	Homo sapiens	INH	%	0.25
	3359018	CHEMBL1174421	Inhibition of FGFR1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.15	CHEMBL3650	Homo sapiens	INH	%	0.15
	3359781	CHEMBL1177622	Inhibition FGFR1 at 10 uM	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	Inhibition	%	48.7	CHEMBL3650	Homo sapiens	INH	%	48.7
	3359782	CHEMBL1177621	Inhibition FGFR1	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3407702	CHEMBL1219745	Inhibition of FGFR1 at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	=	Inhibition	%	77.0	CHEMBL3650	Homo sapiens	INH	%	77.0
	3407703	CHEMBL1219745	Inhibition of FGFR1 at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	=	Inhibition	%	41.0	CHEMBL3650	Homo sapiens	INH	%	41.0
	3420235	CHEMBL1226931	Inhibition of FGFR1	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3434685	CHEMBL1246554	Inhibition of FGFR1 at 5 uM	B	c1cc(-c2cc(C3CCNCC3)n[nH]2)ccn1		CHEMBL1241462	=	Inhibition	%	8.0	CHEMBL3650	Homo sapiens	INH	%	8.0
	3441499	CHEMBL1244082	Inhibition of human FGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	69.0	CHEMBL3650	Homo sapiens	IC50	nmol/L	69.0
	3443396	CHEMBL1244429	Inhibition of FGFR1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	73.0	CHEMBL3650	Homo sapiens	INH	%	73.0
	3443613	CHEMBL1244429	Inhibition of FGFR1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	3444768	CHEMBL1244429	Inhibition of FGFR1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	31.0	CHEMBL3650	Homo sapiens	INH	%	31.0
	3445116	CHEMBL1244838	Binding affinity to FGFR1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	310.0	CHEMBL3650	Homo sapiens	Kd	nM	310.0
	3445392	CHEMBL1244429	Inhibition of FGFR1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	15.0	CHEMBL3650	Homo sapiens	INH	%	15.0
	3445609	CHEMBL1244429	Inhibition of FGFR1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	23.0	CHEMBL3650	Homo sapiens	INH	%	23.0
	3445818	CHEMBL1244429	Inhibition of FGFR1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	71.0	CHEMBL3650	Homo sapiens	INH	%	71.0
	3446008	CHEMBL1244429	Inhibition of FGFR1 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	59.0	CHEMBL3650	Homo sapiens	INH	%	59.0
	3447179	CHEMBL1249722	Inhibition of FGFR-1 kinase	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	580.0	CHEMBL3650	Homo sapiens	IC50	uM	0.58
	3448007	CHEMBL1249765	Inhibition of FGFR-1 kinase activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	9.0	CHEMBL3650	Homo sapiens	INH	%	9.0
	3448083	CHEMBL1249765	Inhibition of FGFR-1 kinase activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	3448434	CHEMBL1244838	Binding affinity to FGFR1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	3448926	CHEMBL1244838	Binding affinity to FGFR1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1600.0	CHEMBL3650	Homo sapiens	Kd	nM	1600.0
	3449172	CHEMBL1244838	Binding affinity to FGFR1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	520.0	CHEMBL3650	Homo sapiens	Kd	nM	520.0
	3449432	CHEMBL1244838	Binding affinity to FGFR1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2800.0	CHEMBL3650	Homo sapiens	Kd	nM	2800.0
	3449669	CHEMBL1244838	Binding affinity to FGFR1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	3451002	CHEMBL1244838	Binding affinity to FGFR1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	uM	10.0
	3463229	CHEMBL1252417	Inhibition of FGFR1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	14.0	CHEMBL3650	Homo sapiens	INH	%	14.0
	3463448	CHEMBL1252417	Inhibition of FGFR1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	14.0	CHEMBL3650	Homo sapiens	INH	%	14.0
	3463992	CHEMBL1252417	Inhibition of FGFR1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	46.0	CHEMBL3650	Homo sapiens	INH	%	46.0
	3465436	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4ccccn4)c(Cl)c3)c21		CHEMBL1254097	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465437	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccnc4)c(Cl)c3)c21		CHEMBL1254098	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465438	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4ccncc4)c(Cl)c3)c21		CHEMBL1254192	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465439	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccn4)c(Cl)c3)c21		CHEMBL1254193	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465440	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cncc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1254277	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465441	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4ccnc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1254278	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465442	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cnn(CC(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1254355	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465443	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cnn(C(C)(C)C)c4)c(Cl)c3)c21		CHEMBL1254356	=	IC50	nM	940.0	CHEMBL3650	Homo sapiens	IC50	nM	940.0
	3465444	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)c(Cl)c3)c21		CHEMBL1253194	=	IC50	nM	220.0	CHEMBL3650	Homo sapiens	IC50	nM	220.0
	3465445	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ncnc3ccn(C)c23)cc1Cl		CHEMBL1254437	=	IC50	nM	260.0	CHEMBL3650	Homo sapiens	IC50	nM	260.0
	3465446	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1254190	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465447	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4ccn(C)c34)cc2Cl)cc1C(F)(F)F		CHEMBL1254515	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465448	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4ccc(N5CCOCC5)c(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1254595	=	IC50	nM	610.0	CHEMBL3650	Homo sapiens	IC50	nM	610.0
	3465449	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1254671	=	IC50	nM	4500.0	CHEMBL3650	Homo sapiens	IC50	nM	4500.0
	3465450	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	CN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ncnc5ccn(C)c45)cc3Cl)cc2C(F)(F)F)CC1		CHEMBL1254755	=	IC50	nM	14.0	CHEMBL3650	Homo sapiens	IC50	nM	14.0
	3465451	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	CN1CCC(Oc2ccc(NC(=O)Nc3ccc(Oc4ncnc5ccn(C)c45)cc3Cl)cc2C(F)(F)F)CC1		CHEMBL1254839	=	IC50	nM	270.0	CHEMBL3650	Homo sapiens	IC50	nM	270.0
	3465452	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	COc1cc(NC(=O)Nc2ccc(Oc3ncnc4ccn(C)c34)cc2Cl)cc(C(F)(F)F)c1		CHEMBL1254840	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465453	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cc(N5CCOCC5)cc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1254927	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465454	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cc(CN5CCOCC5)cc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1255013	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465455	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	CN1CCN(Cc2cc(NC(=O)Nc3ccc(Oc4ncnc5ccn(C)c45)cc3Cl)cc(C(F)(F)F)c2)CC1		CHEMBL1255097	=	IC50	nM	390.0	CHEMBL3650	Homo sapiens	IC50	nM	390.0
	3465463	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	COCCn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1253838	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	nM	27000.0
	3465464	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccc(Oc2ncnc3ccn(CCO)c23)cc1Cl		CHEMBL1253916	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465471	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccc(Oc2ncnc3ccn(CCOCCO)c23)cc1Cl		CHEMBL1253837	=	IC50	nM	6500.0	CHEMBL3650	Homo sapiens	IC50	nM	6500.0
	3465472	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1c(CO)cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1255098	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465473	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	COCc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(Cl)c3)c2n1C		CHEMBL1253917	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465474	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1c(C(C)(C)O)cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1254006	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465475	CHEMBL1250685	Inhibition of His-tagged human FGFR1 expressed in Sf9 cells	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3465478	CHEMBL1250692	Inhibition of FGFR1	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	3471606	CHEMBL1250647	Inhibition of FGFR1	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
Not Active	3499128	CHEMBL1259872	Inhibition of FGF1R at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	3504226	CHEMBL1260159	Inhibition of FGFR1	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	=	IC50	nM	14.0	CHEMBL3650	Homo sapiens	IC50	uM	0.014
	3526986	CHEMBL1275107	Inhibition of FGFR1	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	3556500	CHEMBL1285583	Inhibition of FGFR1 at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	63.0	CHEMBL3650	Homo sapiens	INH	%	63.0
	3590869	CHEMBL1292167	Inhibition of FGFR1	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2F)c1N		CHEMBL1290746	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
Not Active	3599534	CHEMBL1291150	Displacement of radiolabeled Poly(Glu:Tyr) from FGFR1 at 1 to 3 uM	B	Oc1ccc2c(c1)CCN(CCCCc1ccccc1)CC2O		CHEMBL1289626		Activity			CHEMBL3650	Homo sapiens	Activity		
	5120299	CHEMBL1645962	Inhibition of human FGFR1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	98.0	CHEMBL3650	Homo sapiens	INH	%	98.0
	5120376	CHEMBL1645963	Inhibition of human FGFR1 V561M mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	106.0	CHEMBL3650	Homo sapiens	INH	%	106.0
	5120829	CHEMBL1646813	Inhibition of FGFR1 at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	5123796	CHEMBL1649036	Inhibition of FGFR1 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	96.0	CHEMBL3650	Homo sapiens	INH	%	96.0
	5133666	CHEMBL1648746	Inhibition of FGFR1 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	51.0	CHEMBL3650	Homo sapiens	Activity	%	51.0
	5133761	CHEMBL1648746	Inhibition of FGFR1 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	99.0	CHEMBL3650	Homo sapiens	Activity	%	99.0
	5133910	CHEMBL1648746	Inhibition of FGFR1 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	100.0	CHEMBL3650	Homo sapiens	Activity	%	100.0
	5140517	CHEMBL1646077	Inhibition of FGFR1 at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	5191453	CHEMBL1664083	Inhibition of FGF-R1 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	14.0	CHEMBL3650	Homo sapiens	INH	%	14.0
	5191454	CHEMBL1664083	Inhibition of FGF-R1 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	56.0	CHEMBL3650	Homo sapiens	INH	%	56.0
	5243705	CHEMBL1685668	Inhibition of FGFR1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	5243813	CHEMBL1685917	Inhibition of FGFR1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	-2.0	CHEMBL3650	Homo sapiens	INH	%	-2.0
	5243926	CHEMBL1685668	Inhibition of FGFR1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	5244034	CHEMBL1685917	Inhibition of FGFR1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	5244907	CHEMBL1685668	Inhibition of FGFR1 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	63.0	CHEMBL3650	Homo sapiens	INH	%	63.0
	5245015	CHEMBL1685917	Inhibition of FGFR1 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	5245166	CHEMBL1685668	Inhibition of FGFR1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	27.0	CHEMBL3650	Homo sapiens	INH	%	27.0
	5245996	CHEMBL1685917	Inhibition of FGFR1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	23.0	CHEMBL3650	Homo sapiens	INH	%	23.0
	5293859	CHEMBL1697115	Inhibition of FGFR-1 after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	=	IC50	nM	13100.0	CHEMBL3650	Homo sapiens	IC50	uM	13.1
	5312994	CHEMBL1694379	Inhibition of recombinant human FGFR1 kinase assessed as residual activity at 10 uM in presence of 100 uM ATP	B	Cc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1		CHEMBL1689369	=	Activity	%	92.0	CHEMBL3650	Homo sapiens	Activity	%	92.0
	5313002	CHEMBL1694379	Inhibition of recombinant human FGFR1 kinase assessed as residual activity at 10 uM in presence of 100 uM ATP	B	CCOc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1		CHEMBL1689372	=	Activity	%	99.0	CHEMBL3650	Homo sapiens	Activity	%	99.0
	6151129	CHEMBL1764817	Inhibition FGFR1	B	COCCN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cc(CO)ccc1C		CHEMBL1762549	=	IC50	nM	720.0	CHEMBL3650	Homo sapiens	IC50	uM	0.72
	6151130	CHEMBL1764817	Inhibition FGFR1	B	COc1cncc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762535	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	uM	0.14
	6151131	CHEMBL1764817	Inhibition FGFR1	B	COc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)n1		CHEMBL1762534	=	IC50	nM	998.0	CHEMBL3650	Homo sapiens	IC50	uM	0.998
	6151132	CHEMBL1764817	Inhibition FGFR1	B	COc1ccnc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762533	=	IC50	nM	1380.0	CHEMBL3650	Homo sapiens	IC50	uM	1.38
	6151133	CHEMBL1764817	Inhibition FGFR1	B	Cc1ccc(C(C)O)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762532	=	IC50	nM	1550.0	CHEMBL3650	Homo sapiens	IC50	uM	1.55
	6151134	CHEMBL1764817	Inhibition FGFR1	B	CN(c1ccc(Cl)c(CO)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762531	=	IC50	nM	56.0	CHEMBL3650	Homo sapiens	IC50	uM	0.056
	6151135	CHEMBL1764817	Inhibition FGFR1	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762530	=	IC50	nM	3340.0	CHEMBL3650	Homo sapiens	IC50	uM	3.34
	6151136	CHEMBL1764817	Inhibition FGFR1	B	COc1cc(CO)cc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762529	=	IC50	nM	447.0	CHEMBL3650	Homo sapiens	IC50	uM	0.447
	6151137	CHEMBL1764817	Inhibition FGFR1	B	CN(c1cccc(CO)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762528	=	IC50	nM	738.0	CHEMBL3650	Homo sapiens	IC50	uM	0.738
	6151138	CHEMBL1764817	Inhibition FGFR1	B	COc1ccc(C)c(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762527	=	IC50	nM	350.0	CHEMBL3650	Homo sapiens	IC50	uM	0.35
	6151139	CHEMBL1764817	Inhibition FGFR1	B	Cc1ccc(C)c(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762526	=	IC50	nM	1580.0	CHEMBL3650	Homo sapiens	IC50	uM	1.58
	6151140	CHEMBL1764817	Inhibition FGFR1	B	COc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762525	=	IC50	nM	183.0	CHEMBL3650	Homo sapiens	IC50	uM	0.183
	6151141	CHEMBL1764817	Inhibition FGFR1	B	CN(c1cccc(Cl)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762524	=	IC50	nM	112.0	CHEMBL3650	Homo sapiens	IC50	uM	0.112
	6151142	CHEMBL1764817	Inhibition FGFR1	B	Cc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762523	=	IC50	nM	501.0	CHEMBL3650	Homo sapiens	IC50	uM	0.501
	6151143	CHEMBL1764817	Inhibition FGFR1	B	Cc1ccccc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762522	=	IC50	nM	662.0	CHEMBL3650	Homo sapiens	IC50	uM	0.662
	6151144	CHEMBL1764817	Inhibition FGFR1	B	CN(c1ccccc1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762521	=	IC50	nM	313.0	CHEMBL3650	Homo sapiens	IC50	uM	0.313
	6157560	CHEMBL1763572	Inhibition of FGFR1 at 1 uM relative to control	B	N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1615182	=	Inhibition	%	43.0	CHEMBL3650	Homo sapiens	INH	%	43.0
	6157564	CHEMBL1763572	Inhibition of FGFR1 at 1 uM relative to control	B	Cc1nc(NCC#N)nc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1762782	=	Inhibition	%	100.0	CHEMBL3650	Homo sapiens	INH	%	100.0
	6167561	CHEMBL1769034	Binding affinity to human Fgfr1 assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	100.0	CHEMBL3650	Homo sapiens	Activity	%	100.0
	6167577	CHEMBL1769051	Binding affinity to human Fgfr1 assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	80.0	CHEMBL3650	Homo sapiens	Activity	%	80.0
	6171350	CHEMBL1769165	Inhibition of FGFR1	B	CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1		CHEMBL1766529	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	6172479	CHEMBL1767802	Inhibition of FGFR1 assessed as residual activity at 25 uM after 20 mins using IGF-IRtide (12-527) substrate for [gamma-33P]ATP incorporation by liquid scintillation counting	B	CCOC(=O)c1c(O)nc2cccc3c2c1-c1ccccc1C3=O		CHEMBL1345690	=	Activity	%	44.0	CHEMBL3650	Homo sapiens	Activity	%	44.0
	6193897	CHEMBL1777656	Inhibition of FGFR1 at 10 uM by ELISA based method	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	15.5	CHEMBL3650	Homo sapiens	INH	%	15.5
	6193908	CHEMBL1777656	Inhibition of FGFR1 at 10 uM by ELISA based method	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	31.3	CHEMBL3650	Homo sapiens	INH	%	31.3
	6193919	CHEMBL1777656	Inhibition of FGFR1 at 10 uM by ELISA based method	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	61.2	CHEMBL3650	Homo sapiens	INH	%	61.2
	6198119	CHEMBL1776210	Inhibition of FGFR1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6210063	CHEMBL1781090	Inhibition of FGFR1 at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	62.7	CHEMBL3650	Homo sapiens	INH	%	62.7
	6212358	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	=	IC50	nM	74.0	CHEMBL3650	Homo sapiens	IC50	uM	0.074
	6212376	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	N#CC1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784718	=	IC50	nM	4500.0	CHEMBL3650	Homo sapiens	IC50	uM	4.5
	6212377	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCCSc1ccc2c3c(cccc13)C1=NC(=O)C(C#N)=C12		CHEMBL1784719	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212378	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C#N)=C12		CHEMBL1784720	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212379	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CC(C)Sc1ccc2c3c(cccc13)C1=NC(=O)C(C#N)=C12		CHEMBL1784705	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212380	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	N#CC1=C2C(=NC1=O)c1cccc3c(SCCc4cnccn4)ccc2c13		CHEMBL1782083	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212381	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	N#CC1=C2C(=NC1=O)c1cccc3c(SCCO)ccc2c13		CHEMBL1784721	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212382	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CC1OCCC1Sc1ccc2c3c(cccc13)C1=NC(=O)C(C#N)=C12		CHEMBL1784722	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212383	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CC(Sc1ccc2c3c(cccc13)C1=NC(=O)C(C#N)=C12)C1(C)CSCO1		CHEMBL1784723	=	IC50	nM	3600.0	CHEMBL3650	Homo sapiens	IC50	uM	3.6
	6212384	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	N#CC1=C2C(=NC1=O)c1cccc3c(SCCN4CCSC4)ccc2c13		CHEMBL1784724	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212385	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784726	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212386	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784727	=	IC50	nM	485.0	CHEMBL3650	Homo sapiens	IC50	uM	0.485
	6212387	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3c(SC(C)C)ccc2c13		CHEMBL1784728	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212388	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3c(SCCc4cnccn4)ccc2c13		CHEMBL1784729	=	IC50	nM	2100.0	CHEMBL3650	Homo sapiens	IC50	uM	2.1
	6212389	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3c(SCCO)ccc2c13		CHEMBL1784730	=	IC50	nM	320.0	CHEMBL3650	Homo sapiens	IC50	uM	0.32
	6212390	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3c(SC4CCOC4C)ccc2c13		CHEMBL1784731	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212391	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3c(SC(C)C4(C)CSCO4)ccc2c13		CHEMBL1784732	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212392	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3c(SCCN4CCSC4)ccc2c13		CHEMBL1784733	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212393	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	C=CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784734	=	IC50	nM	19.0	CHEMBL3650	Homo sapiens	IC50	uM	0.019
	6212394	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCCSC(=O)COC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784735	=	IC50	nM	65.0	CHEMBL3650	Homo sapiens	IC50	uM	0.065
	6212395	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	O=C(COC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13)OCC(F)(F)C(F)(F)F		CHEMBL1784736	=	IC50	nM	77.0	CHEMBL3650	Homo sapiens	IC50	uM	0.077
	6212396	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	C=CCOC(=O)C1=C2C(=NC1=O)c1cccc3c(SCCC)ccc2c13		CHEMBL1784737	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212397	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	C=CCOC(=O)C1=C2C(=NC1=O)c1cccc3c(SCC=C)ccc2c13		CHEMBL1784738	=	IC50	nM	216.0	CHEMBL3650	Homo sapiens	IC50	uM	0.216
	6212398	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCCSC(=O)COC(=O)C1=C2C(=NC1=O)c1cccc3c(SCCC)ccc2c13		CHEMBL1784739	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212399	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC(=O)SCCC)=C12		CHEMBL1784740	=	IC50	nM	577.0	CHEMBL3650	Homo sapiens	IC50	uM	0.577
	6212400	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC(=O)OCC(F)(F)C(F)(F)F)=C12		CHEMBL1784741	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6212401	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC(=O)OCC(F)(F)C(F)(F)F)=C12		CHEMBL1784742	=	IC50	nM	424.0	CHEMBL3650	Homo sapiens	IC50	uM	0.424
	6212402	CHEMBL1785928	Inhibition of FGFR1 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	334.0	CHEMBL3650	Homo sapiens	IC50	uM	0.334
Active	6212405	CHEMBL1786374	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Akt phosphorylation at 10 uM after 12 hrs by Western blot analysis	B	CCCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784726		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	6212406	CHEMBL1786374	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Akt phosphorylation at 10 uM after 12 hrs by Western blot analysis	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	6212407	CHEMBL1786374	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Akt phosphorylation at 10 uM after 12 hrs by Western blot analysis	B	C=CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784734		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	6212408	CHEMBL1786374	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Akt phosphorylation at 10 uM after 12 hrs by Western blot analysis	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784727		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	6212409	CHEMBL1786369	Inhibition of b-FGF-induced FGFR1 phosphorylation in human BxPC3 cells after 12 hrs by Western blot analysis	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784727		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	6212410	CHEMBL1786371	Inhibition of b-FGF-induced FGFR1 phosphorylation in human BxPC3 cells at 10 uM after 12 hrs by Western blot analysis relative to control	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784727		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	6212411	CHEMBL1786370	Inhibition of b-FGF-induced FGFR1 phosphorylation in human BxPC3 cells at 1.25 uM after 12 hrs by Western blot analysis	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784727		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	6212412	CHEMBL1786373	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Erk1/2 phosphorylation at 10 uM after 12 hrs by Western blot analysis	B	C=CCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784727		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	6212413	CHEMBL1786372	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Erk1/2 phosphorylation after 12 hrs by Western blot analysis	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	6212414	CHEMBL1786372	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Erk1/2 phosphorylation after 12 hrs by Western blot analysis	B	C=CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784734		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	6212415	CHEMBL1786373	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Erk1/2 phosphorylation at 10 uM after 12 hrs by Western blot analysis	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	6212416	CHEMBL1786373	Inhibition of FGFR1 in human BxPC3 cells assessed as reduction of Erk1/2 phosphorylation at 10 uM after 12 hrs by Western blot analysis	B	CCCSc1ccc2c3c(cccc13)C1=NC(=O)C(C(=O)OCC)=C12		CHEMBL1784726		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	6219892	CHEMBL1785580	Inhibition of human FGFR1 using KKKSPGEYVNIEFG peptide substrate by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	1.8	CHEMBL3650	Homo sapiens	IC50	nM	1.8
	6230415	CHEMBL1786950	Inhibition of FGFR1	B	O=C(c1cccs1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1782188	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6230416	CHEMBL1786950	Inhibition of FGFR1	B	O=C(c1ccc[nH]1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1782187	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6230417	CHEMBL1786950	Inhibition of FGFR1	B	CCOc1cccc2cc(C(=O)N3N=C(c4cccnc4)CC3c3ccccc3O)oc12		CHEMBL1782186	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6230418	CHEMBL1786950	Inhibition of FGFR1	B	O=C(c1ccc(Br)o1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1782185	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6230419	CHEMBL1786950	Inhibition of FGFR1	B	O=C(c1cccc(-n2cccn2)c1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1782182	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6231467	CHEMBL1786950	Inhibition of FGFR1	B	O=C(c1ccco1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1779593	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	6265544	CHEMBL1799807	Inhibition of FGFR1 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	=	Inhibition	%	86.0	CHEMBL3650	Homo sapiens	INH	%	86.0
	6265648	CHEMBL1799807	Inhibition of FGFR1 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	=	Inhibition	%	100.0	CHEMBL3650	Homo sapiens	INH	%	100.0
	6273824	CHEMBL1806265	Inhibition of FGFR1 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	86.0	CHEMBL3650	Homo sapiens	Activity	%	86.0
	6281546	CHEMBL1804199	Inhibition of human FGFR1	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	IC50	nM	65.0	CHEMBL3650	Homo sapiens	IC50	nM	65.0
	6299678	CHEMBL1811575	Inhibition of FGFR1	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	>	IC50	nM	25000.0	CHEMBL3650	Homo sapiens	IC50	uM	25.0
	6304895	CHEMBL1816286	Inhibition of FGFR1	B	O=C(Nc1ccc(Oc2ncnc3scc(-c4ccccc4)c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL1813632	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	6340921	CHEMBL1826945	Activity of FGFR1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	91.0	CHEMBL3650	Homo sapiens	Activity	%	91.0
	6352209	CHEMBL1825746	Inhibition of FGF-R1 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	68.0	CHEMBL3650	Homo sapiens	Activity	%	68.0
	6375117	CHEMBL1838157	Inhibition of FGFR1 at 1 uM	B	O=C(O)COc1ncnc2cc(-c3ccc4[nH]ncc4c3)sc12		CHEMBL1836641	=	Inhibition	%	3.3	CHEMBL3650	Homo sapiens	INH	%	3.3
	6375133	CHEMBL1838157	Inhibition of FGFR1 at 1 uM	B	CC(=O)Nc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1		CHEMBL1836724	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	6386431	CHEMBL1838074	Inhibition of FGFR1-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
	6386439	CHEMBL1838066	Inhibition of wild type FGFR1 expressed in HEK293 cells assessed as inhibition of autophosphorylation of tyrosine residue after 40 mins by ELISA assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	4.6	CHEMBL3650	Homo sapiens	IC50	nM	4.6
	6386463	CHEMBL1837845	Inhibition of recombinant FGFR1	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	0.9	CHEMBL3650	Homo sapiens	IC50	uM	0.0009
	6387470	CHEMBL1839974	Inhibition of FGFR1	B	CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL253292	=	IC50	nM	570.0	CHEMBL3650	Homo sapiens	IC50	nM	570.0
	7567551	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7568022	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7568490	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	62.0	CHEMBL3650	Homo sapiens	Kd	nM	62.0
	7568922	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1900.0	CHEMBL3650	Homo sapiens	Kd	nM	1900.0
	7569065	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	53.0	CHEMBL3650	Homo sapiens	Kd	nM	53.0
	7569525	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7569997	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7570460	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7570887	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	520.0	CHEMBL3650	Homo sapiens	Kd	nM	520.0
	7571041	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7571498	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7571974	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7572437	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7573022	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7573479	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3700.0	CHEMBL3650	Homo sapiens	Kd	nM	3700.0
	7573955	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3500.0	CHEMBL3650	Homo sapiens	Kd	nM	3500.0
	7574390	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	47.0	CHEMBL3650	Homo sapiens	Kd	nM	47.0
	7575000	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	92.0	CHEMBL3650	Homo sapiens	Kd	nM	92.0
	7575461	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7575955	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1600.0	CHEMBL3650	Homo sapiens	Kd	nM	1600.0
	7576363	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7576974	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7577433	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	690.0	CHEMBL3650	Homo sapiens	Kd	nM	690.0
	7577469	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7577939	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	5300.0	CHEMBL3650	Homo sapiens	Kd	nM	5300.0
	7578344	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	280.0	CHEMBL3650	Homo sapiens	Kd	nM	280.0
	7578982	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7579356	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	4300.0	CHEMBL3650	Homo sapiens	Kd	nM	4300.0
	7579838	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	370.0	CHEMBL3650	Homo sapiens	Kd	nM	370.0
	7580307	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	570.0	CHEMBL3650	Homo sapiens	Kd	nM	570.0
	7580710	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	560.0	CHEMBL3650	Homo sapiens	Kd	nM	560.0
	7581728	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7582199	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7582663	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7583063	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	550.0	CHEMBL3650	Homo sapiens	Kd	nM	550.0
	7583244	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7583641	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7584086	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7584557	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	4000.0	CHEMBL3650	Homo sapiens	Kd	nM	4000.0
	7585019	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	44.0	CHEMBL3650	Homo sapiens	Kd	nM	44.0
	7585423	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7585574	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7585982	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7586428	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7586899	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7587353	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7587535	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7587954	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	99.0	CHEMBL3650	Homo sapiens	Kd	nM	99.0
	7588407	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7588878	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7589500	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	380.0	CHEMBL3650	Homo sapiens	Kd	nM	380.0
	7589924	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	310.0	CHEMBL3650	Homo sapiens	Kd	nM	310.0
	7590391	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7590874	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7591473	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	6200.0	CHEMBL3650	Homo sapiens	Kd	nM	6200.0
	7591895	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	150.0	CHEMBL3650	Homo sapiens	Kd	nM	150.0
	7592367	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7592398	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7592851	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7593440	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	620.0	CHEMBL3650	Homo sapiens	Kd	nM	620.0
	7593875	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	4700.0	CHEMBL3650	Homo sapiens	Kd	nM	4700.0
	7594378	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2400.0	CHEMBL3650	Homo sapiens	Kd	nM	2400.0
	7594830	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7595408	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7595884	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7596355	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7596802	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2800.0	CHEMBL3650	Homo sapiens	Kd	nM	2800.0
	7597380	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7597391	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7597864	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3650	Homo sapiens	Kd	nM	10000.0
	7598334	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	990.0	CHEMBL3650	Homo sapiens	Kd	nM	990.0
	7598776	CHEMBL1908829	Binding constant for FGFR1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	90.0	CHEMBL3650	Homo sapiens	Kd	nM	90.0
	7922724	CHEMBL1919219	Inhibition of human recombinant FGFR1 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	7939638	CHEMBL1919598	Inhibition of human FGFR1	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	7956220	CHEMBL1924839	Inhibition of N-terminus flag-tagged FGFR1 expressed in baculovirus infected insect cells using ATP as substrate after 10 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	7959765	CHEMBL1932857	Inhibition of FGFR1	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	7959766	CHEMBL1932857	Inhibition of FGFR1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	15000.0	CHEMBL3650	Homo sapiens	IC50	uM	15.0
	7969723	CHEMBL1931223	Inhibition of FGF-R1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	55.0	CHEMBL3650	Homo sapiens	Activity	%	55.0
	7970426	CHEMBL1930191	Inhibition of FGFR1 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	3.0	CHEMBL3650	Homo sapiens	INH	%	3.0
	7984078	CHEMBL1936515	Inhibition of FGFR1	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	7984079	CHEMBL1936515	Inhibition of FGFR1	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	7987130	CHEMBL1936083	Inhibition of FGFR1	B	O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21		CHEMBL1933538	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	7987152	CHEMBL1936083	Inhibition of FGFR1	B	O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21		CHEMBL1933550	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	7987174	CHEMBL1936083	Inhibition of FGFR1	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933551	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	7987206	CHEMBL1936083	Inhibition of FGFR1	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	=	IC50	nM	22700.0	CHEMBL3650	Homo sapiens	IC50	uM	22.7
	7991160	CHEMBL1937312	Inhibition of FGFR1	B	CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)CC1		CHEMBL1934327	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	7991998	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934300	=	Inhibition	%	39.2	CHEMBL3650	Homo sapiens	INH	%	39.2
	7991999	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934301	=	Inhibition	%	27.2	CHEMBL3650	Homo sapiens	INH	%	27.2
	7992000	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	CCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934302	=	Inhibition	%	37.4	CHEMBL3650	Homo sapiens	INH	%	37.4
	7992001	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934303	=	Inhibition	%	32.9	CHEMBL3650	Homo sapiens	INH	%	32.9
	7992002	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	CCCC(CCC)C(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934304	=	Inhibition	%	37.2	CHEMBL3650	Homo sapiens	INH	%	37.2
	7992003	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	C=CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934305	=	Inhibition	%	40.8	CHEMBL3650	Homo sapiens	INH	%	40.8
	7992004	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccco1		CHEMBL1934306	=	Inhibition	%	43.0	CHEMBL3650	Homo sapiens	INH	%	43.0
	7992005	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccncc1		CHEMBL1934307	=	Inhibition	%	40.3	CHEMBL3650	Homo sapiens	INH	%	40.3
Not Determined	7992006	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Determined	7992007	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Determined	7992008	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Determined	7992009	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Determined	7992010	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1		CHEMBL56393		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	7992011	CHEMBL1937687	Inhibition of FGFR1 at 10 uM	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	Inhibition	%	78.6	CHEMBL3650	Homo sapiens	INH	%	78.6
	7992185	CHEMBL1935894	Inhibition of FGFR1 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	85.0	CHEMBL3650	Homo sapiens	INH	%	85.0
	7996688	CHEMBL1944019	Inhibition of FGFR1 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	94.0	CHEMBL3650	Homo sapiens	INH	%	94.0
	7996744	CHEMBL1944019	Inhibition of FGFR1 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	94.0	CHEMBL3650	Homo sapiens	INH	%	94.0
	8002113	CHEMBL1942187	Inhibition of FGFR1 at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	17.0	CHEMBL3650	Homo sapiens	INH	%	17.0
	8002114	CHEMBL1942187	Inhibition of FGFR1 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	8002115	CHEMBL1942187	Inhibition of FGFR1 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	8004492	CHEMBL1943924	Inhibition of FGFR1 at 1 uM	B	O=c1c2ccccc2[se]n1-c1ccccc1		CHEMBL51085	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	8004536	CHEMBL1943924	Inhibition of FGFR1 at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	8005200	CHEMBL1943924	Inhibition of FGFR1 at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	8005243	CHEMBL1943924	Inhibition of FGFR1 at 1 uM	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
Not Active	8012235	CHEMBL1941640	Inhibition of FGFR1 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	8012236	CHEMBL1941640	Inhibition of FGFR1 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	8012237	CHEMBL1941640	Inhibition of FGFR1 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	8012238	CHEMBL1941640	Inhibition of FGFR1 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	8013066	CHEMBL1947853	Inhibition of FGFR1 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	8018768	CHEMBL1948826	Inhibition of FGFR1 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	93.0	CHEMBL3650	Homo sapiens	Activity	%	93.0
	8018769	CHEMBL1948826	Inhibition of FGFR1 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	94.0	CHEMBL3650	Homo sapiens	Activity	%	94.0
	8018770	CHEMBL1948826	Inhibition of FGFR1 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	63.0	CHEMBL3650	Homo sapiens	Activity	%	63.0
	8020188	CHEMBL1948348	Inhibition of FGFR1	B	Cc1ncc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2		CHEMBL1945804	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	nM	200.0
	8020189	CHEMBL1948348	Inhibition of FGFR1	B	CN(C)CCCc1cncc(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945803	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	nM	11.0
	8020190	CHEMBL1948348	Inhibition of FGFR1	B	CN(C)CCCc1ccc(C(F)(F)F)c(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945498	=	IC50	nM	4100.0	CHEMBL3650	Homo sapiens	IC50	nM	4100.0
	8020191	CHEMBL1948348	Inhibition of FGFR1	B	CN(C)CCCc1ccc(OC(F)(F)F)c(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945497	=	IC50	nM	2000.0	CHEMBL3650	Homo sapiens	IC50	nM	2000.0
	8020192	CHEMBL1948348	Inhibition of FGFR1	B	COc1ccc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2		CHEMBL1945173	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	8020193	CHEMBL1948348	Inhibition of FGFR1	B	CN(C)CCCc1ccc(Cl)c(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945172	=	IC50	nM	2800.0	CHEMBL3650	Homo sapiens	IC50	nM	2800.0
	8020194	CHEMBL1948348	Inhibition of FGFR1	B	Cc1ccc(CCCN(C)C)cc1Nc1ncc2c(n1)-c1ccc(Cl)cc1NC(=S)C2		CHEMBL1945171	=	IC50	nM	1600.0	CHEMBL3650	Homo sapiens	IC50	nM	1600.0
	8020195	CHEMBL1948348	Inhibition of FGFR1	B	CN(C)CCCc1cccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1		CHEMBL1945170	=	IC50	nM	12.0	CHEMBL3650	Homo sapiens	IC50	nM	12.0
	8047117	CHEMBL1958858	Inhibition of FGFR1 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8049766	CHEMBL1959607	Inhibition of FGF-R1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957497	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8049767	CHEMBL1959607	Inhibition of FGF-R1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cccc5[nH]ncc45)cn3c2Br)CC1		CHEMBL1957498	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8049768	CHEMBL1959607	Inhibition of FGF-R1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(C#N)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957499	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8049769	CHEMBL1959607	Inhibition of FGF-R1 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957500	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8049770	CHEMBL1959607	Inhibition of FGF-R1 at 5 to 10 uM	B	CNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957502	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8049771	CHEMBL1959607	Inhibition of FGF-R1 at 5 to 10 uM	B	O=C(NCCN1CCOCC1)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957504	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8049772	CHEMBL1959607	Inhibition of FGF-R1 at 5 to 10 uM	B	CN(C)CCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957505	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8049773	CHEMBL1959607	Inhibition of FGF-R1 at 5 to 10 uM	B	COCCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957508	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	8061555	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-5.25	CHEMBL3650	Homo sapiens	Inhibition	%	-5.25
	8061662	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.2	CHEMBL3650	Homo sapiens	Inhibition	%	1.2
	8061886	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.76	CHEMBL3650	Homo sapiens	Inhibition	%	-0.76
	8062077	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	6.57	CHEMBL3650	Homo sapiens	Inhibition	%	6.57
	8062417	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.78	CHEMBL3650	Homo sapiens	Inhibition	%	4.78
	8062579	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-0.75	CHEMBL3650	Homo sapiens	Inhibition	%	-0.75
	8062901	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.46	CHEMBL3650	Homo sapiens	Inhibition	%	-1.46
	8063033	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.32	CHEMBL3650	Homo sapiens	Inhibition	%	-0.32
	8063257	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.38	CHEMBL3650	Homo sapiens	Inhibition	%	1.38
	8063424	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.96	CHEMBL3650	Homo sapiens	Inhibition	%	1.96
	8063756	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.93	CHEMBL3650	Homo sapiens	Inhibition	%	-0.93
	8063938	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	17.32	CHEMBL3650	Homo sapiens	Inhibition	%	17.32
	8064277	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.36	CHEMBL3650	Homo sapiens	Inhibition	%	2.36
	8064487	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.27	CHEMBL3650	Homo sapiens	Inhibition	%	-0.27
	8064849	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-3.4	CHEMBL3650	Homo sapiens	Inhibition	%	-3.4
	8065015	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-2.37	CHEMBL3650	Homo sapiens	Inhibition	%	-2.37
	8065355	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.26	CHEMBL3650	Homo sapiens	Inhibition	%	2.26
	8065530	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.8	CHEMBL3650	Homo sapiens	Inhibition	%	2.8
	8065754	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.15	CHEMBL3650	Homo sapiens	Inhibition	%	5.15
	8065869	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.11	CHEMBL3650	Homo sapiens	Inhibition	%	3.11
	8066079	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.69	CHEMBL3650	Homo sapiens	Inhibition	%	1.69
	8066303	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.52	CHEMBL3650	Homo sapiens	Inhibition	%	-0.52
	8066439	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.44	CHEMBL3650	Homo sapiens	Inhibition	%	5.44
	8066605	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-1.21	CHEMBL3650	Homo sapiens	Inhibition	%	-1.21
	8066829	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.21	CHEMBL3650	Homo sapiens	Inhibition	%	0.21
	8066953	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.32	CHEMBL3650	Homo sapiens	Inhibition	%	3.32
	8067352	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.55	CHEMBL3650	Homo sapiens	Inhibition	%	3.55
	8067473	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.12	CHEMBL3650	Homo sapiens	Inhibition	%	0.12
	8067907	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-4.23	CHEMBL3650	Homo sapiens	Inhibition	%	-4.23
	8068042	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	-4.05	CHEMBL3650	Homo sapiens	Inhibition	%	-4.05
	8068430	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-4.35	CHEMBL3650	Homo sapiens	Inhibition	%	-4.35
	8068555	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.5	CHEMBL3650	Homo sapiens	Inhibition	%	0.5
	8068779	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.48	CHEMBL3650	Homo sapiens	Inhibition	%	1.48
	8068953	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.11	CHEMBL3650	Homo sapiens	Inhibition	%	2.11
	8069078	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.29	CHEMBL3650	Homo sapiens	Inhibition	%	3.29
	8069302	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.56	CHEMBL3650	Homo sapiens	Inhibition	%	0.56
	8069373	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	7.3	CHEMBL3650	Homo sapiens	Inhibition	%	7.3
	8069597	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.43	CHEMBL3650	Homo sapiens	Inhibition	%	2.43
	8069758	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.95	CHEMBL3650	Homo sapiens	Inhibition	%	2.95
	8070108	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.08	CHEMBL3650	Homo sapiens	Inhibition	%	2.08
	8070280	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.66	CHEMBL3650	Homo sapiens	Inhibition	%	0.66
	8070629	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	6.6	CHEMBL3650	Homo sapiens	Inhibition	%	6.6
	8070927	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	5.49	CHEMBL3650	Homo sapiens	Inhibition	%	5.49
	8071084	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.14	CHEMBL3650	Homo sapiens	Inhibition	%	3.14
	8071434	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.21	CHEMBL3650	Homo sapiens	Inhibition	%	-0.21
	8071607	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	17.0	CHEMBL3650	Homo sapiens	Inhibition	%	17.0
	8071956	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.8	CHEMBL3650	Homo sapiens	Inhibition	%	1.8
	8072270	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-2.84	CHEMBL3650	Homo sapiens	Inhibition	%	-2.84
	8072427	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.77	CHEMBL3650	Homo sapiens	Inhibition	%	2.77
	8072651	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-5.22	CHEMBL3650	Homo sapiens	Inhibition	%	-5.22
	8072776	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	8.38	CHEMBL3650	Homo sapiens	Inhibition	%	8.38
	8072943	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.76	CHEMBL3650	Homo sapiens	Inhibition	%	1.76
	8073167	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	5.28	CHEMBL3650	Homo sapiens	Inhibition	%	5.28
	8073292	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	4.86	CHEMBL3650	Homo sapiens	Inhibition	%	4.86
	8073635	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.1	CHEMBL3650	Homo sapiens	Inhibition	%	0.1
	8073868	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	Inhibition	%	0.0
	8074244	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.47	CHEMBL3650	Homo sapiens	Inhibition	%	1.47
	8074374	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.23	CHEMBL3650	Homo sapiens	Inhibition	%	-1.23
	8074755	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.6	CHEMBL3650	Homo sapiens	Inhibition	%	5.6
	8074882	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	16.87	CHEMBL3650	Homo sapiens	Inhibition	%	16.87
	8075106	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-4.53	CHEMBL3650	Homo sapiens	Inhibition	%	-4.53
	8075217	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.71	CHEMBL3650	Homo sapiens	Inhibition	%	4.71
	8075454	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-3.25	CHEMBL3650	Homo sapiens	Inhibition	%	-3.25
	8075819	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.46	CHEMBL3650	Homo sapiens	Inhibition	%	3.46
	8075961	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	10.34	CHEMBL3650	Homo sapiens	Inhibition	%	10.34
	8076185	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.11	CHEMBL3650	Homo sapiens	Inhibition	%	1.11
	8076333	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.15	CHEMBL3650	Homo sapiens	Inhibition	%	3.15
	8076691	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-4.83	CHEMBL3650	Homo sapiens	Inhibition	%	-4.83
	8076793	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.01	CHEMBL3650	Homo sapiens	Inhibition	%	0.01
	8077017	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.73	CHEMBL3650	Homo sapiens	Inhibition	%	-2.73
	8077040	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.63	CHEMBL3650	Homo sapiens	Inhibition	%	-2.63
	8077264	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-5.77	CHEMBL3650	Homo sapiens	Inhibition	%	-5.77
	8077392	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	16.24	CHEMBL3650	Homo sapiens	Inhibition	%	16.24
	8077767	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.51	CHEMBL3650	Homo sapiens	Inhibition	%	-0.51
	8077910	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	14.79	CHEMBL3650	Homo sapiens	Inhibition	%	14.79
	8078273	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.91	CHEMBL3650	Homo sapiens	Inhibition	%	-2.91
	8078599	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-5.96	CHEMBL3650	Homo sapiens	Inhibition	%	-5.96
	8078849	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	6.16	CHEMBL3650	Homo sapiens	Inhibition	%	6.16
	8078965	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-1.37	CHEMBL3650	Homo sapiens	Inhibition	%	-1.37
	8079189	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.5	CHEMBL3650	Homo sapiens	Inhibition	%	1.5
	8079347	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-7.07	CHEMBL3650	Homo sapiens	Inhibition	%	-7.07
	8079489	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.62	CHEMBL3650	Homo sapiens	Inhibition	%	2.62
	8079713	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.71	CHEMBL3650	Homo sapiens	Inhibition	%	2.71
	8079852	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	8.63	CHEMBL3650	Homo sapiens	Inhibition	%	8.63
	8080181	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.14	CHEMBL3650	Homo sapiens	Inhibition	%	-0.14
	8080433	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.13	CHEMBL3650	Homo sapiens	Inhibition	%	0.13
	8080772	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.89	CHEMBL3650	Homo sapiens	Inhibition	%	1.89
	8080936	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.72	CHEMBL3650	Homo sapiens	Inhibition	%	0.72
	8081295	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-2.34	CHEMBL3650	Homo sapiens	Inhibition	%	-2.34
	8081439	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.31	CHEMBL3650	Homo sapiens	Inhibition	%	2.31
	8081766	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-2.65	CHEMBL3650	Homo sapiens	Inhibition	%	-2.65
	8082018	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.86	CHEMBL3650	Homo sapiens	Inhibition	%	4.86
	8082355	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-1.53	CHEMBL3650	Homo sapiens	Inhibition	%	-1.53
	8082528	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-5.66	CHEMBL3650	Homo sapiens	Inhibition	%	-5.66
	8082875	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	5.21	CHEMBL3650	Homo sapiens	Inhibition	%	5.21
	8083031	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.41	CHEMBL3650	Homo sapiens	Inhibition	%	2.41
	8083255	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.31	CHEMBL3650	Homo sapiens	Inhibition	%	1.31
	8083354	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	6.97	CHEMBL3650	Homo sapiens	Inhibition	%	6.97
	8083608	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-7.32	CHEMBL3650	Homo sapiens	Inhibition	%	-7.32
	8083942	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.33	CHEMBL3650	Homo sapiens	Inhibition	%	-0.33
	8084127	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-4.83	CHEMBL3650	Homo sapiens	Inhibition	%	-4.83
	8084351	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	10.84	CHEMBL3650	Homo sapiens	Inhibition	%	10.84
	8084469	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.27	CHEMBL3650	Homo sapiens	Inhibition	%	0.27
	8084854	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.32	CHEMBL3650	Homo sapiens	Inhibition	%	4.32
	8084952	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-6.27	CHEMBL3650	Homo sapiens	Inhibition	%	-6.27
	8085176	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.55	CHEMBL3650	Homo sapiens	Inhibition	%	0.55
	8085208	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-4.22	CHEMBL3650	Homo sapiens	Inhibition	%	-4.22
	8085432	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.93	CHEMBL3650	Homo sapiens	Inhibition	%	-3.93
	8085540	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-2.26	CHEMBL3650	Homo sapiens	Inhibition	%	-2.26
	8085953	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	40.95	CHEMBL3650	Homo sapiens	Inhibition	%	40.95
	8086068	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.28	CHEMBL3650	Homo sapiens	Inhibition	%	2.28
	8086292	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.22	CHEMBL3650	Homo sapiens	Inhibition	%	4.22
	8086454	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.64	CHEMBL3650	Homo sapiens	Inhibition	%	-1.64
	8086777	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.47	CHEMBL3650	Homo sapiens	Inhibition	%	0.47
	8086988	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.94	CHEMBL3650	Homo sapiens	Inhibition	%	1.94
	8087146	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	8.3	CHEMBL3650	Homo sapiens	Inhibition	%	8.3
	8087370	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.39	CHEMBL3650	Homo sapiens	Inhibition	%	2.39
	8087484	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	37.32	CHEMBL3650	Homo sapiens	Inhibition	%	37.32
	8087846	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.3	CHEMBL3650	Homo sapiens	Inhibition	%	2.3
	8087988	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.76	CHEMBL3650	Homo sapiens	Inhibition	%	7.76
	8088212	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.74	CHEMBL3650	Homo sapiens	Inhibition	%	5.74
	8088360	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.45	CHEMBL3650	Homo sapiens	Inhibition	%	0.45
	8088712	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.01	CHEMBL3650	Homo sapiens	Inhibition	%	2.01
	8088805	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.08	CHEMBL3650	Homo sapiens	Inhibition	%	2.08
	8089029	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.29	CHEMBL3650	Homo sapiens	Inhibition	%	2.29
	8089157	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.06	CHEMBL3650	Homo sapiens	Inhibition	%	0.06
	8089529	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-0.4	CHEMBL3650	Homo sapiens	Inhibition	%	-0.4
	8089649	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.91	CHEMBL3650	Homo sapiens	Inhibition	%	0.91
	8090053	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.05	CHEMBL3650	Homo sapiens	Inhibition	%	-0.05
	8090218	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	11.4	CHEMBL3650	Homo sapiens	Inhibition	%	11.4
	8090609	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-1.62	CHEMBL3650	Homo sapiens	Inhibition	%	-1.62
	8090748	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.08	CHEMBL3650	Homo sapiens	Inhibition	%	7.08
	8091177	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	6.5	CHEMBL3650	Homo sapiens	Inhibition	%	6.5
	8091314	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-1.56	CHEMBL3650	Homo sapiens	Inhibition	%	-1.56
	8091693	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.4	CHEMBL3650	Homo sapiens	Inhibition	%	4.4
	8091809	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	8.72	CHEMBL3650	Homo sapiens	Inhibition	%	8.72
	8092033	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.99	CHEMBL3650	Homo sapiens	Inhibition	%	5.99
	8092170	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-5.35	CHEMBL3650	Homo sapiens	Inhibition	%	-5.35
	8092545	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.5	CHEMBL3650	Homo sapiens	Inhibition	%	5.5
	8092693	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.2	CHEMBL3650	Homo sapiens	Inhibition	%	3.2
	8093046	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	17.19	CHEMBL3650	Homo sapiens	Inhibition	%	17.19
	8093358	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	Inhibition	%	6.0
	8093498	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.54	CHEMBL3650	Homo sapiens	Inhibition	%	3.54
	8093861	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	14.74	CHEMBL3650	Homo sapiens	Inhibition	%	14.74
	8093981	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.09	CHEMBL3650	Homo sapiens	Inhibition	%	2.09
	8094205	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	7.29	CHEMBL3650	Homo sapiens	Inhibition	%	7.29
	8094385	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.88	CHEMBL3650	Homo sapiens	Inhibition	%	-0.88
	8094560	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.78	CHEMBL3650	Homo sapiens	Inhibition	%	2.78
	8094784	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	6.98	CHEMBL3650	Homo sapiens	Inhibition	%	6.98
	8094940	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-3.57	CHEMBL3650	Homo sapiens	Inhibition	%	-3.57
	8095080	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.49	CHEMBL3650	Homo sapiens	Inhibition	%	2.49
	8095304	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	20.28	CHEMBL3650	Homo sapiens	Inhibition	%	20.28
	8095507	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.85	CHEMBL3650	Homo sapiens	Inhibition	%	3.85
	8095648	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.72	CHEMBL3650	Homo sapiens	Inhibition	%	1.72
	8095872	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.09	CHEMBL3650	Homo sapiens	Inhibition	%	7.09
	8096020	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-0.45	CHEMBL3650	Homo sapiens	Inhibition	%	-0.45
	8096361	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.49	CHEMBL3650	Homo sapiens	Inhibition	%	6.49
	8096500	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-7.09	CHEMBL3650	Homo sapiens	Inhibition	%	-7.09
	8096880	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.17	CHEMBL3650	Homo sapiens	Inhibition	%	3.17
	8097027	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.36	CHEMBL3650	Homo sapiens	Inhibition	%	4.36
	8097251	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	5.02	CHEMBL3650	Homo sapiens	Inhibition	%	5.02
	8097338	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.65	CHEMBL3650	Homo sapiens	Inhibition	%	4.65
	8097558	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.47	CHEMBL3650	Homo sapiens	Inhibition	%	6.47
	8097708	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-3.47	CHEMBL3650	Homo sapiens	Inhibition	%	-3.47
	8097932	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.43	CHEMBL3650	Homo sapiens	Inhibition	%	5.43
	8098065	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-4.37	CHEMBL3650	Homo sapiens	Inhibition	%	-4.37
	8098409	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-3.37	CHEMBL3650	Homo sapiens	Inhibition	%	-3.37
	8098589	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.5	CHEMBL3650	Homo sapiens	Inhibition	%	2.5
	8098998	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.33	CHEMBL3650	Homo sapiens	Inhibition	%	2.33
	8099142	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.21	CHEMBL3650	Homo sapiens	Inhibition	%	3.21
	8099508	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.64	CHEMBL3650	Homo sapiens	Inhibition	%	2.64
	8099702	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-2.46	CHEMBL3650	Homo sapiens	Inhibition	%	-2.46
	8100073	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.11	CHEMBL3650	Homo sapiens	Inhibition	%	4.11
	8100219	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.82	CHEMBL3650	Homo sapiens	Inhibition	%	3.82
	8100559	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.84	CHEMBL3650	Homo sapiens	Inhibition	%	5.84
	8100699	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-2.69	CHEMBL3650	Homo sapiens	Inhibition	%	-2.69
	8100923	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.21	CHEMBL3650	Homo sapiens	Inhibition	%	1.21
	8101083	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.37	CHEMBL3650	Homo sapiens	Inhibition	%	4.37
	8101449	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-3.33	CHEMBL3650	Homo sapiens	Inhibition	%	-3.33
	8101634	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.72	CHEMBL3650	Homo sapiens	Inhibition	%	-0.72
	8101887	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.74	CHEMBL3650	Homo sapiens	Inhibition	%	0.74
	8102266	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-5.24	CHEMBL3650	Homo sapiens	Inhibition	%	-5.24
	8102397	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.27	CHEMBL3650	Homo sapiens	Inhibition	%	-2.27
	8102741	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.23	CHEMBL3650	Homo sapiens	Inhibition	%	-0.23
	8102919	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-8.22	CHEMBL3650	Homo sapiens	Inhibition	%	-8.22
	8103143	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-7.82	CHEMBL3650	Homo sapiens	Inhibition	%	-7.82
	8103339	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.14	CHEMBL3650	Homo sapiens	Inhibition	%	4.14
	8103477	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.53	CHEMBL3650	Homo sapiens	Inhibition	%	2.53
	8103701	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	9.63	CHEMBL3650	Homo sapiens	Inhibition	%	9.63
	8103851	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.73	CHEMBL3650	Homo sapiens	Inhibition	%	2.73
	8104036	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.96	CHEMBL3650	Homo sapiens	Inhibition	%	1.96
	8104408	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	17.71	CHEMBL3650	Homo sapiens	Inhibition	%	17.71
	8104554	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-2.98	CHEMBL3650	Homo sapiens	Inhibition	%	-2.98
	8104778	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.6	CHEMBL3650	Homo sapiens	Inhibition	%	2.6
	8104892	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.69	CHEMBL3650	Homo sapiens	Inhibition	%	-0.69
	8105256	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-5.16	CHEMBL3650	Homo sapiens	Inhibition	%	-5.16
	8105422	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.58	CHEMBL3650	Homo sapiens	Inhibition	%	8.58
	8105784	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	8.79	CHEMBL3650	Homo sapiens	Inhibition	%	8.79
	8106064	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.54	CHEMBL3650	Homo sapiens	Inhibition	%	5.54
	8106229	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.34	CHEMBL3650	Homo sapiens	Inhibition	%	6.34
	8106609	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	9.11	CHEMBL3650	Homo sapiens	Inhibition	%	9.11
	8106738	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.18	CHEMBL3650	Homo sapiens	Inhibition	%	0.18
	8106962	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	23.69	CHEMBL3650	Homo sapiens	Inhibition	%	23.69
	8107083	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.96	CHEMBL3650	Homo sapiens	Inhibition	%	-0.96
	8107479	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-2.05	CHEMBL3650	Homo sapiens	Inhibition	%	-2.05
	8107680	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.91	CHEMBL3650	Homo sapiens	Inhibition	%	2.91
	8108039	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	10.22	CHEMBL3650	Homo sapiens	Inhibition	%	10.22
	8108197	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-4.6	CHEMBL3650	Homo sapiens	Inhibition	%	-4.6
	8108372	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.31	CHEMBL3650	Homo sapiens	Inhibition	%	2.31
	8108596	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	9.33	CHEMBL3650	Homo sapiens	Inhibition	%	9.33
	8108743	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.32	CHEMBL3650	Homo sapiens	Inhibition	%	5.32
	8109109	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.05	CHEMBL3650	Homo sapiens	Inhibition	%	1.05
	8109223	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.45	CHEMBL3650	Homo sapiens	Inhibition	%	5.45
	8109447	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.25	CHEMBL3650	Homo sapiens	Inhibition	%	2.25
	8109577	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.19	CHEMBL3650	Homo sapiens	Inhibition	%	-0.19
	8109748	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.78	CHEMBL3650	Homo sapiens	Inhibition	%	2.78
	8109972	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	9.26	CHEMBL3650	Homo sapiens	Inhibition	%	9.26
	8110104	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.6	CHEMBL3650	Homo sapiens	Inhibition	%	2.6
	8110383	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	8.04	CHEMBL3650	Homo sapiens	Inhibition	%	8.04
	8110549	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.95	CHEMBL3650	Homo sapiens	Inhibition	%	0.95
	8110773	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.04	CHEMBL3650	Homo sapiens	Inhibition	%	0.04
	8110931	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.75	CHEMBL3650	Homo sapiens	Inhibition	%	-2.75
	8111278	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-3.46	CHEMBL3650	Homo sapiens	Inhibition	%	-3.46
	8111405	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-2.55	CHEMBL3650	Homo sapiens	Inhibition	%	-2.55
	8111629	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.74	CHEMBL3650	Homo sapiens	Inhibition	%	-0.74
	8111795	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.74	CHEMBL3650	Homo sapiens	Inhibition	%	1.74
	8112000	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.23	CHEMBL3650	Homo sapiens	Inhibition	%	5.23
	8112361	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.88	CHEMBL3650	Homo sapiens	Inhibition	%	1.88
	8112529	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.69	CHEMBL3650	Homo sapiens	Inhibition	%	7.69
	8112925	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-2.87	CHEMBL3650	Homo sapiens	Inhibition	%	-2.87
	8113077	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	14.01	CHEMBL3650	Homo sapiens	Inhibition	%	14.01
	8113437	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.27	CHEMBL3650	Homo sapiens	Inhibition	%	5.27
	8113785	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	10.62	CHEMBL3650	Homo sapiens	Inhibition	%	10.62
	8113901	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.59	CHEMBL3650	Homo sapiens	Inhibition	%	-2.59
	8114301	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.33	CHEMBL3650	Homo sapiens	Inhibition	%	6.33
	8114433	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.89	CHEMBL3650	Homo sapiens	Inhibition	%	7.89
	8114709	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.66	CHEMBL3650	Homo sapiens	Inhibition	%	3.66
	8115099	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.81	CHEMBL3650	Homo sapiens	Inhibition	%	3.81
	8115264	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.12	CHEMBL3650	Homo sapiens	Inhibition	%	2.12
	8115608	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.26	CHEMBL3650	Homo sapiens	Inhibition	%	3.26
	8115965	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.08	CHEMBL3650	Homo sapiens	Inhibition	%	0.08
	8116124	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-4.71	CHEMBL3650	Homo sapiens	Inhibition	%	-4.71
	8116327	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.22	CHEMBL3650	Homo sapiens	Inhibition	%	3.22
	8116551	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.54	CHEMBL3650	Homo sapiens	Inhibition	%	1.54
	8116685	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.01	CHEMBL3650	Homo sapiens	Inhibition	%	-1.01
	8116857	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.01	CHEMBL3650	Homo sapiens	Inhibition	%	2.01
	8117081	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	16.09	CHEMBL3650	Homo sapiens	Inhibition	%	16.09
	8117252	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.44	CHEMBL3650	Homo sapiens	Inhibition	%	2.44
	8117410	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	6.92	CHEMBL3650	Homo sapiens	Inhibition	%	6.92
	8117634	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.9	CHEMBL3650	Homo sapiens	Inhibition	%	5.9
	8117764	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.78	CHEMBL3650	Homo sapiens	Inhibition	%	0.78
	8118126	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-3.39	CHEMBL3650	Homo sapiens	Inhibition	%	-3.39
	8118242	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.27	CHEMBL3650	Homo sapiens	Inhibition	%	-2.27
	8118466	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	7.12	CHEMBL3650	Homo sapiens	Inhibition	%	7.12
	8118638	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	10.83	CHEMBL3650	Homo sapiens	Inhibition	%	10.83
	8118774	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.73	CHEMBL3650	Homo sapiens	Inhibition	%	1.73
	8118998	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.35	CHEMBL3650	Homo sapiens	Inhibition	%	5.35
	8119045	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.66	CHEMBL3650	Homo sapiens	Inhibition	%	5.66
	8119269	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.49	CHEMBL3650	Homo sapiens	Inhibition	%	0.49
	8119428	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	29.83	CHEMBL3650	Homo sapiens	Inhibition	%	29.83
	8119595	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-3.81	CHEMBL3650	Homo sapiens	Inhibition	%	-3.81
	8119819	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-5.8	CHEMBL3650	Homo sapiens	Inhibition	%	-5.8
	8119938	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-5.98	CHEMBL3650	Homo sapiens	Inhibition	%	-5.98
	8120301	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.28	CHEMBL3650	Homo sapiens	Inhibition	%	0.28
	8120461	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.07	CHEMBL3650	Homo sapiens	Inhibition	%	1.07
	8120886	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-4.66	CHEMBL3650	Homo sapiens	Inhibition	%	-4.66
	8121014	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.46	CHEMBL3650	Homo sapiens	Inhibition	%	3.46
	8121410	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.97	CHEMBL3650	Homo sapiens	Inhibition	%	1.97
	8121577	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	5.09	CHEMBL3650	Homo sapiens	Inhibition	%	5.09
	8121964	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.09	CHEMBL3650	Homo sapiens	Inhibition	%	6.09
	8122085	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.71	CHEMBL3650	Homo sapiens	Inhibition	%	3.71
	8122309	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.38	CHEMBL3650	Homo sapiens	Inhibition	%	0.38
	8122447	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.21	CHEMBL3650	Homo sapiens	Inhibition	%	0.21
	8122791	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	7.58	CHEMBL3650	Homo sapiens	Inhibition	%	7.58
	8122958	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.54	CHEMBL3650	Homo sapiens	Inhibition	%	5.54
	8123324	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-0.93	CHEMBL3650	Homo sapiens	Inhibition	%	-0.93
	8123602	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.43	CHEMBL3650	Homo sapiens	Inhibition	%	1.43
	8123752	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.01	CHEMBL3650	Homo sapiens	Inhibition	%	1.01
	8124143	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-7.19	CHEMBL3650	Homo sapiens	Inhibition	%	-7.19
	8124262	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.65	CHEMBL3650	Homo sapiens	Inhibition	%	1.65
	8124486	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-2.04	CHEMBL3650	Homo sapiens	Inhibition	%	-2.04
	8124625	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.17	CHEMBL3650	Homo sapiens	Inhibition	%	1.17
	8124790	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-2.97	CHEMBL3650	Homo sapiens	Inhibition	%	-2.97
	8125014	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.28	CHEMBL3650	Homo sapiens	Inhibition	%	-1.28
	8125215	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.59	CHEMBL3650	Homo sapiens	Inhibition	%	7.59
	8125345	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.01	CHEMBL3650	Homo sapiens	Inhibition	%	-0.01
	8125569	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.17	CHEMBL3650	Homo sapiens	Inhibition	%	-0.17
	8125737	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.47	CHEMBL3650	Homo sapiens	Inhibition	%	2.47
	8125901	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	16.74	CHEMBL3650	Homo sapiens	Inhibition	%	16.74
	8126125	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-4.59	CHEMBL3650	Homo sapiens	Inhibition	%	-4.59
	8126289	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.22	CHEMBL3650	Homo sapiens	Inhibition	%	6.22
	8126628	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	19.27	CHEMBL3650	Homo sapiens	Inhibition	%	19.27
	8126764	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	5.4	CHEMBL3650	Homo sapiens	Inhibition	%	5.4
	8127110	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	6.98	CHEMBL3650	Homo sapiens	Inhibition	%	6.98
	8127277	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	11.01	CHEMBL3650	Homo sapiens	Inhibition	%	11.01
	8127501	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	12.66	CHEMBL3650	Homo sapiens	Inhibition	%	12.66
	8127643	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	13.0	CHEMBL3650	Homo sapiens	Inhibition	%	13.0
	8127931	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.41	CHEMBL3650	Homo sapiens	Inhibition	%	2.41
	8128083	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.72	CHEMBL3650	Homo sapiens	Inhibition	%	3.72
	8128307	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.31	CHEMBL3650	Homo sapiens	Inhibition	%	1.31
	8128474	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.61	CHEMBL3650	Homo sapiens	Inhibition	%	-2.61
	8128817	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.55	CHEMBL3650	Homo sapiens	Inhibition	%	4.55
	8128954	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1	Outside typical range	CHEMBL352222	=	Inhibition	%	-11.41	CHEMBL3650	Homo sapiens	Inhibition	%	-11.41
	8129349	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-4.37	CHEMBL3650	Homo sapiens	Inhibition	%	-4.37
	8129538	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.77	CHEMBL3650	Homo sapiens	Inhibition	%	4.77
	8129901	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.08	CHEMBL3650	Homo sapiens	Inhibition	%	-1.08
	8130062	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.83	CHEMBL3650	Homo sapiens	Inhibition	%	4.83
	8130458	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.81	CHEMBL3650	Homo sapiens	Inhibition	%	-1.81
	8130618	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.77	CHEMBL3650	Homo sapiens	Inhibition	%	1.77
	8130958	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.91	CHEMBL3650	Homo sapiens	Inhibition	%	-0.91
	8131097	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	32.78	CHEMBL3650	Homo sapiens	Inhibition	%	32.78
	8131321	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.48	CHEMBL3650	Homo sapiens	Inhibition	%	3.48
	8131441	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.81	CHEMBL3650	Homo sapiens	Inhibition	%	2.81
	8131832	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	46.17	CHEMBL3650	Homo sapiens	Inhibition	%	46.17
	8131973	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	8.01	CHEMBL3650	Homo sapiens	Inhibition	%	8.01
	8132259	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-0.38	CHEMBL3650	Homo sapiens	Inhibition	%	-0.38
	8132630	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.65	CHEMBL3650	Homo sapiens	Inhibition	%	1.65
	8132798	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.0	CHEMBL3650	Homo sapiens	Inhibition	%	-1.0
	8133143	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.58	CHEMBL3650	Homo sapiens	Inhibition	%	0.58
	8133281	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	7.05	CHEMBL3650	Homo sapiens	Inhibition	%	7.05
	8133505	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.21	CHEMBL3650	Homo sapiens	Inhibition	%	0.21
	8133677	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.28	CHEMBL3650	Homo sapiens	Inhibition	%	-0.28
	8133857	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.94	CHEMBL3650	Homo sapiens	Inhibition	%	0.94
	8134229	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-5.35	CHEMBL3650	Homo sapiens	Inhibition	%	-5.35
	8134389	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.89	CHEMBL3650	Homo sapiens	Inhibition	%	2.89
	8134613	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	11.23	CHEMBL3650	Homo sapiens	Inhibition	%	11.23
	8134797	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.9	CHEMBL3650	Homo sapiens	Inhibition	%	-1.9
	8134957	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	11.55	CHEMBL3650	Homo sapiens	Inhibition	%	11.55
	8135296	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.98	CHEMBL3650	Homo sapiens	Inhibition	%	3.98
	8135661	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.26	CHEMBL3650	Homo sapiens	Inhibition	%	6.26
	8135782	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.29	CHEMBL3650	Homo sapiens	Inhibition	%	3.29
	8136006	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-2.94	CHEMBL3650	Homo sapiens	Inhibition	%	-2.94
	8136174	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.2	CHEMBL3650	Homo sapiens	Inhibition	%	4.2
	8136318	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	38.21	CHEMBL3650	Homo sapiens	Inhibition	%	38.21
	8136542	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.51	CHEMBL3650	Homo sapiens	Inhibition	%	3.51
	8136608	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.07	CHEMBL3650	Homo sapiens	Inhibition	%	0.07
	8136967	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.69	CHEMBL3650	Homo sapiens	Inhibition	%	0.69
	8137130	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.84	CHEMBL3650	Homo sapiens	Inhibition	%	-1.84
	8137354	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.48	CHEMBL3650	Homo sapiens	Inhibition	%	0.48
	8137474	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-1.59	CHEMBL3650	Homo sapiens	Inhibition	%	-1.59
	8137846	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.41	CHEMBL3650	Homo sapiens	Inhibition	%	0.41
	8138012	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-6.27	CHEMBL3650	Homo sapiens	Inhibition	%	-6.27
	8138191	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.44	CHEMBL3650	Homo sapiens	Inhibition	%	4.44
	8138415	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.15	CHEMBL3650	Homo sapiens	Inhibition	%	2.15
	8138563	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1	Outside typical range	CHEMBL373073	=	Inhibition	%	-10.05	CHEMBL3650	Homo sapiens	Inhibition	%	-10.05
	8138945	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.99	CHEMBL3650	Homo sapiens	Inhibition	%	3.99
	8139130	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	5.82	CHEMBL3650	Homo sapiens	Inhibition	%	5.82
	8139289	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.35	CHEMBL3650	Homo sapiens	Inhibition	%	1.35
	8139513	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%		CHEMBL3650	Homo sapiens	Inhibition	%	
	8139627	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.07	CHEMBL3650	Homo sapiens	Inhibition	%	1.07
	8139992	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.95	CHEMBL3650	Homo sapiens	Inhibition	%	3.95
	8140339	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.77	CHEMBL3650	Homo sapiens	Inhibition	%	3.77
	8140498	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.4	CHEMBL3650	Homo sapiens	Inhibition	%	2.4
	8140865	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	11.78	CHEMBL3650	Homo sapiens	Inhibition	%	11.78
	8140943	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.58	CHEMBL3650	Homo sapiens	Inhibition	%	-3.58
	8141167	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.98	CHEMBL3650	Homo sapiens	Inhibition	%	2.98
	8141297	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	8.25	CHEMBL3650	Homo sapiens	Inhibition	%	8.25
	8141681	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.31	CHEMBL3650	Homo sapiens	Inhibition	%	3.31
	8141800	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.96	CHEMBL3650	Homo sapiens	Inhibition	%	-3.96
	8142024	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.96	CHEMBL3650	Homo sapiens	Inhibition	%	-3.96
	8142185	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-2.89	CHEMBL3650	Homo sapiens	Inhibition	%	-2.89
	8142353	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.77	CHEMBL3650	Homo sapiens	Inhibition	%	-0.77
	8142753	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.98	CHEMBL3650	Homo sapiens	Inhibition	%	4.98
	8142902	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-5.37	CHEMBL3650	Homo sapiens	Inhibition	%	-5.37
	8143281	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.53	CHEMBL3650	Homo sapiens	Inhibition	%	2.53
	8143468	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.92	CHEMBL3650	Homo sapiens	Inhibition	%	5.92
	8143851	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.59	CHEMBL3650	Homo sapiens	Inhibition	%	5.59
	8143965	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.49	CHEMBL3650	Homo sapiens	Inhibition	%	5.49
	8144189	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-3.67	CHEMBL3650	Homo sapiens	Inhibition	%	-3.67
	8144328	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	9.17	CHEMBL3650	Homo sapiens	Inhibition	%	9.17
	8144682	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	6.13	CHEMBL3650	Homo sapiens	Inhibition	%	6.13
	8144835	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.72	CHEMBL3650	Homo sapiens	Inhibition	%	3.72
	8145196	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.65	CHEMBL3650	Homo sapiens	Inhibition	%	3.65
	8145509	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-1.36	CHEMBL3650	Homo sapiens	Inhibition	%	-1.36
	8145633	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.13	CHEMBL3650	Homo sapiens	Inhibition	%	2.13
	8145857	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.39	CHEMBL3650	Homo sapiens	Inhibition	%	2.39
	8146018	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	6.14	CHEMBL3650	Homo sapiens	Inhibition	%	6.14
	8146362	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-1.07	CHEMBL3650	Homo sapiens	Inhibition	%	-1.07
	8146522	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	11.24	CHEMBL3650	Homo sapiens	Inhibition	%	11.24
	8146689	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-9.02	CHEMBL3650	Homo sapiens	Inhibition	%	-9.02
	8146913	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	13.02	CHEMBL3650	Homo sapiens	Inhibition	%	13.02
	8147082	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.05	CHEMBL3650	Homo sapiens	Inhibition	%	2.05
	8147224	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.8	CHEMBL3650	Homo sapiens	Inhibition	%	-2.8
	8147448	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-1.25	CHEMBL3650	Homo sapiens	Inhibition	%	-1.25
	8147601	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.37	CHEMBL3650	Homo sapiens	Inhibition	%	4.37
	8147788	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.51	CHEMBL3650	Homo sapiens	Inhibition	%	2.51
	8148012	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.15	CHEMBL3650	Homo sapiens	Inhibition	%	3.15
	8148170	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	8.78	CHEMBL3650	Homo sapiens	Inhibition	%	8.78
	8148508	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.36	CHEMBL3650	Homo sapiens	Inhibition	%	4.36
	8148647	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.81	CHEMBL3650	Homo sapiens	Inhibition	%	-0.81
	8148871	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.92	CHEMBL3650	Homo sapiens	Inhibition	%	2.92
	8149009	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.23	CHEMBL3650	Homo sapiens	Inhibition	%	5.23
	8149168	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.1	CHEMBL3650	Homo sapiens	Inhibition	%	5.1
	8149392	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.34	CHEMBL3650	Homo sapiens	Inhibition	%	-3.34
	8149526	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	8.42	CHEMBL3650	Homo sapiens	Inhibition	%	8.42
	8149848	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.22	CHEMBL3650	Homo sapiens	Inhibition	%	3.22
	8150197	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-3.4	CHEMBL3650	Homo sapiens	Inhibition	%	-3.4
	8150357	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-0.4	CHEMBL3650	Homo sapiens	Inhibition	%	-0.4
	8150701	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-3.15	CHEMBL3650	Homo sapiens	Inhibition	%	-3.15
	8150866	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.88	CHEMBL3650	Homo sapiens	Inhibition	%	-0.88
	8151253	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.69	CHEMBL3650	Homo sapiens	Inhibition	%	-0.69
	8151430	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.39	CHEMBL3650	Homo sapiens	Inhibition	%	5.39
	8151792	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.07	CHEMBL3650	Homo sapiens	Inhibition	%	-0.07
	8151946	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.38	CHEMBL3650	Homo sapiens	Inhibition	%	1.38
	8152170	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-1.86	CHEMBL3650	Homo sapiens	Inhibition	%	-1.86
	8152358	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.87	CHEMBL3650	Homo sapiens	Inhibition	%	6.87
	8152516	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	-1.19	CHEMBL3650	Homo sapiens	Inhibition	%	-1.19
	8152854	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	8.89	CHEMBL3650	Homo sapiens	Inhibition	%	8.89
	8153217	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.24	CHEMBL3650	Homo sapiens	Inhibition	%	2.24
	8153354	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	8.19	CHEMBL3650	Homo sapiens	Inhibition	%	8.19
	8153735	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-4.3	CHEMBL3650	Homo sapiens	Inhibition	%	-4.3
	8153868	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.05	CHEMBL3650	Homo sapiens	Inhibition	%	2.05
	8154092	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.72	CHEMBL3650	Homo sapiens	Inhibition	%	4.72
	8154189	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.63	CHEMBL3650	Homo sapiens	Inhibition	%	0.63
	8154539	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	9.84	CHEMBL3650	Homo sapiens	Inhibition	%	9.84
	8154698	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.46	CHEMBL3650	Homo sapiens	Inhibition	%	-1.46
	8154922	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.26	CHEMBL3650	Homo sapiens	Inhibition	%	0.26
	8155042	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	5.25	CHEMBL3650	Homo sapiens	Inhibition	%	5.25
	8155218	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-1.8	CHEMBL3650	Homo sapiens	Inhibition	%	-1.8
	8155442	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-4.71	CHEMBL3650	Homo sapiens	Inhibition	%	-4.71
	8155603	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-5.16	CHEMBL3650	Homo sapiens	Inhibition	%	-5.16
	8155781	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.58	CHEMBL3650	Homo sapiens	Inhibition	%	1.58
	8156005	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	7.38	CHEMBL3650	Homo sapiens	Inhibition	%	7.38
	8156143	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.54	CHEMBL3650	Homo sapiens	Inhibition	%	2.54
	8156355	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.02	CHEMBL3650	Homo sapiens	Inhibition	%	4.02
	8156729	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	12.91	CHEMBL3650	Homo sapiens	Inhibition	%	12.91
	8156872	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.58	CHEMBL3650	Homo sapiens	Inhibition	%	6.58
	8157096	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	8.69	CHEMBL3650	Homo sapiens	Inhibition	%	8.69
	8157216	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-0.57	CHEMBL3650	Homo sapiens	Inhibition	%	-0.57
	8157581	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	0.79	CHEMBL3650	Homo sapiens	Inhibition	%	0.79
	8157711	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	6.8	CHEMBL3650	Homo sapiens	Inhibition	%	6.8
	8157935	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.4	CHEMBL3650	Homo sapiens	Inhibition	%	3.4
	8158096	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.1	CHEMBL3650	Homo sapiens	Inhibition	%	2.1
	8158346	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.54	CHEMBL3650	Homo sapiens	Inhibition	%	6.54
	8158504	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-1.44	CHEMBL3650	Homo sapiens	Inhibition	%	-1.44
	8158728	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.19	CHEMBL3650	Homo sapiens	Inhibition	%	2.19
	8158897	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.53	CHEMBL3650	Homo sapiens	Inhibition	%	0.53
	8159256	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.16	CHEMBL3650	Homo sapiens	Inhibition	%	1.16
	8159376	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.9	CHEMBL3650	Homo sapiens	Inhibition	%	2.9
	8159600	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-4.25	CHEMBL3650	Homo sapiens	Inhibition	%	-4.25
	8159731	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	14.21	CHEMBL3650	Homo sapiens	Inhibition	%	14.21
	8160096	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.51	CHEMBL3650	Homo sapiens	Inhibition	%	2.51
	8160233	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.57	CHEMBL3650	Homo sapiens	Inhibition	%	4.57
	8160607	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.56	CHEMBL3650	Homo sapiens	Inhibition	%	0.56
	8160677	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.46	CHEMBL3650	Homo sapiens	Inhibition	%	7.46
	8160901	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.81	CHEMBL3650	Homo sapiens	Inhibition	%	5.81
	8161051	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.48	CHEMBL3650	Homo sapiens	Inhibition	%	1.48
	8161418	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.77	CHEMBL3650	Homo sapiens	Inhibition	%	5.77
	8161543	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	9.3	CHEMBL3650	Homo sapiens	Inhibition	%	9.3
	8161767	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.34	CHEMBL3650	Homo sapiens	Inhibition	%	4.34
	8161905	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.96	CHEMBL3650	Homo sapiens	Inhibition	%	3.96
	8162259	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.56	CHEMBL3650	Homo sapiens	Inhibition	%	2.56
	8162419	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-4.14	CHEMBL3650	Homo sapiens	Inhibition	%	-4.14
	8162672	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	0.26	CHEMBL3650	Homo sapiens	Inhibition	%	0.26
	8163044	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	13.41	CHEMBL3650	Homo sapiens	Inhibition	%	13.41
	8163213	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.69	CHEMBL3650	Homo sapiens	Inhibition	%	1.69
	8163571	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.49	CHEMBL3650	Homo sapiens	Inhibition	%	3.49
	8163918	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.23	CHEMBL3650	Homo sapiens	Inhibition	%	0.23
	8164052	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.11	CHEMBL3650	Homo sapiens	Inhibition	%	3.11
	8164416	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	6.46	CHEMBL3650	Homo sapiens	Inhibition	%	6.46
	8164571	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.5	CHEMBL3650	Homo sapiens	Inhibition	%	3.5
	8164939	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	11.26	CHEMBL3650	Homo sapiens	Inhibition	%	11.26
	8165233	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	9.89	CHEMBL3650	Homo sapiens	Inhibition	%	9.89
	8165374	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.91	CHEMBL3650	Homo sapiens	Inhibition	%	0.91
	8165598	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.23	CHEMBL3650	Homo sapiens	Inhibition	%	-0.23
	8165741	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.22	CHEMBL3650	Homo sapiens	Inhibition	%	5.22
	8166091	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	7.05	CHEMBL3650	Homo sapiens	Inhibition	%	7.05
	8166229	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.46	CHEMBL3650	Homo sapiens	Inhibition	%	0.46
	8166583	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.95	CHEMBL3650	Homo sapiens	Inhibition	%	1.95
	8166908	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	24.79	CHEMBL3650	Homo sapiens	Inhibition	%	24.79
	8166996	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.87	CHEMBL3650	Homo sapiens	Inhibition	%	1.87
	8167220	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.76	CHEMBL3650	Homo sapiens	Inhibition	%	1.76
	8167361	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	41.93	CHEMBL3650	Homo sapiens	Inhibition	%	41.93
	8167525	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.22	CHEMBL3650	Homo sapiens	Inhibition	%	0.22
	8167749	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.06	CHEMBL3650	Homo sapiens	Inhibition	%	2.06
	8167882	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.73	CHEMBL3650	Homo sapiens	Inhibition	%	3.73
	8168230	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.9	CHEMBL3650	Homo sapiens	Inhibition	%	-0.9
	8168371	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.44	CHEMBL3650	Homo sapiens	Inhibition	%	3.44
	8168595	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	8.04	CHEMBL3650	Homo sapiens	Inhibition	%	8.04
	8168731	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.68	CHEMBL3650	Homo sapiens	Inhibition	%	1.68
	8168895	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	4.73	CHEMBL3650	Homo sapiens	Inhibition	%	4.73
	8169119	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.94	CHEMBL3650	Homo sapiens	Inhibition	%	8.94
	8169261	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.04	CHEMBL3650	Homo sapiens	Inhibition	%	6.04
	8169565	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.03	CHEMBL3650	Homo sapiens	Inhibition	%	3.03
	8169923	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.13	CHEMBL3650	Homo sapiens	Inhibition	%	4.13
	8170068	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	9.08	CHEMBL3650	Homo sapiens	Inhibition	%	9.08
	8170417	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	6.31	CHEMBL3650	Homo sapiens	Inhibition	%	6.31
	8170557	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.62	CHEMBL3650	Homo sapiens	Inhibition	%	3.62
	8170781	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.34	CHEMBL3650	Homo sapiens	Inhibition	%	-2.34
	8170916	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	7.19	CHEMBL3650	Homo sapiens	Inhibition	%	7.19
	8171113	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.63	CHEMBL3650	Homo sapiens	Inhibition	%	0.63
	8171337	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	5.2	CHEMBL3650	Homo sapiens	Inhibition	%	5.2
	8171554	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.99	CHEMBL3650	Homo sapiens	Inhibition	%	5.99
	8171695	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.38	CHEMBL3650	Homo sapiens	Inhibition	%	7.38
	8172072	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-2.97	CHEMBL3650	Homo sapiens	Inhibition	%	-2.97
	8172204	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	10.18	CHEMBL3650	Homo sapiens	Inhibition	%	10.18
	8172428	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	7.8	CHEMBL3650	Homo sapiens	Inhibition	%	7.8
	8172556	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	6.58	CHEMBL3650	Homo sapiens	Inhibition	%	6.58
	8172922	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	8.15	CHEMBL3650	Homo sapiens	Inhibition	%	8.15
	8173058	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.33	CHEMBL3650	Homo sapiens	Inhibition	%	0.33
	8173447	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.8	CHEMBL3650	Homo sapiens	Inhibition	%	4.8
	8173588	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.36	CHEMBL3650	Homo sapiens	Inhibition	%	6.36
	8173899	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.36	CHEMBL3650	Homo sapiens	Inhibition	%	3.36
	8174255	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.08	CHEMBL3650	Homo sapiens	Inhibition	%	4.08
	8174403	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	43.73	CHEMBL3650	Homo sapiens	Inhibition	%	43.73
	8174627	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.86	CHEMBL3650	Homo sapiens	Inhibition	%	2.86
	8174749	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.84	CHEMBL3650	Homo sapiens	Inhibition	%	5.84
	8175116	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.27	CHEMBL3650	Homo sapiens	Inhibition	%	-0.27
	8175252	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.84	CHEMBL3650	Homo sapiens	Inhibition	%	4.84
	8175508	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.75	CHEMBL3650	Homo sapiens	Inhibition	%	2.75
	8175732	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	9.98	CHEMBL3650	Homo sapiens	Inhibition	%	9.98
	8175895	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-0.21	CHEMBL3650	Homo sapiens	Inhibition	%	-0.21
	8176048	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.2	CHEMBL3650	Homo sapiens	Inhibition	%	4.2
	8176272	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.07	CHEMBL3650	Homo sapiens	Inhibition	%	4.07
	8176421	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-3.18	CHEMBL3650	Homo sapiens	Inhibition	%	-3.18
	8176777	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	16.54	CHEMBL3650	Homo sapiens	Inhibition	%	16.54
	8176907	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-3.47	CHEMBL3650	Homo sapiens	Inhibition	%	-3.47
	8177273	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.34	CHEMBL3650	Homo sapiens	Inhibition	%	2.34
	8177411	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.92	CHEMBL3650	Homo sapiens	Inhibition	%	-2.92
	8177635	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	1.76	CHEMBL3650	Homo sapiens	Inhibition	%	1.76
	8177799	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	8.02	CHEMBL3650	Homo sapiens	Inhibition	%	8.02
	8177939	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.47	CHEMBL3650	Homo sapiens	Inhibition	%	4.47
	8178163	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.74	CHEMBL3650	Homo sapiens	Inhibition	%	1.74
	8178251	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	12.1	CHEMBL3650	Homo sapiens	Inhibition	%	12.1
	8178475	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.33	CHEMBL3650	Homo sapiens	Inhibition	%	2.33
	8178602	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.61	CHEMBL3650	Homo sapiens	Inhibition	%	0.61
	8178975	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	8.03	CHEMBL3650	Homo sapiens	Inhibition	%	8.03
	8179098	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.91	CHEMBL3650	Homo sapiens	Inhibition	%	3.91
	8179466	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.12	CHEMBL3650	Homo sapiens	Inhibition	%	3.12
	8179603	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.17	CHEMBL3650	Homo sapiens	Inhibition	%	4.17
	8179827	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.02	CHEMBL3650	Homo sapiens	Inhibition	%	3.02
	8180084	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.69	CHEMBL3650	Homo sapiens	Inhibition	%	5.69
	8180238	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%		CHEMBL3650	Homo sapiens	Inhibition	%	
	8180618	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.76	CHEMBL3650	Homo sapiens	Inhibition	%	6.76
	8180766	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.54	CHEMBL3650	Homo sapiens	Inhibition	%	3.54
	8181123	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.68	CHEMBL3650	Homo sapiens	Inhibition	%	7.68
	8181254	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.09	CHEMBL3650	Homo sapiens	Inhibition	%	3.09
	8181478	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-4.77	CHEMBL3650	Homo sapiens	Inhibition	%	-4.77
	8181618	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.83	CHEMBL3650	Homo sapiens	Inhibition	%	3.83
	8181981	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.2	CHEMBL3650	Homo sapiens	Inhibition	%	3.2
	8182144	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.21	CHEMBL3650	Homo sapiens	Inhibition	%	4.21
	8182508	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	7.42	CHEMBL3650	Homo sapiens	Inhibition	%	7.42
	8182824	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.24	CHEMBL3650	Homo sapiens	Inhibition	%	5.24
	8182946	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.86	CHEMBL3650	Homo sapiens	Inhibition	%	2.86
	8183319	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	9.22	CHEMBL3650	Homo sapiens	Inhibition	%	9.22
	8183448	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.51	CHEMBL3650	Homo sapiens	Inhibition	%	4.51
	8183672	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	7.55	CHEMBL3650	Homo sapiens	Inhibition	%	7.55
	8183814	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	5.51	CHEMBL3650	Homo sapiens	Inhibition	%	5.51
	8184174	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.95	CHEMBL3650	Homo sapiens	Inhibition	%	2.95
	8184440	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.3	CHEMBL3650	Homo sapiens	Inhibition	%	4.3
	8184587	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.92	CHEMBL3650	Homo sapiens	Inhibition	%	-1.92
	8184968	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.68	CHEMBL3650	Homo sapiens	Inhibition	%	4.68
	8185117	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	15.35	CHEMBL3650	Homo sapiens	Inhibition	%	15.35
	8185341	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.81	CHEMBL3650	Homo sapiens	Inhibition	%	-0.81
	8185472	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	8.34	CHEMBL3650	Homo sapiens	Inhibition	%	8.34
	8185827	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	6.33	CHEMBL3650	Homo sapiens	Inhibition	%	6.33
	8185966	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	8.51	CHEMBL3650	Homo sapiens	Inhibition	%	8.51
	8186331	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.92	CHEMBL3650	Homo sapiens	Inhibition	%	4.92
	8186495	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.14	CHEMBL3650	Homo sapiens	Inhibition	%	4.14
	8186719	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.17	CHEMBL3650	Homo sapiens	Inhibition	%	4.17
	8186858	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.6	CHEMBL3650	Homo sapiens	Inhibition	%	4.6
	8187180	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.16	CHEMBL3650	Homo sapiens	Inhibition	%	2.16
	8187304	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	-0.23	CHEMBL3650	Homo sapiens	Inhibition	%	-0.23
	8187528	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.54	CHEMBL3650	Homo sapiens	Inhibition	%	1.54
	8187676	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	40.23	CHEMBL3650	Homo sapiens	Inhibition	%	40.23
	8188029	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.28	CHEMBL3650	Homo sapiens	Inhibition	%	6.28
	8188172	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.63	CHEMBL3650	Homo sapiens	Inhibition	%	1.63
	8188531	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	3.99	CHEMBL3650	Homo sapiens	Inhibition	%	3.99
	8188805	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.51	CHEMBL3650	Homo sapiens	Inhibition	%	7.51
	8188953	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.48	CHEMBL3650	Homo sapiens	Inhibition	%	4.48
	8189177	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.65	CHEMBL3650	Homo sapiens	Inhibition	%	-0.65
	8189333	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	15.87	CHEMBL3650	Homo sapiens	Inhibition	%	15.87
	8189706	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.46	CHEMBL3650	Homo sapiens	Inhibition	%	-0.46
	8189838	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.37	CHEMBL3650	Homo sapiens	Inhibition	%	0.37
	8190194	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.85	CHEMBL3650	Homo sapiens	Inhibition	%	3.85
	8190334	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.95	CHEMBL3650	Homo sapiens	Inhibition	%	2.95
	8190558	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	8.68	CHEMBL3650	Homo sapiens	Inhibition	%	8.68
	8190695	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.84	CHEMBL3650	Homo sapiens	Inhibition	%	0.84
	8191083	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.02	CHEMBL3650	Homo sapiens	Inhibition	%	8.02
	8191221	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	27.85	CHEMBL3650	Homo sapiens	Inhibition	%	27.85
	8191541	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	7.91	CHEMBL3650	Homo sapiens	Inhibition	%	7.91
	8191887	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	0.82	CHEMBL3650	Homo sapiens	Inhibition	%	0.82
	8192036	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.4	CHEMBL3650	Homo sapiens	Inhibition	%	5.4
	8192389	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.05	CHEMBL3650	Homo sapiens	Inhibition	%	3.05
	8192533	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	Inhibition	%	1.0
	8192757	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.11	CHEMBL3650	Homo sapiens	Inhibition	%	4.11
	8192893	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.92	CHEMBL3650	Homo sapiens	Inhibition	%	0.92
	8193165	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.47	CHEMBL3650	Homo sapiens	Inhibition	%	1.47
	8193534	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.77	CHEMBL3650	Homo sapiens	Inhibition	%	2.77
	8193691	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.1	CHEMBL3650	Homo sapiens	Inhibition	%	5.1
	8194064	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.71	CHEMBL3650	Homo sapiens	Inhibition	%	-3.71
	8194195	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.98	CHEMBL3650	Homo sapiens	Inhibition	%	0.98
	8194419	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.9	CHEMBL3650	Homo sapiens	Inhibition	%	4.9
	8194550	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	13.98	CHEMBL3650	Homo sapiens	Inhibition	%	13.98
	8194917	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.54	CHEMBL3650	Homo sapiens	Inhibition	%	6.54
	8195050	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.14	CHEMBL3650	Homo sapiens	Inhibition	%	3.14
	8195274	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-2.05	CHEMBL3650	Homo sapiens	Inhibition	%	-2.05
	8195438	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.35	CHEMBL3650	Homo sapiens	Inhibition	%	3.35
	8195577	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	9.1	CHEMBL3650	Homo sapiens	Inhibition	%	9.1
	8195801	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.91	CHEMBL3650	Homo sapiens	Inhibition	%	5.91
	8195899	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	6.73	CHEMBL3650	Homo sapiens	Inhibition	%	6.73
	8196240	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.15	CHEMBL3650	Homo sapiens	Inhibition	%	2.15
	8196390	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	11.78	CHEMBL3650	Homo sapiens	Inhibition	%	11.78
	8196614	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	9.59	CHEMBL3650	Homo sapiens	Inhibition	%	9.59
	8196742	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.33	CHEMBL3650	Homo sapiens	Inhibition	%	2.33
	8197107	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.14	CHEMBL3650	Homo sapiens	Inhibition	%	3.14
	8197244	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	4.3	CHEMBL3650	Homo sapiens	Inhibition	%	4.3
	8197468	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.38	CHEMBL3650	Homo sapiens	Inhibition	%	-0.38
	8197519	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.1	CHEMBL3650	Homo sapiens	Inhibition	%	5.1
	8197743	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.07	CHEMBL3650	Homo sapiens	Inhibition	%	3.07
	8197883	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	3.46	CHEMBL3650	Homo sapiens	Inhibition	%	3.46
	8198040	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	8.92	CHEMBL3650	Homo sapiens	Inhibition	%	8.92
	8198264	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-4.07	CHEMBL3650	Homo sapiens	Inhibition	%	-4.07
	8198402	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.9	CHEMBL3650	Homo sapiens	Inhibition	%	-1.9
	8198756	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	17.22	CHEMBL3650	Homo sapiens	Inhibition	%	17.22
	8198887	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.27	CHEMBL3650	Homo sapiens	Inhibition	%	5.27
	8199111	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	13.04	CHEMBL3650	Homo sapiens	Inhibition	%	13.04
	8199259	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	8.38	CHEMBL3650	Homo sapiens	Inhibition	%	8.38
	8199617	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.88	CHEMBL3650	Homo sapiens	Inhibition	%	2.88
	8199780	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	8.23	CHEMBL3650	Homo sapiens	Inhibition	%	8.23
	8200142	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.71	CHEMBL3650	Homo sapiens	Inhibition	%	5.71
	8200246	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	7.75	CHEMBL3650	Homo sapiens	Inhibition	%	7.75
	8200470	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.82	CHEMBL3650	Homo sapiens	Inhibition	%	-0.82
	8200585	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.67	CHEMBL3650	Homo sapiens	Inhibition	%	1.67
	8200959	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	10.89	CHEMBL3650	Homo sapiens	Inhibition	%	10.89
	8201089	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-3.02	CHEMBL3650	Homo sapiens	Inhibition	%	-3.02
	8201313	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	7.33	CHEMBL3650	Homo sapiens	Inhibition	%	7.33
	8201448	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.72	CHEMBL3650	Homo sapiens	Inhibition	%	4.72
	8201805	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.12	CHEMBL3650	Homo sapiens	Inhibition	%	-0.12
	8202084	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-1.13	CHEMBL3650	Homo sapiens	Inhibition	%	-1.13
	8202224	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	8.43	CHEMBL3650	Homo sapiens	Inhibition	%	8.43
	8202615	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.42	CHEMBL3650	Homo sapiens	Inhibition	%	1.42
	8202740	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.18	CHEMBL3650	Homo sapiens	Inhibition	%	6.18
	8203094	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.96	CHEMBL3650	Homo sapiens	Inhibition	%	4.96
	8203449	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	24.86	CHEMBL3650	Homo sapiens	Inhibition	%	24.86
	8203595	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	15.25	CHEMBL3650	Homo sapiens	Inhibition	%	15.25
	8203953	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.38	CHEMBL3650	Homo sapiens	Inhibition	%	2.38
	8204119	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.91	CHEMBL3650	Homo sapiens	Inhibition	%	1.91
	8204343	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.93	CHEMBL3650	Homo sapiens	Inhibition	%	3.93
	8204480	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	15.07	CHEMBL3650	Homo sapiens	Inhibition	%	15.07
	8204809	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	7.85	CHEMBL3650	Homo sapiens	Inhibition	%	7.85
	8204924	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.55	CHEMBL3650	Homo sapiens	Inhibition	%	1.55
	8205148	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.94	CHEMBL3650	Homo sapiens	Inhibition	%	7.94
	8205297	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.29	CHEMBL3650	Homo sapiens	Inhibition	%	8.29
	8205657	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.54	CHEMBL3650	Homo sapiens	Inhibition	%	4.54
	8205796	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.35	CHEMBL3650	Homo sapiens	Inhibition	%	3.35
	8206152	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.93	CHEMBL3650	Homo sapiens	Inhibition	%	2.93
	8206428	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.33	CHEMBL3650	Homo sapiens	Inhibition	%	2.33
	8206571	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-5.75	CHEMBL3650	Homo sapiens	Inhibition	%	-5.75
	8206795	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.36	CHEMBL3650	Homo sapiens	Inhibition	%	-1.36
	8206975	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.21	CHEMBL3650	Homo sapiens	Inhibition	%	3.21
	8207101	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.81	CHEMBL3650	Homo sapiens	Inhibition	%	6.81
	8207325	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.71	CHEMBL3650	Homo sapiens	Inhibition	%	3.71
	8207455	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.84	CHEMBL3650	Homo sapiens	Inhibition	%	8.84
	8207811	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	62.61	CHEMBL3650	Homo sapiens	Inhibition	%	62.61
	8207956	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.29	CHEMBL3650	Homo sapiens	Inhibition	%	1.29
	8208180	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.22	CHEMBL3650	Homo sapiens	Inhibition	%	2.22
	8208312	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.12	CHEMBL3650	Homo sapiens	Inhibition	%	1.12
	8208702	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.46	CHEMBL3650	Homo sapiens	Inhibition	%	1.46
	8208835	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	46.64	CHEMBL3650	Homo sapiens	Inhibition	%	46.64
	8209164	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	6.92	CHEMBL3650	Homo sapiens	Inhibition	%	6.92
	8209504	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	Inhibition	%	7.0
	8209654	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	9.37	CHEMBL3650	Homo sapiens	Inhibition	%	9.37
	8210014	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	7.51	CHEMBL3650	Homo sapiens	Inhibition	%	7.51
	8210155	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.11	CHEMBL3650	Homo sapiens	Inhibition	%	5.11
	8210379	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.06	CHEMBL3650	Homo sapiens	Inhibition	%	4.06
	8210515	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.02	CHEMBL3650	Homo sapiens	Inhibition	%	-3.02
	8210774	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-2.72	CHEMBL3650	Homo sapiens	Inhibition	%	-2.72
	8211142	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.22	CHEMBL3650	Homo sapiens	Inhibition	%	3.22
	8211312	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.42	CHEMBL3650	Homo sapiens	Inhibition	%	3.42
	8211659	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.27	CHEMBL3650	Homo sapiens	Inhibition	%	7.27
	8211788	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.1	CHEMBL3650	Homo sapiens	Inhibition	%	7.1
	8212012	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	21.36	CHEMBL3650	Homo sapiens	Inhibition	%	21.36
	8212144	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	8.63	CHEMBL3650	Homo sapiens	Inhibition	%	8.63
	8212509	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.72	CHEMBL3650	Homo sapiens	Inhibition	%	3.72
	8212642	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-0.51	CHEMBL3650	Homo sapiens	Inhibition	%	-0.51
	8213036	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	13.24	CHEMBL3650	Homo sapiens	Inhibition	%	13.24
	8213165	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	13.13	CHEMBL3650	Homo sapiens	Inhibition	%	13.13
	8213389	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	8.28	CHEMBL3650	Homo sapiens	Inhibition	%	8.28
	8213493	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	40.0	CHEMBL3650	Homo sapiens	Inhibition	%	40.0
	8213830	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.84	CHEMBL3650	Homo sapiens	Inhibition	%	5.84
	8213977	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.31	CHEMBL3650	Homo sapiens	Inhibition	%	2.31
	8214201	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	7.63	CHEMBL3650	Homo sapiens	Inhibition	%	7.63
	8214338	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.42	CHEMBL3650	Homo sapiens	Inhibition	%	4.42
	8214696	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.6	CHEMBL3650	Homo sapiens	Inhibition	%	4.6
	8214848	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.95	CHEMBL3650	Homo sapiens	Inhibition	%	-1.95
	8215099	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.85	CHEMBL3650	Homo sapiens	Inhibition	%	-1.85
	8215323	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.48	CHEMBL3650	Homo sapiens	Inhibition	%	1.48
	8215476	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	12.86	CHEMBL3650	Homo sapiens	Inhibition	%	12.86
	8215640	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-0.06	CHEMBL3650	Homo sapiens	Inhibition	%	-0.06
	8215983	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.71	CHEMBL3650	Homo sapiens	Inhibition	%	-0.71
	8216326	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.99	CHEMBL3650	Homo sapiens	Inhibition	%	4.99
	8216462	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	10.69	CHEMBL3650	Homo sapiens	Inhibition	%	10.69
	8216824	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.84	CHEMBL3650	Homo sapiens	Inhibition	%	5.84
	8216958	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.64	CHEMBL3650	Homo sapiens	Inhibition	%	2.64
	8217182	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	0.61	CHEMBL3650	Homo sapiens	Inhibition	%	0.61
	8217356	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-1.76	CHEMBL3650	Homo sapiens	Inhibition	%	-1.76
	8217711	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	12.12	CHEMBL3650	Homo sapiens	Inhibition	%	12.12
	8217812	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.91	CHEMBL3650	Homo sapiens	Inhibition	%	-0.91
	8218036	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.2	CHEMBL3650	Homo sapiens	Inhibition	%	2.2
	8218151	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.05	CHEMBL3650	Homo sapiens	Inhibition	%	6.05
	8218502	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.74	CHEMBL3650	Homo sapiens	Inhibition	%	4.74
	8218645	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	29.43	CHEMBL3650	Homo sapiens	Inhibition	%	29.43
	8219000	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	34.8	CHEMBL3650	Homo sapiens	Inhibition	%	34.8
	8219160	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.52	CHEMBL3650	Homo sapiens	Inhibition	%	3.52
	8219384	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.55	CHEMBL3650	Homo sapiens	Inhibition	%	5.55
	8219634	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.16	CHEMBL3650	Homo sapiens	Inhibition	%	1.16
	8219795	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.15	CHEMBL3650	Homo sapiens	Inhibition	%	3.15
	8219964	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.23	CHEMBL3650	Homo sapiens	Inhibition	%	2.23
	8220188	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.34	CHEMBL3650	Homo sapiens	Inhibition	%	3.34
	8220317	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.9	CHEMBL3650	Homo sapiens	Inhibition	%	5.9
	8220655	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.11	CHEMBL3650	Homo sapiens	Inhibition	%	5.11
	8220793	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	8.16	CHEMBL3650	Homo sapiens	Inhibition	%	8.16
	8221017	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	23.54	CHEMBL3650	Homo sapiens	Inhibition	%	23.54
	8221153	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.25	CHEMBL3650	Homo sapiens	Inhibition	%	2.25
	8221510	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.19	CHEMBL3650	Homo sapiens	Inhibition	%	2.19
	8221675	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.11	CHEMBL3650	Homo sapiens	Inhibition	%	2.11
	8222030	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	19.33	CHEMBL3650	Homo sapiens	Inhibition	%	19.33
	8222352	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	4.89	CHEMBL3650	Homo sapiens	Inhibition	%	4.89
	8222486	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.14	CHEMBL3650	Homo sapiens	Inhibition	%	2.14
	8222828	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	9.7	CHEMBL3650	Homo sapiens	Inhibition	%	9.7
	8222972	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	10.13	CHEMBL3650	Homo sapiens	Inhibition	%	10.13
	8223196	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	65.99	CHEMBL3650	Homo sapiens	Inhibition	%	65.99
	8223325	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.35	CHEMBL3650	Homo sapiens	Inhibition	%	2.35
	8223710	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.78	CHEMBL3650	Homo sapiens	Inhibition	%	1.78
	8223960	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.35	CHEMBL3650	Homo sapiens	Inhibition	%	2.35
	8224122	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	9.2	CHEMBL3650	Homo sapiens	Inhibition	%	9.2
	8224516	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.69	CHEMBL3650	Homo sapiens	Inhibition	%	6.69
	8224651	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.74	CHEMBL3650	Homo sapiens	Inhibition	%	0.74
	8224875	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.7	CHEMBL3650	Homo sapiens	Inhibition	%	5.7
	8224989	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-0.25	CHEMBL3650	Homo sapiens	Inhibition	%	-0.25
	8225347	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.55	CHEMBL3650	Homo sapiens	Inhibition	%	7.55
	8225485	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.04	CHEMBL3650	Homo sapiens	Inhibition	%	-2.04
	8225709	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.69	CHEMBL3650	Homo sapiens	Inhibition	%	0.69
	8225844	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.27	CHEMBL3650	Homo sapiens	Inhibition	%	6.27
	8226002	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.16	CHEMBL3650	Homo sapiens	Inhibition	%	-0.16
	8226226	CHEMBL1962289	GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.62	CHEMBL3650	Homo sapiens	Inhibition	%	1.62
	8226351	CHEMBL1962288	GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.53	CHEMBL3650	Homo sapiens	Inhibition	%	5.53
active	9586573	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586574	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9586575	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586576	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586577	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
active	9586578	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	100.0	CHEMBL3650	Homo sapiens	pKi		7.0
active	9586579	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	50.12	CHEMBL3650	Homo sapiens	pKi		7.3
inactive	9586580	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586581	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
active	9586582	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	100.0	CHEMBL3650	Homo sapiens	pKi		7.0
inactive	9586583	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586584	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586585	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9586586	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	125.89	CHEMBL3650	Homo sapiens	pKi		6.9
active	9586587	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
active	9586588	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586589	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586590	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586591	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586592	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586593	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586594	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586595	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586596	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	19952.62	CHEMBL3650	Homo sapiens	pKi		4.7
inactive	9586597	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586598	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586599	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586600	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
inactive	9586601	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586602	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586603	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586604	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586605	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586606	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9586607	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9586608	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586609	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586610	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
active	9586611	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
inactive	9586612	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586613	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586614	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586615	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586616	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586617	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9586618	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586619	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586620	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	19.95	CHEMBL3650	Homo sapiens	pKi		7.7
inactive	9586621	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586622	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586623	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL3650	Homo sapiens	pKi		4.1
active	9586624	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9586625	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586626	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9586627	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9586628	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	125.89	CHEMBL3650	Homo sapiens	pKi		6.9
active	9586629	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
active	9586630	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9586631	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586632	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	25118.86	CHEMBL3650	Homo sapiens	pKi		4.6
inactive	9586633	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586634	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586635	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586636	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586637	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586638	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586639	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586640	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9586641	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9586642	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586643	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586644	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9586645	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586646	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586647	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586648	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586649	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586650	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586651	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	79.43	CHEMBL3650	Homo sapiens	pKi		7.1
active	9586652	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	31.62	CHEMBL3650	Homo sapiens	pKi		7.5
active	9586653	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
active	9586654	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9586655	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586656	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586657	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	79432.82	CHEMBL3650	Homo sapiens	pKi		4.1
inactive	9586658	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586659	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586660	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9586661	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586662	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586663	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586664	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586665	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586666	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586667	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586668	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586669	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586670	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	=	Ki	nM	19.95	CHEMBL3650	Homo sapiens	pKi		7.7
inactive	9586671	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586672	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586673	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	31.62	CHEMBL3650	Homo sapiens	pKi		7.5
inactive	9586674	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586675	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586676	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	19.95	CHEMBL3650	Homo sapiens	pKi		7.7
inactive	9586677	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586678	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586679	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586680	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
inactive	9586681	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1977619	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9586682	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586683	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
active	9586684	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9586685	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586686	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586687	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586688	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586689	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
active	9586690	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
active	9586691	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9586692	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586693	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586694	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586695	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586696	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	251.19	CHEMBL3650	Homo sapiens	pKi		6.6
active	9586697	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	50.12	CHEMBL3650	Homo sapiens	pKi		7.3
active	9586698	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9586699	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586700	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586701	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586702	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586703	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586704	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586705	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586706	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(=O)[nH]c2[nH]nc(-c3cccc(C(F)(F)F)c3)c12		CHEMBL1991377	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586707	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586708	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586709	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	31.62	CHEMBL3650	Homo sapiens	pKi		7.5
inactive	9586710	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586711	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586712	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586713	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586714	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	6.31	CHEMBL3650	Homo sapiens	pKi		8.2
inactive	9586715	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586716	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586717	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9586718	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9586719	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9586720	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586721	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586722	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586723	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
inactive	9586724	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586725	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9586726	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9586727	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586728	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586729	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586730	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9586731	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586732	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586733	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586734	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586735	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586736	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586737	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
active	9586738	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nccc2nc(-c3ccccc3)cn12		CHEMBL2004887	=	Ki	nM	79432.82	CHEMBL3650	Homo sapiens	pKi		4.1
active	9586739	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	=	Ki	nM	25118.86	CHEMBL3650	Homo sapiens	pKi		4.6
active	9586740	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	63.1	CHEMBL3650	Homo sapiens	pKi		7.2
active	9586741	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586742	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9586743	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9586744	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586745	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9586746	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9586747	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590310	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590311	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
active	9590312	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
active	9590313	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9590314	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590315	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590316	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590317	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590318	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590319	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	15.85	CHEMBL3650	Homo sapiens	pKi		7.8
inactive	9590320	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590321	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590322	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590323	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590324	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	15848.93	CHEMBL3650	Homo sapiens	pKi		4.8
inactive	9590325	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590326	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
inactive	9590327	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590328	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)Cc1nc2c(N)cccc2[nH]1		CHEMBL1981671	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590329	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590330	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590331	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	79.43	CHEMBL3650	Homo sapiens	pKi		7.1
inactive	9590332	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590333	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590334	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590335	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590336	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590337	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9590338	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590339	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590340	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9590341	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	316.23	CHEMBL3650	Homo sapiens	pKi		6.5
active	9590342	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	31.62	CHEMBL3650	Homo sapiens	pKi		7.5
active	9590343	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	5.012	CHEMBL3650	Homo sapiens	pKi		8.3
inactive	9590344	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590345	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590346	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590347	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590348	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590349	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9590350	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590351	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9590352	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590353	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590354	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590355	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	1.585	CHEMBL3650	Homo sapiens	pKi		8.8
inactive	9590356	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590357	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590358	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590359	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
active	9590360	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
active	9590361	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	6.31	CHEMBL3650	Homo sapiens	pKi		8.2
inactive	9590362	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590363	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590364	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]n2ccccc2c1Br		CHEMBL2004033	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590365	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
active	9590366	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9590367	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590368	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590369	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590370	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9590371	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590372	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590373	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590374	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590375	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2nc3ccccc3n12		CHEMBL1983884	<	Ki	nM	79432.82	CHEMBL3650	Homo sapiens	pKi		4.1
inactive	9590376	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590377	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9590378	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590379	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccc(Br)cc34)[nH]c2c1		CHEMBL1965437	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9590380	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590381	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	10000.0	CHEMBL3650	Homo sapiens	pKi		5.0
inactive	9590382	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590383	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590384	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590385	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590386	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590387	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
inactive	9590388	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590389	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590390	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590391	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	7.943	CHEMBL3650	Homo sapiens	pKi		8.1
inactive	9590392	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590393	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590394	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590395	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9590396	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590397	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	19952.62	CHEMBL3650	Homo sapiens	pKi		4.7
inactive	9590398	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590399	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590400	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590401	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
active	9590402	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9590403	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590404	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
active	9590405	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9590406	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590407	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590408	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590409	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590410	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590411	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	39.81	CHEMBL3650	Homo sapiens	pKi		7.4
inactive	9590412	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590413	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590414	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590415	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	31.62	CHEMBL3650	Homo sapiens	pKi		7.5
inactive	9590416	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590417	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590418	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590419	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590420	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590421	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590422	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
active	9590423	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	39810.72	CHEMBL3650	Homo sapiens	pKi		4.4
active	9590424	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9590425	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590426	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	50.12	CHEMBL3650	Homo sapiens	pKi		7.3
inactive	9590427	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590428	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9590429	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590430	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590431	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9590432	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CCNc1ccc(O)c2ccccc12		CHEMBL576113	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590433	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590434	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590435	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590436	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
inactive	9590437	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590438	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590439	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	10000.0	CHEMBL3650	Homo sapiens	pKi		5.0
inactive	9590440	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590441	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590442	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590443	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590444	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590445	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590446	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	25118.86	CHEMBL3650	Homo sapiens	pKi		4.6
inactive	9590447	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590448	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590449	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590450	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590451	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590452	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590453	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	39.81	CHEMBL3650	Homo sapiens	pKi		7.4
active	9590454	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	316.23	CHEMBL3650	Homo sapiens	pKi		6.5
inactive	9590455	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nn(C)c2sc(C(N)=O)cc12		CHEMBL1986588	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9590456	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590457	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	63.1	CHEMBL3650	Homo sapiens	pKi		7.2
inactive	9590458	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590459	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590460	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9590461	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
active	9590462	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
active	9590463	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9590464	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590465	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590466	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2c(-c3ccccc3)cccc12		CHEMBL1991008	=	Ki	nM	79432.82	CHEMBL3650	Homo sapiens	pKi		4.1
active	9590467	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
inactive	9590468	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590469	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
inactive	9590470	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590471	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590472	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9590473	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590474	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590475	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590476	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
active	9590477	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9590478	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590479	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9590480	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590481	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590482	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	251.19	CHEMBL3650	Homo sapiens	pKi		6.6
inactive	9590483	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590484	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590485	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590486	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590487	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590488	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590489	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
active	9590490	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9590491	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590492	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590493	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590494	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	251.19	CHEMBL3650	Homo sapiens	pKi		6.6
inactive	9590495	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590496	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	398.11	CHEMBL3650	Homo sapiens	pKi		6.4
inactive	9590497	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590498	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9590499	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590500	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590501	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590502	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590503	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590504	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590505	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590506	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590507	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
active	9590508	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	251.19	CHEMBL3650	Homo sapiens	pKi		6.6
active	9590509	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
active	9590510	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9590511	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590512	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590513	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590514	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
inactive	9590515	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590516	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590517	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590518	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590519	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1cc2nc(-c3ccccc3)cn2cn1		CHEMBL1972365	=	Ki	nM	10000.0	CHEMBL3650	Homo sapiens	pKi		5.0
inactive	9590520	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590521	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	5.012	CHEMBL3650	Homo sapiens	pKi		8.3
inactive	9590522	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590523	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	19.95	CHEMBL3650	Homo sapiens	pKi		7.7
inactive	9590524	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590525	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590526	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590527	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590528	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
active	9590529	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9590530	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590531	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590532	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc2c(c1)C(=O)Nc1ccccc1N2		CHEMBL1970873	<	Ki	nM	25118.86	CHEMBL3650	Homo sapiens	pKi		4.6
active	9590533	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9590534	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590535	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	398.11	CHEMBL3650	Homo sapiens	pKi		6.4
active	9590536	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
active	9590537	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
inactive	9590538	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9590539	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590540	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	19952.62	CHEMBL3650	Homo sapiens	pKi		4.7
inactive	9590541	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9590542	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	31622.78	CHEMBL3650	Homo sapiens	pKi		4.5
inactive	9590543	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9590544	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9590545	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
active	9590546	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	79432.82	CHEMBL3650	Homo sapiens	pKi		4.1
inactive	9590547	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9590548	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594112	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9594113	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594114	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594115	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9594116	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	100.0	CHEMBL3650	Homo sapiens	pKi		7.0
active	9594117	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9594118	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594119	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594120	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	316.23	CHEMBL3650	Homo sapiens	pKi		6.5
inactive	9594121	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594122	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594123	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]cnc2ccc(Br)cc12		CHEMBL562488	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
active	9594124	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9594125	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594126	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594127	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594128	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594129	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594130	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
active	9594131	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594132	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594133	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
inactive	9594134	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594135	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594136	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594137	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594138	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
active	9594139	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	251.19	CHEMBL3650	Homo sapiens	pKi		6.6
active	9594140	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594141	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594142	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594143	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
active	9594144	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9594145	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594146	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594147	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594148	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594149	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594150	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594151	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594152	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594153	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594154	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9594155	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594156	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
inactive	9594157	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594158	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594159	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594160	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOCC(C)Oc1cccc2[nH]nc(N)c12		CHEMBL2002736	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594161	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594162	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594163	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594164	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594165	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594166	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594167	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594168	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594169	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594170	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594171	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594172	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	100.0	CHEMBL3650	Homo sapiens	pKi		7.0
active	9594173	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	7.943	CHEMBL3650	Homo sapiens	pKi		8.1
inactive	9594174	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594175	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9594176	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594177	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594178	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594179	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594180	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594181	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594182	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
active	9594183	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9594184	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CS(=O)(=O)c1cccc(-c2cnn3c(C(N)=O)cc(-c4ccccc4)nc23)c1		CHEMBL1998477	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9594185	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594186	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
active	9594187	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	25118.86	CHEMBL3650	Homo sapiens	pKi		4.6
inactive	9594188	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594189	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9594190	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	39.81	CHEMBL3650	Homo sapiens	pKi		7.4
inactive	9594191	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9594192	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594193	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9594194	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594195	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594196	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	199.53	CHEMBL3650	Homo sapiens	pKi		6.7
active	9594197	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
active	9594198	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9594199	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594200	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594201	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594202	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594203	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594204	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594205	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	15.85	CHEMBL3650	Homo sapiens	pKi		7.8
inactive	9594206	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2c(Cl)cccc12		CHEMBL1980161	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
active	9594207	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
active	9594208	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
active	9594209	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	15.85	CHEMBL3650	Homo sapiens	pKi		7.8
active	9594210	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	398.11	CHEMBL3650	Homo sapiens	pKi		6.4
active	9594211	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9594212	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
inactive	9594213	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1ccccc1)Nc1ccccn1		CHEMBL143703	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9594214	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594215	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9594216	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594217	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594218	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594219	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Fc1ccc2c(c1)-c1n[nH]cc1CS2		CHEMBL1989069	=	Ki	nM	10000.0	CHEMBL3650	Homo sapiens	pKi		5.0
inactive	9594220	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594221	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCc2ccc(-c3ccc(Cl)cc3)cc21		CHEMBL2002202	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9594222	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594223	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
active	9594224	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9594225	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594226	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594227	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594228	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594229	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594230	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	199.53	CHEMBL3650	Homo sapiens	pKi		6.7
active	9594231	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9594232	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594233	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594234	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594235	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594236	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	125.89	CHEMBL3650	Homo sapiens	pKi		6.9
inactive	9594237	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594238	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	31.62	CHEMBL3650	Homo sapiens	pKi		7.5
inactive	9594239	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594240	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594241	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9594242	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
active	9594243	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	15848.93	CHEMBL3650	Homo sapiens	pKi		4.8
active	9594244	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
active	9594245	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9594246	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594247	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594248	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594249	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594250	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594251	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594252	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9594253	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594254	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594255	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594256	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594257	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594258	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	398.11	CHEMBL3650	Homo sapiens	pKi		6.4
inactive	9594259	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594260	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594261	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594262	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9594263	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594264	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9594265	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594266	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594267	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594268	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594269	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	7.943	CHEMBL3650	Homo sapiens	pKi		8.1
inactive	9594270	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594271	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9594272	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594273	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594274	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594275	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594276	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
active	9594277	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594278	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594279	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594280	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594281	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594282	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594283	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594284	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594285	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594286	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594287	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
active	9594288	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
active	9594289	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
inactive	9594290	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594291	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9594292	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9594293	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594294	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	=	Ki	nM	398.11	CHEMBL3650	Homo sapiens	pKi		6.4
inactive	9594295	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594296	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9594297	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594298	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594299	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594300	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594301	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9594302	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9594303	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9594304	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
active	9594305	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9594306	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
inactive	9594307	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594308	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9594309	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594310	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	12.59	CHEMBL3650	Homo sapiens	pKi		7.9
inactive	9594311	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594312	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9594313	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594314	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9594315	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594316	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594317	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594318	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594319	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594320	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	199.53	CHEMBL3650	Homo sapiens	pKi		6.7
active	9594321	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
inactive	9594322	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594323	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594324	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594325	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9594326	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594327	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594328	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	100.0	CHEMBL3650	Homo sapiens	pKi		7.0
active	9594329	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
inactive	9594330	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594331	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594332	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594333	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594334	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594335	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594336	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	<	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9594337	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9594338	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9594339	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	199.53	CHEMBL3650	Homo sapiens	pKi		6.7
active	9594340	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
inactive	9594341	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594342	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	39810.72	CHEMBL3650	Homo sapiens	pKi		4.4
active	9594343	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9594344	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594345	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9594346	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9594347	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594348	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594349	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9594350	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9597919	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9597920	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597921	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	251.19	CHEMBL3650	Homo sapiens	pKi		6.6
inactive	9597922	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597923	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
active	9597924	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597925	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597926	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597927	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9597928	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597929	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9597930	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597931	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9597932	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597933	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597934	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9597935	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597936	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597937	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597938	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597939	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597940	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597941	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9597942	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597943	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597944	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597945	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9597946	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597947	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597948	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597949	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597950	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597951	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597952	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597953	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597954	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	=	Ki	nM	25.12	CHEMBL3650	Homo sapiens	pKi		7.6
active	9597955	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597956	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9597957	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9597958	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597959	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	19.95	CHEMBL3650	Homo sapiens	pKi		7.7
active	9597960	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9597961	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597962	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	25118.86	CHEMBL3650	Homo sapiens	pKi		4.6
active	9597963	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9597964	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9597965	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597966	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597967	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597968	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597969	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9597970	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597971	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597972	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597973	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597974	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597975	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597976	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nn(C)c2sc3c(=O)[nH]cnc3c12		CHEMBL1967538	<	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9597977	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597978	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597979	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
active	9597980	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597981	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597982	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9597983	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9597984	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597985	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597986	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597987	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9597988	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597989	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597990	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	63.1	CHEMBL3650	Homo sapiens	pKi		7.2
active	9597991	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9597992	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597993	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9597994	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9597995	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9597996	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
active	9597997	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
active	9597998	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
active	9597999	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nnc2ccc(-c3ccccc3)cn12		CHEMBL1987143	=	Ki	nM	10000.0	CHEMBL3650	Homo sapiens	pKi		5.0
inactive	9598000	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598001	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598002	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598003	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598004	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598005	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598006	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598007	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598008	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598009	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598010	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598011	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598012	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598013	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	316.23	CHEMBL3650	Homo sapiens	pKi		6.5
active	9598014	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598015	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	7.943	CHEMBL3650	Homo sapiens	pKi		8.1
active	9598016	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9598017	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598018	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598019	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598020	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598021	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	31622.78	CHEMBL3650	Homo sapiens	pKi		4.5
inactive	9598022	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598023	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9598024	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598025	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
inactive	9598026	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598027	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598028	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598029	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	316.23	CHEMBL3650	Homo sapiens	pKi		6.5
active	9598030	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	=	Ki	nM	7943.28	CHEMBL3650	Homo sapiens	pKi		5.1
active	9598031	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9598032	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598033	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9598034	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598035	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N		CHEMBL1984402	=	Ki	nM	63095.73	CHEMBL3650	Homo sapiens	pKi		4.2
inactive	9598036	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598037	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9598038	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598039	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598040	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598041	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598042	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598043	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598044	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9598045	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	15.85	CHEMBL3650	Homo sapiens	pKi		7.8
active	9598046	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598047	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9598048	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598049	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598050	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598051	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598052	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598053	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598054	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598055	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598056	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598057	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598058	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	12589.25	CHEMBL3650	Homo sapiens	pKi		4.9
inactive	9598059	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598060	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	316.23	CHEMBL3650	Homo sapiens	pKi		6.5
active	9598061	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9598062	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598063	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598064	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598065	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
active	9598066	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	19.95	CHEMBL3650	Homo sapiens	pKi		7.7
inactive	9598067	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598068	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598069	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598070	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598071	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598072	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598073	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	63.1	CHEMBL3650	Homo sapiens	pKi		7.2
inactive	9598074	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	12589.25	CHEMBL3650	Homo sapiens	pKi		4.9
active	9598075	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	251.19	CHEMBL3650	Homo sapiens	pKi		6.6
inactive	9598076	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598077	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598078	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598079	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598080	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598081	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598082	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598083	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598084	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	501.19	CHEMBL3650	Homo sapiens	pKi		6.3
inactive	9598085	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598086	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598087	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	<	Ki	nM	39810.72	CHEMBL3650	Homo sapiens	pKi		4.4
active	9598088	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	7943.28	CHEMBL3650	Homo sapiens	pKi		5.1
inactive	9598089	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598090	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598091	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9598092	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598093	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598094	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
active	9598095	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	50.12	CHEMBL3650	Homo sapiens	pKi		7.3
inactive	9598096	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598097	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	63.1	CHEMBL3650	Homo sapiens	pKi		7.2
active	9598098	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9598099	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598100	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1C(=O)NCCN2		CHEMBL1992607	=	Ki	nM	100000.0	CHEMBL3650	Homo sapiens	pKi		4.0
inactive	9598101	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598102	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598103	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598104	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598105	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598106	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598107	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598108	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
active	9598109	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9598110	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598111	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598112	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598113	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598114	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	316.23	CHEMBL3650	Homo sapiens	pKi		6.5
inactive	9598115	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598116	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	158.49	CHEMBL3650	Homo sapiens	pKi		6.8
inactive	9598117	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
inactive	9598118	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598119	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598120	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598121	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598122	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598123	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598124	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	316.23	CHEMBL3650	Homo sapiens	pKi		6.5
active	9598125	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9598126	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598127	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	50.12	CHEMBL3650	Homo sapiens	pKi		7.3
active	9598128	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	398.11	CHEMBL3650	Homo sapiens	pKi		6.4
inactive	9598129	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598130	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598131	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	1995.26	CHEMBL3650	Homo sapiens	pKi		5.7
active	9598132	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	79.43	CHEMBL3650	Homo sapiens	pKi		7.1
inactive	9598133	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598134	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598135	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
active	9598136	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9598137	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598138	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9598139	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598140	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598141	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
inactive	9598142	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9598143	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598144	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	100.0	CHEMBL3650	Homo sapiens	pKi		7.0
active	9598145	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
active	9598146	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	12.59	CHEMBL3650	Homo sapiens	pKi		7.9
inactive	9598147	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598148	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9598149	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9598150	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9598151	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9598152	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598153	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9598154	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598155	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9598156	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9598157	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9601719	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601720	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601721	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	10.0	CHEMBL3650	Homo sapiens	pKi		8.0
active	9601722	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	19.95	CHEMBL3650	Homo sapiens	pKi		7.7
inactive	9601723	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601724	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	3.162	CHEMBL3650	Homo sapiens	pKi		8.5
active	9601725	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	63.1	CHEMBL3650	Homo sapiens	pKi		7.2
active	9601726	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601727	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601728	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	31622.78	CHEMBL3650	Homo sapiens	pKi		4.5
inactive	9601729	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601730	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601731	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601732	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601733	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601734	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601735	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601736	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCO)c2)n1		CHEMBL2007073	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601737	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601738	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9601739	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601740	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601741	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601742	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601743	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	=	Ki	nM	15848.93	CHEMBL3650	Homo sapiens	pKi		4.8
inactive	9601744	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601745	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601746	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601747	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
inactive	9601748	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601749	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601750	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	63.1	CHEMBL3650	Homo sapiens	pKi		7.2
inactive	9601751	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601752	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601753	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601754	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	794.33	CHEMBL3650	Homo sapiens	pKi		6.1
inactive	9601755	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601756	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601757	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601758	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601759	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	398.11	CHEMBL3650	Homo sapiens	pKi		6.4
inactive	9601760	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601761	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601762	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601763	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	79.43	CHEMBL3650	Homo sapiens	pKi		7.1
inactive	9601764	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601765	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	1584.89	CHEMBL3650	Homo sapiens	pKi		5.8
inactive	9601766	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601767	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	79.43	CHEMBL3650	Homo sapiens	pKi		7.1
inactive	9601768	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601769	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9601770	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601771	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601772	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601773	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601774	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	3162.28	CHEMBL3650	Homo sapiens	pKi		5.5
inactive	9601775	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601776	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601777	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601778	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601779	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	50118.72	CHEMBL3650	Homo sapiens	pKi		4.3
inactive	9601780	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601781	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601782	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601783	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601784	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601785	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601786	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601787	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	39.81	CHEMBL3650	Homo sapiens	pKi		7.4
inactive	9601788	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601789	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601790	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601791	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	12.59	CHEMBL3650	Homo sapiens	pKi		7.9
inactive	9601792	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601793	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601794	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601795	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9601796	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601797	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601798	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9601799	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601800	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601801	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601802	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1000.0	CHEMBL3650	Homo sapiens	pKi		6.0
inactive	9601803	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601804	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601805	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601806	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	630.96	CHEMBL3650	Homo sapiens	pKi		6.2
active	9601807	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	100.0	CHEMBL3650	Homo sapiens	pKi		7.0
active	9601808	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	2511.89	CHEMBL3650	Homo sapiens	pKi		5.6
inactive	9601809	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601810	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	10.0	CHEMBL3650	Homo sapiens	pKi		8.0
inactive	9601811	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601812	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601813	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601814	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
active	9601815	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
inactive	9601816	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601817	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1258.93	CHEMBL3650	Homo sapiens	pKi		5.9
active	9601818	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	100.0	CHEMBL3650	Homo sapiens	pKi		7.0
active	9601819	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	63.1	CHEMBL3650	Homo sapiens	pKi		7.2
inactive	9601820	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
inactive	9601821	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601822	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601823	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	19.95	CHEMBL3650	Homo sapiens	pKi		7.7
active	9601824	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	398.11	CHEMBL3650	Homo sapiens	pKi		6.4
inactive	9601825	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
inactive	9601826	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601827	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	12.59	CHEMBL3650	Homo sapiens	pKi		7.9
inactive	9601828	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	5011.87	CHEMBL3650	Homo sapiens	pKi		5.3
active	9601829	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	50.12	CHEMBL3650	Homo sapiens	pKi		7.3
active	9601830	CHEMBL1963740	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	3981.07	CHEMBL3650	Homo sapiens	pKi		5.4
	10838582	CHEMBL2014205	Inhibition of FGFR1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	10839533	CHEMBL2015017	Inhibition of FGF-R1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	2.0	CHEMBL3650	Homo sapiens	Activity	%	2.0
	10839536	CHEMBL2016261	Inhibition of FGF-R1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	10.0	CHEMBL3650	Homo sapiens	Activity	%	10.0
	10843858	CHEMBL2016110	Inhibition of human FGFR1 using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	13.0	CHEMBL3650	Homo sapiens	IC50	nM	13.0
Not Active	10861135	CHEMBL2019279	Inhibition of human recombinant FGFR1 expressed in insect cells using Ulight-CAGAGAIETDKEYYTVKD as substrate at 1 uM after 60 mins by fluorescence assay	B	C#CCNC(=O)Nc1cccc(CCl)c1		CHEMBL2017300		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	10861136	CHEMBL2019279	Inhibition of human recombinant FGFR1 expressed in insect cells using Ulight-CAGAGAIETDKEYYTVKD as substrate at 1 uM after 60 mins by fluorescence assay	B	C#CCNC(=O)Nc1cccc(COc2ccc(C(=O)OC)cc2)c1		CHEMBL2017301		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	10863750	CHEMBL2024905	Inhibition of FGFR1 by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	188.0	CHEMBL3650	Homo sapiens	IC50	nM	188.0
	10889044	CHEMBL2032471	Inhibition of FGFRK	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	25000.0	CHEMBL3650	Homo sapiens	IC50	uM	25.0
	10889071	CHEMBL2032471	Inhibition of FGFRK	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	uM	1.0
	10896863	CHEMBL2039237	Inhibition of FGFR1 at 3 uM	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	10896881	CHEMBL2039255	Inhibition of FGFR1	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	>	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	10934982	CHEMBL2051518	Inhibition of FGFR1 at 10 uM	B	O=C(Nc1ccc(Oc2ccnc(-c3ncc(C(F)(F)F)[nH]3)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2047981	=	Inhibition	%	20.2	CHEMBL3650	Homo sapiens	INH	%	20.2
	10949776	CHEMBL2049402	Inhibition of FGFR1 using ATP preincubated with compound for 5 mins measured after 10 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	10962876	CHEMBL2060390	Inhibition of FGFR1 assessed as remaining enzyme activity at 0.4 uM	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	Activity	%	0.0	CHEMBL3650	Homo sapiens	Activity	%	0.0
	10978471	CHEMBL2066235	Inhibition of human recombinant FGFR1 expressed in insect cells using ulight-CAGAGAIETDKEYYTVKD as substrate assessed as residual activity at 1 uM after 60 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL3650	Homo sapiens	Activity	%	80.0
	10983098	CHEMBL2072601	Inhibition of FGFR1	B	C[C@H](NC(=O)c1cc(-c2cnn(C3CCOCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2071457	=	IC50	nM	3480.0	CHEMBL3650	Homo sapiens	IC50	uM	3.48
	11010870	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc(NCCc3cccnc3)ncc2Br)n[nH]1		CHEMBL2088089	=	IC50	nM	501.19	CHEMBL3650	Homo sapiens	pIC50		6.3
	11010871	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	C=CCNc1ncc(Br)c(Nc2cc(C)[nH]n2)n1		CHEMBL2088090	=	IC50	nM	630.96	CHEMBL3650	Homo sapiens	pIC50		6.2
	11010872	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(CNc2ncc(Br)c(Nc3cc(C)[nH]n3)n2)on1		CHEMBL2088091	=	IC50	nM	63.1	CHEMBL3650	Homo sapiens	pIC50		7.2
	11010873	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc(NCc3cc(C(C)(C)C)no3)ncc2Br)n[nH]1		CHEMBL2088092	=	IC50	nM	31.62	CHEMBL3650	Homo sapiens	pIC50		7.5
	11010874	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	COCCCc1cc(Nc2nc(NCc3cc(C)no3)ncc2Br)n[nH]1		CHEMBL2088093	=	IC50	nM	63.1	CHEMBL3650	Homo sapiens	pIC50		7.2
	11010875	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	CCCc1cc(Nc2nc(NCc3cc(C)no3)ncc2Br)n[nH]1		CHEMBL2088094	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	11010876	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(CNc2ncc(Br)c(Nc3cc(CCc4ccccc4)[nH]n3)n2)on1		CHEMBL2088095	=	IC50	nM	2.512	CHEMBL3650	Homo sapiens	pIC50		8.6
	11010877	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	COc1cc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc(OC)c1		CHEMBL2088096	=	IC50	nM	1.995	CHEMBL3650	Homo sapiens	pIC50		8.7
	11010878	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(CNc2ncc(Cl)c(Nc3cc(C)[nH]n3)n2)on1		CHEMBL2088097	=	IC50	nM	31.62	CHEMBL3650	Homo sapiens	pIC50		7.5
	11010879	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(CNc2nccc(Nc3cc(C)[nH]n3)n2)on1		CHEMBL2088098	=	IC50	nM	79.43	CHEMBL3650	Homo sapiens	pIC50		7.1
	11010880	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	COCCCc1cc(Nc2ccnc(NCc3cc(C)no3)n2)n[nH]1		CHEMBL2088099	=	IC50	nM	79.43	CHEMBL3650	Homo sapiens	pIC50		7.1
	11010881	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(CNc2nccc(Nc3cc(CCc4ccccc4)[nH]n3)n2)on1		CHEMBL2088100	=	IC50	nM	7.943	CHEMBL3650	Homo sapiens	pIC50		8.1
	11010882	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc(NCc3ccccn3)ncc2Br)n[nH]1		CHEMBL2088101	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	11010883	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc(NCCCc3c[nH]nc3C)ncc2Br)n[nH]1		CHEMBL2088102	=	IC50	nM	125.89	CHEMBL3650	Homo sapiens	pIC50		6.9
	11010884	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc(NCCc3ccco3)ncc2Br)n[nH]1		CHEMBL2088103	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	11010885	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cnc(CNc2ncc(Br)c(Nc3cc(C)[nH]n3)n2)cn1		CHEMBL2088104	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	pIC50		7.0
	11010886	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(CCNc2ncc(Br)c(Nc3cc(C)[nH]n3)n2)on1		CHEMBL2088105	=	IC50	nM	398.11	CHEMBL3650	Homo sapiens	pIC50		6.4
	11010887	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc(NCc3ncccc3C)ncc2Br)n[nH]1		CHEMBL2088106	=	IC50	nM	79.43	CHEMBL3650	Homo sapiens	pIC50		7.1
	11010888	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2nc(NCc3cc(C(=O)N4CCCC4)no3)ncc2Br)n[nH]1		CHEMBL2088107	=	IC50	nM	5011.87	CHEMBL3650	Homo sapiens	pIC50		5.3
	11010889	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2ccnc(NCc3cc(C4CC4)no3)n2)n[nH]1		CHEMBL2088108	=	IC50	nM	25.12	CHEMBL3650	Homo sapiens	pIC50		7.6
	11010890	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(Nc2ccnc(NCc3cc(C(N)=O)no3)n2)n[nH]1		CHEMBL2088109	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	pIC50		7.0
	11010891	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	Cc1cc(CNc2nccc(Nc3cc(CO)[nH]n3)n2)on1		CHEMBL2088110	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	11010892	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	CCc1cc(Nc2nc(NCc3ccccn3)ncc2Br)n[nH]1		CHEMBL2088111	=	IC50	nM	39.81	CHEMBL3650	Homo sapiens	pIC50		7.4
	11010893	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	CCc1cc(Nc2nc(NCc3cc(-c4ccccn4)no3)ncc2Br)n[nH]1		CHEMBL2088112	=	IC50	nM	79.43	CHEMBL3650	Homo sapiens	pIC50		7.1
	11010894	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	CCCc1cc(Nc2nc(NCc3cccnc3)ncc2Br)n[nH]1		CHEMBL2088113	=	IC50	nM	25.12	CHEMBL3650	Homo sapiens	pIC50		7.6
	11010895	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	CC(C)c1cc(Nc2nc(NCc3cccnc3)ncc2Br)n[nH]1		CHEMBL2088256	=	IC50	nM	63.1	CHEMBL3650	Homo sapiens	pIC50		7.2
	11010896	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	COCCCc1cc(Nc2ccnc(NCc3cc(C4CC4)no3)n2)n[nH]1		CHEMBL2088257	=	IC50	nM	25.12	CHEMBL3650	Homo sapiens	pIC50		7.6
	11010897	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	COCCCc1cc(Nc2ccnc(NCc3cc(C(N)=O)no3)n2)n[nH]1		CHEMBL2088258	=	IC50	nM	63.1	CHEMBL3650	Homo sapiens	pIC50		7.2
	11010898	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	COc1cc(CCc2cc(Nc3ccnc(NCc4ccccn4)n3)n[nH]2)cc(OC)c1		CHEMBL2088259	=	IC50	nM	5.012	CHEMBL3650	Homo sapiens	pIC50		8.3
	11010899	CHEMBL2090012	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells after 40 mins by caliper mobility shift assay	B	COc1cc(CCc2cc(Nc3ccnc(NCc4cc(C)on4)n3)n[nH]2)cc(OC)c1		CHEMBL2088260	=	IC50	nM	1.995	CHEMBL3650	Homo sapiens	pIC50		8.7
	11016434	CHEMBL2092104	Inhibition of FGFR1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016435	CHEMBL2092104	Inhibition of FGFR1 at 1 uM	B	Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1		CHEMBL2087480	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016436	CHEMBL2092104	Inhibition of FGFR1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1		CHEMBL2087491	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016437	CHEMBL2092104	Inhibition of FGFR1 at 1 uM	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12		CHEMBL2087492	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016438	CHEMBL2092104	Inhibition of FGFR1 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087493	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016575	CHEMBL2090015	Inhibition of human FGFR1 phosphorylation expressed in COS1 cells after 1 hr by immunoblotting	B	Cc1cc(Nc2nc(NCCc3cccnc3)ncc2Br)n[nH]1		CHEMBL2088089	=	IC50	nM	2511.89	CHEMBL3650	Homo sapiens	pIC50		5.6
	11016576	CHEMBL2090015	Inhibition of human FGFR1 phosphorylation expressed in COS1 cells after 1 hr by immunoblotting	B	C=CCNc1ncc(Br)c(Nc2cc(C)[nH]n2)n1		CHEMBL2088090	=	IC50	nM	3162.28	CHEMBL3650	Homo sapiens	pIC50		5.5
	11016577	CHEMBL2090015	Inhibition of human FGFR1 phosphorylation expressed in COS1 cells after 1 hr by immunoblotting	B	Cc1cc(CNc2ncc(Br)c(Nc3cc(C)[nH]n3)n2)on1		CHEMBL2088091	=	IC50	nM	158.49	CHEMBL3650	Homo sapiens	pIC50		6.8
	11016578	CHEMBL2090015	Inhibition of human FGFR1 phosphorylation expressed in COS1 cells after 1 hr by immunoblotting	B	Cc1cc(Nc2nc(NCc3cc(C(C)(C)C)no3)ncc2Br)n[nH]1		CHEMBL2088092	=	IC50	nM	158.49	CHEMBL3650	Homo sapiens	pIC50		6.8
	11016579	CHEMBL2090015	Inhibition of human FGFR1 phosphorylation expressed in COS1 cells after 1 hr by immunoblotting	B	COCCCc1cc(Nc2nc(NCc3cc(C)no3)ncc2Br)n[nH]1		CHEMBL2088093	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	11016580	CHEMBL2090015	Inhibition of human FGFR1 phosphorylation expressed in COS1 cells after 1 hr by immunoblotting	B	CCCc1cc(Nc2nc(NCc3cc(C)no3)ncc2Br)n[nH]1		CHEMBL2088094	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	pIC50		7.0
	11016581	CHEMBL2090015	Inhibition of human FGFR1 phosphorylation expressed in COS1 cells after 1 hr by immunoblotting	B	Cc1cc(CNc2ncc(Br)c(Nc3cc(CCc4ccccc4)[nH]n3)n2)on1		CHEMBL2088095	=	IC50	nM	63.1	CHEMBL3650	Homo sapiens	pIC50		7.2
	11016582	CHEMBL2090015	Inhibition of human FGFR1 phosphorylation expressed in COS1 cells after 1 hr by immunoblotting	B	COc1cc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc(OC)c1		CHEMBL2088096	>	IC50	nM	15.85	CHEMBL3650	Homo sapiens	pIC50		7.8
	11016609	CHEMBL2090021	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells at 10 uM after 40 mins by caliper mobility shift assay	B	Cc1cc(CNc2ncc(Br)c(Nc3cc(CCc4ccccc4)[nH]n3)n2)on1		CHEMBL2088095	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	11016611	CHEMBL2090023	Inhibition of recombinant N terminal GST-tagged human FGFR1 (456 to 765) expressed in baculovirus infected Sf21 cells at 1 uM after 40 mins by caliper mobility shift assay	B	COc1cc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc(OC)c1		CHEMBL2088096	=	Inhibition	%	91.0	CHEMBL3650	Homo sapiens	INH	%	91.0
	11016983	CHEMBL2092421	Inhibition of FGFR1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016984	CHEMBL2092421	Inhibition of FGFR1 at 5 uM	B	Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1		CHEMBL2087480	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016985	CHEMBL2092421	Inhibition of FGFR1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1		CHEMBL2087491	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016986	CHEMBL2092421	Inhibition of FGFR1 at 5 uM	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12		CHEMBL2087492	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11016987	CHEMBL2092421	Inhibition of FGFR1 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087493	<	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	11019179	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	1064.0	CHEMBL3650	Homo sapiens	IC50	nM	1064.0
	11019180	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	1950.0	CHEMBL3650	Homo sapiens	IC50	nM	1950.0
	11019181	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	Cc1ccccc1C(=C1C(=O)Nc2ccccc21)c1nc2ccccc2[nH]1		CHEMBL2086721	=	IC50	nM	205.0	CHEMBL3650	Homo sapiens	IC50	nM	205.0
	11019182	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	Cc1cccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)c1		CHEMBL2086722	=	IC50	nM	814.0	CHEMBL3650	Homo sapiens	IC50	nM	814.0
	11019183	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	Cc1ccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086723	=	IC50	nM	187.0	CHEMBL3650	Homo sapiens	IC50	nM	187.0
	11019184	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1ccc(F)cc1)c1nc2ccccc2[nH]1		CHEMBL2086724	=	IC50	nM	950.0	CHEMBL3650	Homo sapiens	IC50	nM	950.0
	11019185	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1cccc(F)c1)c1nc2ccccc2[nH]1		CHEMBL2086725	=	IC50	nM	79.0	CHEMBL3650	Homo sapiens	IC50	nM	79.0
	11019186	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1cc(F)cc(F)c1)c1nc2ccccc2[nH]1		CHEMBL2086726	=	IC50	nM	4000.0	CHEMBL3650	Homo sapiens	IC50	nM	4000.0
	11019187	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1nc2ccccc2[nH]1)c1ccc(F)cc1F		CHEMBL2086727	=	IC50	nM	628.0	CHEMBL3650	Homo sapiens	IC50	nM	628.0
	11019188	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1ccc(C(F)(F)F)cc1)c1nc2ccccc2[nH]1		CHEMBL2086728	=	IC50	nM	4899.0	CHEMBL3650	Homo sapiens	IC50	nM	4899.0
	11019189	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1nc2ccccc2[nH]1)c1ccc(Cl)cc1Cl		CHEMBL2086729	=	IC50	nM	725.0	CHEMBL3650	Homo sapiens	IC50	nM	725.0
	11019190	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	COc1ccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086730	=	IC50	nM	86.0	CHEMBL3650	Homo sapiens	IC50	nM	86.0
	11019191	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCOc1ccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086731	=	IC50	nM	6293.0	CHEMBL3650	Homo sapiens	IC50	nM	6293.0
	11019192	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	Nc1ccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086732	=	IC50	nM	57.0	CHEMBL3650	Homo sapiens	IC50	nM	57.0
	11019193	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccc(Br)cc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086733	=	IC50	nM	446.0	CHEMBL3650	Homo sapiens	IC50	nM	446.0
	11019194	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2cc(Br)ccc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086734	=	IC50	nM	4880.0	CHEMBL3650	Homo sapiens	IC50	nM	4880.0
	11019195	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2c(Br)cccc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086735	=	IC50	nM	4880.0	CHEMBL3650	Homo sapiens	IC50	nM	4880.0
	11019196	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccc(C(=O)O)cc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086736	=	IC50	nM	75.0	CHEMBL3650	Homo sapiens	IC50	nM	75.0
	11019197	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2cc(C(=O)O)ccc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086737	=	IC50	nM	1586.0	CHEMBL3650	Homo sapiens	IC50	nM	1586.0
	11019198	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2c(C(=O)O)cccc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086738	=	IC50	nM	24400.0	CHEMBL3650	Homo sapiens	IC50	nM	24400.0
	11019199	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	Nc1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086739	=	IC50	nM	13.0	CHEMBL3650	Homo sapiens	IC50	nM	13.0
	11019200	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	Cc1ccc(C(=C2C(=O)Nc3ccc(C(=O)O)cc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086740	=	IC50	nM	67.0	CHEMBL3650	Homo sapiens	IC50	nM	67.0
	11019201	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	Cc1ccc(C(=C2C(=O)Nc3ccc(N)cc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086741	=	IC50	nM	51.0	CHEMBL3650	Homo sapiens	IC50	nM	51.0
	11019202	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	COc1ccc2[nH]c(C(=C3C(=O)Nc4ccc(C(=O)O)cc43)c3ccccc3)nc2c1		CHEMBL2086742	=	IC50	nM	39.0	CHEMBL3650	Homo sapiens	IC50	nM	39.0
	11019203	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	COc1ccc2[nH]c(C(=C3C(=O)Nc4ccc(N)cc43)c3ccccc3)nc2c1		CHEMBL2086743	=	IC50	nM	42.0	CHEMBL3650	Homo sapiens	IC50	nM	42.0
	11019204	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCCCNC(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086744	=	IC50	nM	326.0	CHEMBL3650	Homo sapiens	IC50	nM	326.0
	11019205	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	COCCNC(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086397	=	IC50	nM	199.0	CHEMBL3650	Homo sapiens	IC50	nM	199.0
	11019206	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CN1CCN(C(=O)c2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086745	=	IC50	nM	70.0	CHEMBL3650	Homo sapiens	IC50	nM	70.0
	11019207	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCCCNS(=O)(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086746	=	IC50	nM	300.0	CHEMBL3650	Homo sapiens	IC50	nM	300.0
	11019208	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	COCCNS(=O)(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086747	=	IC50	nM	287.0	CHEMBL3650	Homo sapiens	IC50	nM	287.0
	11019209	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CN1CCN(S(=O)(=O)c2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086748	=	IC50	nM	1950.0	CHEMBL3650	Homo sapiens	IC50	nM	1950.0
	11019210	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Oc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086749	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	nM	20.0
	11019211	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)C1		CHEMBL2086750	=	IC50	nM	216.0	CHEMBL3650	Homo sapiens	IC50	nM	216.0
	11019212	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086751	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	nM	11.0
	11019213	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	COCCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086752	=	IC50	nM	46.0	CHEMBL3650	Homo sapiens	IC50	nM	46.0
	11019214	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086753	=	IC50	nM	5.0	CHEMBL3650	Homo sapiens	IC50	nM	5.0
	11019215	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(C)cc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086754	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
	11019216	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(OC)cc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086755	=	IC50	nM	14.0	CHEMBL3650	Homo sapiens	IC50	nM	14.0
	11019217	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086756	=	IC50	nM	5.0	CHEMBL3650	Homo sapiens	IC50	nM	5.0
	11019218	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cc(F)cc(F)c2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086757	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
	11019219	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086758	=	IC50	nM	12.0	CHEMBL3650	Homo sapiens	IC50	nM	12.0
	11019220	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086759	=	IC50	nM	13.0	CHEMBL3650	Homo sapiens	IC50	nM	13.0
	11019221	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	6.0	CHEMBL3650	Homo sapiens	IC50	nM	6.0
	11019222	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1		CHEMBL2087167	=	IC50	nM	4.0	CHEMBL3650	Homo sapiens	IC50	nM	4.0
	11019223	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cc(F)cc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1		CHEMBL2087168	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	nM	7.0
	11019224	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2nc(C)c[nH]2)c2ccccc2F)C(=O)N3)CC1		CHEMBL2087169	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
	11019225	CHEMBL2090042	Inhibition of N-terminal GST-tagged FGFR1 using poly(Glu,Tyr) as substrate after 30 mins by alphascreen assay	B	O=C1Nc2ccccc2/C1=C/c1nc2ccccc2[nH]1		CHEMBL2087170	>	IC50	nM	4880.0	CHEMBL3650	Homo sapiens	IC50	nM	4880.0
	11019266	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCCCNC(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086744	=	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	nM	30000.0
	11019267	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	COCCNC(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086397	=	IC50	nM	9666.0	CHEMBL3650	Homo sapiens	IC50	nM	9666.0
	11019268	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CN1CCN(C(=O)c2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086745	=	IC50	nM	983.0	CHEMBL3650	Homo sapiens	IC50	nM	983.0
	11019269	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	COCCNS(=O)(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086747	=	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	nM	30000.0
	11019270	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CN1CCN(S(=O)(=O)c2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086748	=	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	nM	30000.0
	11019271	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Oc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086749	=	IC50	nM	736.0	CHEMBL3650	Homo sapiens	IC50	nM	736.0
	11019272	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)C1		CHEMBL2086750	=	IC50	nM	1010.0	CHEMBL3650	Homo sapiens	IC50	nM	1010.0
	11019273	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086751	=	IC50	nM	41.0	CHEMBL3650	Homo sapiens	IC50	nM	41.0
	11019274	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	COCCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086752	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	nM	50.0
	11019275	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086753	=	IC50	nM	17.0	CHEMBL3650	Homo sapiens	IC50	nM	17.0
	11019276	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(C)cc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086754	=	IC50	nM	59.0	CHEMBL3650	Homo sapiens	IC50	nM	59.0
	11019277	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(OC)cc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086755	=	IC50	nM	44.0	CHEMBL3650	Homo sapiens	IC50	nM	44.0
	11019278	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086756	=	IC50	nM	38.0	CHEMBL3650	Homo sapiens	IC50	nM	38.0
	11019279	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cc(F)cc(F)c2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086757	=	IC50	nM	46.0	CHEMBL3650	Homo sapiens	IC50	nM	46.0
	11019280	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086758	=	IC50	nM	154.0	CHEMBL3650	Homo sapiens	IC50	nM	154.0
	11019281	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086759	=	IC50	nM	17.0	CHEMBL3650	Homo sapiens	IC50	nM	17.0
	11019282	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	nM	24.0
	11019283	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1		CHEMBL2087167	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	nM	20.0
	11019284	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cc(F)cc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1		CHEMBL2087168	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	nM	24.0
	11019285	CHEMBL2090045	Inhibition of FGFR1 in human SK-N-MC cells assessed as inhibition of FGF-induced ERK phosphorylation incubated for 1 hr prior to VEGF-stimulation measured after 30 mins by ELISA	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2nc(C)c[nH]2)c2ccccc2F)C(=O)N3)CC1		CHEMBL2087169	=	IC50	nM	15.0	CHEMBL3650	Homo sapiens	IC50	nM	15.0
	12036444	CHEMBL2150415	Inhibition of FGFR1 after 5 min	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	12046304	CHEMBL2156634	Inhibition of FGFR1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	2.4	CHEMBL3650	Homo sapiens	INH	%	2.4
	12051568	CHEMBL2154708	Inhibition of FGFR1	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	=	IC50	nM	8.7	CHEMBL3650	Homo sapiens	IC50	nM	8.7
	12051590	CHEMBL2154969	Inhibition of FGFR1 at 10 uM	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	>	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	12060772	CHEMBL2156899	Inhibition of FGFR1	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152252	>	IC50	nM	3600.0	CHEMBL3650	Homo sapiens	IC50	nM	3600.0
	12060773	CHEMBL2156899	Inhibition of FGFR1	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N		CHEMBL2152253	>	IC50	nM	3600.0	CHEMBL3650	Homo sapiens	IC50	nM	3600.0
	12074632	CHEMBL2161194	Inhibition of FGFR1 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
Active	12136267	CHEMBL2185478	Inhibition of FGFR1 at 10 uM in presence of ATP at Km level by kinase profiler method	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc(Cl)cc3Cl)nc(Br)c3cccnc23)CC1		CHEMBL2180568		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	12136268	CHEMBL2185478	Inhibition of FGFR1 at 10 uM in presence of ATP at Km level by kinase profiler method	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc(Cl)cc3)nc(Br)c3cccnc23)CC1		CHEMBL2180567		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	12136269	CHEMBL2185478	Inhibition of FGFR1 at 10 uM in presence of ATP at Km level by kinase profiler method	B	COc1ccc(CNC(=O)c2nc(Br)c3cccnc3c2N[C@H]2CC[C@H](N)CC2)cc1		CHEMBL2180561		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	12138550	CHEMBL2186464	Inhibition of FGFR1	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12.Cl		CHEMBL2180605	=	IC50	nM	17.5	CHEMBL3650	Homo sapiens	IC50	nM	17.5
	12145259	CHEMBL2183034	Inhibition of FGFR1 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL3650	Homo sapiens	INH	%	25.0
	12145260	CHEMBL2183034	Inhibition of FGFR1 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL3650	Homo sapiens	INH	%	25.0
	12166127	CHEMBL2211600	Binding affinity to FGFR1 at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL3650	Homo sapiens	Activity	%	50.0
	12170809	CHEMBL2210334	Inhibition of FGF-R1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	110.0	CHEMBL3650	Homo sapiens	Activity	%	110.0
	12172110	CHEMBL2213936	Inhibition of FGF-R1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL3650	Homo sapiens	Activity	%	93.0
	12173614	CHEMBL2213990	Inhibition of FGFR1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3650	Homo sapiens	Activity	%	100.0
	12183886	CHEMBL2211501	Inhibition of FGFR1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	12191215	CHEMBL2215711	Inhibition of FGFR1 by AlphaScreen analysis	B	O=C(Nc1cccc(Oc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL2206666	=	IC50	nM	5100.0	CHEMBL3650	Homo sapiens	IC50	nM	5100.0
	12195616	CHEMBL2212865	Inhibition of human recombinant FGFR1 using Ulight-CAGAGAIETDKEYYTVKD as substrate assessed as residual activity at 1 uM after 60 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	98.2	CHEMBL3650	Homo sapiens	Activity	%	98.2
	12205241	CHEMBL2217231	Inhibition of recombinant FGFR1	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	9.2	CHEMBL3650	Homo sapiens	IC50	nM	9.2
	12242270	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	108.0	CHEMBL3650	Homo sapiens	Residual Activity	%	108.0
	12242271	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	9.0	CHEMBL3650	Homo sapiens	Residual Activity	%	9.0
	12242272	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL3650	Homo sapiens	Residual Activity	%	97.0
	12242273	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL3650	Homo sapiens	Residual Activity	%	101.0
	12242274	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	102.0	CHEMBL3650	Homo sapiens	Residual Activity	%	102.0
	12242275	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	127.0	CHEMBL3650	Homo sapiens	Residual Activity	%	127.0
	12242276	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	19.0	CHEMBL3650	Homo sapiens	Residual Activity	%	19.0
	12242277	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	99.0	CHEMBL3650	Homo sapiens	Residual Activity	%	99.0
	12242278	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	102.0	CHEMBL3650	Homo sapiens	Residual Activity	%	102.0
	12242279	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	74.0	CHEMBL3650	Homo sapiens	Residual Activity	%	74.0
	12242280	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	97.0	CHEMBL3650	Homo sapiens	Residual Activity	%	97.0
	12242281	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	114.0	CHEMBL3650	Homo sapiens	Residual Activity	%	114.0
	12242282	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	108.0	CHEMBL3650	Homo sapiens	Residual Activity	%	108.0
	12242283	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	28.0	CHEMBL3650	Homo sapiens	Residual Activity	%	28.0
	12242284	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	113.0	CHEMBL3650	Homo sapiens	Residual Activity	%	113.0
	12242285	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	98.0	CHEMBL3650	Homo sapiens	Residual Activity	%	98.0
	12242286	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	99.0	CHEMBL3650	Homo sapiens	Residual Activity	%	99.0
	12242287	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	85.0	CHEMBL3650	Homo sapiens	Residual Activity	%	85.0
	12242288	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	87.0	CHEMBL3650	Homo sapiens	Residual Activity	%	87.0
	12242289	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	43.0	CHEMBL3650	Homo sapiens	Residual Activity	%	43.0
	12242290	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	110.0	CHEMBL3650	Homo sapiens	Residual Activity	%	110.0
	12242291	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	85.0	CHEMBL3650	Homo sapiens	Residual Activity	%	85.0
	12242292	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	115.0	CHEMBL3650	Homo sapiens	Residual Activity	%	115.0
	12242293	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	75.0	CHEMBL3650	Homo sapiens	Residual Activity	%	75.0
	12242294	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	111.0	CHEMBL3650	Homo sapiens	Residual Activity	%	111.0
	12242295	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	66.0	CHEMBL3650	Homo sapiens	Residual Activity	%	66.0
	12242296	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	40.0	CHEMBL3650	Homo sapiens	Residual Activity	%	40.0
	12242297	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	58.0	CHEMBL3650	Homo sapiens	Residual Activity	%	58.0
	12242298	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	90.0	CHEMBL3650	Homo sapiens	Residual Activity	%	90.0
	12242299	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	77.0	CHEMBL3650	Homo sapiens	Residual Activity	%	77.0
	12242300	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	80.0	CHEMBL3650	Homo sapiens	Residual Activity	%	80.0
	12242301	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	4.0	CHEMBL3650	Homo sapiens	Residual Activity	%	4.0
	12242302	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	112.0	CHEMBL3650	Homo sapiens	Residual Activity	%	112.0
	12242303	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	109.0	CHEMBL3650	Homo sapiens	Residual Activity	%	109.0
	12242304	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	112.0	CHEMBL3650	Homo sapiens	Residual Activity	%	112.0
	12242305	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	125.0	CHEMBL3650	Homo sapiens	Residual Activity	%	125.0
	12242306	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	91.0	CHEMBL3650	Homo sapiens	Residual Activity	%	91.0
	12242307	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	111.0	CHEMBL3650	Homo sapiens	Residual Activity	%	111.0
	12242308	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	119.0	CHEMBL3650	Homo sapiens	Residual Activity	%	119.0
	12242309	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	81.0	CHEMBL3650	Homo sapiens	Residual Activity	%	81.0
	12242310	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	113.0	CHEMBL3650	Homo sapiens	Residual Activity	%	113.0
	12242311	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	97.0	CHEMBL3650	Homo sapiens	Residual Activity	%	97.0
	12242312	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	7.0	CHEMBL3650	Homo sapiens	Residual Activity	%	7.0
	12242313	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	28.0	CHEMBL3650	Homo sapiens	Residual Activity	%	28.0
	12242314	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	49.0	CHEMBL3650	Homo sapiens	Residual Activity	%	49.0
	12242315	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	121.0	CHEMBL3650	Homo sapiens	Residual Activity	%	121.0
	12242316	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	131.0	CHEMBL3650	Homo sapiens	Residual Activity	%	131.0
	12242317	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	65.0	CHEMBL3650	Homo sapiens	Residual Activity	%	65.0
	12242318	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	113.0	CHEMBL3650	Homo sapiens	Residual Activity	%	113.0
	12242319	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	97.0	CHEMBL3650	Homo sapiens	Residual Activity	%	97.0
	12242320	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	38.0	CHEMBL3650	Homo sapiens	Residual Activity	%	38.0
	12242321	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	13.0	CHEMBL3650	Homo sapiens	Residual Activity	%	13.0
	12242322	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	9.0	CHEMBL3650	Homo sapiens	Residual Activity	%	9.0
	12242323	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	76.0	CHEMBL3650	Homo sapiens	Residual Activity	%	76.0
	12242324	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	105.0	CHEMBL3650	Homo sapiens	Residual Activity	%	105.0
	12242325	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	117.0	CHEMBL3650	Homo sapiens	Residual Activity	%	117.0
	12242326	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	121.0	CHEMBL3650	Homo sapiens	Residual Activity	%	121.0
	12242327	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	83.0	CHEMBL3650	Homo sapiens	Residual Activity	%	83.0
	12242328	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	90.0	CHEMBL3650	Homo sapiens	Residual Activity	%	90.0
	12242329	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	107.0	CHEMBL3650	Homo sapiens	Residual Activity	%	107.0
	12242330	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	93.0	CHEMBL3650	Homo sapiens	Residual Activity	%	93.0
	12242331	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	5.0	CHEMBL3650	Homo sapiens	Residual Activity	%	5.0
	12242332	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	100.0	CHEMBL3650	Homo sapiens	Residual Activity	%	100.0
	12242333	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	98.0	CHEMBL3650	Homo sapiens	Residual Activity	%	98.0
	12242334	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	96.0	CHEMBL3650	Homo sapiens	Residual Activity	%	96.0
	12242335	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	61.0	CHEMBL3650	Homo sapiens	Residual Activity	%	61.0
	12242336	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	82.0	CHEMBL3650	Homo sapiens	Residual Activity	%	82.0
	12242337	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	105.0	CHEMBL3650	Homo sapiens	Residual Activity	%	105.0
	12242338	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	113.0	CHEMBL3650	Homo sapiens	Residual Activity	%	113.0
	12242339	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	62.0	CHEMBL3650	Homo sapiens	Residual Activity	%	62.0
	12242340	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	86.0	CHEMBL3650	Homo sapiens	Residual Activity	%	86.0
	12242341	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	69.0	CHEMBL3650	Homo sapiens	Residual Activity	%	69.0
	12242342	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	50.0	CHEMBL3650	Homo sapiens	Residual Activity	%	50.0
	12242343	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	88.0	CHEMBL3650	Homo sapiens	Residual Activity	%	88.0
	12242344	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	59.0	CHEMBL3650	Homo sapiens	Residual Activity	%	59.0
	12242345	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	55.0	CHEMBL3650	Homo sapiens	Residual Activity	%	55.0
	12242346	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	116.0	CHEMBL3650	Homo sapiens	Residual Activity	%	116.0
	12242347	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	7.0	CHEMBL3650	Homo sapiens	Residual Activity	%	7.0
	12242348	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	113.0	CHEMBL3650	Homo sapiens	Residual Activity	%	113.0
	12242349	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	-1.0
	12242350	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	87.0	CHEMBL3650	Homo sapiens	Residual Activity	%	87.0
	12242351	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	10.0	CHEMBL3650	Homo sapiens	Residual Activity	%	10.0
	12242352	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	90.0	CHEMBL3650	Homo sapiens	Residual Activity	%	90.0
	12242353	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	95.0	CHEMBL3650	Homo sapiens	Residual Activity	%	95.0
	12242354	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	36.0	CHEMBL3650	Homo sapiens	Residual Activity	%	36.0
	12242355	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	124.0	CHEMBL3650	Homo sapiens	Residual Activity	%	124.0
	12244959	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	126.0	CHEMBL3650	Homo sapiens	Residual Activity	%	126.0
	12244960	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	142.0	CHEMBL3650	Homo sapiens	Residual Activity	%	142.0
	12244961	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	120.0	CHEMBL3650	Homo sapiens	Residual Activity	%	120.0
	12244962	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	3.0	CHEMBL3650	Homo sapiens	Residual Activity	%	3.0
	12244963	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	116.0	CHEMBL3650	Homo sapiens	Residual Activity	%	116.0
	12244964	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	110.0	CHEMBL3650	Homo sapiens	Residual Activity	%	110.0
	12244965	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	4.0	CHEMBL3650	Homo sapiens	Residual Activity	%	4.0
	12244966	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	113.0	CHEMBL3650	Homo sapiens	Residual Activity	%	113.0
	12244967	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	127.0	CHEMBL3650	Homo sapiens	Residual Activity	%	127.0
	12244968	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	127.0	CHEMBL3650	Homo sapiens	Residual Activity	%	127.0
	12244969	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	106.0	CHEMBL3650	Homo sapiens	Residual Activity	%	106.0
	12244970	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	91.0	CHEMBL3650	Homo sapiens	Residual Activity	%	91.0
	12244971	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	106.0	CHEMBL3650	Homo sapiens	Residual Activity	%	106.0
	12244972	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	108.0	CHEMBL3650	Homo sapiens	Residual Activity	%	108.0
	12244973	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	41.0	CHEMBL3650	Homo sapiens	Residual Activity	%	41.0
	12244974	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	10.0	CHEMBL3650	Homo sapiens	Residual Activity	%	10.0
	12244975	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	143.0	CHEMBL3650	Homo sapiens	Residual Activity	%	143.0
	12244976	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	72.0	CHEMBL3650	Homo sapiens	Residual Activity	%	72.0
	12244977	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	74.0	CHEMBL3650	Homo sapiens	Residual Activity	%	74.0
	12244978	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	104.0	CHEMBL3650	Homo sapiens	Residual Activity	%	104.0
	12244979	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	89.0	CHEMBL3650	Homo sapiens	Residual Activity	%	89.0
	12244980	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	100.0	CHEMBL3650	Homo sapiens	Residual Activity	%	100.0
	12244981	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	107.0	CHEMBL3650	Homo sapiens	Residual Activity	%	107.0
	12244982	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	87.0	CHEMBL3650	Homo sapiens	Residual Activity	%	87.0
	12244983	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	102.0	CHEMBL3650	Homo sapiens	Residual Activity	%	102.0
	12244984	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	120.0	CHEMBL3650	Homo sapiens	Residual Activity	%	120.0
	12244985	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	47.0	CHEMBL3650	Homo sapiens	Residual Activity	%	47.0
	12244986	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	107.0	CHEMBL3650	Homo sapiens	Residual Activity	%	107.0
	12244987	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	118.0	CHEMBL3650	Homo sapiens	Residual Activity	%	118.0
	12244988	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL3650	Homo sapiens	Residual Activity	%	92.0
	12244989	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	29.0	CHEMBL3650	Homo sapiens	Residual Activity	%	29.0
	12244990	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	108.0	CHEMBL3650	Homo sapiens	Residual Activity	%	108.0
	12244991	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	119.0	CHEMBL3650	Homo sapiens	Residual Activity	%	119.0
	12244992	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	137.0	CHEMBL3650	Homo sapiens	Residual Activity	%	137.0
	12244993	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	41.0	CHEMBL3650	Homo sapiens	Residual Activity	%	41.0
	12244994	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	76.0	CHEMBL3650	Homo sapiens	Residual Activity	%	76.0
	12244995	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	87.0	CHEMBL3650	Homo sapiens	Residual Activity	%	87.0
	12244996	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	98.0	CHEMBL3650	Homo sapiens	Residual Activity	%	98.0
	12244997	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	2.0	CHEMBL3650	Homo sapiens	Residual Activity	%	2.0
	12244998	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	122.0	CHEMBL3650	Homo sapiens	Residual Activity	%	122.0
	12244999	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	98.0	CHEMBL3650	Homo sapiens	Residual Activity	%	98.0
	12245000	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	128.0	CHEMBL3650	Homo sapiens	Residual Activity	%	128.0
	12245001	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	46.0	CHEMBL3650	Homo sapiens	Residual Activity	%	46.0
	12245002	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	1.0
	12245003	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	89.0	CHEMBL3650	Homo sapiens	Residual Activity	%	89.0
	12245004	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	102.0	CHEMBL3650	Homo sapiens	Residual Activity	%	102.0
	12245005	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	39.0	CHEMBL3650	Homo sapiens	Residual Activity	%	39.0
	12245006	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	118.0	CHEMBL3650	Homo sapiens	Residual Activity	%	118.0
	12245007	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	2.0	CHEMBL3650	Homo sapiens	Residual Activity	%	2.0
	12245008	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	37.0	CHEMBL3650	Homo sapiens	Residual Activity	%	37.0
	12245009	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	101.0	CHEMBL3650	Homo sapiens	Residual Activity	%	101.0
	12245010	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	40.0	CHEMBL3650	Homo sapiens	Residual Activity	%	40.0
	12245011	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	3.0	CHEMBL3650	Homo sapiens	Residual Activity	%	3.0
	12245012	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	110.0	CHEMBL3650	Homo sapiens	Residual Activity	%	110.0
	12245013	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	112.0	CHEMBL3650	Homo sapiens	Residual Activity	%	112.0
	12245014	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	101.0	CHEMBL3650	Homo sapiens	Residual Activity	%	101.0
	12245015	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	94.0	CHEMBL3650	Homo sapiens	Residual Activity	%	94.0
	12245016	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	47.0	CHEMBL3650	Homo sapiens	Residual Activity	%	47.0
	12245017	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	104.0	CHEMBL3650	Homo sapiens	Residual Activity	%	104.0
	12245018	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	70.0	CHEMBL3650	Homo sapiens	Residual Activity	%	70.0
	12245019	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	17.0	CHEMBL3650	Homo sapiens	Residual Activity	%	17.0
	12245020	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	92.0	CHEMBL3650	Homo sapiens	Residual Activity	%	92.0
	12245021	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	88.0	CHEMBL3650	Homo sapiens	Residual Activity	%	88.0
	12245022	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	104.0	CHEMBL3650	Homo sapiens	Residual Activity	%	104.0
	12245023	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	65.0	CHEMBL3650	Homo sapiens	Residual Activity	%	65.0
	12245024	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	111.0	CHEMBL3650	Homo sapiens	Residual Activity	%	111.0
	12245025	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	107.0	CHEMBL3650	Homo sapiens	Residual Activity	%	107.0
	12245026	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	80.0	CHEMBL3650	Homo sapiens	Residual Activity	%	80.0
	12245027	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	128.0	CHEMBL3650	Homo sapiens	Residual Activity	%	128.0
	12245028	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	92.0	CHEMBL3650	Homo sapiens	Residual Activity	%	92.0
	12245029	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	112.0	CHEMBL3650	Homo sapiens	Residual Activity	%	112.0
	12245030	CHEMBL2219062	Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	21.0	CHEMBL3650	Homo sapiens	Residual Activity	%	21.0
	12245031	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	89.0	CHEMBL3650	Homo sapiens	Residual Activity	%	89.0
	12245032	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	1.0
	12245033	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	58.0	CHEMBL3650	Homo sapiens	Residual Activity	%	58.0
	12245034	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	55.0	CHEMBL3650	Homo sapiens	Residual Activity	%	55.0
	12245035	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	66.0	CHEMBL3650	Homo sapiens	Residual Activity	%	66.0
	12245036	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	94.0	CHEMBL3650	Homo sapiens	Residual Activity	%	94.0
	12245037	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	5.0	CHEMBL3650	Homo sapiens	Residual Activity	%	5.0
	12245038	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	32.0	CHEMBL3650	Homo sapiens	Residual Activity	%	32.0
	12245039	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	41.0	CHEMBL3650	Homo sapiens	Residual Activity	%	41.0
	12245040	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	43.0	CHEMBL3650	Homo sapiens	Residual Activity	%	43.0
	12245041	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	80.0	CHEMBL3650	Homo sapiens	Residual Activity	%	80.0
	12245042	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	96.0	CHEMBL3650	Homo sapiens	Residual Activity	%	96.0
	12245043	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	84.0	CHEMBL3650	Homo sapiens	Residual Activity	%	84.0
	12245044	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	2.0	CHEMBL3650	Homo sapiens	Residual Activity	%	2.0
	12245045	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	68.0	CHEMBL3650	Homo sapiens	Residual Activity	%	68.0
	12245046	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	80.0	CHEMBL3650	Homo sapiens	Residual Activity	%	80.0
	12245047	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	55.0	CHEMBL3650	Homo sapiens	Residual Activity	%	55.0
	12245048	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	44.0	CHEMBL3650	Homo sapiens	Residual Activity	%	44.0
	12245049	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	118.0	CHEMBL3650	Homo sapiens	Residual Activity	%	118.0
	12245050	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	35.0	CHEMBL3650	Homo sapiens	Residual Activity	%	35.0
	12245051	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	109.0	CHEMBL3650	Homo sapiens	Residual Activity	%	109.0
	12245052	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	135.0	CHEMBL3650	Homo sapiens	Residual Activity	%	135.0
	12245053	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	94.0	CHEMBL3650	Homo sapiens	Residual Activity	%	94.0
	12245054	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	10.0	CHEMBL3650	Homo sapiens	Residual Activity	%	10.0
	12245055	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	94.0	CHEMBL3650	Homo sapiens	Residual Activity	%	94.0
	12245056	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	18.0	CHEMBL3650	Homo sapiens	Residual Activity	%	18.0
	12245057	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	5.0	CHEMBL3650	Homo sapiens	Residual Activity	%	5.0
	12245058	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	24.0	CHEMBL3650	Homo sapiens	Residual Activity	%	24.0
	12245059	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	89.0	CHEMBL3650	Homo sapiens	Residual Activity	%	89.0
	12245060	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	17.0	CHEMBL3650	Homo sapiens	Residual Activity	%	17.0
	12245061	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	72.0	CHEMBL3650	Homo sapiens	Residual Activity	%	72.0
	12245062	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	1.0
	12245063	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	38.0	CHEMBL3650	Homo sapiens	Residual Activity	%	38.0
	12245064	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	71.0	CHEMBL3650	Homo sapiens	Residual Activity	%	71.0
	12245065	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	83.0	CHEMBL3650	Homo sapiens	Residual Activity	%	83.0
	12245066	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	95.0	CHEMBL3650	Homo sapiens	Residual Activity	%	95.0
	12245067	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	38.0	CHEMBL3650	Homo sapiens	Residual Activity	%	38.0
	12245068	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	63.0	CHEMBL3650	Homo sapiens	Residual Activity	%	63.0
	12245069	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	86.0	CHEMBL3650	Homo sapiens	Residual Activity	%	86.0
	12245070	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	81.0	CHEMBL3650	Homo sapiens	Residual Activity	%	81.0
	12245071	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	82.0	CHEMBL3650	Homo sapiens	Residual Activity	%	82.0
	12245072	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	121.0	CHEMBL3650	Homo sapiens	Residual Activity	%	121.0
	12245073	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	6.0	CHEMBL3650	Homo sapiens	Residual Activity	%	6.0
	12245074	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	4.0	CHEMBL3650	Homo sapiens	Residual Activity	%	4.0
	12245075	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	8.0	CHEMBL3650	Homo sapiens	Residual Activity	%	8.0
	12245076	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	90.0	CHEMBL3650	Homo sapiens	Residual Activity	%	90.0
	12245077	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	125.0	CHEMBL3650	Homo sapiens	Residual Activity	%	125.0
	12245078	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	13.0	CHEMBL3650	Homo sapiens	Residual Activity	%	13.0
	12245079	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	81.0	CHEMBL3650	Homo sapiens	Residual Activity	%	81.0
	12245080	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	78.0	CHEMBL3650	Homo sapiens	Residual Activity	%	78.0
	12245081	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	3.0	CHEMBL3650	Homo sapiens	Residual Activity	%	3.0
	12245082	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	-1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	-1.0
	12245083	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	1.0
	12245084	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	20.0	CHEMBL3650	Homo sapiens	Residual Activity	%	20.0
	12245085	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	91.0	CHEMBL3650	Homo sapiens	Residual Activity	%	91.0
	12245086	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	104.0	CHEMBL3650	Homo sapiens	Residual Activity	%	104.0
	12245087	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	79.0	CHEMBL3650	Homo sapiens	Residual Activity	%	79.0
	12245088	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	49.0	CHEMBL3650	Homo sapiens	Residual Activity	%	49.0
	12245089	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	36.0	CHEMBL3650	Homo sapiens	Residual Activity	%	36.0
	12245090	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	81.0	CHEMBL3650	Homo sapiens	Residual Activity	%	81.0
	12245091	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	53.0	CHEMBL3650	Homo sapiens	Residual Activity	%	53.0
	12245092	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	-4.0	CHEMBL3650	Homo sapiens	Residual Activity	%	-4.0
	12245093	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	75.0	CHEMBL3650	Homo sapiens	Residual Activity	%	75.0
	12245094	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	73.0	CHEMBL3650	Homo sapiens	Residual Activity	%	73.0
	12245095	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	92.0	CHEMBL3650	Homo sapiens	Residual Activity	%	92.0
	12245096	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	10.0	CHEMBL3650	Homo sapiens	Residual Activity	%	10.0
	12245097	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	93.0	CHEMBL3650	Homo sapiens	Residual Activity	%	93.0
	12245098	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	84.0	CHEMBL3650	Homo sapiens	Residual Activity	%	84.0
	12245099	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	91.0	CHEMBL3650	Homo sapiens	Residual Activity	%	91.0
	12245100	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	48.0	CHEMBL3650	Homo sapiens	Residual Activity	%	48.0
	12245101	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	101.0	CHEMBL3650	Homo sapiens	Residual Activity	%	101.0
	12245102	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	8.0	CHEMBL3650	Homo sapiens	Residual Activity	%	8.0
	12245103	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	3.0	CHEMBL3650	Homo sapiens	Residual Activity	%	3.0
	12245104	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	69.0	CHEMBL3650	Homo sapiens	Residual Activity	%	69.0
	12245105	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	8.0	CHEMBL3650	Homo sapiens	Residual Activity	%	8.0
	12245106	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	25.0	CHEMBL3650	Homo sapiens	Residual Activity	%	25.0
	12245107	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	99.0	CHEMBL3650	Homo sapiens	Residual Activity	%	99.0
	12245108	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	1.0
	12245109	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	88.0	CHEMBL3650	Homo sapiens	Residual Activity	%	88.0
	12245110	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	-1.0
	12245111	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	58.0	CHEMBL3650	Homo sapiens	Residual Activity	%	58.0
	12245112	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	0.0	CHEMBL3650	Homo sapiens	Residual Activity	%	0.0
	12245113	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	57.0	CHEMBL3650	Homo sapiens	Residual Activity	%	57.0
	12245114	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	98.0	CHEMBL3650	Homo sapiens	Residual Activity	%	98.0
	12245115	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	54.0	CHEMBL3650	Homo sapiens	Residual Activity	%	54.0
	12245116	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	91.0	CHEMBL3650	Homo sapiens	Residual Activity	%	91.0
	12245117	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	53.0	CHEMBL3650	Homo sapiens	Residual Activity	%	53.0
	12245118	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	90.0	CHEMBL3650	Homo sapiens	Residual Activity	%	90.0
	12245119	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	95.0	CHEMBL3650	Homo sapiens	Residual Activity	%	95.0
	12245120	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	-1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	-1.0
	12245121	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	82.0	CHEMBL3650	Homo sapiens	Residual Activity	%	82.0
	12245122	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	61.0	CHEMBL3650	Homo sapiens	Residual Activity	%	61.0
	12245123	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	2.0	CHEMBL3650	Homo sapiens	Residual Activity	%	2.0
	12245124	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	90.0	CHEMBL3650	Homo sapiens	Residual Activity	%	90.0
	12245125	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	40.0	CHEMBL3650	Homo sapiens	Residual Activity	%	40.0
	12245126	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	81.0	CHEMBL3650	Homo sapiens	Residual Activity	%	81.0
	12245127	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	59.0	CHEMBL3650	Homo sapiens	Residual Activity	%	59.0
	12245128	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	82.0	CHEMBL3650	Homo sapiens	Residual Activity	%	82.0
	12245129	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	112.0	CHEMBL3650	Homo sapiens	Residual Activity	%	112.0
	12245130	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL3650	Homo sapiens	Residual Activity	%	92.0
	12245131	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	9.0	CHEMBL3650	Homo sapiens	Residual Activity	%	9.0
	12245132	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	11.0	CHEMBL3650	Homo sapiens	Residual Activity	%	11.0
	12245133	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	105.0	CHEMBL3650	Homo sapiens	Residual Activity	%	105.0
	12245134	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	41.0	CHEMBL3650	Homo sapiens	Residual Activity	%	41.0
	12245135	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	59.0	CHEMBL3650	Homo sapiens	Residual Activity	%	59.0
	12245136	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	65.0	CHEMBL3650	Homo sapiens	Residual Activity	%	65.0
	12245137	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	77.0	CHEMBL3650	Homo sapiens	Residual Activity	%	77.0
	12245138	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	78.0	CHEMBL3650	Homo sapiens	Residual Activity	%	78.0
	12245139	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	88.0	CHEMBL3650	Homo sapiens	Residual Activity	%	88.0
	12245140	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	32.0	CHEMBL3650	Homo sapiens	Residual Activity	%	32.0
	12245141	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	82.0	CHEMBL3650	Homo sapiens	Residual Activity	%	82.0
	12245142	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	83.0	CHEMBL3650	Homo sapiens	Residual Activity	%	83.0
	12245143	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	17.0	CHEMBL3650	Homo sapiens	Residual Activity	%	17.0
	12245144	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	38.0	CHEMBL3650	Homo sapiens	Residual Activity	%	38.0
	12245145	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	101.0	CHEMBL3650	Homo sapiens	Residual Activity	%	101.0
	12245146	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	86.0	CHEMBL3650	Homo sapiens	Residual Activity	%	86.0
	12245147	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	5.0	CHEMBL3650	Homo sapiens	Residual Activity	%	5.0
	12245148	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	64.0	CHEMBL3650	Homo sapiens	Residual Activity	%	64.0
	12245149	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	27.0	CHEMBL3650	Homo sapiens	Residual Activity	%	27.0
	12245150	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	103.0	CHEMBL3650	Homo sapiens	Residual Activity	%	103.0
	12245151	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	11.0	CHEMBL3650	Homo sapiens	Residual Activity	%	11.0
	12245152	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	11.0	CHEMBL3650	Homo sapiens	Residual Activity	%	11.0
	12245153	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	19.0	CHEMBL3650	Homo sapiens	Residual Activity	%	19.0
	12245154	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	71.0	CHEMBL3650	Homo sapiens	Residual Activity	%	71.0
	12245155	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	-1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	-1.0
	12245156	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	85.0	CHEMBL3650	Homo sapiens	Residual Activity	%	85.0
	12245157	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	15.0	CHEMBL3650	Homo sapiens	Residual Activity	%	15.0
	12245158	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	86.0	CHEMBL3650	Homo sapiens	Residual Activity	%	86.0
	12245159	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	46.0	CHEMBL3650	Homo sapiens	Residual Activity	%	46.0
	12245160	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL3650	Homo sapiens	Residual Activity	%	-1.0
	12245161	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	67.0	CHEMBL3650	Homo sapiens	Residual Activity	%	67.0
	12245162	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	77.0	CHEMBL3650	Homo sapiens	Residual Activity	%	77.0
	12245163	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	4.0	CHEMBL3650	Homo sapiens	Residual Activity	%	4.0
	12245164	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	94.0	CHEMBL3650	Homo sapiens	Residual Activity	%	94.0
	12245165	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL3650	Homo sapiens	Residual Activity	%	0.0
	12245166	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	4.0	CHEMBL3650	Homo sapiens	Residual Activity	%	4.0
	12245167	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	65.0	CHEMBL3650	Homo sapiens	Residual Activity	%	65.0
	12245168	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	2.0	CHEMBL3650	Homo sapiens	Residual Activity	%	2.0
	12245169	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	3.0	CHEMBL3650	Homo sapiens	Residual Activity	%	3.0
	12245170	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	66.0	CHEMBL3650	Homo sapiens	Residual Activity	%	66.0
	12245171	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	83.0	CHEMBL3650	Homo sapiens	Residual Activity	%	83.0
	12245172	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	35.0	CHEMBL3650	Homo sapiens	Residual Activity	%	35.0
	12245173	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	75.0	CHEMBL3650	Homo sapiens	Residual Activity	%	75.0
	12245174	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	5.0	CHEMBL3650	Homo sapiens	Residual Activity	%	5.0
	12245175	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	81.0	CHEMBL3650	Homo sapiens	Residual Activity	%	81.0
	12245176	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	27.0	CHEMBL3650	Homo sapiens	Residual Activity	%	27.0
	12245177	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	0.0	CHEMBL3650	Homo sapiens	Residual Activity	%	0.0
	12245178	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	17.0	CHEMBL3650	Homo sapiens	Residual Activity	%	17.0
	12245179	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	25.0	CHEMBL3650	Homo sapiens	Residual Activity	%	25.0
	12245180	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	80.0	CHEMBL3650	Homo sapiens	Residual Activity	%	80.0
	12245181	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	3.0	CHEMBL3650	Homo sapiens	Residual Activity	%	3.0
	12245182	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	69.0	CHEMBL3650	Homo sapiens	Residual Activity	%	69.0
	12245183	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	73.0	CHEMBL3650	Homo sapiens	Residual Activity	%	73.0
	12245184	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	68.0	CHEMBL3650	Homo sapiens	Residual Activity	%	68.0
	12245185	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	88.0	CHEMBL3650	Homo sapiens	Residual Activity	%	88.0
	12245186	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	28.0	CHEMBL3650	Homo sapiens	Residual Activity	%	28.0
	12245187	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	41.0	CHEMBL3650	Homo sapiens	Residual Activity	%	41.0
	12245188	CHEMBL2219063	Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	12.0	CHEMBL3650	Homo sapiens	Residual Activity	%	12.0
	12626732	CHEMBL2317005	Inhibition of FGFR1 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	12629533	CHEMBL2319131	Inhibition of FGFR1 (unknown origin)	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	12629534	CHEMBL2319131	Inhibition of FGFR1 (unknown origin)	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312303	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
Not Determined	12629535	CHEMBL2319131	Inhibition of FGFR1 (unknown origin)	B	COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL2312301		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	12629536	CHEMBL2319131	Inhibition of FGFR1 (unknown origin)	B	COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC		CHEMBL2312290		IC50			CHEMBL3650	Homo sapiens	IC50		
	12631692	CHEMBL2317774	Inhibition of FGFR1 (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	1710.0	CHEMBL3650	Homo sapiens	IC50	uM	1.71
	12631693	CHEMBL2317774	Inhibition of FGFR1 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	12631694	CHEMBL2317774	Inhibition of FGFR1 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649	=	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	12631695	CHEMBL2317774	Inhibition of FGFR1 (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646	=	IC50	nM	12510.0	CHEMBL3650	Homo sapiens	IC50	uM	12.51
	12631696	CHEMBL2317774	Inhibition of FGFR1 (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645	=	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	12647967	CHEMBL2329193	Inhibition of FGFR1 (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	63.0	CHEMBL3650	Homo sapiens	INH	%	63.0
	12647968	CHEMBL2329193	Inhibition of FGFR1 (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	37.0	CHEMBL3650	Homo sapiens	INH	%	37.0
	12647969	CHEMBL2329193	Inhibition of FGFR1 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	67.0	CHEMBL3650	Homo sapiens	INH	%	67.0
	12647970	CHEMBL2329193	Inhibition of FGFR1 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	12649636	CHEMBL2329545	Inhibition of FGFR1 (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	12649637	CHEMBL2329545	Inhibition of FGFR1 (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	99.0	CHEMBL3650	Homo sapiens	INH	%	99.0
	12649638	CHEMBL2329545	Inhibition of FGFR1 (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	12656873	CHEMBL2327151	Inhibition of FGFR1 (unknown origin)	B	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	uM	0.028
	12656874	CHEMBL2327151	Inhibition of FGFR1 (unknown origin)	B	Cc1[nH]nc2c1N=C(c1ccccc1Cl)c1cc(N)ccc1N2		CHEMBL2322701	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	uM	0.05
	12670879	CHEMBL2338943	Inhibition of FGFR-1 kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)C(Nc1ccc(Cl)cc1Cl)=NS2(=O)=O	Outside typical range	CHEMBL2334805	=	Inhibition	%	-51.0	CHEMBL3650	Homo sapiens	INH	%	-51.0
	12673043	CHEMBL2340163	Inhibition of recombinant FGF-R1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	5.0	CHEMBL3650	Homo sapiens	Activity	%	5.0
	12673044	CHEMBL2340163	Inhibition of recombinant FGF-R1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	4.0	CHEMBL3650	Homo sapiens	Activity	%	4.0
	12693268	CHEMBL2343952	Inhibition of FGFR1 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	12700145	CHEMBL2342683	Inhibition of recombinant FGFR1 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	66.0	CHEMBL3650	Homo sapiens	INH	%	66.0
	12718790	CHEMBL2350673	Inhibition of FGFR1 (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	12.0	CHEMBL3650	Homo sapiens	IC50	nM	12.0
	12718812	CHEMBL2350696	Inhibition of FGFR1 (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	44.0	CHEMBL3650	Homo sapiens	INH	%	44.0
	12718835	CHEMBL2350988	Inhibition of FGFR1 (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	65.0	CHEMBL3650	Homo sapiens	INH	%	65.0
	12728084	CHEMBL2351299	Inhibition of FGFR1 (unknown origin) incubated for 5 mins prior to ATP addition measured after 10 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	12728836	CHEMBL2352909	Inhibition of FGFR1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	90.0	CHEMBL3650	Homo sapiens	Activity	%	90.0
	12729777	CHEMBL2350022	Inhibition of FGFR1 V561M mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	98.0	CHEMBL3650	Homo sapiens	Activity	%	98.0
	12729961	CHEMBL2352198	Inhibition of FGFR1 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	95.0	CHEMBL3650	Homo sapiens	Activity	%	95.0
	12729976	CHEMBL2352259	Inhibition of FGFR1 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	90.0	CHEMBL3650	Homo sapiens	Activity	%	90.0
	12730224	CHEMBL2352909	Inhibition of FGFR1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	106.0	CHEMBL3650	Homo sapiens	Activity	%	106.0
	12731145	CHEMBL2352233	Inhibition of human FGFR1 using IGF-IRtide (12 to 527) as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccccc3F)o2)SC1=S		CHEMBL2349212	=	Activity	%	22.0	CHEMBL3650	Homo sapiens	Activity	%	22.0
	12731146	CHEMBL2352233	Inhibition of human FGFR1 using IGF-IRtide (12 to 527) as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349206	=	Activity	%	5.0	CHEMBL3650	Homo sapiens	Activity	%	5.0
	12731147	CHEMBL2352233	Inhibition of human FGFR1 using IGF-IRtide (12 to 527) as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349205	=	Activity	%	10.0	CHEMBL3650	Homo sapiens	Activity	%	10.0
	12731148	CHEMBL2352233	Inhibition of human FGFR1 using IGF-IRtide (12 to 527) as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S		CHEMBL2346710	=	Activity	%	88.0	CHEMBL3650	Homo sapiens	Activity	%	88.0
	12731149	CHEMBL2352233	Inhibition of human FGFR1 using IGF-IRtide (12 to 527) as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccccc3Cl)o2)SC1=S		CHEMBL2348833	=	Activity	%	16.0	CHEMBL3650	Homo sapiens	Activity	%	16.0
	13282354	CHEMBL2378446	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	41.0	CHEMBL3650	Homo sapiens	INH	%	41.0
	13282355	CHEMBL2378446	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	80.0	CHEMBL3650	Homo sapiens	INH	%	80.0
	13282356	CHEMBL2378446	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	77.0	CHEMBL3650	Homo sapiens	INH	%	77.0
	13282357	CHEMBL2378446	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	13.0	CHEMBL3650	Homo sapiens	INH	%	13.0
	13282358	CHEMBL2378446	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1	Outside typical range	CHEMBL2376144	=	Inhibition	%	-11.0	CHEMBL3650	Homo sapiens	INH	%	-11.0
	13282359	CHEMBL2378446	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	56.0	CHEMBL3650	Homo sapiens	INH	%	56.0
	13293010	CHEMBL2379866	Inhibition of FGFR1 (unknown origin)	B	C[C@@H](Oc1c[nH]c(=O)c(C(=O)Nc2ccc(N3CCN(C)CC3)cc2)c1)c1c(Cl)ccc(F)c1Cl		CHEMBL2376650	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	13301299	CHEMBL2382835	Inhibition of FGFR1 (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1		CHEMBL2380845	=	IC50	nM	175.0	CHEMBL3650	Homo sapiens	IC50	nM	175.0
	13327682	CHEMBL2389838	Inhibition of FGFR1 (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	48.0	CHEMBL3650	Homo sapiens	INH	%	48.0
Not Determined	13327683	CHEMBL2389838	Inhibition of FGFR1 (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	13328772	CHEMBL2388497	Inhibition of FGFR1 (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	13375866	CHEMBL2405130	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	13389919	CHEMBL2410826	Inhibition of FGFR1 (unknown origin) using biotinylated poly-GluTyr as substrate preincubated for 5 mins followed by ATP addition by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	=	IC50	nM	2700.0	CHEMBL3650	Homo sapiens	IC50	nM	2700.0
Active	13392421	CHEMBL2411017	Inhibition of FGFR1 in human HMEC1 cells assessed as reduction of bFGF-induced Erk1/2 phosphorylation at Thr 202/204 at 1.25 to 2.5 uM incubated for 10 hrs prior to bFGF challenge measured after 10 mins by Western blotting analysis	B	CCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598852		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	13392422	CHEMBL2411018	Inhibition of FGFR1 in human HMEC1 cells assessed as reduction of bFGF-induced AKT phosphorylation at Ser 473 at 1.25 to 5 uM incubated for 10 hrs prior to bFGF challenge measured after 10 mins by Western blotting analysis	B	CCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598852		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	13392423	CHEMBL2411169	Inhibition of FGFR1 in human HMEC1 cells assessed as reduction of bFGF-induced FGFR1 phosphorylation at Tyr 653/654 at 1.25 to 2.5 uM incubated for 10 hrs prior to bFGF challenge measured after 10 mins by Western blotting analysis	B	CCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598852		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	13392424	CHEMBL2411170	Inhibition of FGFR1 in human HMEC1 cells assessed as inhibition of bFGF-induced FGFR1 phosphorylation at Tyr 653/654 incubated for 10 hrs prior to bFGF challenge measured after 10 mins by Western blotting analysis	B	CCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598852		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	13392435	CHEMBL2411323	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	60.0	CHEMBL3650	Homo sapiens	IC50	uM	0.06
	13392436	CHEMBL2411323	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCCCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407635	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	13392437	CHEMBL2411323	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598022	=	IC50	nM	28790.0	CHEMBL3650	Homo sapiens	IC50	uM	28.79
	13392438	CHEMBL2411323	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598852	=	IC50	nM	18060.0	CHEMBL3650	Homo sapiens	IC50	uM	18.06
	13392439	CHEMBL2411323	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407519	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	13392440	CHEMBL2411323	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407518	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	13392441	CHEMBL2411323	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407517	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	13392442	CHEMBL2411323	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CN(C)CCNCCNc1ccc2c3c(cccc13)C(=O)N(C)C2=O		CHEMBL2407516	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	13414491	CHEMBL2422325	Inhibition of FGFR1 (unknown origin)	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1		CHEMBL2419762	=	IC50	nM	63.0	CHEMBL3650	Homo sapiens	IC50	uM	0.063
	13414492	CHEMBL2422325	Inhibition of FGFR1 (unknown origin)	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCO5)c2)cc1		CHEMBL2419761	=	IC50	nM	178.0	CHEMBL3650	Homo sapiens	IC50	uM	0.178
	13414493	CHEMBL2422325	Inhibition of FGFR1 (unknown origin)	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCO5)c2)cc1		CHEMBL2419760	=	IC50	nM	63.0	CHEMBL3650	Homo sapiens	IC50	uM	0.063
	13419619	CHEMBL2422079	Inhibition of FGFR1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	42.0	CHEMBL3650	Homo sapiens	INH	%	42.0
	13419620	CHEMBL2422079	Inhibition of FGFR1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	44.0	CHEMBL3650	Homo sapiens	INH	%	44.0
	13419621	CHEMBL2422079	Inhibition of FGFR1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	27.0	CHEMBL3650	Homo sapiens	INH	%	27.0
	13437642	CHEMBL2423638	Inhibition of FGFR1 (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5)c4)c3c2)cn1		CHEMBL2418750	=	Inhibition	%	14.0	CHEMBL3650	Homo sapiens	INH	%	14.0
	13442359	CHEMBL2427791	Competitive binding affinity to FGFR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	13445494	CHEMBL2427791	Competitive binding affinity to FGFR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	80.0	CHEMBL3650	Homo sapiens	INH	%	80.0
	13448549	CHEMBL2427791	Competitive binding affinity to FGFR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	13448685	CHEMBL2427791	Competitive binding affinity to FGFR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	13451480	CHEMBL2427791	Competitive binding affinity to FGFR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	13454665	CHEMBL2427791	Competitive binding affinity to FGFR1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	13464309	CHEMBL2432949	Inhibition of human FGFR1 in presence of 20 uM ATP	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	IC50	nM	6000.0	CHEMBL3650	Homo sapiens	IC50	uM	6.0
	13464333	CHEMBL2433466	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	92.0	CHEMBL3650	Homo sapiens	Activity	%	92.0
	13465278	CHEMBL2434024	Inhibition of human FGFR1 assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	68.0	CHEMBL3650	Homo sapiens	Activity	%	68.0
	13465356	CHEMBL2433466	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	99.79	CHEMBL3650	Homo sapiens	Activity	%	99.79
	13465387	CHEMBL2434024	Inhibition of human FGFR1 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	99.64	CHEMBL3650	Homo sapiens	Activity	%	99.64
	13465418	CHEMBL2433466	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	106.95	CHEMBL3650	Homo sapiens	Activity	%	106.95
	13465449	CHEMBL2434024	Inhibition of human FGFR1 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	54.61	CHEMBL3650	Homo sapiens	Activity	%	54.61
Active	13488418	CHEMBL2439423	Inhibition of human FGFR1 at 1 uM	B	c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1		CHEMBL2436454		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	13499586	CHEMBL2447160	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	13503634	CHEMBL2447751	Inhibition of FGFR1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Br)cc(Br)c3o2)ccc1O		CHEMBL2442531	=	Activity	%	74.0	CHEMBL3650	Homo sapiens	Activity	%	74.0
	13503635	CHEMBL2447751	Inhibition of FGFR1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Br)cc(Br)c3o2)cc(Cl)c1O		CHEMBL2442530	=	Activity	%	54.0	CHEMBL3650	Homo sapiens	Activity	%	54.0
	13503636	CHEMBL2447751	Inhibition of FGFR1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Cl)cc(C)c3o2)ccc1O		CHEMBL2442529	=	Activity	%	81.0	CHEMBL3650	Homo sapiens	Activity	%	81.0
	13503637	CHEMBL2447751	Inhibition of FGFR1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Cl)cc(Cl)c3o2)ccc1O		CHEMBL2442424	=	Activity	%	74.0	CHEMBL3650	Homo sapiens	Activity	%	74.0
	13507607	CHEMBL2444008	Inhibition of FGFR1 (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
	13507608	CHEMBL2444008	Inhibition of FGFR1 (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
	13507609	CHEMBL2444008	Inhibition of FGFR1 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
	13507610	CHEMBL2444008	Inhibition of FGFR1 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
	13851883	CHEMBL3095039	Inhibition of FGFR1 (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCN(CC)CCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092314	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	13851884	CHEMBL3095039	Inhibition of FGFR1 (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C(NCCN1CCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092308	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	13872147	CHEMBL3101772	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	101.0	CHEMBL3650	Homo sapiens	Activity	%	101.0
	13872227	CHEMBL3102533	Inhibition of FGF-R1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	81.0	CHEMBL3650	Homo sapiens	Activity	%	81.0
	13872257	CHEMBL3100333	Inhibition of FGF-R1 (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	85.0	CHEMBL3650	Homo sapiens	Activity	%	85.0
	13891680	CHEMBL3111125	Binding affinity to N-terminal 6xHis-tagged human recombinant FGFR1 (458 to 765) by surface plasmon resonance analysis	B	Cc1cc(CNc2nccc(Nc3cc(CCc4ccccc4)[nH]n3)n2)on1		CHEMBL2088100	=	Kd	nM	67.9	CHEMBL3650	Homo sapiens	Kd	nM	67.9
	13891681	CHEMBL3111125	Binding affinity to N-terminal 6xHis-tagged human recombinant FGFR1 (458 to 765) by surface plasmon resonance analysis	B	COc1ccc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc1OC		CHEMBL3109570	=	Kd	nM	311.4	CHEMBL3650	Homo sapiens	Kd	nM	311.4
	13891682	CHEMBL3111125	Binding affinity to N-terminal 6xHis-tagged human recombinant FGFR1 (458 to 765) by surface plasmon resonance analysis	B	COc1cc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc(OC)c1		CHEMBL2088096	=	Kd	nM	3.1	CHEMBL3650	Homo sapiens	Kd	nM	3.1
	13891683	CHEMBL3111126	Binding affinity to N-terminal 6xHis-tagged human recombinant FGFR1 (458 to 765) by isothermal titration calorimetric analysis	B	Cc1cc(CNc2nccc(Nc3cc(CCc4ccccc4)[nH]n3)n2)on1		CHEMBL2088100	=	Kd	nM	69.1	CHEMBL3650	Homo sapiens	Kd	nM	69.1
	13891684	CHEMBL3111126	Binding affinity to N-terminal 6xHis-tagged human recombinant FGFR1 (458 to 765) by isothermal titration calorimetric analysis	B	COc1ccc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc1OC		CHEMBL3109570	=	Kd	nM	447.0	CHEMBL3650	Homo sapiens	Kd	nM	447.0
	13891685	CHEMBL3111126	Binding affinity to N-terminal 6xHis-tagged human recombinant FGFR1 (458 to 765) by isothermal titration calorimetric analysis	B	COc1cc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc(OC)c1		CHEMBL2088096	=	Kd	nM	5.8	CHEMBL3650	Homo sapiens	Kd	nM	5.8
	13891686	CHEMBL3111127	Inhibition of N-terminal GST-tagged human recombinant FGFR1 (456 to 765) after 40 mins by mobility shift assay	B	COc1ccc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc1OC		CHEMBL3109570	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	pIC50		7.0
	13891687	CHEMBL3111127	Inhibition of N-terminal GST-tagged human recombinant FGFR1 (456 to 765) after 40 mins by mobility shift assay	B	COc1ccc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc1OC		CHEMBL3109570	=	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	13891688	CHEMBL3111127	Inhibition of N-terminal GST-tagged human recombinant FGFR1 (456 to 765) after 40 mins by mobility shift assay	B	COc1cc(CCc2cc(Nc3ccnc(NCc4cc(C)no4)n3)n[nH]2)cc(OC)c1		CHEMBL2088096	=	IC50	nM	60.0	CHEMBL3650	Homo sapiens	IC50	nM	60.0
	13906528	CHEMBL3117698	Inhibition of FGFR1 (unknown origin) at 10 uM after 30 mins relative to control	B	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC		CHEMBL3113284	=	Inhibition	%	6.5	CHEMBL3650	Homo sapiens	INH	%	6.5
	13917425	CHEMBL3117354	Inhibition of FGFR1 (unknown origin)	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	13917462	CHEMBL3117354	Inhibition of FGFR1 (unknown origin)	B	CN1CCN(c2ccc(Nc3ncc4cc(C#N)c(=O)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL3115681	=	IC50	nM	26.0	CHEMBL3650	Homo sapiens	IC50	nM	26.0
	13918696	CHEMBL3118216	Inhibition of human FGFR1	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc[nH]c2n1)c1ncc(F)cn1		CHEMBL3116050	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	uM	0.05
	13953308	CHEMBL3130703	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	94.0	CHEMBL3650	Homo sapiens	Activity	%	94.0
	13953331	CHEMBL3130703	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	91.0	CHEMBL3650	Homo sapiens	Activity	%	91.0
	13953365	CHEMBL3132649	Inhibition of human FGFR1 V561M mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	85.0	CHEMBL3650	Homo sapiens	Activity	%	85.0
	13954560	CHEMBL3130703	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	70.0	CHEMBL3650	Homo sapiens	Activity	%	70.0
	13954626	CHEMBL3132649	Inhibition of human FGFR1 V561M mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	104.0	CHEMBL3650	Homo sapiens	Activity	%	104.0
	13954701	CHEMBL3132649	Inhibition of human FGFR1 V561M mutant assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	90.0	CHEMBL3650	Homo sapiens	Activity	%	90.0
	13965708	CHEMBL3135920	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	43.0	CHEMBL3650	Homo sapiens	INH	%	43.0
	13966086	CHEMBL3137074	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	64.5	CHEMBL3650	Homo sapiens	INH	%	64.5
	13973988	CHEMBL3135888	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	2.5	CHEMBL3650	Homo sapiens	INH	%	2.5
	13974079	CHEMBL3134917	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	13974170	CHEMBL3136968	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	55.5	CHEMBL3650	Homo sapiens	INH	%	55.5
	13974261	CHEMBL3136239	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	61.5	CHEMBL3650	Homo sapiens	INH	%	61.5
	13974999	CHEMBL3135295	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	97.0	CHEMBL3650	Homo sapiens	INH	%	97.0
	13975090	CHEMBL3136862	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	13975181	CHEMBL3135635	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	13975272	CHEMBL3137155	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	1.5	CHEMBL3650	Homo sapiens	INH	%	1.5
	13975915	CHEMBL3136282	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	36.5	CHEMBL3650	Homo sapiens	INH	%	36.5
	13976008	CHEMBL3136433	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	13.0	CHEMBL3650	Homo sapiens	INH	%	13.0
	13976099	CHEMBL3136770	Inhibition of human FGFR1 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	72.0	CHEMBL3650	Homo sapiens	INH	%	72.0
	14544034	CHEMBL3226043	Inhibition of FGFR1 (unknown origin) at 10 uM	B	CC1(C)C(=O)Nc2cc3nccc(Oc4ccc(NC(=O)Nc5ccc(F)c(C(F)(F)F)c5)cc4Cl)c3cc21		CHEMBL3218350	=	Inhibition	%	20.2	CHEMBL3650	Homo sapiens	INH	%	20.2
	14553647	CHEMBL3224239	Inhibition of FGFR1 (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	90.1	CHEMBL3650	Homo sapiens	Activity	%	90.1
	14582497	CHEMBL3242349	Inhibition of human FGFR1 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	110.0	CHEMBL3650	Homo sapiens	Activity	%	110.0
	14589549	CHEMBL3239043	Inhibition of FGFR1 (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233767	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14589550	CHEMBL3239043	Inhibition of FGFR1 (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	O=C(/C=C/CN1CC2CCC1C(=O)C2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233785	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14648166	CHEMBL3267040	Inhibition of human FGF-R1 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	14648167	CHEMBL3267040	Inhibition of human FGF-R1 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	>	Inhibition	%	80.0	CHEMBL3650	Homo sapiens	INH	%	80.0
Active	14653676	CHEMBL3267815	Inhibition of purified recombinant FGFR1 (unknown origin) at 1 uM after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	14653677	CHEMBL3267815	Inhibition of purified recombinant FGFR1 (unknown origin) at 1 uM after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263971		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	14664170	CHEMBL3270872	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	89.0	CHEMBL3650	Homo sapiens	INH	%	89.0
	14664171	CHEMBL3270872	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	87.0	CHEMBL3650	Homo sapiens	INH	%	87.0
	14664172	CHEMBL3270872	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	100.0	CHEMBL3650	Homo sapiens	INH	%	100.0
	14666349	CHEMBL3270468	Inhibition of FGFR1 (unknown origin) assessed as [33P] incorporation in substrate by TopCount microplate scintillation counting analysis	B	COc1ccc(Oc2cc(C)c(-c3csc(NC(=O)c4ccnc(F)c4)n3)c(C)c2)cc1		CHEMBL3263869	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14713706	CHEMBL3296771	Binding affinity to FGFR1 (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	350.0	CHEMBL3650	Homo sapiens	Ki	uM	0.35
	14713735	CHEMBL3296860	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	71.0	CHEMBL3650	Homo sapiens	INH	%	71.0
Not Determined	14713763	CHEMBL3296771	Binding affinity to FGFR1 (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Ki			CHEMBL3650	Homo sapiens	Ki		
	14746948	CHEMBL3295617	Inhibition of FGFR-1 (unknown origin) expressed in baculovirus expression system using poly (4 Glu, Tyr) as substrate after 60 mins by ELISA	B	Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12		CHEMBL3288526	=	IC50	nM	643.7	CHEMBL3650	Homo sapiens	IC50	nM	643.7
	14751755	CHEMBL3301277	Inhibition of FGFR1 (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14751756	CHEMBL3301277	Inhibition of FGFR1 (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753633	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCO5)c2)cc1		CHEMBL3040861	=	IC50	nM	63.0	CHEMBL3650	Homo sapiens	IC50	uM	0.063
	14753634	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCO5)c2)cc1		CHEMBL3040806	=	IC50	nM	178.0	CHEMBL3650	Homo sapiens	IC50	uM	0.178
	14753635	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1		CHEMBL3040910	=	IC50	nM	63.0	CHEMBL3650	Homo sapiens	IC50	uM	0.063
	14753636	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	Cl.c1cc(Nc2ncnc3cc4c(cc23)OCCO4)cc(-c2ccco2)c1		CHEMBL3297954	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753637	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	Cl.c1cc(Nc2ncnc3cc4c(cc23)OCCO4)cc(-c2cccs2)c1		CHEMBL3297955	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753638	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCO5)c2)nc1		CHEMBL3297956	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753639	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2ccnc(Nc3ncnc4cc5c(cc34)OCCO5)n2)cc1		CHEMBL3297957	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753640	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	c1ccc(-c2csc(Nc3ncnc4cc5c(cc34)OCCO5)n2)cc1		CHEMBL3297958	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753641	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	Cl.c1cc(Nc2ncnc3cc4c(cc23)OCCO4)cc(-c2ccc[nH]2)c1		CHEMBL3297959	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753642	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	COc1cc2ncnc(Nc3cccc(-c4ccccc4)c3)c2cc1OC		CHEMBL2333991	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753643	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753644	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O		CHEMBL67	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14753645	CHEMBL3300695	Inhibition of FGFR1 (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL428647	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	14979256	CHEMBL3379625	Inhibition of FGFR1 (unknown origin) at 1 uM	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	Inhibition	%	91.0	CHEMBL3650	Homo sapiens	INH	%	91.0
	14979257	CHEMBL3379626	Inhibition of FGFR1 (unknown origin)	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	IC50	nM	250.0	CHEMBL3650	Homo sapiens	IC50	nM	250.0
	14981501	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ncccc43)cc2)CC1		CHEMBL3356292	=	Inhibition	%	22.24	CHEMBL3650	Homo sapiens	INH	%	22.24
	14981511	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ncccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356293	=	Inhibition	%	30.3	CHEMBL3650	Homo sapiens	INH	%	30.3
	14981521	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ncccc2/C1=C/c1ccc(N2CCN(C(=O)c3ccccc3)CC2)cc1		CHEMBL3356294	=	Inhibition	%	49.3	CHEMBL3650	Homo sapiens	INH	%	49.3
	14981531	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccc(Cl)cc2/C1=N/c1ccc2nc(S)[nH]c2c1	Outside typical range	CHEMBL3356295	=	Inhibition	%	-28.85	CHEMBL3650	Homo sapiens	INH	%	-28.85
	14981541	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	Cc1cc2cc(/N=C3\C(=O)Nc4ccc(Cl)cc43)ccc2[nH]1		CHEMBL3356296	=	Inhibition	%	4.8	CHEMBL3650	Homo sapiens	INH	%	4.8
	14981551	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccc(Cl)cc2/C1=N/c1ccc2[nH]ccc2c1		CHEMBL3356297	=	Inhibition	%	9.3	CHEMBL3650	Homo sapiens	INH	%	9.3
	14981561	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccc(Cl)cc2/C1=N/c1ccc2ncccc2c1		CHEMBL3356298	=	Inhibition	%	0.58	CHEMBL3650	Homo sapiens	INH	%	0.58
	14981571	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	CCn1c2ccccc2c2cc(/N=C3/C(=O)Nc4ccc(Cl)cc43)ccc21		CHEMBL3356299	=	Inhibition	%	0.36	CHEMBL3650	Homo sapiens	INH	%	0.36
	14981581	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccc(Cl)cc2/C1=N/c1ccc2cc[nH]c2c1		CHEMBL3356300	=	Inhibition	%	21.8	CHEMBL3650	Homo sapiens	INH	%	21.8
	14981591	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	Nc1nc(N2CCOCC2)ccc1/N=C1\C(=O)Nc2ccc(Cl)cc21		CHEMBL3356301	=	Inhibition	%	16.6	CHEMBL3650	Homo sapiens	INH	%	16.6
	14981601	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	CCOC(=O)c1ccc(/N=C2\C(=O)Nc3ccc(Cl)cc32)c(N2CCOCC2)n1	Outside typical range	CHEMBL3356302	=	Inhibition	%	-14.8	CHEMBL3650	Homo sapiens	INH	%	-14.8
	14981611	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	CCOC(=O)c1ccc(/N=C2\C(=O)Nc3ccc(Cl)cc32)c(Nc2cc(OC)cc(OC)c2)c1		CHEMBL3356303	=	Inhibition	%	-1.42	CHEMBL3650	Homo sapiens	INH	%	-1.42
	14981621	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ncccc2/C1=C/c1ccccc1C(F)(F)F		CHEMBL3356280	=	Inhibition	%	53.2	CHEMBL3650	Homo sapiens	INH	%	53.2
	14981631	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ncccc32)c(OC)c1		CHEMBL3356281	=	Inhibition	%	38.4	CHEMBL3650	Homo sapiens	INH	%	38.4
	14981641	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ncccc2/C1=C/c1ncc[nH]1		CHEMBL3356282	=	Inhibition	%	6.7	CHEMBL3650	Homo sapiens	INH	%	6.7
	14981651	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ncccc2/C1=C/c1c[nH]c2ccc(Br)cc12		CHEMBL3356283	=	Inhibition	%	10.9	CHEMBL3650	Homo sapiens	INH	%	10.9
	14981661	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	Cn1cc(/C=C2/C(=O)Nc3ncccc32)c2ccccc21		CHEMBL3356284	=	Inhibition	%	6.4	CHEMBL3650	Homo sapiens	INH	%	6.4
	14981671	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ncccc2/C1=C/c1c[nH]c2ccccc12		CHEMBL3356285	=	Inhibition	%	3.11	CHEMBL3650	Homo sapiens	INH	%	3.11
	14981681	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ncccc2/C1=C/c1ccc(N2CCOCC2)cc1		CHEMBL3356286	=	Inhibition	%	16.6	CHEMBL3650	Homo sapiens	INH	%	16.6
	14981691	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccc(Cl)cc2/C1=N/NC(=O)c1ccc(N2CCOCC2)c([N+](=O)[O-])c1	Outside typical range	CHEMBL3356304	=	Inhibition	%	-16.8	CHEMBL3650	Homo sapiens	INH	%	-16.8
	14981701	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccc(Cl)cc2/C1=N/NC(=O)c1ccco1		CHEMBL3356305	=	Inhibition	%	11.4	CHEMBL3650	Homo sapiens	INH	%	11.4
	14981711	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCOCC2)cc1		CHEMBL86480	=	Inhibition	%	46.0	CHEMBL3650	Homo sapiens	INH	%	46.0
	14981721	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1c[nH]c2ncccc12		CHEMBL3356287	=	Inhibition	%	8.1	CHEMBL3650	Homo sapiens	INH	%	8.1
	14981731	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=CN1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL315546	=	Inhibition	%	72.5	CHEMBL3650	Homo sapiens	INH	%	72.5
	14981741	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=CN1CCN(c2ccc(/C=C3\C(=O)Nc4ncccc43)cc2)CC1		CHEMBL3356288	=	Inhibition	%	49.1	CHEMBL3650	Homo sapiens	INH	%	49.1
	14983210	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	C=CC(=O)N1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL3356289	=	Inhibition	%	48.2	CHEMBL3650	Homo sapiens	INH	%	48.2
	14983251	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)CCCl)CC2)cc1		CHEMBL3356290	=	Inhibition	%	47.4	CHEMBL3650	Homo sapiens	INH	%	47.4
	14983287	CHEMBL3383535	Inhibition of recombinant FGFR1 (unknown origin) at 10 uM after 1 hr by microfluidic assay	B	O=C1Nc2ccccc2/C1=C/c1ccc(N2CCN(C(=O)c3ccccc3)CC2)cc1		CHEMBL3356291	=	Inhibition	%	65.0	CHEMBL3650	Homo sapiens	INH	%	65.0
	14984377	CHEMBL3384998	Inhibition of FGFR1 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	53.0	CHEMBL3650	Homo sapiens	INH	%	53.0
	14984443	CHEMBL3382484	Inhibition of FGFR1 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	14992053	CHEMBL3374151	Inhibition of FGFR1 (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	7.4	CHEMBL3650	Homo sapiens	INH	%	7.4
	14992120	CHEMBL3374166	Inhibition of FGFR1 (unknown origin) at 10 nM by ELISA method	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	Inhibition	%	95.1	CHEMBL3650	Homo sapiens	INH	%	95.1
	14994861	CHEMBL3372487	Inhibition of FGFR1 (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	0.7	CHEMBL3650	Homo sapiens	IC50	nM	0.7
	14994862	CHEMBL3372473	Inhibition of FGFR1 (unknown origin) at 100 uM	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(Cc2ccccc2)C1=O		CHEMBL3358803	=	Inhibition	%	29.3	CHEMBL3650	Homo sapiens	INH	%	29.3
	15005103	CHEMBL3366511	Inhibition of FGFR1 (unknown origin) at 0.1 nM after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	15008012	CHEMBL3367999	Inhibition of human FGFR1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	65.0	CHEMBL3650	Homo sapiens	INH	%	65.0
	15008013	CHEMBL3367999	Inhibition of human FGFR1 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	49.0	CHEMBL3650	Homo sapiens	INH	%	49.0
	15008014	CHEMBL3367999	Inhibition of human FGFR1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	70.0	CHEMBL3650	Homo sapiens	INH	%	70.0
	15018592	CHEMBL3362256	Inhibition of FGFR1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	2.4	CHEMBL3650	Homo sapiens	INH	%	2.4
	15022492	CHEMBL3380455	Inhibition of FGFR1 (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	23.0	CHEMBL3650	Homo sapiens	INH	%	23.0
	15025408	CHEMBL3362516	Inhibition of FGFR1 (unknown origin) at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	15036788	CHEMBL3381073	Inhibition of FGFR1 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	15036789	CHEMBL3381073	Inhibition of FGFR1 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	15036790	CHEMBL3381073	Inhibition of FGFR1 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	15036791	CHEMBL3381073	Inhibition of FGFR1 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	15036792	CHEMBL3381073	Inhibition of FGFR1 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	15037213	CHEMBL3368338	Inhibition of FGFR1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	89.0	CHEMBL3650	Homo sapiens	INH	%	89.0
	15037214	CHEMBL3368338	Inhibition of FGFR1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	100.0	CHEMBL3650	Homo sapiens	INH	%	100.0
	15037215	CHEMBL3368338	Inhibition of FGFR1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	90.0	CHEMBL3650	Homo sapiens	INH	%	90.0
	15037216	CHEMBL3368338	Inhibition of FGFR1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	84.0	CHEMBL3650	Homo sapiens	INH	%	84.0
	15037217	CHEMBL3368338	Inhibition of FGFR1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	15072606	CHEMBL3382666	Inhibition of FGFR1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	127.0	CHEMBL3650	Homo sapiens	Activity	%	127.0
	15085832	CHEMBL3384762	Inhibition of purified FGFR1 (unknown origin) at 0.1 uM after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	Inhibition	%	69.2	CHEMBL3650	Homo sapiens	INH	%	69.2
	15085842	CHEMBL3383512	Inhibition of purified FGFR1 (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	Inhibition	%	100.0	CHEMBL3650	Homo sapiens	INH	%	100.0
	15091095	CHEMBL3381534	Inhibition of human recombinant FGFR1 kinase using Ulight-CAGAGAIETDKEYYTVKD substrate assessed as remaining enzyme activity at 1 uM after 60 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	101.0	CHEMBL3650	Homo sapiens	Activity	%	101.0
	15136195	CHEMBL3382074	Inhibition of FGFR1 (unknown origin)	B	CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C/N=C/c1c(O)ccc2ccccc12		CHEMBL3343787	=	IC50	nM	1200.0	CHEMBL3650	Homo sapiens	IC50	uM	1.2
	15143821	CHEMBL3396124	Inhibition of purified FGFR1 (unknown origin) at 1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	21.5	CHEMBL3650	Homo sapiens	INH	%	21.5
Not Determined	15143836	CHEMBL3396222	Inhibition of purified FGFR1 (unknown origin) at 0.1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Determined	15143851	CHEMBL3396237	Inhibition of purified FGFR1 (unknown origin) at 0.01 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	15149973	CHEMBL3395926	Inhibition of FGFR1 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	15149974	CHEMBL3395926	Inhibition of FGFR1 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	15149975	CHEMBL3395926	Inhibition of FGFR1 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	15149976	CHEMBL3395926	Inhibition of FGFR1 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	15149977	CHEMBL3395926	Inhibition of FGFR1 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	15165377	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3c[nH]c4cccc(Br)c34)[nH]c2n1		CHEMBL3401370	=	IC50	nM	1560.0	CHEMBL3650	Homo sapiens	IC50	uM	1.56
	15165378	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3c[nH]c4ccccc34)[nH]c2n1		CHEMBL3401369	=	IC50	nM	3170.0	CHEMBL3650	Homo sapiens	IC50	uM	3.17
	15165379	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3ccc(C)cc3C)[nH]c2n1		CHEMBL3401368	=	IC50	nM	9590.0	CHEMBL3650	Homo sapiens	IC50	uM	9.59
	15165380	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cccc(-c2nc3c(O)nc(NC(C)=O)nc3[nH]2)c1OC		CHEMBL3401367	=	IC50	nM	9130.0	CHEMBL3650	Homo sapiens	IC50	uM	9.13
	15165381	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	COc1ccccc1-c1nc2c(O)nc(NC(C)=O)nc2[nH]1		CHEMBL3401366	=	IC50	nM	15040.0	CHEMBL3650	Homo sapiens	IC50	uM	15.04
	15165382	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3ccccc3)[nH]c2n1		CHEMBL3401365	=	IC50	nM	17840.0	CHEMBL3650	Homo sapiens	IC50	uM	17.84
	15165383	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3c[nH]c4cccc(Br)c34)[nH]c2n1		CHEMBL3401364	=	IC50	nM	4840.0	CHEMBL3650	Homo sapiens	IC50	uM	4.84
	15165384	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3c[nH]c4ccccc34)[nH]c2n1		CHEMBL3401363	=	IC50	nM	5330.0	CHEMBL3650	Homo sapiens	IC50	uM	5.33
	15165385	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	Cc1ccc(-c2nc3c(O)nc(N)nc3[nH]2)c(C)c1		CHEMBL3401362	=	IC50	nM	12650.0	CHEMBL3650	Homo sapiens	IC50	uM	12.65
	15165386	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cccc(-c2nc3c(O)nc(N)nc3[nH]2)c1OC		CHEMBL3401361	=	IC50	nM	11910.0	CHEMBL3650	Homo sapiens	IC50	uM	11.91
	15165387	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	COc1ccccc1-c1nc2c(O)nc(N)nc2[nH]1		CHEMBL3401360	=	IC50	nM	15220.0	CHEMBL3650	Homo sapiens	IC50	uM	15.22
	15165388	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3ccccc3)[nH]c2n1		CHEMBL3401359	=	IC50	nM	15180.0	CHEMBL3650	Homo sapiens	IC50	uM	15.18
	15165389	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	110.0	CHEMBL3650	Homo sapiens	IC50	uM	0.11
	15165390	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	CN1CCN(c2ccc(-c3nc4c(N5CCN(CC(=O)Nc6nccs6)CC5)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL3401358	=	IC50	nM	82.0	CHEMBL3650	Homo sapiens	IC50	uM	0.082
	15165391	CHEMBL3404248	Inhibition of FGFR1 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	uM	0.0013
	15165395	CHEMBL3404244	Inhibition of FGFR1 (unknown origin)	B	CN1CCN(c2ccc(-c3nc4c(N5CCN(CC(=O)Nc6nccs6)CC5)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL3401358	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	nM	20.0
	15165396	CHEMBL3404244	Inhibition of FGFR1 (unknown origin)	B	COc1cccc(Cc2c[nH]c3ncccc23)c1		CHEMBL1231606	=	IC50	nM	1900.0	CHEMBL3650	Homo sapiens	IC50	uM	1.9
	15181168	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CC(C)CCOc1cccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)c1		CHEMBL3402508	=	Activity	%	100.0	CHEMBL3650	Homo sapiens	Activity	%	100.0
	15181169	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)cc1		CHEMBL3402507	=	Activity	%	26.85	CHEMBL3650	Homo sapiens	Activity	%	26.85
	15181170	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402506	=	Activity	%	25.53	CHEMBL3650	Homo sapiens	Activity	%	25.53
	15181171	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402505	=	Activity	%	36.17	CHEMBL3650	Homo sapiens	Activity	%	36.17
	15181172	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402503	=	Activity	%	58.09	CHEMBL3650	Homo sapiens	Activity	%	58.09
	15181173	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1OCC		CHEMBL3402502	=	Activity	%	18.01	CHEMBL3650	Homo sapiens	Activity	%	18.01
	15181174	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CC(C)(C)c1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402501	=	Activity	%	46.81	CHEMBL3650	Homo sapiens	Activity	%	46.81
	15181175	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402500	=	Activity	%	22.63	CHEMBL3650	Homo sapiens	Activity	%	22.63
	15181176	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccc(C)cc4)C3c3ccc(C(C)(C)C)cc3)sc2c1		CHEMBL3402493	=	Activity	%	40.33	CHEMBL3650	Homo sapiens	Activity	%	40.33
	15181177	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccccc4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3402491	=	Activity	%	65.69	CHEMBL3650	Homo sapiens	Activity	%	65.69
	15181178	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1cccc(Cl)c1)c1cccs1		CHEMBL3402489	=	Activity	%	74.42	CHEMBL3650	Homo sapiens	Activity	%	74.42
	15181179	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4cccs4)C3c3ccc(C)cc3)sc2c1		CHEMBL3400173	=	Activity	%	88.69	CHEMBL3650	Homo sapiens	Activity	%	88.69
	15181180	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(F)cc4s3)C2c2ccc(C(C)(C)C)cc2)o1		CHEMBL3402485	=	Activity	%	92.71	CHEMBL3650	Homo sapiens	Activity	%	92.71
	15181181	CHEMBL3405547	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM using IGF-IRtide (12 to 527) substrate	B	COc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3400828	=	Activity	%	46.36	CHEMBL3650	Homo sapiens	Activity	%	46.36
	15186199	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Fc1ccccc1Nc1ncnc2sc3c(c12)CCCCC3		CHEMBL3400599	=	IC50	nM	4300.0	CHEMBL3650	Homo sapiens	IC50	uM	4.3
	15186200	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Fc1ccccc1Nc1ncnc2sc(-c3ccccc3)cc12		CHEMBL3401759	=	IC50	nM	18200.0	CHEMBL3650	Homo sapiens	IC50	uM	18.2
	15186201	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Fc1ccccc1Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL3401760	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186202	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Fc1ccc(Nc2ncnc3scc(-c4ccccc4)c23)cc1		CHEMBL3401761	=	IC50	nM	6300.0	CHEMBL3650	Homo sapiens	IC50	uM	6.3
	15186203	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Fc1ccc(Nc2ncnc3sc(-c4ccccc4)cc23)cc1		CHEMBL3401762	=	IC50	nM	4300.0	CHEMBL3650	Homo sapiens	IC50	uM	4.3
	15186204	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Fc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1		CHEMBL3237080	=	IC50	nM	3200.0	CHEMBL3650	Homo sapiens	IC50	uM	3.2
	15186205	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Cc1ccc(-c2csc3ncnc(Nc4ccc(F)cc4)c23)cc1		CHEMBL3401763	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186206	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Fc1ccc(Nc2ncnc3scc(-c4ccc(Cl)cc4)c23)cc1		CHEMBL3237083	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186207	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	CCOC(=O)c1sc2ncnc(Nc3ccc(F)cc3)c2c1C		CHEMBL3237084	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186208	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Cc1ccc(-c2csc3ncnc(Nc4cccc(C(=O)O)c4)c23)cc1		CHEMBL3401764	=	IC50	nM	11000.0	CHEMBL3650	Homo sapiens	IC50	uM	11.0
	15186209	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	CCOC(=O)c1sc2ncnc(Nc3cccc(C(=O)O)c3)c2c1C		CHEMBL1470707	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186210	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Cc1ccc(-c2csc3ncnc(Nc4ccc(C(=O)O)cc4)c23)cc1		CHEMBL1513159	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186211	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Fc1ccc(Nc2ncnc3sc4c(c23)CCCCC4)cc1Cl		CHEMBL3401765	=	IC50	nM	1600.0	CHEMBL3650	Homo sapiens	IC50	uM	1.6
	15186212	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	CCOC(=O)c1sc2ncnc(Nc3ccc(OC)cc3)c2c1C		CHEMBL3401766	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186213	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	COc1ccc(Nc2ncnc3scc(-c4ccccc4)c23)cc1		CHEMBL3401767	=	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	15186214	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	COc1ccc(Nc2ncnc3scc(-c4ccc(C)cc4)c23)cc1		CHEMBL3401768	=	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	15186215	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	CCOC(=O)c1sc2ncnc(Nc3cccc(OC)c3)c2c1C		CHEMBL3401769	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186216	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	COc1cccc(Nc2ncnc3scc(-c4ccc(Cl)cc4)c23)c1		CHEMBL3401770	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186217	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	COc1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL3401771	=	IC50	nM	2500.0	CHEMBL3650	Homo sapiens	IC50	uM	2.5
	15186218	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	CCOc1ccc(-c2csc3ncnc(Nc4ccc(O)cc4)c23)cc1		CHEMBL3401772	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	15186219	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Cc1cc2c(Nc3ccc(O)cc3)ncnc2s1		CHEMBL1617780	=	IC50	nM	5600.0	CHEMBL3650	Homo sapiens	IC50	uM	5.6
	15186220	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Cc1nc(Nc2ccc(O)cc2)c2cc(-c3ccccc3)sc2n1		CHEMBL3401773	=	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	15186221	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Oc1ccc(Nc2ncnc3scc(-c4ccccc4)c23)cc1		CHEMBL1626011	=	IC50	nM	1660.0	CHEMBL3650	Homo sapiens	IC50	uM	1.66
	15186222	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Cc1sc2ncnc(Nc3ccc(O)cc3)c2c1-c1ccccc1		CHEMBL3401774	=	IC50	nM	1250.0	CHEMBL3650	Homo sapiens	IC50	uM	1.25
	15186223	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Oc1ccc(Nc2ncnc3sc(-c4ccccc4)cc23)cc1		CHEMBL3401775	=	IC50	nM	1200.0	CHEMBL3650	Homo sapiens	IC50	uM	1.2
	15186224	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Oc1ccc(Nc2ncnc3scc(-c4ccc(Cl)cc4)c23)cc1		CHEMBL3401776	=	IC50	nM	3000.0	CHEMBL3650	Homo sapiens	IC50	uM	3.0
	15186225	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	CCOc1ccc(-c2csc3ncnc(Nc4cccc(O)c4)c23)cc1		CHEMBL1574987	=	IC50	nM	12500.0	CHEMBL3650	Homo sapiens	IC50	uM	12.5
	15186226	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Cc1ccc(-c2csc3ncnc(Nc4cccc(O)c4)c23)cc1		CHEMBL3401777	=	IC50	nM	700.0	CHEMBL3650	Homo sapiens	IC50	uM	0.7
	15186227	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Oc1cccc(Nc2ncnc3scc(-c4ccc(Cl)cc4)c23)c1		CHEMBL3401778	=	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	uM	0.5
	15186228	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	CCOC(=O)c1sc2ncnc(Nc3cccc(O)c3)c2c1C		CHEMBL3401779	=	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	uM	0.5
	15186229	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	CC1CCc2sc3ncnc(Nc4cccc(O)c4)c3c2C1		CHEMBL3401780	=	IC50	nM	450.0	CHEMBL3650	Homo sapiens	IC50	uM	0.45
	15186230	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Oc1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL3401781	=	IC50	nM	180.0	CHEMBL3650	Homo sapiens	IC50	uM	0.18
	15186231	CHEMBL3405644	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as incorporation of [32P] into peptide by scintillation counting analysis	B	Oc1cccc(Nc2ncnc3sc(-c4ccccc4)cc23)c1		CHEMBL3401782	=	IC50	nM	160.0	CHEMBL3650	Homo sapiens	IC50	uM	0.16
	15186244	CHEMBL3405651	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as residual activity measured as incorporation of [32P] into peptide at 33 uM by scintillation counting analysis	B	Oc1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL3401781	=	Activity	%	3.5	CHEMBL3650	Homo sapiens	Activity	%	3.5
	15186245	CHEMBL3405651	Inhibition of FGFR1 (unknown origin) using KKKSPGEYVNIEFG peptide substrate assessed as residual activity measured as incorporation of [32P] into peptide at 33 uM by scintillation counting analysis	B	Oc1cccc(Nc2ncnc3sc(-c4ccccc4)cc23)c1		CHEMBL3401782	=	Activity	%	1.2	CHEMBL3650	Homo sapiens	Activity	%	1.2
	15193438	CHEMBL3411884	Inhibition of human FGFR1	B	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL3039504	=	IC50	nM	69.0	CHEMBL3650	Homo sapiens	IC50	nM	69.0
	15211853	CHEMBL3420207	Inhibition of FGFR1 (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	=	EC50	nM	1100.0	CHEMBL3650	Homo sapiens	EC50	nM	1100.0
	15223347	CHEMBL3420303	Inhibition of FGFR1 (unknown origin)	B	O=c1ccc(-n2ccc3ccc(F)cc32)nn1CCOc1ccnc2cc(OCCCN3CCOCC3)ccc12		CHEMBL3417489	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	15249281	CHEMBL3428311	Inhibition of human FGFR1 using KKKSPGEYVNIEFG peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	86.4	CHEMBL3650	Homo sapiens	INH	%	86.4
	15250045	CHEMBL3429146	Inhibition of human FGFR1 using KKKSPGEYVNIEFG peptide substrate by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	IC50	nM	160.0	CHEMBL3650	Homo sapiens	IC50	nM	160.0
	15251853	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	23.0	CHEMBL3650	Homo sapiens	Activity	%	23.0
	15251944	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	113.0	CHEMBL3650	Homo sapiens	Activity	%	113.0
	15252046	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	81.0	CHEMBL3650	Homo sapiens	Activity	%	81.0
	15252691	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	97.0	CHEMBL3650	Homo sapiens	Activity	%	97.0
	15252793	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	75.0	CHEMBL3650	Homo sapiens	Activity	%	75.0
	15252895	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	104.0	CHEMBL3650	Homo sapiens	Activity	%	104.0
	15253569	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	73.0	CHEMBL3650	Homo sapiens	Activity	%	73.0
	15253671	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	108.0	CHEMBL3650	Homo sapiens	Activity	%	108.0
	15253773	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	84.0	CHEMBL3650	Homo sapiens	Activity	%	84.0
	15254439	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	99.0	CHEMBL3650	Homo sapiens	Activity	%	99.0
	15254541	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	92.0	CHEMBL3650	Homo sapiens	Activity	%	92.0
	15254643	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	65.0	CHEMBL3650	Homo sapiens	Activity	%	65.0
	15255334	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	21.0	CHEMBL3650	Homo sapiens	Activity	%	21.0
	15255436	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	31.0	CHEMBL3650	Homo sapiens	Activity	%	31.0
	15255539	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	48.0	CHEMBL3650	Homo sapiens	Activity	%	48.0
	15256270	CHEMBL3428228	Inhibition of FGF-R1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	48.0	CHEMBL3650	Homo sapiens	Activity	%	48.0
	15462666	CHEMBL3536556	Inhibition of recombinant FGFR-1 (unknown origin)	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	nM	28.0
	15462667	CHEMBL3536556	Inhibition of recombinant FGFR-1 (unknown origin)	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL427202	=	IC50	nM	22.0	CHEMBL3650	Homo sapiens	IC50	nM	22.0
	15469022	CHEMBL3538197	Inhibition of human recombinant FGFR-1	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OS(=O)(=O)O)c(C)c34)ccc2[nH]1		CHEMBL3527569	=	IC50	nM	26.0	CHEMBL3650	Homo sapiens	IC50	nM	26.0
	15469024	CHEMBL3538197	Inhibition of human recombinant FGFR-1	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	nM	28.0
	15469046	CHEMBL3538197	Inhibition of human recombinant FGFR-1	B	Cc1c(OC[C@@H](C)O)cn2ncnc(Oc3ccc4[nH]c(CO)cc4c3F)c12		CHEMBL3526621	=	IC50	nM	760.0	CHEMBL3650	Homo sapiens	IC50	nM	760.0
	15469055	CHEMBL3538197	Inhibition of human recombinant FGFR-1	B	Cc1c(OC[C@@H](C)O)cn2ncnc(Oc3ccc4[nH]c(C(=O)O)cc4c3F)c12		CHEMBL3526543	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	nM	30000.0
	15650164	CHEMBL3595484	Inhibition of human FGFR1 at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	15685885	CHEMBL3607961	Inhibition of human FGFR1	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	15690286	CHEMBL3611082	Inhibition of FGFR1 (unknown origin) at 100 nM	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNCC2		CHEMBL3608524	=	Inhibition	%	97.0	CHEMBL3650	Homo sapiens	INH	%	97.0
	15747317	CHEMBL3624068	Inhibition of FGFR1 (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	>	Activity	%	65.0	CHEMBL3650	Homo sapiens	Activity	%	65.0
	15754935	CHEMBL3631827	Inhibition of FGFR1 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	0.3	CHEMBL3650	Homo sapiens	INH	%	0.3
Not Active	15774415	CHEMBL3636789	Inhibition of FGFR1 (unknown origin) after 120 mins by HotSpot assay	B	CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1		CHEMBL3633929		IC50			CHEMBL3650	Homo sapiens	IC50		
201300	16259345	CHEMBL3705581	Inhibition Assay: Purified recombinant human FGFR4 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR4 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR4 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR4 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	C#CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701239	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
201223	16264916	CHEMBL3705581	Inhibition Assay: Purified recombinant human FGFR4 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR4 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR4 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR4 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	C=CC(=O)N1CC(N2C=C(C#Cc3cc(OC)cc(OC)c3)C3C(N)=NC=NC32)C1		CHEMBL3701266	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
201304	16287797	CHEMBL3705581	Inhibition Assay: Purified recombinant human FGFR4 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR4 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR4 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR4 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701267	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
201303	16296284	CHEMBL3705581	Inhibition Assay: Purified recombinant human FGFR4 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR4 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR4 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR4 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	COc1cc(C#Cc2cn([C@H]3CCN(C(=O)C#CC(C)(C)O)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701262	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	nM	20.0
201305	16326785	CHEMBL3705581	Inhibition Assay: Purified recombinant human FGFR4 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR4 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR4 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR4 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN4CC[C@H](O)C4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701274	=	IC50	nM	3.1	CHEMBL3650	Homo sapiens	IC50	nM	3.1
201302	16327859	CHEMBL3705581	Inhibition Assay: Purified recombinant human FGFR4 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR4 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR4 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR4 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701238	=	IC50	nM	3.6	CHEMBL3650	Homo sapiens	IC50	nM	3.6
273857	16332323	CHEMBL3707529	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3702566	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
273889	16334847	CHEMBL3707529	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4		CHEMBL3975634	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
201301	16343606	CHEMBL3705581	Inhibition Assay: Purified recombinant human FGFR4 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR4 kinase activity, a biotinylated peptide (biotin-EEPLYWSFPAKKK) was synthesized for use as a substrate by utilizing the amino acid sequence of FL-Peptide 22 (Caliper Life Sciences, Inc.) with biotin. The purified recombinant human FGFR4 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration 20 times higher than the final concentration. Next, the purified human FGFR4 protein, substrate peptide (final concentration: 250 nM), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 190 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer.	B	C=CC(=O)N1CC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701241	=	IC50	nM	3.2	CHEMBL3650	Homo sapiens	IC50	nM	3.2
	16376449	CHEMBL3734473	Inhibition of recombinant human FGFR1 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	3.0	CHEMBL3650	Homo sapiens	INH	%	3.0
	16379611	CHEMBL3738404	Inhibition of FGFR1 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	16379612	CHEMBL3738404	Inhibition of FGFR1 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	3.1	CHEMBL3650	Homo sapiens	INH	%	3.1
	16396110	CHEMBL3742499	Inhibition of human recombinant FGFR1 expressed in baculovirus using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1		CHEMBL3740721	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	16396111	CHEMBL3742499	Inhibition of human recombinant FGFR1 expressed in baculovirus using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccc(F)c5)cccc4c3)n2)c1		CHEMBL3740487	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	16396112	CHEMBL3742499	Inhibition of human recombinant FGFR1 expressed in baculovirus using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccnc5)cccc4c3)n2)c1		CHEMBL3739732	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	16421909	CHEMBL3750391	Inhibition of FGFR1 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	16425396	CHEMBL3751057	Inhibition of FGFR1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-3.1	CHEMBL3650	Homo sapiens	INH	%	-3.1
	16431832	CHEMBL3748186	Inhibition of human FGFR1 using [KKKSPGEYVNIEFG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	16433835	CHEMBL3756754	Inhibition of human FGFR1 using IGF-1Rtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	Inhibition	%	21.6	CHEMBL3650	Homo sapiens	INH	%	21.6
	16433836	CHEMBL3756754	Inhibition of human FGFR1 using IGF-1Rtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1		CHEMBL3752265	=	Inhibition	%	5.2	CHEMBL3650	Homo sapiens	INH	%	5.2
	16435132	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1cc(NC(=O)Nc2ccccn2)cc(-c2cccnc2)c1OC		CHEMBL3752074	=	IC50	nM	69.34	CHEMBL3650	Homo sapiens	IC50	nM	69.34
	16435133	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1ccc(-c2cc(NC(=O)Nc3ccccn3)cc(OC)c2OC)cn1		CHEMBL3754785	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16435134	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1ccccn1)Nc1cc(-c2cccnc2)ccc1OC(F)(F)F		CHEMBL3753208	=	IC50	nM	129.86	CHEMBL3650	Homo sapiens	IC50	nM	129.86
	16435135	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1ccc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3ccccn3)c2)cn1		CHEMBL3752874	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16435136	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1ccccn1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F		CHEMBL3754057	=	IC50	nM	81.28	CHEMBL3650	Homo sapiens	IC50	nM	81.28
	16435137	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1cc(NC(=O)Nc2ccncc2)cc(-c2cccnc2)c1OC		CHEMBL3753836	=	IC50	nM	271.85	CHEMBL3650	Homo sapiens	IC50	nM	271.85
	16435138	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1ccc(-c2cc(NC(=O)Nc3ccncc3)cc(OC)c2OC)cn1		CHEMBL3753444	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16435139	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1cc(NC(=O)Nc2ccncc2)cc(-c2cncnc2)c1OC		CHEMBL3754722	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16435140	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1ccncc1)Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1		CHEMBL3752404	=	IC50	nM	138.06	CHEMBL3650	Homo sapiens	IC50	nM	138.06
	16435141	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1ccc(-c2cc(NC(=O)Nc3ccncc3)cc(C(F)(F)F)c2)cn1		CHEMBL3753904	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16435142	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1ccncc1)Nc1cc(-c2cncnc2)cc(C(F)(F)F)c1		CHEMBL3752008	=	IC50	nM	28.23	CHEMBL3650	Homo sapiens	IC50	nM	28.23
	16435143	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1ccncc1)Nc1cc(-c2cccnc2)ccc1OC(F)(F)F		CHEMBL3753886	=	IC50	nM	104.2	CHEMBL3650	Homo sapiens	IC50	nM	104.2
	16435144	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1ccc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3ccncc3)c2)cn1		CHEMBL3753623	=	IC50	nM	99.75	CHEMBL3650	Homo sapiens	IC50	nM	99.75
	16435145	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1ccncc1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F		CHEMBL3752370	=	IC50	nM	32.57	CHEMBL3650	Homo sapiens	IC50	nM	32.57
	16435146	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1cc(NC(=O)Nc2nccs2)cc(-c2cccnc2)c1OC		CHEMBL3754709	=	IC50	nM	333.89	CHEMBL3650	Homo sapiens	IC50	nM	333.89
	16435147	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1)Nc1nccs1		CHEMBL3753142	=	IC50	nM	99.15	CHEMBL3650	Homo sapiens	IC50	nM	99.15
	16435148	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1ccc(-c2cc(NC(=O)Nc3nccs3)cc(C(F)(F)F)c2)cn1		CHEMBL3751967	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16435149	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1cc(-c2cncnc2)cc(C(F)(F)F)c1)Nc1nccs1		CHEMBL3754556	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16436366	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1nccs1)Nc1cc(-c2cccnc2)ccc1OC(F)(F)F		CHEMBL3753811	=	IC50	nM	96.15	CHEMBL3650	Homo sapiens	IC50	nM	96.15
	16436367	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1ccc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3nccs3)c2)cn1		CHEMBL3753157	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16436368	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	O=C(Nc1nccs1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F		CHEMBL3752248	=	IC50	nM	154.16	CHEMBL3650	Homo sapiens	IC50	nM	154.16
	16436369	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1cc(NC(=O)Nc2ccccn2)cc(-c2c[nH]cn2)c1OC		CHEMBL3753532	=	IC50	nM	56.49	CHEMBL3650	Homo sapiens	IC50	nM	56.49
	16436370	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	Cn1cnc(-c2cc(NC(=O)Nc3ccncc3)cc(C(F)(F)F)c2)c1		CHEMBL3754301	=	IC50	nM	260.79	CHEMBL3650	Homo sapiens	IC50	nM	260.79
	16436371	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	Cn1cnc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3ccncc3)c2)c1		CHEMBL3752825	=	IC50	nM	370.6	CHEMBL3650	Homo sapiens	IC50	nM	370.6
	16436372	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	COc1cc(NC(=O)Nc2nccs2)cc(-c2cn(C)cn2)c1OC		CHEMBL3752129	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16436373	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	Cn1cnc(-c2cc(NC(=O)Nc3nccs3)cc(C(F)(F)F)c2)c1		CHEMBL3752916	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	16436374	CHEMBL3756970	Inhibition of FGFR1 (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	4.63	CHEMBL3650	Homo sapiens	IC50	nM	4.63
	16450841	CHEMBL3762697	Inhibition of FGFR1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	27.7	CHEMBL3650	Homo sapiens	INH	%	27.7
	16451716	CHEMBL3762697	Inhibition of FGFR1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	85.1	CHEMBL3650	Homo sapiens	INH	%	85.1
	16457711	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	-6.0	CHEMBL3650	Homo sapiens	INH	%	-6.0
	16457712	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	-7.0	CHEMBL3650	Homo sapiens	INH	%	-7.0
	16457713	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	-5.0	CHEMBL3650	Homo sapiens	INH	%	-5.0
	16457714	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	-10.0	CHEMBL3650	Homo sapiens	INH	%	-10.0
	16457715	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	16457716	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	16457717	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	4.0	CHEMBL3650	Homo sapiens	INH	%	4.0
	16457718	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	16457719	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	-6.0	CHEMBL3650	Homo sapiens	INH	%	-6.0
	16457720	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	-7.0	CHEMBL3650	Homo sapiens	INH	%	-7.0
	16457721	CHEMBL3761571	Inhibition of FGFR1 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	16461598	CHEMBL3762055	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1		CHEMBL3759079	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	16461599	CHEMBL3762055	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	16474688	CHEMBL3767174	Inhibition of FGFR1 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	20.5	CHEMBL3650	Homo sapiens	INH	%	20.5
	16495991	CHEMBL3778582	Inhibition of N-terminal His6-tagged recombinant human FGFR1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	7.0	CHEMBL3650	Homo sapiens	Activity	%	7.0
	16495992	CHEMBL3778583	Inhibition of N-terminal His6-tagged recombinant human FGFR1 V561M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL3650	Homo sapiens	Activity	%	-4.0
	16499010	CHEMBL3778338	Inhibition of human recombinant FGFR1 at 1 uM after 50 mins by microtiter plate based luciferase reporter gene assay	B	O=C(COc1nc2ccccc2nc1/C=C\c1ccncc1)Nc1ccc(Cl)cc1		CHEMBL3774474	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	16499011	CHEMBL3778338	Inhibition of human recombinant FGFR1 at 1 uM after 50 mins by microtiter plate based luciferase reporter gene assay	B	O=C(Cn1c(=O)c(/C=C\c2ccncc2)nc2ccccc21)Nc1ccc(Cl)c(Cl)c1		CHEMBL3774699	=	Inhibition	%	8.0	CHEMBL3650	Homo sapiens	INH	%	8.0
	16499012	CHEMBL3778338	Inhibition of human recombinant FGFR1 at 1 uM after 50 mins by microtiter plate based luciferase reporter gene assay	B	O=C(Cn1c(=O)c(/C=C\c2ccncc2)nc2ccccc21)Nc1ccc(Cl)cc1		CHEMBL3775981	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	16499013	CHEMBL3778338	Inhibition of human recombinant FGFR1 at 1 uM after 50 mins by microtiter plate based luciferase reporter gene assay	B	O=C(Cn1c(=O)c(/C=C\c2ccncc2)nc2ccccc21)Nc1ccc(F)cc1		CHEMBL3774729	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	16499014	CHEMBL3778338	Inhibition of human recombinant FGFR1 at 1 uM after 50 mins by microtiter plate based luciferase reporter gene assay	B	Cc1nc2ccccc2n(CC(=O)Nc2ccc(Cl)cc2)c1=O		CHEMBL3775968	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	16501359	CHEMBL3778048	Inhibition of human FGF-R1 V561M mutant expressed in sf9 cells by flashplate based radiometric 33pan-quinase assay	B	CS(=O)(=O)O.Cc1oc2c(O)c3c(c(O)c2c1C(=O)N1CC[C@H](N)C1)C(=O)c1ccccc1C3=O		CHEMBL3775181	<	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	16508178	CHEMBL3778582	Inhibition of N-terminal His6-tagged recombinant human FGFR1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	9.0	CHEMBL3650	Homo sapiens	Activity	%	9.0
	16508179	CHEMBL3778583	Inhibition of N-terminal His6-tagged recombinant human FGFR1 V561M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	5.0	CHEMBL3650	Homo sapiens	Activity	%	5.0
	16509155	CHEMBL3778582	Inhibition of N-terminal His6-tagged recombinant human FGFR1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	6.0	CHEMBL3650	Homo sapiens	Activity	%	6.0
	16509156	CHEMBL3778583	Inhibition of N-terminal His6-tagged recombinant human FGFR1 V561M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	2.0	CHEMBL3650	Homo sapiens	Activity	%	2.0
	16509769	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cc1ccc2nc(C3=C(N)N(c4cccc(Cl)c4)CC3=O)[nH]c2c1		CHEMBL3779986	=	IC50	nM	1850.0	CHEMBL3650	Homo sapiens	IC50	uM	1.85
	16509770	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cc1ccc2nc(C3=C(N)N(c4cccc(F)c4)CC3=O)[nH]c2c1		CHEMBL3779927	=	IC50	nM	7300.0	CHEMBL3650	Homo sapiens	IC50	uM	7.3
	16509771	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1ccccc1Cl		CHEMBL3781089	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	16509772	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1ccccc1F		CHEMBL3780837	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	16509773	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cc1ccc2nc(C3=C(N)N(c4ccc(Cl)cc4)CC3=O)[nH]c2c1		CHEMBL3779960	=	IC50	nM	28200.0	CHEMBL3650	Homo sapiens	IC50	uM	28.2
	16509774	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1ccc(F)cc1		CHEMBL1457887	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	uM	27.0
	16509775	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1cccc(C(F)(F)F)c1		CHEMBL3780105	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	16509776	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1ccc(O)cc1		CHEMBL3780362	=	IC50	nM	2120.0	CHEMBL3650	Homo sapiens	IC50	uM	2.12
	16509777	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cn1c(C2=C(N)N(c3ccc(O)cc3)CC2=O)nc2ccccc21		CHEMBL3781192	=	IC50	nM	27000.0	CHEMBL3650	Homo sapiens	IC50	uM	27.0
	16509778	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cc1ccc(N2CC(=O)C(c3nc4ccccc4[nH]3)=C2N)cc1O		CHEMBL3780482	=	IC50	nM	2280.0	CHEMBL3650	Homo sapiens	IC50	uM	2.28
	16509779	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cn1c(C2=C(N)N(c3cccc(O)c3)CC2=O)nc2ccccc21		CHEMBL3780794	=	IC50	nM	3800.0	CHEMBL3650	Homo sapiens	IC50	uM	3.8
	16509780	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cc1ccc2nc(C3=C(N)N(c4cccc(O)c4)CC3=O)[nH]c2c1		CHEMBL3781980	=	IC50	nM	630.0	CHEMBL3650	Homo sapiens	IC50	uM	0.63
	16509781	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1cccc(O)c1		CHEMBL3781511	=	IC50	nM	320.0	CHEMBL3650	Homo sapiens	IC50	uM	0.32
	16509788	CHEMBL3782935	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells assessed as residual activity at 10 uM	B	Cc1ccc2nc(C3=C(N)N(c4cccc(O)c4)CC3=O)[nH]c2c1		CHEMBL3781980	=	Activity	%	5.0	CHEMBL3650	Homo sapiens	Activity	%	5.0
	16509789	CHEMBL3782935	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells assessed as residual activity at 10 uM	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1cccc(O)c1		CHEMBL3781511	=	Activity	%	2.1	CHEMBL3650	Homo sapiens	Activity	%	2.1
	16509795	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	COc1cccc(N2CC(=O)C(c3nc4ccccc4[nH]3)=C2N)c1		CHEMBL3782011	=	IC50	nM	3500.0	CHEMBL3650	Homo sapiens	IC50	uM	3.5
	16509796	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1ccccc1		CHEMBL1605162	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	16509797	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cc1cccc(N2CC(=O)C(c3nc4ccccc4[nH]3)=C2N)c1		CHEMBL3780849	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	16509798	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	Cc1ccc(N2CC(=O)C(c3nc4ccccc4[nH]3)=C2N)cc1		CHEMBL3781563	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	16509799	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	COc1ccccc1N1CC(=O)C(c2nc3ccccc3[nH]2)=C1N		CHEMBL3781175	=	IC50	nM	9900.0	CHEMBL3650	Homo sapiens	IC50	uM	9.9
	16509800	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	COc1ccc(N2CC(=O)C(c3nc4ccccc4[nH]3)=C2N)cc1		CHEMBL3781238	=	IC50	nM	7000.0	CHEMBL3650	Homo sapiens	IC50	uM	7.0
	16509801	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	CCOc1ccccc1N1CC(=O)C(c2nc3ccccc3[nH]2)=C1N		CHEMBL3781689	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	16509802	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	COc1ccc(OC)c(N2CC(=O)C(c3nc4ccccc4[nH]3)=C2N)c1		CHEMBL3780825	=	IC50	nM	3280.0	CHEMBL3650	Homo sapiens	IC50	uM	3.28
	16509803	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	COc1ccc(N2CC(=O)C(c3nc4ccccc4[nH]3)=C2N)c(OC)c1		CHEMBL3781310	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	uM	30.0
	16509804	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	COc1ccc(C)cc1N1CC(=O)C(c2nc3ccc(C)cc3[nH]2)=C1N		CHEMBL3780392	=	IC50	nM	11000.0	CHEMBL3650	Homo sapiens	IC50	uM	11.0
	16509805	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	COc1ccc(Cl)cc1N1CC(=O)C(c2nc3ccccc3[nH]2)=C1N		CHEMBL3781099	=	IC50	nM	600.0	CHEMBL3650	Homo sapiens	IC50	uM	0.6
	16525011	CHEMBL3782932	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected insect Sf21 cells after 25 mins using KKKSPGEYVNIEFG peptide substrate by scintillation counting analysis	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1cccc(Cl)c1		CHEMBL3781649	=	IC50	nM	1120.0	CHEMBL3650	Homo sapiens	IC50	uM	1.12
	16534393	CHEMBL3789043	Inhibition of human FGFR1 at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	100.0	CHEMBL3650	Homo sapiens	INH	%	100.0
	16540779	CHEMBL3789984	Inhibition of FGFR1 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	4300.0	CHEMBL3650	Homo sapiens	IC50	uM	4.3
	16540780	CHEMBL3789984	Inhibition of FGFR1 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	16547716	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccnc3Br)c(=O)c2cc1OC		CHEMBL3792855	=	Inhibition	%	13.0	CHEMBL3650	Homo sapiens	INH	%	13.0
	16547717	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccc(-c4ccccc4)c3)c(=O)c2cc1OC		CHEMBL3793594	=	Inhibition	%	13.0	CHEMBL3650	Homo sapiens	INH	%	13.0
	16547718	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3cccc(Br)c3)c(=O)c2cc1OC		CHEMBL3793760	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	16547719	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(Cc3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3793678	=	Inhibition	%	14.0	CHEMBL3650	Homo sapiens	INH	%	14.0
	16547720	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(CC(=O)c3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3793297	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	16547721	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	COc1cc2ncn(CC(O)c3ccc(Br)cc3)c(=O)c2cc1OC		CHEMBL3792891	=	Inhibition	%	8.0	CHEMBL3650	Homo sapiens	INH	%	8.0
	16547722	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(-c2ccccc2)cc1)OCCO3		CHEMBL3794032	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	16547723	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1cccc(Br)c1)OCCO3		CHEMBL3793623	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	16547724	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(Br)cc1)OCCO3		CHEMBL3792773	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	16547725	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=C(Cn1cnc2cc3c(cc2c1=O)OCCO3)c1ccc(Br)cc1		CHEMBL3793356	=	Inhibition	%	18.0	CHEMBL3650	Homo sapiens	INH	%	18.0
	16547726	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=C(Cn1cnc2cc3c(cc2c1=O)OCCO3)c1cccc(Br)c1		CHEMBL3792910	=	Inhibition	%	18.0	CHEMBL3650	Homo sapiens	INH	%	18.0
	16547727	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1CC(O)c1cccc(Cl)c1)OCCO3		CHEMBL3793972	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	16547728	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(Br)cc1)OCO3		CHEMBL3793896	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	16547729	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1cccc(-c2ccccc2)c1)OCO3		CHEMBL3794041	=	Inhibition	%	8.0	CHEMBL3650	Homo sapiens	INH	%	8.0
	16547730	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	O=c1c2cc3c(cc2ncn1Cc1ccc(-c2ccccc2)cc1)OCO3		CHEMBL3794304	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	16547731	CHEMBL3796155	Inhibition of human FGFR1 using myelin basic protein as substrate at 1 uM measured after 20 mins at 30 degC by liquid scintillation counting method in presence of [gamma-32P]-ATP	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Inhibition	%	31.0	CHEMBL3650	Homo sapiens	INH	%	31.0
	16556379	CHEMBL3796364	Inhibition of human recombinant FGFR1 assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	Cc1sc2ncnc(Nc3cccc(C(=O)O)c3)c2c1-c1ccccc1		CHEMBL3792965	=	Activity	%	73.9	CHEMBL3650	Homo sapiens	Activity	%	73.9
	16556380	CHEMBL3796364	Inhibition of human recombinant FGFR1 assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	O=C(O)c1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL1719248	=	Activity	%	78.9	CHEMBL3650	Homo sapiens	Activity	%	78.9
	16556381	CHEMBL3796364	Inhibition of human recombinant FGFR1 assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	Cc1ccc(-c2csc3ncnc(Nc4cccc(C(=O)O)c4)c23)cc1		CHEMBL3401764	=	Activity	%	60.5	CHEMBL3650	Homo sapiens	Activity	%	60.5
	16559573	CHEMBL3794766	Inhibition of human N-terminal GST-tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system using fluorescence labelled CSKtide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	-1.0	CHEMBL3650	Homo sapiens	INH	%	-1.0
	16559574	CHEMBL3794766	Inhibition of human N-terminal GST-tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system using fluorescence labelled CSKtide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	6.3	CHEMBL3650	Homo sapiens	INH	%	6.3
	16559575	CHEMBL3794766	Inhibition of human N-terminal GST-tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system using fluorescence labelled CSKtide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	17.0	CHEMBL3650	Homo sapiens	INH	%	17.0
	16563799	CHEMBL3802301	Inhibition of FGFR1 (unknown origin) by Z-LYTE assay	B	CC(NC(=O)c1ccc2[nH]nc(-c3ccncc3)c2c1)c1cccc(Cl)c1		CHEMBL3798631	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	16563800	CHEMBL3802301	Inhibition of FGFR1 (unknown origin) by Z-LYTE assay	B	Cc1cc(-c2n[nH]c3ccc(C(=O)NC(C)c4c(Cl)cncc4Cl)cc23)ccn1		CHEMBL3798257	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	16574809	CHEMBL3802399	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	12.8	CHEMBL3650	Homo sapiens	INH	%	12.8
	16578339	CHEMBL3804393	Inhibition of partial length wild type human FGFR1 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	83.0	CHEMBL3650	Homo sapiens	Activity	%	83.0
	16580856	CHEMBL3804520	Inhibition of recombinant FGFR1 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	16580857	CHEMBL3804520	Inhibition of recombinant FGFR1 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
Dose-dependent effect	16580863	CHEMBL3804524	Inhibition of FGFR1 phosphorylation in human KG1 cells incubated for 2 hrs by Western blot analysis	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	16580864	CHEMBL3804526	Inhibition of FGFR1 phosphorylation in human KG1 cells assessed as reduction of phospho-ERK level at 0.4 to 10 nM incubated for 2 hrs by Western blot analysis	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	16580865	CHEMBL3804527	Inhibition of FGFR1 in human H1581 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526	<	IC50	nM	0.5	CHEMBL3650	Homo sapiens	IC50	nM	0.5
	16580866	CHEMBL3804527	Inhibition of FGFR1 in human H1581 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	32.9	CHEMBL3650	Homo sapiens	IC50	nM	32.9
	16580867	CHEMBL3804528	Inhibition of FGFR1 in human KG1 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526	<	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
	16580868	CHEMBL3804528	Inhibition of FGFR1 in human KG1 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	<	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
Active	16580873	CHEMBL3804525	Inhibition of FGFR1 phosphorylation in human KG1 cells assessed as reduction of phospho-PLCgamma level at 0.4 to 10 nM incubated for 2 hrs by Western blot analysis	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	16587010	CHEMBL3807422	Inhibition of FGFR1 (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	uM	1.0
	16593491	CHEMBL3812174	Inhibition of His-tagged human recombinant FGFR1 (308 to 731 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL3650	Homo sapiens	INH	%	40.0
	16611847	CHEMBL3816754	Inhibition of human FGFR1 (400 to 820 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-80.0	CHEMBL3650	Homo sapiens	Activity	%	-80.0
	16611848	CHEMBL3816754	Inhibition of human FGFR1 (400 to 820 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-79.0	CHEMBL3650	Homo sapiens	Activity	%	-79.0
	16611849	CHEMBL3816754	Inhibition of human FGFR1 (400 to 820 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	3.0	CHEMBL3650	Homo sapiens	Activity	%	3.0
	16611850	CHEMBL3816754	Inhibition of human FGFR1 (400 to 820 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-8.0	CHEMBL3650	Homo sapiens	Activity	%	-8.0
	16614475	CHEMBL3816605	Inhibition of human FGFR1 at 1 uM using [KKKSPGEYVNIEFG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	16618220	CHEMBL3816334	Inhibition of recombinant human His-tagged cytoplasmic FGFR1 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
Active	16619799	CHEMBL3821675	Agonist activity at FGFR1 in human MCF7 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)C(=O)CN(C(=O)CN(Cc1ccccc1)C(=O)CN(C(=O)CN(Cc1ccccc1)C(=O)CNC1CCCC1)C1CCCC1)[C@H](C)c1ccccc1		CHEMBL3819565		Activity			CHEMBL3650	Homo sapiens	Activity		
Active	16619800	CHEMBL3821675	Agonist activity at FGFR1 in human MCF7 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCN1CCCC1=O)CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)CC1CCCO1)C(=O)CN(C(=O)CN(Cc1cccc(C(F)(F)F)c1)C(=O)CNCCCN1CCCC1=O)[C@H](C)c1ccccc1		CHEMBL4299682		Activity			CHEMBL3650	Homo sapiens	Activity		
Not Active	16619843	CHEMBL3821675	Agonist activity at FGFR1 in human MCF7 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)Cc1ccco1)C(=O)CN(Cc1ccco1)C(=O)CN(CC1CCCO1)C(=O)CN(C(=O)CNCCc1ccc(Cl)cc1)C1CCCC1		CHEMBL3818048		Activity			CHEMBL3650	Homo sapiens	Activity		
Active	16619844	CHEMBL3821675	Agonist activity at FGFR1 in human MCF7 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)[C@H](C)c1ccccc1)C(=O)CN(Cc1ccco1)C(=O)CN(C(=O)CN(Cc1cccc(C(F)(F)F)c1)C(=O)CNCc1ccccc1)C1CCCC1		CHEMBL3817971		Activity			CHEMBL3650	Homo sapiens	Activity		
	16621498	CHEMBL3820491	Inhibition of FGFR1 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	nM	30000.0
	16622213	CHEMBL3820491	Inhibition of FGFR1 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.3	CHEMBL3650	Homo sapiens	IC50	nM	6.3
	16627512	CHEMBL3820332	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-5.0	CHEMBL3650	Homo sapiens	INH	%	-5.0
	16627513	CHEMBL3820332	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	5.0	CHEMBL3650	Homo sapiens	INH	%	5.0
	16628482	CHEMBL3820185	Inhibition of human recombinant FGFR1 (400 to 820 residues) expressed in insect Sf21 cells at 1 uM using poly(Glu4-Tyr1) as substrate after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL3650	Homo sapiens	INH	%	80.0
	16653229	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	c1cc(COc2ccc3[nH]nc(-c4nc5cc(N6CCCCC6)ccc5[nH]4)c3c2)ccn1		CHEMBL3828723	=	IC50	nM	20.8	CHEMBL3650	Homo sapiens	IC50	nM	20.8
	16653230	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	Clc1cnccc1COc1ccc2[nH]nc(-c3nc4cc(N5CCCCC5)ccc4[nH]3)c2c1		CHEMBL3827165	=	IC50	nM	13.6	CHEMBL3650	Homo sapiens	IC50	nM	13.6
	16653231	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	Clc1cncc(Cl)c1COc1ccc2[nH]nc(-c3nc4cc(N5CCCCC5)ccc4[nH]3)c2c1		CHEMBL3827042	=	IC50	nM	6.6	CHEMBL3650	Homo sapiens	IC50	nM	6.6
	16653232	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	c1cncc(COc2ccc3[nH]nc(-c4nc5cc(N6CCCCC6)ccc5[nH]4)c3c2)c1		CHEMBL3827145	=	IC50	nM	1.7	CHEMBL3650	Homo sapiens	IC50	nM	1.7
	16653233	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	c1ccc(COc2ccc3[nH]nc(-c4nc5cc(N6CCCCC6)ccc5[nH]4)c3c2)nc1		CHEMBL3828317	=	IC50	nM	4.1	CHEMBL3650	Homo sapiens	IC50	nM	4.1
	16653234	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(N5CCCCC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828561	=	IC50	nM	2.7	CHEMBL3650	Homo sapiens	IC50	nM	2.7
	16653235	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCC(Oc1ccc2[nH]nc(-c3nc4cc(N5CCCCC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827608	=	IC50	nM	5.7	CHEMBL3650	Homo sapiens	IC50	nM	5.7
	16653236	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(N5CCCCC5)ccc4[nH]3)c2c1)c1c(Cl)ccnc1Cl		CHEMBL3827325	=	IC50	nM	22.4	CHEMBL3650	Homo sapiens	IC50	nM	22.4
	16653237	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	Fc1ccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc2c1		CHEMBL212054	=	IC50	nM	20.3	CHEMBL3650	Homo sapiens	IC50	nM	20.3
	16653238	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828009	=	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	16653239	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.6	CHEMBL3650	Homo sapiens	IC50	nM	0.6
	16653240	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827659	=	IC50	nM	1.8	CHEMBL3650	Homo sapiens	IC50	nM	1.8
	16653241	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4ccccc4o3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827803	=	IC50	nM	5.1	CHEMBL3650	Homo sapiens	IC50	nM	5.1
	16653242	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4ccccc4s3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827811	=	IC50	nM	228.2	CHEMBL3650	Homo sapiens	IC50	nM	228.2
	16653243	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3cc4ccccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828173	=	IC50	nM	2.4	CHEMBL3650	Homo sapiens	IC50	nM	2.4
	16653244	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1cccc2[nH]c(-c3n[nH]c4ccc(OC(C)c5c(Cl)cncc5Cl)cc34)nc12		CHEMBL3827322	=	IC50	nM	16.2	CHEMBL3650	Homo sapiens	IC50	nM	16.2
	16653245	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4c(N5CCCCC5)cccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827443	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	16653246	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(F)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827601	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
	16653247	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc2[nH]c(-c3n[nH]c4ccc(OC(C)c5c(Cl)cncc5Cl)cc34)nc2c1		CHEMBL3827387	=	IC50	nM	2.0	CHEMBL3650	Homo sapiens	IC50	nM	2.0
	16653248	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1ccc2[nH]c(-c3n[nH]c4ccc(OC(C)c5c(Cl)cncc5Cl)cc34)nc2c1		CHEMBL3828142	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
	16653249	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CNc1ccc2[nH]c(-c3n[nH]c4ccc(OC(C)c5c(Cl)cncc5Cl)cc34)nc2c1		CHEMBL3828649	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
	16653250	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(C5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827268	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	16653251	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828465	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	16653252	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(N5C[C@H](C)N[C@H](C)C5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828122	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
	16653253	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828740	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	16653254	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCN1CCN(c2ccc3[nH]c(-c4n[nH]c5ccc(OC(C)c6c(Cl)cncc6Cl)cc45)nc3c2)CC1		CHEMBL3827706	=	IC50	nM	3.6	CHEMBL3650	Homo sapiens	IC50	nM	3.6
	16653255	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(N5CCOCC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827818	=	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
	16653256	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(N5CCCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827594	=	IC50	nM	7.6	CHEMBL3650	Homo sapiens	IC50	nM	7.6
	16653257	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(N(C)C(=O)CN(C)C)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828439	=	IC50	nM	0.4	CHEMBL3650	Homo sapiens	IC50	nM	0.4
	16653258	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(NCCN(C)C)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827492	=	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	16653259	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	COCCNc1ccc2[nH]c(-c3n[nH]c4ccc(OC(C)c5c(Cl)cncc5Cl)cc34)nc2c1		CHEMBL3827725	=	IC50	nM	0.6	CHEMBL3650	Homo sapiens	IC50	nM	0.6
	16653260	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(Oc1ccc2[nH]nc(-c3nc4cc(CCO)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827180	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
	16653261	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	=	IC50	nM	0.9	CHEMBL3650	Homo sapiens	IC50	nM	0.9
	16653262	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828022	=	IC50	nM	9.4	CHEMBL3650	Homo sapiens	IC50	nM	9.4
	16653263	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(CCO)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827330	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	16653264	CHEMBL3830044	Inhibition of recombinant human FGFR1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@H](Oc1ccc2[nH]nc(-c3nc4cc(CCO)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827752	=	IC50	nM	6.5	CHEMBL3650	Homo sapiens	IC50	nM	6.5
Dose-dependent effect	16653362	CHEMBL3830186	Inhibition of FGFR1 phosphorylation in human KG1 cells after 2 hrs by Western blot method	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	16653363	CHEMBL3830187	Inhibition of FGFR1 in human KG1 cells assessed as reduction of PLCgamma phosphorylation at 0.1 to 10 nM after 2 hrs by Western blot method	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	16653364	CHEMBL3830188	Inhibition of FGFR1 in human KG1 cells assessed as reduction of ERK phosphorylation at 0.1 to 10 nM after 2 hrs by Western blot method	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	16654254	CHEMBL3829900	Inhibition of human FGFR1 (400 to 820 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	66.0	CHEMBL3650	Homo sapiens	Activity	%	66.0
	16655125	CHEMBL3830425	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	16737936	CHEMBL3856653	Inhibition of recombinant human FGFR1 expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	53.0	CHEMBL3650	Homo sapiens	Activity	%	53.0
	16739454	CHEMBL3857048	Inhibition of His tagged recombinant human FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	16739455	CHEMBL3857048	Inhibition of His tagged recombinant human FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	16739456	CHEMBL3857048	Inhibition of His tagged recombinant human FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	16742598	CHEMBL3857913	Inhibition of FLT2 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	11.3	CHEMBL3650	Homo sapiens	IC50	nM	11.3
	16760050	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681244	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	nM	50.0
	16760051	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1ccc2cc(C(=O)c3cnn(-c4ccc5nc(C)[nH]c5c4)c3N)[nH]c2c1		CHEMBL3895337	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
	16760052	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676329	=	IC50	nM	49.0	CHEMBL3650	Homo sapiens	IC50	nM	49.0
	16760053	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(S(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681317	=	IC50	nM	56.0	CHEMBL3650	Homo sapiens	IC50	nM	56.0
	16760054	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(F)(F)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681314	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	nM	3.0
	16760055	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681278	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
	16760056	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5cc(CN6CCOCC6)ccc5[nH]4)c3N)cc2[nH]1		CHEMBL3891894	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
	16760057	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(=O)[nH]c2c1		CHEMBL3952373	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	nM	50000.0
	16760058	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1cc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3959997	=	IC50	nM	69.0	CHEMBL3650	Homo sapiens	IC50	nM	69.0
	16760059	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]ccc2c1		CHEMBL3941474	=	IC50	nM	160.0	CHEMBL3650	Homo sapiens	IC50	nM	160.0
	16760060	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	CCc1nc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681287	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
	16760061	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	9.3	CHEMBL3650	Homo sapiens	IC50	nM	9.3
	16760062	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2nc[nH]c2c1		CHEMBL3934547	=	IC50	nM	33.0	CHEMBL3650	Homo sapiens	IC50	nM	33.0
	16760063	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3cc(CN4CCOCC4)ccc3[nH]2)cnn1-c1cc(O)ccc1Cl		CHEMBL3984621	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	16760064	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccccc1Cl		CHEMBL3956001	=	IC50	nM	1100.0	CHEMBL3650	Homo sapiens	IC50	nM	1100.0
	16760065	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1cc(O)ccc1Cl		CHEMBL3976548	=	IC50	nM	130.0	CHEMBL3650	Homo sapiens	IC50	nM	130.0
	16760066	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2ccc3ncccc3c2)cnn1-c1cc(O)ccc1Cl		CHEMBL3947281	=	IC50	nM	450.0	CHEMBL3650	Homo sapiens	IC50	nM	450.0
	16760067	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3o2)cnn1-c1cc(O)ccc1Cl		CHEMBL3981956	=	IC50	nM	270.0	CHEMBL3650	Homo sapiens	IC50	nM	270.0
	16760068	CHEMBL3861870	Inhibition of human FGFR1 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1cccc(C(=O)c2cnn(-c3cc(O)ccc3Cl)c2N)c1		CHEMBL3905685	=	IC50	nM	1900.0	CHEMBL3650	Homo sapiens	IC50	nM	1900.0
Active	16760156	CHEMBL3861900	Binding affinity to wild type human partial length FGFR1 expressed in bacterial system at 100 nM by KINOMEscan panel assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479		Activity			CHEMBL3650	Homo sapiens	Activity		
	16817232	CHEMBL3871909	Activity at FGFR1 (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Km	nM	200000.0	CHEMBL3650	Homo sapiens	Km	uM	200.0
	16817240	CHEMBL3871917	Inhibition of FGFR1 (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Ki	nM	80.0	CHEMBL3650	Homo sapiens	Ki	uM	0.08
	16817248	CHEMBL3871925	Ratio of Km to Ki for FGFR1 (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Ratio	10'-4No_unit	40.0	CHEMBL3650	Homo sapiens	Ratio	10'-4No_unit	40.0
	16871417	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3931533	=	IC50	nM	2.951	CHEMBL3650	Homo sapiens	pIC50		8.53
	16871418	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947740	=	IC50	nM	4.365	CHEMBL3650	Homo sapiens	pIC50		8.36
	16871419	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963816	=	IC50	nM	50.12	CHEMBL3650	Homo sapiens	pIC50		7.3
	16871420	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909951	=	IC50	nM	11.75	CHEMBL3650	Homo sapiens	pIC50		7.93
	16871421	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3912630	=	IC50	nM	54.95	CHEMBL3650	Homo sapiens	pIC50		7.26
	16871422	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3933449	=	IC50	nM	5.37	CHEMBL3650	Homo sapiens	pIC50		8.27
	16871423	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898908	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871424	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3986163	=	IC50	nM	7.079	CHEMBL3650	Homo sapiens	pIC50		8.15
	16871425	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3898120	=	IC50	nM	1.38	CHEMBL3650	Homo sapiens	pIC50		8.86
	16871426	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3955288	=	IC50	nM	4.467	CHEMBL3650	Homo sapiens	pIC50		8.35
	16871427	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957914	=	IC50	nM	44.67	CHEMBL3650	Homo sapiens	pIC50		7.35
	16871428	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)F)c4)cc3n2)cn1		CHEMBL3908978	=	IC50	nM	1202.26	CHEMBL3650	Homo sapiens	pIC50		5.92
	16871429	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3906155	=	IC50	nM	4.266	CHEMBL3650	Homo sapiens	pIC50		8.37
	16871430	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940334	=	IC50	nM	5.129	CHEMBL3650	Homo sapiens	pIC50		8.29
	16871431	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958153	=	IC50	nM	2.57	CHEMBL3650	Homo sapiens	pIC50		8.59
	16871432	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N(C)C)c4)nc3c2)c1		CHEMBL3925254	=	IC50	nM	3.715	CHEMBL3650	Homo sapiens	pIC50		8.43
	16871433	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3907600	=	IC50	nM	4.677	CHEMBL3650	Homo sapiens	pIC50		8.33
	16871434	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1		CHEMBL3954368	=	IC50	nM	69.18	CHEMBL3650	Homo sapiens	pIC50		7.16
	16871435	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCN5CCCC5)c4)nc3c2)c1		CHEMBL3951714	=	IC50	nM	1.38	CHEMBL3650	Homo sapiens	pIC50		8.86
	16871436	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CC(C)Oc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965364	=	IC50	nM	1023.29	CHEMBL3650	Homo sapiens	pIC50		5.99
	16871437	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3969446	=	IC50	nM	1.023	CHEMBL3650	Homo sapiens	pIC50		8.99
	16871438	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951126	=	IC50	nM	1.698	CHEMBL3650	Homo sapiens	pIC50		8.77
	16871439	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3933015	=	IC50	nM	676.08	CHEMBL3650	Homo sapiens	pIC50		6.17
	16871440	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898881	=	IC50	nM	1.95	CHEMBL3650	Homo sapiens	pIC50		8.71
	16871441	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2OCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901644	=	IC50	nM	3.802	CHEMBL3650	Homo sapiens	pIC50		8.42
	16871442	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944665	=	IC50	nM	112.2	CHEMBL3650	Homo sapiens	pIC50		6.95
	16871443	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCN(c1cccc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3947293	=	IC50	nM	53.7	CHEMBL3650	Homo sapiens	pIC50		7.27
	16871444	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1OC		CHEMBL3947826	=	IC50	nM	234.42	CHEMBL3650	Homo sapiens	pIC50		6.63
	16871445	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3985692	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871446	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947990	=	IC50	nM	14.45	CHEMBL3650	Homo sapiens	pIC50		7.84
	16871447	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCC5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3925306	=	IC50	nM	1.259	CHEMBL3650	Homo sapiens	pIC50		8.9
	16871448	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3951245	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871449	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3948623	=	IC50	nM	6.918	CHEMBL3650	Homo sapiens	pIC50		8.16
	16871450	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3892018	=	IC50	nM	1.445	CHEMBL3650	Homo sapiens	pIC50		8.84
	16871451	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987037	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871452	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3921313	=	IC50	nM	3.09	CHEMBL3650	Homo sapiens	pIC50		8.51
	16871453	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3927327	=	IC50	nM	2.951	CHEMBL3650	Homo sapiens	pIC50		8.53
	16871454	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1		CHEMBL3976280	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871455	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCNCCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3973820	=	IC50	nM	6.918	CHEMBL3650	Homo sapiens	pIC50		8.16
	16871456	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCN(S(C)(=O)=O)CC5)c4)nc3c2)c1		CHEMBL3918011	=	IC50	nM	17.38	CHEMBL3650	Homo sapiens	pIC50		7.76
	16871457	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)nc3c2)c1		CHEMBL3915235	=	IC50	nM	9.12	CHEMBL3650	Homo sapiens	pIC50		8.04
	16871458	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(C#N)c4)cc3n2)cn1		CHEMBL3965673	<	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16871459	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968094	=	IC50	nM	21.38	CHEMBL3650	Homo sapiens	pIC50		7.67
	16871460	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3918751	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871461	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	=	IC50	nM	8.128	CHEMBL3650	Homo sapiens	pIC50		8.09
	16871462	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3908829	=	IC50	nM	4.786	CHEMBL3650	Homo sapiens	pIC50		8.32
	16871463	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(O)CCNCC5)c4)nc3c2)c1		CHEMBL3911573	=	IC50	nM	1.66	CHEMBL3650	Homo sapiens	pIC50		8.78
	16871464	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969879	=	IC50	nM	19.05	CHEMBL3650	Homo sapiens	pIC50		7.72
	16871465	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(Cl)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972564	=	IC50	nM	144.54	CHEMBL3650	Homo sapiens	pIC50		6.84
	16871466	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3927875	=	IC50	nM	0.9772	CHEMBL3650	Homo sapiens	pIC50		9.01
	16871467	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C#N)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930634	=	IC50	nM	288.4	CHEMBL3650	Homo sapiens	pIC50		6.54
	16871468	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3901627	=	IC50	nM	2.754	CHEMBL3650	Homo sapiens	pIC50		8.56
	16871469	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904329	=	IC50	nM	4.467	CHEMBL3650	Homo sapiens	pIC50		8.35
	16871470	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969408	=	IC50	nM	1380.38	CHEMBL3650	Homo sapiens	pIC50		5.86
	16871471	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3985853	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871472	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(OC)CCNCC5)c4)nc3c2)c1		CHEMBL3908326	=	IC50	nM	1.995	CHEMBL3650	Homo sapiens	pIC50		8.7
	16871473	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3918092	=	IC50	nM	0.7586	CHEMBL3650	Homo sapiens	pIC50		9.12
	16871474	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1		CHEMBL3964675	=	IC50	nM	1.905	CHEMBL3650	Homo sapiens	pIC50		8.72
	16871475	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955706	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871476	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3937533	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871477	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCCC5)c4)nc3c2)c1.Cl		CHEMBL3962814	=	IC50	nM	5.37	CHEMBL3650	Homo sapiens	pIC50		8.27
	16871478	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3931674	=	IC50	nM	6.31	CHEMBL3650	Homo sapiens	pIC50		8.2
	16871479	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)NCCO)c4)nc3c2)c1		CHEMBL3976219	=	IC50	nM	6.026	CHEMBL3650	Homo sapiens	pIC50		8.22
	16871480	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924872	=	IC50	nM	13.18	CHEMBL3650	Homo sapiens	pIC50		7.88
	16871481	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3908529	=	IC50	nM	3.548	CHEMBL3650	Homo sapiens	pIC50		8.45
	16871482	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3962805	=	IC50	nM	4.467	CHEMBL3650	Homo sapiens	pIC50		8.35
	16871483	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)N5CCNCC5)c4)nc3c2)c1		CHEMBL3960128	=	IC50	nM	18.62	CHEMBL3650	Homo sapiens	pIC50		7.73
	16871484	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3909565	=	IC50	nM	1.778	CHEMBL3650	Homo sapiens	pIC50		8.75
	16871485	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3948321	=	IC50	nM	1.585	CHEMBL3650	Homo sapiens	pIC50		8.8
	16871486	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCO)c4)nc3c2)c1		CHEMBL3985750	=	IC50	nM	2.884	CHEMBL3650	Homo sapiens	pIC50		8.54
	16871487	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3983115	=	IC50	nM	3.89	CHEMBL3650	Homo sapiens	pIC50		8.41
	16871488	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3926311	=	IC50	nM	16.6	CHEMBL3650	Homo sapiens	pIC50		7.78
	16871489	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3926406	=	IC50	nM	2.692	CHEMBL3650	Homo sapiens	pIC50		8.57
	16871490	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)on2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979490	=	IC50	nM	0.6166	CHEMBL3650	Homo sapiens	pIC50		9.21
	16871491	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898355	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871492	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940725	=	IC50	nM	10.96	CHEMBL3650	Homo sapiens	pIC50		7.96
	16871493	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943387	=	IC50	nM	3.162	CHEMBL3650	Homo sapiens	pIC50		8.5
	16871494	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)OCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3973531	=	IC50	nM	5.012	CHEMBL3650	Homo sapiens	pIC50		8.3
	16871495	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3913757	=	IC50	nM	1.549	CHEMBL3650	Homo sapiens	pIC50		8.81
	16871496	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3961210	=	IC50	nM	1.622	CHEMBL3650	Homo sapiens	pIC50		8.79
	16871497	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936765	=	IC50	nM	741.31	CHEMBL3650	Homo sapiens	pIC50		6.13
	16871498	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951156	=	IC50	nM	7.943	CHEMBL3650	Homo sapiens	pIC50		8.1
	16871499	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H]2CCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979170	=	IC50	nM	1.95	CHEMBL3650	Homo sapiens	pIC50		8.71
	16871500	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921618	=	IC50	nM	0.5129	CHEMBL3650	Homo sapiens	pIC50		9.29
	16871501	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3969815	=	IC50	nM	1.66	CHEMBL3650	Homo sapiens	pIC50		8.78
	16871502	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3961872	=	IC50	nM	1.778	CHEMBL3650	Homo sapiens	pIC50		8.75
	16871503	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985222	=	IC50	nM	1.072	CHEMBL3650	Homo sapiens	pIC50		8.97
	16871504	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1		CHEMBL3935232	=	IC50	nM	1.622	CHEMBL3650	Homo sapiens	pIC50		8.79
	16871505	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1.Cl		CHEMBL3909140	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871506	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974664	=	IC50	nM	3.467	CHEMBL3650	Homo sapiens	pIC50		8.46
	16871507	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3972173	=	IC50	nM	14.79	CHEMBL3650	Homo sapiens	pIC50		7.83
	16871508	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919173	=	IC50	nM	0.5623	CHEMBL3650	Homo sapiens	pIC50		9.25
	16871509	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3956737	=	IC50	nM	524.81	CHEMBL3650	Homo sapiens	pIC50		6.28
	16871510	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3966022	=	IC50	nM	7.244	CHEMBL3650	Homo sapiens	pIC50		8.14
	16871511	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968499	=	IC50	nM	0.955	CHEMBL3650	Homo sapiens	pIC50		9.02
	16871512	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912505	=	IC50	nM	77.62	CHEMBL3650	Homo sapiens	pIC50		7.11
	16871513	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCC2CC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915158	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	16871514	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3950262	=	IC50	nM	7.586	CHEMBL3650	Homo sapiens	pIC50		8.12
	16871515	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871516	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3949470	=	IC50	nM	2.512	CHEMBL3650	Homo sapiens	pIC50		8.6
	16871517	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3893008	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871518	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CO)c4)nc3c2)c1		CHEMBL3889493	=	IC50	nM	9.12	CHEMBL3650	Homo sapiens	pIC50		8.04
	16871519	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCS(C)(=O)=O)c3)nc2c1		CHEMBL3984548	=	IC50	nM	3.467	CHEMBL3650	Homo sapiens	pIC50		8.46
	16871520	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cn[nH]c3)nc2c1		CHEMBL3920908	=	IC50	nM	3.715	CHEMBL3650	Homo sapiens	pIC50		8.43
	16871521	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3939278	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871522	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974693	=	IC50	nM	3.89	CHEMBL3650	Homo sapiens	pIC50		8.41
	16871523	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3972208	=	IC50	nM	407.38	CHEMBL3650	Homo sapiens	pIC50		6.39
	16871524	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3935264	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871525	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3932577	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871526	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3950907	=	IC50	nM	8.71	CHEMBL3650	Homo sapiens	pIC50		8.06
	16871527	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(C)=N\O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948270	=	IC50	nM	6.166	CHEMBL3650	Homo sapiens	pIC50		8.21
	16871528	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(C)=N/O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955817	=	IC50	nM	4.677	CHEMBL3650	Homo sapiens	pIC50		8.33
	16871529	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	=	IC50	nM	0.8511	CHEMBL3650	Homo sapiens	pIC50		9.07
	16871530	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923296	=	IC50	nM	1.778	CHEMBL3650	Homo sapiens	pIC50		8.75
	16871531	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918495	=	IC50	nM	4.677	CHEMBL3650	Homo sapiens	pIC50		8.33
	16871532	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCOc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945369	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	16871533	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OCCO)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3961267	=	IC50	nM	22.39	CHEMBL3650	Homo sapiens	pIC50		7.65
	16871534	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	=	IC50	nM	1.349	CHEMBL3650	Homo sapiens	pIC50		8.87
	16871535	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3928627	=	IC50	nM	97.72	CHEMBL3650	Homo sapiens	pIC50		7.01
	16871536	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3908877	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871537	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3907488	=	IC50	nM	15.49	CHEMBL3650	Homo sapiens	pIC50		7.81
	16871538	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N5CCC(O)C5)c4)nc3c2)c1		CHEMBL3929803	=	IC50	nM	5.623	CHEMBL3650	Homo sapiens	pIC50		8.25
	16871539	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3970430	=	IC50	nM	1.38	CHEMBL3650	Homo sapiens	pIC50		8.86
	16871540	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969475	=	IC50	nM	2.455	CHEMBL3650	Homo sapiens	pIC50		8.61
	16871541	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.c1ccc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)cc1		CHEMBL3963728	=	IC50	nM	691.83	CHEMBL3650	Homo sapiens	pIC50		6.16
	16871542	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944224	=	IC50	nM	6.457	CHEMBL3650	Homo sapiens	pIC50		8.19
	16871543	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909318	=	IC50	nM	3.802	CHEMBL3650	Homo sapiens	pIC50		8.42
	16871544	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982668	=	IC50	nM	8.71	CHEMBL3650	Homo sapiens	pIC50		8.06
	16871545	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C5CCCCO5)c4)nc3c2)c1		CHEMBL3980232	=	IC50	nM	1.175	CHEMBL3650	Homo sapiens	pIC50		8.93
	16871546	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937633	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871547	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3955563	=	IC50	nM	1.072	CHEMBL3650	Homo sapiens	pIC50		8.97
	16871548	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3890607	=	IC50	nM	3.715	CHEMBL3650	Homo sapiens	pIC50		8.43
	16871549	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCO)c3)nc2c1		CHEMBL3893373	=	IC50	nM	7.079	CHEMBL3650	Homo sapiens	pIC50		8.15
	16871550	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3954298	=	IC50	nM	2.138	CHEMBL3650	Homo sapiens	pIC50		8.67
	16871551	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3900620	=	IC50	nM	2.042	CHEMBL3650	Homo sapiens	pIC50		8.69
	16871552	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3983996	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871553	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3935124	=	IC50	nM	10.72	CHEMBL3650	Homo sapiens	pIC50		7.97
	16871554	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3973645	=	IC50	nM	263.03	CHEMBL3650	Homo sapiens	pIC50		6.58
	16871555	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCF)c4)nc3c2)c1		CHEMBL3971073	=	IC50	nM	16.6	CHEMBL3650	Homo sapiens	pIC50		7.78
	16871556	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957264	=	IC50	nM	1.549	CHEMBL3650	Homo sapiens	pIC50		8.81
	16871557	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969096	=	IC50	nM	26.92	CHEMBL3650	Homo sapiens	pIC50		7.57
	16871558	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCc2nnn[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905212	=	IC50	nM	4.074	CHEMBL3650	Homo sapiens	pIC50		8.39
	16871559	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897034	=	IC50	nM	9.12	CHEMBL3650	Homo sapiens	pIC50		8.04
	16871560	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CCCN(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979885	=	IC50	nM	3.388	CHEMBL3650	Homo sapiens	pIC50		8.47
	16871561	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3982334	=	IC50	nM	131.83	CHEMBL3650	Homo sapiens	pIC50		6.88
	16871562	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	=	IC50	nM	0.7244	CHEMBL3650	Homo sapiens	pIC50		9.14
	16871563	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC1CCN(CCCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)C1.Cl		CHEMBL3922453	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871564	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	=	IC50	nM	1.514	CHEMBL3650	Homo sapiens	pIC50		8.82
	16871565	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959201	=	IC50	nM	3.388	CHEMBL3650	Homo sapiens	pIC50		8.47
	16871566	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915233	=	IC50	nM	42.66	CHEMBL3650	Homo sapiens	pIC50		7.37
	16871567	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCS(=O)(=O)NCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3912569	=	IC50	nM	0.871	CHEMBL3650	Homo sapiens	pIC50		9.06
	16871568	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccco2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975954	=	IC50	nM	3.09	CHEMBL3650	Homo sapiens	pIC50		8.51
	16871569	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3966748	=	IC50	nM	0.6166	CHEMBL3650	Homo sapiens	pIC50		9.21
	16871570	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3929648	=	IC50	nM	5.754	CHEMBL3650	Homo sapiens	pIC50		8.24
	16871571	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926964	=	IC50	nM	275.42	CHEMBL3650	Homo sapiens	pIC50		6.56
	16871572	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3891619	=	IC50	nM	11.48	CHEMBL3650	Homo sapiens	pIC50		7.94
	16871573	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3986661	=	IC50	nM	8.913	CHEMBL3650	Homo sapiens	pIC50		8.05
	16871574	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943043	=	IC50	nM	1.23	CHEMBL3650	Homo sapiens	pIC50		8.91
	16871575	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)C1CCN(CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC1		CHEMBL3904745	=	IC50	nM	2.818	CHEMBL3650	Homo sapiens	pIC50		8.55
	16871576	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(Cl)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965614	=	IC50	nM	2.089	CHEMBL3650	Homo sapiens	pIC50		8.68
	16871577	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nnc(N)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968009	=	IC50	nM	1.38	CHEMBL3650	Homo sapiens	pIC50		8.86
	16871578	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CN(CCO)C5)c4)nc3c2)c1		CHEMBL3906122	=	IC50	nM	4.169	CHEMBL3650	Homo sapiens	pIC50		8.38
	16871579	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(Cc5ccc(Cl)s5)c4)nc3c2)c1		CHEMBL3900268	=	IC50	nM	229.09	CHEMBL3650	Homo sapiens	pIC50		6.64
	16871580	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3949132	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871581	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3951728	=	IC50	nM	8.511	CHEMBL3650	Homo sapiens	pIC50		8.07
	16871582	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962554	=	IC50	nM	4.571	CHEMBL3650	Homo sapiens	pIC50		8.34
	16871583	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913970	=	IC50	nM	3.715	CHEMBL3650	Homo sapiens	pIC50		8.43
	16871584	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN4CCCC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3972979	=	IC50	nM	1.047	CHEMBL3650	Homo sapiens	pIC50		8.98
	16871585	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975447	=	IC50	nM	0.9772	CHEMBL3650	Homo sapiens	pIC50		9.01
	16871586	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921243	=	IC50	nM	20.89	CHEMBL3650	Homo sapiens	pIC50		7.68
	16871587	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911516	=	IC50	nM	3.09	CHEMBL3650	Homo sapiens	pIC50		8.51
	16871588	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958756	=	IC50	nM	32.36	CHEMBL3650	Homo sapiens	pIC50		7.49
	16871589	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956120	=	IC50	nM	8.511	CHEMBL3650	Homo sapiens	pIC50		8.07
	16871590	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3907551	=	IC50	nM	354.81	CHEMBL3650	Homo sapiens	pIC50		6.45
	16871591	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)Cn1cc(CN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nn1		CHEMBL3904777	=	IC50	nM	12.3	CHEMBL3650	Homo sapiens	pIC50		7.91
	16871592	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	OCCn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3975007	=	IC50	nM	50.12	CHEMBL3650	Homo sapiens	pIC50		7.3
	16871593	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(OC)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972517	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871594	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928956	=	IC50	nM	147.91	CHEMBL3650	Homo sapiens	pIC50		6.83
	16871595	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919270	=	IC50	nM	22.39	CHEMBL3650	Homo sapiens	pIC50		7.65
	16871596	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941705	=	IC50	nM	13.49	CHEMBL3650	Homo sapiens	pIC50		7.87
	16871597	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982570	=	IC50	nM	33.88	CHEMBL3650	Homo sapiens	pIC50		7.47
	16871598	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C(C)CCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920007	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871599	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3922698	=	IC50	nM	1.202	CHEMBL3650	Homo sapiens	pIC50		8.92
	16871600	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957533	=	IC50	nM	3.89	CHEMBL3650	Homo sapiens	pIC50		8.41
	16871601	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969373	=	IC50	nM	2.291	CHEMBL3650	Homo sapiens	pIC50		8.64
	16871602	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3905485	=	IC50	nM	1.148	CHEMBL3650	Homo sapiens	pIC50		8.94
	16871603	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904674	=	IC50	nM	0.5495	CHEMBL3650	Homo sapiens	pIC50		9.26
	16871604	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945845	=	IC50	nM	7.244	CHEMBL3650	Homo sapiens	pIC50		8.14
	16871605	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3951694	=	IC50	nM	1.096	CHEMBL3650	Homo sapiens	pIC50		8.96
	16871606	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3929914	=	IC50	nM	2.089	CHEMBL3650	Homo sapiens	pIC50		8.68
	16871607	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	1.585	CHEMBL3650	Homo sapiens	pIC50		8.8
	16871608	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891892	=	IC50	nM	1.096	CHEMBL3650	Homo sapiens	pIC50		8.96
	16871609	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985498	=	IC50	nM	10.96	CHEMBL3650	Homo sapiens	pIC50		7.96
	16871610	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912831	=	IC50	nM	2.344	CHEMBL3650	Homo sapiens	pIC50		8.63
	16871611	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931154	=	IC50	nM	3.467	CHEMBL3650	Homo sapiens	pIC50		8.46
	16871612	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893718	=	IC50	nM	5.888	CHEMBL3650	Homo sapiens	pIC50		8.23
	16871613	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909529	=	IC50	nM	1.096	CHEMBL3650	Homo sapiens	pIC50		8.96
	16871614	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973321	=	IC50	nM	7.586	CHEMBL3650	Homo sapiens	pIC50		8.12
	16871615	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936672	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	pIC50		9.0
	16871616	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960327	=	IC50	nM	3.02	CHEMBL3650	Homo sapiens	pIC50		8.52
	16871617	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	=	IC50	nM	12.3	CHEMBL3650	Homo sapiens	pIC50		7.91
	16871618	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907314	=	IC50	nM	0.4467	CHEMBL3650	Homo sapiens	pIC50		9.35
	16871619	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cn[nH]n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904561	=	IC50	nM	3.388	CHEMBL3650	Homo sapiens	pIC50		8.47
	16871620	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945264	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871621	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3942594	=	IC50	nM	3.715	CHEMBL3650	Homo sapiens	pIC50		8.43
	16871622	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915268	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871623	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925081	=	IC50	nM	2.63	CHEMBL3650	Homo sapiens	pIC50		8.58
	16871624	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])n1cc(-c2ccc3ncc(N(CCO)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3959849	=	IC50	nM	2.818	CHEMBL3650	Homo sapiens	pIC50		8.55
	16871625	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962549	=	IC50	nM	17.78	CHEMBL3650	Homo sapiens	pIC50		7.75
	16871626	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3966626	=	IC50	nM	63.1	CHEMBL3650	Homo sapiens	pIC50		7.2
	16871627	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969192	=	IC50	nM	61.66	CHEMBL3650	Homo sapiens	pIC50		7.21
	16871628	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975986	=	IC50	nM	389.05	CHEMBL3650	Homo sapiens	pIC50		6.41
	16871629	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	=	IC50	nM	1.445	CHEMBL3650	Homo sapiens	pIC50		8.84
	16871630	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C2OCCO2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979996	=	IC50	nM	239.88	CHEMBL3650	Homo sapiens	pIC50		6.62
	16871631	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(OC)CCCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3891474	=	IC50	nM	7.244	CHEMBL3650	Homo sapiens	pIC50		8.14
	16871632	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3892135	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871633	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969824	=	IC50	nM	2.884	CHEMBL3650	Homo sapiens	pIC50		8.54
	16871634	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932285	=	IC50	nM	1.905	CHEMBL3650	Homo sapiens	pIC50		8.72
	16871635	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922586	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871636	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901682	=	IC50	nM	114.82	CHEMBL3650	Homo sapiens	pIC50		6.94
	16871637	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927733	=	IC50	nM	3.02	CHEMBL3650	Homo sapiens	pIC50		8.52
	16871638	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2ccc3ncc(N(CCN)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3976053	=	IC50	nM	1.995	CHEMBL3650	Homo sapiens	pIC50		8.7
	16871639	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973587	=	IC50	nM	7.079	CHEMBL3650	Homo sapiens	pIC50		8.15
	16871640	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936828	=	IC50	nM	3.236	CHEMBL3650	Homo sapiens	pIC50		8.49
	16871641	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(F)(F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934039	=	IC50	nM	12.59	CHEMBL3650	Homo sapiens	pIC50		7.9
	16871642	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981418	=	IC50	nM	1.23	CHEMBL3650	Homo sapiens	pIC50		8.91
	16871643	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2ccc3ncc(N(CCN)c4cc(F)cc(OCCO)c4)nc3c2)cn1		CHEMBL3972694	=	IC50	nM	11.48	CHEMBL3650	Homo sapiens	pIC50		7.94
	16871644	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cn(CCO)nn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921457	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871645	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3918739	=	IC50	nM	1.259	CHEMBL3650	Homo sapiens	pIC50		8.9
	16871646	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968793	=	IC50	nM	12.3	CHEMBL3650	Homo sapiens	pIC50		7.91
	16871647	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3966305	=	IC50	nM	1.175	CHEMBL3650	Homo sapiens	pIC50		8.93
	16871648	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3935825	=	IC50	nM	1.698	CHEMBL3650	Homo sapiens	pIC50		8.77
	16871649	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897101	=	IC50	nM	1.698	CHEMBL3650	Homo sapiens	pIC50		8.77
	16871650	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3891115	=	IC50	nM	154.88	CHEMBL3650	Homo sapiens	pIC50		6.81
	16871651	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3979662	=	IC50	nM	123.03	CHEMBL3650	Homo sapiens	pIC50		6.91
	16871652	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3983387	=	IC50	nM	2.754	CHEMBL3650	Homo sapiens	pIC50		8.56
	16871653	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986068	=	IC50	nM	2.239	CHEMBL3650	Homo sapiens	pIC50		8.65
	16871654	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CC)CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3916975	=	IC50	nM	1.622	CHEMBL3650	Homo sapiens	pIC50		8.79
	16871655	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])n1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3919709	=	IC50	nM	0.871	CHEMBL3650	Homo sapiens	pIC50		9.06
	16871656	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975791	=	IC50	nM	0.912	CHEMBL3650	Homo sapiens	pIC50		9.04
	16871657	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963323	=	IC50	nM	2.63	CHEMBL3650	Homo sapiens	pIC50		8.58
	16871658	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945373	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871659	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933341	=	IC50	nM	1.585	CHEMBL3650	Homo sapiens	pIC50		8.8
	16871660	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3893344	=	IC50	nM	2.455	CHEMBL3650	Homo sapiens	pIC50		8.61
	16871661	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3896052	=	IC50	nM	2.042	CHEMBL3650	Homo sapiens	pIC50		8.69
	16871662	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3947361	=	IC50	nM	2.884	CHEMBL3650	Homo sapiens	pIC50		8.54
	16871663	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3944739	=	IC50	nM	10.47	CHEMBL3650	Homo sapiens	pIC50		7.98
	16871664	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3909551	=	IC50	nM	2.344	CHEMBL3650	Homo sapiens	pIC50		8.63
	16871665	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899692	=	IC50	nM	1.698	CHEMBL3650	Homo sapiens	pIC50		8.77
	16871666	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3C[C@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3961400	=	IC50	nM	2.884	CHEMBL3650	Homo sapiens	pIC50		8.54
	16871667	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958708	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871668	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974080	=	IC50	nM	25.12	CHEMBL3650	Homo sapiens	pIC50		7.6
	16871669	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1		CHEMBL3921197	=	IC50	nM	0.8318	CHEMBL3650	Homo sapiens	pIC50		9.08
	16871670	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898568	=	IC50	nM	3.631	CHEMBL3650	Homo sapiens	pIC50		8.44
	16871671	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986036	=	IC50	nM	7.943	CHEMBL3650	Homo sapiens	pIC50		8.1
	16871672	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3914615	=	IC50	nM	7.943	CHEMBL3650	Homo sapiens	pIC50		8.1
	16871673	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3924422	=	IC50	nM	5.754	CHEMBL3650	Homo sapiens	pIC50		8.24
	16871674	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCF)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959193	=	IC50	nM	17.38	CHEMBL3650	Homo sapiens	pIC50		7.76
	16871675	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936087	=	IC50	nM	2.63	CHEMBL3650	Homo sapiens	pIC50		8.58
	16871676	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893070	=	IC50	nM	4.898	CHEMBL3650	Homo sapiens	pIC50		8.31
	16871677	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942763	=	IC50	nM	0.8913	CHEMBL3650	Homo sapiens	pIC50		9.05
	16871678	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nnc(NCCO)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977904	=	IC50	nM	9.55	CHEMBL3650	Homo sapiens	pIC50		8.02
	16871679	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3906894	=	IC50	nM	0.5888	CHEMBL3650	Homo sapiens	pIC50		9.23
	16871680	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	=	IC50	nM	1.778	CHEMBL3650	Homo sapiens	pIC50		8.75
	16871681	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	=	IC50	nM	2.042	CHEMBL3650	Homo sapiens	pIC50		8.69
	16871682	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3904441	=	IC50	nM	4.074	CHEMBL3650	Homo sapiens	pIC50		8.39
	16871683	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3945159	=	IC50	nM	0.7762	CHEMBL3650	Homo sapiens	pIC50		9.11
	16871684	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3915021	=	IC50	nM	13.18	CHEMBL3650	Homo sapiens	pIC50		7.88
	16871685	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3892776	=	IC50	nM	4.786	CHEMBL3650	Homo sapiens	pIC50		8.32
	16871686	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981077	=	IC50	nM	8.71	CHEMBL3650	Homo sapiens	pIC50		8.06
	16871687	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930819	=	IC50	nM	12.3	CHEMBL3650	Homo sapiens	pIC50		7.91
	16871688	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3926082	=	IC50	nM	1.514	CHEMBL3650	Homo sapiens	pIC50		8.82
	16871689	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3970423	=	IC50	nM	1.259	CHEMBL3650	Homo sapiens	pIC50		8.9
	16871690	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967739	=	IC50	nM	7.413	CHEMBL3650	Homo sapiens	pIC50		8.13
	16871691	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939764	=	IC50	nM	2.291	CHEMBL3650	Homo sapiens	pIC50		8.64
	16871692	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3900574	=	IC50	nM	2.291	CHEMBL3650	Homo sapiens	pIC50		8.64
	16871693	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3950089	=	IC50	nM	1.122	CHEMBL3650	Homo sapiens	pIC50		8.95
	16871694	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3959573	=	IC50	nM	1.514	CHEMBL3650	Homo sapiens	pIC50		8.82
	16871695	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912310	=	IC50	nM	5.623	CHEMBL3650	Homo sapiens	pIC50		8.25
	16871696	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914955	=	IC50	nM	2.692	CHEMBL3650	Homo sapiens	pIC50		8.57
	16871697	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973263	=	IC50	nM	4.467	CHEMBL3650	Homo sapiens	pIC50		8.35
	16871698	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975714	=	IC50	nM	12.02	CHEMBL3650	Homo sapiens	pIC50		7.92
	16871699	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933707	=	IC50	nM	1.259	CHEMBL3650	Homo sapiens	pIC50		8.9
	16871700	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950069	=	IC50	nM	2.138	CHEMBL3650	Homo sapiens	pIC50		8.67
	16871701	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3979013	=	IC50	nM	0.6166	CHEMBL3650	Homo sapiens	pIC50		9.21
	16871702	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCN2CCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942811	=	IC50	nM	6.761	CHEMBL3650	Homo sapiens	pIC50		8.17
	16871703	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3940175	=	IC50	nM	1.622	CHEMBL3650	Homo sapiens	pIC50		8.79
	16871704	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968038	=	IC50	nM	15.85	CHEMBL3650	Homo sapiens	pIC50		7.8
	16871705	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965640	=	IC50	nM	4.677	CHEMBL3650	Homo sapiens	pIC50		8.33
	16871706	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ncc[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928393	=	IC50	nM	1.023	CHEMBL3650	Homo sapiens	pIC50		8.99
	16871707	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918704	=	IC50	nM	3.162	CHEMBL3650	Homo sapiens	pIC50		8.5
	16871708	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3947189	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871709	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944438	=	IC50	nM	1.95	CHEMBL3650	Homo sapiens	pIC50		8.71
	16871710	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3965710	=	IC50	nM	1.995	CHEMBL3650	Homo sapiens	pIC50		8.7
	16871711	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968124	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871712	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964574	=	IC50	nM	1.23	CHEMBL3650	Homo sapiens	pIC50		8.91
	16871713	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907047	=	IC50	nM	6.607	CHEMBL3650	Homo sapiens	pIC50		8.18
	16871714	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3942328	=	IC50	nM	1.023	CHEMBL3650	Homo sapiens	pIC50		8.99
	16871715	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951847	=	IC50	nM	6.026	CHEMBL3650	Homo sapiens	pIC50		8.22
	16871716	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N\O		CHEMBL3889890	=	IC50	nM	28.18	CHEMBL3650	Homo sapiens	pIC50		7.55
	16871717	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N/O		CHEMBL3892632	=	IC50	nM	7.943	CHEMBL3650	Homo sapiens	pIC50		8.1
	16871718	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930298	=	IC50	nM	27.54	CHEMBL3650	Homo sapiens	pIC50		7.56
	16871719	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3891464	=	IC50	nM	5.623	CHEMBL3650	Homo sapiens	pIC50		8.25
	16871720	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950910	=	IC50	nM	1.259	CHEMBL3650	Homo sapiens	pIC50		8.9
	16871721	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3901420	=	IC50	nM	8.318	CHEMBL3650	Homo sapiens	pIC50		8.08
	16871722	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939200	=	IC50	nM	2.512	CHEMBL3650	Homo sapiens	pIC50		8.6
	16871723	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905866	=	IC50	nM	1.38	CHEMBL3650	Homo sapiens	pIC50		8.86
	16871724	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903198	=	IC50	nM	4.898	CHEMBL3650	Homo sapiens	pIC50		8.31
	16871725	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)N[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943933	=	IC50	nM	16.98	CHEMBL3650	Homo sapiens	pIC50		7.77
	16871726	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCS(=O)(=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925077	=	IC50	nM	11.22	CHEMBL3650	Homo sapiens	pIC50		7.95
	16871727	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCF)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3946674	=	IC50	nM	4.266	CHEMBL3650	Homo sapiens	pIC50		8.37
	16871728	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931790	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871729	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934487	=	IC50	nM	2.951	CHEMBL3650	Homo sapiens	pIC50		8.53
	16871730	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3893786	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871731	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(CO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917141	=	IC50	nM	1.95	CHEMBL3650	Homo sapiens	pIC50		8.71
	16871732	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975397	=	IC50	nM	7.244	CHEMBL3650	Homo sapiens	pIC50		8.14
	16871733	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891966	=	IC50	nM	4.365	CHEMBL3650	Homo sapiens	pIC50		8.36
	16871734	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3941700	=	IC50	nM	1.778	CHEMBL3650	Homo sapiens	pIC50		8.75
	16871735	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3980252	=	IC50	nM	9.333	CHEMBL3650	Homo sapiens	pIC50		8.03
	16871736	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967065	=	IC50	nM	5.129	CHEMBL3650	Homo sapiens	pIC50		8.29
	16871737	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969665	=	IC50	nM	6.607	CHEMBL3650	Homo sapiens	pIC50		8.18
	16871738	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C(C)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981076	=	IC50	nM	9.772	CHEMBL3650	Homo sapiens	pIC50		8.01
	16871739	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983529	=	IC50	nM	3.631	CHEMBL3650	Homo sapiens	pIC50		8.44
	16871740	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935457	=	IC50	nM	2.291	CHEMBL3650	Homo sapiens	pIC50		8.64
	16871741	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905048	=	IC50	nM	3.631	CHEMBL3650	Homo sapiens	pIC50		8.44
	16871742	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925610	=	IC50	nM	6.166	CHEMBL3650	Homo sapiens	pIC50		8.21
	16871743	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3928261	=	IC50	nM	2.692	CHEMBL3650	Homo sapiens	pIC50		8.57
	16871744	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2COC2)c1		CHEMBL3985259	=	IC50	nM	10.72	CHEMBL3650	Homo sapiens	pIC50		7.97
	16871745	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890205	=	IC50	nM	52.48	CHEMBL3650	Homo sapiens	pIC50		7.28
	16871746	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944610	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871747	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)C(C)C.Cl		CHEMBL3944320	=	IC50	nM	2.344	CHEMBL3650	Homo sapiens	pIC50		8.63
	16871748	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943860	=	IC50	nM	1.549	CHEMBL3650	Homo sapiens	pIC50		8.81
	16871749	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(=N/O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941174	=	IC50	nM	93.33	CHEMBL3650	Homo sapiens	pIC50		7.03
	16871750	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(=N\O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982351	=	IC50	nM	6.918	CHEMBL3650	Homo sapiens	pIC50		8.16
	16871751	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3979908	=	IC50	nM	56.23	CHEMBL3650	Homo sapiens	pIC50		7.25
	16871752	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCNC(=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934355	=	IC50	nM	12.02	CHEMBL3650	Homo sapiens	pIC50		7.92
	16871753	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919750	=	IC50	nM	17.38	CHEMBL3650	Homo sapiens	pIC50		7.76
	16871754	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969112	=	IC50	nM	2.951	CHEMBL3650	Homo sapiens	pIC50		8.53
	16871755	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966560	=	IC50	nM	4.786	CHEMBL3650	Homo sapiens	pIC50		8.32
	16871756	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910444	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871757	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)nc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907642	=	IC50	nM	3.02	CHEMBL3650	Homo sapiens	pIC50		8.52
	16871758	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973929	=	IC50	nM	1.995	CHEMBL3650	Homo sapiens	pIC50		8.7
	16871759	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C(=O)C3CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972617	=	IC50	nM	7.244	CHEMBL3650	Homo sapiens	pIC50		8.14
	16871760	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(F)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908149	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871761	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1		CHEMBL3911621	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871762	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@H](NC(C)C)CC2)c1		CHEMBL3918800	=	IC50	nM	2.818	CHEMBL3650	Homo sapiens	pIC50		8.55
	16871763	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902353	=	IC50	nM	2.042	CHEMBL3650	Homo sapiens	pIC50		8.69
	16871764	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943080	=	IC50	nM	33.11	CHEMBL3650	Homo sapiens	pIC50		7.48
	16871765	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968139	=	IC50	nM	2.951	CHEMBL3650	Homo sapiens	pIC50		8.53
	16871766	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3904294	=	IC50	nM	4.677	CHEMBL3650	Homo sapiens	pIC50		8.33
	16871767	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907063	=	IC50	nM	7.244	CHEMBL3650	Homo sapiens	pIC50		8.14
	16871768	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3896623	=	IC50	nM	4.898	CHEMBL3650	Homo sapiens	pIC50		8.31
	16871769	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC[Si](C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3893950	=	IC50	nM	7.244	CHEMBL3650	Homo sapiens	pIC50		8.14
	16871770	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955745	=	IC50	nM	13.18	CHEMBL3650	Homo sapiens	pIC50		7.88
	16871771	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953117	=	IC50	nM	15.14	CHEMBL3650	Homo sapiens	pIC50		7.82
	16871772	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951360	=	IC50	nM	4.074	CHEMBL3650	Homo sapiens	pIC50		8.39
	16871773	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948744	=	IC50	nM	1.995	CHEMBL3650	Homo sapiens	pIC50		8.7
	16871774	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3941695	=	IC50	nM	2.512	CHEMBL3650	Homo sapiens	pIC50		8.6
	16871775	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3903811	=	IC50	nM	1.905	CHEMBL3650	Homo sapiens	pIC50		8.72
	16871776	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930158	=	IC50	nM	31.62	CHEMBL3650	Homo sapiens	pIC50		7.5
	16871777	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927451	=	IC50	nM	2.692	CHEMBL3650	Homo sapiens	pIC50		8.57
	16871778	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3911746	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16871779	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CCN(S(N)(=O)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917295	=	IC50	nM	4.266	CHEMBL3650	Homo sapiens	pIC50		8.37
	16871780	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902110	=	IC50	nM	7.943	CHEMBL3650	Homo sapiens	pIC50		8.1
	16871781	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cc(C)nc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904814	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	pIC50		7.0
	16871782	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911948	=	IC50	nM	66.07	CHEMBL3650	Homo sapiens	pIC50		7.18
	16871783	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928239	=	IC50	nM	2.692	CHEMBL3650	Homo sapiens	pIC50		8.57
	16871784	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979028	=	IC50	nM	16.98	CHEMBL3650	Homo sapiens	pIC50		7.77
	16871785	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890378	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871786	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1.Cl		CHEMBL3932363	=	IC50	nM	5.623	CHEMBL3650	Homo sapiens	pIC50		8.25
	16871787	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3934260	=	IC50	nM	1.318	CHEMBL3650	Homo sapiens	pIC50		8.88
	16871788	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932756	=	IC50	nM	3.715	CHEMBL3650	Homo sapiens	pIC50		8.43
	16871789	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3919479	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871790	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968818	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871791	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966316	=	IC50	nM	32.36	CHEMBL3650	Homo sapiens	pIC50		7.49
	16871792	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(Br)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940940	=	IC50	nM	14.13	CHEMBL3650	Homo sapiens	pIC50		7.85
	16871793	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3982107	=	IC50	nM	4.786	CHEMBL3650	Homo sapiens	pIC50		8.32
	16871794	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3979670	=	IC50	nM	2.884	CHEMBL3650	Homo sapiens	pIC50		8.54
	16871795	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3921476	=	IC50	nM	2.042	CHEMBL3650	Homo sapiens	pIC50		8.69
	16871796	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3911738	=	IC50	nM	10.23	CHEMBL3650	Homo sapiens	pIC50		7.99
	16871797	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951090	=	IC50	nM	9.772	CHEMBL3650	Homo sapiens	pIC50		8.01
	16871798	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960571	=	IC50	nM	1.95	CHEMBL3650	Homo sapiens	pIC50		8.71
	16871799	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3949508	=	IC50	nM	17.38	CHEMBL3650	Homo sapiens	pIC50		7.76
	16871800	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901612	=	IC50	nM	2.291	CHEMBL3650	Homo sapiens	pIC50		8.64
	16871801	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3974206	=	IC50	nM	1.66	CHEMBL3650	Homo sapiens	pIC50		8.78
	16871802	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3911635	=	IC50	nM	2.754	CHEMBL3650	Homo sapiens	pIC50		8.56
	16871803	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913322	=	IC50	nM	1.175	CHEMBL3650	Homo sapiens	pIC50		8.93
	16871804	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916037	=	IC50	nM	4.365	CHEMBL3650	Homo sapiens	pIC50		8.36
	16871805	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nccn2S(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889711	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871806	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927585	=	IC50	nM	7.586	CHEMBL3650	Homo sapiens	pIC50		8.12
	16871807	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1		CHEMBL3984461	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871808	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3981955	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871809	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3946103	=	IC50	nM	1.95	CHEMBL3650	Homo sapiens	pIC50		8.71
	16871810	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1ccnc1CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3936421	=	IC50	nM	7.079	CHEMBL3650	Homo sapiens	pIC50		8.15
	16871811	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2COCC(C)(C)N2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901119	=	IC50	nM	0.7586	CHEMBL3650	Homo sapiens	pIC50		9.12
	16871812	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898346	=	IC50	nM	4.677	CHEMBL3650	Homo sapiens	pIC50		8.33
	16871813	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895378	=	IC50	nM	3.802	CHEMBL3650	Homo sapiens	pIC50		8.42
	16871814	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H](C)CN)c1		CHEMBL3957414	=	IC50	nM	2.089	CHEMBL3650	Homo sapiens	pIC50		8.68
	16871815	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1		CHEMBL3922607	=	IC50	nM	3.388	CHEMBL3650	Homo sapiens	pIC50		8.47
	16871816	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919884	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871817	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNC(C)C)c1		CHEMBL3942606	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871818	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945277	=	IC50	nM	1.514	CHEMBL3650	Homo sapiens	pIC50		8.82
	16871819	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897523	=	IC50	nM	2.692	CHEMBL3650	Homo sapiens	pIC50		8.57
	16871820	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907327	=	IC50	nM	4.074	CHEMBL3650	Homo sapiens	pIC50		8.39
	16871821	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956579	=	IC50	nM	5.495	CHEMBL3650	Homo sapiens	pIC50		8.26
	16871822	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959260	=	IC50	nM	7.943	CHEMBL3650	Homo sapiens	pIC50		8.1
	16871823	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNCC(F)(F)F)c1		CHEMBL3890852	=	IC50	nM	4.786	CHEMBL3650	Homo sapiens	pIC50		8.32
	16871824	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893642	=	IC50	nM	2.512	CHEMBL3650	Homo sapiens	pIC50		8.6
	16871825	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950156	=	IC50	nM	4.169	CHEMBL3650	Homo sapiens	pIC50		8.38
	16871826	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3952866	=	IC50	nM	7.079	CHEMBL3650	Homo sapiens	pIC50		8.15
	16871827	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3925114	=	IC50	nM	1.479	CHEMBL3650	Homo sapiens	pIC50		8.83
	16871828	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3897155	=	IC50	nM	2.951	CHEMBL3650	Homo sapiens	pIC50		8.53
	16871829	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937972	=	IC50	nM	0.9772	CHEMBL3650	Homo sapiens	pIC50		9.01
	16871830	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935177	=	IC50	nM	7.943	CHEMBL3650	Homo sapiens	pIC50		8.1
	16871831	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962492	=	IC50	nM	2.512	CHEMBL3650	Homo sapiens	pIC50		8.6
	16871832	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903823	=	IC50	nM	6.761	CHEMBL3650	Homo sapiens	pIC50		8.17
	16871833	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3964096	=	IC50	nM	0.912	CHEMBL3650	Homo sapiens	pIC50		9.04
	16871834	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3948755	=	IC50	nM	7.762	CHEMBL3650	Homo sapiens	pIC50		8.11
	16871835	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3892155	=	IC50	nM	3.548	CHEMBL3650	Homo sapiens	pIC50		8.45
	16871836	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987162	=	IC50	nM	28.18	CHEMBL3650	Homo sapiens	pIC50		7.55
	16871837	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921441	=	IC50	nM	1.622	CHEMBL3650	Homo sapiens	pIC50		8.79
	16871838	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905015	=	IC50	nM	38.02	CHEMBL3650	Homo sapiens	pIC50		7.42
	16871839	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3921817	=	IC50	nM	0.7762	CHEMBL3650	Homo sapiens	pIC50		9.11
	16871840	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927219	=	IC50	nM	13.18	CHEMBL3650	Homo sapiens	pIC50		7.88
	16871841	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(CCCN)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902434	=	IC50	nM	3.236	CHEMBL3650	Homo sapiens	pIC50		8.49
	16871842	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927158	=	IC50	nM	57.54	CHEMBL3650	Homo sapiens	pIC50		7.24
	16871843	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985182	=	IC50	nM	10.47	CHEMBL3650	Homo sapiens	pIC50		7.98
	16871844	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933442	=	IC50	nM	6.026	CHEMBL3650	Homo sapiens	pIC50		8.22
	16871845	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934080	=	IC50	nM	1.585	CHEMBL3650	Homo sapiens	pIC50		8.8
	16871846	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895443	=	IC50	nM	4.169	CHEMBL3650	Homo sapiens	pIC50		8.38
	16871847	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CCCNCC(F)(F)F)c4cc(Cl)cc(Cl)c4)cc3n2)cn1		CHEMBL3904736	=	IC50	nM	436.52	CHEMBL3650	Homo sapiens	pIC50		6.36
	16871848	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CC)Cc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914473	=	IC50	nM	131.83	CHEMBL3650	Homo sapiens	pIC50		6.88
	16871849	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CC(C)NCCN(c1cc(Cl)cc(Cl)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3898926	=	IC50	nM	10.96	CHEMBL3650	Homo sapiens	pIC50		7.96
	16871850	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952277	=	IC50	nM	1.549	CHEMBL3650	Homo sapiens	pIC50		8.81
	16871851	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926245	=	IC50	nM	18.62	CHEMBL3650	Homo sapiens	pIC50		7.73
	16871852	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3978617	=	IC50	nM	1.905	CHEMBL3650	Homo sapiens	pIC50		8.72
	16871853	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)nc3c2)c1		CHEMBL3966071	=	IC50	nM	1.585	CHEMBL3650	Homo sapiens	pIC50		8.8
	16871854	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966200	=	IC50	nM	2.63	CHEMBL3650	Homo sapiens	pIC50		8.58
	16871855	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3940672	=	IC50	nM	2.692	CHEMBL3650	Homo sapiens	pIC50		8.57
	16871856	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3979328	=	IC50	nM	1.585	CHEMBL3650	Homo sapiens	pIC50		8.8
	16871857	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3983918	=	IC50	nM	0.7586	CHEMBL3650	Homo sapiens	pIC50		9.12
	16871858	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975193	=	IC50	nM	8.318	CHEMBL3650	Homo sapiens	pIC50		8.08
	16871859	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924172	=	IC50	nM	1.445	CHEMBL3650	Homo sapiens	pIC50		8.84
	16871860	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)(C)CF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921469	=	IC50	nM	1.175	CHEMBL3650	Homo sapiens	pIC50		8.93
	16871861	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(F)c1F.Cl		CHEMBL3900551	=	IC50	nM	257.04	CHEMBL3650	Homo sapiens	pIC50		6.59
	16871862	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3897783	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871863	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891525	=	IC50	nM	2.754	CHEMBL3650	Homo sapiens	pIC50		8.56
	16871864	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1		CHEMBL3935838	=	IC50	nM	6.457	CHEMBL3650	Homo sapiens	pIC50		8.19
	16871865	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3977010	=	IC50	nM	3.09	CHEMBL3650	Homo sapiens	pIC50		8.51
	16871866	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3967761	=	IC50	nM	1.995	CHEMBL3650	Homo sapiens	pIC50		8.7
	16871867	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893556	=	IC50	nM	48.98	CHEMBL3650	Homo sapiens	pIC50		7.31
	16871868	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3896249	=	IC50	nM	0.6761	CHEMBL3650	Homo sapiens	pIC50		9.17
	16871869	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C#N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952789	=	IC50	nM	6.457	CHEMBL3650	Homo sapiens	pIC50		8.19
	16871870	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955385	=	IC50	nM	16.98	CHEMBL3650	Homo sapiens	pIC50		7.77
	16871871	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977708	=	IC50	nM	6.607	CHEMBL3650	Homo sapiens	pIC50		8.18
	16871872	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3980069	=	IC50	nM	0.3631	CHEMBL3650	Homo sapiens	pIC50		9.44
	16871873	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3946938	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871874	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941337	=	IC50	nM	134.9	CHEMBL3650	Homo sapiens	pIC50		6.87
	16871875	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983585	=	IC50	nM	120.23	CHEMBL3650	Homo sapiens	pIC50		6.92
	16871876	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])NC(C)C)c1		CHEMBL3918638	=	IC50	nM	0.4571	CHEMBL3650	Homo sapiens	pIC50		9.34
	16871877	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920637	=	IC50	nM	3.802	CHEMBL3650	Homo sapiens	pIC50		8.42
	16871878	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1.Cl		CHEMBL3917908	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871879	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980712	=	IC50	nM	263.03	CHEMBL3650	Homo sapiens	pIC50		6.58
	16871880	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1		CHEMBL3978349	=	IC50	nM	5.495	CHEMBL3650	Homo sapiens	pIC50		8.26
	16871881	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(CO)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3976721	=	IC50	nM	28.18	CHEMBL3650	Homo sapiens	pIC50		7.55
	16871882	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974273	=	IC50	nM	33.11	CHEMBL3650	Homo sapiens	pIC50		7.48
	16871883	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3898255	=	IC50	nM	48.98	CHEMBL3650	Homo sapiens	pIC50		7.31
	16871884	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3927794	=	IC50	nM	54.95	CHEMBL3650	Homo sapiens	pIC50		7.26
	16871885	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953833	=	IC50	nM	2.63	CHEMBL3650	Homo sapiens	pIC50		8.58
	16871886	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964043	=	IC50	nM	1.905	CHEMBL3650	Homo sapiens	pIC50		8.72
	16871887	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945658	=	IC50	nM	75.86	CHEMBL3650	Homo sapiens	pIC50		7.12
	16871888	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948306	=	IC50	nM	223.87	CHEMBL3650	Homo sapiens	pIC50		6.65
	16871889	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984035	=	IC50	nM	5.888	CHEMBL3650	Homo sapiens	pIC50		8.23
	16871890	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3986725	=	IC50	nM	9.12	CHEMBL3650	Homo sapiens	pIC50		8.04
	16871891	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2		CHEMBL3896142	=	IC50	nM	1.349	CHEMBL3650	Homo sapiens	pIC50		8.87
	16871892	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908707	=	IC50	nM	1.413	CHEMBL3650	Homo sapiens	pIC50		8.85
	16871893	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941227	=	IC50	nM	8.71	CHEMBL3650	Homo sapiens	pIC50		8.06
	16871894	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3943917	=	IC50	nM	6.166	CHEMBL3650	Homo sapiens	pIC50		8.21
	16871895	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979972	=	IC50	nM	7.762	CHEMBL3650	Homo sapiens	pIC50		8.11
	16871896	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)nc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982399	=	IC50	nM	6.026	CHEMBL3650	Homo sapiens	pIC50		8.22
	16871897	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1.Cl		CHEMBL3932817	=	IC50	nM	8.128	CHEMBL3650	Homo sapiens	pIC50		8.09
	16871898	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCNCC(F)(F)F)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3930088	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16871899	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972445	=	IC50	nM	91.2	CHEMBL3650	Homo sapiens	pIC50		7.04
	16871900	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3969747	=	IC50	nM	40.74	CHEMBL3650	Homo sapiens	pIC50		7.39
	16871901	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cnn1C.Cl		CHEMBL3918426	=	IC50	nM	1.778	CHEMBL3650	Homo sapiens	pIC50		8.75
	16871902	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906938	=	IC50	nM	10.47	CHEMBL3650	Homo sapiens	pIC50		7.98
	16871903	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nc1		CHEMBL3956028	=	IC50	nM	134.9	CHEMBL3650	Homo sapiens	pIC50		6.87
	16871904	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964762	=	IC50	nM	6.457	CHEMBL3650	Homo sapiens	pIC50		8.19
	16871905	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)c1.Cl		CHEMBL3948234	=	IC50	nM	2.512	CHEMBL3650	Homo sapiens	pIC50		8.6
	16871906	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CO)nc3c2)c1		CHEMBL3932022	=	IC50	nM	1.82	CHEMBL3650	Homo sapiens	pIC50		8.74
	16871907	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3957473	=	IC50	nM	1.549	CHEMBL3650	Homo sapiens	pIC50		8.81
	16871908	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3926556	=	IC50	nM	2.57	CHEMBL3650	Homo sapiens	pIC50		8.59
	16871909	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3965482	=	IC50	nM	4.786	CHEMBL3650	Homo sapiens	pIC50		8.32
	16871910	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(Cc2ccc(N)cc2)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950496	=	IC50	nM	3.89	CHEMBL3650	Homo sapiens	pIC50		8.41
	16871911	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902961	=	IC50	nM	1.66	CHEMBL3650	Homo sapiens	pIC50		8.78
	16871912	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905633	=	IC50	nM	14.45	CHEMBL3650	Homo sapiens	pIC50		7.84
	16871913	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3937212	=	IC50	nM	12.59	CHEMBL3650	Homo sapiens	pIC50		7.9
	16871914	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])NCC(F)(F)F)c1		CHEMBL3966929	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16871915	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922100	=	IC50	nM	3.981	CHEMBL3650	Homo sapiens	pIC50		8.4
	16871916	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3906284	=	IC50	nM	3.981	CHEMBL3650	Homo sapiens	pIC50		8.4
	16871917	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3921787	=	IC50	nM	52.48	CHEMBL3650	Homo sapiens	pIC50		7.28
	16871918	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969405	=	IC50	nM	30.2	CHEMBL3650	Homo sapiens	pIC50		7.52
	16871919	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964589	=	IC50	nM	38.9	CHEMBL3650	Homo sapiens	pIC50		7.41
	16871920	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3972998	=	IC50	nM	37.15	CHEMBL3650	Homo sapiens	pIC50		7.43
	16871921	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3908068	=	IC50	nM	25.7	CHEMBL3650	Homo sapiens	pIC50		7.59
	16871922	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3905276	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871923	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969414	=	IC50	nM	5.888	CHEMBL3650	Homo sapiens	pIC50		8.23
	16871924	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3951171	=	IC50	nM	2.188	CHEMBL3650	Homo sapiens	pIC50		8.66
	16871925	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983694	=	IC50	nM	8.913	CHEMBL3650	Homo sapiens	pIC50		8.05
	16871926	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3981207	=	IC50	nM	20.42	CHEMBL3650	Homo sapiens	pIC50		7.69
	16871927	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnc(N)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3986631	=	IC50	nM	83.18	CHEMBL3650	Homo sapiens	pIC50		7.08
	16871928	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3969667	=	IC50	nM	6.607	CHEMBL3650	Homo sapiens	pIC50		8.18
	16871929	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933908	=	IC50	nM	12.59	CHEMBL3650	Homo sapiens	pIC50		7.9
	16871930	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3936673	=	IC50	nM	27.54	CHEMBL3650	Homo sapiens	pIC50		7.56
	16871931	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(CO)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980417	=	IC50	nM	2.399	CHEMBL3650	Homo sapiens	pIC50		8.62
	16871932	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C(N)=O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921190	=	IC50	nM	1.778	CHEMBL3650	Homo sapiens	pIC50		8.75
	16871933	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920274	=	IC50	nM	275.42	CHEMBL3650	Homo sapiens	pIC50		6.56
	16871934	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(Cl)c(OC)cc(OC)c2Cl)n1		CHEMBL3953771	=	IC50	nM	12.59	CHEMBL3650	Homo sapiens	pIC50		7.9
	16871935	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950292	=	IC50	nM	15.49	CHEMBL3650	Homo sapiens	pIC50		7.81
	16871936	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ncn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959787	=	IC50	nM	70.79	CHEMBL3650	Homo sapiens	pIC50		7.15
	16871937	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986861	=	IC50	nM	7.079	CHEMBL3650	Homo sapiens	pIC50		8.15
	16871938	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891816	=	IC50	nM	16.6	CHEMBL3650	Homo sapiens	pIC50		7.78
	16871939	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927140	=	IC50	nM	3.162	CHEMBL3650	Homo sapiens	pIC50		8.5
	16871940	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3929849	=	IC50	nM	61.66	CHEMBL3650	Homo sapiens	pIC50		7.21
	16871941	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966941	=	IC50	nM	29.51	CHEMBL3650	Homo sapiens	pIC50		7.53
	16871942	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1		CHEMBL3939018	=	IC50	nM	5.495	CHEMBL3650	Homo sapiens	pIC50		8.26
	16871943	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912757	=	IC50	nM	28.18	CHEMBL3650	Homo sapiens	pIC50		7.55
	16871944	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915450	=	IC50	nM	38.02	CHEMBL3650	Homo sapiens	pIC50		7.42
	16871945	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3950510	=	IC50	nM	1.95	CHEMBL3650	Homo sapiens	pIC50		8.71
	16871946	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3964701	=	IC50	nM	1.047	CHEMBL3650	Homo sapiens	pIC50		8.98
	16871947	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)N(C)OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956493	=	IC50	nM	5.129	CHEMBL3650	Homo sapiens	pIC50		8.29
	16871948	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964931	=	IC50	nM	12.59	CHEMBL3650	Homo sapiens	pIC50		7.9
	16871949	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nc(OC)cc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918956	=	IC50	nM	26.3	CHEMBL3650	Homo sapiens	pIC50		7.58
	16871950	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3916200	=	IC50	nM	2.089	CHEMBL3650	Homo sapiens	pIC50		8.68
	16871951	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3942506	=	IC50	nM	3.981	CHEMBL3650	Homo sapiens	pIC50		8.4
	16871952	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939852	=	IC50	nM	44.67	CHEMBL3650	Homo sapiens	pIC50		7.35
	16871953	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904470	=	IC50	nM	77.62	CHEMBL3650	Homo sapiens	pIC50		7.11
	16871954	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3894754	=	IC50	nM	6.918	CHEMBL3650	Homo sapiens	pIC50		8.16
	16871955	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC(=O)c1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3963296	=	IC50	nM	19.5	CHEMBL3650	Homo sapiens	pIC50		7.71
	16871956	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)(C)C#Cc2nccc(OC)n2)c1		CHEMBL3890187	=	IC50	nM	91.2	CHEMBL3650	Homo sapiens	pIC50		7.04
	16871957	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924891	=	IC50	nM	89.13	CHEMBL3650	Homo sapiens	pIC50		7.05
	16871958	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923190	=	IC50	nM	47.86	CHEMBL3650	Homo sapiens	pIC50		7.32
	16871959	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNc1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3978313	=	IC50	nM	12.88	CHEMBL3650	Homo sapiens	pIC50		7.89
	16871960	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889604	=	IC50	nM	18.62	CHEMBL3650	Homo sapiens	pIC50		7.73
	16871961	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939332	=	IC50	nM	8.913	CHEMBL3650	Homo sapiens	pIC50		8.05
	16871962	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912250	=	IC50	nM	26.3	CHEMBL3650	Homo sapiens	pIC50		7.58
	16871963	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901265	=	IC50	nM	5.623	CHEMBL3650	Homo sapiens	pIC50		8.25
	16871964	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3903973	=	IC50	nM	1.38	CHEMBL3650	Homo sapiens	pIC50		8.86
	16871965	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957928	=	IC50	nM	44.67	CHEMBL3650	Homo sapiens	pIC50		7.35
	16871966	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960591	=	IC50	nM	33.11	CHEMBL3650	Homo sapiens	pIC50		7.48
	16871967	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899721	=	IC50	nM	109.65	CHEMBL3650	Homo sapiens	pIC50		6.96
	16871968	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934772	=	IC50	nM	22.39	CHEMBL3650	Homo sapiens	pIC50		7.65
	16871969	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3n2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909752	=	IC50	nM	56.23	CHEMBL3650	Homo sapiens	pIC50		7.25
	16871970	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906945	=	IC50	nM	18.2	CHEMBL3650	Homo sapiens	pIC50		7.74
	16871971	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3954396	=	IC50	nM	1.778	CHEMBL3650	Homo sapiens	pIC50		8.75
	16871972	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944937	=	IC50	nM	162.18	CHEMBL3650	Homo sapiens	pIC50		6.79
	16871973	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895267	=	IC50	nM	1.549	CHEMBL3650	Homo sapiens	pIC50		8.81
	16871974	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3892529	=	IC50	nM	1.38	CHEMBL3650	Homo sapiens	pIC50		8.86
	16871975	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3935597	=	IC50	nM	0.9333	CHEMBL3650	Homo sapiens	pIC50		9.03
	16871976	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932893	=	IC50	nM	74.13	CHEMBL3650	Homo sapiens	pIC50		7.13
	16871977	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952706	=	IC50	nM	43.65	CHEMBL3650	Homo sapiens	pIC50		7.36
	16871978	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939860	=	IC50	nM	8.318	CHEMBL3650	Homo sapiens	pIC50		8.08
	16871979	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3976275	=	IC50	nM	1.738	CHEMBL3650	Homo sapiens	pIC50		8.76
	16871980	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(F)c(OC)cc(OC)c2F)n1		CHEMBL3978754	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871981	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942716	=	IC50	nM	5.248	CHEMBL3650	Homo sapiens	pIC50		8.28
	16871982	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982718	=	IC50	nM	15.14	CHEMBL3650	Homo sapiens	pIC50		7.82
	16871983	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892005	=	IC50	nM	28.84	CHEMBL3650	Homo sapiens	pIC50		7.54
	16871984	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3894762	=	IC50	nM	1.549	CHEMBL3650	Homo sapiens	pIC50		8.81
	16871985	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)S(=O)(=O)N(C)C)c1		CHEMBL3896514	=	IC50	nM	16.22	CHEMBL3650	Homo sapiens	pIC50		7.79
	16871986	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC(=O)c1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3906253	=	IC50	nM	20.42	CHEMBL3650	Homo sapiens	pIC50		7.69
	16871987	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946877	=	IC50	nM	354.81	CHEMBL3650	Homo sapiens	pIC50		6.45
	16871988	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2c2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944241	=	IC50	nM	51.29	CHEMBL3650	Homo sapiens	pIC50		7.29
	16871989	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947664	=	IC50	nM	10.47	CHEMBL3650	Homo sapiens	pIC50		7.98
	16871990	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899151	=	IC50	nM	1.862	CHEMBL3650	Homo sapiens	pIC50		8.73
	16871991	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960877	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	pIC50		9.0
	16871992	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCC#N)c4)nc3c2)c1		CHEMBL3958209	=	IC50	nM	1.38	CHEMBL3650	Homo sapiens	pIC50		8.86
	16871993	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)(F)F)c4)cc3n2)cn1		CHEMBL3933492	=	IC50	nM	7943.28	CHEMBL3650	Homo sapiens	pIC50		5.1
	16871994	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(C(F)(F)F)c1		CHEMBL3982416	=	IC50	nM	5011.87	CHEMBL3650	Homo sapiens	pIC50		5.3
	16871995	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CN(C)c1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984969	=	IC50	nM	1995.26	CHEMBL3650	Homo sapiens	pIC50		5.7
	16871996	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953206	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16871997	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCN2Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946591	=	IC50	nM	67.61	CHEMBL3650	Homo sapiens	pIC50		7.17
	16871998	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939494	=	IC50	nM	36.31	CHEMBL3650	Homo sapiens	pIC50		7.44
	16871999	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cnnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942179	=	IC50	nM	38.9	CHEMBL3650	Homo sapiens	pIC50		7.41
	16872000	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC(C)(C)N=C2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930685	=	IC50	nM	158.49	CHEMBL3650	Homo sapiens	pIC50		6.8
	16872001	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910555	=	IC50	nM	4.169	CHEMBL3650	Homo sapiens	pIC50		8.38
	16872002	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918036	=	IC50	nM	346.74	CHEMBL3650	Homo sapiens	pIC50		6.46
	16872003	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3920759	=	IC50	nM	36.31	CHEMBL3650	Homo sapiens	pIC50		7.44
	16872004	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965805	=	IC50	nM	204.17	CHEMBL3650	Homo sapiens	pIC50		6.69
	16872005	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CN(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926088	=	IC50	nM	436.52	CHEMBL3650	Homo sapiens	pIC50		6.36
	16872006	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948043	=	IC50	nM	104.71	CHEMBL3650	Homo sapiens	pIC50		6.98
	16872007	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2nccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972657	=	IC50	nM	54.95	CHEMBL3650	Homo sapiens	pIC50		7.26
	16872008	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979172	=	IC50	nM	3.388	CHEMBL3650	Homo sapiens	pIC50		8.47
	16872009	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CN)c1		CHEMBL3976752	=	IC50	nM	1.349	CHEMBL3650	Homo sapiens	pIC50		8.87
	16872010	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918892	=	IC50	nM	169.82	CHEMBL3650	Homo sapiens	pIC50		6.77
	16872011	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnn(C)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966660	=	IC50	nM	81.28	CHEMBL3650	Homo sapiens	pIC50		7.09
	16872012	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(=O)NC(C)C)c1		CHEMBL3899891	=	IC50	nM	23.99	CHEMBL3650	Homo sapiens	pIC50		7.62
	16872013	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(N)=O)c1		CHEMBL3890118	=	IC50	nM	16.6	CHEMBL3650	Homo sapiens	pIC50		7.78
	16872014	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Br.COc1cc(OC)cc(N(CCP(=O)(O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950169	=	IC50	nM	3.311	CHEMBL3650	Homo sapiens	pIC50		8.48
	16872015	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2ncnc2C)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3952885	=	IC50	nM	134.9	CHEMBL3650	Homo sapiens	pIC50		6.87
	16872016	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cnc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890870	=	IC50	nM	79.43	CHEMBL3650	Homo sapiens	pIC50		7.1
	16872017	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(C)Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893659	<	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16872018	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1C(O)C(F)(F)F		CHEMBL3928923	=	IC50	nM	19.95	CHEMBL3650	Homo sapiens	pIC50		7.7
	16872019	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3938712	=	IC50	nM	120.23	CHEMBL3650	Homo sapiens	pIC50		6.92
	16872020	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975295	=	IC50	nM	61.66	CHEMBL3650	Homo sapiens	pIC50		7.21
	16872021	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977791	=	IC50	nM	147.91	CHEMBL3650	Homo sapiens	pIC50		6.83
	16872022	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C#N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916904	=	IC50	nM	218.78	CHEMBL3650	Homo sapiens	pIC50		6.66
	16872023	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974131	=	IC50	nM	173.78	CHEMBL3650	Homo sapiens	pIC50		6.76
	16872024	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3925322	=	IC50	nM	64.57	CHEMBL3650	Homo sapiens	pIC50		7.19
	16872025	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)nc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922592	<	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16872026	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3985007	=	IC50	nM	158.49	CHEMBL3650	Homo sapiens	pIC50		6.8
	16872027	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4c(C(F)(F)F)nn(C)c4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3982466	<	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16872028	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCN(Cc2ccccc2N)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC(OC)=C1		CHEMBL3910921	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16872029	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnc3[nH]ccc3n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908141	<	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16872030	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971947	=	IC50	nM	91.2	CHEMBL3650	Homo sapiens	pIC50		7.04
	16872031	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960102	=	IC50	nM	257.04	CHEMBL3650	Homo sapiens	pIC50		6.59
	16872032	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(CC(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891736	=	IC50	nM	40.74	CHEMBL3650	Homo sapiens	pIC50		7.39
	16872033	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984571	=	IC50	nM	234.42	CHEMBL3650	Homo sapiens	pIC50		6.63
	16872034	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H]2C[C@@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975903	=	IC50	nM	120.23	CHEMBL3650	Homo sapiens	pIC50		6.92
	16872035	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896720	=	IC50	nM	36.31	CHEMBL3650	Homo sapiens	pIC50		7.44
	16872036	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984841	=	IC50	nM	36.31	CHEMBL3650	Homo sapiens	pIC50		7.44
	16872037	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982303	=	IC50	nM	204.17	CHEMBL3650	Homo sapiens	pIC50		6.69
	16872038	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(CNC(C)C)C(C)C)c1		CHEMBL3932123	=	IC50	nM	104.71	CHEMBL3650	Homo sapiens	pIC50		6.98
	16874532	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3931533	=	IC50	nM	389.05	CHEMBL3650	Homo sapiens	pIC50		6.41
	16874533	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947740	=	IC50	nM	501.19	CHEMBL3650	Homo sapiens	pIC50		6.3
	16874534	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963816	=	IC50	nM	1905.46	CHEMBL3650	Homo sapiens	pIC50		5.72
	16874535	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909951	=	IC50	nM	1122.02	CHEMBL3650	Homo sapiens	pIC50		5.95
	16874536	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3912630	=	IC50	nM	3235.94	CHEMBL3650	Homo sapiens	pIC50		5.49
	16874537	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3933449	=	IC50	nM	295.12	CHEMBL3650	Homo sapiens	pIC50		6.53
	16874538	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898908	=	IC50	nM	380.19	CHEMBL3650	Homo sapiens	pIC50		6.42
	16874539	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3986163	=	IC50	nM	1621.81	CHEMBL3650	Homo sapiens	pIC50		5.79
	16874540	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3898120	=	IC50	nM	2570.4	CHEMBL3650	Homo sapiens	pIC50		5.59
	16874541	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3955288	=	IC50	nM	758.58	CHEMBL3650	Homo sapiens	pIC50		6.12
	16874542	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957914	=	IC50	nM	1862.09	CHEMBL3650	Homo sapiens	pIC50		5.73
	16874543	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)F)c4)cc3n2)cn1		CHEMBL3908978	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874544	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3906155	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	16874545	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940334	=	IC50	nM	363.08	CHEMBL3650	Homo sapiens	pIC50		6.44
	16874546	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958153	=	IC50	nM	275.42	CHEMBL3650	Homo sapiens	pIC50		6.56
	16874547	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N(C)C)c4)nc3c2)c1		CHEMBL3925254	=	IC50	nM	436.52	CHEMBL3650	Homo sapiens	pIC50		6.36
	16874548	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3907600	=	IC50	nM	354.81	CHEMBL3650	Homo sapiens	pIC50		6.45
	16874549	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1		CHEMBL3954368	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874550	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCN5CCCC5)c4)nc3c2)c1		CHEMBL3951714	=	IC50	nM	2041.74	CHEMBL3650	Homo sapiens	pIC50		5.69
	16874551	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CC(C)Oc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965364	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874552	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3969446	=	IC50	nM	1584.89	CHEMBL3650	Homo sapiens	pIC50		5.8
	16874553	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951126	=	IC50	nM	436.52	CHEMBL3650	Homo sapiens	pIC50		6.36
	16874554	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3933015	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874555	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898881	=	IC50	nM	57.54	CHEMBL3650	Homo sapiens	pIC50		7.24
	16874556	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2OCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901644	=	IC50	nM	194.98	CHEMBL3650	Homo sapiens	pIC50		6.71
	16874557	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944665	=	IC50	nM	8912.51	CHEMBL3650	Homo sapiens	pIC50		5.05
	16874558	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCN(c1cccc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3947293	=	IC50	nM	3630.78	CHEMBL3650	Homo sapiens	pIC50		5.44
	16874559	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1OC		CHEMBL3947826	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874560	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3985692	=	IC50	nM	186.21	CHEMBL3650	Homo sapiens	pIC50		6.73
	16874561	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947990	=	IC50	nM	2290.87	CHEMBL3650	Homo sapiens	pIC50		5.64
	16874562	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCC5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3925306	=	IC50	nM	1318.26	CHEMBL3650	Homo sapiens	pIC50		5.88
	16874563	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3951245	=	IC50	nM	95.5	CHEMBL3650	Homo sapiens	pIC50		7.02
	16874564	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3948623	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16874565	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3892018	=	IC50	nM	1096.48	CHEMBL3650	Homo sapiens	pIC50		5.96
	16874566	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987037	=	IC50	nM	1148.15	CHEMBL3650	Homo sapiens	pIC50		5.94
	16874567	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3921313	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16874568	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3927327	=	IC50	nM	1778.28	CHEMBL3650	Homo sapiens	pIC50		5.75
	16874569	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1		CHEMBL3976280	=	IC50	nM	812.83	CHEMBL3650	Homo sapiens	pIC50		6.09
	16874570	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCNCCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3973820	=	IC50	nM	1949.84	CHEMBL3650	Homo sapiens	pIC50		5.71
	16874571	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCN(S(C)(=O)=O)CC5)c4)nc3c2)c1		CHEMBL3918011	=	IC50	nM	457.09	CHEMBL3650	Homo sapiens	pIC50		6.34
	16874572	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)nc3c2)c1		CHEMBL3915235	=	IC50	nM	1995.26	CHEMBL3650	Homo sapiens	pIC50		5.7
	16874573	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(C#N)c4)cc3n2)cn1		CHEMBL3965673	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874574	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968094	=	IC50	nM	676.08	CHEMBL3650	Homo sapiens	pIC50		6.17
	16874575	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3918751	=	IC50	nM	218.78	CHEMBL3650	Homo sapiens	pIC50		6.66
	16874576	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	=	IC50	nM	6309.57	CHEMBL3650	Homo sapiens	pIC50		5.2
	16874577	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3908829	=	IC50	nM	691.83	CHEMBL3650	Homo sapiens	pIC50		6.16
	16874578	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(O)CCNCC5)c4)nc3c2)c1		CHEMBL3911573	=	IC50	nM	1905.46	CHEMBL3650	Homo sapiens	pIC50		5.72
	16874579	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969879	=	IC50	nM	2818.38	CHEMBL3650	Homo sapiens	pIC50		5.55
	16874580	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(Cl)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972564	=	IC50	nM	6918.31	CHEMBL3650	Homo sapiens	pIC50		5.16
	16874581	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3927875	=	IC50	nM	630.96	CHEMBL3650	Homo sapiens	pIC50		6.2
	16874582	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C#N)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930634	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874583	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3901627	=	IC50	nM	309.03	CHEMBL3650	Homo sapiens	pIC50		6.51
	16874584	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904329	=	IC50	nM	194.98	CHEMBL3650	Homo sapiens	pIC50		6.71
	16874585	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969408	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874586	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3985853	=	IC50	nM	1148.15	CHEMBL3650	Homo sapiens	pIC50		5.94
	16874587	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(OC)CCNCC5)c4)nc3c2)c1		CHEMBL3908326	=	IC50	nM	831.76	CHEMBL3650	Homo sapiens	pIC50		6.08
	16874588	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3918092	=	IC50	nM	10.72	CHEMBL3650	Homo sapiens	pIC50		7.97
	16874589	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1		CHEMBL3964675	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	16874590	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955706	=	IC50	nM	109.65	CHEMBL3650	Homo sapiens	pIC50		6.96
	16874591	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3937533	=	IC50	nM	977.24	CHEMBL3650	Homo sapiens	pIC50		6.01
	16874592	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCCC5)c4)nc3c2)c1.Cl		CHEMBL3962814	=	IC50	nM	1445.44	CHEMBL3650	Homo sapiens	pIC50		5.84
	16874593	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3931674	=	IC50	nM	123.03	CHEMBL3650	Homo sapiens	pIC50		6.91
	16874594	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)NCCO)c4)nc3c2)c1		CHEMBL3976219	=	IC50	nM	2041.74	CHEMBL3650	Homo sapiens	pIC50		5.69
	16874595	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924872	=	IC50	nM	1071.52	CHEMBL3650	Homo sapiens	pIC50		5.97
	16874596	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3908529	=	IC50	nM	281.84	CHEMBL3650	Homo sapiens	pIC50		6.55
	16874597	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3962805	=	IC50	nM	1862.09	CHEMBL3650	Homo sapiens	pIC50		5.73
	16874598	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)N5CCNCC5)c4)nc3c2)c1		CHEMBL3960128	=	IC50	nM	4897.79	CHEMBL3650	Homo sapiens	pIC50		5.31
	16874599	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3909565	=	IC50	nM	177.83	CHEMBL3650	Homo sapiens	pIC50		6.75
	16874600	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3948321	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	16874601	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCO)c4)nc3c2)c1		CHEMBL3985750	=	IC50	nM	1202.26	CHEMBL3650	Homo sapiens	pIC50		5.92
	16874602	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3983115	=	IC50	nM	741.31	CHEMBL3650	Homo sapiens	pIC50		6.13
	16874603	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3926311	=	IC50	nM	724.44	CHEMBL3650	Homo sapiens	pIC50		6.14
	16874604	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3926406	=	IC50	nM	123.03	CHEMBL3650	Homo sapiens	pIC50		6.91
	16874605	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)on2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979490	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	pIC50		7.0
	16874606	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898355	=	IC50	nM	141.25	CHEMBL3650	Homo sapiens	pIC50		6.85
	16874607	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940725	=	IC50	nM	346.74	CHEMBL3650	Homo sapiens	pIC50		6.46
	16874608	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943387	=	IC50	nM	204.17	CHEMBL3650	Homo sapiens	pIC50		6.69
	16874609	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)OCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3973531	=	IC50	nM	436.52	CHEMBL3650	Homo sapiens	pIC50		6.36
	16874610	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3913757	=	IC50	nM	57.54	CHEMBL3650	Homo sapiens	pIC50		7.24
	16874611	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3961210	=	IC50	nM	63.1	CHEMBL3650	Homo sapiens	pIC50		7.2
	16874612	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936765	=	IC50	nM	2137.96	CHEMBL3650	Homo sapiens	pIC50		5.67
	16874613	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951156	=	IC50	nM	645.65	CHEMBL3650	Homo sapiens	pIC50		6.19
	16874614	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2CCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979170	=	IC50	nM	1096.48	CHEMBL3650	Homo sapiens	pIC50		5.96
	16874615	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921618	=	IC50	nM	18.2	CHEMBL3650	Homo sapiens	pIC50		7.74
	16874616	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3969815	=	IC50	nM	44.67	CHEMBL3650	Homo sapiens	pIC50		7.35
	16874617	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3961872	=	IC50	nM	190.55	CHEMBL3650	Homo sapiens	pIC50		6.72
	16874618	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985222	=	IC50	nM	33.88	CHEMBL3650	Homo sapiens	pIC50		7.47
	16874619	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1		CHEMBL3935232	=	IC50	nM	309.03	CHEMBL3650	Homo sapiens	pIC50		6.51
	16874620	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1.Cl		CHEMBL3909140	=	IC50	nM	1621.81	CHEMBL3650	Homo sapiens	pIC50		5.79
	16874621	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974664	=	IC50	nM	66.07	CHEMBL3650	Homo sapiens	pIC50		7.18
	16874622	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3972173	=	IC50	nM	2041.74	CHEMBL3650	Homo sapiens	pIC50		5.69
	16874623	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919173	=	IC50	nM	18.2	CHEMBL3650	Homo sapiens	pIC50		7.74
	16874624	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3956737	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874625	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3966022	=	IC50	nM	724.44	CHEMBL3650	Homo sapiens	pIC50		6.14
	16874626	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968499	=	IC50	nM	43.65	CHEMBL3650	Homo sapiens	pIC50		7.36
	16874627	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912505	=	IC50	nM	1862.09	CHEMBL3650	Homo sapiens	pIC50		5.73
	16874628	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCC2CC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915158	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874629	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3950262	=	IC50	nM	724.44	CHEMBL3650	Homo sapiens	pIC50		6.14
	16874630	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	83.18	CHEMBL3650	Homo sapiens	pIC50		7.08
	16874631	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3949470	=	IC50	nM	102.33	CHEMBL3650	Homo sapiens	pIC50		6.99
	16874632	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3893008	=	IC50	nM	70.79	CHEMBL3650	Homo sapiens	pIC50		7.15
	16874633	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CO)c4)nc3c2)c1		CHEMBL3889493	=	IC50	nM	1318.26	CHEMBL3650	Homo sapiens	pIC50		5.88
	16874634	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCS(C)(=O)=O)c3)nc2c1		CHEMBL3984548	=	IC50	nM	1202.26	CHEMBL3650	Homo sapiens	pIC50		5.92
	16874635	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cn[nH]c3)nc2c1		CHEMBL3920908	=	IC50	nM	1737.8	CHEMBL3650	Homo sapiens	pIC50		5.76
	16874636	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3939278	=	IC50	nM	114.82	CHEMBL3650	Homo sapiens	pIC50		6.94
	16874637	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974693	=	IC50	nM	46.77	CHEMBL3650	Homo sapiens	pIC50		7.33
	16874638	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3972208	=	IC50	nM	5888.44	CHEMBL3650	Homo sapiens	pIC50		5.23
	16874639	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3935264	=	IC50	nM	95.5	CHEMBL3650	Homo sapiens	pIC50		7.02
	16874640	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3932577	=	IC50	nM	51.29	CHEMBL3650	Homo sapiens	pIC50		7.29
	16874641	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3950907	=	IC50	nM	269.15	CHEMBL3650	Homo sapiens	pIC50		6.57
	16874642	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(C)=N\O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948270	=	IC50	nM	245.47	CHEMBL3650	Homo sapiens	pIC50		6.61
	16874643	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(C)=N/O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955817	=	IC50	nM	204.17	CHEMBL3650	Homo sapiens	pIC50		6.69
	16874644	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	=	IC50	nM	27.54	CHEMBL3650	Homo sapiens	pIC50		7.56
	16874645	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923296	=	IC50	nM	57.54	CHEMBL3650	Homo sapiens	pIC50		7.24
	16874646	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918495	=	IC50	nM	416.87	CHEMBL3650	Homo sapiens	pIC50		6.38
	16874647	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCOc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945369	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874648	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OCCO)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3961267	=	IC50	nM	7079.46	CHEMBL3650	Homo sapiens	pIC50		5.15
	16874649	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	=	IC50	nM	19.05	CHEMBL3650	Homo sapiens	pIC50		7.72
	16874650	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3928627	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874651	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3908877	=	IC50	nM	1659.59	CHEMBL3650	Homo sapiens	pIC50		5.78
	16874652	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3907488	=	IC50	nM	676.08	CHEMBL3650	Homo sapiens	pIC50		6.17
	16874653	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N5CCC(O)C5)c4)nc3c2)c1		CHEMBL3929803	=	IC50	nM	851.14	CHEMBL3650	Homo sapiens	pIC50		6.07
	16874654	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3970430	=	IC50	nM	10.72	CHEMBL3650	Homo sapiens	pIC50		7.97
	16874655	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969475	=	IC50	nM	33.88	CHEMBL3650	Homo sapiens	pIC50		7.47
	16874656	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.c1ccc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)cc1		CHEMBL3963728	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874657	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944224	=	IC50	nM	4466.84	CHEMBL3650	Homo sapiens	pIC50		5.35
	16874658	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909318	=	IC50	nM	194.98	CHEMBL3650	Homo sapiens	pIC50		6.71
	16874659	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982668	=	IC50	nM	154.88	CHEMBL3650	Homo sapiens	pIC50		6.81
	16874660	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C5CCCCO5)c4)nc3c2)c1		CHEMBL3980232	=	IC50	nM	74.13	CHEMBL3650	Homo sapiens	pIC50		7.13
	16874661	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937633	=	IC50	nM	158.49	CHEMBL3650	Homo sapiens	pIC50		6.8
	16874662	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3955563	=	IC50	nM	11.75	CHEMBL3650	Homo sapiens	pIC50		7.93
	16874663	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3890607	=	IC50	nM	186.21	CHEMBL3650	Homo sapiens	pIC50		6.73
	16874664	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCO)c3)nc2c1		CHEMBL3893373	=	IC50	nM	1819.7	CHEMBL3650	Homo sapiens	pIC50		5.74
	16874665	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3928646	=	IC50	nM	416.87	CHEMBL3650	Homo sapiens	pIC50		6.38
	16874666	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3931381	=	IC50	nM	1479.11	CHEMBL3650	Homo sapiens	pIC50		5.83
	16874667	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3938610	=	IC50	nM	1819.7	CHEMBL3650	Homo sapiens	pIC50		5.74
	16874668	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)N2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923808	=	IC50	nM	1819.7	CHEMBL3650	Homo sapiens	pIC50		5.74
	16874669	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3890896	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	16874670	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986607	=	IC50	nM	416.87	CHEMBL3650	Homo sapiens	pIC50		6.38
	16874671	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3902581	=	IC50	nM	1737.8	CHEMBL3650	Homo sapiens	pIC50		5.76
	16874672	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3954298	=	IC50	nM	275.42	CHEMBL3650	Homo sapiens	pIC50		6.56
	16874673	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892025	=	IC50	nM	1202.26	CHEMBL3650	Homo sapiens	pIC50		5.92
	16874674	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935912	=	IC50	nM	194.98	CHEMBL3650	Homo sapiens	pIC50		6.71
	16874675	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3900620	=	IC50	nM	1174.9	CHEMBL3650	Homo sapiens	pIC50		5.93
	16874676	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897858	=	IC50	nM	251.19	CHEMBL3650	Homo sapiens	pIC50		6.6
	16874677	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896104	=	IC50	nM	37.15	CHEMBL3650	Homo sapiens	pIC50		7.43
	16874678	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893398	=	IC50	nM	36.31	CHEMBL3650	Homo sapiens	pIC50		7.44
	16874679	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3983996	=	IC50	nM	251.19	CHEMBL3650	Homo sapiens	pIC50		6.6
	16874680	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3935124	=	IC50	nM	1202.26	CHEMBL3650	Homo sapiens	pIC50		5.92
	16874681	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3973645	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874682	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCF)c4)nc3c2)c1		CHEMBL3971073	=	IC50	nM	2754.23	CHEMBL3650	Homo sapiens	pIC50		5.56
	16874683	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957264	=	IC50	nM	75.86	CHEMBL3650	Homo sapiens	pIC50		7.12
	16874684	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969096	=	IC50	nM	1621.81	CHEMBL3650	Homo sapiens	pIC50		5.79
	16874685	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCc2nnn[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905212	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874686	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897034	=	IC50	nM	660.69	CHEMBL3650	Homo sapiens	pIC50		6.18
	16874687	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CCCN(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979885	=	IC50	nM	208.93	CHEMBL3650	Homo sapiens	pIC50		6.68
	16874688	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3982334	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874689	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	=	IC50	nM	114.82	CHEMBL3650	Homo sapiens	pIC50		6.94
	16874690	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC1CCN(CCCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)C1.Cl		CHEMBL3922453	=	IC50	nM	323.59	CHEMBL3650	Homo sapiens	pIC50		6.49
	16874691	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	=	IC50	nM	53.7	CHEMBL3650	Homo sapiens	pIC50		7.27
	16874692	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959201	=	IC50	nM	2089.3	CHEMBL3650	Homo sapiens	pIC50		5.68
	16874693	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915233	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874694	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCS(=O)(=O)NCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3912569	=	IC50	nM	74.13	CHEMBL3650	Homo sapiens	pIC50		7.13
	16874695	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccco2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975954	=	IC50	nM	436.52	CHEMBL3650	Homo sapiens	pIC50		6.36
	16874696	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3966748	=	IC50	nM	302.0	CHEMBL3650	Homo sapiens	pIC50		6.52
	16874697	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3929648	=	IC50	nM	1202.26	CHEMBL3650	Homo sapiens	pIC50		5.92
	16874698	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926964	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874699	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3891619	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	16874700	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3986661	=	IC50	nM	288.4	CHEMBL3650	Homo sapiens	pIC50		6.54
	16874701	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943043	=	IC50	nM	48.98	CHEMBL3650	Homo sapiens	pIC50		7.31
	16874702	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)C1CCN(CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC1		CHEMBL3904745	=	IC50	nM	302.0	CHEMBL3650	Homo sapiens	pIC50		6.52
	16874703	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(Cl)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965614	=	IC50	nM	125.89	CHEMBL3650	Homo sapiens	pIC50		6.9
	16874704	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nnc(N)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968009	=	IC50	nM	141.25	CHEMBL3650	Homo sapiens	pIC50		6.85
	16874705	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CN(CCO)C5)c4)nc3c2)c1		CHEMBL3906122	=	IC50	nM	1513.56	CHEMBL3650	Homo sapiens	pIC50		5.82
	16874706	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(Cc5ccc(Cl)s5)c4)nc3c2)c1		CHEMBL3900268	=	IC50	nM	6760.83	CHEMBL3650	Homo sapiens	pIC50		5.17
	16874707	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3949132	=	IC50	nM	34.67	CHEMBL3650	Homo sapiens	pIC50		7.46
	16874708	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3951728	=	IC50	nM	616.6	CHEMBL3650	Homo sapiens	pIC50		6.21
	16874709	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962554	=	IC50	nM	1174.9	CHEMBL3650	Homo sapiens	pIC50		5.93
	16874710	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913970	=	IC50	nM	467.74	CHEMBL3650	Homo sapiens	pIC50		6.33
	16874711	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN4CCCC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3972979	=	IC50	nM	31.62	CHEMBL3650	Homo sapiens	pIC50		7.5
	16874712	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975447	=	IC50	nM	30.9	CHEMBL3650	Homo sapiens	pIC50		7.51
	16874713	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921243	=	IC50	nM	2290.87	CHEMBL3650	Homo sapiens	pIC50		5.64
	16874714	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911516	=	IC50	nM	630.96	CHEMBL3650	Homo sapiens	pIC50		6.2
	16874715	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958756	=	IC50	nM	6456.54	CHEMBL3650	Homo sapiens	pIC50		5.19
	16874716	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956120	=	IC50	nM	630.96	CHEMBL3650	Homo sapiens	pIC50		6.2
	16874717	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3907551	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874718	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)Cn1cc(CN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nn1		CHEMBL3904777	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874719	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	OCCn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3975007	=	IC50	nM	3630.78	CHEMBL3650	Homo sapiens	pIC50		5.44
	16874720	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(OC)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972517	=	IC50	nM	123.03	CHEMBL3650	Homo sapiens	pIC50		6.91
	16874721	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928956	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874722	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919270	=	IC50	nM	2041.74	CHEMBL3650	Homo sapiens	pIC50		5.69
	16874723	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941705	=	IC50	nM	3162.28	CHEMBL3650	Homo sapiens	pIC50		5.5
	16874724	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982570	=	IC50	nM	2137.96	CHEMBL3650	Homo sapiens	pIC50		5.67
	16874725	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C(C)CCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920007	=	IC50	nM	251.19	CHEMBL3650	Homo sapiens	pIC50		6.6
	16874726	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3922698	=	IC50	nM	1584.89	CHEMBL3650	Homo sapiens	pIC50		5.8
	16874727	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957533	=	IC50	nM	1148.15	CHEMBL3650	Homo sapiens	pIC50		5.94
	16874728	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969373	=	IC50	nM	512.86	CHEMBL3650	Homo sapiens	pIC50		6.29
	16874729	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3905485	=	IC50	nM	58.88	CHEMBL3650	Homo sapiens	pIC50		7.23
	16874730	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904674	=	IC50	nM	67.61	CHEMBL3650	Homo sapiens	pIC50		7.17
	16874731	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945845	>	IC50	nM	120.23	CHEMBL3650	Homo sapiens	pIC50		6.92
	16874732	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3951694	=	IC50	nM	1174.9	CHEMBL3650	Homo sapiens	pIC50		5.93
	16874733	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3929914	=	IC50	nM	1122.02	CHEMBL3650	Homo sapiens	pIC50		5.95
	16874734	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	912.01	CHEMBL3650	Homo sapiens	pIC50		6.04
	16874735	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891892	=	IC50	nM	223.87	CHEMBL3650	Homo sapiens	pIC50		6.65
	16874736	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985498	=	IC50	nM	2344.23	CHEMBL3650	Homo sapiens	pIC50		5.63
	16874737	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915533	=	IC50	nM	281.84	CHEMBL3650	Homo sapiens	pIC50		6.55
	16874738	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912831	=	IC50	nM	131.83	CHEMBL3650	Homo sapiens	pIC50		6.88
	16874739	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(C3C[C@@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3976183	=	IC50	nM	120.23	CHEMBL3650	Homo sapiens	pIC50		6.92
	16874740	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967011	=	IC50	nM	549.54	CHEMBL3650	Homo sapiens	pIC50		6.26
	16874741	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931154	=	IC50	nM	66.07	CHEMBL3650	Homo sapiens	pIC50		7.18
	16874742	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893718	=	IC50	nM	741.31	CHEMBL3650	Homo sapiens	pIC50		6.13
	16874743	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3922285	=	IC50	nM	204.17	CHEMBL3650	Homo sapiens	pIC50		6.69
	16874744	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925008	=	IC50	nM	154.88	CHEMBL3650	Homo sapiens	pIC50		6.81
	16874745	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909529	=	IC50	nM	51.29	CHEMBL3650	Homo sapiens	pIC50		7.29
	16874746	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973321	=	IC50	nM	549.54	CHEMBL3650	Homo sapiens	pIC50		6.26
	16874747	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936672	=	IC50	nM	35.48	CHEMBL3650	Homo sapiens	pIC50		7.45
	16874748	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939439	=	IC50	nM	61.66	CHEMBL3650	Homo sapiens	pIC50		7.21
	16874749	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C[Si](C)(C)C)c4)nc3c2)c1		CHEMBL3898601	=	IC50	nM	3235.94	CHEMBL3650	Homo sapiens	pIC50		5.49
	16874750	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901357	=	IC50	nM	275.42	CHEMBL3650	Homo sapiens	pIC50		6.56
	16874751	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3957643	=	IC50	nM	562.34	CHEMBL3650	Homo sapiens	pIC50		6.25
	16874752	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960327	=	IC50	nM	181.97	CHEMBL3650	Homo sapiens	pIC50		6.74
	16874753	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC(C)(C)NC(C)(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981706	=	IC50	nM	2754.23	CHEMBL3650	Homo sapiens	pIC50		5.56
	16874754	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3979314	=	IC50	nM	5623.41	CHEMBL3650	Homo sapiens	pIC50		5.25
	16874755	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985678	=	IC50	nM	213.8	CHEMBL3650	Homo sapiens	pIC50		6.67
	16874756	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969381	=	IC50	nM	67.61	CHEMBL3650	Homo sapiens	pIC50		7.17
	16874757	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968361	=	IC50	nM	1584.89	CHEMBL3650	Homo sapiens	pIC50		5.8
	16874758	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	=	IC50	nM	1122.02	CHEMBL3650	Homo sapiens	pIC50		5.95
	16874759	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907314	=	IC50	nM	16.6	CHEMBL3650	Homo sapiens	pIC50		7.78
	16874760	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cn[nH]n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904561	=	IC50	nM	389.05	CHEMBL3650	Homo sapiens	pIC50		6.41
	16874761	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945264	=	IC50	nM	16.6	CHEMBL3650	Homo sapiens	pIC50		7.78
	16874762	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3942594	=	IC50	nM	177.83	CHEMBL3650	Homo sapiens	pIC50		6.75
	16874763	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915268	=	IC50	nM	363.08	CHEMBL3650	Homo sapiens	pIC50		6.44
	16874764	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925081	=	IC50	nM	257.04	CHEMBL3650	Homo sapiens	pIC50		6.59
	16874765	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])n1cc(-c2ccc3ncc(N(CCO)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3959849	=	IC50	nM	281.84	CHEMBL3650	Homo sapiens	pIC50		6.55
	16874766	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962549	=	IC50	nM	1778.28	CHEMBL3650	Homo sapiens	pIC50		5.75
	16874767	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3966626	=	IC50	nM	2398.83	CHEMBL3650	Homo sapiens	pIC50		5.62
	16874768	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969192	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874769	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975986	<	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16874770	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	=	IC50	nM	151.36	CHEMBL3650	Homo sapiens	pIC50		6.82
	16874771	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C2OCCO2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979996	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874772	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(OC)CCCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3891474	=	IC50	nM	446.68	CHEMBL3650	Homo sapiens	pIC50		6.35
	16874773	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3892135	=	IC50	nM	16.22	CHEMBL3650	Homo sapiens	pIC50		7.79
	16874774	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969824	=	IC50	nM	223.87	CHEMBL3650	Homo sapiens	pIC50		6.65
	16874775	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932285	=	IC50	nM	213.8	CHEMBL3650	Homo sapiens	pIC50		6.67
	16874776	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922586	=	IC50	nM	39.81	CHEMBL3650	Homo sapiens	pIC50		7.4
	16874777	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901682	=	IC50	nM	3715.35	CHEMBL3650	Homo sapiens	pIC50		5.43
	16874778	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927733	=	IC50	nM	1023.29	CHEMBL3650	Homo sapiens	pIC50		5.99
	16874779	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2ccc3ncc(N(CCN)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3976053	=	IC50	nM	1318.26	CHEMBL3650	Homo sapiens	pIC50		5.88
	16874780	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973587	=	IC50	nM	741.31	CHEMBL3650	Homo sapiens	pIC50		6.13
	16874781	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936828	=	IC50	nM	416.87	CHEMBL3650	Homo sapiens	pIC50		6.38
	16874782	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(F)(F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934039	=	IC50	nM	1584.89	CHEMBL3650	Homo sapiens	pIC50		5.8
	16874783	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981418	=	IC50	nM	91.2	CHEMBL3650	Homo sapiens	pIC50		7.04
	16874784	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2ccc3ncc(N(CCN)c4cc(F)cc(OCCO)c4)nc3c2)cn1		CHEMBL3972694	=	IC50	nM	2137.96	CHEMBL3650	Homo sapiens	pIC50		5.67
	16874785	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cn(CCO)nn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921457	=	IC50	nM	323.59	CHEMBL3650	Homo sapiens	pIC50		6.49
	16874786	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3918739	=	IC50	nM	218.78	CHEMBL3650	Homo sapiens	pIC50		6.66
	16874787	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968793	=	IC50	nM	1348.96	CHEMBL3650	Homo sapiens	pIC50		5.87
	16874788	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3966305	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	16874789	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3935825	=	IC50	nM	147.91	CHEMBL3650	Homo sapiens	pIC50		6.83
	16874790	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897101	=	IC50	nM	147.91	CHEMBL3650	Homo sapiens	pIC50		6.83
	16874791	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3891115	=	IC50	nM	4897.79	CHEMBL3650	Homo sapiens	pIC50		5.31
	16874792	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3979662	=	IC50	nM	5495.41	CHEMBL3650	Homo sapiens	pIC50		5.26
	16874793	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3983387	=	IC50	nM	239.88	CHEMBL3650	Homo sapiens	pIC50		6.62
	16874794	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986068	=	IC50	nM	6.457	CHEMBL3650	Homo sapiens	pIC50		8.19
	16874795	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CC)CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3916975	=	IC50	nM	42.66	CHEMBL3650	Homo sapiens	pIC50		7.37
	16874796	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])n1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3919709	=	IC50	nM	29.51	CHEMBL3650	Homo sapiens	pIC50		7.53
	16874797	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975791	=	IC50	nM	23.99	CHEMBL3650	Homo sapiens	pIC50		7.62
	16874798	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963323	=	IC50	nM	295.12	CHEMBL3650	Homo sapiens	pIC50		6.53
	16874799	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945373	=	IC50	nM	83.18	CHEMBL3650	Homo sapiens	pIC50		7.08
	16874800	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933341	=	IC50	nM	416.87	CHEMBL3650	Homo sapiens	pIC50		6.38
	16874801	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3893344	=	IC50	nM	169.82	CHEMBL3650	Homo sapiens	pIC50		6.77
	16874802	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3896052	=	IC50	nM	85.11	CHEMBL3650	Homo sapiens	pIC50		7.07
	16874803	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3947361	=	IC50	nM	15.49	CHEMBL3650	Homo sapiens	pIC50		7.81
	16874804	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3944739	=	IC50	nM	2089.3	CHEMBL3650	Homo sapiens	pIC50		5.68
	16874805	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3909551	=	IC50	nM	21.88	CHEMBL3650	Homo sapiens	pIC50		7.66
	16874806	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899692	=	IC50	nM	181.97	CHEMBL3650	Homo sapiens	pIC50		6.74
	16874807	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3C[C@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3961400	=	IC50	nM	79.43	CHEMBL3650	Homo sapiens	pIC50		7.1
	16874808	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958708	=	IC50	nM	363.08	CHEMBL3650	Homo sapiens	pIC50		6.44
	16874809	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974080	=	IC50	nM	1698.24	CHEMBL3650	Homo sapiens	pIC50		5.77
	16874810	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1		CHEMBL3921197	=	IC50	nM	645.65	CHEMBL3650	Homo sapiens	pIC50		6.19
	16874811	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898568	=	IC50	nM	162.18	CHEMBL3650	Homo sapiens	pIC50		6.79
	16874812	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986036	=	IC50	nM	870.96	CHEMBL3650	Homo sapiens	pIC50		6.06
	16874813	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3914615	=	IC50	nM	870.96	CHEMBL3650	Homo sapiens	pIC50		6.06
	16874814	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3924422	=	IC50	nM	537.03	CHEMBL3650	Homo sapiens	pIC50		6.27
	16874815	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCF)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959193	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	16874816	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3961923	=	IC50	nM	38.02	CHEMBL3650	Homo sapiens	pIC50		7.42
	16874817	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936087	=	IC50	nM	138.04	CHEMBL3650	Homo sapiens	pIC50		6.86
	16874818	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893070	=	IC50	nM	457.09	CHEMBL3650	Homo sapiens	pIC50		6.34
	16874819	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942763	=	IC50	nM	17.38	CHEMBL3650	Homo sapiens	pIC50		7.76
	16874820	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nnc(NCCO)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977904	=	IC50	nM	3019.95	CHEMBL3650	Homo sapiens	pIC50		5.52
	16874821	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3906894	=	IC50	nM	7.586	CHEMBL3650	Homo sapiens	pIC50		8.12
	16874822	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	=	IC50	nM	251.19	CHEMBL3650	Homo sapiens	pIC50		6.6
	16874823	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	=	IC50	nM	47.86	CHEMBL3650	Homo sapiens	pIC50		7.32
	16874824	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3904441	=	IC50	nM	1584.89	CHEMBL3650	Homo sapiens	pIC50		5.8
	16874825	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3945159	=	IC50	nM	16.22	CHEMBL3650	Homo sapiens	pIC50		7.79
	16874826	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3915021	=	IC50	nM	831.76	CHEMBL3650	Homo sapiens	pIC50		6.08
	16874827	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3892776	=	IC50	nM	141.25	CHEMBL3650	Homo sapiens	pIC50		6.85
	16874828	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981077	=	IC50	nM	1202.26	CHEMBL3650	Homo sapiens	pIC50		5.92
	16874829	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930819	=	IC50	nM	3630.78	CHEMBL3650	Homo sapiens	pIC50		5.44
	16874830	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3926082	=	IC50	nM	9.55	CHEMBL3650	Homo sapiens	pIC50		8.02
	16874831	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3970423	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	16874832	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967739	=	IC50	nM	416.87	CHEMBL3650	Homo sapiens	pIC50		6.38
	16874833	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939764	=	IC50	nM	97.72	CHEMBL3650	Homo sapiens	pIC50		7.01
	16874834	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3900574	=	IC50	nM	128.82	CHEMBL3650	Homo sapiens	pIC50		6.89
	16874835	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3950089	=	IC50	nM	323.59	CHEMBL3650	Homo sapiens	pIC50		6.49
	16874836	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3959573	=	IC50	nM	389.05	CHEMBL3650	Homo sapiens	pIC50		6.41
	16874837	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912310	=	IC50	nM	46.77	CHEMBL3650	Homo sapiens	pIC50		7.33
	16874838	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914955	=	IC50	nM	457.09	CHEMBL3650	Homo sapiens	pIC50		6.34
	16874839	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973263	=	IC50	nM	446.68	CHEMBL3650	Homo sapiens	pIC50		6.35
	16874840	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975714	=	IC50	nM	1995.26	CHEMBL3650	Homo sapiens	pIC50		5.7
	16874841	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933707	=	IC50	nM	38.02	CHEMBL3650	Homo sapiens	pIC50		7.42
	16874842	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950069	=	IC50	nM	53.7	CHEMBL3650	Homo sapiens	pIC50		7.27
	16874843	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3979013	=	IC50	nM	77.62	CHEMBL3650	Homo sapiens	pIC50		7.11
	16874844	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942811	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	16874845	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3940175	=	IC50	nM	26.92	CHEMBL3650	Homo sapiens	pIC50		7.57
	16874846	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968038	=	IC50	nM	1949.84	CHEMBL3650	Homo sapiens	pIC50		5.71
	16874847	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965640	=	IC50	nM	186.21	CHEMBL3650	Homo sapiens	pIC50		6.73
	16874848	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ncc[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928393	=	IC50	nM	28.84	CHEMBL3650	Homo sapiens	pIC50		7.54
	16874849	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918704	=	IC50	nM	229.09	CHEMBL3650	Homo sapiens	pIC50		6.64
	16874850	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3947189	=	IC50	nM	40.74	CHEMBL3650	Homo sapiens	pIC50		7.39
	16874851	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944438	=	IC50	nM	87.1	CHEMBL3650	Homo sapiens	pIC50		7.06
	16874852	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3965710	=	IC50	nM	64.57	CHEMBL3650	Homo sapiens	pIC50		7.19
	16874853	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968124	=	IC50	nM	36.31	CHEMBL3650	Homo sapiens	pIC50		7.44
	16874854	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964574	=	IC50	nM	14.79	CHEMBL3650	Homo sapiens	pIC50		7.83
	16874855	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907047	=	IC50	nM	95.5	CHEMBL3650	Homo sapiens	pIC50		7.02
	16874856	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3942328	=	IC50	nM	112.2	CHEMBL3650	Homo sapiens	pIC50		6.95
	16874857	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951847	=	IC50	nM	380.19	CHEMBL3650	Homo sapiens	pIC50		6.42
	16874858	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N\O		CHEMBL3889890	=	IC50	nM	741.31	CHEMBL3650	Homo sapiens	pIC50		6.13
	16874859	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N/O		CHEMBL3892632	=	IC50	nM	309.03	CHEMBL3650	Homo sapiens	pIC50		6.51
	16874860	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930298	=	IC50	nM	363.08	CHEMBL3650	Homo sapiens	pIC50		6.44
	16874861	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CNS(=O)(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933000	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16874862	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3891464	=	IC50	nM	112.2	CHEMBL3650	Homo sapiens	pIC50		6.95
	16874863	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950910	=	IC50	nM	138.04	CHEMBL3650	Homo sapiens	pIC50		6.86
	16874864	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3901420	=	IC50	nM	19.5	CHEMBL3650	Homo sapiens	pIC50		7.71
	16874865	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939200	=	IC50	nM	19.05	CHEMBL3650	Homo sapiens	pIC50		7.72
	16874866	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905866	=	IC50	nM	75.86	CHEMBL3650	Homo sapiens	pIC50		7.12
	16874867	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903198	=	IC50	nM	123.03	CHEMBL3650	Homo sapiens	pIC50		6.91
	16874868	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)N[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943933	=	IC50	nM	741.31	CHEMBL3650	Homo sapiens	pIC50		6.13
	16874869	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCS(=O)(=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925077	=	IC50	nM	169.82	CHEMBL3650	Homo sapiens	pIC50		6.77
	16874870	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCF)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3946674	=	IC50	nM	95.5	CHEMBL3650	Homo sapiens	pIC50		7.02
	16874871	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931790	=	IC50	nM	31.62	CHEMBL3650	Homo sapiens	pIC50		7.5
	16874872	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934487	=	IC50	nM	85.11	CHEMBL3650	Homo sapiens	pIC50		7.07
	16874873	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3893786	=	IC50	nM	6.761	CHEMBL3650	Homo sapiens	pIC50		8.17
	16874874	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(CO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917141	=	IC50	nM	30.2	CHEMBL3650	Homo sapiens	pIC50		7.52
	16874875	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975397	=	IC50	nM	251.19	CHEMBL3650	Homo sapiens	pIC50		6.6
	16874876	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891966	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	16874877	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3941700	=	IC50	nM	141.25	CHEMBL3650	Homo sapiens	pIC50		6.85
	16874878	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3980252	=	IC50	nM	186.21	CHEMBL3650	Homo sapiens	pIC50		6.73
	16874879	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967065	=	IC50	nM	38.02	CHEMBL3650	Homo sapiens	pIC50		7.42
	16874880	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969665	=	IC50	nM	478.63	CHEMBL3650	Homo sapiens	pIC50		6.32
	16874881	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C(C)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981076	=	IC50	nM	218.78	CHEMBL3650	Homo sapiens	pIC50		6.66
	16874882	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983529	=	IC50	nM	128.82	CHEMBL3650	Homo sapiens	pIC50		6.89
	16874883	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935457	=	IC50	nM	53.7	CHEMBL3650	Homo sapiens	pIC50		7.27
	16874884	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905048	=	IC50	nM	120.23	CHEMBL3650	Homo sapiens	pIC50		6.92
	16874885	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925610	=	IC50	nM	107.15	CHEMBL3650	Homo sapiens	pIC50		6.97
	16874886	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3928261	=	IC50	nM	43.65	CHEMBL3650	Homo sapiens	pIC50		7.36
	16874887	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2COC2)c1		CHEMBL3985259	=	IC50	nM	446.68	CHEMBL3650	Homo sapiens	pIC50		6.35
	16874888	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890205	=	IC50	nM	1513.56	CHEMBL3650	Homo sapiens	pIC50		5.82
	16874889	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944610	=	IC50	nM	42.66	CHEMBL3650	Homo sapiens	pIC50		7.37
	16874890	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)C(C)C.Cl		CHEMBL3944320	=	IC50	nM	38.9	CHEMBL3650	Homo sapiens	pIC50		7.41
	16874891	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943860	=	IC50	nM	33.11	CHEMBL3650	Homo sapiens	pIC50		7.48
	16874892	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(=N/O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941174	=	IC50	nM	2187.76	CHEMBL3650	Homo sapiens	pIC50		5.66
	16874893	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(=N\O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982351	=	IC50	nM	630.96	CHEMBL3650	Homo sapiens	pIC50		6.2
	16874894	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3979908	=	IC50	nM	4073.8	CHEMBL3650	Homo sapiens	pIC50		5.39
	16874895	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCNC(=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934355	=	IC50	nM	354.81	CHEMBL3650	Homo sapiens	pIC50		6.45
	16874896	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919750	=	IC50	nM	316.23	CHEMBL3650	Homo sapiens	pIC50		6.5
	16874897	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969112	=	IC50	nM	30.2	CHEMBL3650	Homo sapiens	pIC50		7.52
	16874898	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966560	=	IC50	nM	57.54	CHEMBL3650	Homo sapiens	pIC50		7.24
	16874899	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910444	=	IC50	nM	21.38	CHEMBL3650	Homo sapiens	pIC50		7.67
	16874900	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)nc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907642	=	IC50	nM	213.8	CHEMBL3650	Homo sapiens	pIC50		6.67
	16874901	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973929	=	IC50	nM	30.2	CHEMBL3650	Homo sapiens	pIC50		7.52
	16874902	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C(=O)C3CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972617	=	IC50	nM	218.78	CHEMBL3650	Homo sapiens	pIC50		6.66
	16874903	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(F)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908149	=	IC50	nM	44.67	CHEMBL3650	Homo sapiens	pIC50		7.35
	16874904	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1		CHEMBL3911621	=	IC50	nM	13.18	CHEMBL3650	Homo sapiens	pIC50		7.88
	16874905	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@H](NC(C)C)CC2)c1		CHEMBL3918800	=	IC50	nM	114.82	CHEMBL3650	Homo sapiens	pIC50		6.94
	16874906	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902353	=	IC50	nM	4.898	CHEMBL3650	Homo sapiens	pIC50		8.31
	16874907	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943080	=	IC50	nM	741.31	CHEMBL3650	Homo sapiens	pIC50		6.13
	16874908	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968139	=	IC50	nM	13.8	CHEMBL3650	Homo sapiens	pIC50		7.86
	16874909	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3904294	=	IC50	nM	131.83	CHEMBL3650	Homo sapiens	pIC50		6.88
	16874910	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907063	=	IC50	nM	44.67	CHEMBL3650	Homo sapiens	pIC50		7.35
	16874911	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3896623	=	IC50	nM	54.95	CHEMBL3650	Homo sapiens	pIC50		7.26
	16874912	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC[Si](C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3893950	=	IC50	nM	72.44	CHEMBL3650	Homo sapiens	pIC50		7.14
	16874913	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955745	=	IC50	nM	588.84	CHEMBL3650	Homo sapiens	pIC50		6.23
	16874914	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953117	=	IC50	nM	812.83	CHEMBL3650	Homo sapiens	pIC50		6.09
	16874915	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951360	=	IC50	nM	97.72	CHEMBL3650	Homo sapiens	pIC50		7.01
	16874916	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948744	=	IC50	nM	42.66	CHEMBL3650	Homo sapiens	pIC50		7.37
	16874917	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3941695	=	IC50	nM	50.12	CHEMBL3650	Homo sapiens	pIC50		7.3
	16874918	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3903811	=	IC50	nM	20.89	CHEMBL3650	Homo sapiens	pIC50		7.68
	16874919	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930158	=	IC50	nM	630.96	CHEMBL3650	Homo sapiens	pIC50		6.2
	16874920	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927451	=	IC50	nM	32.36	CHEMBL3650	Homo sapiens	pIC50		7.49
	16874921	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3911746	=	IC50	nM	588.84	CHEMBL3650	Homo sapiens	pIC50		6.23
	16874922	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CCN(S(N)(=O)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917295	=	IC50	nM	77.62	CHEMBL3650	Homo sapiens	pIC50		7.11
	16874923	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902110	=	IC50	nM	363.08	CHEMBL3650	Homo sapiens	pIC50		6.44
	16874924	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cc(C)nc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904814	=	IC50	nM	1479.11	CHEMBL3650	Homo sapiens	pIC50		5.83
	16874925	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911948	=	IC50	nM	794.33	CHEMBL3650	Homo sapiens	pIC50		6.1
	16874926	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928239	=	IC50	nM	141.25	CHEMBL3650	Homo sapiens	pIC50		6.85
	16874927	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979028	=	IC50	nM	1412.54	CHEMBL3650	Homo sapiens	pIC50		5.85
	16874928	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890378	=	IC50	nM	104.71	CHEMBL3650	Homo sapiens	pIC50		6.98
	16874929	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1.Cl		CHEMBL3932363	=	IC50	nM	34.67	CHEMBL3650	Homo sapiens	pIC50		7.46
	16874930	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3934260	=	IC50	nM	34.67	CHEMBL3650	Homo sapiens	pIC50		7.46
	16874931	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932756	=	IC50	nM	18.2	CHEMBL3650	Homo sapiens	pIC50		7.74
	16874932	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3919479	=	IC50	nM	9.333	CHEMBL3650	Homo sapiens	pIC50		8.03
	16874933	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968818	=	IC50	nM	15.14	CHEMBL3650	Homo sapiens	pIC50		7.82
	16874934	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966316	=	IC50	nM	3162.28	CHEMBL3650	Homo sapiens	pIC50		5.5
	16874935	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C3CCN(C(C)=O)CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943610	=	IC50	nM	63.1	CHEMBL3650	Homo sapiens	pIC50		7.2
	16874936	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(Br)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940940	=	IC50	nM	208.93	CHEMBL3650	Homo sapiens	pIC50		6.68
	16874937	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3982107	=	IC50	nM	181.97	CHEMBL3650	Homo sapiens	pIC50		6.74
	16874938	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3979670	=	IC50	nM	17.78	CHEMBL3650	Homo sapiens	pIC50		7.75
	16874939	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3921476	=	IC50	nM	10.23	CHEMBL3650	Homo sapiens	pIC50		7.99
	16874940	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3911738	=	IC50	nM	208.93	CHEMBL3650	Homo sapiens	pIC50		6.68
	16874941	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960571	=	IC50	nM	169.82	CHEMBL3650	Homo sapiens	pIC50		6.77
	16874942	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3974206	=	IC50	nM	79.43	CHEMBL3650	Homo sapiens	pIC50		7.1
	16874943	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3911635	=	IC50	nM	102.33	CHEMBL3650	Homo sapiens	pIC50		6.99
	16874944	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913322	=	IC50	nM	50.12	CHEMBL3650	Homo sapiens	pIC50		7.3
	16874945	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916037	=	IC50	nM	131.83	CHEMBL3650	Homo sapiens	pIC50		6.88
	16874946	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nccn2S(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889711	=	IC50	nM	524.81	CHEMBL3650	Homo sapiens	pIC50		6.28
	16874947	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927585	=	IC50	nM	257.04	CHEMBL3650	Homo sapiens	pIC50		6.59
	16874948	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1		CHEMBL3984461	=	IC50	nM	117.49	CHEMBL3650	Homo sapiens	pIC50		6.93
	16874949	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3981955	=	IC50	nM	117.49	CHEMBL3650	Homo sapiens	pIC50		6.93
	16874950	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3946103	=	IC50	nM	177.83	CHEMBL3650	Homo sapiens	pIC50		6.75
	16874951	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1ccnc1CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3936421	=	IC50	nM	5248.07	CHEMBL3650	Homo sapiens	pIC50		5.28
	16874952	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2COCC(C)(C)N2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901119	=	IC50	nM	25.7	CHEMBL3650	Homo sapiens	pIC50		7.59
	16874953	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898346	=	IC50	nM	199.53	CHEMBL3650	Homo sapiens	pIC50		6.7
	16874954	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895378	=	IC50	nM	234.42	CHEMBL3650	Homo sapiens	pIC50		6.63
	16874955	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H](C)CN)c1		CHEMBL3957414	=	IC50	nM	120.23	CHEMBL3650	Homo sapiens	pIC50		6.92
	16874956	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1		CHEMBL3922607	=	IC50	nM	234.42	CHEMBL3650	Homo sapiens	pIC50		6.63
	16874957	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919884	=	IC50	nM	54.95	CHEMBL3650	Homo sapiens	pIC50		7.26
	16874958	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNC(C)C)c1		CHEMBL3942606	=	IC50	nM	50.12	CHEMBL3650	Homo sapiens	pIC50		7.3
	16874959	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945277	=	IC50	nM	37.15	CHEMBL3650	Homo sapiens	pIC50		7.43
	16874960	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897523	=	IC50	nM	16.22	CHEMBL3650	Homo sapiens	pIC50		7.79
	16874961	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907327	=	IC50	nM	446.68	CHEMBL3650	Homo sapiens	pIC50		6.35
	16874962	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956579	=	IC50	nM	154.88	CHEMBL3650	Homo sapiens	pIC50		6.81
	16874963	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959260	=	IC50	nM	977.24	CHEMBL3650	Homo sapiens	pIC50		6.01
	16874964	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNCC(F)(F)F)c1		CHEMBL3890852	=	IC50	nM	104.71	CHEMBL3650	Homo sapiens	pIC50		6.98
	16874965	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893642	=	IC50	nM	53.7	CHEMBL3650	Homo sapiens	pIC50		7.27
	16874966	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950156	=	IC50	nM	549.54	CHEMBL3650	Homo sapiens	pIC50		6.26
	16874967	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3952866	=	IC50	nM	436.52	CHEMBL3650	Homo sapiens	pIC50		6.36
	16874968	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3925114	=	IC50	nM	27.54	CHEMBL3650	Homo sapiens	pIC50		7.56
	16874969	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3897155	=	IC50	nM	851.14	CHEMBL3650	Homo sapiens	pIC50		6.07
	16874970	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937972	=	IC50	nM	45.71	CHEMBL3650	Homo sapiens	pIC50		7.34
	16874971	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935177	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16874972	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962492	=	IC50	nM	323.59	CHEMBL3650	Homo sapiens	pIC50		6.49
	16874973	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903823	=	IC50	nM	812.83	CHEMBL3650	Homo sapiens	pIC50		6.09
	16874974	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3964096	=	IC50	nM	131.83	CHEMBL3650	Homo sapiens	pIC50		6.88
	16874975	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3948755	=	IC50	nM	1202.26	CHEMBL3650	Homo sapiens	pIC50		5.92
	16874976	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3892155	=	IC50	nM	602.56	CHEMBL3650	Homo sapiens	pIC50		6.22
	16874977	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987162	=	IC50	nM	1778.28	CHEMBL3650	Homo sapiens	pIC50		5.75
	16874978	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921441	=	IC50	nM	57.54	CHEMBL3650	Homo sapiens	pIC50		7.24
	16874979	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905015	=	IC50	nM	2238.72	CHEMBL3650	Homo sapiens	pIC50		5.65
	16874980	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3921817	=	IC50	nM	60.26	CHEMBL3650	Homo sapiens	pIC50		7.22
	16874981	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927219	=	IC50	nM	85.11	CHEMBL3650	Homo sapiens	pIC50		7.07
	16874982	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(CCCN)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902434	=	IC50	nM	58.88	CHEMBL3650	Homo sapiens	pIC50		7.23
	16874983	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927158	=	IC50	nM	2630.27	CHEMBL3650	Homo sapiens	pIC50		5.58
	16874984	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985182	=	IC50	nM	32.36	CHEMBL3650	Homo sapiens	pIC50		7.49
	16874985	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933442	=	IC50	nM	107.15	CHEMBL3650	Homo sapiens	pIC50		6.97
	16874986	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934080	=	IC50	nM	64.57	CHEMBL3650	Homo sapiens	pIC50		7.19
	16874987	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895443	=	IC50	nM	2454.71	CHEMBL3650	Homo sapiens	pIC50		5.61
	16874988	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CCCNCC(F)(F)F)c4cc(Cl)cc(Cl)c4)cc3n2)cn1		CHEMBL3904736	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874989	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CC)Cc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914473	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16874990	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CC(C)NCCN(c1cc(Cl)cc(Cl)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3898926	=	IC50	nM	2398.83	CHEMBL3650	Homo sapiens	pIC50		5.62
	16874991	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952277	=	IC50	nM	50.12	CHEMBL3650	Homo sapiens	pIC50		7.3
	16874992	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926245	=	IC50	nM	676.08	CHEMBL3650	Homo sapiens	pIC50		6.17
	16874993	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3978617	=	IC50	nM	51.29	CHEMBL3650	Homo sapiens	pIC50		7.29
	16874994	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)nc3c2)c1		CHEMBL3966071	=	IC50	nM	36.31	CHEMBL3650	Homo sapiens	pIC50		7.44
	16874995	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966200	=	IC50	nM	134.9	CHEMBL3650	Homo sapiens	pIC50		6.87
	16874996	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3940672	=	IC50	nM	134.9	CHEMBL3650	Homo sapiens	pIC50		6.87
	16874997	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3979328	=	IC50	nM	20.89	CHEMBL3650	Homo sapiens	pIC50		7.68
	16874998	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3983918	=	IC50	nM	30.2	CHEMBL3650	Homo sapiens	pIC50		7.52
	16874999	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975193	=	IC50	nM	52.48	CHEMBL3650	Homo sapiens	pIC50		7.28
	16875000	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924172	=	IC50	nM	125.89	CHEMBL3650	Homo sapiens	pIC50		6.9
	16875001	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)(C)CF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921469	=	IC50	nM	15.85	CHEMBL3650	Homo sapiens	pIC50		7.8
	16875002	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(F)c1F.Cl		CHEMBL3900551	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875003	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891525	=	IC50	nM	251.19	CHEMBL3650	Homo sapiens	pIC50		6.6
	16875004	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1		CHEMBL3935838	=	IC50	nM	223.87	CHEMBL3650	Homo sapiens	pIC50		6.65
	16875005	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3977010	=	IC50	nM	288.4	CHEMBL3650	Homo sapiens	pIC50		6.54
	16875006	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3967761	=	IC50	nM	61.66	CHEMBL3650	Homo sapiens	pIC50		7.21
	16875007	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893556	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	pIC50		7.0
	16875008	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3896249	=	IC50	nM	89.13	CHEMBL3650	Homo sapiens	pIC50		7.05
	16875009	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C#N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952789	=	IC50	nM	6.761	CHEMBL3650	Homo sapiens	pIC50		8.17
	16875010	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955385	=	IC50	nM	309.03	CHEMBL3650	Homo sapiens	pIC50		6.51
	16875011	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977708	=	IC50	nM	20.89	CHEMBL3650	Homo sapiens	pIC50		7.68
	16875012	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3980069	=	IC50	nM	7.079	CHEMBL3650	Homo sapiens	pIC50		8.15
	16875013	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3946938	=	IC50	nM	61.66	CHEMBL3650	Homo sapiens	pIC50		7.21
	16875014	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941337	=	IC50	nM	2818.38	CHEMBL3650	Homo sapiens	pIC50		5.55
	16875015	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983585	=	IC50	nM	1047.13	CHEMBL3650	Homo sapiens	pIC50		5.98
	16875016	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])NC(C)C)c1		CHEMBL3918638	=	IC50	nM	15.49	CHEMBL3650	Homo sapiens	pIC50		7.81
	16875017	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920637	=	IC50	nM	389.05	CHEMBL3650	Homo sapiens	pIC50		6.41
	16875018	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1.Cl		CHEMBL3917908	=	IC50	nM	52.48	CHEMBL3650	Homo sapiens	pIC50		7.28
	16875019	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980712	=	IC50	nM	5888.44	CHEMBL3650	Homo sapiens	pIC50		5.23
	16875020	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1		CHEMBL3978349	=	IC50	nM	190.55	CHEMBL3650	Homo sapiens	pIC50		6.72
	16875021	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(CO)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3976721	=	IC50	nM	275.42	CHEMBL3650	Homo sapiens	pIC50		6.56
	16875022	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974273	=	IC50	nM	239.88	CHEMBL3650	Homo sapiens	pIC50		6.62
	16875023	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3898255	=	IC50	nM	2691.53	CHEMBL3650	Homo sapiens	pIC50		5.57
	16875024	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3927794	=	IC50	nM	2290.87	CHEMBL3650	Homo sapiens	pIC50		5.64
	16875025	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953833	=	IC50	nM	2.884	CHEMBL3650	Homo sapiens	pIC50		8.54
	16875026	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964043	=	IC50	nM	19.05	CHEMBL3650	Homo sapiens	pIC50		7.72
	16875027	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945658	=	IC50	nM	1412.54	CHEMBL3650	Homo sapiens	pIC50		5.85
	16875028	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948306	=	IC50	nM	4168.69	CHEMBL3650	Homo sapiens	pIC50		5.38
	16875029	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984035	=	IC50	nM	1862.09	CHEMBL3650	Homo sapiens	pIC50		5.73
	16875030	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3986725	=	IC50	nM	630.96	CHEMBL3650	Homo sapiens	pIC50		6.2
	16875031	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2		CHEMBL3896142	=	IC50	nM	21.38	CHEMBL3650	Homo sapiens	pIC50		7.67
	16875032	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908707	=	IC50	nM	31.62	CHEMBL3650	Homo sapiens	pIC50		7.5
	16875033	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941227	=	IC50	nM	776.25	CHEMBL3650	Homo sapiens	pIC50		6.11
	16875034	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3943917	=	IC50	nM	15.85	CHEMBL3650	Homo sapiens	pIC50		7.8
	16875035	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979972	=	IC50	nM	478.63	CHEMBL3650	Homo sapiens	pIC50		6.32
	16875036	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)nc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982399	=	IC50	nM	24.55	CHEMBL3650	Homo sapiens	pIC50		7.61
	16875037	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1.Cl		CHEMBL3932817	=	IC50	nM	173.78	CHEMBL3650	Homo sapiens	pIC50		6.76
	16875038	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCNCC(F)(F)F)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3930088	=	IC50	nM	1905.46	CHEMBL3650	Homo sapiens	pIC50		5.72
	16875039	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972445	=	IC50	nM	7079.46	CHEMBL3650	Homo sapiens	pIC50		5.15
	16875040	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3969747	=	IC50	nM	1778.28	CHEMBL3650	Homo sapiens	pIC50		5.75
	16875041	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cnn1C.Cl		CHEMBL3918426	=	IC50	nM	69.18	CHEMBL3650	Homo sapiens	pIC50		7.16
	16875042	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906938	=	IC50	nM	66.07	CHEMBL3650	Homo sapiens	pIC50		7.18
	16875043	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nc1		CHEMBL3956028	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875044	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964762	=	IC50	nM	85.11	CHEMBL3650	Homo sapiens	pIC50		7.07
	16875045	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)c1.Cl		CHEMBL3948234	=	IC50	nM	346.74	CHEMBL3650	Homo sapiens	pIC50		6.46
	16875046	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CO)nc3c2)c1		CHEMBL3932022	=	IC50	nM	31.62	CHEMBL3650	Homo sapiens	pIC50		7.5
	16875047	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3957473	=	IC50	nM	60.26	CHEMBL3650	Homo sapiens	pIC50		7.22
	16875048	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3926556	=	IC50	nM	69.18	CHEMBL3650	Homo sapiens	pIC50		7.16
	16875049	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3965482	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	pIC50		7.0
	16875050	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(Cc2ccc(N)cc2)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950496	=	IC50	nM	46.77	CHEMBL3650	Homo sapiens	pIC50		7.33
	16875051	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902961	=	IC50	nM	10.47	CHEMBL3650	Homo sapiens	pIC50		7.98
	16875052	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905633	=	IC50	nM	478.63	CHEMBL3650	Homo sapiens	pIC50		6.32
	16875053	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3937212	=	IC50	nM	389.05	CHEMBL3650	Homo sapiens	pIC50		6.41
	16875054	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])NCC(F)(F)F)c1		CHEMBL3966929	=	IC50	nM	194.98	CHEMBL3650	Homo sapiens	pIC50		6.71
	16875055	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922100	=	IC50	nM	177.83	CHEMBL3650	Homo sapiens	pIC50		6.75
	16875056	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3906284	=	IC50	nM	67.61	CHEMBL3650	Homo sapiens	pIC50		7.17
	16875057	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3921787	=	IC50	nM	104.71	CHEMBL3650	Homo sapiens	pIC50		6.98
	16875058	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969405	=	IC50	nM	26.3	CHEMBL3650	Homo sapiens	pIC50		7.58
	16875059	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964589	=	IC50	nM	251.19	CHEMBL3650	Homo sapiens	pIC50		6.6
	16875060	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3972998	=	IC50	nM	269.15	CHEMBL3650	Homo sapiens	pIC50		6.57
	16875061	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3908068	=	IC50	nM	147.91	CHEMBL3650	Homo sapiens	pIC50		6.83
	16875062	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3905276	=	IC50	nM	19.95	CHEMBL3650	Homo sapiens	pIC50		7.7
	16875063	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969414	=	IC50	nM	83.18	CHEMBL3650	Homo sapiens	pIC50		7.08
	16875064	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3951171	=	IC50	nM	25.7	CHEMBL3650	Homo sapiens	pIC50		7.59
	16875065	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983694	=	IC50	nM	10.96	CHEMBL3650	Homo sapiens	pIC50		7.96
	16875066	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3981207	=	IC50	nM	501.19	CHEMBL3650	Homo sapiens	pIC50		6.3
	16875067	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnc(N)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3986631	=	IC50	nM	3981.07	CHEMBL3650	Homo sapiens	pIC50		5.4
	16875068	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3969667	=	IC50	nM	2.63	CHEMBL3650	Homo sapiens	pIC50		8.58
	16875069	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933908	=	IC50	nM	19.05	CHEMBL3650	Homo sapiens	pIC50		7.72
	16875070	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3936673	=	IC50	nM	48.98	CHEMBL3650	Homo sapiens	pIC50		7.31
	16875071	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(CO)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980417	=	IC50	nM	4.467	CHEMBL3650	Homo sapiens	pIC50		8.35
	16875072	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C(N)=O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921190	=	IC50	nM	2.818	CHEMBL3650	Homo sapiens	pIC50		8.55
	16875073	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920274	=	IC50	nM	6165.95	CHEMBL3650	Homo sapiens	pIC50		5.21
	16875074	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(Cl)c(OC)cc(OC)c2Cl)n1		CHEMBL3953771	=	IC50	nM	7.762	CHEMBL3650	Homo sapiens	pIC50		8.11
	16875075	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950292	=	IC50	nM	46.77	CHEMBL3650	Homo sapiens	pIC50		7.33
	16875076	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ncn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959787	=	IC50	nM	114.82	CHEMBL3650	Homo sapiens	pIC50		6.94
	16875077	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986861	=	IC50	nM	309.03	CHEMBL3650	Homo sapiens	pIC50		6.51
	16875078	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891816	=	IC50	nM	691.83	CHEMBL3650	Homo sapiens	pIC50		6.16
	16875079	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927140	=	IC50	nM	4.786	CHEMBL3650	Homo sapiens	pIC50		8.32
	16875080	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3929849	=	IC50	nM	147.91	CHEMBL3650	Homo sapiens	pIC50		6.83
	16875081	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966941	=	IC50	nM	831.76	CHEMBL3650	Homo sapiens	pIC50		6.08
	16875082	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1		CHEMBL3939018	=	IC50	nM	204.17	CHEMBL3650	Homo sapiens	pIC50		6.69
	16875083	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912757	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16875084	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915450	=	IC50	nM	173.78	CHEMBL3650	Homo sapiens	pIC50		6.76
	16875085	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3950510	=	IC50	nM	190.55	CHEMBL3650	Homo sapiens	pIC50		6.72
	16875086	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3964701	=	IC50	nM	69.18	CHEMBL3650	Homo sapiens	pIC50		7.16
	16875087	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)N(C)OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956493	=	IC50	nM	173.78	CHEMBL3650	Homo sapiens	pIC50		6.76
	16875088	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964931	=	IC50	nM	218.78	CHEMBL3650	Homo sapiens	pIC50		6.66
	16875089	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nc(OC)cc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918956	=	IC50	nM	1819.7	CHEMBL3650	Homo sapiens	pIC50		5.74
	16875090	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3916200	=	IC50	nM	194.98	CHEMBL3650	Homo sapiens	pIC50		6.71
	16875091	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3942506	=	IC50	nM	257.04	CHEMBL3650	Homo sapiens	pIC50		6.59
	16875092	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939852	=	IC50	nM	2187.76	CHEMBL3650	Homo sapiens	pIC50		5.66
	16875093	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904470	=	IC50	nM	2238.72	CHEMBL3650	Homo sapiens	pIC50		5.65
	16875094	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3894754	=	IC50	nM	3.631	CHEMBL3650	Homo sapiens	pIC50		8.44
	16875095	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC(=O)c1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3963296	=	IC50	nM	74.13	CHEMBL3650	Homo sapiens	pIC50		7.13
	16875096	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)(C)C#Cc2nccc(OC)n2)c1		CHEMBL3890187	=	IC50	nM	7244.36	CHEMBL3650	Homo sapiens	pIC50		5.14
	16875097	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924891	=	IC50	nM	2630.27	CHEMBL3650	Homo sapiens	pIC50		5.58
	16875098	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923190	=	IC50	nM	1096.48	CHEMBL3650	Homo sapiens	pIC50		5.96
	16875099	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNc1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3978313	=	IC50	nM	33.88	CHEMBL3650	Homo sapiens	pIC50		7.47
	16875100	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889604	=	IC50	nM	549.54	CHEMBL3650	Homo sapiens	pIC50		6.26
	16875101	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939332	=	IC50	nM	257.04	CHEMBL3650	Homo sapiens	pIC50		6.59
	16875102	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912250	=	IC50	nM	724.44	CHEMBL3650	Homo sapiens	pIC50		6.14
	16875103	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901265	=	IC50	nM	85.11	CHEMBL3650	Homo sapiens	pIC50		7.07
	16875104	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3903973	=	IC50	nM	2.344	CHEMBL3650	Homo sapiens	pIC50		8.63
	16875105	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957928	=	IC50	nM	93.33	CHEMBL3650	Homo sapiens	pIC50		7.03
	16875106	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960591	=	IC50	nM	380.19	CHEMBL3650	Homo sapiens	pIC50		6.42
	16875107	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899721	=	IC50	nM	154.88	CHEMBL3650	Homo sapiens	pIC50		6.81
	16875108	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934772	=	IC50	nM	44.67	CHEMBL3650	Homo sapiens	pIC50		7.35
	16875109	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3n2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909752	=	IC50	nM	1513.56	CHEMBL3650	Homo sapiens	pIC50		5.82
	16875110	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906945	=	IC50	nM	524.81	CHEMBL3650	Homo sapiens	pIC50		6.28
	16875111	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3954396	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16875112	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944937	=	IC50	nM	1819.7	CHEMBL3650	Homo sapiens	pIC50		5.74
	16875113	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895267	=	IC50	nM	58.88	CHEMBL3650	Homo sapiens	pIC50		7.23
	16875114	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3892529	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16875115	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3935597	=	IC50	nM	15.14	CHEMBL3650	Homo sapiens	pIC50		7.82
	16875116	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932893	=	IC50	nM	1949.84	CHEMBL3650	Homo sapiens	pIC50		5.71
	16875117	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952706	=	IC50	nM	912.01	CHEMBL3650	Homo sapiens	pIC50		6.04
	16875118	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939860	=	IC50	nM	229.09	CHEMBL3650	Homo sapiens	pIC50		6.64
	16875119	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3976275	=	IC50	nM	0.6026	CHEMBL3650	Homo sapiens	pIC50		9.22
	16875120	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(F)c(OC)cc(OC)c2F)n1		CHEMBL3978754	=	IC50	nM	0.631	CHEMBL3650	Homo sapiens	pIC50		9.2
	16875121	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942716	=	IC50	nM	75.86	CHEMBL3650	Homo sapiens	pIC50		7.12
	16875122	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982718	=	IC50	nM	6.026	CHEMBL3650	Homo sapiens	pIC50		8.22
	16875123	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3894762	=	IC50	nM	28.18	CHEMBL3650	Homo sapiens	pIC50		7.55
	16875124	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)S(=O)(=O)N(C)C)c1		CHEMBL3896514	=	IC50	nM	2290.87	CHEMBL3650	Homo sapiens	pIC50		5.64
	16875125	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC(=O)c1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3906253	=	IC50	nM	741.31	CHEMBL3650	Homo sapiens	pIC50		6.13
	16875126	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946877	=	IC50	nM	9549.93	CHEMBL3650	Homo sapiens	pIC50		5.02
	16875127	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2c2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944241	=	IC50	nM	2884.03	CHEMBL3650	Homo sapiens	pIC50		5.54
	16875128	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947664	=	IC50	nM	85.11	CHEMBL3650	Homo sapiens	pIC50		7.07
	16875129	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960877	=	IC50	nM	31.62	CHEMBL3650	Homo sapiens	pIC50		7.5
	16875130	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCC#N)c4)nc3c2)c1		CHEMBL3958209	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16875131	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951253	=	IC50	nM	89.13	CHEMBL3650	Homo sapiens	pIC50		7.05
	16875132	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(c3nccc(OC)n3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948629	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875133	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCOCC5)c4)nc3c2)c1		CHEMBL3913492	>	IC50	nM	10.0	CHEMBL3650	Homo sapiens	pIC50		8.0
	16875134	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)(F)F)c4)cc3n2)cn1		CHEMBL3933492	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875135	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(C(F)(F)F)c1		CHEMBL3982416	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875136	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CN(C)c1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984969	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875137	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953206	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875138	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCN2Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946591	=	IC50	nM	4677.35	CHEMBL3650	Homo sapiens	pIC50		5.33
	16875139	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939494	=	IC50	nM	3235.94	CHEMBL3650	Homo sapiens	pIC50		5.49
	16875140	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cnnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942179	=	IC50	nM	3090.3	CHEMBL3650	Homo sapiens	pIC50		5.51
	16875141	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC(C)(C)N=C2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930685	=	IC50	nM	3981.07	CHEMBL3650	Homo sapiens	pIC50		5.4
	16875142	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910555	=	IC50	nM	5370.32	CHEMBL3650	Homo sapiens	pIC50		5.27
	16875143	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918036	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875144	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3920759	=	IC50	nM	1096.48	CHEMBL3650	Homo sapiens	pIC50		5.96
	16875145	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965805	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875146	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CN(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926088	=	IC50	nM	9120.11	CHEMBL3650	Homo sapiens	pIC50		5.04
	16875147	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2nccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972657	=	IC50	nM	3630.78	CHEMBL3650	Homo sapiens	pIC50		5.44
	16875148	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979172	=	IC50	nM	134.9	CHEMBL3650	Homo sapiens	pIC50		6.87
	16875149	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CN)c1		CHEMBL3976752	=	IC50	nM	72.44	CHEMBL3650	Homo sapiens	pIC50		7.14
	16875150	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918892	=	IC50	nM	7079.46	CHEMBL3650	Homo sapiens	pIC50		5.15
	16875151	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnn(C)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966660	=	IC50	nM	4073.8	CHEMBL3650	Homo sapiens	pIC50		5.39
	16875152	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(=O)NC(C)C)c1		CHEMBL3899891	=	IC50	nM	4786.3	CHEMBL3650	Homo sapiens	pIC50		5.32
	16875153	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(N)=O)c1		CHEMBL3890118	=	IC50	nM	426.58	CHEMBL3650	Homo sapiens	pIC50		6.37
	16875154	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	Br.COc1cc(OC)cc(N(CCP(=O)(O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950169	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875155	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2ncnc2C)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3952885	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875156	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cnc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890870	=	IC50	nM	1862.09	CHEMBL3650	Homo sapiens	pIC50		5.73
	16875157	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(C)Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893659	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875158	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1C(O)C(F)(F)F		CHEMBL3928923	=	IC50	nM	6165.95	CHEMBL3650	Homo sapiens	pIC50		5.21
	16875159	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3938712	=	IC50	nM	7585.78	CHEMBL3650	Homo sapiens	pIC50		5.12
	16875160	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975295	=	IC50	nM	97.72	CHEMBL3650	Homo sapiens	pIC50		7.01
	16875161	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977791	=	IC50	nM	6309.57	CHEMBL3650	Homo sapiens	pIC50		5.2
	16875162	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C#N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916904	=	IC50	nM	7585.78	CHEMBL3650	Homo sapiens	pIC50		5.12
	16875163	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974131	=	IC50	nM	9120.11	CHEMBL3650	Homo sapiens	pIC50		5.04
	16875164	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3925322	=	IC50	nM	2570.4	CHEMBL3650	Homo sapiens	pIC50		5.59
	16875165	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)nc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922592	=	IC50	nM	7943.28	CHEMBL3650	Homo sapiens	pIC50		5.1
	16875166	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3985007	=	IC50	nM	8317.64	CHEMBL3650	Homo sapiens	pIC50		5.08
	16875167	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4c(C(F)(F)F)nn(C)c4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3982466	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875168	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCN(Cc2ccccc2N)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC(OC)=C1		CHEMBL3910921	=	IC50	nM	123.03	CHEMBL3650	Homo sapiens	pIC50		6.91
	16875169	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnc3[nH]ccc3n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908141	<	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	16875170	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971947	=	IC50	nM	1995.26	CHEMBL3650	Homo sapiens	pIC50		5.7
	16875171	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960102	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875172	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(CC(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891736	=	IC50	nM	2511.89	CHEMBL3650	Homo sapiens	pIC50		5.6
	16875173	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984571	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875174	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896720	=	IC50	nM	3235.94	CHEMBL3650	Homo sapiens	pIC50		5.49
	16875175	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984841	=	IC50	nM	1096.48	CHEMBL3650	Homo sapiens	pIC50		5.96
	16875176	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982303	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875177	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3931533	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875178	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947740	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875179	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963816	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875180	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909951	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875181	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3912630	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875182	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3933449	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875183	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898908	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875184	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3986163	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875185	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3898120	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875186	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3955288	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875187	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957914	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875188	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)F)c4)cc3n2)cn1		CHEMBL3908978	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875189	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3906155	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875190	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940334	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875191	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958153	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875192	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N(C)C)c4)nc3c2)c1		CHEMBL3925254	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875193	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3907600	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875194	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1		CHEMBL3954368	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875195	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCN5CCCC5)c4)nc3c2)c1		CHEMBL3951714	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875196	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CC(C)Oc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965364	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875197	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3969446	=	IC50	nM	6456.54	CHEMBL3650	Homo sapiens	pIC50		5.19
	16875198	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951126	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875199	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3933015	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875200	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898881	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875201	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2OCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901644	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875202	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944665	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875203	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCN(c1cccc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3947293	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875204	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1OC		CHEMBL3947826	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875205	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3985692	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875206	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947990	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875207	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCC5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3925306	=	IC50	nM	5623.41	CHEMBL3650	Homo sapiens	pIC50		5.25
	16875208	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3951245	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875209	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3948623	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875210	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3892018	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875211	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987037	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875212	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3921313	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875213	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3927327	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875214	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1		CHEMBL3976280	=	IC50	nM	8511.38	CHEMBL3650	Homo sapiens	pIC50		5.07
	16875215	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCNCCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3973820	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875216	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCN(S(C)(=O)=O)CC5)c4)nc3c2)c1		CHEMBL3918011	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875217	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)nc3c2)c1		CHEMBL3915235	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875218	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(C#N)c4)cc3n2)cn1		CHEMBL3965673	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875219	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968094	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875220	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3918751	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875221	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875222	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3908829	=	IC50	nM	5623.41	CHEMBL3650	Homo sapiens	pIC50		5.25
	16875223	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(O)CCNCC5)c4)nc3c2)c1		CHEMBL3911573	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875224	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969879	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875225	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(Cl)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972564	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875226	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3927875	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875227	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C#N)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930634	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875228	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3901627	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875229	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904329	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875230	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969408	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875231	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3985853	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875232	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(OC)CCNCC5)c4)nc3c2)c1		CHEMBL3908326	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875233	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3918092	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875234	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1		CHEMBL3964675	=	IC50	nM	6918.31	CHEMBL3650	Homo sapiens	pIC50		5.16
	16875235	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955706	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875236	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3937533	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875237	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCCC5)c4)nc3c2)c1.Cl		CHEMBL3962814	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875238	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3931674	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875239	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)NCCO)c4)nc3c2)c1		CHEMBL3976219	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875240	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924872	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875241	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3908529	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875242	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3962805	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875243	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)N5CCNCC5)c4)nc3c2)c1		CHEMBL3960128	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875244	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3909565	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875245	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3948321	=	IC50	nM	8912.51	CHEMBL3650	Homo sapiens	pIC50		5.05
	16875246	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCO)c4)nc3c2)c1		CHEMBL3985750	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875247	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3983115	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875248	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3926311	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875249	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3926406	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875250	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)on2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979490	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875251	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898355	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875252	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940725	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875253	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943387	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875254	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)OCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3973531	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875255	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3913757	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875256	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3961210	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875257	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936765	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875258	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951156	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875259	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2CCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979170	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875260	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921618	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875261	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3969815	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875262	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3961872	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875263	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985222	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875264	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1		CHEMBL3935232	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875265	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1.Cl		CHEMBL3909140	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875266	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974664	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875267	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3972173	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875268	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919173	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875269	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3956737	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875270	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3966022	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875271	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968499	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875272	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912505	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875273	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCC2CC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915158	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875274	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3950262	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875275	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875276	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3949470	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875277	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3893008	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875278	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CO)c4)nc3c2)c1		CHEMBL3889493	=	IC50	nM	8511.38	CHEMBL3650	Homo sapiens	pIC50		5.07
	16875279	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCS(C)(=O)=O)c3)nc2c1		CHEMBL3984548	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875280	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cn[nH]c3)nc2c1		CHEMBL3920908	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875281	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3939278	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875282	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974693	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875283	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3972208	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875284	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3935264	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875285	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3932577	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875286	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3950907	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875287	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(C)=N\O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948270	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875288	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(C)=N/O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955817	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875289	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875290	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923296	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875291	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918495	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875292	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCOc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945369	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875293	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OCCO)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3961267	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875294	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875295	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3928627	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875296	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3908877	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875297	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3907488	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875298	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N5CCC(O)C5)c4)nc3c2)c1		CHEMBL3929803	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875299	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3970430	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875300	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969475	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875301	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.c1ccc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)cc1		CHEMBL3963728	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875302	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944224	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875303	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909318	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875304	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982668	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875305	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C5CCCCO5)c4)nc3c2)c1		CHEMBL3980232	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875306	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937633	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875307	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3955563	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875308	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3890607	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875309	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCO)c3)nc2c1		CHEMBL3893373	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875310	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3928646	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875311	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3931381	=	IC50	nM	6456.54	CHEMBL3650	Homo sapiens	pIC50		5.19
	16875312	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3938610	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875313	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)N2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923808	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875314	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3890896	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875315	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986607	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875316	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3902581	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875317	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3954298	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875318	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892025	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875319	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935912	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875320	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3900620	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875321	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897858	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875322	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896104	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875323	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893398	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875324	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3983996	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875325	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3935124	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875326	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3973645	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875327	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCF)c4)nc3c2)c1		CHEMBL3971073	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875328	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957264	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875329	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969096	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875330	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCc2nnn[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905212	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875331	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897034	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875332	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CCCN(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979885	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875333	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3982334	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875334	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875335	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC1CCN(CCCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)C1.Cl		CHEMBL3922453	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875336	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875337	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959201	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875338	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915233	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875339	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCS(=O)(=O)NCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3912569	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875340	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccco2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975954	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875341	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3966748	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875342	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3929648	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875343	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926964	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875344	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3891619	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875345	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3986661	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875346	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943043	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875347	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)C1CCN(CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC1		CHEMBL3904745	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875348	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(Cl)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965614	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875349	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nnc(N)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968009	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875350	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CN(CCO)C5)c4)nc3c2)c1		CHEMBL3906122	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875351	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(Cc5ccc(Cl)s5)c4)nc3c2)c1		CHEMBL3900268	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875352	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3949132	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875353	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3951728	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875354	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962554	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875355	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913970	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875356	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN4CCCC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3972979	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875357	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975447	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875358	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921243	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875359	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911516	<	IC50	nM	3019.95	CHEMBL3650	Homo sapiens	pIC50		5.52
	16875360	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958756	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875361	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956120	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875362	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3907551	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875363	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOC(=O)Cn1cc(CN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nn1		CHEMBL3904777	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875364	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	OCCn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3975007	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875365	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(OC)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972517	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875366	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928956	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875367	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919270	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875368	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941705	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875369	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982570	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875370	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C(C)CCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920007	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875371	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3922698	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875372	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957533	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875373	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969373	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875374	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3905485	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875375	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904674	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875376	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945845	<=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875377	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3951694	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875378	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3929914	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875379	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	9332.54	CHEMBL3650	Homo sapiens	pIC50		5.03
	16875380	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891892	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875381	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985498	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875382	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915533	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875383	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912831	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875384	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(C3C[C@@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3976183	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875385	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967011	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875386	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931154	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875387	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893718	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875388	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3922285	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875389	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925008	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875390	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909529	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875391	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973321	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875392	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936672	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875393	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939439	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875394	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C[Si](C)(C)C)c4)nc3c2)c1		CHEMBL3898601	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875395	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901357	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875396	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)C[C@@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3957643	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875397	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960327	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875398	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CC(C)(C)NC(C)(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981706	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875399	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCO)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3979314	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875400	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985678	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875401	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969381	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875402	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968361	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875403	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875404	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907314	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875405	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cn[nH]n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904561	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875406	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945264	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875407	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3942594	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875408	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915268	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875409	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925081	<	IC50	nM	3019.95	CHEMBL3650	Homo sapiens	pIC50		5.52
	16875410	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])n1cc(-c2ccc3ncc(N(CCO)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3959849	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875411	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962549	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875412	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3966626	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875413	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969192	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875414	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975986	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875415	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875416	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C2OCCO2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979996	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875417	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(OC)CCCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3891474	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875418	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3892135	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875419	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969824	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875420	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932285	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875421	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922586	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875422	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901682	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875423	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927733	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875424	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2ccc3ncc(N(CCN)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3976053	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875425	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973587	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875426	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936828	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875427	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(F)(F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934039	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875428	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981418	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875429	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2ccc3ncc(N(CCN)c4cc(F)cc(OCCO)c4)nc3c2)cn1		CHEMBL3972694	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875430	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cn(CCO)nn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921457	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875431	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3918739	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875432	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968793	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875433	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3966305	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875434	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3935825	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875435	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897101	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875436	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3891115	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875437	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(OC)c(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3979662	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875438	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3983387	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875439	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986068	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875440	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CC)CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3916975	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875441	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])n1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3919709	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875442	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975791	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875443	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963323	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875444	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945373	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875445	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933341	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875446	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3893344	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875447	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3896052	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875448	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(C)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3947361	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875449	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3944739	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875450	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3909551	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875451	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899692	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875452	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3C[C@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3961400	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875453	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958708	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875454	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974080	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875455	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1		CHEMBL3921197	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875456	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898568	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875457	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986036	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875458	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3914615	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875459	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3924422	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875460	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCF)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959193	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875461	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1		CHEMBL3961923	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875462	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936087	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875463	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893070	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875464	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942763	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875465	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nnc(NCCO)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977904	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875466	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3906894	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875467	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875468	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875469	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3904441	=	IC50	nM	2754.23	CHEMBL3650	Homo sapiens	pIC50		5.56
	16875470	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3945159	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875471	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3915021	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875472	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3892776	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875473	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981077	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875474	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930819	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875475	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3926082	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875476	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3970423	=	IC50	nM	5754.4	CHEMBL3650	Homo sapiens	pIC50		5.24
	16875477	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967739	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875478	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939764	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875479	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3900574	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875480	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3950089	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875481	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3959573	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875482	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912310	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875483	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914955	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875484	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973263	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875485	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975714	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875486	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933707	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875487	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950069	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875488	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3979013	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875489	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCN2CCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942811	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875490	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3940175	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875491	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968038	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875492	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965640	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875493	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ncc[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928393	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875494	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918704	<=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875495	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3947189	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875496	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944438	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875497	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3965710	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875498	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968124	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875499	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964574	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875500	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907047	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875501	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3942328	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875502	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951847	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875503	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N\O		CHEMBL3889890	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875504	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N/O		CHEMBL3892632	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875505	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930298	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875506	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CNS(=O)(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933000	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875507	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3891464	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875508	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950910	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875509	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3901420	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875510	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939200	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875511	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905866	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875512	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903198	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875513	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)N[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943933	=	IC50	nM	5754.4	CHEMBL3650	Homo sapiens	pIC50		5.24
	16875514	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCS(=O)(=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925077	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875515	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OCCF)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3946674	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875516	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931790	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875517	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934487	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875518	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3893786	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875519	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(CO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917141	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875520	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975397	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875521	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891966	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875522	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3941700	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875523	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3980252	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875524	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967065	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875525	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969665	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875526	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C(C)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981076	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875527	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983529	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875528	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935457	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875529	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905048	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875530	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925610	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875531	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3928261	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875532	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2COC2)c1		CHEMBL3985259	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875533	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890205	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875534	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944610	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875535	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)C(C)C.Cl		CHEMBL3944320	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875536	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943860	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875537	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(=N/O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941174	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875538	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C(=N\O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982351	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875539	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3979908	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875540	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCNC(=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934355	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875541	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919750	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875542	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969112	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875543	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)CN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966560	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875544	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910444	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875545	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)nc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907642	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875546	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCC(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973929	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875547	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C(=O)C3CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972617	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875548	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(F)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908149	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875549	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1		CHEMBL3911621	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875550	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@H](NC(C)C)CC2)c1		CHEMBL3918800	=	IC50	nM	5495.41	CHEMBL3650	Homo sapiens	pIC50		5.26
	16875551	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902353	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875552	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943080	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875553	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968139	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875554	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3904294	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875555	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907063	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875556	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3896623	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875557	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC[Si](C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3893950	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875558	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955745	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875559	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953117	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875560	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951360	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875561	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948744	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875562	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3941695	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875563	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3903811	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875564	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930158	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875565	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927451	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875566	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3911746	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875567	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC2CCN(S(N)(=O)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917295	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875568	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902110	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875569	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cc(C)nc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904814	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875570	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911948	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875571	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928239	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875572	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979028	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875573	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890378	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875574	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1.Cl		CHEMBL3932363	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875575	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3934260	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875576	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932756	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875577	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3919479	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875578	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCCC2(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968818	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875579	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966316	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875580	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCN(C3CCN(C(C)=O)CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943610	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875581	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(Br)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940940	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875582	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CCCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3982107	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875583	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3979670	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875584	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3921476	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875585	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3911738	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875586	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960571	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875587	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3974206	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875588	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3911635	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875589	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913322	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875590	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916037	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875591	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nccn2S(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889711	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875592	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927585	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875593	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1		CHEMBL3984461	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875594	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3981955	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875595	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3946103	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875596	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCn1ccnc1CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3936421	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875597	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2COCC(C)(C)N2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901119	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875598	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898346	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875599	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895378	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875600	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H](C)CN)c1		CHEMBL3957414	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875601	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1		CHEMBL3922607	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875602	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919884	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875603	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNC(C)C)c1		CHEMBL3942606	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875604	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945277	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875605	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897523	=	IC50	nM	5623.41	CHEMBL3650	Homo sapiens	pIC50		5.25
	16875606	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907327	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875607	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956579	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875608	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959260	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875609	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNCC(F)(F)F)c1		CHEMBL3890852	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875610	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893642	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875611	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950156	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875612	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3952866	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875613	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3925114	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875614	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3897155	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875615	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937972	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875616	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935177	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875617	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962492	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875618	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903823	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875619	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3964096	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875620	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3948755	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875621	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3892155	=	IC50	nM	9120.11	CHEMBL3650	Homo sapiens	pIC50		5.04
	16875622	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987162	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875623	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921441	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875624	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905015	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875625	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3921817	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875626	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927219	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875627	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(CCCN)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902434	=	IC50	nM	6606.93	CHEMBL3650	Homo sapiens	pIC50		5.18
	16875628	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927158	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875629	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985182	=	IC50	nM	9549.93	CHEMBL3650	Homo sapiens	pIC50		5.02
	16875630	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933442	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875631	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934080	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875632	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895443	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875633	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cn1cc(-c2cnc3ccc(N(CCCNCC(F)(F)F)c4cc(Cl)cc(Cl)c4)cc3n2)cn1		CHEMBL3904736	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875634	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(CC)Cc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914473	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875635	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CC(C)NCCN(c1cc(Cl)cc(Cl)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3898926	=	IC50	nM	5754.4	CHEMBL3650	Homo sapiens	pIC50		5.24
	16875636	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952277	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875637	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926245	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875638	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3978617	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875639	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)nc3c2)c1		CHEMBL3966071	=	IC50	nM	6165.95	CHEMBL3650	Homo sapiens	pIC50		5.21
	16875640	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966200	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875641	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3940672	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875642	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3979328	=	IC50	nM	6760.83	CHEMBL3650	Homo sapiens	pIC50		5.17
	16875643	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3983918	=	IC50	nM	9332.54	CHEMBL3650	Homo sapiens	pIC50		5.03
	16875644	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975193	=	IC50	nM	7079.46	CHEMBL3650	Homo sapiens	pIC50		5.15
	16875645	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924172	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875646	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNC(C)(C)CF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921469	=	IC50	nM	7585.78	CHEMBL3650	Homo sapiens	pIC50		5.12
	16875647	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(F)c1F.Cl		CHEMBL3900551	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875648	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891525	=	IC50	nM	3019.95	CHEMBL3650	Homo sapiens	pIC50		5.52
	16875649	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1		CHEMBL3935838	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875650	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3977010	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875651	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3967761	=	IC50	nM	9772.37	CHEMBL3650	Homo sapiens	pIC50		5.01
	16875652	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893556	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875653	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3896249	=	IC50	nM	4466.84	CHEMBL3650	Homo sapiens	pIC50		5.35
	16875654	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C#N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952789	=	IC50	nM	7762.47	CHEMBL3650	Homo sapiens	pIC50		5.11
	16875655	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955385	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875656	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977708	=	IC50	nM	5623.41	CHEMBL3650	Homo sapiens	pIC50		5.25
	16875657	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3980069	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875658	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3946938	=	IC50	nM	6165.95	CHEMBL3650	Homo sapiens	pIC50		5.21
	16875659	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941337	=	IC50	nM	8317.64	CHEMBL3650	Homo sapiens	pIC50		5.08
	16875660	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983585	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875661	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])NC(C)C)c1		CHEMBL3918638	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875662	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920637	<=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875663	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1.Cl		CHEMBL3917908	=	IC50	nM	4265.8	CHEMBL3650	Homo sapiens	pIC50		5.37
	16875664	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980712	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875665	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1		CHEMBL3978349	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875666	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(CO)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3976721	=	IC50	nM	8709.64	CHEMBL3650	Homo sapiens	pIC50		5.06
	16875667	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974273	=	IC50	nM	7585.78	CHEMBL3650	Homo sapiens	pIC50		5.12
	16875668	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3898255	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875669	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3927794	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875670	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953833	=	IC50	nM	6309.57	CHEMBL3650	Homo sapiens	pIC50		5.2
	16875671	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964043	=	IC50	nM	1348.96	CHEMBL3650	Homo sapiens	pIC50		5.87
	16875672	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945658	=	IC50	nM	6760.83	CHEMBL3650	Homo sapiens	pIC50		5.17
	16875673	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948306	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875674	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984035	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875675	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3986725	=	IC50	nM	9772.37	CHEMBL3650	Homo sapiens	pIC50		5.01
	16875676	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2		CHEMBL3896142	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875677	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908707	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875678	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941227	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875679	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3943917	=	IC50	nM	6025.6	CHEMBL3650	Homo sapiens	pIC50		5.22
	16875680	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979972	=	IC50	nM	1096.48	CHEMBL3650	Homo sapiens	pIC50		5.96
	16875681	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)nc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982399	=	IC50	nM	1412.54	CHEMBL3650	Homo sapiens	pIC50		5.85
	16875682	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1.Cl		CHEMBL3932817	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875683	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCNCC(F)(F)F)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3930088	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875684	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972445	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875685	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3969747	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875686	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1c(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cnn1C.Cl		CHEMBL3918426	=	IC50	nM	6760.83	CHEMBL3650	Homo sapiens	pIC50		5.17
	16875687	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906938	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875688	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nc1		CHEMBL3956028	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875689	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964762	=	IC50	nM	2041.74	CHEMBL3650	Homo sapiens	pIC50		5.69
	16875690	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)c1.Cl		CHEMBL3948234	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875691	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CO)nc3c2)c1		CHEMBL3932022	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875692	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3957473	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875693	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3926556	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875694	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3965482	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875695	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN(Cc2ccc(N)cc2)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950496	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875696	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902961	=	IC50	nM	870.96	CHEMBL3650	Homo sapiens	pIC50		6.06
	16875697	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905633	=	IC50	nM	1862.09	CHEMBL3650	Homo sapiens	pIC50		5.73
	16875698	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3937212	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875699	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])NCC(F)(F)F)c1		CHEMBL3966929	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875700	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922100	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875701	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3906284	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875702	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3921787	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875703	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969405	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875704	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964589	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875705	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3972998	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875706	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3908068	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875707	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3905276	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875708	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969414	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875709	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3951171	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875710	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983694	=	IC50	nM	5888.44	CHEMBL3650	Homo sapiens	pIC50		5.23
	16875711	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3981207	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875712	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnc(N)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3986631	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875713	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3969667	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875714	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933908	=	IC50	nM	6918.31	CHEMBL3650	Homo sapiens	pIC50		5.16
	16875715	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3936673	=	IC50	nM	7413.1	CHEMBL3650	Homo sapiens	pIC50		5.13
	16875716	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(CO)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980417	=	IC50	nM	7762.47	CHEMBL3650	Homo sapiens	pIC50		5.11
	16875717	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C(N)=O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921190	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875718	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920274	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875719	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(Cl)c(OC)cc(OC)c2Cl)n1	Outside typical range	CHEMBL3953771	=	IC50	nM	517.0	CHEMBL3650	Homo sapiens	pIC50		517.0
	16875720	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950292	=	IC50	nM	3715.35	CHEMBL3650	Homo sapiens	pIC50		5.43
	16875721	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ncn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959787	=	IC50	nM	1905.46	CHEMBL3650	Homo sapiens	pIC50		5.72
	16875722	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986861	=	IC50	nM	6309.57	CHEMBL3650	Homo sapiens	pIC50		5.2
	16875723	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891816	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875724	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927140	=	IC50	nM	4365.16	CHEMBL3650	Homo sapiens	pIC50		5.36
	16875725	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3929849	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875726	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966941	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875727	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1		CHEMBL3939018	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875728	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912757	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875729	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915450	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875730	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3950510	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875731	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3964701	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875732	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)N(C)OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956493	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875733	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964931	=	IC50	nM	3388.44	CHEMBL3650	Homo sapiens	pIC50		5.47
	16875734	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2nc(OC)cc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918956	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875735	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3916200	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875736	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3942506	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875737	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939852	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875738	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904470	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875739	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3894754	=	IC50	nM	7585.78	CHEMBL3650	Homo sapiens	pIC50		5.12
	16875740	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC(=O)c1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3963296	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875741	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)(C)C#Cc2nccc(OC)n2)c1		CHEMBL3890187	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875742	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924891	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875743	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923190	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875744	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNc1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3978313	=	IC50	nM	5888.44	CHEMBL3650	Homo sapiens	pIC50		5.23
	16875745	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889604	=	IC50	nM	2570.4	CHEMBL3650	Homo sapiens	pIC50		5.59
	16875746	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939332	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875747	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912250	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875748	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901265	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875749	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3903973	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875750	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957928	=	IC50	nM	7943.28	CHEMBL3650	Homo sapiens	pIC50		5.1
	16875751	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960591	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875752	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899721	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875753	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934772	=	IC50	nM	7585.78	CHEMBL3650	Homo sapiens	pIC50		5.12
	16875754	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3n2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909752	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875755	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906945	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875756	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3954396	=	IC50	nM	6025.6	CHEMBL3650	Homo sapiens	pIC50		5.22
	16875757	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944937	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875758	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895267	=	IC50	nM	6918.31	CHEMBL3650	Homo sapiens	pIC50		5.16
	16875759	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)c(F)c(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3892529	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875760	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3935597	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875761	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932893	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875762	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952706	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875763	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939860	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875764	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3976275	=	IC50	nM	7244.36	CHEMBL3650	Homo sapiens	pIC50		5.14
	16875765	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(F)c(OC)cc(OC)c2F)n1		CHEMBL3978754	=	IC50	nM	4677.35	CHEMBL3650	Homo sapiens	pIC50		5.33
	16875766	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942716	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875767	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982718	=	IC50	nM	4570.88	CHEMBL3650	Homo sapiens	pIC50		5.34
	16875768	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3894762	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875769	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)S(=O)(=O)N(C)C)c1		CHEMBL3896514	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875770	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC(=O)c1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3906253	=	IC50	nM	4168.69	CHEMBL3650	Homo sapiens	pIC50		5.38
	16875771	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946877	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875772	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CC2c2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944241	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875773	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947664	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875774	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCCNCC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960877	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875775	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCC#N)c4)nc3c2)c1		CHEMBL3958209	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875776	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNCC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951253	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875777	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(c3nccc(OC)n3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948629	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875778	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCOCC5)c4)nc3c2)c1		CHEMBL3913492	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875779	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Cl.Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)(F)F)c4)cc3n2)cn1		CHEMBL3933492	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875780	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(C(F)(F)F)c1		CHEMBL3982416	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875781	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CN(C)c1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984969	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875782	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953206	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875783	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCN2Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946591	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875784	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939494	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875785	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cnnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942179	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875786	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCN2CC(C)(C)N=C2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930685	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875787	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CNC(=O)c1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910555	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875788	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCOCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918036	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875789	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3920759	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875790	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965805	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875791	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(CN(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926088	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875792	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2nccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972657	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875793	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979172	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875794	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CN)c1		CHEMBL3976752	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875795	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918892	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875796	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnn(C)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966660	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875797	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(=O)NC(C)C)c1		CHEMBL3899891	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875798	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(N)=O)c1		CHEMBL3890118	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875799	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	Br.COc1cc(OC)cc(N(CCP(=O)(O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950169	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875800	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2ncnc2C)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3952885	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875801	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cnc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890870	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875802	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	CCN(C)Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893659	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875803	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1C(O)C(F)(F)F		CHEMBL3928923	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875804	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3938712	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875805	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975295	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875806	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977791	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875807	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C#N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916904	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875808	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974131	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875809	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3925322	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875810	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)nc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922592	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875811	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3985007	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875812	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4c(C(F)(F)F)nn(C)c4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3982466	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875813	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COC1=CC(N(CCN(Cc2ccccc2N)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC(OC)=C1		CHEMBL3910921	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875814	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cnc3[nH]ccc3n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908141	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875815	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971947	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875816	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960102	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875817	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC2CCN(CC(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891736	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875818	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984571	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875819	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(C[C@H]2C[C@@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975903	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875820	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896720	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875821	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984841	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875822	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982303	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16875823	CHEMBL3880337	Inhibition of human FGFR1 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cncn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952488	=	IC50	nM	17.38	CHEMBL3650	Homo sapiens	pIC50		7.76
	16875827	CHEMBL3880342	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in absence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cncn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952488	=	IC50	nM	6309.57	CHEMBL3650	Homo sapiens	pIC50		5.2
	16875829	CHEMBL3880343	Inhibition of FGFR1 (unknown origin) transfected in mouse BA/F3 cells assessed as decrease in cell proliferation in presence of mouse IL3 after 24 hrs by Alamar blue assay	B	COc1cc(OC)cc(N(CC#Cc2cncn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952488	<	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	pIC50		5.0
	16881702	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)C2C[C@H]2c2ccccc2)c1)c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3899609	=	Inhibition	%	66.0	CHEMBL3650	Homo sapiens	INH	%	66.0
	16882104	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(-c2ccc3c(-c4ccccc4)n[nH]c3c2)ccc1O		CHEMBL3896803	=	Ki	nM	228.0	CHEMBL3650	Homo sapiens	Ki	nM	228.0
	16882105	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(-c2ccc3c(/C=C/c4ccc(OC)c(OC)c4)n[nH]c3c2)ccc1O		CHEMBL3923888	=	Ki	nM	27.0	CHEMBL3650	Homo sapiens	Ki	nM	27.0
	16882106	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(-c2ccc3c(-c4cc5ccccc5[nH]4)n[nH]c3c2)ccc1O		CHEMBL3891392	=	Ki	nM	68.0	CHEMBL3650	Homo sapiens	Ki	nM	68.0
	16882107	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C(=C/c1n[nH]c2cc(Oc3ccccc3)ccc12)\c1ccccc1		CHEMBL3975092	=	Ki	nM	42.0	CHEMBL3650	Homo sapiens	Ki	nM	42.0
	16882108	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Oc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3961315	=	Ki	nM	15.4	CHEMBL3650	Homo sapiens	Ki	nM	15.4
	16882109	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CN(c1cccc(N)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3939894	=	Ki	nM	34000.0	CHEMBL3650	Homo sapiens	Ki	nM	34000.0
	16882110	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=C(c1cccc(NC(=O)c2ccccc2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3915043	=	Ki	nM	21.5	CHEMBL3650	Homo sapiens	Ki	nM	21.5
	16882111	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)Nc1cccc(Oc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1		CHEMBL3944307	=	Ki	nM	4.9	CHEMBL3650	Homo sapiens	Ki	nM	4.9
	16882112	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)Nc1cccc(N(C)c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1		CHEMBL3953791	=	Ki	nM	19.0	CHEMBL3650	Homo sapiens	Ki	nM	19.0
	16882113	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cnc(C(=O)Nc2cccc(Oc3ccc4c(/C=C/c5ccccc5)n[nH]c4c3)c2)s1		CHEMBL3898789	=	Ki	nM	10.4	CHEMBL3650	Homo sapiens	Ki	nM	10.4
	16882114	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cccc(C(=O)Nc2cccc(Oc3ccc4c(/C=C/c5ccccc5)n[nH]c4c3)c2)c1		CHEMBL3942288	=	Ki	nM	14.0	CHEMBL3650	Homo sapiens	Ki	nM	14.0
	16882115	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3952496	=	Ki	nM	65.0	CHEMBL3650	Homo sapiens	Ki	nM	65.0
	16882116	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Ki	nM	56.0	CHEMBL3650	Homo sapiens	Ki	nM	56.0
	16882117	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Cl)c1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3972140	=	Ki	nM	24.0	CHEMBL3650	Homo sapiens	Ki	nM	24.0
	16882118	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3915607	=	Ki	nM	20.0	CHEMBL3650	Homo sapiens	Ki	nM	20.0
	16882119	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)n(C)n1		CHEMBL3891895	=	Ki	nM	90.0	CHEMBL3650	Homo sapiens	Ki	nM	90.0
	16882120	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cccc(Oc2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3953227	=	Ki	nM	14.0	CHEMBL3650	Homo sapiens	Ki	nM	14.0
	16882121	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCONC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3963146	=	Ki	nM	75.0	CHEMBL3650	Homo sapiens	Ki	nM	75.0
	16882122	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NNc1ccccn1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3931953	=	Ki	nM	92.0	CHEMBL3650	Homo sapiens	Ki	nM	92.0
	16882123	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=CCn1nc(C)cc1C(=O)Nc1cc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)ccc1C		CHEMBL3947527	=	Ki	nM	12.0	CHEMBL3650	Homo sapiens	Ki	nM	12.0
	16882124	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCCn1nc(C)cc1C(=O)Nc1cc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)ccc1C		CHEMBL3965963	=	Ki	nM	11.0	CHEMBL3650	Homo sapiens	Ki	nM	11.0
	16882125	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CONC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3960830	=	Ki	nM	20.0	CHEMBL3650	Homo sapiens	Ki	nM	20.0
	16882126	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)n(C(C)C)n1		CHEMBL3911423	=	Ki	nM	3.4	CHEMBL3650	Homo sapiens	Ki	nM	3.4
	16882127	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)Nc1cc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)ccc1C		CHEMBL3963901	=	Ki	nM	3.5	CHEMBL3650	Homo sapiens	Ki	nM	3.5
	16882128	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1		CHEMBL3545335	=	Ki	nM	79.0	CHEMBL3650	Homo sapiens	Ki	nM	79.0
	16882129	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Sc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3960801	=	Inhibition	%	28.0	CHEMBL3650	Homo sapiens	INH	%	28.0
	16882130	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=C(c1cccc(NC(C)=O)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3927752	=	Inhibition	%	14.0	CHEMBL3650	Homo sapiens	INH	%	14.0
	16882131	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3941907	=	Inhibition	%	60.0	CHEMBL3650	Homo sapiens	INH	%	60.0
	16882132	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1		CHEMBL3983004	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	16882133	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)OCc1ccccc1		CHEMBL3944638	=	Inhibition	%	68.0	CHEMBL3650	Homo sapiens	INH	%	68.0
	16882134	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cnc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccc5)n[nH]c4c3)c2)s1		CHEMBL3948411	=	Inhibition	%	39.0	CHEMBL3650	Homo sapiens	INH	%	39.0
	16882135	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cnc(C(=O)Nc2cccc(N(C)c3ccc4c(/C=C/c5ccccc5)n[nH]c4c3)c2)s1		CHEMBL3896103	=	Inhibition	%	61.0	CHEMBL3650	Homo sapiens	INH	%	61.0
	16882136	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Nc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3985867	=	Inhibition	%	74.0	CHEMBL3650	Homo sapiens	INH	%	74.0
	16882137	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CN(c1cccc(NC(=O)c2ccccc2)c1)c1ccc2c(/C=C/c3ccc4c(c3)OCO4)n[nH]c2c1		CHEMBL3889841	=	Inhibition	%	65.0	CHEMBL3650	Homo sapiens	INH	%	65.0
	16882138	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Oc2ccc3c(/C=C/c4ccc(Cl)cc4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3892583	=	Inhibition	%	67.0	CHEMBL3650	Homo sapiens	INH	%	67.0
	16882139	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cccc(C(=O)Nc2cccc(N(C)c3ccc4c(/C=C/c5ccc6c(c5)OCO6)n[nH]c4c3)c2)c1		CHEMBL3951790	=	Inhibition	%	73.0	CHEMBL3650	Homo sapiens	INH	%	73.0
	16882140	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CN(c1cccc(NC(=O)c2cccc(C(F)(F)F)c2)c1)c1ccc2c(/C=C/c3ccc4c(c3)OCO4)n[nH]c2c1		CHEMBL3906996	=	Inhibition	%	90.0	CHEMBL3650	Homo sapiens	INH	%	90.0
	16882141	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)c1cccc(C(=O)Nc2cccc(N(C)c3ccc4c(/C=C/c5ccc6c(c5)OCO6)n[nH]c4c3)c2)c1		CHEMBL3984623	=	Inhibition	%	59.0	CHEMBL3650	Homo sapiens	INH	%	59.0
	16882142	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cccc(C(=O)Nc2cccc(Oc3ccc4c(-c5cc6ccccc6[nH]5)n[nH]c4c3)c2)c1		CHEMBL3938388	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	16882143	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Oc2ccc3c(/C=C/c4cccs4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3959522	=	Inhibition	%	94.0	CHEMBL3650	Homo sapiens	INH	%	94.0
	16882144	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)c2cccc3[nH]ccc23)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3956824	=	Inhibition	%	58.0	CHEMBL3650	Homo sapiens	INH	%	58.0
	16882145	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Oc2ccc3c(/C=C/c4ccco4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3907574	=	Inhibition	%	82.0	CHEMBL3650	Homo sapiens	INH	%	82.0
	16882146	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1ccc2cc(NC(=O)c3ccccc3Sc3ccc4c(/C=C/c5ccccc5)n[nH]c4c3)ccc2n1		CHEMBL3966821	=	Inhibition	%	74.0	CHEMBL3650	Homo sapiens	INH	%	74.0
	16882147	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(/C=N/n4cccc4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3981871	=	Inhibition	%	79.0	CHEMBL3650	Homo sapiens	INH	%	79.0
	16882148	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3954085	=	Inhibition	%	27.0	CHEMBL3650	Homo sapiens	INH	%	27.0
	16882149	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)c2ccccn2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3935569	=	Inhibition	%	41.0	CHEMBL3650	Homo sapiens	INH	%	41.0
	16882150	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1ccc2cc(NC(=O)c3ccccc3Sc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2n1		CHEMBL3938361	=	Inhibition	%	77.0	CHEMBL3650	Homo sapiens	INH	%	77.0
	16882151	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)c2ccno2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3922509	=	Inhibition	%	44.0	CHEMBL3650	Homo sapiens	INH	%	44.0
	16882152	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)c2cccc(Cl)n2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3907378	=	Inhibition	%	23.0	CHEMBL3650	Homo sapiens	INH	%	23.0
	16882153	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)c2cc(Cl)ccn2)c1)c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL3945318	=	Inhibition	%	48.0	CHEMBL3650	Homo sapiens	INH	%	48.0
	16882154	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1ccccc1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3963347	=	Inhibition	%	76.0	CHEMBL3650	Homo sapiens	INH	%	76.0
	16882155	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)c2ccccn2)c1)c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3959310	=	Inhibition	%	37.0	CHEMBL3650	Homo sapiens	INH	%	37.0
	16882156	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1)c1ccncc1		CHEMBL3956618	=	Inhibition	%	31.0	CHEMBL3650	Homo sapiens	INH	%	31.0
	16882157	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C/C=C/C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3891979	=	Inhibition	%	77.0	CHEMBL3650	Homo sapiens	INH	%	77.0
	16882158	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)c1ccc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)s1		CHEMBL3899200	=	Inhibition	%	31.0	CHEMBL3650	Homo sapiens	INH	%	31.0
	16882159	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Cc1cc(F)cc(F)c1)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3978730	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	16882160	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)n[nH]1		CHEMBL3891135	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	16882161	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cccc(Oc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)c1		CHEMBL3925826	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	16882162	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NC1CC1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3907423	=	Inhibition	%	68.0	CHEMBL3650	Homo sapiens	INH	%	68.0
	16882163	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cc(Nc2ccc3c(/C=C/c4ccccc4)n[nH]c3c2)ccc1F)c1ccccc1		CHEMBL3919150	=	Inhibition	%	88.0	CHEMBL3650	Homo sapiens	INH	%	88.0
	16882164	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Oc2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3921873	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	16882165	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(Oc2ccc3c(/C=C/c4c[nH]cn4)n[nH]c3c2)c1)c1ccccc1		CHEMBL3959357	=	Inhibition	%	96.0	CHEMBL3650	Homo sapiens	INH	%	96.0
	16882166	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)C2CC2)c1)c1ccc2[nH]nc(/C=C/c3ccccn3)c2c1		CHEMBL3891951	=	Inhibition	%	49.0	CHEMBL3650	Homo sapiens	INH	%	49.0
	16882167	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)on1		CHEMBL3918357	=	Inhibition	%	67.0	CHEMBL3650	Homo sapiens	INH	%	67.0
	16882168	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cn1nc(C(C)(C)C)cc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3915626	=	Inhibition	%	87.0	CHEMBL3650	Homo sapiens	INH	%	87.0
	16882169	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)nn1C		CHEMBL3949546	=	Inhibition	%	97.0	CHEMBL3650	Homo sapiens	INH	%	97.0
	16882170	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)c2ccc(Cl)s2)c1)c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3969695	=	Inhibition	%	74.0	CHEMBL3650	Homo sapiens	INH	%	74.0
	16882171	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CS(=O)(=O)c1ccc(C(=O)Nc2cccc(Oc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)s1		CHEMBL3904637	=	Inhibition	%	98.0	CHEMBL3650	Homo sapiens	INH	%	98.0
	16882172	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(N[C@@H]1C[C@H]1c1ccccc1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3965471	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	16882173	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NCC1CC1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3978265	=	Inhibition	%	59.0	CHEMBL3650	Homo sapiens	INH	%	59.0
	16882174	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCCNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3962576	=	Inhibition	%	59.0	CHEMBL3650	Homo sapiens	INH	%	59.0
	16882175	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(C)NC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3967498	=	Inhibition	%	59.0	CHEMBL3650	Homo sapiens	INH	%	59.0
	16882176	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NC1CCC1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3986951	=	Inhibition	%	42.0	CHEMBL3650	Homo sapiens	INH	%	42.0
	16882177	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(C)=CC(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3951147	=	Inhibition	%	69.0	CHEMBL3650	Homo sapiens	INH	%	69.0
	16882178	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cccc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)c1		CHEMBL3911428	=	Inhibition	%	88.0	CHEMBL3650	Homo sapiens	INH	%	88.0
	16882179	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1nccs1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3914097	=	Inhibition	%	82.0	CHEMBL3650	Homo sapiens	INH	%	82.0
	16882180	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)cc(Cl)n1		CHEMBL3899112	=	Inhibition	%	91.0	CHEMBL3650	Homo sapiens	INH	%	91.0
	16882181	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cn1cccc1C(=O)NNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3963477	=	Inhibition	%	69.0	CHEMBL3650	Homo sapiens	INH	%	69.0
	16882182	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(C)ONC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3955019	=	Inhibition	%	34.0	CHEMBL3650	Homo sapiens	INH	%	34.0
	16882183	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)ccc1C		CHEMBL3930485	=	Inhibition	%	94.0	CHEMBL3650	Homo sapiens	INH	%	94.0
	16882184	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3901827	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	16882185	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1)Oc1ccccc1		CHEMBL3980946	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	16882186	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C#CCNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3965277	=	Inhibition	%	74.0	CHEMBL3650	Homo sapiens	INH	%	74.0
	16882187	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NCc1cccc(F)c1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3967940	=	Inhibition	%	75.0	CHEMBL3650	Homo sapiens	INH	%	75.0
	16882188	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cccc(Oc2ccc3c(/C=C/c4c[nH]cn4)n[nH]c3c2)c1		CHEMBL3954818	=	Inhibition	%	95.0	CHEMBL3650	Homo sapiens	INH	%	95.0
	16882189	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NCCc1cccs1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3900801	=	Inhibition	%	73.0	CHEMBL3650	Homo sapiens	INH	%	73.0
	16882190	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)c1cccs1		CHEMBL3915544	=	Inhibition	%	82.0	CHEMBL3650	Homo sapiens	INH	%	82.0
	16882191	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(C)(C)c1ccc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)cc1		CHEMBL3922242	=	Inhibition	%	86.0	CHEMBL3650	Homo sapiens	INH	%	86.0
	16882192	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CN(O)C(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3894668	=	Inhibition	%	44.0	CHEMBL3650	Homo sapiens	INH	%	44.0
	16882193	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C=CCn1nc(C)cc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3904168	=	Inhibition	%	85.0	CHEMBL3650	Homo sapiens	INH	%	85.0
	16882194	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cccc(Oc2ccc3c(/C=C/c4c[nH]c(C)n4)n[nH]c3c2)c1		CHEMBL3965764	=	Inhibition	%	96.0	CHEMBL3650	Homo sapiens	INH	%	96.0
	16882195	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(N/N=C/c1ccccn1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3968184	=	Inhibition	%	43.0	CHEMBL3650	Homo sapiens	INH	%	43.0
	16882196	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CNC(=O)c1cccc(F)c1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3918836	=	Inhibition	%	38.0	CHEMBL3650	Homo sapiens	INH	%	38.0
	16882197	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(C)ONC(=O)c1cccc(F)c1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3928528	=	Inhibition	%	39.0	CHEMBL3650	Homo sapiens	INH	%	39.0
	16882198	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NC1CC1)c1cccc(F)c1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3979120	=	Inhibition	%	36.0	CHEMBL3650	Homo sapiens	INH	%	36.0
	16882199	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)cc(Cl)n1		CHEMBL3912174	=	Inhibition	%	74.0	CHEMBL3650	Homo sapiens	INH	%	74.0
	16882200	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2C)n(C)n1		CHEMBL3914819	=	Inhibition	%	74.0	CHEMBL3650	Homo sapiens	INH	%	74.0
	16882201	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(N/N=C/C(F)(F)F)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3973118	=	Inhibition	%	60.0	CHEMBL3650	Homo sapiens	INH	%	60.0
	16882202	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cn1ccnc1/C=N/NC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3975603	=	Inhibition	%	38.0	CHEMBL3650	Homo sapiens	INH	%	38.0
	16882203	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(NCc1ccncc1)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3912410	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	16882204	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1ccccc1C(=O)NNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3909731	=	Inhibition	%	51.0	CHEMBL3650	Homo sapiens	INH	%	51.0
	16882205	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1ccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)cc1N		CHEMBL3962007	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	16882206	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCONC(=O)c1cccc(F)c1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3897909	=	Inhibition	%	35.0	CHEMBL3650	Homo sapiens	INH	%	35.0
	16882207	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCc1cc(C(=O)Nc2cccc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)n(C)n1		CHEMBL3916334	=	Inhibition	%	68.0	CHEMBL3650	Homo sapiens	INH	%	68.0
	16882208	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CON(C(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)C1CC1		CHEMBL3904608	=	Inhibition	%	64.0	CHEMBL3650	Homo sapiens	INH	%	64.0
	16882209	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCCONC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3900618	=	Inhibition	%	63.0	CHEMBL3650	Homo sapiens	INH	%	63.0
	16882210	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c(C)cc1C		CHEMBL3965725	=	Inhibition	%	91.0	CHEMBL3650	Homo sapiens	INH	%	91.0
	16882211	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1)c1ccnc(Cl)c1		CHEMBL3974908	=	Inhibition	%	67.0	CHEMBL3650	Homo sapiens	INH	%	67.0
	16882212	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c(C)cc2C)n(C)n1		CHEMBL3908857	=	Inhibition	%	46.0	CHEMBL3650	Homo sapiens	INH	%	46.0
	16882213	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCc1cc(C(=O)Nc2cc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2C)n(C)n1		CHEMBL3977771	=	Inhibition	%	81.0	CHEMBL3650	Homo sapiens	INH	%	81.0
	16882214	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(C)OC(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3890452	=	Inhibition	%	86.0	CHEMBL3650	Homo sapiens	INH	%	86.0
	16882215	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cn1ccnc1C(=O)Nc1cccc(Oc2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3925855	=	Inhibition	%	62.0	CHEMBL3650	Homo sapiens	INH	%	62.0
	16882216	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C)c(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)cc1N		CHEMBL3928496	=	Inhibition	%	59.0	CHEMBL3650	Homo sapiens	INH	%	59.0
	16882217	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CC(=O)Nc1cc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c(C)cc1C		CHEMBL3940103	=	Inhibition	%	91.0	CHEMBL3650	Homo sapiens	INH	%	91.0
	16882218	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cnccc1C(=O)Nc1cccc(C(=O)c2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c1		CHEMBL3947493	=	Inhibition	%	41.0	CHEMBL3650	Homo sapiens	INH	%	41.0
	16882219	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c(F)cc2C)n(C)n1		CHEMBL3896427	=	Inhibition	%	77.0	CHEMBL3650	Homo sapiens	INH	%	77.0
	16882220	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	O=C(c1cccc(NC(=O)c2cc(Cl)ccn2)c1)c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3958163	=	Inhibition	%	74.0	CHEMBL3650	Homo sapiens	INH	%	74.0
	16882221	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cc(C(=O)c3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2C)n(C(C)C)n1		CHEMBL3953173	=	Inhibition	%	97.0	CHEMBL3650	Homo sapiens	INH	%	97.0
	16882222	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	C#CCNC(=O)c1ccccc1Nc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL3913600	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	16882223	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cccc(Oc2ccc3c(/C=C/c4cn(C)c(C)n4)n[nH]c3c2)c1		CHEMBL3920315	=	Inhibition	%	99.0	CHEMBL3650	Homo sapiens	INH	%	99.0
	16882224	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2C)n(C)n1		CHEMBL3932298	=	Inhibition	%	80.0	CHEMBL3650	Homo sapiens	INH	%	80.0
	16882225	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)c2)n(C)n1		CHEMBL3968085	=	Inhibition	%	89.0	CHEMBL3650	Homo sapiens	INH	%	89.0
	16882226	CHEMBL3881033	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cc(Oc2ccc3c(/C=C/c4ncc[nH]4)n[nH]c3c2)ccc1C		CHEMBL3928425	=	Inhibition	%	98.0	CHEMBL3650	Homo sapiens	INH	%	98.0
	16882921	CHEMBL3881032	Inhibition of human phosphorylated FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CCn1nc(C)cc1C(=O)Nc1cc(Nc2ccc3c(/C=C/c4ccccn4)n[nH]c3c2)c(F)cc1C		CHEMBL3982880	=	Ki	nM	14.0	CHEMBL3650	Homo sapiens	Ki	nM	14.0
	16883281	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(-c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)c(C)cc1O		CHEMBL3937879	=	Inhibition	%	72.0	CHEMBL3650	Homo sapiens	INH	%	72.0
	16883282	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL538361	=	Inhibition	%	88.0	CHEMBL3650	Homo sapiens	INH	%	88.0
	16883283	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	Cc1cc(O)c(Cl)cc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL3924544	=	Inhibition	%	89.0	CHEMBL3650	Homo sapiens	INH	%	89.0
	16883284	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL3914503	=	Inhibition	%	66.0	CHEMBL3650	Homo sapiens	INH	%	66.0
	16883285	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4ccncc4[nH]3)n[nH]c2c1		CHEMBL3923584	=	Inhibition	%	62.0	CHEMBL3650	Homo sapiens	INH	%	62.0
	16883286	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4ccc(C(=O)NCCN5CCOCC5)cc4[nH]3)n[nH]c2c1		CHEMBL3892217	=	Inhibition	%	87.0	CHEMBL3650	Homo sapiens	INH	%	87.0
	16883287	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4ccc(N5CCN(C)CC5)cc4[nH]3)n[nH]c2c1		CHEMBL3889461	=	Inhibition	%	96.0	CHEMBL3650	Homo sapiens	INH	%	96.0
	16883288	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	=	Inhibition	%	80.0	CHEMBL3650	Homo sapiens	INH	%	80.0
	16883289	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(O)ccc1-c1ccc2c(-c3ncc[nH]3)n[nH]c2c1		CHEMBL3932910	=	Inhibition	%	26.0	CHEMBL3650	Homo sapiens	INH	%	26.0
	16883290	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(SCCO)cccc4[nH]3)n[nH]c2c1		CHEMBL3921210	=	Inhibition	%	56.0	CHEMBL3650	Homo sapiens	INH	%	56.0
	16883291	CHEMBL3881048	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation at 1 uM using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CNC(=O)c1ccc2[nH]c(-c3n[nH]c4cc(-c5ccc(O)cc5OC)ccc34)nc2c1		CHEMBL3904805	=	Inhibition	%	82.0	CHEMBL3650	Homo sapiens	INH	%	82.0
	16883292	CHEMBL3881049	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CSc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1		CHEMBL3901400	=	Ki	nM	160.0	CHEMBL3650	Homo sapiens	Ki	uM	0.16
	16883293	CHEMBL3881049	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4cc(N(C)C)ccc4[nH]3)n[nH]c2c1		CHEMBL3915814	=	Ki	nM	91000.0	CHEMBL3650	Homo sapiens	Ki	uM	91.0
	16883294	CHEMBL3881049	Inhibition of human FGFR1 L457V/C488A/C584S mutant expressed in baculovirus/insect expression system assessed as reduction in NADH oxidation using poly(E4Y1) as substrate by pyruvate kinase/lactate dehydrogenase coupled assay	B	CNC(=O)c1cccc2[nH]c(-c3n[nH]c4cc(-c5ccc(O)cc5OC)ccc34)nc12		CHEMBL3976302	=	Ki	nM	70000.0	CHEMBL3650	Homo sapiens	Ki	uM	70.0
262696	17645188	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=CC=CC5N4)c3N)ccc2[nH]1		CHEMBL3676312	=	IC50	nM	5.0	CHEMBL3650	Homo sapiens	IC50	nM	5.0
262697	17645189	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(O)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676313	=	IC50	nM	5.3	CHEMBL3650	Homo sapiens	IC50	nM	5.3
262698	17645190	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCNCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676314	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	nM	28.0
262699	17645191	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCCN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676315	=	IC50	nM	2.7	CHEMBL3650	Homo sapiens	IC50	nM	2.7
262700	17645192	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OC6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676316	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	nM	3.0
262701	17645193	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(F)c(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676317	=	IC50	nM	31.0	CHEMBL3650	Homo sapiens	IC50	nM	31.0
262702	17645194	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(F)cc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676318	=	IC50	nM	42.0	CHEMBL3650	Homo sapiens	IC50	nM	42.0
262703	17645195	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccc(C(F)(F)F)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676319	=	IC50	nM	460.0	CHEMBL3650	Homo sapiens	IC50	nM	460.0
262704	17645196	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCCC(F)(F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676320	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	nM	30.0
262705	17645197	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)NCC(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676321	=	IC50	nM	99.0	CHEMBL3650	Homo sapiens	IC50	nM	99.0
262706	17645198	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(C(F)(F)F)cn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676322	=	IC50	nM	93.0	CHEMBL3650	Homo sapiens	IC50	nM	93.0
262707	17645199	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CO)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676323	=	IC50	nM	15.0	CHEMBL3650	Homo sapiens	IC50	nM	15.0
262708	17645200	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCCN6CCN(C)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676324	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
262709	17645201	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCC6(C)COC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676325	=	IC50	nM	0.81	CHEMBL3650	Homo sapiens	IC50	nM	0.81
262710	17645202	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCN(CCOC)Cc1ccc2cc(C(=O)C3C=NN(c4ccc5[nH]c(C)nc5c4)C3N)[nH]c2c1		CHEMBL3676326	=	IC50	nM	9.6	CHEMBL3650	Homo sapiens	IC50	nM	9.6
262711	17645203	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	C#CCN(C)Cc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3676327	=	IC50	nM	17.0	CHEMBL3650	Homo sapiens	IC50	nM	17.0
262712	17645204	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOC[C@@H]6C)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676328	=	IC50	nM	2.7	CHEMBL3650	Homo sapiens	IC50	nM	2.7
262713	17645205	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676329	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	nM	30.0
262714	17645206	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ncccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676330	=	IC50	nM	42.0	CHEMBL3650	Homo sapiens	IC50	nM	42.0
262715	17645207	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(I)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676331	=	IC50	nM	16.0	CHEMBL3650	Homo sapiens	IC50	nM	16.0
262716	17645208	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676332	=	IC50	nM	43.0	CHEMBL3650	Homo sapiens	IC50	nM	43.0
262717	17645209	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C(C)C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676333	=	IC50	nM	89.0	CHEMBL3650	Homo sapiens	IC50	nM	89.0
262718	17645210	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Cc6ccccc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676334	=	IC50	nM	51.0	CHEMBL3650	Homo sapiens	IC50	nM	51.0
262719	17645211	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6=C(C(F)(F)F)CCC=C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676335	=	IC50	nM	260.0	CHEMBL3650	Homo sapiens	IC50	nM	260.0
262720	17645212	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	C#Cc1cccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc12		CHEMBL3676336	=	IC50	nM	77.0	CHEMBL3650	Homo sapiens	IC50	nM	77.0
262721	17645213	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2c(F)cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3676337	=	IC50	nM	35.0	CHEMBL3650	Homo sapiens	IC50	nM	35.0
262722	17645214	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCCCOc1ccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2c1		CHEMBL3681236	=	IC50	nM	22.0	CHEMBL3650	Homo sapiens	IC50	nM	22.0
262723	17645215	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(NS(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681237	=	IC50	nM	25.0	CHEMBL3650	Homo sapiens	IC50	nM	25.0
262724	17645216	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(N7CCOCC7)nc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681238	=	IC50	nM	29.0	CHEMBL3650	Homo sapiens	IC50	nM	29.0
262725	17645217	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCCCc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681239	=	IC50	nM	230.0	CHEMBL3650	Homo sapiens	IC50	nM	230.0
262726	17645218	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cnn(C)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681240	=	IC50	nM	23.0	CHEMBL3650	Homo sapiens	IC50	nM	23.0
262727	17645219	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ncccc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681241	=	IC50	nM	60.0	CHEMBL3650	Homo sapiens	IC50	nM	60.0
262728	17645220	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(C6CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681242	=	IC50	nM	45.0	CHEMBL3650	Homo sapiens	IC50	nM	45.0
262729	17645221	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccccc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681243	=	IC50	nM	76.0	CHEMBL3650	Homo sapiens	IC50	nM	76.0
262730	17645222	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681244	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	nM	50.0
262731	17645223	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cncc(S(C)(=O)=O)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681245	=	IC50	nM	43.0	CHEMBL3650	Homo sapiens	IC50	nM	43.0
262732	17645224	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccnn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681246	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
262733	17645225	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCOc1ccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2c1		CHEMBL3681247	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
262734	17645226	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(OCC6CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681248	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	nM	24.0
262735	17645227	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc6c(cc5[nH]4)OC(F)(F)O6)c3N)ccc2[nH]1		CHEMBL3681249	=	IC50	nM	57.0	CHEMBL3650	Homo sapiens	IC50	nM	57.0
262736	17645228	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(F)cn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681250	=	IC50	nM	22.0	CHEMBL3650	Homo sapiens	IC50	nM	22.0
262737	17645229	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Cl)c(OCC6CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681251	=	IC50	nM	62.0	CHEMBL3650	Homo sapiens	IC50	nM	62.0
262738	17645230	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2ccc(-n3ncc(C(=O)c4[nH]c5ccccc5c4F)c3N)cc2[nH]1		CHEMBL3681262	=	IC50	nM	75.0	CHEMBL3650	Homo sapiens	IC50	nM	75.0
262739	17645231	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C(C)C)CC6)c(C(F)(F)F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681263	=	IC50	nM	39.0	CHEMBL3650	Homo sapiens	IC50	nM	39.0
262740	17645232	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=CC(C#N)=CC5N4)c3N)ccc2[nH]1		CHEMBL3681264	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	nM	9.0
262741	17645233	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6=CCNCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681265	=	IC50	nM	43.0	CHEMBL3650	Homo sapiens	IC50	nM	43.0
262742	17645234	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCNCC6)c(F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681266	=	IC50	nM	33.0	CHEMBL3650	Homo sapiens	IC50	nM	33.0
262743	17645235	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C(C)C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681267	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	nM	11.0
262744	17645236	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-c6cccnc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681268	=	IC50	nM	48.0	CHEMBL3650	Homo sapiens	IC50	nM	48.0
262745	17645237	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-c6ccc(O)nc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681269	=	IC50	nM	36.0	CHEMBL3650	Homo sapiens	IC50	nM	36.0
262746	17645238	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(C6CCN(C)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681270	=	IC50	nM	6.9	CHEMBL3650	Homo sapiens	IC50	nM	6.9
262747	17645239	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6C(C)CCC6C)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681271	=	IC50	nM	0.32	CHEMBL3650	Homo sapiens	IC50	nM	0.32
262748	17645240	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCCC(F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681272	=	IC50	nM	0.67	CHEMBL3650	Homo sapiens	IC50	nM	0.67
262749	17645241	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CN1CCC(c2ccc3[nH]c(C(=O)c4cnn(-c5ccc6[nH]c(C(F)F)nc6c5)c4N)cc3c2)CC1		CHEMBL3681273	=	IC50	nM	87.0	CHEMBL3650	Homo sapiens	IC50	nM	87.0
262750	17645242	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C7CCCC7)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681274	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	nM	11.0
262751	17645243	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(Br)c[nH]4)c3N)ccc2[nH]1		CHEMBL3681275	=	IC50	nM	390.0	CHEMBL3650	Homo sapiens	IC50	nM	390.0
262752	17645244	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc[nH]4)c3N)ccc2[nH]1		CHEMBL3681276	=	IC50	nM	980.0	CHEMBL3650	Homo sapiens	IC50	nM	980.0
262753	17645245	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(-c5cccc(F)c5)c[nH]4)c3N)ccc2[nH]1		CHEMBL3681277	=	IC50	nM	210.0	CHEMBL3650	Homo sapiens	IC50	nM	210.0
262754	17645246	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681278	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
262755	17645247	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NCCN6CCOCC6)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681279	=	IC50	nM	5.1	CHEMBL3650	Homo sapiens	IC50	nM	5.1
262756	17645248	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCN(C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681280	=	IC50	nM	2.0	CHEMBL3650	Homo sapiens	IC50	nM	2.0
262757	17645249	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCNc1cccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc12		CHEMBL3681281	=	IC50	nM	6.4	CHEMBL3650	Homo sapiens	IC50	nM	6.4
262758	17645250	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NC(CO)CO)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681282	=	IC50	nM	4.2	CHEMBL3650	Homo sapiens	IC50	nM	4.2
262759	17645251	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NCCc6ccncc6)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681283	=	IC50	nM	8.5	CHEMBL3650	Homo sapiens	IC50	nM	8.5
262760	17645252	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(N6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681284	=	IC50	nM	2.5	CHEMBL3650	Homo sapiens	IC50	nM	2.5
262761	17645253	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCOCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681285	=	IC50	nM	3.8	CHEMBL3650	Homo sapiens	IC50	nM	3.8
262762	17645254	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(C(F)(F)F)nc2c1		CHEMBL3681286	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	nM	24.0
262763	17645255	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCc1nc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681287	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
262764	17645256	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(Cc3ccccc3)nc2c1		CHEMBL3681288	=	IC50	nM	82.0	CHEMBL3650	Homo sapiens	IC50	nM	82.0
262765	17645257	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2c([nH]1)CCC(n1ncc(C(=O)c3cc4cc(CN5CCN(S(C)(=O)=O)CC5)ccc4[nH]3)c1N)=C2		CHEMBL3681289	=	IC50	nM	7.9	CHEMBL3650	Homo sapiens	IC50	nM	7.9
262766	17645258	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCNCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3639801	=	IC50	nM	66.0	CHEMBL3650	Homo sapiens	IC50	nM	66.0
262767	17645259	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CC(=O)N1CCN(Cc2ccc3cc(C(=O)c4cnn(-c5ccc6[nH]c(C)nc6c5)c4N)[nH]c3c2)CC1		CHEMBL3681290	=	IC50	nM	1.8	CHEMBL3650	Homo sapiens	IC50	nM	1.8
262768	17645260	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCN(C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681291	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
262769	17645261	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681292	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
262770	17645262	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(F)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681293	=	IC50	nM	70.0	CHEMBL3650	Homo sapiens	IC50	nM	70.0
262771	17645263	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c([nH]4)=CC(CN4CCOCC4)C(F)C=5)c3N)ccc2[nH]1		CHEMBL3681294	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
262772	17645264	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)O)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681295	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	nM	3.0
262773	17645265	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1cc(OC)c2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681296	=	IC50	nM	40.0	CHEMBL3650	Homo sapiens	IC50	nM	40.0
262774	17645266	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681297	=	IC50	nM	48.0	CHEMBL3650	Homo sapiens	IC50	nM	48.0
262775	17645267	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1cc(C)c2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681298	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	nM	30.0
262776	17645268	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(C)(C)C)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681299	=	IC50	nM	150.0	CHEMBL3650	Homo sapiens	IC50	nM	150.0
262777	17645269	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Oc6ccccc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681300	=	IC50	nM	120.0	CHEMBL3650	Homo sapiens	IC50	nM	120.0
262778	17645270	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CSc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681301	=	IC50	nM	33.0	CHEMBL3650	Homo sapiens	IC50	nM	33.0
262779	17645271	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(F)c(C(F)(F)F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681302	=	IC50	nM	60.0	CHEMBL3650	Homo sapiens	IC50	nM	60.0
262780	17645272	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1cc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2cc1Cl		CHEMBL3681303	=	IC50	nM	5.5	CHEMBL3650	Homo sapiens	IC50	nM	5.5
262781	17645273	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCc6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681304	=	IC50	nM	46.0	CHEMBL3650	Homo sapiens	IC50	nM	46.0
262782	17645274	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(OC(C)C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681305	=	IC50	nM	91.0	CHEMBL3650	Homo sapiens	IC50	nM	91.0
262783	17645275	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc6c(cc5[nH]4)OCCO6)c3N)ccc2[nH]1		CHEMBL3681306	=	IC50	nM	38.0	CHEMBL3650	Homo sapiens	IC50	nM	38.0
262784	17645276	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C(C)(C)C)cc(C(C)(C)C)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681307	=	IC50	nM	34.0	CHEMBL3650	Homo sapiens	IC50	nM	34.0
262785	17645277	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-n6ccnc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681308	=	IC50	nM	31.0	CHEMBL3650	Homo sapiens	IC50	nM	31.0
262786	17645278	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(SC(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681309	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	nM	140.0
262787	17645279	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(F)(F)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681314	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
262788	17645280	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OC6COC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681315	=	IC50	nM	21.0	CHEMBL3650	Homo sapiens	IC50	nM	21.0
262789	17645281	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681316	=	IC50	nM	27.0	CHEMBL3650	Homo sapiens	IC50	nM	27.0
262790	17645282	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(S(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681317	=	IC50	nM	56.0	CHEMBL3650	Homo sapiens	IC50	nM	56.0
262791	17645283	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(Br)c(Br)[nH]4)c3N)ccc2[nH]1		CHEMBL3681318	=	IC50	nM	260.0	CHEMBL3650	Homo sapiens	IC50	nM	260.0
262792	17645284	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(-c5cccnc5)c(-c5cccnc5)[nH]4)c3N)ccc2[nH]1		CHEMBL3681319	=	IC50	nM	1700.0	CHEMBL3650	Homo sapiens	IC50	nM	1700.0
262793	17645285	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Cl)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681252	=	IC50	nM	91.0	CHEMBL3650	Homo sapiens	IC50	nM	91.0
262794	17645286	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc5cc[nH]c5c4)c3N)ccc2[nH]1		CHEMBL3681253	=	IC50	nM	3600.0	CHEMBL3650	Homo sapiens	IC50	nM	3600.0
262795	17645287	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681254	=	IC50	nM	92.0	CHEMBL3650	Homo sapiens	IC50	nM	92.0
262796	17645288	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(F)cc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681255	=	IC50	nM	45.0	CHEMBL3650	Homo sapiens	IC50	nM	45.0
262797	17645289	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1ccc(-c2ccc3cc(C(=O)c4cnn(-c5ccc6[nH]c(C)nc6c5)c4N)[nH]c3c2)cn1		CHEMBL3681256	=	IC50	nM	53.0	CHEMBL3650	Homo sapiens	IC50	nM	53.0
262798	17645290	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ncc(Cl)cc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681257	=	IC50	nM	53.0	CHEMBL3650	Homo sapiens	IC50	nM	53.0
262799	17645291	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccs6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681258	=	IC50	nM	36.0	CHEMBL3650	Homo sapiens	IC50	nM	36.0
262800	17645292	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=C(C(=O)N6CCC(F)(F)C6)C=CC5N4)c3N)ccc2[nH]1		CHEMBL3681259	=	IC50	nM	56.0	CHEMBL3650	Homo sapiens	IC50	nM	56.0
262801	17645293	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CC(C)OC(C)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681260	=	IC50	nM	210.0	CHEMBL3650	Homo sapiens	IC50	nM	210.0
262802	17645294	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CC[C@H](F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681261	=	IC50	nM	2800.0	CHEMBL3650	Homo sapiens	IC50	nM	2800.0
262803	17645295	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccc(-c2c[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)c2)cc1		CHEMBL3681313	=	IC50	nM	850.0	CHEMBL3650	Homo sapiens	IC50	nM	850.0
262804	17645296	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4nc5ccccc5s4)c3N)ccc2[nH]1		CHEMBL3681310	=	IC50	nM	38.0	CHEMBL3650	Homo sapiens	IC50	nM	38.0
262805	17645297	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc(F)cc4)c3N)ccc2[nH]1		CHEMBL3681311	=	IC50	nM	95.0	CHEMBL3650	Homo sapiens	IC50	nM	95.0
262806	17645298	CHEMBL3705411	Enzyme Inhibition Assay: The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cccc(Cl)c4)c3N)ccc2[nH]1		CHEMBL3681312	=	IC50	nM	77.0	CHEMBL3650	Homo sapiens	IC50	nM	77.0
278016	17660361	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	Cc1ccc(N2CCC(O)CC2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C		CHEMBL3686863	=	IC50	nM	9.8	CHEMBL3650	Homo sapiens	IC50	nM	9.8
278017	17660362	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC)ccn3)cc2)CC1		CHEMBL3686864	=	IC50	nM	10.1	CHEMBL3650	Homo sapiens	IC50	nM	10.1
278018	17660363	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OC)cc21		CHEMBL3686865	=	IC50	nM	7.9	CHEMBL3650	Homo sapiens	IC50	nM	7.9
278019	17660364	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@H](C)O)CC5)cc4)c3)c(OC)cc21		CHEMBL3686866	=	IC50	nM	7.2	CHEMBL3650	Homo sapiens	IC50	nM	7.2
278020	17660365	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCCF)CC5)cc4)c3)c(OC)cc21		CHEMBL3686867	=	IC50	nM	12.0	CHEMBL3650	Homo sapiens	IC50	nM	12.0
278021	17660366	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCNCC5F)cc4)c3)c(OC)cc21		CHEMBL3686868	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	nM	11.0
278022	17660367	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5(F)CCNCC5)cc4)c3)c(OC)cc21		CHEMBL3686869	=	IC50	nM	11.6	CHEMBL3650	Homo sapiens	IC50	nM	11.6
278023	17660368	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCC(N6CCCC6)CC5)cc4)c3)c(OC)cc21		CHEMBL3686870	=	IC50	nM	13.2	CHEMBL3650	Homo sapiens	IC50	nM	13.2
278024	17660369	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC(O)CC5)cc4)c3)c(OC)cc21		CHEMBL3686871	=	IC50	nM	30.0	CHEMBL3650	Homo sapiens	IC50	nM	30.0
278025	17660370	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5C[C@H](O)[C@@H](OC)C5)cc4)c3)c(OC)cc21		CHEMBL3686872	=	IC50	nM	37.7	CHEMBL3650	Homo sapiens	IC50	nM	37.7
278026	17660371	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCN(CCc2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC)ccn3)cc2)CC1		CHEMBL3686873	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
278027	17660372	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(OCCN5CCC(O)CC5)cc4)c3)c(OC)cc21		CHEMBL3686874	=	IC50	nM	19.9	CHEMBL3650	Homo sapiens	IC50	nM	19.9
278028	17660373	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCC(n2cc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC)ccn3)cn2)CC1		CHEMBL3686875	=	IC50	nM	31.2	CHEMBL3650	Homo sapiens	IC50	nM	31.2
278029	17660374	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(OC5CCN(CCO)CC5)cc4)c3)c(OC)cc21		CHEMBL3686876	=	IC50	nM	10.9	CHEMBL3650	Homo sapiens	IC50	nM	10.9
278030	17660375	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCNCC3)cc2)c1		CHEMBL3686877	=	IC50	nM	12.5	CHEMBL3650	Homo sapiens	IC50	nM	12.5
278031	17660376	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(CC)CC3)cc2)c1		CHEMBL3686878	=	IC50	nM	11.5	CHEMBL3650	Homo sapiens	IC50	nM	11.5
278032	17660377	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCNCC5)cc4)c3)c(OC(C)C)cc21		CHEMBL3686879	=	IC50	nM	14.6	CHEMBL3650	Homo sapiens	IC50	nM	14.6
278033	17660378	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@@H](C)O)CC5)cc4)c3)c(OC(C)C)cc21		CHEMBL3686880	=	IC50	nM	12.7	CHEMBL3650	Homo sapiens	IC50	nM	12.7
278034	17660379	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC(O)CC5)cc4)c3)c(OC(F)F)cc21		CHEMBL3686881	=	IC50	nM	13.5	CHEMBL3650	Homo sapiens	IC50	nM	13.5
278035	17660380	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCNCC5)cc4)c3)c(OCCOC)cc21		CHEMBL3686882	=	IC50	nM	5.6	CHEMBL3650	Homo sapiens	IC50	nM	5.6
278036	17660381	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C)CC5)cc4)c3)c(OCCOC)cc21		CHEMBL3686883	=	IC50	nM	5.7	CHEMBL3650	Homo sapiens	IC50	nM	5.7
278037	17660382	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCOC)cc21		CHEMBL3686884	=	IC50	nM	5.8	CHEMBL3650	Homo sapiens	IC50	nM	5.8
278038	17660383	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C(C)C)CC5)cc4)c3)c(OCCOC)cc21		CHEMBL3686885	=	IC50	nM	5.3	CHEMBL3650	Homo sapiens	IC50	nM	5.3
278039	17660384	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCNCC3)cc2)c1		CHEMBL3686886	=	IC50	nM	4.4	CHEMBL3650	Homo sapiens	IC50	nM	4.4
278040	17660385	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(CCO)CC3)cc2)c1		CHEMBL3686887	=	IC50	nM	5.2	CHEMBL3650	Homo sapiens	IC50	nM	5.2
278041	17660386	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CN(CC)C3)cc2)c1		CHEMBL3686888	=	IC50	nM	6.3	CHEMBL3650	Homo sapiens	IC50	nM	6.3
278042	17660387	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CN(CCO)C3)cc2)c1		CHEMBL3691258	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
278043	17660388	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(CC)CC3)nc2)c1		CHEMBL3691259	=	IC50	nM	11.2	CHEMBL3650	Homo sapiens	IC50	nM	11.2
278044	17660389	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCC[C@H]3CO)cc2)c1		CHEMBL3691260	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
278045	17660390	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3C[C@H](C)N[C@H](C)C3)cc2)c1		CHEMBL3691261	=	IC50	nM	14.5	CHEMBL3650	Homo sapiens	IC50	nM	14.5
278046	17660391	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CC[C@@H](O)C3)s2)c1		CHEMBL3691262	=	IC50	nM	6.5	CHEMBL3650	Homo sapiens	IC50	nM	6.5
278047	17660392	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CN(C)C3)cc2)c1		CHEMBL3691263	=	IC50	nM	10.9	CHEMBL3650	Homo sapiens	IC50	nM	10.9
278048	17660393	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OCCCF)ccn3)cc2)CC1		CHEMBL3691264	=	IC50	nM	8.5	CHEMBL3650	Homo sapiens	IC50	nM	8.5
278049	17660394	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC[C@@H]5CO)s4)c3)c(OC)cc21		CHEMBL3691265	=	IC50	nM	12.3	CHEMBL3650	Homo sapiens	IC50	nM	12.3
278050	17660395	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC[C@H]5CO)s4)c3)c(OC)cc21		CHEMBL3691266	=	IC50	nM	10.8	CHEMBL3650	Homo sapiens	IC50	nM	10.8
278051	17660396	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5C[C@H](C)N[C@H](C)C5)s4)c3)c(OC)cc21		CHEMBL3691267	=	IC50	nM	11.2	CHEMBL3650	Homo sapiens	IC50	nM	11.2
278052	17660397	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCN(Cc2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC)ccn3)s2)CC1		CHEMBL3691268	=	IC50	nM	10.9	CHEMBL3650	Homo sapiens	IC50	nM	10.9
278053	17660398	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC(O)CC5)s4)c3)c(OC)cc21		CHEMBL3691269	=	IC50	nM	10.5	CHEMBL3650	Homo sapiens	IC50	nM	10.5
278054	17660399	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CC(C)(C)O)CC5)cc4)c3)c(OC)cc21		CHEMBL3691280	=	IC50	nM	7.9	CHEMBL3650	Homo sapiens	IC50	nM	7.9
278055	17660400	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C(C)C)CC5)cc4)c3)c(OC)cc21		CHEMBL3691281	=	IC50	nM	8.9	CHEMBL3650	Homo sapiens	IC50	nM	8.9
278056	17660401	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(OC5CCN(C[C@@H](C)O)CC5)cc4)c3)c(OC)cc21		CHEMBL3691282	=	IC50	nM	10.6	CHEMBL3650	Homo sapiens	IC50	nM	10.6
278057	17660402	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(OC5CCN(C[C@H](C)O)CC5)cc4)c3)c(OC)cc21		CHEMBL3691270	=	IC50	nM	13.0	CHEMBL3650	Homo sapiens	IC50	nM	13.0
278058	17660403	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCC(Oc2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC)ccn3)cc2)CC1		CHEMBL3691271	=	IC50	nM	12.5	CHEMBL3650	Homo sapiens	IC50	nM	12.5
278059	17660404	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4cnn(C5CCN(C[C@@H](C)O)CC5)c4)c3)c(OC)cc21		CHEMBL3691272	=	IC50	nM	22.8	CHEMBL3650	Homo sapiens	IC50	nM	22.8
278060	17660405	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4cnn(C5CCN(C[C@H](C)O)CC5)c4)c3)c(OC)cc21		CHEMBL3691273	=	IC50	nM	26.5	CHEMBL3650	Homo sapiens	IC50	nM	26.5
278061	17660406	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4cnn(C5CCN(C(C)C)CC5)c4)c3)c(OC)cc21		CHEMBL3691274	=	IC50	nM	24.1	CHEMBL3650	Homo sapiens	IC50	nM	24.1
278062	17660407	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(C(C)C)C5)cc4)c3)c(OC)cc21		CHEMBL3691283	=	IC50	nM	12.8	CHEMBL3650	Homo sapiens	IC50	nM	12.8
278063	17660408	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(CC(C)(C)O)C5)cc4)c3)c(OC)cc21		CHEMBL3691284	=	IC50	nM	12.1	CHEMBL3650	Homo sapiens	IC50	nM	12.1
278064	17660409	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC)ccn3)cc2)C1		CHEMBL3691285	=	IC50	nM	11.7	CHEMBL3650	Homo sapiens	IC50	nM	11.7
278065	17660410	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC[C@@H]5CO)cc4)c3)c(OC)cc21		CHEMBL3691275	=	IC50	nM	32.3	CHEMBL3650	Homo sapiens	IC50	nM	32.3
278066	17660411	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC[C@H]5CO)cc4)c3)c(OC)cc21		CHEMBL3691276	=	IC50	nM	18.3	CHEMBL3650	Homo sapiens	IC50	nM	18.3
278067	17660412	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CC[C@H](O)C5)cc4)c3)c(OC)cc21		CHEMBL3691277	=	IC50	nM	23.7	CHEMBL3650	Homo sapiens	IC50	nM	23.7
278068	17660413	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CC[C@@H](O)C5)cc4)c3)c(OC)cc21		CHEMBL3691278	=	IC50	nM	23.4	CHEMBL3650	Homo sapiens	IC50	nM	23.4
278069	17660414	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@@H](C)O)CC5)cc4)c3)c(OC)cc21		CHEMBL3691279	=	IC50	nM	5.5	CHEMBL3650	Homo sapiens	IC50	nM	5.5
278070	17660415	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCN(CCOc2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC)ccn3)cc2)CC1		CHEMBL3691286	=	IC50	nM	34.1	CHEMBL3650	Homo sapiens	IC50	nM	34.1
278071	17660416	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CCN5CCC(O)CC5)cc4)c3)c(OC)cc21		CHEMBL3691287	=	IC50	nM	24.2	CHEMBL3650	Homo sapiens	IC50	nM	24.2
278072	17660417	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C)CC5)cc4)c3)c(OC)cc21		CHEMBL3691288	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
278073	17660418	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(CC(C)(C)O)CC3)cc2)c1		CHEMBL3639901	=	IC50	nM	9.8	CHEMBL3650	Homo sapiens	IC50	nM	9.8
278074	17660419	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C(C)C)CC3)cc2)c1		CHEMBL3691289	=	IC50	nM	8.7	CHEMBL3650	Homo sapiens	IC50	nM	8.7
278075	17660420	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C[C@@H](C)O)CC3)cc2)c1		CHEMBL3691290	=	IC50	nM	9.6	CHEMBL3650	Homo sapiens	IC50	nM	9.6
278076	17660421	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C[C@H](C)O)CC3)cc2)c1		CHEMBL3691291	=	IC50	nM	8.9	CHEMBL3650	Homo sapiens	IC50	nM	8.9
278077	17660422	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(N3CCC(N4CCCC4)CC3)cc2)c1		CHEMBL3691292	=	IC50	nM	18.8	CHEMBL3650	Homo sapiens	IC50	nM	18.8
278078	17660423	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(CCO)CC3)cc2)c1		CHEMBL3691293	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
278079	17660424	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C)CC3)cc2)c1		CHEMBL3691294	=	IC50	nM	11.8	CHEMBL3650	Homo sapiens	IC50	nM	11.8
278080	17660425	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCC(O)CC3)cc2)c1		CHEMBL3691295	=	IC50	nM	33.8	CHEMBL3650	Homo sapiens	IC50	nM	33.8
278081	17660426	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@H](C)O)CC5)cc4)c3)c(OC(C)C)cc21		CHEMBL3691296	=	IC50	nM	10.3	CHEMBL3650	Homo sapiens	IC50	nM	10.3
278082	17660427	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OC(C)C)cc21		CHEMBL3691297	=	IC50	nM	11.2	CHEMBL3650	Homo sapiens	IC50	nM	11.2
278083	17660428	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OC(C)C)ccn3)cc2)CC1		CHEMBL3691298	=	IC50	nM	11.7	CHEMBL3650	Homo sapiens	IC50	nM	11.7
278084	17660429	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C)CC5)cc4)c3)c(OC(C)C)cc21		CHEMBL3691299	=	IC50	nM	12.4	CHEMBL3650	Homo sapiens	IC50	nM	12.4
278085	17660430	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC(O)CC5)cc4)c3)c(OC(C)C)cc21		CHEMBL3691300	=	IC50	nM	32.0	CHEMBL3650	Homo sapiens	IC50	nM	32.0
278086	17660431	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CC[C@H](O)C5)cc4)c3)c(OCCCF)cc21		CHEMBL3691301	=	IC50	nM	18.4	CHEMBL3650	Homo sapiens	IC50	nM	18.4
278087	17660432	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CC[C@@H](O)C5)cc4)c3)c(OCCCF)cc21		CHEMBL3691302	=	IC50	nM	22.5	CHEMBL3650	Homo sapiens	IC50	nM	22.5
278088	17660433	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC(O)CC5)cc4)c3)c(OCCCF)cc21		CHEMBL3691303	=	IC50	nM	24.2	CHEMBL3650	Homo sapiens	IC50	nM	24.2
278089	17660434	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@@H](C)O)CC5)cc4)c3)c(OCCCF)cc21		CHEMBL3691304	=	IC50	nM	8.5	CHEMBL3650	Homo sapiens	IC50	nM	8.5
278090	17660435	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@H](C)O)CC5)cc4)c3)c(OCCCF)cc21		CHEMBL3691305	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
278091	17660436	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C)CC5)cc4)c3)c(OCCCF)cc21		CHEMBL3691306	=	IC50	nM	10.4	CHEMBL3650	Homo sapiens	IC50	nM	10.4
278092	17660437	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C(C)C)CC5)nc4)c3)c(OCCOC)cc21		CHEMBL3691307	=	IC50	nM	19.1	CHEMBL3650	Homo sapiens	IC50	nM	19.1
278093	17660438	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OCCOC)ccn3)cn2)CC1		CHEMBL3691308	=	IC50	nM	20.2	CHEMBL3650	Homo sapiens	IC50	nM	20.2
278094	17660439	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(CC(C)(C)O)C5)cc4)c3)c(OCCOC)cc21		CHEMBL3691309	=	IC50	nM	8.5	CHEMBL3650	Homo sapiens	IC50	nM	8.5
278095	17660440	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(C[C@@H](C)O)C5)cc4)c3)c(OCCOC)cc21		CHEMBL3691310	=	IC50	nM	8.5	CHEMBL3650	Homo sapiens	IC50	nM	8.5
278096	17660441	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(C[C@H](C)O)C5)cc4)c3)c(OCCOC)cc21		CHEMBL3691311	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	nM	7.0
278097	17660442	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC[C@@H]5CO)s4)c3)c(OCCOC)cc21		CHEMBL3691312	=	IC50	nM	6.4	CHEMBL3650	Homo sapiens	IC50	nM	6.4
278098	17660443	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC[C@H]5CO)s4)c3)c(OCCOC)cc21		CHEMBL3691313	=	IC50	nM	10.2	CHEMBL3650	Homo sapiens	IC50	nM	10.2
278099	17660444	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CC[C@H](O)C5)s4)c3)c(OCCOC)cc21		CHEMBL3691314	=	IC50	nM	8.6	CHEMBL3650	Homo sapiens	IC50	nM	8.6
278100	17660445	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CC[C@@H](O)C5)s4)c3)c(OCCOC)cc21		CHEMBL3691315	=	IC50	nM	6.7	CHEMBL3650	Homo sapiens	IC50	nM	6.7
278101	17660446	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC(O)CC5)s4)c3)c(OCCOC)cc21		CHEMBL3691316	=	IC50	nM	6.5	CHEMBL3650	Homo sapiens	IC50	nM	6.5
278102	17660447	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(C)C5)cc4)c3)c(OCCOC)cc21		CHEMBL3691317	=	IC50	nM	7.1	CHEMBL3650	Homo sapiens	IC50	nM	7.1
278103	17660448	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(C(C)C)C5)cc4)c3)c(OCCOC)cc21		CHEMBL3691318	=	IC50	nM	6.7	CHEMBL3650	Homo sapiens	IC50	nM	6.7
278104	17660449	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OCCOC)ccn3)cc2)C1		CHEMBL3691319	=	IC50	nM	5.7	CHEMBL3650	Homo sapiens	IC50	nM	5.7
278105	17660450	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@@H](C)O)CC5)cc4)c3)c(OCCOC)cc21		CHEMBL3691320	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	nM	7.0
278106	17660451	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@H](C)O)CC5)cc4)c3)c(OCCOC)cc21		CHEMBL3691321	=	IC50	nM	5.0	CHEMBL3650	Homo sapiens	IC50	nM	5.0
278107	17660452	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OCCOC)ccn3)cc2)CC1		CHEMBL3691322	=	IC50	nM	5.4	CHEMBL3650	Homo sapiens	IC50	nM	5.4
278108	17660453	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC(O)CC5)cc4)c3)c(OCCOC)cc21		CHEMBL3691323	=	IC50	nM	14.9	CHEMBL3650	Homo sapiens	IC50	nM	14.9
278109	17660454	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C(C)C)CC3)nc2)c1		CHEMBL3691324	=	IC50	nM	10.6	CHEMBL3650	Homo sapiens	IC50	nM	10.6
278110	17660455	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CN(CC(C)(C)O)C3)cc2)c1		CHEMBL3691325	=	IC50	nM	5.7	CHEMBL3650	Homo sapiens	IC50	nM	5.7
278111	17660456	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CN(C[C@@H](C)O)C3)cc2)c1		CHEMBL3691326	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	nM	11.0
278112	17660457	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CN(C[C@H](C)O)C3)cc2)c1		CHEMBL3691327	=	IC50	nM	7.2	CHEMBL3650	Homo sapiens	IC50	nM	7.2
278113	17660458	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCC[C@@H]3CO)s2)c1		CHEMBL3691335	=	IC50	nM	6.6	CHEMBL3650	Homo sapiens	IC50	nM	6.6
278114	17660459	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCC[C@H]3CO)s2)c1		CHEMBL3691336	=	IC50	nM	5.1	CHEMBL3650	Homo sapiens	IC50	nM	5.1
278115	17660460	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CC[C@@H](O)C3)s2)c1		CHEMBL3691262	=	IC50	nM	5.4	CHEMBL3650	Homo sapiens	IC50	nM	5.4
278116	17660461	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCC(O)CC3)s2)c1		CHEMBL3691337	=	IC50	nM	5.6	CHEMBL3650	Homo sapiens	IC50	nM	5.6
278117	17660462	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CN(C)C3)cc2)c1		CHEMBL3691263	=	IC50	nM	6.5	CHEMBL3650	Homo sapiens	IC50	nM	6.5
278118	17660463	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CN(C(C)C)C3)cc2)c1		CHEMBL3691328	=	IC50	nM	5.0	CHEMBL3650	Homo sapiens	IC50	nM	5.0
278119	17660464	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3691329	=	IC50	nM	12.1	CHEMBL3650	Homo sapiens	IC50	nM	12.1
278120	17660465	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CC[C@H](O)C3)cc2)c1		CHEMBL3691330	=	IC50	nM	8.6	CHEMBL3650	Homo sapiens	IC50	nM	8.6
278121	17660466	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CC[C@@H](O)C3)cc2)c1		CHEMBL3691338	=	IC50	nM	8.9	CHEMBL3650	Homo sapiens	IC50	nM	8.9
278122	17660467	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCC(F)CC3)cc2)c1		CHEMBL3691339	=	IC50	nM	16.1	CHEMBL3650	Homo sapiens	IC50	nM	16.1
278123	17660468	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCN(CC)CC3)cc2)c1		CHEMBL3691340	=	IC50	nM	11.5	CHEMBL3650	Homo sapiens	IC50	nM	11.5
278124	17660469	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(CC(C)(C)O)CC3)cc2)c1		CHEMBL3691341	=	IC50	nM	3.9	CHEMBL3650	Homo sapiens	IC50	nM	3.9
278125	17660470	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C(C)C)CC3)cc2)c1		CHEMBL3691331	=	IC50	nM	5.4	CHEMBL3650	Homo sapiens	IC50	nM	5.4
278126	17660471	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C[C@@H](C)O)CC3)cc2)c1		CHEMBL3691332	=	IC50	nM	4.2	CHEMBL3650	Homo sapiens	IC50	nM	4.2
278127	17660472	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C[C@H](C)O)CC3)cc2)c1		CHEMBL3691333	=	IC50	nM	3.4	CHEMBL3650	Homo sapiens	IC50	nM	3.4
278128	17660473	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(CC)CC3)cc2)c1		CHEMBL3691334	=	IC50	nM	4.2	CHEMBL3650	Homo sapiens	IC50	nM	4.2
278129	17660474	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(C3CCN(C)CC3)cc2)c1		CHEMBL3691342	=	IC50	nM	3.7	CHEMBL3650	Homo sapiens	IC50	nM	3.7
278130	17660475	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCOCCOc1cc2c(ccn2C(=O)NC)cc1Oc1ccnc(NC(=O)c2ccc(CN3CCC(O)CC3)cc2)c1		CHEMBL3691343	=	IC50	nM	10.3	CHEMBL3650	Homo sapiens	IC50	nM	10.3
278131	17660476	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC[C@@H]5CO)cc4)c3)c(OCCCOC)cc21		CHEMBL3691344	=	IC50	nM	22.3	CHEMBL3650	Homo sapiens	IC50	nM	22.3
278132	17660477	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC[C@H]5CO)cc4)c3)c(OCCCOC)cc21		CHEMBL3691345	=	IC50	nM	10.7	CHEMBL3650	Homo sapiens	IC50	nM	10.7
278133	17660478	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(C[C@@H](C)O)C5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691346	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	nM	7.0
278134	17660479	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(C[C@H](C)O)C5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691347	=	IC50	nM	11.5	CHEMBL3650	Homo sapiens	IC50	nM	11.5
278135	17660480	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CC[C@H](O)C5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691348	=	IC50	nM	16.6	CHEMBL3650	Homo sapiens	IC50	nM	16.6
278136	17660481	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CC[C@@H](O)C5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691349	=	IC50	nM	16.1	CHEMBL3650	Homo sapiens	IC50	nM	16.1
278137	17660482	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(CN5CCC(O)CC5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691350	=	IC50	nM	17.9	CHEMBL3650	Homo sapiens	IC50	nM	17.9
278138	17660483	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CN(C(C)C)C5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691351	=	IC50	nM	8.9	CHEMBL3650	Homo sapiens	IC50	nM	8.9
278139	17660484	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OCCCOC)ccn3)cc2)C1		CHEMBL3691352	=	IC50	nM	8.5	CHEMBL3650	Homo sapiens	IC50	nM	8.5
278140	17660485	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@@H](C)O)CC5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691353	=	IC50	nM	5.2	CHEMBL3650	Homo sapiens	IC50	nM	5.2
278141	17660486	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C[C@H](C)O)CC5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691354	=	IC50	nM	6.4	CHEMBL3650	Homo sapiens	IC50	nM	6.4
278142	17660487	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C(C)C)CC5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691355	=	IC50	nM	7.1	CHEMBL3650	Homo sapiens	IC50	nM	7.1
278143	17660488	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691356	=	IC50	nM	6.1	CHEMBL3650	Homo sapiens	IC50	nM	6.1
278144	17660489	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CCN1CCC(c2ccc(C(=O)Nc3cc(Oc4cc5ccn(C(=O)NC)c5cc4OCCCOC)ccn3)cc2)CC1		CHEMBL3691357	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	nM	7.0
278145	17660490	CHEMBL3706135	ADP-Glo Kinase Assay: In this assay, the inhibitory activity of a test substance against the tyrosine kinase activity of FGFR1 protein is measured.To each well of a flat bottom 96 well white plate (Sumitomo Bakelite Co., Ltd., MS-8496W), 10 ul of FGFR1 protein (Cama Biosciences, Inc., 08-133) solution diluted to 1 ug/mL with an assay buffer (20 mM HEPES NaOH, 0.01% Triton X-100, 2 mM DTT, and 5 mM MgCl2), 10 ul, of an assay buffer solution containing CSK-tide substrate (Ana Spec Inc., 63843) in a final concentration of 1000 nM and ATP (Promega Corporation, V9102) in a final concentration of 58.3 uM, and 5 ul of a test substance diluted with the assay buffer were added, and the reaction was performed at room temperature for 1 hour (kinase reaction). For measuring kinase activity, ADP-Glo Kinase Assay (Promega Corporation, V9102) was used. After the reaction, 25 uL of ADP-Glo reagent was added to each well of the plate, and the reaction was performed at morn temperature for 40 minutes.	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(C)CC5)cc4)c3)c(OCCCOC)cc21		CHEMBL3691358	=	IC50	nM	6.2	CHEMBL3650	Homo sapiens	IC50	nM	6.2
347250	17723787	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3963485	=	IC50	nM	12.2	CHEMBL3650	Homo sapiens	IC50	nM	12.2
347251	17723788	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3963485	=	IC50	nM	7.2	CHEMBL3650	Homo sapiens	IC50	nM	7.2
347252	17723789	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@@H]1CCNC1=O		CHEMBL4111992	=	IC50	nM	6.6	CHEMBL3650	Homo sapiens	IC50	nM	6.6
347253	17723790	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@@H]1CCNC1=O		CHEMBL4111992	=	IC50	nM	13.7	CHEMBL3650	Homo sapiens	IC50	nM	13.7
347254	17723791	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3979989	=	IC50	nM	4.6	CHEMBL3650	Homo sapiens	IC50	nM	4.6
347255	17723792	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3979989	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	nM	9.0
347256	17723793	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@@H]1CCNC1=O		CHEMBL4106638	=	IC50	nM	4.2	CHEMBL3650	Homo sapiens	IC50	nM	4.2
347257	17723794	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@@H]1CCNC1=O		CHEMBL4106638	=	IC50	nM	9.4	CHEMBL3650	Homo sapiens	IC50	nM	9.4
347258	17723795	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CNCC(N)=O		CHEMBL3930278	=	IC50	nM	31.0	CHEMBL3650	Homo sapiens	IC50	nM	31.0
347259	17723796	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3969781	=	IC50	nM	12.7	CHEMBL3650	Homo sapiens	IC50	nM	12.7
347260	17723797	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCN(C(C)=O)CC1		CHEMBL3901861	=	IC50	nM	6.5	CHEMBL3650	Homo sapiens	IC50	nM	6.5
347261	17723798	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3929808	=	IC50	nM	3.3	CHEMBL3650	Homo sapiens	IC50	nM	3.3
347262	17723799	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(CN4CCNC(=O)C4)n4ncnc(N)c34)sc12		CHEMBL3914307	=	IC50	nM	2.5	CHEMBL3650	Homo sapiens	IC50	nM	2.5
347263	17723800	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CC[C@](C)(N)C1		CHEMBL3938823	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
347264	17723801	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CC[C@](C)(N)C1		CHEMBL3985178	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
347265	17723802	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCN(C(C)=O)CC1		CHEMBL3915403	=	IC50	nM	12.5	CHEMBL3650	Homo sapiens	IC50	nM	12.5
347266	17723803	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3892887	=	IC50	nM	0.9	CHEMBL3650	Homo sapiens	IC50	nM	0.9
347267	17723804	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3924399	=	IC50	nM	0.7	CHEMBL3650	Homo sapiens	IC50	nM	0.7
347268	17723805	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3924399	=	IC50	nM	0.5	CHEMBL3650	Homo sapiens	IC50	nM	0.5
347269	17723806	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCN(C(C)=O)CC1		CHEMBL3901861	=	IC50	nM	25.0	CHEMBL3650	Homo sapiens	IC50	nM	25.0
347270	17723807	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCCO)c(CN4CCNC(=O)C4)n4ncnc(N)c34)sc12		CHEMBL3923490	=	IC50	nM	4.2	CHEMBL3650	Homo sapiens	IC50	nM	4.2
347271	17723808	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCCO)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3895503	=	IC50	nM	0.9	CHEMBL3650	Homo sapiens	IC50	nM	0.9
347272	17723809	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCCCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3932448	=	IC50	nM	17.9	CHEMBL3650	Homo sapiens	IC50	nM	17.9
347273	17723810	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3907995	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
347274	17723811	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC4CC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3909132	=	IC50	nM	0.7	CHEMBL3650	Homo sapiens	IC50	nM	0.7
347275	17723812	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COC4CCC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3979384	=	IC50	nM	0.9	CHEMBL3650	Homo sapiens	IC50	nM	0.9
347276	17723813	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COC(C)C)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3918062	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
347277	17723814	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3984301	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
347278	17723815	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC(F)(F)F)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3889953	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
347279	17723816	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCCN)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3958993	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
347280	17723817	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COC(=O)COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3938826	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
347281	17723818	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC(=O)O)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3962751	=	IC50	nM	5.2	CHEMBL3650	Homo sapiens	IC50	nM	5.2
347282	17723819	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC(N)=O)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3926373	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
347283	17723820	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COCC(N)=O)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3954008	=	IC50	nM	6.0	CHEMBL3650	Homo sapiens	IC50	nM	6.0
347284	17723821	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(COc4ccccc4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3917388	=	IC50	nM	61.3	CHEMBL3650	Homo sapiens	IC50	nM	61.3
347285	17723822	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CNCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3948716	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	nM	3.0
347286	17723823	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN(C)C)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3911960	=	IC50	nM	22.1	CHEMBL3650	Homo sapiens	IC50	nM	22.1
347287	17723824	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCNCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3939941	=	IC50	nM	6.9	CHEMBL3650	Homo sapiens	IC50	nM	6.9
347288	17723825	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCCO)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3905236	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
347289	17723826	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCCC(O)C4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3929725	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
347290	17723827	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCC(O)CC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3906882	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
347291	17723828	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCC(O)C4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3980564	=	IC50	nM	5.1	CHEMBL3650	Homo sapiens	IC50	nM	5.1
347292	17723829	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCN(CC)Cc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNCC1		CHEMBL3897866	=	IC50	nM	8.6	CHEMBL3650	Homo sapiens	IC50	nM	8.6
347293	17723830	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC4CCC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3969060	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
347294	17723831	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCCC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3907380	=	IC50	nM	3.4	CHEMBL3650	Homo sapiens	IC50	nM	3.4
347295	17723832	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC4CC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3930377	=	IC50	nM	3.2	CHEMBL3650	Homo sapiens	IC50	nM	3.2
347296	17723833	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC4CC4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3952635	=	IC50	nM	1.7	CHEMBL3650	Homo sapiens	IC50	nM	1.7
347297	17723834	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(=O)O)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3924925	=	IC50	nM	12.8	CHEMBL3650	Homo sapiens	IC50	nM	12.8
347298	17723835	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN[C@H]4CCNC4=O)c(CN4CCOCC4)n4ncnc(N)c34)sc12		CHEMBL3905636	=	IC50	nM	4.4	CHEMBL3650	Homo sapiens	IC50	nM	4.4
347299	17723836	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(CN4CCOCC4)n4ncnc(N)c34)sc12		CHEMBL3921263	=	IC50	nM	9.7	CHEMBL3650	Homo sapiens	IC50	nM	9.7
347300	17723837	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)O)c(CN4CCOCC4)n4ncnc(N)c34)sc12		CHEMBL3944881	=	IC50	nM	3.9	CHEMBL3650	Homo sapiens	IC50	nM	3.9
347301	17723838	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(CN4CCOCC4)n4ncnc(N)c34)sc12		CHEMBL3957859	=	IC50	nM	11.2	CHEMBL3650	Homo sapiens	IC50	nM	11.2
347302	17723839	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN[C@@H]4CCNC4=O)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL4108692	=	IC50	nM	2.4	CHEMBL3650	Homo sapiens	IC50	nM	2.4
347303	17723840	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3949626	=	IC50	nM	3.2	CHEMBL3650	Homo sapiens	IC50	nM	3.2
347304	17723841	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(CN4CCN(C=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3974164	=	IC50	nM	6.8	CHEMBL3650	Homo sapiens	IC50	nM	6.8
347305	17723842	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3954561	=	IC50	nM	3.8	CHEMBL3650	Homo sapiens	IC50	nM	3.8
347306	17723843	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COC(=O)c1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCNCC1		CHEMBL3983205	=	IC50	nM	16.2	CHEMBL3650	Homo sapiens	IC50	nM	16.2
347307	17723844	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(-c4cnco4)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3951786	=	IC50	nM	0.5	CHEMBL3650	Homo sapiens	IC50	nM	0.5
347308	17723845	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3924079	=	IC50	nM	3.1	CHEMBL3650	Homo sapiens	IC50	nM	3.1
347309	17723846	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3934668	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
347310	17723847	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CN4CCN(C=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3968059	=	IC50	nM	5.6	CHEMBL3650	Homo sapiens	IC50	nM	5.6
347311	17723848	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CN4CCN(C(C)=O)CC4)n4ncnc(N)c34)sc12		CHEMBL3938513	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
347312	17723849	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CN4CCNC(=O)C4)n4ncnc(N)c34)sc12		CHEMBL3976573	=	IC50	nM	5.0	CHEMBL3650	Homo sapiens	IC50	nM	5.0
347313	17723850	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(C#N)n4ncnc(N)c34)sc12		CHEMBL3950723	=	IC50	nM	27.0	CHEMBL3650	Homo sapiens	IC50	nM	27.0
347314	17723851	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C#N		CHEMBL3890365	=	IC50	nM	55.3	CHEMBL3650	Homo sapiens	IC50	nM	55.3
347315	17723852	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C#N		CHEMBL3959438	=	IC50	nM	39.1	CHEMBL3650	Homo sapiens	IC50	nM	39.1
347316	17723853	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(C#N)n4ncnc(N)c34)sc12		CHEMBL3897839	=	IC50	nM	2.7	CHEMBL3650	Homo sapiens	IC50	nM	2.7
347317	17723854	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNC(C)=O)c(CNC(C)=O)n4ncnc(N)c34)sc12		CHEMBL3929322	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
347318	17723855	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(C(C)(C)O)n4ncnc(N)c34)sc12		CHEMBL3892430	=	IC50	nM	4.4	CHEMBL3650	Homo sapiens	IC50	nM	4.4
347319	17723856	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(C(C)(C)O)n4ncnc(N)c34)sc12		CHEMBL3920417	=	IC50	nM	4.0	CHEMBL3650	Homo sapiens	IC50	nM	4.0
347320	17723857	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(C)n4ncnc(N)c34)sc12		CHEMBL3919371	=	IC50	nM	4.1	CHEMBL3650	Homo sapiens	IC50	nM	4.1
347321	17723858	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(C)n4ncnc(N)c34)sc12		CHEMBL3943773	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
347322	17723859	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(C)n4ncnc(N)c34)sc12		CHEMBL3906839	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
347323	17723860	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(C)n4ncnc(N)c34)sc12		CHEMBL3906839	=	IC50	nM	1.7	CHEMBL3650	Homo sapiens	IC50	nM	1.7
347324	17723861	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CO)c(Cl)n4ncnc(N)c34)sc12		CHEMBL3933729	=	IC50	nM	12.6	CHEMBL3650	Homo sapiens	IC50	nM	12.6
347325	17723862	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(Cl)n4ncnc(N)c34)sc12		CHEMBL3937124	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
347326	17723863	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(Cl)n4ncnc(N)c34)sc12		CHEMBL3911335	=	IC50	nM	1.9	CHEMBL3650	Homo sapiens	IC50	nM	1.9
347327	17723864	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CNCC(C)(C)O)c(Cl)n4ncnc(N)c34)sc12		CHEMBL3911335	=	IC50	nM	3.4	CHEMBL3650	Homo sapiens	IC50	nM	3.4
347328	17723865	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1Cl		CHEMBL3916756	=	IC50	nM	14.5	CHEMBL3650	Homo sapiens	IC50	nM	14.5
347329	17723866	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(C)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3948076	=	IC50	nM	3.7	CHEMBL3650	Homo sapiens	IC50	nM	3.7
347330	17723867	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(Cl)c(CN4CCNCC4)n4ncnc(N)c34)sc12		CHEMBL3925756	=	IC50	nM	26.4	CHEMBL3650	Homo sapiens	IC50	nM	26.4
347331	17723868	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CO		CHEMBL3953385	=	IC50	nM	3.9	CHEMBL3650	Homo sapiens	IC50	nM	3.9
347332	17723869	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC1=O		CHEMBL3967890	=	IC50	nM	14.1	CHEMBL3650	Homo sapiens	IC50	nM	14.1
347333	17723870	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cccc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3905179	=	IC50	nM	79.6	CHEMBL3650	Homo sapiens	IC50	nM	79.6
347334	17723871	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)ccc3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3976420	=	IC50	nM	82.9	CHEMBL3650	Homo sapiens	IC50	nM	82.9
347335	17723872	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(C)O		CHEMBL3889482	=	IC50	nM	9.9	CHEMBL3650	Homo sapiens	IC50	nM	9.9
347336	17723873	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(O)C1CC1		CHEMBL3976970	=	IC50	nM	52.9	CHEMBL3650	Homo sapiens	IC50	nM	52.9
347337	17723874	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@H]1CCNC1=O		CHEMBL3951109	=	IC50	nM	8.2	CHEMBL3650	Homo sapiens	IC50	nM	8.2
347338	17723875	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN[C@H]1CCNC1=O		CHEMBL3938754	=	IC50	nM	5.5	CHEMBL3650	Homo sapiens	IC50	nM	5.5
347339	17723876	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCCCO1		CHEMBL3910837	=	IC50	nM	81.9	CHEMBL3650	Homo sapiens	IC50	nM	81.9
347340	17723877	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1(C)C		CHEMBL3933274	=	IC50	nM	17.0	CHEMBL3650	Homo sapiens	IC50	nM	17.0
347341	17723878	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCCC1		CHEMBL3901798	=	IC50	nM	54.5	CHEMBL3650	Homo sapiens	IC50	nM	54.5
347342	17723879	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CC(O)C1		CHEMBL3924336	=	IC50	nM	16.4	CHEMBL3650	Homo sapiens	IC50	nM	16.4
347343	17723880	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCC(O)CC1		CHEMBL3896327	=	IC50	nM	17.0	CHEMBL3650	Homo sapiens	IC50	nM	17.0
347344	17723881	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCS(=O)(=O)CC1		CHEMBL3914178	=	IC50	nM	24.8	CHEMBL3650	Homo sapiens	IC50	nM	24.8
347345	17723882	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCN(C2CC2)CC1		CHEMBL3889724	=	IC50	nM	54.5	CHEMBL3650	Homo sapiens	IC50	nM	54.5
347346	17723883	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCC(O)C1		CHEMBL3920658	=	IC50	nM	30.8	CHEMBL3650	Homo sapiens	IC50	nM	30.8
347347	17723884	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CC(F)(F)C1		CHEMBL3945043	=	IC50	nM	39.2	CHEMBL3650	Homo sapiens	IC50	nM	39.2
347348	17723885	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCC(F)(F)C1		CHEMBL3908158	=	IC50	nM	50.3	CHEMBL3650	Homo sapiens	IC50	nM	50.3
347349	17723886	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CNC(=O)C1		CHEMBL3985125	=	IC50	nM	5.6	CHEMBL3650	Homo sapiens	IC50	nM	5.6
347350	17723887	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1C		CHEMBL3927292	=	IC50	nM	8.7	CHEMBL3650	Homo sapiens	IC50	nM	8.7
347351	17723888	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N[C@@H]1CCNC1=O		CHEMBL4112606	=	IC50	nM	6.4	CHEMBL3650	Homo sapiens	IC50	nM	6.4
347352	17723889	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCNC(=O)C1		CHEMBL3921890	=	IC50	nM	9.4	CHEMBL3650	Homo sapiens	IC50	nM	9.4
347353	17723890	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)NCCO		CHEMBL3949665	=	IC50	nM	3.9	CHEMBL3650	Homo sapiens	IC50	nM	3.9
347354	17723891	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(N)=O		CHEMBL3912904	=	IC50	nM	8.4	CHEMBL3650	Homo sapiens	IC50	nM	8.4
347355	17723892	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)NC		CHEMBL3937359	=	IC50	nM	17.5	CHEMBL3650	Homo sapiens	IC50	nM	17.5
347356	17723893	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCNC(=O)c1c(COCC)c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn12		CHEMBL3983959	=	IC50	nM	27.0	CHEMBL3650	Homo sapiens	IC50	nM	27.0
347357	17723894	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCCCO1		CHEMBL3955323	=	IC50	nM	42.1	CHEMBL3650	Homo sapiens	IC50	nM	42.1
347358	17723895	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCC(C(N)=O)CC1		CHEMBL3895152	=	IC50	nM	52.7	CHEMBL3650	Homo sapiens	IC50	nM	52.7
347359	17723896	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N(C)C		CHEMBL3969794	=	IC50	nM	11.2	CHEMBL3650	Homo sapiens	IC50	nM	11.2
347360	17723897	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)NC1CC1		CHEMBL3899826	=	IC50	nM	24.9	CHEMBL3650	Homo sapiens	IC50	nM	24.9
347361	17723898	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N[C@H]1CCNC1=O		CHEMBL3944496	=	IC50	nM	3.7	CHEMBL3650	Homo sapiens	IC50	nM	3.7
347362	17723899	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CNC(=O)C1		CHEMBL3934358	=	IC50	nM	8.8	CHEMBL3650	Homo sapiens	IC50	nM	8.8
347363	17723900	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCC(O)C1		CHEMBL3976049	=	IC50	nM	6.8	CHEMBL3650	Homo sapiens	IC50	nM	6.8
347364	17723901	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCS(=O)(=O)C1		CHEMBL3977038	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	nM	9.0
347365	17723902	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CC(O)C1		CHEMBL3947786	=	IC50	nM	6.8	CHEMBL3650	Homo sapiens	IC50	nM	6.8
347366	17723903	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCC(O)CC1		CHEMBL3981692	=	IC50	nM	8.2	CHEMBL3650	Homo sapiens	IC50	nM	8.2
347367	17723904	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CC(F)(F)C1		CHEMBL3911723	=	IC50	nM	18.9	CHEMBL3650	Homo sapiens	IC50	nM	18.9
347368	17723905	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1C(=O)N1CCS(=O)(=O)CC1		CHEMBL3896144	=	IC50	nM	25.1	CHEMBL3650	Homo sapiens	IC50	nM	25.1
347369	17723906	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(-c2cc3cc(OC)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1		CHEMBL3920657	=	IC50	nM	27.3	CHEMBL3650	Homo sapiens	IC50	nM	27.3
347370	17723907	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COc1cc(C)cc2cc(-c3c(CN4CCNC(=O)C4)c(CO)n4ncnc(N)c34)sc12		CHEMBL3968346	=	IC50	nM	5.0	CHEMBL3650	Homo sapiens	IC50	nM	5.0
347371	17723908	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	COCc1c(CN2CCNC(=O)C2)c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn12		CHEMBL3897224	=	IC50	nM	3.9	CHEMBL3650	Homo sapiens	IC50	nM	3.9
347372	17723909	CHEMBL3887674	High ATP Kinase Assay: For the assay, 50 nl of each stock solution of the test compound in DMSO was pipetted into a black, low-volume 384-well microtiter plate (Greiner Bio-One, Frickenhausen, Germany) 2 Î¼l of a solution of the above FGFR-1 fusion protein in aqueous assay buffer [8 mM MOPS pH 7.0, 10 mM magnesium acetate, 1.0 mM dithiothreitol, 0.05% (w/v) bovine serum albumin (BSA), 0.07% (v/v) Tween-20, 0.2 mM EDTA] was added, and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compound to the enzyme. Then, the kinase reaction was started by the addition of 3 ul of a solution of adenosine triphosphate (ATP, 3.3 mM; final concentration in the 5 ul assay volume=2 mM) and substrate (0.16 uM; final concentration in the 5 ul assay volume=0.1 uM) in assay buffer, and the resulting mixture was incubated for a reaction time of 15 min at 22° C. The concentration of FGFR-1 fusion protein was adjusted depending on the activity of the enzyme lot.	B	CCOCc1c(CN2CCNC(=O)C2)c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn12		CHEMBL3973687	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
412020	17776735	CHEMBL3888664	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
415927	17779508	CHEMBL3888791	Inhibition Assay: In a similar manner to Experimental Example 1, the % inhibitory activity (concentration of the compound 1.0 μM) and the IC50 values of the inventive compound of Example 1 against various kinases were obtained by using Kinase Profiling Service (Invitrogen) according to the manufacturer's instructions.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cccc2c(N)nccc12		CHEMBL3967980	>	IC50	nM	2500.0	CHEMBL3650	Homo sapiens	IC50	nM	2500.0
431428	17791536	CHEMBL3889038	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	8.5	CHEMBL3650	Homo sapiens	IC50	nM	8.5
431546	17791654	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	Cn1cc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)C3CC3)cc(-c3ccc(F)cc3F)c2)cn1		CHEMBL3964954	=	IC50	nM	12.0	CHEMBL3650	Homo sapiens	IC50	nM	12.0
431547	17791655	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-c4cnco4)ccc32)c1		CHEMBL3912202	=	IC50	nM	3.8	CHEMBL3650	Homo sapiens	IC50	nM	3.8
431548	17791656	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(C)S(=O)(=O)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-c4cnco4)ccc32)c1		CHEMBL3891158	=	IC50	nM	34.0	CHEMBL3650	Homo sapiens	IC50	nM	34.0
431549	17791657	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	O=S(=O)(Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-c4cnco4)ccc32)c1)c1ccccc1		CHEMBL3951113	=	IC50	nM	21.0	CHEMBL3650	Homo sapiens	IC50	nM	21.0
431550	17791658	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CCS(=O)(=O)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-n4cccn4)ccc32)c1		CHEMBL3891303	=	IC50	nM	16.0	CHEMBL3650	Homo sapiens	IC50	nM	16.0
431551	17791659	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	O=C(Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-n4cccn4)ccc32)c1)NC1CCCC1		CHEMBL3964197	=	IC50	nM	33.0	CHEMBL3650	Homo sapiens	IC50	nM	33.0
431552	17791660	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(C)(O)CCn1cc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)C3CC3)cc(-c3ccc(F)cc3F)c2)nn1		CHEMBL3956305	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	nM	7.0
431553	17791661	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CCS(=O)(=O)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-c4cn(CCN5CCOCC5)nn4)ccc32)c1		CHEMBL3942896	=	IC50	nM	3.4	CHEMBL3650	Homo sapiens	IC50	nM	3.4
431554	17791662	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	COc1ccc(-c2ccc3c(c2)ncn3-c2cc(NC(C)=O)cc(-c3ccc(F)cc3)c2)cn1		CHEMBL3908779	=	IC50	nM	22.0	CHEMBL3650	Homo sapiens	IC50	nM	22.0
431555	17791663	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(F)cc2)cc(-n2cnc3cc(-n4cccn4)ccc32)c1		CHEMBL3970763	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
431556	17791664	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CCS(=O)(=O)Nc1cc(-c2ccc(F)cc2)cc(-n2cnc3cc(-n4cccn4)ccc32)c1		CHEMBL3967207	=	IC50	nM	32.0	CHEMBL3650	Homo sapiens	IC50	nM	32.0
431557	17791665	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(C)o2)cc(-n2cnc3cc(-c4cnn(CCN(C)C)c4)ccc32)c1		CHEMBL3973618	=	IC50	nM	16.0	CHEMBL3650	Homo sapiens	IC50	nM	16.0
431558	17791666	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(C)o2)cc(-n2cnc3cc(-c4cnn(CCN5CCOCC5)c4)ccc32)c1		CHEMBL3899036	=	IC50	nM	37.0	CHEMBL3650	Homo sapiens	IC50	nM	37.0
431559	17791667	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-n2cccc2)cc(-n2cnc3cc(-c4cn(CCC(C)(C)O)nn4)ccc32)c1		CHEMBL3942773	=	IC50	nM	1.8	CHEMBL3650	Homo sapiens	IC50	nM	1.8
431560	17791668	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	Cn1cc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)N3CCCCC3)cc(-n3cccn3)c2)cn1		CHEMBL3911361	=	IC50	nM	83.0	CHEMBL3650	Homo sapiens	IC50	nM	83.0
431561	17791669	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	O=C(NCc1ccco1)Nc1cc(-n2cccn2)cc(-n2cnc3cc(-n4cccn4)ccc32)c1		CHEMBL3933804	=	IC50	nM	61.0	CHEMBL3650	Homo sapiens	IC50	nM	61.0
431562	17791670	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-n2cccn2)cc(-n2cnc3cc(-c4cnn(CC5CC5)c4)ccc32)c1		CHEMBL3905783	=	IC50	nM	62.0	CHEMBL3650	Homo sapiens	IC50	nM	62.0
431563	17791671	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-c4cnn(C)c4)cnc32)c1		CHEMBL3956762	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
431564	17791672	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CCS(=O)(=O)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-c4cnn(C)c4)cnc32)c1		CHEMBL3932752	=	IC50	nM	14.0	CHEMBL3650	Homo sapiens	IC50	nM	14.0
431565	17791673	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	Cn1cc(-c2cnc3c(c2)ncn3-c2cc(NS(=O)(=O)c3ccccc3)cc(-c3ccc(F)cc3F)c2)cn1		CHEMBL3948108	=	IC50	nM	98.0	CHEMBL3650	Homo sapiens	IC50	nM	98.0
431566	17791674	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(C)S(=O)(=O)Nc1cc(-c2cc(F)ccc2F)cc(-n2cnc3cc(-c4cnn(CCN5CCOCC5)c4)ccc32)c1		CHEMBL3920288	=	IC50	nM	48.0	CHEMBL3650	Homo sapiens	IC50	nM	48.0
431567	17791675	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2c(F)cccc2F)cc(-n2cnc3cc(-n4cccn4)ccc32)c1		CHEMBL3950320	=	IC50	nM	7.3	CHEMBL3650	Homo sapiens	IC50	nM	7.3
431568	17791676	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-n2cncn2)cc(-n2cnc3cc(-c4cnn(C)c4)ccc32)c1		CHEMBL3947041	=	IC50	nM	62.0	CHEMBL3650	Homo sapiens	IC50	nM	62.0
431569	17791677	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	COc1ccc(-c2cc(NC(C)=O)cc(-n3cnc4cc(-c5cnn(C)c5)ccc43)c2)cn1		CHEMBL3957172	=	IC50	nM	22.0	CHEMBL3650	Homo sapiens	IC50	nM	22.0
431570	17791678	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(C4=NCCN4)ccc32)c1		CHEMBL3985844	=	IC50	nM	94.0	CHEMBL3650	Homo sapiens	IC50	nM	94.0
431571	17791679	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(F)cc2)cc(-n2cnc3cc(-c4ccc(F)nc4)ccc32)c1		CHEMBL3983506	=	IC50	nM	59.0	CHEMBL3650	Homo sapiens	IC50	nM	59.0
431572	17791680	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-c4ccc(F)nc4)cnc32)c1		CHEMBL3897035	=	IC50	nM	14.9	CHEMBL3650	Homo sapiens	IC50	nM	14.9
431573	17791681	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	COc1ccc(-c2cc(NC(C)=O)cc(-n3cnc4cc(-c5cnn(C)c5)ccc43)c2)c(F)c1		CHEMBL3943168	=	IC50	nM	4.3	CHEMBL3650	Homo sapiens	IC50	nM	4.3
431574	17791682	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(C)n1cc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)C3CC3)cc(-c3ccc(F)cc3F)c2)cn1		CHEMBL3972729	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	nM	20.0
431575	17791683	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CNS(=O)(=O)N(C)c1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-c4cnn(C(C)C)c4)cnc32)c1		CHEMBL3948497	=	IC50	nM	10.4	CHEMBL3650	Homo sapiens	IC50	nM	10.4
431576	17791684	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	Cn1cc(-c2ccc3c(c2)ncn3-c2cc(NC(=O)Cn3cncn3)cc(-c3ccc(F)cc3F)c2)cn1		CHEMBL3963522	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
431577	17791685	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	Cn1cc(-c2cnc3c(c2)ncn3-c2cc(NS(=O)(=O)NC3CC3)cc(-c3ccc(F)cc3F)c2)cn1		CHEMBL3949708	=	IC50	nM	14.0	CHEMBL3650	Homo sapiens	IC50	nM	14.0
431578	17791686	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	Cn1cc(-c2ccc3c(c2)ncn3-c2cc(Nc3ncccn3)cc(-c3ccc(F)cc3F)c2)cn1		CHEMBL3978775	=	IC50	nM	90.0	CHEMBL3650	Homo sapiens	IC50	nM	90.0
431579	17791687	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	Cn1cc(-c2ccc3c(c2)ncn3-c2cc(Nc3nccs3)cc(-c3ccc(F)cc3F)c2)cn1		CHEMBL3899205	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	nM	9.0
431580	17791688	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CC(=O)Nc1cc(-c2ccc(F)cc2)cc(-n2cnc3cc(-c4cnn(CCC(C)(C)O)c4)ccc32)c1		CHEMBL3970388	=	IC50	nM	3.4	CHEMBL3650	Homo sapiens	IC50	nM	3.4
431581	17791689	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	O=c1ccc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)C3CC3)cc(-c3ccc(F)cc3F)c2)c[nH]1		CHEMBL3908262	=	IC50	nM	32.0	CHEMBL3650	Homo sapiens	IC50	nM	32.0
431582	17791690	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CS(=O)(=O)Nc1cc(-c2ncccc2F)cc(-n2cnc3cc(-c4cnn(CCN5CCOCC5)c4)ccc32)c1		CHEMBL3975520	=	IC50	nM	9.3	CHEMBL3650	Homo sapiens	IC50	nM	9.3
431583	17791691	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	CN1CCC(C(=O)Nc2cc(-c3ccc(F)cc3F)cc(-n3cnc4cc(-c5cnn(C)c5)cnc43)c2)CC1		CHEMBL3913690	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
431584	17791692	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	O=S(=O)(Nc1cc(C2=CC=C(F)CC2F)cc(-n2cnc3cc(N4CCC(O)C4)ccc32)c1)C1CC1		CHEMBL3966196	=	IC50	nM	65.8	CHEMBL3650	Homo sapiens	IC50	nM	65.8
431585	17791693	CHEMBL3889056	TR-FRET Assay: Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated with the kinase for 30 minutes at RT. After the incubation, substrate mix [40 nM Ultra light poly GT (Perkin Elmer, USA) and 13 μM ATP (Sigma)] was added. The above reaction was stopped by the addition of 40 mM EDTA after the 30 mM kinase reaction. The Eu-labelled antiphospho-tyrosine antibody [Perkin Elmer, USA] was added at 0.5 nM and the fluorescence emission at 615 nm/665 nm [excitation at 340 nm] was measured. The compounds were initially screened at 100 nM and 1 μM concentrations. The compounds with >50% inhibition at 100 nM of FGFR1 were taken for the full dose response studies. The final DMSO concentration in the assay was 1%.	B	O=C(CN1CCCCC1)Nc1cc(-c2ccc(F)cc2F)cc(-n2cnc3cc(-n4cccn4)ccc32)c1		CHEMBL3922675	=	IC50	nM	45.0	CHEMBL3650	Homo sapiens	IC50	nM	45.0
435166	17795127	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3961994	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435167	17795128	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2cc(OC)cc(OC)c2)ncn1		CHEMBL3953386	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435168	17795129	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2cccc(OC)c2Cl)ncn1		CHEMBL3957557	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435169	17795130	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2cc(OC)cc(OC)c2Cl)ncn1		CHEMBL3944659	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435170	17795131	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(Cc2cccnc2)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3922336	=	IC50	nM	720.0	CHEMBL3650	Homo sapiens	IC50	nM	720.0
435171	17795132	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	173.0	CHEMBL3650	Homo sapiens	IC50	nM	173.0
435172	17795133	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=C(F)C(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3968830	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	nM	50000.0
435173	17795134	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3905232	=	IC50	nM	1280.0	CHEMBL3650	Homo sapiens	IC50	nM	1280.0
435174	17795135	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C2CCN(C)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3957409	=	IC50	nM	2600.0	CHEMBL3650	Homo sapiens	IC50	nM	2600.0
435175	17795136	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(CN(C)C)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3957874	=	IC50	nM	621.0	CHEMBL3650	Homo sapiens	IC50	nM	621.0
435176	17795137	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C#CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3892342	=	IC50	nM	42.0	CHEMBL3650	Homo sapiens	IC50	nM	42.0
435177	17795138	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(CCOC)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3952638	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	nM	20000.0
435178	17795139	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(CCCN(C)C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3981394	=	IC50	nM	1190.0	CHEMBL3650	Homo sapiens	IC50	nM	1190.0
435179	17795140	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(CCCN2CCN(C)CC2)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3980461	=	IC50	nM	1020.0	CHEMBL3650	Homo sapiens	IC50	nM	1020.0
435180	17795141	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C2CCNCC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3906748	=	IC50	nM	324.0	CHEMBL3650	Homo sapiens	IC50	nM	324.0
435181	17795142	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCOCC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3968033	=	IC50	nM	3890.0	CHEMBL3650	Homo sapiens	IC50	nM	3890.0
435182	17795143	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2C[C@H](C)N[C@H](C)C2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3897741	=	IC50	nM	164.0	CHEMBL3650	Homo sapiens	IC50	nM	164.0
435183	17795144	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3896681	=	IC50	nM	2860.0	CHEMBL3650	Homo sapiens	IC50	nM	2860.0
435184	17795145	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(CCCN(C)C)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3900071	=	IC50	nM	601.0	CHEMBL3650	Homo sapiens	IC50	nM	601.0
435185	17795146	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(OCCN(C)C)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3963148	=	IC50	nM	3200.0	CHEMBL3650	Homo sapiens	IC50	nM	3200.0
435186	17795147	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	CC#CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3900168	=	IC50	nM	1680.0	CHEMBL3650	Homo sapiens	IC50	nM	1680.0
435187	17795148	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C/C=C/C(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3937266	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435188	17795149	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(Cc2ccccc2)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3967316	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435189	17795150	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(Cc2ccccn2)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3960125	=	IC50	nM	1170.0	CHEMBL3650	Homo sapiens	IC50	nM	1170.0
435190	17795151	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(Cc2ccncc2)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3912538	=	IC50	nM	495.0	CHEMBL3650	Homo sapiens	IC50	nM	495.0
435191	17795152	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccc(N2CCN(CC)CC2)cc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3914013	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435192	17795153	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(CN2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3889525	=	IC50	nM	2027.0	CHEMBL3650	Homo sapiens	IC50	nM	2027.0
435193	17795154	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(Cc2cc(C)no2)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3926533	=	IC50	nM	112.0	CHEMBL3650	Homo sapiens	IC50	nM	112.0
435194	17795155	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccc(CCN(C)C)cc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3898484	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435195	17795156	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2cc(OC)cc(OC)c2)ncn1		CHEMBL3976424	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	nM	20000.0
435196	17795157	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)cccc2Cl)ncn1		CHEMBL3889496	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	nM	20000.0
435197	17795158	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2cc(OC)cc(OC)c2Cl)ncn1		CHEMBL3948664	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	nM	20000.0
435198	17795159	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(OCCOC)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3915751	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435199	17795160	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(F)c(OC)cc(OC)c2F)ncn1		CHEMBL3891261	=	IC50	nM	155.0	CHEMBL3650	Homo sapiens	IC50	nM	155.0
435200	17795161	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(F)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3891253	=	IC50	nM	105.0	CHEMBL3650	Homo sapiens	IC50	nM	105.0
435201	17795162	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(CO)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3959844	=	IC50	nM	2190.0	CHEMBL3650	Homo sapiens	IC50	nM	2190.0
435202	17795163	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(COC)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3900286	=	IC50	nM	5940.0	CHEMBL3650	Homo sapiens	IC50	nM	5940.0
435203	17795164	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C(=O)N2CCN(C)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3983322	=	IC50	nM	6440.0	CHEMBL3650	Homo sapiens	IC50	nM	6440.0
435204	17795165	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C(=O)N(C)C)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3913504	=	IC50	nM	7700.0	CHEMBL3650	Homo sapiens	IC50	nM	7700.0
435205	17795166	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C(=O)N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3963799	=	IC50	nM	2290.0	CHEMBL3650	Homo sapiens	IC50	nM	2290.0
435206	17795167	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(C(C)C)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3924624	=	IC50	nM	197.0	CHEMBL3650	Homo sapiens	IC50	nM	197.0
435207	17795168	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)N(C)c1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3951868	=	IC50	nM	297.0	CHEMBL3650	Homo sapiens	IC50	nM	297.0
435208	17795169	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3941511	=	IC50	nM	777.0	CHEMBL3650	Homo sapiens	IC50	nM	777.0
435209	17795170	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C(C)OC)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3932109	=	IC50	nM	8030.0	CHEMBL3650	Homo sapiens	IC50	nM	8030.0
435210	17795171	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C(C)O)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3940348	=	IC50	nM	1950.0	CHEMBL3650	Homo sapiens	IC50	nM	1950.0
435211	17795172	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCNCC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3963529	=	IC50	nM	131.0	CHEMBL3650	Homo sapiens	IC50	nM	131.0
435212	17795173	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N(C)CCO)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3927803	=	IC50	nM	2152.0	CHEMBL3650	Homo sapiens	IC50	nM	2152.0
435213	17795174	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(C)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3915603	=	IC50	nM	115.0	CHEMBL3650	Homo sapiens	IC50	nM	115.0
435214	17795175	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(C(C)N)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3921678	=	IC50	nM	660.0	CHEMBL3650	Homo sapiens	IC50	nM	660.0
435215	17795176	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CCN)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3949590	=	IC50	nM	2694.0	CHEMBL3650	Homo sapiens	IC50	nM	2694.0
435216	17795177	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cccc(F)c1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3910442	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435217	17795178	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(CCN(C)C)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3937272	=	IC50	nM	519.0	CHEMBL3650	Homo sapiens	IC50	nM	519.0
435218	17795179	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(OCCO)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3967008	=	IC50	nM	3510.0	CHEMBL3650	Homo sapiens	IC50	nM	3510.0
435219	17795180	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cccc(C)c1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3956014	=	IC50	nM	7370.0	CHEMBL3650	Homo sapiens	IC50	nM	7370.0
435220	17795181	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cccc(OC)c1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3959290	=	IC50	nM	4920.0	CHEMBL3650	Homo sapiens	IC50	nM	4920.0
435221	17795182	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cccc(Cl)c1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3958828	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435222	17795183	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CCO)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3937344	=	IC50	nM	1030.0	CHEMBL3650	Homo sapiens	IC50	nM	1030.0
435223	17795184	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccccc3NC(=O)/C=C/Cl)ncn2)c1Cl		CHEMBL3941999	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435224	17795185	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccccc3NC(=O)/C=C/Cl)ncn2)c1Cl		CHEMBL3941999	=	IC50	nM	3920.0	CHEMBL3650	Homo sapiens	IC50	nM	3920.0
435225	17795186	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C/C=C\C(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3900101	=	IC50	nM	7370.0	CHEMBL3650	Homo sapiens	IC50	nM	7370.0
435226	17795187	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=C(C)C(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3927229	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435227	17795188	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)c(NC(=O)/C=C\Cl)c2)CC1		CHEMBL3953646	=	IC50	nM	224.0	CHEMBL3650	Homo sapiens	IC50	nM	224.0
435228	17795189	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(CCNC(C)C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3932175	=	IC50	nM	6210.0	CHEMBL3650	Homo sapiens	IC50	nM	6210.0
435229	17795190	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1c(C)cccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3982659	=	IC50	nM	6475.0	CHEMBL3650	Homo sapiens	IC50	nM	6475.0
435230	17795191	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1c(F)cccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3911943	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435231	17795192	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1c(Nc2cc(N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)ncn2)cccc1OC		CHEMBL3948944	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
435236	17795197	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3961994	>	IC50	nM	10100.0	CHEMBL3650	Homo sapiens	IC50	nM	10100.0
435237	17795198	CHEMBL3889130	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	173.0	CHEMBL3650	Homo sapiens	IC50	nM	173.0
435242	17795203	CHEMBL3889134	Biochemical Kinase Assay : Recombinant FGFR1 (2.5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μM, FGFR1 substrate); Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, 33P-γ-ATP was added at a final concentration of 10 μM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	513.0	CHEMBL3650	Homo sapiens	IC50	nM	513.0
435243	17795204	CHEMBL3889134	Biochemical Kinase Assay : Recombinant FGFR1 (2.5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μM, FGFR1 substrate); Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, 33P-γ-ATP was added at a final concentration of 10 μM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature.	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
Inactive	17903155	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903156	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903157	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903158	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903159	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1903.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	1903.0
Inactive	17903160	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903161	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903162	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903163	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903164	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	9.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	9.0
Inactive	17903165	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903166	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903167	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903168	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903169	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903170	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	2511.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	2511.0
Active	17903171	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	3302.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	3302.0
Inactive	17903172	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903173	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903174	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903175	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903176	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903177	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903178	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903179	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903180	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903181	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903182	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903183	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	409.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	409.0
Inactive	17903184	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903185	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	396.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	396.0
Inactive	17903186	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903187	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903188	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903189	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903190	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903191	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903192	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	949.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	949.0
Inactive	17903193	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903194	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903195	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903196	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903197	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903198	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	=	Kd	nM	3896.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	3896.0
Inactive	17903199	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903200	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903201	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903202	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903203	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903204	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903205	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903206	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903207	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903208	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903209	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903210	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903211	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903212	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903213	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903214	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903215	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903216	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903217	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903218	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903219	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	=	Kd	nM	777.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	777.0
Inactive	17903220	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903221	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903222	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903223	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903224	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903225	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903226	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903227	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903228	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903229	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903230	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903231	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903232	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903233	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903234	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903235	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903236	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903237	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903238	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903239	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903240	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17903241	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	865.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	865.0
Inactive	17903242	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903243	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903244	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903245	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903246	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903247	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903248	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	2.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	2.0
Active	17903249	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	192.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	192.0
Inactive	17903250	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903251	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903252	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903253	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903254	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903255	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903256	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903257	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903258	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903259	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903260	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903261	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3595.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	3595.0
Inactive	17903262	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903263	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903264	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903265	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903266	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903267	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903268	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903269	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903270	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903271	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903272	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903273	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	892.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	892.0
Active	17903274	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	2675.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	2675.0
Inactive	17903275	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903276	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903277	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903278	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903279	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903280	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903281	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903282	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903283	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903284	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903285	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	Kd	nM	3.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	3.0
Inactive	17903286	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903287	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	957.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	957.0
Inactive	17903288	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903289	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903290	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903291	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1282.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	1282.0
Inactive	17903292	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903293	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903294	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903295	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903296	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903297	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903298	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903299	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903300	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903301	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903302	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	81.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	81.0
Inactive	17903303	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903304	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903305	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903306	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903307	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903308	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903309	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903310	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	1421.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	1421.0
Inactive	17903311	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903312	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903313	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903314	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903315	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903316	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903317	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903318	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	40.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	40.0
Inactive	17903319	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903320	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903321	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903322	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903323	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	3777.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	3777.0
Active	17903324	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	243.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	243.0
Inactive	17903325	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903326	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903327	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903328	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903329	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903330	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903331	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903332	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903333	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903334	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903335	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903336	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903337	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903338	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903339	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903340	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903341	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903342	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903343	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903344	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903345	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903346	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903347	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903348	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903349	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903350	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903351	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903352	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17903353	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	0.3	CHEMBL3650	Homo sapiens	Kd apparent	nM	0.3
Active	17903354	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	25.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	25.0
Inactive	17903355	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903356	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903357	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903358	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	1388.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	1388.0
Inactive	17903359	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903360	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903361	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903362	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	208.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	208.0
Inactive	17903363	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903364	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903365	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903366	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903367	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903368	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903369	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903370	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903371	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903372	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903373	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903374	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903375	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903376	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903377	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903378	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903379	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903380	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903381	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903382	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903383	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	268.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	268.0
Inactive	17903384	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903385	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903386	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Active	17903387	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	547.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	547.0
Inactive	17903388	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903389	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903390	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903391	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903392	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903393	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903394	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903395	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903396	CHEMBL3991717	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3650	Homo sapiens	Kd apparent	nM	30000.0
	17951997	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CC/C(=C\c3ccc(OC)c(OC(=O)CC)c3)C2=O)cc1OC		CHEMBL4101358	=	Inhibition	%	4.6	CHEMBL3650	Homo sapiens	INH	%	4.6
	17951998	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CC/C(=C\c3ccc(OC)c(OC)c3)C2=O)cc1OC	Outside typical range	CHEMBL4075911	=	Inhibition	%	-21.7	CHEMBL3650	Homo sapiens	INH	%	-21.7
	17951999	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CC/C(=C\c3ccc(OC(=O)CC)c(OC)c3)C2=O)cc1		CHEMBL4063280	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	17952000	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CC/C(=C\c3ccc(OC)cc3)C2=O)cc1OC		CHEMBL4091154	=	Inhibition	%	18.7	CHEMBL3650	Homo sapiens	INH	%	18.7
	17952001	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CC/C(=C\c3ccc(C(=O)CC)cc3)C2=O)cc1OC		CHEMBL4071911	=	Inhibition	%	6.3	CHEMBL3650	Homo sapiens	INH	%	6.3
	17952002	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CC/C(=C\c3ccc(F)cc3)C2=O)cc1OC		CHEMBL4098902	=	Inhibition	%	12.8	CHEMBL3650	Homo sapiens	INH	%	12.8
	17952003	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CC/C(=C\c3ccc(N4CCCC4)cc3)C2=O)cc1OC		CHEMBL4104699	=	Inhibition	%	93.6	CHEMBL3650	Homo sapiens	INH	%	93.6
	17952004	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccc(OC)c(OC(=O)C(C)C)c3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4086801	=	Inhibition	%	29.6	CHEMBL3650	Homo sapiens	INH	%	29.6
	17952005	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1ccc(/C=C2\CC/C(=C\c3ccc(OC(=O)C(C)C)c(OC)c3)C2=O)cc1OC		CHEMBL4086453	=	Inhibition	%	2.5	CHEMBL3650	Homo sapiens	INH	%	2.5
	17952006	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1ccc(/C=C2\CC/C(=C\c3ccc(OC(=O)C(C)C)c(OC)c3)C2=O)cc1		CHEMBL4104346	=	Inhibition	%	31.2	CHEMBL3650	Homo sapiens	INH	%	31.2
	17952007	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccc(F)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4094215	=	Inhibition	%	24.1	CHEMBL3650	Homo sapiens	INH	%	24.1
	17952008	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)c1ccc(/C=C2\CC/C(=C\c3ccc(OC(=O)C(C)C)c(OC)c3)C2=O)cc1		CHEMBL4066685	=	Inhibition	%	6.8	CHEMBL3650	Homo sapiens	INH	%	6.8
	17952009	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccc(N4CCOCC4)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4101949	=	Inhibition	%	77.0	CHEMBL3650	Homo sapiens	INH	%	77.0
	17952010	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccc(N4CCCC4)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4077680	=	Inhibition	%	94.9	CHEMBL3650	Homo sapiens	INH	%	94.9
	17952011	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CCC/C(=C\c3ccc(N4CCOCC4)cc3)C2=O)cc1OC		CHEMBL4063955	=	Inhibition	%	84.3	CHEMBL3650	Homo sapiens	INH	%	84.3
	17952012	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CCC/C(=C\c3ccc(N4CCCCC4)cc3)C2=O)cc1OC		CHEMBL4085530	=	Inhibition	%	90.2	CHEMBL3650	Homo sapiens	INH	%	90.2
	17952013	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CCC/C(=C\c3ccc(N(CC)CC)cc3)C2=O)cc1OC		CHEMBL4072548	=	Inhibition	%	85.4	CHEMBL3650	Homo sapiens	INH	%	85.4
	17952014	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CCC/C(=C\c3ccc(N4CCOCC4)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4093277	=	Inhibition	%	92.2	CHEMBL3650	Homo sapiens	INH	%	92.2
	17952015	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CCC/C(=C\c3ccc(N4CCCCC4)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4084793	=	Inhibition	%	90.9	CHEMBL3650	Homo sapiens	INH	%	90.9
	17952016	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccccc3F)C2=O)ccc1O		CHEMBL4063149	=	Inhibition	%	25.2	CHEMBL3650	Homo sapiens	INH	%	25.2
	17952017	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccccc3Br)C2=O)ccc1O		CHEMBL4074517	=	Inhibition	%	4.1	CHEMBL3650	Homo sapiens	INH	%	4.1
	17952018	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccc(O)cc3)C2=O)ccc1O		CHEMBL4101243	=	Inhibition	%	12.2	CHEMBL3650	Homo sapiens	INH	%	12.2
	17952019	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1ccc(/C=C2\CC/C(=C\c3ccc(O)c(OC)c3)C2=O)cc1		CHEMBL4100289	=	Inhibition	%	-3.3	CHEMBL3650	Homo sapiens	INH	%	-3.3
	17952020	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1ccc(/C=C2\CC/C(=C\c3ccc(O)c(OC)c3)C2=O)c(F)c1		CHEMBL3753225	=	Inhibition	%	20.9	CHEMBL3650	Homo sapiens	INH	%	20.9
	17952021	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3cccn3C)C2=O)ccc1O		CHEMBL4092550	=	Inhibition	%	4.6	CHEMBL3650	Homo sapiens	INH	%	4.6
	17952022	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CNC/C(=C\c3ccc(OC(=O)CC)c(OC)c3)C2=O)cc1OC		CHEMBL4072927	=	Inhibition	%	15.9	CHEMBL3650	Homo sapiens	INH	%	15.9
	17952023	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C/C(=O)/C=C/c2ccc(OC(=O)C(C)C)c(OC)c2)ccc1OC(=O)C(C)C		CHEMBL4093623	=	Inhibition	%	80.5	CHEMBL3650	Homo sapiens	INH	%	80.5
	17952024	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C/C(=O)/C=C/c2ccc(OC(=O)CC)c(OC)c2)cc1OC		CHEMBL4102065	=	Inhibition	%	-1.1	CHEMBL3650	Homo sapiens	INH	%	-1.1
	17952025	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CCC/C(=C\c3ccc(OC(=O)C(C)C)c(OC)c3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4084082	=	Inhibition	%	88.5	CHEMBL3650	Homo sapiens	INH	%	88.5
	17952026	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\CCC/C(=C\c3ccc(OC(=O)CC)c(OC)c3)C2=O)cc1OC		CHEMBL2235196	=	Inhibition	%	75.5	CHEMBL3650	Homo sapiens	INH	%	75.5
	17952027	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\COC/C(=C\c3ccc(OC(=O)C(C)C)c(OC)c3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4068885	=	Inhibition	%	39.3	CHEMBL3650	Homo sapiens	INH	%	39.3
	17952028	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCC(=O)Oc1ccc(/C=C2\COC/C(=C\c3ccc(OC(=O)CC)c(OC)c3)C2=O)cc1OC		CHEMBL4097706	=	Inhibition	%	34.5	CHEMBL3650	Homo sapiens	INH	%	34.5
Dose-dependent effect	17952032	CHEMBL3992929	Inhibition of FGFR1 in human SGC7901 cells assessed as reduction in FGF-induced phosphorylation of ERK1/2 preincubated with cells followed by FGF addition by Western blot method	B	CCN(CC)c1ccc(/C=C/C(=O)/C=C/c2ccc(O)c(OC)c2)cc1		CHEMBL4096815		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	17952033	CHEMBL3992929	Inhibition of FGFR1 in human SGC7901 cells assessed as reduction in FGF-induced phosphorylation of ERK1/2 preincubated with cells followed by FGF addition by Western blot method	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ccc(Br)cc34)C2=O)ccc1O		CHEMBL3753495		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	17952034	CHEMBL3992928	Inhibition of FGF-induced phosphorylation of FGFR1 at T653/654 residues in human SGC7901 cells preincubated with cells followed by FGF addition by Western blot method	B	CCN(CC)c1ccc(/C=C/C(=O)/C=C/c2ccc(O)c(OC)c2)cc1		CHEMBL4096815		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	17952035	CHEMBL3992928	Inhibition of FGF-induced phosphorylation of FGFR1 at T653/654 residues in human SGC7901 cells preincubated with cells followed by FGF addition by Western blot method	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ccc(Br)cc34)C2=O)ccc1O		CHEMBL3753495		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	17952060	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	CCN(CC)c1ccc(/C=C/C(=O)/C=C/c2ccc(O)c(OC)c2)cc1		CHEMBL4096815	=	IC50	nM	4800.0	CHEMBL3650	Homo sapiens	IC50	uM	4.8
	17952061	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C/C(=O)/C=C/c2ccc(N3CCCC3)cc2)ccc1O		CHEMBL4078788	=	IC50	nM	9300.0	CHEMBL3650	Homo sapiens	IC50	uM	9.3
	17952062	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CCC/C(=C\c3ccc(N4CCCC4)cc3)C2=O)ccc1O		CHEMBL4070628	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	17952063	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ccc(Br)cc34)C2=O)ccc1O		CHEMBL3753495	=	IC50	nM	5200.0	CHEMBL3650	Homo sapiens	IC50	uM	5.2
	17952064	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ncccc34)C2=O)ccc1O		CHEMBL3753805	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	17952065	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ccccc34)C2=O)ccc1O		CHEMBL4105493	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	17952066	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CC/C(=C\c3ccc(N4CCCC4)cc3)C2=O)ccc1O		CHEMBL4097839	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	17952067	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CCC/C(=C\c3ccc(N4CCCCC4)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4084793	=	IC50	nM	8600.0	CHEMBL3650	Homo sapiens	IC50	uM	8.6
	17952068	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CCC/C(=C\c3ccc(N4CCOCC4)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4093277	=	IC50	nM	11800.0	CHEMBL3650	Homo sapiens	IC50	uM	11.8
	17952069	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	CCC(=O)Oc1ccc(/C=C2\CCC/C(=C\c3ccc(N(CC)CC)cc3)C2=O)cc1OC		CHEMBL4072548	=	IC50	nM	12200.0	CHEMBL3650	Homo sapiens	IC50	uM	12.2
	17952070	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	CCC(=O)Oc1ccc(/C=C2\CCC/C(=C\c3ccc(N4CCCCC4)cc3)C2=O)cc1OC		CHEMBL4085530	=	IC50	nM	15000.0	CHEMBL3650	Homo sapiens	IC50	uM	15.0
	17952071	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	CCC(=O)Oc1ccc(/C=C2\CCC/C(=C\c3ccc(N4CCOCC4)cc3)C2=O)cc1OC		CHEMBL4063955	=	IC50	nM	19200.0	CHEMBL3650	Homo sapiens	IC50	uM	19.2
	17952072	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CC/C(=C\c3ccc(N4CCCC4)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4077680	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	17952073	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CC/C(=C\c3ccc(N4CCOCC4)cc3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4101949	=	IC50	nM	10400.0	CHEMBL3650	Homo sapiens	IC50	uM	10.4
	17952074	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	CCC(=O)Oc1ccc(/C=C2\CC/C(=C\c3ccc(N4CCCC4)cc3)C2=O)cc1OC		CHEMBL4104699	=	IC50	nM	10800.0	CHEMBL3650	Homo sapiens	IC50	uM	10.8
	17952075	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C/C(=O)/C=C/c2ccc(OC(=O)C(C)C)c(OC)c2)ccc1OC(=O)C(C)C		CHEMBL4093623	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
	17952076	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	COc1cc(/C=C2\CCC/C(=C\c3ccc(OC(=O)C(C)C)c(OC)c3)C2=O)ccc1OC(=O)C(C)C		CHEMBL4084082	=	IC50	nM	19100.0	CHEMBL3650	Homo sapiens	IC50	uM	19.1
	17952077	CHEMBL3992924	Inhibition of FGFR1 (unknown origin) using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay	B	CCC(=O)Oc1ccc(/C=C2\CCC/C(=C\c3ccc(OC(=O)CC)c(OC)c3)C2=O)cc1OC		CHEMBL2235196	>	IC50	nM	20000.0	CHEMBL3650	Homo sapiens	IC50	uM	20.0
Active	17952078	CHEMBL3992923	Non-ATP competitive inhibition of FGFR1 (unknown origin) up to 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate and varying levels of ATP addition measured up to 1 hr by caliper mobility shift assay	B	CCN(CC)c1ccc(/C=C/C(=O)/C=C/c2ccc(O)c(OC)c2)cc1		CHEMBL4096815		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	17952079	CHEMBL3992923	Non-ATP competitive inhibition of FGFR1 (unknown origin) up to 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate and varying levels of ATP addition measured up to 1 hr by caliper mobility shift assay	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ccc(Br)cc34)C2=O)ccc1O		CHEMBL3753495		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	17952080	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	CCN(CC)c1ccc(/C=C/C(=O)/C=C/c2ccc(O)c(OC)c2)cc1		CHEMBL4096815	=	Inhibition	%	87.1	CHEMBL3650	Homo sapiens	INH	%	87.1
	17952081	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C/C(=O)/C=C/c2ccc(N3CCCC3)cc2)ccc1O		CHEMBL4078788	=	Inhibition	%	83.0	CHEMBL3650	Homo sapiens	INH	%	83.0
	17952082	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CCC/C(=C\c3ccc(N4CCCC4)cc3)C2=O)ccc1O		CHEMBL4070628	=	Inhibition	%	82.9	CHEMBL3650	Homo sapiens	INH	%	82.9
	17952083	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ccc(Br)cc34)C2=O)ccc1O		CHEMBL3753495	=	Inhibition	%	81.4	CHEMBL3650	Homo sapiens	INH	%	81.4
	17952084	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ncccc34)C2=O)ccc1O		CHEMBL3753805	=	Inhibition	%	66.6	CHEMBL3650	Homo sapiens	INH	%	66.6
	17952085	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3c[nH]c4ccccc34)C2=O)ccc1O		CHEMBL4105493	=	Inhibition	%	50.7	CHEMBL3650	Homo sapiens	INH	%	50.7
	17952086	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccc(N4CCCC4)cc3)C2=O)ccc1O		CHEMBL4097839	=	Inhibition	%	81.7	CHEMBL3650	Homo sapiens	INH	%	81.7
	17952087	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3cccs3)C2=O)ccc1O		CHEMBL4070719	=	Inhibition	%	14.0	CHEMBL3650	Homo sapiens	INH	%	14.0
	17952088	CHEMBL3992922	Inhibition of FGFR1 (unknown origin) at 20 uM using FAM-P22 as substrate preincubated for 10 mins followed by substrate/ATP addition measured after 1 hr by mobility shift assay relative to control	B	COc1cc(/C=C2\CC/C(=C\c3ccco3)C2=O)ccc1O		CHEMBL4071763	=	Inhibition	%	13.4	CHEMBL3650	Homo sapiens	INH	%	13.4
	17957991	CHEMBL3994001	Inhibition of recombinant human GST-tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)cc1)c1ccccc1		CHEMBL4069394	>	IC50	nM	500.0	CHEMBL3650	Homo sapiens	IC50	nM	500.0
	17957992	CHEMBL3994001	Inhibition of recombinant human GST-tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	99.1	CHEMBL3650	Homo sapiens	IC50	nM	99.1
	17964902	CHEMBL3995011	Inhibition of human FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	64.0	CHEMBL3650	Homo sapiens	Activity	%	64.0
	17979248	CHEMBL3998053	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	17979924	CHEMBL3998327	Inhibition of recombinant FGFR1 (unknown origin) using peptidic substrates in presence of ATP by Kinase-Glo luminescent kinase assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	17979930	CHEMBL3998325	Inhibition of recombinant full length human FGFR1 expressed in baculovirus infected insect cells in presence of [gamma-32P]ATP after 10 mins by scintillation counting based radioactive filter binding assay	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	21.5	CHEMBL3650	Homo sapiens	IC50	nM	21.5
	17979933	CHEMBL3998323	Inhibition of FGFR1 kinase domain (unknown origin)	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	17979934	CHEMBL3998323	Inhibition of FGFR1 kinase domain (unknown origin)	B	O=CN1CCN(c2ccc(/C=C3\C(=O)Nc4ccccc43)cc2)CC1		CHEMBL315546	=	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	17979942	CHEMBL3998338	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5)ccc34)cc2)CC1		CHEMBL4063676	=	IC50	nM	15.0	CHEMBL3650	Homo sapiens	IC50	nM	15.0
	17979943	CHEMBL3998338	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4076610	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
	17979946	CHEMBL3998340	Inhibition of recombinant FGFR1 (unknown origin) expressed in baculovirus infected insect cells using biotinylated peptide substrate GGGGQDGKDYIVLPI in presence of ATP incubated for 1 to 4 hrs by time resolved fluorescence assay	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
	17979957	CHEMBL3998351	Inhibition of recombinant human FGFR1 using substrate KKKSPGEYVNIEFG in presence of [33-P]ATP by kinase hotspot assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	2.2	CHEMBL3650	Homo sapiens	IC50	nM	2.2
	17979968	CHEMBL3998357	Inhibition of recombinant His6-tagged FGFR1 (unknown origin) expressed in Escherichia coli BL21(DE3)-RILP using peptidic substrate by ELISA	B	Nc1ncc2c(n1)-c1ccccc1[C@H](c1ccccc1)C2		CHEMBL1738735	=	IC50	nM	840.0	CHEMBL3650	Homo sapiens	IC50	uM	0.84
	17979970	CHEMBL3998359	Inhibition of FGFR1 (unknown origin)	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	9.3	CHEMBL3650	Homo sapiens	IC50	nM	9.3
	17979971	CHEMBL3998359	Inhibition of FGFR1 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	17.5	CHEMBL3650	Homo sapiens	IC50	nM	17.5
	17979972	CHEMBL3998359	Inhibition of FGFR1 (unknown origin)	B	C=CC(=O)Nc1ccc(CN2C(=O)N(c3cc(OC)cc(OC)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)cc1		CHEMBL4065323	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	17979973	CHEMBL3998359	Inhibition of FGFR1 (unknown origin)	B	C=CC(=O)Nc1ccc(CN(C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1		CHEMBL4092990	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	17979976	CHEMBL3998361	Inhibition of human N-terminal GST-tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system using CSKtide as substrate after 90 mins	B	C=CC(=O)Nc1ccccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4090527	=	IC50	nM	591.0	CHEMBL3650	Homo sapiens	IC50	nM	591.0
	17979980	CHEMBL3998334	Inhibition of recombinant human FGFR1 in presence of ATP	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
	17990929	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990930	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(NCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061383	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990931	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1c(C)cccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4091534	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990932	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(C)ccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4077138	=	IC50	nM	825.3	CHEMBL3650	Homo sapiens	IC50	nM	825.3
	17990933	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1ccc(C)cc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4099268	=	IC50	nM	975.1	CHEMBL3650	Homo sapiens	IC50	nM	975.1
	17990934	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1ccccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4082818	=	IC50	nM	431.0	CHEMBL3650	Homo sapiens	IC50	nM	431.0
	17990935	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4060935	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990936	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4067483	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990937	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OCC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4086040	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990938	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OC(C)C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4084175	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990939	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4102146	=	IC50	nM	617.7	CHEMBL3650	Homo sapiens	IC50	nM	617.7
	17990940	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4073826	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990941	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C(F)(F)F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4094408	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990942	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4065231	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990943	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(Cl)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4086669	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990944	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(C(F)(F)F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4103091	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990945	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	CCC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4078819	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990946	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OC(C)c2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4070060	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990947	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)ccc(OC)c2Cl)cn1		CHEMBL4091031	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990948	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)cc(OC)c2Cl)cn1		CHEMBL4082121	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990949	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)cccc2Cl)cn1		CHEMBL4060226	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990950	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cccc(OC)c2Cl)cn1		CHEMBL4071593	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990951	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)ccc2Cl)cn1		CHEMBL4098624	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990952	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)cc(OC)c2)cn1		CHEMBL4097713	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990953	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2ccccc2Cl)cn1		CHEMBL4079677	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990954	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cccc(OC)c2)cn1		CHEMBL4089981	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	17990955	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	239.9	CHEMBL3650	Homo sapiens	IC50	nM	239.9
	17990956	CHEMBL4000066	Inhibition of His-tagged cytoplasmic recombinant human FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	3.6	CHEMBL3650	Homo sapiens	IC50	nM	3.6
	17996256	CHEMBL4001405	Inhibition of human wild type partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system at 10 uM by KinomeScan method relative to control	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4083528	=	Inhibition	%	18.0	CHEMBL3650	Homo sapiens	INH	%	18.0
	18002329	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628	=	IC50	nM	0.5	CHEMBL3650	Homo sapiens	IC50	nM	0.5
	18002330	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	COc1cncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c1		CHEMBL4101852	=	IC50	nM	12.8	CHEMBL3650	Homo sapiens	IC50	nM	12.8
	18002331	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc(N2CCN(C)CC2)c1		CHEMBL4083853	=	IC50	nM	5.7	CHEMBL3650	Homo sapiens	IC50	nM	5.7
	18002332	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc(N2CCOCC2)c1		CHEMBL4094115	=	IC50	nM	3.0	CHEMBL3650	Homo sapiens	IC50	nM	3.0
	18002333	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc(N2CCCC2)c1		CHEMBL4073474	=	IC50	nM	7.6	CHEMBL3650	Homo sapiens	IC50	nM	7.6
	18002334	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CCN(CC)c1cncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c1		CHEMBL4086340	=	IC50	nM	6.5	CHEMBL3650	Homo sapiens	IC50	nM	6.5
	18002335	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc(NC(C)C)c1		CHEMBL4064874	=	IC50	nM	3.6	CHEMBL3650	Homo sapiens	IC50	nM	3.6
	18002336	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2c1ccn2C		CHEMBL4067760	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
	18002337	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2[nH]ccc12		CHEMBL4088977	=	IC50	nM	6.7	CHEMBL3650	Homo sapiens	IC50	nM	6.7
	18002338	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3ccnc(C#Cc4cncc5ccccc45)n3)cc2C(F)(F)F)CC1		CHEMBL4071501	=	IC50	nM	11.2	CHEMBL3650	Homo sapiens	IC50	nM	11.2
	18002339	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3ccnc(C#Cc4cncc5ccccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4092294	=	IC50	nM	2.2	CHEMBL3650	Homo sapiens	IC50	nM	2.2
	18002340	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3cncc(C#Cc4cncc5ccccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4062884	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
	18002341	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3cccc(C#Cc4cncc5ccccc45)n3)cc2C(F)(F)F)CC1		CHEMBL4084556	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	18002342	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3cc(C#Cc4cncc5ccccc45)ccn3)cc2C(F)(F)F)CC1		CHEMBL4089898	=	IC50	nM	8.1	CHEMBL3650	Homo sapiens	IC50	nM	8.1
	18002343	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CC(C)c1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2ccccc12		CHEMBL4061838	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	18002344	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)c(C#Cc4cncc5ccccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4082034	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	18002345	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	COc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2ccccc12		CHEMBL4100047	=	IC50	nM	26.5	CHEMBL3650	Homo sapiens	IC50	nM	26.5
	18002346	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc5ccccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4104537	=	IC50	nM	5.2	CHEMBL3650	Homo sapiens	IC50	nM	5.2
	18002347	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(F)c(C#Cc4cncc5ccccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4086643	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
	18002348	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	CN1CCN(Cc2ccc(NC(=O)c3cccc(C#Cc4cncc5ccccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4081243	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
	18002349	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2ccccc12		CHEMBL4105491	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
Dose-dependent effect	18002390	CHEMBL4002784	Inhibition of FGFR1 phosphorylation in FGFR1 translocated human KG1 cells after 2 hrs by Western blot method	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	18002391	CHEMBL4002785	Inhibition of FGFR1 in FGFR1 translocated human KG1 cells assessed as suppression of PLCgamma phosphorylation after 2 hrs by Western blot analysis	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	18002392	CHEMBL4002786	Inhibition of FGFR1 in FGFR1 translocated human KG1 cells assessed as suppression of phosphorylated ERK after 2 hrs by Western blot analysis	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	18002408	CHEMBL4002763	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 after 60 mins by ELISA method	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	18021241	CHEMBL4005950	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 amino acid residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCNCC3)cn2)n1		CHEMBL4071812	<	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	18021242	CHEMBL4005950	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 amino acid residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1nc(Nc2ccc(N3CCN(C)CC3)cn2)ncc1F		CHEMBL4072255	<	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	18031693	CHEMBL4007706	Inhibition of FGFR1 (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	4060.0	CHEMBL3650	Homo sapiens	IC50	uM	4.06
	18031694	CHEMBL4007706	Inhibition of FGFR1 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	18031695	CHEMBL4007706	Inhibition of FGFR1 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	18031696	CHEMBL4007706	Inhibition of FGFR1 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	18031697	CHEMBL4007706	Inhibition of FGFR1 (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	18033096	CHEMBL4007912	Inhibition of human FGFR1 at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	27.0	CHEMBL3650	Homo sapiens	INH	%	27.0
	18052954	CHEMBL4011859	Inhibition of FGFR1 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-2.4	CHEMBL3650	Homo sapiens	INH	%	-2.4
	18057640	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cc(O)nc4[nH]nc(C)c34)cc2)c1		CHEMBL4091741	=	IC50	nM	4635.0	CHEMBL3650	Homo sapiens	IC50	nM	4635.0
	18057641	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3cc(O)nc4[nH]nc(C)c34)cc2)c1		CHEMBL4100645	=	IC50	nM	2264.0	CHEMBL3650	Homo sapiens	IC50	nM	2264.0
	18057642	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4074713	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	nM	50000.0
	18057654	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(C3CC(O)=Nc4[nH]nc(C)c43)cc2)c1		CHEMBL4076032	=	IC50	nM	33849.0	CHEMBL3650	Homo sapiens	IC50	nM	33849.0
	18057655	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(C3CC(O)=Nc4[nH]nc(C)c43)cc2)c1		CHEMBL4063976	=	IC50	nM	18325.0	CHEMBL3650	Homo sapiens	IC50	nM	18325.0
	18057770	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=S)Nc4cccc(Br)c4)cc3)c12		CHEMBL4087221	=	IC50	nM	19999.0	CHEMBL3650	Homo sapiens	IC50	nM	19999.0
	18057774	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL4079338	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	nM	50000.0
	18057827	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	5479.0	CHEMBL3650	Homo sapiens	IC50	nM	5479.0
	18057946	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=S)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL4101778	=	IC50	nM	42859.0	CHEMBL3650	Homo sapiens	IC50	nM	42859.0
	18057961	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL4065800	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	nM	50000.0
	18057965	CHEMBL4012621	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4103605	>	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	nM	50000.0
	18064082	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)NCc1cccc(Cn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL4101091	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18064083	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(Cn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4065736	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18064084	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL4093349	=	IC50	nM	250.0	CHEMBL3650	Homo sapiens	IC50	nM	250.0
	18064085	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4103536	=	IC50	nM	38.0	CHEMBL3650	Homo sapiens	IC50	nM	38.0
	18064086	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1cccc(Cn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4085605	=	IC50	nM	5.3	CHEMBL3650	Homo sapiens	IC50	nM	5.3
	18064087	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4095783	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
	18064088	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N(C)c1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4068712	=	IC50	nM	9.4	CHEMBL3650	Homo sapiens	IC50	nM	9.4
	18064089	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1cc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)ccn1		CHEMBL4088057	=	IC50	nM	1.9	CHEMBL3650	Homo sapiens	IC50	nM	1.9
	18064090	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)n1		CHEMBL4066763	=	IC50	nM	1.7	CHEMBL3650	Homo sapiens	IC50	nM	1.7
	18064091	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cc1		CHEMBL4099578	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
	18064092	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N(C)c1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cc1		CHEMBL4072676	=	IC50	nM	4.7	CHEMBL3650	Homo sapiens	IC50	nM	4.7
	18064093	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cn1		CHEMBL4061286	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
	18064094	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)nc1		CHEMBL4083151	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
	18064095	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1cnc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cn1		CHEMBL4084079	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
	18064096	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC4CCN(C)CC4)nc32)cc1		CHEMBL4102058	=	IC50	nM	4.7	CHEMBL3650	Homo sapiens	IC50	nM	4.7
	18064097	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN(CC)CC)nc32)cc1		CHEMBL4091839	=	IC50	nM	24.0	CHEMBL3650	Homo sapiens	IC50	nM	24.0
	18064098	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCOCC4)nc32)cc1		CHEMBL4064081	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
	18064099	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCCCC4)nc32)cc1		CHEMBL4065128	=	IC50	nM	13.0	CHEMBL3650	Homo sapiens	IC50	nM	13.0
	18064100	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(C)CC4)nc32)cc1		CHEMBL4086567	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	18064101	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(CC)CC4)nc32)cc1		CHEMBL4102642	=	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
	18064102	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(C(C)=O)CC4)nc32)cc1		CHEMBL4084708	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
	18064103	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCCN4CCOCC4)nc32)cc1		CHEMBL4064756	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
	18064104	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCO)nc32)cc1		CHEMBL4092456	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	18064105	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC(CO)CO)nc32)cc1		CHEMBL4073347	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	18064106	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCC(O)CO)nc32)cc1		CHEMBL4100201	=	IC50	nM	3.9	CHEMBL3650	Homo sapiens	IC50	nM	3.9
	18064107	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)NCCCCn1c(=O)c(-c2c(Cl)c(OC)cc(OC)c2Cl)cc2cnc(NC)nc21		CHEMBL4083740	=	IC50	nM	0.7	CHEMBL3650	Homo sapiens	IC50	nM	0.7
	18064108	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4062003	=	IC50	nM	2.3	CHEMBL3650	Homo sapiens	IC50	nM	2.3
	18064109	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	IC50	nM	0.6	CHEMBL3650	Homo sapiens	IC50	nM	0.6
	18064110	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCC(N(C)CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4095844	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
	18064111	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CC(N(C)CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4089842	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	18064112	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCCC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4061766	=	IC50	nM	0.7	CHEMBL3650	Homo sapiens	IC50	nM	0.7
	18064113	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4081984	=	IC50	nM	1.8	CHEMBL3650	Homo sapiens	IC50	nM	1.8
	18064114	CHEMBL4013816	Inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4099992	=	IC50	nM	0.4	CHEMBL3650	Homo sapiens	IC50	nM	0.4
	18064136	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1cccc(Cn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4085605	=	Occ	%	65.0	CHEMBL3650	Homo sapiens	Occ	%	65.0
	18064137	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4095783	=	Occ	%	82.0	CHEMBL3650	Homo sapiens	Occ	%	82.0
	18064138	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N(C)c1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4068712	=	Occ	%	64.0	CHEMBL3650	Homo sapiens	Occ	%	64.0
	18064139	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1cc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)ccn1		CHEMBL4088057	=	Occ	%	104.0	CHEMBL3650	Homo sapiens	Occ	%	104.0
	18064140	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)n1		CHEMBL4066763	=	Occ	%	107.0	CHEMBL3650	Homo sapiens	Occ	%	107.0
	18064141	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cc1		CHEMBL4099578	=	Occ	%	90.0	CHEMBL3650	Homo sapiens	Occ	%	90.0
	18064142	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N(C)c1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cc1		CHEMBL4072676	=	Occ	%	65.0	CHEMBL3650	Homo sapiens	Occ	%	65.0
	18064143	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cn1		CHEMBL4061286	=	Occ	%	112.0	CHEMBL3650	Homo sapiens	Occ	%	112.0
	18064144	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)nc1		CHEMBL4083151	=	Occ	%	108.0	CHEMBL3650	Homo sapiens	Occ	%	108.0
	18064145	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1cnc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cn1		CHEMBL4084079	=	Occ	%	102.0	CHEMBL3650	Homo sapiens	Occ	%	102.0
	18064146	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN(CC)CC)nc32)cc1		CHEMBL4091839	=	Occ	%	93.0	CHEMBL3650	Homo sapiens	Occ	%	93.0
	18064147	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCOCC4)nc32)cc1		CHEMBL4064081	=	Occ	%	103.0	CHEMBL3650	Homo sapiens	Occ	%	103.0
	18064148	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCCCC4)nc32)cc1		CHEMBL4065128	=	Occ	%	108.0	CHEMBL3650	Homo sapiens	Occ	%	108.0
	18064149	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(C)CC4)nc32)cc1		CHEMBL4086567	=	Occ	%	96.0	CHEMBL3650	Homo sapiens	Occ	%	96.0
	18064150	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(CC)CC4)nc32)cc1		CHEMBL4102642	=	Occ	%	100.0	CHEMBL3650	Homo sapiens	Occ	%	100.0
	18064151	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCCN4CCOCC4)nc32)cc1		CHEMBL4064756	=	Occ	%	96.0	CHEMBL3650	Homo sapiens	Occ	%	96.0
	18064152	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCO)nc32)cc1		CHEMBL4092456	=	Occ	%	82.0	CHEMBL3650	Homo sapiens	Occ	%	82.0
	18064153	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)NCCCCn1c(=O)c(-c2c(Cl)c(OC)cc(OC)c2Cl)cc2cnc(NC)nc21		CHEMBL4083740	=	Occ	%	108.0	CHEMBL3650	Homo sapiens	Occ	%	108.0
	18064154	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N1CCN(CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4062003	=	Occ	%	102.0	CHEMBL3650	Homo sapiens	Occ	%	102.0
	18064155	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Occ	%	101.0	CHEMBL3650	Homo sapiens	Occ	%	101.0
	18064156	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N1CCC(N(C)CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4095844	=	Occ	%	135.0	CHEMBL3650	Homo sapiens	Occ	%	135.0
	18064157	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N1CC(N(C)CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4089842	=	Occ	%	103.0	CHEMBL3650	Homo sapiens	Occ	%	103.0
	18064158	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N1CCCC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4061766	=	Occ	%	108.0	CHEMBL3650	Homo sapiens	Occ	%	108.0
	18064159	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N1CCC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4081984	=	Occ	%	87.0	CHEMBL3650	Homo sapiens	Occ	%	87.0
	18064160	CHEMBL4013827	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 15 mins by TR-FRET assay relative to control	B	C=CC(=O)N1CC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4099992	=	Occ	%	130.0	CHEMBL3650	Homo sapiens	Occ	%	130.0
	18064161	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1cccc(Cn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4085605	=	Occ	%	56.0	CHEMBL3650	Homo sapiens	Occ	%	56.0
	18064162	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4095783	=	Occ	%	60.0	CHEMBL3650	Homo sapiens	Occ	%	60.0
	18064163	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N(C)c1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4068712	=	Occ	%	60.0	CHEMBL3650	Homo sapiens	Occ	%	60.0
	18064164	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1cc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)ccn1		CHEMBL4088057	=	Occ	%	102.0	CHEMBL3650	Homo sapiens	Occ	%	102.0
	18064165	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)n1		CHEMBL4066763	=	Occ	%	102.0	CHEMBL3650	Homo sapiens	Occ	%	102.0
	18064166	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cc1		CHEMBL4099578	=	Occ	%	52.0	CHEMBL3650	Homo sapiens	Occ	%	52.0
	18064167	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N(C)c1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cc1		CHEMBL4072676	=	Occ	%	49.0	CHEMBL3650	Homo sapiens	Occ	%	49.0
	18064168	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cn1		CHEMBL4061286	=	Occ	%	105.0	CHEMBL3650	Homo sapiens	Occ	%	105.0
	18064169	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)nc1		CHEMBL4083151	=	Occ	%	102.0	CHEMBL3650	Homo sapiens	Occ	%	102.0
	18064170	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1cnc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cn1		CHEMBL4084079	=	Occ	%	97.0	CHEMBL3650	Homo sapiens	Occ	%	97.0
	18064171	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN(CC)CC)nc32)cc1		CHEMBL4091839	=	Occ	%	86.0	CHEMBL3650	Homo sapiens	Occ	%	86.0
	18064172	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCOCC4)nc32)cc1		CHEMBL4064081	=	Occ	%	97.0	CHEMBL3650	Homo sapiens	Occ	%	97.0
	18064173	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCCCC4)nc32)cc1		CHEMBL4065128	=	Occ	%	110.0	CHEMBL3650	Homo sapiens	Occ	%	110.0
	18064174	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(C)CC4)nc32)cc1		CHEMBL4086567	=	Occ	%	89.0	CHEMBL3650	Homo sapiens	Occ	%	89.0
	18064175	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(CC)CC4)nc32)cc1		CHEMBL4102642	=	Occ	%	84.0	CHEMBL3650	Homo sapiens	Occ	%	84.0
	18064176	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCCN4CCOCC4)nc32)cc1		CHEMBL4064756	=	Occ	%	65.0	CHEMBL3650	Homo sapiens	Occ	%	65.0
	18064177	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCO)nc32)cc1		CHEMBL4092456	=	Occ	%	60.0	CHEMBL3650	Homo sapiens	Occ	%	60.0
	18064178	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)NCCCCn1c(=O)c(-c2c(Cl)c(OC)cc(OC)c2Cl)cc2cnc(NC)nc21		CHEMBL4083740	=	Occ	%	43.0	CHEMBL3650	Homo sapiens	Occ	%	43.0
	18064179	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N1CCN(CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4062003	=	Occ	%	50.0	CHEMBL3650	Homo sapiens	Occ	%	50.0
	18064180	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Occ	%	96.0	CHEMBL3650	Homo sapiens	Occ	%	96.0
	18064181	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N1CCC(N(C)CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4095844	=	Occ	%	87.0	CHEMBL3650	Homo sapiens	Occ	%	87.0
	18064182	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N1CC(N(C)CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4089842	=	Occ	%	99.0	CHEMBL3650	Homo sapiens	Occ	%	99.0
	18064183	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N1CCCC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4061766	=	Occ	%	32.0	CHEMBL3650	Homo sapiens	Occ	%	32.0
	18064184	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N1CCC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4081984	=	Occ	%	57.0	CHEMBL3650	Homo sapiens	Occ	%	57.0
	18064185	CHEMBL4013828	Receptor occupancy at recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 15 uM preincubated for 60 mins followed by compound wash out and subsequent Cy5-labeled pyrido-pyrimidinone tracer addition measured after 24 hrs by TR-FRET assay relative to control	B	C=CC(=O)N1CC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4099992	=	Occ	%	110.0	CHEMBL3650	Homo sapiens	Occ	%	110.0
	18064186	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)c1		CHEMBL4095783	=	IC50	nM	6.0	CHEMBL3650	Homo sapiens	IC50	nM	6.0
	18064187	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1cc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)ccn1		CHEMBL4088057	=	IC50	nM	2.2	CHEMBL3650	Homo sapiens	IC50	nM	2.2
	18064188	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)n1		CHEMBL4066763	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
	18064189	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cc1		CHEMBL4099578	=	IC50	nM	3.4	CHEMBL3650	Homo sapiens	IC50	nM	3.4
	18064190	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)cn1		CHEMBL4061286	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
	18064191	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)nc1		CHEMBL4083151	=	IC50	nM	9.5	CHEMBL3650	Homo sapiens	IC50	nM	9.5
	18064192	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC4CCN(C)CC4)nc32)cc1		CHEMBL4102058	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	nM	28.0
	18064193	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCOCC4)nc32)cc1		CHEMBL4064081	=	IC50	nM	8.6	CHEMBL3650	Homo sapiens	IC50	nM	8.6
	18064194	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(CC)CC4)nc32)cc1		CHEMBL4102642	=	IC50	nM	9.4	CHEMBL3650	Homo sapiens	IC50	nM	9.4
	18064195	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCN4CCN(C(C)=O)CC4)nc32)cc1		CHEMBL4084708	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	nM	11.0
	18064196	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCCN4CCOCC4)nc32)cc1		CHEMBL4064756	=	IC50	nM	12.0	CHEMBL3650	Homo sapiens	IC50	nM	12.0
	18064197	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCCO)nc32)cc1		CHEMBL4092456	=	IC50	nM	2.4	CHEMBL3650	Homo sapiens	IC50	nM	2.4
	18064198	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NC(CO)CO)nc32)cc1		CHEMBL4073347	=	IC50	nM	16.0	CHEMBL3650	Homo sapiens	IC50	nM	16.0
	18064199	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3cc(OC)cc(OC)c3Cl)cc3cnc(NCC(O)CO)nc32)cc1		CHEMBL4100201	=	IC50	nM	37.0	CHEMBL3650	Homo sapiens	IC50	nM	37.0
	18064200	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)N1CCN(CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4062003	=	IC50	nM	11.0	CHEMBL3650	Homo sapiens	IC50	nM	11.0
	18064201	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
	18064202	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)N1CCC(N(C)CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4095844	=	IC50	nM	4.1	CHEMBL3650	Homo sapiens	IC50	nM	4.1
	18064203	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)N1CC(N(C)CCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4089842	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
	18064204	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)N1CCCC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4061766	=	IC50	nM	5.6	CHEMBL3650	Homo sapiens	IC50	nM	5.6
	18064205	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)N1CCC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4081984	=	IC50	nM	7.8	CHEMBL3650	Homo sapiens	IC50	nM	7.8
	18064206	CHEMBL4013829	Inhibition of FGFR1 in HUVEC assessed as reduction in FGF2-induced ERK phosphorylation preincubated for 60 mins followed by FGF2 stimulation for 10 mins by AlphaScreen assay	B	C=CC(=O)N1CC(OCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)C1		CHEMBL4099992	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	18064293	CHEMBL4013848	Inhibition of human FGFR1 at 1 uM using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	>	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
Active	18064335	CHEMBL4013890	Time dependent inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509		TDI			CHEMBL3650	Homo sapiens	TDI		
	18064339	CHEMBL4013894	Irreversible inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Kinact	/s	0.0019	CHEMBL3650	Homo sapiens	Kinact	/s	0.0019
	18064343	CHEMBL4013898	Ratio of Kinact to Ki for human FGFR1	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Ratio	/uM/s	1.2	CHEMBL3650	Homo sapiens	Ratio	/uM/s	1.2
	18064377	CHEMBL4013894	Irreversible inhibition of human FGFR1 using 5-FAM-KKKKEEIYFFF-NH2 as substrate preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Ki	nM	1.6	CHEMBL3650	Homo sapiens	Ki	nM	1.6
Active	18078268	CHEMBL4016723	Inhibition of human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in baculovirus infected sf9 cells at 1 uM using Poly(Glu,Tyr)4:1 as substrate by filter binding assay	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCC(O)CO		CHEMBL1276317		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	18078269	CHEMBL4016723	Inhibition of human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in baculovirus infected sf9 cells at 1 uM using Poly(Glu,Tyr)4:1 as substrate by filter binding assay	B	CN1CCN(CCO/N=C2C(=C3/C(=O)Nc4ccccc43)/Nc3ccccc3/2)CC1.Cl		CHEMBL4084775		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18078270	CHEMBL4016723	Inhibition of human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in baculovirus infected sf9 cells at 1 uM using Poly(Glu,Tyr)4:1 as substrate by filter binding assay	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18078271	CHEMBL4016723	Inhibition of human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in baculovirus infected sf9 cells at 1 uM using Poly(Glu,Tyr)4:1 as substrate by filter binding assay	B	Cc1ccc2c(c1)NC(=O)/C2=C1\Nc2ccccc2\C1=N/O		CHEMBL4067175		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	18083213	CHEMBL4018003	Inhibition of recombinant human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in Sf9 insect cells at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
Not Active	18083214	CHEMBL4018003	Inhibition of recombinant human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in Sf9 insect cells at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CCN(S(=O)(=O)C2CC2)C4)cn1		CHEMBL4098032		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	18083215	CHEMBL4018003	Inhibition of recombinant human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in Sf9 insect cells at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCc2c(nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn23)C1		CHEMBL4068727		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	18083216	CHEMBL4018003	Inhibition of recombinant human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in Sf9 insect cells at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CN(c2ccc(F)cc2)CC4)cn1		CHEMBL4088855	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	18084557	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)Nc1cc(N2CCN(CC)CC2)cc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4081380	=	IC50	nM	2900.0	CHEMBL3650	Homo sapiens	IC50	nM	2900.0
	18084558	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4077859	=	IC50	nM	3500.0	CHEMBL3650	Homo sapiens	IC50	nM	3500.0
	18084560	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)N[C@@H]1COC[C@@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4064147	=	IC50	nM	7400.0	CHEMBL3650	Homo sapiens	IC50	nM	7400.0
	18084567	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4089245	=	IC50	nM	8600.0	CHEMBL3650	Homo sapiens	IC50	nM	8600.0
	18084581	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	=	IC50	nM	4340.0	CHEMBL3650	Homo sapiens	IC50	nM	4340.0
	18084584	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2cc(OC)cc(OC)c2)cn1		CHEMBL4096950	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18084586	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OC(C)c2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4069755	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18084588	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)Nc1ccccc1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4070782	=	IC50	nM	60.0	CHEMBL3650	Homo sapiens	IC50	nM	60.0
	18084590	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	2700.0	CHEMBL3650	Homo sapiens	IC50	nM	2700.0
	18084636	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)N[C@H]1CCCC[C@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4085712	=	IC50	nM	3300.0	CHEMBL3650	Homo sapiens	IC50	nM	3300.0
	18084642	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4073517	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18084645	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=C(C)C(=O)Nc1cc(N2CCN(CC)CC2)cc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4070631	=	IC50	nM	4800.0	CHEMBL3650	Homo sapiens	IC50	nM	4800.0
	18084650	CHEMBL4018312	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using tyr 04 as substrate measured within 60 mins by Z-LYTE assay	A	C=CC(=O)Nc1cc(N2CCN(C(C)=O)CC2)cc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4099401	=	IC50	nM	9500.0	CHEMBL3650	Homo sapiens	IC50	nM	9500.0
	18085831	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3O)cc12		CHEMBL4073545	=	IC50	nM	14.9	CHEMBL3650	Homo sapiens	IC50	nM	14.9
	18085832	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3C(N)=O)cc12		CHEMBL4094883	=	IC50	nM	48.8	CHEMBL3650	Homo sapiens	IC50	nM	48.8
	18085833	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3CO)cc12		CHEMBL4084547	=	IC50	nM	167.3	CHEMBL3650	Homo sapiens	IC50	nM	167.3
	18085834	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(=O)Nc1ccccc1-c1ncc(N[C@@H](CO)c2ccccc2)cc1-c1ccc2[nH]nc(C)c2c1		CHEMBL4062871	=	IC50	nM	418.4	CHEMBL3650	Homo sapiens	IC50	nM	418.4
	18085835	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3C(F)(F)F)cc12		CHEMBL4092280	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085836	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3F)cc12		CHEMBL4071491	=	IC50	nM	437.3	CHEMBL3650	Homo sapiens	IC50	nM	437.3
	18085837	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc4cc[nH]c34)cc12		CHEMBL4060706	=	IC50	nM	456.0	CHEMBL3650	Homo sapiens	IC50	nM	456.0
	18085838	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc4cccnc34)cc12		CHEMBL4082577	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085839	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccnc3)cc12		CHEMBL4064545	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085840	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3)cc12		CHEMBL4086068	=	IC50	nM	127.9	CHEMBL3650	Homo sapiens	IC50	nM	127.9
	18085841	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccs3)cc12		CHEMBL4102447	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085842	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccsc3)cc12		CHEMBL4078176	=	IC50	nM	327.4	CHEMBL3650	Homo sapiens	IC50	nM	327.4
	18085843	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccco3)cc12		CHEMBL4083543	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085844	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccoc3)cc12		CHEMBL4101542	=	IC50	nM	3800.0	CHEMBL3650	Homo sapiens	IC50	nM	3800.0
	18085891	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)cc(F)c3O)cc12		CHEMBL4077448	=	IC50	nM	63.5	CHEMBL3650	Homo sapiens	IC50	nM	63.5
	18085892	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)c(F)cc3O)cc12		CHEMBL4074407	=	IC50	nM	10.6	CHEMBL3650	Homo sapiens	IC50	nM	10.6
	18085893	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc(F)c3O)cc12		CHEMBL4076118	=	IC50	nM	27.9	CHEMBL3650	Homo sapiens	IC50	nM	27.9
	18085894	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	=	IC50	nM	25.2	CHEMBL3650	Homo sapiens	IC50	nM	25.2
	18085895	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	18.0	CHEMBL3650	Homo sapiens	IC50	nM	18.0
	18085896	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(C(C)C)ccc3O)cc12		CHEMBL4102355	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085897	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(O)c(-c2ncc(N[C@@H](CO)c3ccccc3)cc2-c2ccc3[nH]nc(C)c3c2)c1		CHEMBL4084388	=	IC50	nM	32.3	CHEMBL3650	Homo sapiens	IC50	nM	32.3
	18085898	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NC[C@H](O)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4095830	=	IC50	nM	168.3	CHEMBL3650	Homo sapiens	IC50	nM	168.3
	18085899	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NCCCO)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4068491	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085900	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NCCO)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4100109	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085901	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](C)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4101681	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085902	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4091460	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085903	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3[nH]ccc3c2)c1)c1ccccc1		CHEMBL4075768	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085904	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(=O)Nc1ccc(-c2cc(N[C@@H](CO)c3ccccc3)cnc2-c2cc(Cl)ccc2O)cc1		CHEMBL4063010	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18085905	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C1Cc2cc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)ccc2N1		CHEMBL4077119	=	IC50	nM	91.5	CHEMBL3650	Homo sapiens	IC50	nM	91.5
	18085906	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	=	IC50	nM	16.1	CHEMBL3650	Homo sapiens	IC50	nM	16.1
	18085907	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ncc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4082721	=	IC50	nM	24.9	CHEMBL3650	Homo sapiens	IC50	nM	24.9
	18085908	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.7	CHEMBL3650	Homo sapiens	IC50	nM	0.7
	18085909	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	=	IC50	nM	55.8	CHEMBL3650	Homo sapiens	IC50	nM	55.8
	18085910	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc(O)c3)cc12		CHEMBL4100031	=	IC50	nM	66.5	CHEMBL3650	Homo sapiens	IC50	nM	66.5
	18085911	CHEMBL4018625	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1ccccc1-c1ncc(N[C@@H](CO)c2ccccc2)cc1-c1ccc2[nH]nc(C)c2c1		CHEMBL4082023	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18086073	CHEMBL4018657	Inhibition of FGFR1 in human NCI-H1581 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	62.6	CHEMBL3650	Homo sapiens	IC50	nM	62.6
	18086074	CHEMBL4018657	Inhibition of FGFR1 in human NCI-H1581 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	391.2	CHEMBL3650	Homo sapiens	IC50	nM	391.2
	18086075	CHEMBL4018685	Inhibition of FGFR1OP2 fused FGFR1 in human KG1 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	16.1	CHEMBL3650	Homo sapiens	IC50	nM	16.1
	18086076	CHEMBL4018685	Inhibition of FGFR1OP2 fused FGFR1 in human KG1 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	14.5	CHEMBL3650	Homo sapiens	IC50	nM	14.5
Dose-dependent effect	18086101	CHEMBL4018697	Inhibition of FGFR1OP2-fused FGFR1 phosphorylation in human KG1 cells after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18086104	CHEMBL4018699	Inhibition of FGFR1OP2-fused FGFR1 in human KG1 cells assessed as decrease in phosphorylation of PLCgamma at 31.2 to 125 nM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18086107	CHEMBL4018702	Inhibition of FGFR1OP2-fused FGFR1 in human KG1 cells assessed as decrease in phosphorylation of ERK at 31.2 to 125 nM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	18086113	CHEMBL4018716	Inhibition of recombinant human FGFR1 at 50 uM using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccoc3)cc12		CHEMBL4101542	=	Inhibition	%	76.5	CHEMBL3650	Homo sapiens	INH	%	76.5
Dose-dependent effect	18086114	CHEMBL4018713	Inhibition of FGFR1OP2-fused FGFR1 in human KG1 cells assessed as decrease in FRS2alpha phosphorylation after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	18086115	CHEMBL4018717	Inhibition of FGFR1 phosphorylation in human NCI-H1581 cells after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	18086116	CHEMBL4018718	Inhibition of FGFR1 in human NCI-H1581 cells assessed as decrease in FRS2alpha phosphorylation after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18086119	CHEMBL4018714	Inhibition of FGFR1 in human NCI-H1581 cells assessed as decrease in phosphorylation of PLCgamma at 0.5 to 2 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18086120	CHEMBL4018715	Inhibition of FGFR1 in human NCI-H1581 cells assessed as decrease in phosphorylation of ERK at 0.5 to 2 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	18092339	CHEMBL4020195	Inhibition of FGFR1 (unknown origin)	B	Fc1cccc(Cl)c1CNc1nc(-c2ccco2)n[nH]1		CHEMBL1354522		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	18096350	CHEMBL4021237	Inhibition of FGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	nM	30000.0
	18105924	CHEMBL4022696	Inhibition of human bFGF receptor tyrosine kinase using KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH2 peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-n3ccnc3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL3185148	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	uM	1.0
	18105925	CHEMBL4022696	Inhibition of human bFGF receptor tyrosine kinase using KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH2 peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	>	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	18105926	CHEMBL4022696	Inhibition of human bFGF receptor tyrosine kinase using KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH2 peptide substrate after 1 hr by scintillation counting method	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	>	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	uM	5.0
	18114355	CHEMBL4025139	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	94.0	CHEMBL3650	Homo sapiens	Activity	%	94.0
	18117606	CHEMBL4025917	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells at 3 uM relative to control	B	COc1ccc(-c2nnc(-n3c(-c4ccccc4)nc4cc(Cl)ccc4c3=O)s2)cc1		CHEMBL4103440	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	18121172	CHEMBL4026812	Inhibition of human FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as percent enzyme activity at 1 uM relative to control	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Activity	%	12.0	CHEMBL3650	Homo sapiens	Activity	%	12.0
	18149650	CHEMBL4033343	Inhibition of human FGFR1 at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561	>	Inhibition	%	96.0	CHEMBL3650	Homo sapiens	INH	%	96.0
	18156550	CHEMBL4035095	Inhibition of FGFR1 (unknown origin)	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2c(Cl)cc(Cl)cc2Cl)nc2ccc(N)cc12		CHEMBL4090364	=	IC50	nM	9000.0	CHEMBL3650	Homo sapiens	IC50	uM	9.0
	18172175	CHEMBL4038029	Inhibition of cytoplasmic recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay	B	CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1		CHEMBL4066141	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	nM	10.0
Not Active	18203437	CHEMBL4043788	Inhibition of FGFR1 in human FGFR1-amplified H520 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18203438	CHEMBL4043788	Inhibition of FGFR1 in human FGFR1-amplified H520 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18203439	CHEMBL4043788	Inhibition of FGFR1 in human FGFR1-amplified H520 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18203446	CHEMBL4043787	Inhibition of FGFR1 in human FGFR1-amplified H520 cells assessed as decrease in FGF-induced ERK1/2 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	18203523	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	3.65	CHEMBL3650	Homo sapiens	IC50	nM	3.65
	18203524	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1ccc(Nc2ncc3c(n2)N(C2CCN(C(=O)/C=C/CN(C)C)CC2)C(=O)N(c2c(Cl)c(OC)cc(OC)c2Cl)C3)cc1		CHEMBL4100258	=	IC50	nM	0.28	CHEMBL3650	Homo sapiens	IC50	nM	0.28
	18203525	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1ccccc1Nc1ncc2c(n1)N(C1CCN(C(=O)/C=C/CN(C)C)CC1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4077029	=	IC50	nM	0.91	CHEMBL3650	Homo sapiens	IC50	nM	0.91
	18203526	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	IC50	nM	0.99	CHEMBL3650	Homo sapiens	IC50	nM	0.99
	18203527	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)c(Cl)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4072483	=	IC50	nM	1.97	CHEMBL3650	Homo sapiens	IC50	nM	1.97
	18203528	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(Nc2ncc3c(n2)N(C2CCN(C(=O)/C=C/CN(C)C)CC2)C(=O)N(c2c(Cl)c(OC)cc(OC)c2Cl)C3)ccc1F		CHEMBL4099403	=	IC50	nM	2.28	CHEMBL3650	Homo sapiens	IC50	nM	2.28
	18203529	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)c(F)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4087420	=	IC50	nM	4.59	CHEMBL3650	Homo sapiens	IC50	nM	4.59
	18203530	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4cc(F)cc(F)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4066038	=	IC50	nM	1.81	CHEMBL3650	Homo sapiens	IC50	nM	1.81
	18203531	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4cccc(F)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4079538	=	IC50	nM	1.21	CHEMBL3650	Homo sapiens	IC50	nM	1.21
	18203532	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4cccc(C)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4103795	=	IC50	nM	1.16	CHEMBL3650	Homo sapiens	IC50	nM	1.16
	18203533	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cccc(Nc2ncc3c(n2)N(C2CCN(C(=O)/C=C/CN(C)C)CC2)C(=O)N(c2c(Cl)c(OC)cc(OC)c2Cl)C3)c1		CHEMBL4068733	=	IC50	nM	1.18	CHEMBL3650	Homo sapiens	IC50	nM	1.18
	18203534	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041	=	IC50	nM	1.06	CHEMBL3650	Homo sapiens	IC50	nM	1.06
	18203535	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCOCC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4060079	=	IC50	nM	1.32	CHEMBL3650	Homo sapiens	IC50	nM	1.32
	18203536	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCCCC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4088313	=	IC50	nM	1.06	CHEMBL3650	Homo sapiens	IC50	nM	1.06
	18203537	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCOC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096738	=	IC50	nM	1.23	CHEMBL3650	Homo sapiens	IC50	nM	1.23
	18203538	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC(C)C)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4069509	=	IC50	nM	1.07	CHEMBL3650	Homo sapiens	IC50	nM	1.07
	18203539	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(N(C)C)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4084614	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	nM	200.0
	18203540	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	CNc1ncc2c(n1)N(CCCNC(=O)/C=C/CN(C)C)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4102560	=	IC50	nM	1.77	CHEMBL3650	Homo sapiens	IC50	nM	1.77
	18203541	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	CNc1ncc2c(n1)N(C1CCN(C(=O)/C=C/CN(C)C)CC1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4092354	=	IC50	nM	0.73	CHEMBL3650	Homo sapiens	IC50	nM	0.73
	18203542	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	CNc1ncc2c(n1)N([C@@H]1CCCN(C(=O)/C=C/CN(C)C)C1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4064676	=	IC50	nM	3.54	CHEMBL3650	Homo sapiens	IC50	nM	3.54
	18203543	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	CNc1ncc2c(n1)N([C@H]1CCCN(C(=O)/C=C/CN(C)C)C1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4100110	=	IC50	nM	3.08	CHEMBL3650	Homo sapiens	IC50	nM	3.08
	18203544	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	CNc1ncc2c(n1)N([C@@H]1CCN(C(=O)/C=C/CN(C)C)C1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4073261	=	IC50	nM	10.7	CHEMBL3650	Homo sapiens	IC50	nM	10.7
	18203545	CHEMBL4043777	Inhibition of human recombinant His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	CNc1ncc2c(n1)N([C@H]1CCN(C(=O)/C=C/CN(C)C)C1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4061908	=	IC50	nM	2.33	CHEMBL3650	Homo sapiens	IC50	nM	2.33
	18203663	CHEMBL4043950	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	0.6	CHEMBL3650	Homo sapiens	Activity	%	0.6
Active	18203982	CHEMBL4044269	Inhibition of FGFR1 in human FGFR1-amplified H520 cells assessed as decrease in FGF-induced FGFR1 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18203986	CHEMBL4044271	Inhibition of FGFR1 in human FGFR1-amplified H520 cells assessed as decrease in FGF-induced FGFR1 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	18203987	CHEMBL4044271	Inhibition of FGFR1 in human FGFR1-amplified H520 cells assessed as decrease in FGF-induced FGFR1 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	18212111	CHEMBL4046129	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL3650	Homo sapiens	INH	%	20.0
	18232123	CHEMBL4050379	Inhibition of human FGFR1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	92.0	CHEMBL3650	Homo sapiens	Activity	%	92.0
	18248592	CHEMBL4053875	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	18250471	CHEMBL4054288	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	9.3	CHEMBL3650	Homo sapiens	INH	%	9.3
	18250472	CHEMBL4054289	Inhibition of FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
	18253475	CHEMBL4055021	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	81.0	CHEMBL3650	Homo sapiens	Activity	%	81.0
	18253476	CHEMBL4055021	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	92.0	CHEMBL3650	Homo sapiens	Activity	%	92.0
	18264484	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)c(F)cc34)cc2)CC1		CHEMBL4079317	=	IC50	nM	35.2	CHEMBL3650	Homo sapiens	IC50	nM	35.2
	18264485	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)cc(F)c34)cc2)CC1		CHEMBL4105046	=	IC50	nM	219.6	CHEMBL3650	Homo sapiens	IC50	nM	219.6
	18264486	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1cccc(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)c(F)c4)n[nH]c3c2)c1F		CHEMBL4087200	=	IC50	nM	147.6	CHEMBL3650	Homo sapiens	IC50	nM	147.6
	18264487	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1cccc(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4F)n[nH]c3c2)c1F		CHEMBL4092994	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18264488	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)ccc34)cc2C(F)(F)F)CC1		CHEMBL4072232	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18264489	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5c(F)cc(F)c(OC)c5F)ccc34)cc2)CC1		CHEMBL4076490	=	IC50	nM	49.0	CHEMBL3650	Homo sapiens	IC50	nM	49.0
	18264490	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5c(F)cc(F)c(OC)c5F)ccc34)cc2)CC1		CHEMBL4099060	=	IC50	nM	99.3	CHEMBL3650	Homo sapiens	IC50	nM	99.3
	18264491	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5c(F)ccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4105407	<	IC50	nM	4.1	CHEMBL3650	Homo sapiens	IC50	nM	4.1
	18264492	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)n[nH]c3c2)c1F		CHEMBL4081153	=	IC50	nM	14.0	CHEMBL3650	Homo sapiens	IC50	nM	14.0
	18264493	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N5CCCN(C)CC5)cc4)n[nH]c3c2)c1F		CHEMBL4086560	=	IC50	nM	3.7	CHEMBL3650	Homo sapiens	IC50	nM	3.7
	18264494	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C(C)=O)CC5)cc4)n[nH]c3c2)c1F		CHEMBL4104460	=	IC50	nM	13.0	CHEMBL3650	Homo sapiens	IC50	nM	13.0
	18264495	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5c(F)ccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4078715	=	IC50	nM	10.4	CHEMBL3650	Homo sapiens	IC50	nM	10.4
	18264496	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c2)c1F		CHEMBL4096740	=	IC50	nM	5.6	CHEMBL3650	Homo sapiens	IC50	nM	5.6
	18264497	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N(C)CCN(C)C)cc4)n[nH]c3c2)c1F		CHEMBL4090974	=	IC50	nM	21.1	CHEMBL3650	Homo sapiens	IC50	nM	21.1
	18264498	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4076610	=	IC50	nM	6.2	CHEMBL3650	Homo sapiens	IC50	nM	6.2
	18264499	CHEMBL4056997	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	18265787	CHEMBL4057237	Inhibition of FGFR1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	35.0	CHEMBL3650	Homo sapiens	INH	%	35.0
	18265788	CHEMBL4057238	Inhibition of FGFR1 V561M mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	23.7	CHEMBL3650	Homo sapiens	INH	%	23.7
	18266047	CHEMBL4057497	Inhibition of FGFR1 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.7	CHEMBL3650	Homo sapiens	INH	%	0.7
	18266048	CHEMBL4057498	Inhibition of FGFR1 V561M mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	3.7	CHEMBL3650	Homo sapiens	INH	%	3.7
	18266203	CHEMBL4057653	Inhibition of FGFR1 (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	-2.7	CHEMBL3650	Homo sapiens	INH	%	-2.7
	18274890	CHEMBL4118342	Inhibition of FGFR1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKMLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	33.7	CHEMBL3650	Homo sapiens	INH	%	33.7
	18274891	CHEMBL4118342	Inhibition of FGFR1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKMLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	7.6	CHEMBL3650	Homo sapiens	INH	%	7.6
	18274892	CHEMBL4118342	Inhibition of FGFR1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKMLK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	18.4	CHEMBL3650	Homo sapiens	INH	%	18.4
	18282097	CHEMBL4120052	Inhibition of recombinant His-tagged human FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	2.4	CHEMBL3650	Homo sapiens	INH	%	2.4
	18282416	CHEMBL4120052	Inhibition of recombinant His-tagged human FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	3.4	CHEMBL3650	Homo sapiens	INH	%	3.4
	18282724	CHEMBL4120309	Inhibition of FGFR1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	35.0	CHEMBL3650	Homo sapiens	INH	%	35.0
	18282779	CHEMBL4120364	Inhibition of FGFR1 V561M mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	23.7	CHEMBL3650	Homo sapiens	INH	%	23.7
	18282951	CHEMBL4120536	Inhibition of FGFR1 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	10.3	CHEMBL3650	Homo sapiens	INH	%	10.3
	18283006	CHEMBL4120591	Inhibition of FGFR1 V561M mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	18283175	CHEMBL4120760	Inhibition of FGFR1 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	9.7	CHEMBL3650	Homo sapiens	INH	%	9.7
	18283230	CHEMBL4120815	Inhibition of FGFR1 V561M mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	4.7	CHEMBL3650	Homo sapiens	INH	%	4.7
	18286301	CHEMBL4121536	Inhibition of recombinant His-tagged human FGFR1 cytoplasmic domain expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	18311472	CHEMBL4132125	Inhibition of FGFR1 kinase domain (unknown origin) by caliper mobility shift assay	B	COc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCC(C)C4)ccc1OCC(=O)O		CHEMBL597990	=	IC50	nM	50000.0	CHEMBL3650	Homo sapiens	IC50	uM	50.0
	18314197	CHEMBL4132792	Inhibition of N-terminal GST tagged human FGFR1 (398 to 822 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(C(=O)N3CCN(C)CC3)cc2c1)c1ccccc1		CHEMBL4165429	=	IC50	nM	1507.0	CHEMBL3650	Homo sapiens	IC50	nM	1507.0
	18314198	CHEMBL4132792	Inhibition of N-terminal GST tagged human FGFR1 (398 to 822 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	98.2	CHEMBL3650	Homo sapiens	IC50	nM	98.2
	18328499	CHEMBL4135865	Inhibition of FGFR-1 (unknown origin)	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cn1		CHEMBL4171543	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	nM	200.0
	18330794	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN(C)C)CC2)c1ccccc1		CHEMBL4166319	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	nM	140.0
	18330795	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CC(C)OC(C)C1)CC2)c1ccccc1		CHEMBL4173370	=	IC50	nM	6600.0	CHEMBL3650	Homo sapiens	IC50	nM	6600.0
	18330796	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCCC1=O)CC2)c1ccccc1		CHEMBL4165455	=	IC50	nM	1800.0	CHEMBL3650	Homo sapiens	IC50	nM	1800.0
	18330797	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)Cn1cncn1)CC2)c1ccccc1		CHEMBL4172155	=	IC50	nM	620.0	CHEMBL3650	Homo sapiens	IC50	nM	620.0
	18330798	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)Cn1cccn1)CC2)c1ccccc1		CHEMBL4161551	=	IC50	nM	4700.0	CHEMBL3650	Homo sapiens	IC50	nM	4700.0
	18330893	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-n5nccn5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4177014	=	IC50	nM	61.0	CHEMBL3650	Homo sapiens	IC50	nM	61.0
	18330894	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5ccco5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4172546	=	IC50	nM	15.0	CHEMBL3650	Homo sapiens	IC50	nM	15.0
	18330895	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5cnco5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4161897	=	IC50	nM	270.0	CHEMBL3650	Homo sapiens	IC50	nM	270.0
	18330896	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5nnn(C)n5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4175951	=	IC50	nM	170.0	CHEMBL3650	Homo sapiens	IC50	nM	170.0
	18330897	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5ncon5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4165331	=	IC50	nM	44.0	CHEMBL3650	Homo sapiens	IC50	nM	44.0
	18330898	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(-c5nnco5)ccc43)c3ccccc3)cc2)CC1		CHEMBL4160821	=	IC50	nM	62.0	CHEMBL3650	Homo sapiens	IC50	nM	62.0
	18330899	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(OC(F)(F)F)ccc43)c3ccccc3)cc2)CC1		CHEMBL4169611	=	IC50	nM	200.0	CHEMBL3650	Homo sapiens	IC50	nM	200.0
	18330900	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2CCC(CN3CCN(C)CC3)C2=O)cc1)c1ccccc1		CHEMBL4166187	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	nM	140.0
	18330901	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2C(=O)CC[C@@H]2CN(C)C)cc1)c1ccccc1		CHEMBL4162743	=	IC50	nM	94.0	CHEMBL3650	Homo sapiens	IC50	nM	94.0
	18330902	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2C(=O)CC[C@@H]2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4170680	=	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	18330903	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N2C(=O)CC[C@H]2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4171244	=	IC50	nM	120.0	CHEMBL3650	Homo sapiens	IC50	nM	120.0
	18330904	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	41.0	CHEMBL3650	Homo sapiens	IC50	nM	41.0
	18330905	CHEMBL4136260	Inhibition of recombinant FGFR1 (unknown origin) by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCOCC1)CC2)c1ccccc1		CHEMBL4168811	=	IC50	nM	1600.0	CHEMBL3650	Homo sapiens	IC50	nM	1600.0
	18333417	CHEMBL4136627	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 500 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	c1ccc(-c2ccc3cc[nH]c3c2)cc1		CHEMBL4161903	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	18333418	CHEMBL4136627	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 500 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	c1cncc(-c2ccc3cc[nH]c3c2)c1		CHEMBL4175955	=	Inhibition	%	16.0	CHEMBL3650	Homo sapiens	INH	%	16.0
	18333419	CHEMBL4136627	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 500 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	Clc1cncc(-c2ccc3cc[nH]c3c2)c1		CHEMBL4165338	=	Inhibition	%	21.0	CHEMBL3650	Homo sapiens	INH	%	21.0
	18333420	CHEMBL4136627	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 500 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	c1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4170644	=	Inhibition	%	53.0	CHEMBL3650	Homo sapiens	INH	%	53.0
	18333421	CHEMBL4136627	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 500 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	c1cncc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4159996	=	Inhibition	%	66.0	CHEMBL3650	Homo sapiens	INH	%	66.0
	18333422	CHEMBL4136627	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 500 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	Clc1cncc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4165408	=	Inhibition	%	73.0	CHEMBL3650	Homo sapiens	INH	%	73.0
Not Determined	18333423	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	c1ccc(-c2ccc3cc[nH]c3c2)cc1		CHEMBL4161903		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	18333424	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	c1cncc(-c2ccc3cc[nH]c3c2)c1		CHEMBL4175955		IC50			CHEMBL3650	Homo sapiens	IC50		
	18333425	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Clc1cncc(-c2ccc3cc[nH]c3c2)c1		CHEMBL4165338	>	IC50	nM	500000.0	CHEMBL3650	Homo sapiens	IC50	uM	500.0
	18333426	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	c1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4170644	=	IC50	nM	77000.0	CHEMBL3650	Homo sapiens	IC50	uM	77.0
	18333427	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	c1cncc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4159996	=	IC50	nM	90000.0	CHEMBL3650	Homo sapiens	IC50	uM	90.0
	18333428	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Clc1cncc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4165408	=	IC50	nM	36000.0	CHEMBL3650	Homo sapiens	IC50	uM	36.0
Not Determined	18333429	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Fc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4168833		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	18333430	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Clc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4160892		IC50			CHEMBL3650	Homo sapiens	IC50		
	18333431	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	CCOc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4172184	=	IC50	nM	2000.0	CHEMBL3650	Homo sapiens	IC50	uM	2.0
	18333432	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Oc1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4061296	=	IC50	nM	12000.0	CHEMBL3650	Homo sapiens	IC50	uM	12.0
Not Determined	18333433	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	COc1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4175614		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	18333434	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Clc1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4167742		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	18333435	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	c1cc(-c2ccc3cn[nH]c3c2)cs1		CHEMBL4170283		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	18333436	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	c1coc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4162359		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	18333437	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Cc1csc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4166568		IC50			CHEMBL3650	Homo sapiens	IC50		
Not Determined	18333438	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	FC(F)(F)c1cc(-c2ccc3cn[nH]c3c2)cc(C(F)(F)F)c1		CHEMBL4174480		IC50			CHEMBL3650	Homo sapiens	IC50		
	18333439	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	CCOc1cc(F)cc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4163123	=	IC50	nM	83000.0	CHEMBL3650	Homo sapiens	IC50	uM	83.0
	18333440	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	CCOc1cccc(-c2ccc3cn[nH]c3c2)c1F		CHEMBL4171043	=	IC50	nM	9700.0	CHEMBL3650	Homo sapiens	IC50	uM	9.7
	18333441	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	CCOc1ccc(F)c(-c2ccc3cn[nH]c3c2)c1F		CHEMBL4173432	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	18333442	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Oc1ccc(-c2ccc3cn[nH]c3c2)c(F)c1		CHEMBL4162722	=	IC50	nM	9900.0	CHEMBL3650	Homo sapiens	IC50	uM	9.9
	18333443	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Oc1ccc(-c2ccc3cn[nH]c3c2)cc1F		CHEMBL4169984	=	IC50	nM	14000.0	CHEMBL3650	Homo sapiens	IC50	uM	14.0
	18333444	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Cc1cc(O)ccc1-c1ccc2cn[nH]c2c1		CHEMBL4159347	=	IC50	nM	6400.0	CHEMBL3650	Homo sapiens	IC50	uM	6.4
	18333445	CHEMBL4136628	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	A	Cc1cc(-c2ccc3cn[nH]c3c2)ccc1O		CHEMBL4171437	=	IC50	nM	8800.0	CHEMBL3650	Homo sapiens	IC50	uM	8.8
	18333446	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	Fc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4168833	=	Inhibition	%	19.0	CHEMBL3650	Homo sapiens	INH	%	19.0
	18333447	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	Clc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4160892	=	Inhibition	%	32.0	CHEMBL3650	Homo sapiens	INH	%	32.0
	18333448	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	CCOc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4172184	=	Inhibition	%	85.0	CHEMBL3650	Homo sapiens	INH	%	85.0
	18333449	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	Oc1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4061296	=	Inhibition	%	83.0	CHEMBL3650	Homo sapiens	INH	%	83.0
	18333450	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	COc1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4175614	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	18333451	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	Clc1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4167742	=	Inhibition	%	12.0	CHEMBL3650	Homo sapiens	INH	%	12.0
	18333452	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	c1cc(-c2ccc3cn[nH]c3c2)cs1		CHEMBL4170283	=	Inhibition	%	20.0	CHEMBL3650	Homo sapiens	INH	%	20.0
	18333453	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	c1coc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4162359	=	Inhibition	%	29.0	CHEMBL3650	Homo sapiens	INH	%	29.0
	18333454	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	Cc1csc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4166568	=	Inhibition	%	19.0	CHEMBL3650	Homo sapiens	INH	%	19.0
	18333455	CHEMBL4136629	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 100 uM using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay relative to control	A	FC(F)(F)c1cc(-c2ccc3cn[nH]c3c2)cc(C(F)(F)F)c1		CHEMBL4174480	=	Inhibition	%	-5.0	CHEMBL3650	Homo sapiens	INH	%	-5.0
	18333476	CHEMBL4136633	Inhibition of FGFR1 (unknown origin)	A	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	9.3	CHEMBL3650	Homo sapiens	IC50	nM	9.3
	18356035	CHEMBL4140586	Inhibition of FGFR1 (unknown origin)	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12		CHEMBL4160854	=	IC50	nM	167.0	CHEMBL3650	Homo sapiens	IC50	nM	167.0
	18366734	CHEMBL4142790	Inhibition of recombinant human His-tagged FGFR1 expressed in baculovirus expression system at 1 uM by Z'LYTE assay relative to control	B	COc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C5CCNCC5)c4)c3)c2)cc1OC		CHEMBL4166182	=	Inhibition	%	16.0	CHEMBL3650	Homo sapiens	INH	%	16.0
	18366735	CHEMBL4142790	Inhibition of recombinant human His-tagged FGFR1 expressed in baculovirus expression system at 1 uM by Z'LYTE assay relative to control	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C5CCN(C)CC5)c4)c3)c2)cc1		CHEMBL4173409	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	18398319	CHEMBL4149573	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in Escherichia coli at 10 uM	B	Cc1ccc(C(=O)c2c(N)c(C(N)=O)c3ccccn23)cc1		CHEMBL4165173	=	Inhibition	%	54.0	CHEMBL3650	Homo sapiens	INH	%	54.0
	18420727	CHEMBL4153878	Inhibition of FGFR1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	18420728	CHEMBL4153878	Inhibition of FGFR1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	COc1ccc(CCN2CCC(Nc3nc4nc5ccc(C)cc5nc4c(=O)[nH]3)CC2)cc1		CHEMBL4167512	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	18420729	CHEMBL4153878	Inhibition of FGFR1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	COc1ccc2nc3nc(NCc4ccc(CN5CCN(C)CC5)cc4)[nH]c(=O)c3nc2c1		CHEMBL4171939	=	Inhibition	%	8.0	CHEMBL3650	Homo sapiens	INH	%	8.0
	18420730	CHEMBL4153878	Inhibition of FGFR1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	O=c1[nH]c(NCc2ccc(CN3CCCCC3)cc2)nc2nc3ccccc3cc12		CHEMBL4160278	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	18420731	CHEMBL4153878	Inhibition of FGFR1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	CN1CCN(Cc2ccc(CNc3nc4nc5ccc(Cl)cc5cc4c(=O)[nH]3)cc2)CC1		CHEMBL4171176	=	Inhibition	%	37.0	CHEMBL3650	Homo sapiens	INH	%	37.0
	18420732	CHEMBL4153878	Inhibition of FGFR1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	Cc1ccc2nc3nc(NCc4ccc(CN5CCN(C)CC5)cc4)[nH]c(=O)c3cc2c1		CHEMBL4163273	=	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	18431056	CHEMBL4155737	Inhibition of recombinant His-tagged human FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	93.0	CHEMBL3650	Homo sapiens	INH	%	93.0
	18440205	CHEMBL4157029	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	97.0	CHEMBL3650	Homo sapiens	Activity	%	97.0
	18449926	CHEMBL4178160	Inhibition of human FGFR1 (400 to 820 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	85.0	CHEMBL3650	Homo sapiens	Activity	%	85.0
	18457570	CHEMBL4179648	Inhibition of recombinant human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in Sf9 insect cells at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4212439	<	Inhibition	%	25.0	CHEMBL3650	Homo sapiens	INH	%	25.0
	18457571	CHEMBL4179648	Inhibition of recombinant human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in Sf9 insect cells at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4217392	<	Inhibition	%	25.0	CHEMBL3650	Homo sapiens	INH	%	25.0
	18457572	CHEMBL4179648	Inhibition of recombinant human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in Sf9 insect cells at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL4208064	<	Inhibition	%	25.0	CHEMBL3650	Homo sapiens	INH	%	25.0
	18457573	CHEMBL4179648	Inhibition of recombinant human N-terminal GST/His6-tagged FGFR1 (G400 to R820 residues) expressed in Sf9 insect cells at 1 uM using poly(Glu,Tyr)4:1 as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1		CHEMBL4205584	<	Inhibition	%	25.0	CHEMBL3650	Homo sapiens	INH	%	25.0
	18463749	CHEMBL4181165	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	4.0	CHEMBL3650	Homo sapiens	INH	%	4.0
	18484645	CHEMBL4185808	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	82.0	CHEMBL3650	Homo sapiens	Activity	%	82.0
	18484982	CHEMBL4185808	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	84.0	CHEMBL3650	Homo sapiens	Activity	%	84.0
	18490614	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	COc1cccc(-c2ccc3c(NC(=O)c4ccc(C(=O)NO)cc4)n[nH]c3c2)c1F		CHEMBL4205573	=	Inhibition	%	39.0	CHEMBL3650	Homo sapiens	INH	%	39.0
	18490615	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	CCOc1cccc(-c2ccc3c(NC(=O)c4ccc(C(=O)NO)cc4)n[nH]c3c2)c1		CHEMBL4203874	=	Inhibition	%	64.0	CHEMBL3650	Homo sapiens	INH	%	64.0
	18490616	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	CC(C)Oc1cccc(-c2ccc3c(NC(=O)c4ccc(C(=O)NO)cc4)n[nH]c3c2)c1		CHEMBL4208584	=	Inhibition	%	22.0	CHEMBL3650	Homo sapiens	INH	%	22.0
	18490617	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	COc1ccc(-c2ccc3c(NC(=O)c4ccc(C(=O)NO)cc4)n[nH]c3c2)cc1		CHEMBL4217830	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	18490618	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	O=C(NO)c1ccc(C(=O)Nc2n[nH]c3cc(-c4ccccc4)ccc23)cc1		CHEMBL4211477	=	Inhibition	%	26.0	CHEMBL3650	Homo sapiens	INH	%	26.0
	18490619	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	O=C(NO)c1ccc(C(=O)Nc2n[nH]c3cc(-c4ccc(Cl)c(F)c4)ccc23)cc1		CHEMBL4203741	=	Inhibition	%	18.0	CHEMBL3650	Homo sapiens	INH	%	18.0
	18490620	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	O=C(NO)c1ccc(C(=O)Nc2n[nH]c3cc(-c4ccc(C(F)(F)F)cc4)ccc23)cc1		CHEMBL4205375	=	Inhibition	%	12.0	CHEMBL3650	Homo sapiens	INH	%	12.0
	18490621	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	COc1ccc(F)cc1-c1ccc2c(NC(=O)c3ccc(C(=O)NO)cc3)n[nH]c2c1		CHEMBL4212669	=	Inhibition	%	13.0	CHEMBL3650	Homo sapiens	INH	%	13.0
	18490622	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	O=C(NO)c1ccc(C(=O)Nc2n[nH]c3cc(-c4ccccc4Cl)ccc23)cc1		CHEMBL4217618	=	Inhibition	%	22.0	CHEMBL3650	Homo sapiens	INH	%	22.0
	18490623	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	O=C(NO)c1ccc(C(=O)Nc2n[nH]c3cc(-c4cccc(Cl)c4)ccc23)cc1		CHEMBL4212219	=	Inhibition	%	33.0	CHEMBL3650	Homo sapiens	INH	%	33.0
	18490624	CHEMBL4187418	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA relative to control	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4076610	=	Inhibition	%	98.0	CHEMBL3650	Homo sapiens	INH	%	98.0
	18490625	CHEMBL4187419	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4076610	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
	18507791	CHEMBL4190971	Inhibition of recombinant human FGFR1 V561M mutant (456 to 765 residues) at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	12.0	CHEMBL3650	Homo sapiens	INH	%	12.0
	18507792	CHEMBL4190970	Inhibition of recombinant human FGFR1 (456 to 765 residues) at 1 uM using KKKSPGEYVNIEFG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	63.0	CHEMBL3650	Homo sapiens	INH	%	63.0
	18531087	CHEMBL4195393	Inhibition of FGFR1 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCCCC(=O)NO)cc4)n3)cc2nn1C		CHEMBL4212117	=	IC50	nM	409.0	CHEMBL3650	Homo sapiens	IC50	uM	0.409
	18531088	CHEMBL4195393	Inhibition of FGFR1 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)Nc5ccccc5N)cc4)n3)cc2nn1C		CHEMBL4213341	=	IC50	nM	192.0	CHEMBL3650	Homo sapiens	IC50	uM	0.192
	18531089	CHEMBL4195393	Inhibition of FGFR1 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	163.0	CHEMBL3650	Homo sapiens	IC50	uM	0.163
	18558676	CHEMBL4201079	Inhibition of human FGFR1 at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	93.0	CHEMBL3650	Homo sapiens	INH	%	93.0
	18577623	CHEMBL4222209	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	26.4	CHEMBL3650	Homo sapiens	INH	%	26.4
	18577647	CHEMBL4222209	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	2.4	CHEMBL3650	Homo sapiens	INH	%	2.4
	18577671	CHEMBL4222209	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	23.2	CHEMBL3650	Homo sapiens	INH	%	23.2
	18653637	CHEMBL4230085	Inhibition of FGFR1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	98.0	CHEMBL3650	Homo sapiens	INH	%	98.0
	18653638	CHEMBL4230085	Inhibition of FGFR1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	91.0	CHEMBL3650	Homo sapiens	INH	%	91.0
	18655527	CHEMBL4230708	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	98.0	CHEMBL3650	Homo sapiens	Activity	%	98.0
	18658988	CHEMBL4231712	Inhibition of GST-tagged human FGFR1 at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay	B	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1	Outside typical range	CHEMBL4249147	=	Inhibition	%	-14.57	CHEMBL3650	Homo sapiens	INH	%	-14.57
	18665425	CHEMBL4233322	Inhibition of FGFR1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18674664	CHEMBL4235355	Inhibition of FGFR1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL3650	Homo sapiens	Ki	nM	2000.0
	18674665	CHEMBL4235355	Inhibition of FGFR1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL3650	Homo sapiens	Ki	nM	2000.0
Not Determined	18674666	CHEMBL4235355	Inhibition of FGFR1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL3650	Homo sapiens	Ki		
	18693985	CHEMBL4253438	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-8.0	CHEMBL3650	Homo sapiens	INH	%	-8.0
	18694067	CHEMBL4253520	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	13.0	CHEMBL3650	Homo sapiens	INH	%	13.0
	18697638	CHEMBL4254311	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	91.0	CHEMBL3650	Homo sapiens	Activity	%	91.0
	18702496	CHEMBL4255111	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	-6.0	CHEMBL3650	Homo sapiens	INH	%	-6.0
	18702543	CHEMBL4255111	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	-2.0	CHEMBL3650	Homo sapiens	INH	%	-2.0
	18702587	CHEMBL4255111	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1	Outside typical range	CHEMBL4287097	=	Inhibition	%	-15.0	CHEMBL3650	Homo sapiens	INH	%	-15.0
	18702639	CHEMBL4255111	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	18702683	CHEMBL4255111	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	18702726	CHEMBL4255111	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	18725385	CHEMBL4259082	Inhibition of wild-type FGFR1 (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	18737828	CHEMBL4261411	Inhibition of recombinant human FGFR1 (456 to 765 residues) using KKKSPGEYVNIEF as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	127.0	CHEMBL3650	Homo sapiens	IC50	nM	127.0
	18745410	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	O=Cc1ccc2cccc(C(=O)Nc3ccc(C(F)(F)F)cn3)c2n1		CHEMBL4277111	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18745411	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	O=[N+]([O-])c1ccc(Cl)nc1Nc1ncc(C(F)(F)F)cc1Cl		CHEMBL4294665	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18745412	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	C=CC(=O)Nc1ccccc1C(=O)Nc1cc(CCc2cc(OC)cc(OC)c2)[nH]n1		CHEMBL4284069	=	IC50	nM	4.5	CHEMBL3650	Homo sapiens	IC50	nM	4.5
	18745413	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CC(C)COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(C#N)c(N[C@H]2[C@@H](C(N)=O)[C@@H]3C=C[C@H]2C3)n1		CHEMBL4279514	=	IC50	nM	280.0	CHEMBL3650	Homo sapiens	IC50	nM	280.0
	18745414	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	19.0	CHEMBL3650	Homo sapiens	IC50	nM	19.0
	18745415	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CC(C)Oc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL2403844	=	IC50	nM	6350.0	CHEMBL3650	Homo sapiens	IC50	nM	6350.0
	18745416	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	3200.0	CHEMBL3650	Homo sapiens	IC50	nM	3200.0
	18745417	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	18745418	CHEMBL4262863	Inhibition of phosphorylated FGFR1 (407 to 822 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	18751111	CHEMBL4263803	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	24.0	CHEMBL3650	Homo sapiens	INH	%	24.0
	18751606	CHEMBL4264297	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	95.0	CHEMBL3650	Homo sapiens	Activity	%	95.0
	18753866	CHEMBL4264845	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	7.0	CHEMBL3650	Homo sapiens	Activity	%	7.0
	18753867	CHEMBL4264845	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	1.0	CHEMBL3650	Homo sapiens	Activity	%	1.0
	18753868	CHEMBL4264845	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	7.0	CHEMBL3650	Homo sapiens	Activity	%	7.0
	18753869	CHEMBL4264845	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	8.0	CHEMBL3650	Homo sapiens	Activity	%	8.0
	18753870	CHEMBL4264846	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	1.0	CHEMBL3650	Homo sapiens	Activity	%	1.0
	18753871	CHEMBL4264846	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	2.0	CHEMBL3650	Homo sapiens	Activity	%	2.0
	18753872	CHEMBL4264846	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	1.0	CHEMBL3650	Homo sapiens	Activity	%	1.0
	18753873	CHEMBL4264846	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	2.0	CHEMBL3650	Homo sapiens	Activity	%	2.0
	18753874	CHEMBL4264847	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	11.0	CHEMBL3650	Homo sapiens	Activity	%	11.0
	18753875	CHEMBL4264847	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	6.0	CHEMBL3650	Homo sapiens	Activity	%	6.0
	18753876	CHEMBL4264847	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	1.0	CHEMBL3650	Homo sapiens	Activity	%	1.0
	18753877	CHEMBL4264847	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	15.0	CHEMBL3650	Homo sapiens	Activity	%	15.0
	18761484	CHEMBL4266562	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	30.0	CHEMBL3650	Homo sapiens	INH	%	30.0
	18761510	CHEMBL4266563	Inhibition of recombinant human N-terminal GST-tagged FGFR1 V561M mutant (456 to 765 residues) at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	29.0	CHEMBL3650	Homo sapiens	INH	%	29.0
	18761780	CHEMBL4266562	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	18761781	CHEMBL4266563	Inhibition of recombinant human N-terminal GST-tagged FGFR1 V561M mutant (456 to 765 residues) at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	2.0	CHEMBL3650	Homo sapiens	INH	%	2.0
	18761943	CHEMBL4266562	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	9.0	CHEMBL3650	Homo sapiens	INH	%	9.0
	18761944	CHEMBL4266563	Inhibition of recombinant human N-terminal GST-tagged FGFR1 V561M mutant (456 to 765 residues) at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	7.0	CHEMBL3650	Homo sapiens	INH	%	7.0
	18763718	CHEMBL4266997	Inhibition of FGFR1 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4cc(F)c(O)c(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4292020	<	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	uM	1.0
	18764590	CHEMBL4267099	Inhibition of human FGFR1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL3650	Homo sapiens	INH	%	70.0
	18764591	CHEMBL4267099	Inhibition of human FGFR1 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL3650	Homo sapiens	INH	%	70.0
	18764592	CHEMBL4267099	Inhibition of human FGFR1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL3650	Homo sapiens	INH	%	70.0
	18765519	CHEMBL4267265	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	4.8	CHEMBL3650	Homo sapiens	INH	%	4.8
	18765520	CHEMBL4267265	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	-1.6	CHEMBL3650	Homo sapiens	INH	%	-1.6
	18765521	CHEMBL4267265	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	13.5	CHEMBL3650	Homo sapiens	INH	%	13.5
	18765522	CHEMBL4267265	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	5.6	CHEMBL3650	Homo sapiens	INH	%	5.6
	18765523	CHEMBL4267265	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	24.0	CHEMBL3650	Homo sapiens	INH	%	24.0
	18765524	CHEMBL4267265	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	5.6	CHEMBL3650	Homo sapiens	INH	%	5.6
	18765838	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(Cl)c3)ncn2)c1		CHEMBL4278031	=	Inhibition	%	-3.8	CHEMBL3650	Homo sapiens	INH	%	-3.8
	18765839	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3ccc(Cl)cc3)ncn2)c1		CHEMBL4288692	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	18765840	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1	Outside typical range	CHEMBL4281484	=	Inhibition	%	-10.4	CHEMBL3650	Homo sapiens	INH	%	-10.4
	18765841	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(Nc3cccc(OC)c3)ncn2)cc1		CHEMBL4292110	=	Inhibition	%	-9.3	CHEMBL3650	Homo sapiens	INH	%	-9.3
	18765842	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3ccc(S(N)(=O)=O)cc3)ncn2)c1		CHEMBL4284911	=	Inhibition	%	-8.8	CHEMBL3650	Homo sapiens	INH	%	-8.8
	18765843	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(Nc3ccc(S(N)(=O)=O)cc3)ncn2)c1		CHEMBL4276965	=	Inhibition	%	-8.2	CHEMBL3650	Homo sapiens	INH	%	-8.2
	18765844	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	-9.3	CHEMBL3650	Homo sapiens	INH	%	-9.3
	18765845	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(Nc3ccc(F)cc3)ncn2)c1		CHEMBL4280395	=	Inhibition	%	-3.1	CHEMBL3650	Homo sapiens	INH	%	-3.1
	18765846	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(Nc3ccc(Cl)cc3)ncn2)c1		CHEMBL4290281	=	Inhibition	%	-8.2	CHEMBL3650	Homo sapiens	INH	%	-8.2
	18765847	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4279620	=	Inhibition	%	-2.7	CHEMBL3650	Homo sapiens	INH	%	-2.7
	18765848	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1		CHEMBL4293690	=	Inhibition	%	4.7	CHEMBL3650	Homo sapiens	INH	%	4.7
	18765849	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NCCc3cccs3)ncn2)c1		CHEMBL4283097	=	Inhibition	%	-8.2	CHEMBL3650	Homo sapiens	INH	%	-8.2
	18765850	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cc(Nc2cc(Nc3ccc(Cl)cc3)ncn2)cc(OC)c1OC		CHEMBL4283517	=	Inhibition	%	1.2	CHEMBL3650	Homo sapiens	INH	%	1.2
	18765851	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCNc1cc(Nc2cc(OC)ccc2OC)ncn1		CHEMBL4291359	=	Inhibition	%	-0.4	CHEMBL3650	Homo sapiens	INH	%	-0.4
	18765852	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCNc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4286871	=	Inhibition	%	-7.7	CHEMBL3650	Homo sapiens	INH	%	-7.7
	18765853	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Clc1cccc(Nc2cc(Nc3cccc(Cl)c3)ncn2)c1		CHEMBL4294771	=	Inhibition	%	-9.8	CHEMBL3650	Homo sapiens	INH	%	-9.8
	18765854	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Clc1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL4295226	=	Inhibition	%	-3.6	CHEMBL3650	Homo sapiens	INH	%	-3.6
	18765855	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Clc1ccc(Nc2cc(Nc3cccc(Cl)c3)ncn2)cc1		CHEMBL4284577	=	Inhibition	%	-3.4	CHEMBL3650	Homo sapiens	INH	%	-3.4
	18765856	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Clc1ccc(Nc2cc(Nc3cccc(Cl)n3)ncn2)cc1		CHEMBL4288262	=	Inhibition	%	-5.7	CHEMBL3650	Homo sapiens	INH	%	-5.7
	18765857	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Clc1ccc(Nc2cc(Nc3ccc(Cl)cc3)ncn2)cc1		CHEMBL4280360	=	Inhibition	%	-1.3	CHEMBL3650	Homo sapiens	INH	%	-1.3
	18765858	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Fc1ccc(Nc2cc(Nc3ccc(Cl)cc3)ncn2)cc1		CHEMBL4284868	=	Inhibition	%	1.8	CHEMBL3650	Homo sapiens	INH	%	1.8
	18765859	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Clc1ccc(Nc2cc(Nc3ccc4[nH]ncc4c3)ncn2)cc1		CHEMBL4276936	=	Inhibition	%	-5.3	CHEMBL3650	Homo sapiens	INH	%	-5.3
	18765860	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Fc1ccc(Nc2cc(Nc3ccc(F)cc3)ncn2)cc1		CHEMBL4295104	=	Inhibition	%	0.5	CHEMBL3650	Homo sapiens	INH	%	0.5
	18765861	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(Nc3ccc(C(=O)OCC)cc3)ncn2)cc1		CHEMBL4287176	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	18765862	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)c3ccccc3)ncn2)c1		CHEMBL4291681	=	Inhibition	%	-6.0	CHEMBL3650	Homo sapiens	INH	%	-6.0
	18765863	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	2.8	CHEMBL3650	Homo sapiens	INH	%	2.8
	18765864	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4293134	=	Inhibition	%	-8.8	CHEMBL3650	Homo sapiens	INH	%	-8.8
	18765865	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(Nc1cc(Nc2ccc(Cl)cc2)ncn1)c1ccccc1		CHEMBL4285317	=	Inhibition	%	-1.3	CHEMBL3650	Homo sapiens	INH	%	-1.3
	18765866	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(Nc1cc(Nc2cccc(Cl)c2)ncn1)c1ccccc1		CHEMBL4291638	=	Inhibition	%	-5.8	CHEMBL3650	Homo sapiens	INH	%	-5.8
	18765867	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)c([N+](=O)[O-])c1		CHEMBL4280996	=	Inhibition	%	5.2	CHEMBL3650	Homo sapiens	INH	%	5.2
	18765868	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(Nc1cc(N2CCOCC2)ncn1)c1ccccc1		CHEMBL1583316	=	Inhibition	%	-1.8	CHEMBL3650	Homo sapiens	INH	%	-1.8
	18765869	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccc(F)cc3)ncn2)cc1		CHEMBL4277577	=	Inhibition	%	0.5	CHEMBL3650	Homo sapiens	INH	%	0.5
	18765870	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)c3ccc(F)cc3)ncn2)c1		CHEMBL4284823	=	Inhibition	%	4.3	CHEMBL3650	Homo sapiens	INH	%	4.3
	18765871	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOc1cccc(Nc2cc(NC(=O)c3ccc(F)cc3)ncn2)c1		CHEMBL4292692	=	Inhibition	%	2.2	CHEMBL3650	Homo sapiens	INH	%	2.2
	18765872	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(Nc1cc(Nc2ccc(Cl)cc2)ncn1)c1ccc(F)cc1		CHEMBL4281413	=	Inhibition	%	16.3	CHEMBL3650	Homo sapiens	INH	%	16.3
	18765873	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(Nc1cc(Nc2cccc(Cl)c2)ncn1)c1ccc(F)cc1		CHEMBL4289280	=	Inhibition	%	4.2	CHEMBL3650	Homo sapiens	INH	%	4.2
	18765874	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(Nc1cc(Nc2ccc(N3CCOCC3)cc2)ncn1)c1ccc(F)cc1		CHEMBL4286720	=	Inhibition	%	3.5	CHEMBL3650	Homo sapiens	INH	%	3.5
	18765875	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(Nc1cc(N2CCOCC2)ncn1)c1ccc(F)cc1		CHEMBL1379917	=	Inhibition	%	8.8	CHEMBL3650	Homo sapiens	INH	%	8.8
	18765876	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOc1ccc(Nc2cc(NC(=O)c3ccc(F)cc3)ncn2)cc1		CHEMBL4289611	=	Inhibition	%	5.9	CHEMBL3650	Homo sapiens	INH	%	5.9
	18765877	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	Cc1ccc(Nc2cc(NC(=O)c3ccc(F)cc3)ncn2)cc1		CHEMBL4281730	=	Inhibition	%	-4.8	CHEMBL3650	Homo sapiens	INH	%	-4.8
	18765878	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)/C=C/c3ccccc3)ncn2)cc1		CHEMBL4292992	=	Inhibition	%	8.7	CHEMBL3650	Homo sapiens	INH	%	8.7
	18765879	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOc1ccc(Nc2cc(NC(=O)/C=C/c3ccccc3)ncn2)cc1		CHEMBL4285158	=	Inhibition	%	1.5	CHEMBL3650	Homo sapiens	INH	%	1.5
	18765880	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)/C=C/c3ccccc3)ncn2)c1		CHEMBL4282787	=	Inhibition	%	-0.4	CHEMBL3650	Homo sapiens	INH	%	-0.4
	18765881	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)/C=C/c3ccccc3)ncn2)c([N+](=O)[O-])c1		CHEMBL4293400	=	Inhibition	%	-4.9	CHEMBL3650	Homo sapiens	INH	%	-4.9
	18765882	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(/C=C/c1ccccc1)Nc1cc(Nc2ccc(O)cc2)ncn1		CHEMBL4286178	=	Inhibition	%	-3.7	CHEMBL3650	Homo sapiens	INH	%	-3.7
	18765883	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(/C=C/c1ccccc1)Nc1cc(Nc2ccc(N3CCOCC3)cc2)ncn1		CHEMBL4278262	=	Inhibition	%	-0.3	CHEMBL3650	Homo sapiens	INH	%	-0.3
	18765884	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(/C=C/c1ccc(F)cc1)Nc1cc(Nc2ccc(Cl)cc2)ncn1		CHEMBL4284727	=	Inhibition	%	3.1	CHEMBL3650	Homo sapiens	INH	%	3.1
	18765885	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(/C=C/c1ccc(F)cc1)Nc1cc(Nc2ccc(N3CCOCC3)cc2)ncn1		CHEMBL4276786	=	Inhibition	%	-3.9	CHEMBL3650	Homo sapiens	INH	%	-3.9
	18765886	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(/C=C/c1ccc(F)cc1)Nc1cc(Nc2ccc(Cl)cc2Cl)ncn1		CHEMBL4293689	=	Inhibition	%	-2.9	CHEMBL3650	Homo sapiens	INH	%	-2.9
	18765887	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(/C=C/c1ccc(F)cc1Br)Nc1cc(Nc2ccc(Cl)cc2Cl)ncn1		CHEMBL4285811	=	Inhibition	%	-4.6	CHEMBL3650	Homo sapiens	INH	%	-4.6
	18765888	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)/C=C/c3ccc(F)cc3Br)ncn2)c([N+](=O)[O-])c1		CHEMBL4290280	=	Inhibition	%	-2.3	CHEMBL3650	Homo sapiens	INH	%	-2.3
	18765889	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(/C=C/c1ccc(F)cc1Br)Nc1cc(Nc2ccc(N3CCOCC3)cc2)ncn1		CHEMBL4282405	=	Inhibition	%	-2.8	CHEMBL3650	Homo sapiens	INH	%	-2.8
	18765890	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CN1CCN(c2ccc(Nc3cc(NC(=O)/C=C/c4ccc(F)cc4)ncn3)cc2)CC1		CHEMBL4286870	=	Inhibition	%	-5.4	CHEMBL3650	Homo sapiens	INH	%	-5.4
	18765891	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(Nc3cccc(Br)c3)ncn2)cc1		CHEMBL4278953	=	Inhibition	%	-5.4	CHEMBL3650	Homo sapiens	INH	%	-5.4
	18765892	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(Nc3ccc(Cl)cc3Cl)ncn2)cc1		CHEMBL4283515	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	18765893	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(Nc3ccc(Cl)cc3)ncn2)cc1		CHEMBL4294094	=	Inhibition	%	-8.8	CHEMBL3650	Homo sapiens	INH	%	-8.8
	18765894	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOc1ccc(Nc2cc(NC(=O)/C=C/c3ccc(OC)cc3)ncn2)cc1		CHEMBL4288809	=	Inhibition	%	0.7	CHEMBL3650	Homo sapiens	INH	%	0.7
	18765895	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CN1CCN(c2cc(NC(=O)/C=C/c3ccc(F)cc3)ncn2)CC1		CHEMBL4280910	=	Inhibition	%	-6.1	CHEMBL3650	Homo sapiens	INH	%	-6.1
	18765896	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(/C=C/c1ccc(F)cc1Br)Nc1cc(N2CCOCC2)ncn1		CHEMBL4294871	=	Inhibition	%	-7.1	CHEMBL3650	Homo sapiens	INH	%	-7.1
	18765897	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(N3CCOCC3)ncn2)cc1		CHEMBL4284243	=	Inhibition	%	-4.8	CHEMBL3650	Homo sapiens	INH	%	-4.8
	18765898	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(N3CCN(C)CC3)ncn2)cc1		CHEMBL4279722	=	Inhibition	%	-6.1	CHEMBL3650	Homo sapiens	INH	%	-6.1
	18765899	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCC(=O)Nc1cc(Nc2ccc(Cl)cc2)ncn1		CHEMBL4287629	=	Inhibition	%	5.2	CHEMBL3650	Homo sapiens	INH	%	5.2
	18765900	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4283201	=	Inhibition	%	-3.6	CHEMBL3650	Homo sapiens	INH	%	-3.6
	18765901	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCC(=O)Nc1cc(Nc2cccc(Br)c2)ncn1		CHEMBL4291054	=	Inhibition	%	-5.3	CHEMBL3650	Homo sapiens	INH	%	-5.3
	18765902	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCC(=O)O)ncn2)c1		CHEMBL4286565	=	Inhibition	%	0.5	CHEMBL3650	Homo sapiens	INH	%	0.5
	18765903	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCC(=O)O)ncn2)cc1		CHEMBL4294457	=	Inhibition	%	-5.4	CHEMBL3650	Homo sapiens	INH	%	-5.4
	18765904	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCC(=O)Nc1cc(Nc2cccc(C(=O)O)c2)ncn1	Outside typical range	CHEMBL4281263	=	Inhibition	%	-12.5	CHEMBL3650	Homo sapiens	INH	%	-12.5
	18765905	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CN1CCN(c2ccc(Nc3cc(NC(=O)CCC(=O)O)ncn3)cc2)CC1	Outside typical range	CHEMBL4289137	=	Inhibition	%	-10.8	CHEMBL3650	Homo sapiens	INH	%	-10.8
	18765906	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2ccccc2)ncn1		CHEMBL4278997	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	18765907	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2ccc(Cl)cc2)ncn1		CHEMBL4289682	=	Inhibition	%	-7.2	CHEMBL3650	Homo sapiens	INH	%	-7.2
	18765908	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	-8.8	CHEMBL3650	Homo sapiens	INH	%	-8.8
	18765909	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2ccccc2Br)ncn1		CHEMBL4293070	=	Inhibition	%	-9.3	CHEMBL3650	Homo sapiens	INH	%	-9.3
	18765910	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	-5.3	CHEMBL3650	Homo sapiens	INH	%	-5.3
	18765911	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4282879	=	Inhibition	%	-3.7	CHEMBL3650	Homo sapiens	INH	%	-3.7
	18765912	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	-5.5	CHEMBL3650	Homo sapiens	INH	%	-5.5
	18765913	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Br)c2)ncn1		CHEMBL4286263	=	Inhibition	%	-1.1	CHEMBL3650	Homo sapiens	INH	%	-1.1
	18765914	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1	Outside typical range	CHEMBL4283970	=	Inhibition	%	-19.5	CHEMBL3650	Homo sapiens	INH	%	-19.5
	18765915	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CN1CCN(c2cc(NC(=O)CCCC(=O)O)ncn2)CC1		CHEMBL4294565	=	Inhibition	%	-2.3	CHEMBL3650	Homo sapiens	INH	%	-2.3
	18765916	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(Nc2cccc(Br)c2)ncn1		CHEMBL4288761	=	Inhibition	%	-7.1	CHEMBL3650	Homo sapiens	INH	%	-7.1
	18765917	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(Nc2ccc(Cl)cc2)ncn1		CHEMBL4278103	=	Inhibition	%	-3.6	CHEMBL3650	Homo sapiens	INH	%	-3.6
	18765918	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(Nc2cccc(OC)c2)ncn1		CHEMBL4285407	=	Inhibition	%	-7.1	CHEMBL3650	Homo sapiens	INH	%	-7.1
	18765919	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(Nc2cc(OC)ccc2OC)ncn1		CHEMBL4293232	=	Inhibition	%	-8.8	CHEMBL3650	Homo sapiens	INH	%	-8.8
	18765920	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(Nc2ccc(C(=O)OCC)cc2)ncn1		CHEMBL4281981	=	Inhibition	%	-4.6	CHEMBL3650	Homo sapiens	INH	%	-4.6
	18765921	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(Nc2cccc(C(=O)OCC)c2)ncn1		CHEMBL4289855	=	Inhibition	%	2.6	CHEMBL3650	Homo sapiens	INH	%	2.6
	18765922	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(Nc2ccc(S(N)(=O)=O)cc2)ncn1		CHEMBL4278518	=	Inhibition	%	-3.6	CHEMBL3650	Homo sapiens	INH	%	-3.6
	18765923	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(Nc2ccc(N3CCN(C)CC3)cc2)ncn1		CHEMBL4286433	=	Inhibition	%	-6.6	CHEMBL3650	Homo sapiens	INH	%	-6.6
	18765924	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCC(=O)Nc1cc(NCCc2cccs2)ncn1	Outside typical range	CHEMBL4293654	=	Inhibition	%	-10.7	CHEMBL3650	Homo sapiens	INH	%	-10.7
	18765925	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4283061	=	Inhibition	%	0.5	CHEMBL3650	Homo sapiens	INH	%	0.5
	18765926	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CCCC(=O)Nc1cc(Nc2cc(OC)ccc2OC)ncn1		CHEMBL4278458	=	Inhibition	%	-9.3	CHEMBL3650	Homo sapiens	INH	%	-9.3
	18765927	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCCC(C)OC(=O)CCC(=O)Nc1cc(Nc2cccc(Br)c2)ncn1		CHEMBL4284551	=	Inhibition	%	-4.9	CHEMBL3650	Homo sapiens	INH	%	-4.9
	18765928	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCCC(C)OC(=O)CCC(=O)Nc1cc(Nc2cccc(C(=O)OC(C)CCC)c2)ncn1		CHEMBL4289032	=	Inhibition	%	-5.0	CHEMBL3650	Homo sapiens	INH	%	-5.0
	18765929	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CC(C)OC(=O)CCC(=O)Nc1cc(Nc2ccc(C(=O)OC(C)C)cc2)ncn1		CHEMBL4281136	=	Inhibition	%	-2.3	CHEMBL3650	Homo sapiens	INH	%	-2.3
	18765930	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CC(C)OC(=O)CCC(=O)Nc1cc(Nc2ccc(F)cc2)ncn1		CHEMBL4280689	=	Inhibition	%	-6.5	CHEMBL3650	Homo sapiens	INH	%	-6.5
	18765931	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1c(Nc2cc(NC(=O)CCC(=O)OC(C)C)ncn2)sc2c1CCCC2		CHEMBL4290567	=	Inhibition	%	-4.1	CHEMBL3650	Homo sapiens	INH	%	-4.1
	18765932	CHEMBL4267374	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus expression system at 5 uL using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)CC(=O)Nc1cc(Nc2ccc(F)cc2)ncn1		CHEMBL4277295	=	Inhibition	%	-1.1	CHEMBL3650	Homo sapiens	INH	%	-1.1
	18785053	CHEMBL4271415	Inhibition of Tel-fused FGFR1 (unknown origin) expressed in mouse Ba/F3 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	EC50	nM	14.0	CHEMBL3650	Homo sapiens	EC50	nM	14.0
	18786308	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)c3)ccc12		CHEMBL4276742	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
	18786309	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4OC)c3)ccc12		CHEMBL4278015	=	IC50	nM	285.0	CHEMBL3650	Homo sapiens	IC50	nM	285.0
	18786310	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4C)c3)ccc12		CHEMBL4289353	=	IC50	nM	12.9	CHEMBL3650	Homo sapiens	IC50	nM	12.9
	18786311	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4F)c3)ccc12		CHEMBL4281469	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18786312	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4cnn(CCO)c4)c3)ccc12		CHEMBL4284064	=	IC50	nM	23.5	CHEMBL3650	Homo sapiens	IC50	nM	23.5
	18786313	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4csc(N5CCN(C)CC5)n4)c3)ccc12		CHEMBL4294660	=	IC50	nM	7.6	CHEMBL3650	Homo sapiens	IC50	nM	7.6
	18786314	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4coc(N5CCN(C)CC5)n4)c3)ccc12		CHEMBL4277282	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
	18786315	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4cnc(N5C[C@H](C)N[C@H](C)C5)nc4)c3)ccc12		CHEMBL4290644	=	IC50	nM	10.2	CHEMBL3650	Homo sapiens	IC50	nM	10.2
	18786316	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.9	CHEMBL3650	Homo sapiens	IC50	nM	0.9
	18786317	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	COC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)c3)ccc12		CHEMBL4281259	=	IC50	nM	4.6	CHEMBL3650	Homo sapiens	IC50	nM	4.6
	18786318	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)c3)c(OC)cc12		CHEMBL4279621	=	IC50	nM	8.2	CHEMBL3650	Homo sapiens	IC50	nM	8.2
	18786319	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CCNC(=O)N1CCCc2cc(Oc3ccnc(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)c3)ccc21		CHEMBL4288005	=	IC50	nM	132.0	CHEMBL3650	Homo sapiens	IC50	nM	132.0
	18786320	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CCNC(=O)Nc1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)c3)ccc12		CHEMBL4292423	=	IC50	nM	67.5	CHEMBL3650	Homo sapiens	IC50	nM	67.5
	18786321	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CCNC(=O)Nc1ccc(Oc2ccnc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)c2)c(OC)c1		CHEMBL4288708	=	IC50	nM	36.1	CHEMBL3650	Homo sapiens	IC50	nM	36.1
	18786322	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	COc1cc(CCOc2ccnc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)c2)cc(OC)c1		CHEMBL4290925	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18786323	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	COc1cc(OC)c(Cl)c(CCOc2ccnc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)c2)c1Cl		CHEMBL4280290	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18786324	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	COc1cc(OC)c(F)c(COc2ccc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)nc2)c1F		CHEMBL4293772	=	IC50	nM	22.2	CHEMBL3650	Homo sapiens	IC50	nM	22.2
	18786325	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CC(Oc1ccc(NC(=O)c2ccc(N3C[C@H](C)N[C@H](C)C3)cc2)nc1)c1c(Cl)cncc1Cl		CHEMBL4285889	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18786326	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3)ccc12		CHEMBL4290371	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	18786327	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCOCC5)cc4)c3)ccc12		CHEMBL4282503	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	18786328	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CC(C)OC(C)C5)cc4)c3)ccc12		CHEMBL4282107	=	IC50	nM	1.9	CHEMBL3650	Homo sapiens	IC50	nM	1.9
	18786329	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCNC(C)C5)cc4)c3)ccc12		CHEMBL4292708	=	IC50	nM	2.0	CHEMBL3650	Homo sapiens	IC50	nM	2.0
	18786330	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(CCO)CC5)cc4)c3)ccc12		CHEMBL4278642	=	IC50	nM	1.9	CHEMBL3650	Homo sapiens	IC50	nM	1.9
	18786331	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCNCC5)cc4)c3)ccc12		CHEMBL4289296	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
	18786332	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)ccc12		CHEMBL4288908	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	18786333	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(NCC5(O)CCOCC5)cc4)c3)ccc12		CHEMBL4284153	=	IC50	nM	6.2	CHEMBL3650	Homo sapiens	IC50	nM	6.2
	18786334	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	C=CC(=O)Nc1ccc(C(=O)Nc2cc(Oc3ccc4c(C(=O)NC)cccc4c3)ccn2)cc1		CHEMBL4278402	=	IC50	nM	12.8	CHEMBL3650	Homo sapiens	IC50	nM	12.8
	18786335	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(OCCN5CCCC5)cc4)c3)ccc12		CHEMBL4278930	=	IC50	nM	4.1	CHEMBL3650	Homo sapiens	IC50	nM	4.1
	18786336	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(OCCN5CC(F)(F)C5)cc4)c3)ccc12		CHEMBL4293539	=	IC50	nM	6.1	CHEMBL3650	Homo sapiens	IC50	nM	6.1
	18786337	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(OCCN5CC(F)C5)cc4)c3)ccc12		CHEMBL4282937	=	IC50	nM	3.6	CHEMBL3650	Homo sapiens	IC50	nM	3.6
	18786338	CHEMBL4271704	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(OCC5(N)CC5)cc4)c3)ccc12		CHEMBL4290147	=	IC50	nM	7.4	CHEMBL3650	Homo sapiens	IC50	nM	7.4
	18786398	CHEMBL4271729	Inhibition of FGFR1 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	17.5	CHEMBL3650	Homo sapiens	IC50	nM	17.5
	18786401	CHEMBL4271732	Inhibition of human N-terminal GST-tagged FGFR1 (398 to 822 residues) cytoplasmic domain expressed in baculovirus expression system after 60 mins by off-chip mobility shift assay	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCO)cc21		CHEMBL4294625	=	IC50	nM	0.5	CHEMBL3650	Homo sapiens	IC50	nM	0.5
	18811975	CHEMBL4276184	Inhibition of human FGFR1 at 100 uM	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	Inhibition	%	13.5	CHEMBL3650	Homo sapiens	INH	%	13.5
	18811976	CHEMBL4276184	Inhibition of human FGFR1 at 100 uM	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682	=	Inhibition	%	5.4	CHEMBL3650	Homo sapiens	INH	%	5.4
	18812031	CHEMBL4276197	Inhibition of human FGFR1	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	0.7	CHEMBL3650	Homo sapiens	IC50	nM	0.7
	18851344	CHEMBL4305836	Inhibition of FGFR1 (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	nM	30000.0
	18854796	CHEMBL4307248	Inhibition of FGFR1 (unknown origin) relative to control	B	COc1cc(/C=C/C(=O)O)ccc1O		CHEMBL32749	=	Inhibition	%	92.0	CHEMBL3650	Homo sapiens	INH	%	92.0
	18857966	CHEMBL4307812	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	84.0	CHEMBL3650	Homo sapiens	Activity	%	84.0
	18864265	CHEMBL4309588	Inhibition of human FGFR1 at 10 uM using KKKSPGEYVNIEFG as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1		CHEMBL4436746	=	Inhibition	%	-1.71	CHEMBL3650	Homo sapiens	INH	%	-1.71
	18885060	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccccc2)oc2ccccc12		CHEMBL4470504	=	IC50	nM	114.5	CHEMBL3650	Homo sapiens	IC50	nM	114.5
	18885061	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1ccc2oc(-c3c4c(N)n[nH]c(=O)c4nn3-c3ccccc3)c(C)c2c1		CHEMBL4586512	=	IC50	nM	10.8	CHEMBL3650	Homo sapiens	IC50	nM	10.8
	18885062	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	18885063	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	=	IC50	nM	16.3	CHEMBL3650	Homo sapiens	IC50	nM	16.3
	18885064	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.6	CHEMBL3650	Homo sapiens	IC50	nM	0.6
	18885065	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(Cl)cc3c2C)cc1		CHEMBL4467025	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	18885066	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1ccc2oc(-c3c4c(N)n[nH]c(=O)c4nn3-c3ccc(NC(=O)/C=C/CN(C)C)cc3)c(C)c2c1		CHEMBL4463714	=	IC50	nM	2.4	CHEMBL3650	Homo sapiens	IC50	nM	2.4
	18885067	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1ccc2oc(-c3c4c(N)n[nH]c(=O)c4nn3-c3ccc(NC(=O)/C=C/CN4CCOCC4)cc3)c(C)c2c1		CHEMBL4447110	=	IC50	nM	30.9	CHEMBL3650	Homo sapiens	IC50	nM	30.9
	18885068	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12		CHEMBL4462946	=	IC50	nM	20.4	CHEMBL3650	Homo sapiens	IC50	nM	20.4
	18885069	CHEMBL4313066	Inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Br)cc12		CHEMBL4448252	=	IC50	nM	0.4	CHEMBL3650	Homo sapiens	IC50	nM	0.4
Active	18885133	CHEMBL4313092	Inhibition of FGFR1 in FGFR1-translocated human KG1 cells assessed as reduction in ERK phosphorylation at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18885134	CHEMBL4313093	Inhibition of FGFR1 phosphorylation in FGFR1-translocated human KG1 cells at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18885169	CHEMBL4313100	Irreversible inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by caliper assay	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	18885170	CHEMBL4313100	Irreversible inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by caliper assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	18885171	CHEMBL4313100	Irreversible inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by caliper assay	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12		CHEMBL4462946		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	18885172	CHEMBL4313101	Irreversible inhibition of human FGFR1 assessed as inactivation rate constant using poly (Glu, Tyr)4:1 as substrate measured after 60 mins	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	=	Kinact	10'-4/s	7.2	CHEMBL3650	Homo sapiens	Kinact	10'-4/s	7.2
	18885173	CHEMBL4313101	Irreversible inhibition of human FGFR1 assessed as inactivation rate constant using poly (Glu, Tyr)4:1 as substrate measured after 60 mins	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12		CHEMBL4462946	=	Kinact	10'-4/s	7.1	CHEMBL3650	Homo sapiens	Kinact	10'-4/s	7.1
	18885174	CHEMBL4313102	Irreversible inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	=	Ki	nM	1.9	CHEMBL3650	Homo sapiens	Ki	nM	1.9
	18885175	CHEMBL4313102	Irreversible inhibition of human FGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12		CHEMBL4462946	=	Ki	nM	10.0	CHEMBL3650	Homo sapiens	Ki	nM	10.0
	18885176	CHEMBL4313103	Irreversible inhibition of human FGFR1 assessed as ratio of Kinact to Ki using poly (Glu, Tyr)4:1 as substrate measured after 60 mins	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	=	Ratio	/uM/s	0.38	CHEMBL3650	Homo sapiens	Ratio	/uM/s	0.38
	18885177	CHEMBL4313103	Irreversible inhibition of human FGFR1 assessed as ratio of Kinact to Ki using poly (Glu, Tyr)4:1 as substrate measured after 60 mins	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12		CHEMBL4462946	=	Ratio	/uM/s	0.07	CHEMBL3650	Homo sapiens	Ratio	/uM/s	0.07
	18886127	CHEMBL4313420	Inhibition of human FGFR1 at 10 uM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	24.42	CHEMBL3650	Homo sapiens	INH	%	24.42
	18886212	CHEMBL4313420	Inhibition of human FGFR1 at 10 uM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4559825	=	Inhibition	%	4.66	CHEMBL3650	Homo sapiens	INH	%	4.66
	18890196	CHEMBL4314029	Inhibition of recombinant His-tagged human FGFR1 (308 to 731 resides) expressed in baculovirus expression system at 0.5 uM using tyr 04 as substrate in presence of ATP at Km concentration after 1 hr by Z'-LYTE assay relative to control	B	COc1cc(C(=O)NC2CCNCC2)ccc1Nc1nc(Nc2ccccc2P(C)(C)=O)c2cc[nH]c2n1		CHEMBL4448754	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	18892615	CHEMBL4314686	Inhibition of recombinant human FGFR1 (456 to 765 residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	108.0	CHEMBL3650	Homo sapiens	Activity	%	108.0
	18892616	CHEMBL4314685	Inhibition of recombinant human FGFR1 V561M mutant (456 to 765 residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	95.5	CHEMBL3650	Homo sapiens	Activity	%	95.5
	18902221	CHEMBL4316543	Agonist activity at FGFR1 (unknown origin) in expressed in U2OS cells incubated for 3 hrs and measured after 60 hrs in presence of (bFGF(FGF-2))by fluorescence complementation assay	B	COc1cc(-n2c(=O)[nH]c(=O)n(-c3ccccc3)c2=O)ccc1Oc1ccccc1		CHEMBL4464173	=	EC50	nM	340.0	CHEMBL3650	Homo sapiens	EC50	uM	0.34
	18902222	CHEMBL4316543	Agonist activity at FGFR1 (unknown origin) in expressed in U2OS cells incubated for 3 hrs and measured after 60 hrs in presence of (bFGF(FGF-2))by fluorescence complementation assay	B	COc1cc(Oc2ccccc2)ccc1-n1c(=O)[nH]c(=O)n(-c2ccccc2)c1=O		CHEMBL4483402	=	EC50	nM	170.0	CHEMBL3650	Homo sapiens	EC50	uM	0.17
	18902223	CHEMBL4316543	Agonist activity at FGFR1 (unknown origin) in expressed in U2OS cells incubated for 3 hrs and measured after 60 hrs in presence of (bFGF(FGF-2))by fluorescence complementation assay	B	Cc1cc(-n2c(=O)[nH]c(=O)n(-c3ccccc3)c2=O)ccc1Oc1ccccc1		CHEMBL4464037	=	EC50	nM	290.0	CHEMBL3650	Homo sapiens	EC50	uM	0.29
	18902224	CHEMBL4316543	Agonist activity at FGFR1 (unknown origin) in expressed in U2OS cells incubated for 3 hrs and measured after 60 hrs in presence of (bFGF(FGF-2))by fluorescence complementation assay	B	COc1cccc(-n2c(=O)[nH]c(=O)n(-c3ccc(Oc4ccccc4)cc3)c2=O)c1		CHEMBL4518577	=	EC50	nM	580.0	CHEMBL3650	Homo sapiens	EC50	uM	0.58
	18902225	CHEMBL4316543	Agonist activity at FGFR1 (unknown origin) in expressed in U2OS cells incubated for 3 hrs and measured after 60 hrs in presence of (bFGF(FGF-2))by fluorescence complementation assay	B	O=c1[nH]c(=O)n(-c2ccc(Oc3ccccc3)cc2)c(=O)n1-c1ccccc1		CHEMBL4542212	=	EC50	nM	890.0	CHEMBL3650	Homo sapiens	EC50	uM	0.89
	18919400	CHEMBL4322760	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged FGFR1 (unknown origin) (396 to 820 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	268.0	CHEMBL3650	Homo sapiens	Kd	nM	268.0
	18919588	CHEMBL4322760	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged FGFR1 (unknown origin) (396 to 820 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	643.0	CHEMBL3650	Homo sapiens	Kd	nM	643.0
	18930921	CHEMBL4325583	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA	B	COc1cc(NC(=O)c2ccc(C)c(C#Cc3cncc4ccccc34)c2)cc(OC)c1		CHEMBL4475726	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18930922	CHEMBL4325583	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	18930923	CHEMBL4325583	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2ccccc12		CHEMBL4105491	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	18930946	CHEMBL4325604	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	18930970	CHEMBL4325628	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	18934096	CHEMBL4326628	Inhibition of human FGFR1 at 10 uM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	26.0	CHEMBL3650	Homo sapiens	INH	%	26.0
	18937929	CHEMBL4327696	Inhibition of human FGFR1 assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.23	CHEMBL3650	Homo sapiens	Activity	%	97.23
	18937930	CHEMBL4327696	Inhibition of human FGFR1 assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.33	CHEMBL3650	Homo sapiens	Activity	%	100.33
	18938535	CHEMBL4328055	Inhibition of human FGFR1 assessed as residual activity at 100 uM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3650	Homo sapiens	Activity	%	65.0
	18938913	CHEMBL4328419	Inhibition of human FGFR1 using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.89	CHEMBL3650	Homo sapiens	IC50	10'-9M	3.89
	18948230	CHEMBL4330497	Inhibition of recombinant FGFR1 (unknown origin) expressed in baculovirus infected insect cells using GGGGQDGKDYIVLPI as substrate after 1 to 4 hrs by time-resolved fluorescence assay	B	CN1CCN(c2ccc3c(c2)N/C(=C2/C(=O)N=c4cccc(F)c4=C2N)N3)CC1		CHEMBL4578973	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
	18948738	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)Nc3ccccc3)cc1)C(=O)N2		CHEMBL4590038	=	IC50	nM	280.0	CHEMBL3650	Homo sapiens	IC50	uM	0.28
	18948739	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)Nc3ccc(Cl)cc3)cc1)C(=O)N2		CHEMBL4540917	=	IC50	nM	390.0	CHEMBL3650	Homo sapiens	IC50	uM	0.39
	18948740	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1ccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Br)cc43)cc2)cc1		CHEMBL4583526	=	IC50	nM	610.0	CHEMBL3650	Homo sapiens	IC50	uM	0.61
	18948741	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1ccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(OC)cc43)cc2)cc1		CHEMBL4553770	=	IC50	nM	170.0	CHEMBL3650	Homo sapiens	IC50	uM	0.17
	18948742	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1cccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Cl)cc43)cc2)c1		CHEMBL4580040	=	IC50	nM	420.0	CHEMBL3650	Homo sapiens	IC50	uM	0.42
	18948743	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1cccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Br)cc43)cc2)c1		CHEMBL4471270	=	IC50	nM	480.0	CHEMBL3650	Homo sapiens	IC50	uM	0.48
	18948744	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1cccc(NC(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(OC)cc43)cc2)c1		CHEMBL4457815	=	IC50	nM	300.0	CHEMBL3650	Homo sapiens	IC50	uM	0.3
	18948745	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	O=C(Nc1ccc(C(=O)N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4461094	=	IC50	nM	310.0	CHEMBL3650	Homo sapiens	IC50	uM	0.31
	18948746	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc1)C(=O)N2		CHEMBL4454772	=	IC50	nM	230.0	CHEMBL3650	Homo sapiens	IC50	uM	0.23
	18948747	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1ccc2c(c1)/C(=N/NC(=O)c1ccc(NC(=O)c3ccc(Cl)cc3)cc1)C(=O)N2		CHEMBL4469902	=	IC50	nM	390.0	CHEMBL3650	Homo sapiens	IC50	uM	0.39
	18948748	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1ccc(C(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(Br)cc43)cc2)cc1		CHEMBL4463359	=	IC50	nM	380.0	CHEMBL3650	Homo sapiens	IC50	uM	0.38
	18948749	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	COc1ccc(C(=O)Nc2ccc(C(=O)N/N=C3\C(=O)Nc4ccc(OC)cc43)cc2)cc1		CHEMBL4469330	=	IC50	nM	460.0	CHEMBL3650	Homo sapiens	IC50	uM	0.46
	18948750	CHEMBL4330588	Inhibition of FGFR-1 (unknown origin) by ELISA	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	670.0	CHEMBL3650	Homo sapiens	IC50	uM	0.67
	18948920	CHEMBL4330596	Inhibition of FGFR-1 (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	0.7	CHEMBL3650	Homo sapiens	IC50	nM	0.7
	18950229	CHEMBL4331081	Inhibition of human FGFR1 assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	6.14	CHEMBL3650	Homo sapiens	Activity	%	6.14
	18950273	CHEMBL4331120	Inhibition of human FGFR1 using KKKSPGEYVNIEFG as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	961.7	CHEMBL3650	Homo sapiens	IC50	nM	961.7
	18950343	CHEMBL4331120	Inhibition of human FGFR1 using KKKSPGEYVNIEFG as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
	18953696	CHEMBL4331921	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	69.0	CHEMBL3650	Homo sapiens	INH	%	69.0
	18953762	CHEMBL4331921	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	66.0	CHEMBL3650	Homo sapiens	INH	%	66.0
	18953835	CHEMBL4331921	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	84.0	CHEMBL3650	Homo sapiens	INH	%	84.0
	18953927	CHEMBL4331980	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	56.0	CHEMBL3650	Homo sapiens	INH	%	56.0
	18953991	CHEMBL4331980	Inhibition of FGFR1 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	4.0	CHEMBL3650	Homo sapiens	INH	%	4.0
	18954058	CHEMBL4331921	Inhibition of FGFR1 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	74.0	CHEMBL3650	Homo sapiens	INH	%	74.0
	18958883	CHEMBL4333402	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	70.0	CHEMBL3650	Homo sapiens	Activity	%	70.0
	18964289	CHEMBL4335082	Inhibition of recombinant human FGFR1 (456 to 765 residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEF as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	99.0	CHEMBL3650	Homo sapiens	Activity	%	99.0
	18964290	CHEMBL4335082	Inhibition of recombinant human FGFR1 (456 to 765 residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEF as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	113.0	CHEMBL3650	Homo sapiens	Activity	%	113.0
	18964291	CHEMBL4335083	Inhibition of recombinant human FGFR1 V561M mutant (456 to 765 residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	91.0	CHEMBL3650	Homo sapiens	Activity	%	91.0
	18964292	CHEMBL4335083	Inhibition of recombinant human FGFR1 V561M mutant (456 to 765 residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	102.0	CHEMBL3650	Homo sapiens	Activity	%	102.0
	18971899	CHEMBL4336909	Inhibition of recombinant human FGFR1 (456 to 765 residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEF as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	34.0	CHEMBL3650	Homo sapiens	Activity	%	34.0
	18971900	CHEMBL4336910	Inhibition of recombinant human FGFR1 V561M mutant (456 to 765 residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEF as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	22.0	CHEMBL3650	Homo sapiens	Activity	%	22.0
	18985532	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CC[C@H](OC)C4=O)c(C=O)nc32)ncc1C#N		CHEMBL4446965	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985533	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CC[C@@H](OC)C4=O)c(C=O)nc32)ncc1C#N		CHEMBL4518346	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985534	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985535	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COC[C@@H](C)Oc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4446464	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985536	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COC[C@@H](C)Oc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4533697	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985537	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COCCOc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4556198	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985538	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COCCSc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4587476	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985539	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3968334	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985540	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3908979	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985615	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CO[C@H]1CCN(c2cc(NC(=O)N3CCCc4cc(CN5C(=O)OC[C@@H]5C)c(C=O)nc43)ncc2C#N)C1		CHEMBL4469046	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985616	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CO[C@@H]1CCN(c2cc(NC(=O)N3CCCc4cc(CN5C(=O)OC[C@@H]5C)c(C=O)nc43)ncc2C#N)C1		CHEMBL4564505	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985617	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CO[C@@H]1CCN(c2cc(NC(=O)N3CCCc4cc(CN5CCOC5=O)c(C=O)nc43)ncc2C#N)C1		CHEMBL4470137	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985618	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CO[C@H]1CCN(c2cc(NC(=O)N3CCCc4cc(CN5CCOC5=O)c(C=O)nc43)ncc2C#N)C1		CHEMBL4471404	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985619	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CN(C)C1CCN(c2cc(NC(=O)N3CCCc4cc(CN5CCOCC5=O)c(C=O)nc43)ncc2C#N)C1		CHEMBL4447090	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985620	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COC[C@@H]1CCCN1c1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4441426	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985621	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CO[C@H]1CCN(c2cc(NC(=O)N3CCCc4cc(CN5CCOCC5=O)c(C=O)nc43)ncc2C#N)C1		CHEMBL4571626	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985622	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CO[C@@H]1CCN(Cc2cc3c(nc2C=O)N(C(=O)Nc2cc(N[C@@H]4CCOC4)c(C#N)cn2)CCC3)C1=O		CHEMBL4457168	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985623	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	N#Cc1cnc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)cc1N[C@@H]1CCOC1		CHEMBL4562284	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985624	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	N#Cc1cnc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)cc1N[C@H]1CCOC1		CHEMBL4532389	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985625	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CO[C@H]1CCOC[C@@H]1Oc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4553307	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985626	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	CO[C@@H]1CCC[C@H]1Nc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4439119	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985627	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	N#Cc1cnc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)cc1S[C@@H]1CCOC1		CHEMBL4471457	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985628	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	N#Cc1cnc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)cc1S[C@H]1CCOC1		CHEMBL4472588	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985629	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COc1ccncc1Nc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4533002	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985630	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COc1ccccc1Oc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4476676	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985631	CHEMBL4339976	Inhibition of FGFR1 (unknown origin) incubated for 60 mins by caliper microfluidic mobility shift technology based assay	B	COC[C@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CC[C@H](OC)C4=O)c(C=O)nc32)ncc1C#N		CHEMBL4544586	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18985719	CHEMBL4340018	Inhibition of FGFR1 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	18989195	CHEMBL4340729	Inhibition of recombinant human wild-type N-terminal GST-His6-fused FGFR1 C-terminal domain (G400 to R820 residues) expressed in Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	13000.0	CHEMBL3650	Homo sapiens	IC50	uM	13.0
	18989953	CHEMBL4340970	Inhibition of FGF-R1 (unknown origin) at 1 uM relative to control	B	COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21		CHEMBL4556293	<	Inhibition	%	25.0	CHEMBL3650	Homo sapiens	INH	%	25.0
	19021486	CHEMBL4347709	Inhibition of recombinant human FGFR1 at 20 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	-3.0	CHEMBL3650	Homo sapiens	INH	%	-3.0
	19021487	CHEMBL4347710	Inhibition of recombinant human FGFR1 at 200 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	32.0	CHEMBL3650	Homo sapiens	INH	%	32.0
	19032187	CHEMBL4349781	Inhibition of recombinant human N-terminal GST/His6-tagged FGF-R1 wt C-terminal (G400 to R820) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1	Outside typical range	CHEMBL4555442	=	Inhibition	%	-12.0	CHEMBL3650	Homo sapiens	INH	%	-12.0
	19035303	CHEMBL4350399	Inhibition of human FGFR1 assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL3650	Homo sapiens	Activity	%	100.0
Not Active	19039781	CHEMBL4351861	Inhibition of recombinant human FGFR1 V561M mutant (456 to 765 residues) at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Not Active	19039782	CHEMBL4351860	Inhibition of recombinant human FGFR1 (456 to 765 residues) at 10 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19041111	CHEMBL4352372	Inhibition of human FGFR1 at 10 uM using KKKSPGEYVNIEFG as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	19043761	CHEMBL4353227	Inhibition of human FGFR1 using KKKSPGEYVNIEFG as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	65.49	CHEMBL3650	Homo sapiens	INH	%	65.49
	19052182	CHEMBL4355249	Inhibition of FGFR1 (unknown origin)	B	Cc1ccc2c(c1)nc(CCN1C(=O)c3cccc4cccc(c34)C1=O)n2-c1ccncc1		CHEMBL4558162	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	19059355	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1ccc(Oc2ccccc2)cc1		CHEMBL4443649	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	19059356	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1ccccc1CC		CHEMBL4592277	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	19059357	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL4528820	=	IC50	nM	391.0	CHEMBL3650	Homo sapiens	IC50	nM	391.0
	19059358	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1cc(OC)c(OC)cc1C		CHEMBL4475369	=	IC50	nM	6710.0	CHEMBL3650	Homo sapiens	IC50	nM	6710.0
	19059359	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1cc(C)cc(Cl)c1		CHEMBL4561015	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	19059360	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cc(C#N)cc1Cl		CHEMBL4442593	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	19059361	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cc(C)cc1Cl		CHEMBL4453645	>	IC50	nM	3330.0	CHEMBL3650	Homo sapiens	IC50	nM	3330.0
	19059362	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cc(Cl)cc1Cl		CHEMBL4436957	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	19059363	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	IC50	nM	8340.0	CHEMBL3650	Homo sapiens	IC50	nM	8340.0
	19059394	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	IC50	nM	54.0	CHEMBL3650	Homo sapiens	IC50	nM	54.0
	19059395	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1cccs1		CHEMBL4574265	=	IC50	nM	17.0	CHEMBL3650	Homo sapiens	IC50	nM	17.0
	19059396	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccoc1		CHEMBL4538743	=	IC50	nM	12.0	CHEMBL3650	Homo sapiens	IC50	nM	12.0
	19059397	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(OC)nc1		CHEMBL4563120	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	nM	20.0
	19059398	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(C(C)=O)cc1		CHEMBL4562024	=	IC50	nM	72.0	CHEMBL3650	Homo sapiens	IC50	nM	72.0
	19059399	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(Oc2ccccc2)cc1		CHEMBL4442889	=	IC50	nM	89.0	CHEMBL3650	Homo sapiens	IC50	nM	89.0
	19059400	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1ccc(C)cc1		CHEMBL4460150	=	IC50	nM	119.0	CHEMBL3650	Homo sapiens	IC50	nM	119.0
	19059401	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1c(C)cccc1Cl		CHEMBL4462060	=	IC50	nM	373.0	CHEMBL3650	Homo sapiens	IC50	nM	373.0
	19059402	CHEMBL4357706	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 1 hr by Z'-LYTE assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1ccc(Oc2ccccc2)cc1		CHEMBL4569421	=	IC50	nM	1050.0	CHEMBL3650	Homo sapiens	IC50	nM	1050.0
	19059585	CHEMBL4357886	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3650	Homo sapiens	Activity	%	100.0
	19090156	CHEMBL4365730	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	95.0	CHEMBL3650	Homo sapiens	Activity	%	95.0
	19091928	CHEMBL4366402	Inhibition of human FGFR1 at 100 nM using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-9.98	CHEMBL3650	Homo sapiens	INH	%	-9.98
	19099841	CHEMBL4368284	Inhibition of recombinant His-tagged FGFR1 C584S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)Nc1cccc(F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4102146	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	19099842	CHEMBL4368284	Inhibition of recombinant His-tagged FGFR1 C584S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)Nc1cc(F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4065231	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	19099843	CHEMBL4368284	Inhibition of recombinant His-tagged FGFR1 C584S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)Nc1cccc(C(F)(F)F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4094408	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	19099844	CHEMBL4368284	Inhibition of recombinant His-tagged FGFR1 C584S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	19099845	CHEMBL4368284	Inhibition of recombinant His-tagged FGFR1 C584S mutant (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	A	C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4514636	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	19118512	CHEMBL4372356	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells using IGF-IRtide (12-527) as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	IC50	nM	145.0	CHEMBL3650	Homo sapiens	IC50	nM	145.0
	19118538	CHEMBL4372382	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using IGF-IRtide (12-527) as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	>	Inhibition	%	60.0	CHEMBL3650	Homo sapiens	INH	%	60.0
	19140816	CHEMBL4376580	Inhibition of recombinant human N-terminal His-tagged FGFR1 catalytic domain (399 to 822 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	19144798	CHEMBL4377814	Inhibition of recombinant human FGFR1 (456 to 765 residues) at 1 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	72.0	CHEMBL3650	Homo sapiens	INH	%	72.0
	19144799	CHEMBL4377815	Inhibition of recombinant human FGFR1 V561M mutant (456 to 765 residues) at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	86.0	CHEMBL3650	Homo sapiens	INH	%	86.0
	19147850	CHEMBL4379324	Inhibition of recombinant human FGFR1 (456 to 765 residues) using KKKSPGEYVNIEF as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	19147851	CHEMBL4379325	Inhibition of recombinant human FGFR1 V561M mutant (456 to 765 residues) using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	19159413	CHEMBL4382517	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	3.7	CHEMBL3650	Homo sapiens	Activity	%	3.7
	19159748	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4469557	=	IC50	nM	0.6	CHEMBL3650	Homo sapiens	IC50	nM	0.6
	19159749	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4554319	=	IC50	nM	0.6	CHEMBL3650	Homo sapiens	IC50	nM	0.6
	19159750	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	<	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	19159751	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCCC1Cn1cc(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnc21		CHEMBL4472968	=	IC50	nM	2.5	CHEMBL3650	Homo sapiens	IC50	nM	2.5
	19159752	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)NCCn1cc(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnc21		CHEMBL4559175	=	IC50	nM	7.2	CHEMBL3650	Homo sapiens	IC50	nM	7.2
	19159753	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCC(=O)N1CCC(Cn2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4438069	=	IC50	nM	1.7	CHEMBL3650	Homo sapiens	IC50	nM	1.7
	19159754	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)NC1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)CC1		CHEMBL4564948	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
	19159755	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4554916	=	IC50	nM	2.6	CHEMBL3650	Homo sapiens	IC50	nM	2.6
	19159756	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)CC1		CHEMBL4441696	=	IC50	nM	0.6	CHEMBL3650	Homo sapiens	IC50	nM	0.6
	19159757	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=C(CN(C)C)C(=O)N1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4557987	=	IC50	nM	0.9	CHEMBL3650	Homo sapiens	IC50	nM	0.9
	19159758	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1cc(C)cc2cc(-c3cn(C4CCN(C(=O)/C=C/CN(C)C)C4)c4ncnc(N)c34)sc12		CHEMBL4444412	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	19159759	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C#CC(=O)N1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4461734	=	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	19159760	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CS(=O)(=O)N1CC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4438578	<	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	19159761	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCC(=O)N1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4552123	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	19159762	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(NC)ncnc32)C1		CHEMBL4474645	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	19159763	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)nc(N)nc32)C1		CHEMBL4576360	=	IC50	nM	40.3	CHEMBL3650	Homo sapiens	IC50	nM	40.3
	19159764	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)nc(C)nc32)C1		CHEMBL4443506	=	IC50	nM	163.9	CHEMBL3650	Homo sapiens	IC50	nM	163.9
	19159765	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)nc(Cl)nc32)C1		CHEMBL4437175	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	nM	9.0
	19159766	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC(n2cc(-c3cc4cc(C)cc(OC)c4o3)c3c(N)ncnc32)C1		CHEMBL4445676	=	IC50	nM	105.1	CHEMBL3650	Homo sapiens	IC50	nM	105.1
	19159767	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4ccccc4o3)c3c(N)ncnc32)C1		CHEMBL4591002	=	IC50	nM	389.3	CHEMBL3650	Homo sapiens	IC50	nM	389.3
	19159768	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4560984	<	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	19159769	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC(n2cc(-c3cc4c(OC)ccc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4543663	=	IC50	nM	4.4	CHEMBL3650	Homo sapiens	IC50	nM	4.4
	19159770	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC(n2cc(-c3cc4ccccc4s3)c3c(N)ncnc32)C1		CHEMBL4521898	=	IC50	nM	3.8	CHEMBL3650	Homo sapiens	IC50	nM	3.8
	19159771	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4cccc(C)c4s3)c3c(N)ncnc32)C1		CHEMBL4471530	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
	19159772	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC(n2cc(-c3cc4cc(OC)ccc4s3)c3c(N)ncnc32)C1		CHEMBL4575973	=	IC50	nM	2.0	CHEMBL3650	Homo sapiens	IC50	nM	2.0
	19159773	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC(n2cc(-c3cc4ccc(OC)cc4s3)c3c(N)ncnc32)C1		CHEMBL4437731	=	IC50	nM	2.9	CHEMBL3650	Homo sapiens	IC50	nM	2.9
	19159774	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC(n2cc(-c3cc4cccc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4558466	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	19159775	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4cccc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4580623	=	IC50	nM	0.8	CHEMBL3650	Homo sapiens	IC50	nM	0.8
	19159776	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc4cc(OC)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4567572	=	IC50	nM	2.6	CHEMBL3650	Homo sapiens	IC50	nM	2.6
	19159777	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CCC(n2cc(-c3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL4440512	=	IC50	nM	30.9	CHEMBL3650	Homo sapiens	IC50	nM	30.9
	19159778	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828009	=	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	19159779	CHEMBL4382839	Inhibition of recombinant FGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
Active	19159863	CHEMBL4382869	Inhibition of FGFR1 phosphorylation in human KG1 cells at 5 to 20 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19159864	CHEMBL4382870	Inhibition of FGFR1 in human KG1 cells assessed as reduction in PLCgamma phosphorylation at 5 to 20 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19159865	CHEMBL4382871	Inhibition of FGFR1 in human KG1 cells assessed as reduction in ERK phosphorylation at 5 to 20 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19159872	CHEMBL4382878	Irreversible inhibition of FGFR1 (unknown origin) at 100 times IC50 concentration using 5-FAM-KKSRGDYMTMQIG-CONH2 peptide as substrate preincubated for 30 mins followed 100 fold dilution with substrate and ATP and measured for 1 hr	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	19161575	CHEMBL4383421	Inhibition of wild type C-terminal FLAG-tagged human TEL fused FGFR1 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	42.0	CHEMBL3650	Homo sapiens	GI50	uM	0.042
	19181030	CHEMBL4387241	Inhibition of recombinant human His-tagged FGFR1 catalytic domain (308 to 731 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	-0.4	CHEMBL3650	Homo sapiens	INH	%	-0.4
	19181256	CHEMBL4387241	Inhibition of recombinant human His-tagged FGFR1 catalytic domain (308 to 731 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	19181902	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	COc1ccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccccc4)c3)cn2)cc1		CHEMBL4530048	=	IC50	nM	36980.0	CHEMBL3650	Homo sapiens	IC50	uM	36.98
	19181903	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	Cc1ccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccccc4)c3)cn2)cc1		CHEMBL4549604	=	IC50	nM	16250.0	CHEMBL3650	Homo sapiens	IC50	uM	16.25
	19181904	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	O=C(Nc1cnn(-c2ccccc2)c1)c1cccc(NS(=O)(=O)c2ccccc2)c1		CHEMBL4459052	=	IC50	nM	18220.0	CHEMBL3650	Homo sapiens	IC50	uM	18.22
	19181905	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	Cn1cc(NC(=O)c2cccc(NS(=O)(=O)c3ccccc3)c2)cn1		CHEMBL4552065	=	IC50	nM	57150.0	CHEMBL3650	Homo sapiens	IC50	uM	57.15
	19181952	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	COc1cccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccccc4)c3)cn2)c1		CHEMBL4520103	=	IC50	nM	33450.0	CHEMBL3650	Homo sapiens	IC50	uM	33.45
	19181953	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	Cn1cc(NC(=O)c2cccc(NS(=O)(=O)c3ccc(Cl)cc3)c2)cn1		CHEMBL4455321	=	IC50	nM	58940.0	CHEMBL3650	Homo sapiens	IC50	uM	58.94
	19181954	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	O=C(Nc1cnn(-c2ccccc2)c1)c1cccc(NS(=O)(=O)c2ccc(Cl)cc2)c1		CHEMBL4439053	=	IC50	nM	18520.0	CHEMBL3650	Homo sapiens	IC50	uM	18.52
	19181955	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	Cc1ccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2)cc1		CHEMBL4460897	=	IC50	nM	17230.0	CHEMBL3650	Homo sapiens	IC50	uM	17.23
	19181956	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	COc1ccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2)cc1		CHEMBL4471464	=	IC50	nM	25450.0	CHEMBL3650	Homo sapiens	IC50	uM	25.45
	19181957	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	COc1cccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2)c1		CHEMBL4554486	=	IC50	nM	22160.0	CHEMBL3650	Homo sapiens	IC50	uM	22.16
	19181958	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	Cn1cc(NC(=O)c2ccc(NS(=O)(=O)c3ccccc3)cc2)cn1		CHEMBL4522594	=	IC50	nM	62150.0	CHEMBL3650	Homo sapiens	IC50	uM	62.15
	19181959	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	O=C(Nc1cnn(-c2ccccc2)c1)c1ccc(NS(=O)(=O)c2ccccc2)cc1		CHEMBL4445843	=	IC50	nM	35890.0	CHEMBL3650	Homo sapiens	IC50	uM	35.89
	19181960	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	Cc1ccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccccc4)cc3)cn2)cc1		CHEMBL4470214	=	IC50	nM	28150.0	CHEMBL3650	Homo sapiens	IC50	uM	28.15
	19181961	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	COc1ccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccccc4)cc3)cn2)cc1		CHEMBL4448424	=	IC50	nM	45260.0	CHEMBL3650	Homo sapiens	IC50	uM	45.26
	19181962	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	COc1cccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccccc4)cc3)cn2)c1		CHEMBL4442932	=	IC50	nM	47520.0	CHEMBL3650	Homo sapiens	IC50	uM	47.52
	19181963	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	O=C(Nc1cnn(-c2ccccc2)c1)c1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1		CHEMBL4459564	=	IC50	nM	21560.0	CHEMBL3650	Homo sapiens	IC50	uM	21.56
	19181964	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	Cc1ccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3)cn2)cc1		CHEMBL4549295	=	IC50	nM	16230.0	CHEMBL3650	Homo sapiens	IC50	uM	16.23
	19181965	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	COc1ccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3)cn2)cc1		CHEMBL4576626	=	IC50	nM	26470.0	CHEMBL3650	Homo sapiens	IC50	uM	26.47
	19181966	CHEMBL4387505	Inhibition of bFGFR (unknown origin) incubated for 30 mins by enzyme immunoassay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	4690.0	CHEMBL3650	Homo sapiens	IC50	uM	4.69
	19191594	CHEMBL4389236	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	36.0	CHEMBL3650	Homo sapiens	INH	%	36.0
	19191899	CHEMBL4389713	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	46.0	CHEMBL3650	Homo sapiens	INH	%	46.0
	19199883	CHEMBL4391339	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	27.0	CHEMBL3650	Homo sapiens	Activity	%	27.0
	19225463	CHEMBL4395883	Inhibition of human recombinant FGFR at 1 uM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 60 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	47.03	CHEMBL3650	Homo sapiens	INH	%	47.03
	19236741	CHEMBL4398814	Inhibition of FGFR1 (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL3650	Homo sapiens	INH	%	25.0
	19237281	CHEMBL4398955	Inhibition of FGFR1 (unknown origin) at 10 uM using peptide as substrate incubated for 10 mins by caliper assay relative to control	B	O=C(Nc1nc(NCc2ccc(Cl)cc2)c2nc[nH]c2n1)c1ccccc1		CHEMBL4474543	=	Inhibition	%	7.9	CHEMBL3650	Homo sapiens	INH	%	7.9
	19238873	CHEMBL4399181	Inhibition of FGFR1 (unknown origin)	B	CCOC(=O)c1ccc(Nc2ccnc(SCC(=O)c3ccc(C#N)cc3)n2)cc1		CHEMBL4573547	=	IC50	nM	280.0	CHEMBL3650	Homo sapiens	IC50	uM	0.28
	19238874	CHEMBL4399181	Inhibition of FGFR1 (unknown origin)	B	O=C(CSc1nccc(Nc2ccc(N3CCOCC3)cc2)n1)c1ccc(F)cc1		CHEMBL4449189	=	IC50	nM	130.0	CHEMBL3650	Homo sapiens	IC50	uM	0.13
	19238875	CHEMBL4399181	Inhibition of FGFR1 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	670.0	CHEMBL3650	Homo sapiens	IC50	uM	0.67
	19239350	CHEMBL4399181	Inhibition of FGFR1 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
	19245626	CHEMBL4400606	Inhibition of human FGFR1 using KKKSPGEYVNIEFG substrate pre-incubated for 15 to 60 mins followed by ATP and [gamma33P]-ATP addition	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	320.0	CHEMBL3650	Homo sapiens	IC50	uM	0.32
	19245630	CHEMBL4400602	Inhibition of N-terminal GST-fused human FGFR1 cytoplasmic domain (398 to 822(end) amino acids) using CSKtide substrate incubated for 90 mins	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	591.0	CHEMBL3650	Homo sapiens	IC50	nM	591.0
	19245634	CHEMBL4400598	Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 amino acids) incubated for 60 mins by time-resolved fluorescence kinase assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	19245642	CHEMBL4400590	Inhibition of FGFR1 (unknown origin) using poly[Glu:Tyr] (4:1) substrate and ATP and [gamma33P]-ATP incubated for 30 mins	B	C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828009	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
	19245647	CHEMBL4400585	Inhibition of human FGFR1 using poly[Glu:Tyr] (4:1) substrate and ATP and [gamma33P]-ATP	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	2.0	CHEMBL3650	Homo sapiens	IC50	nM	2.0
	19266424	CHEMBL4405374	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3650	Homo sapiens	INH	%	50.0
	19274871	CHEMBL4407572	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 25 uM using FRET-labeled tyr 04 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	Inhibition	%	78.0	CHEMBL3650	Homo sapiens	INH	%	78.0
	19274872	CHEMBL4407572	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 25 uM using FRET-labeled tyr 04 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Cl)cccc3-c3cccnc3)c(N3C[C@H]4[C@H](N)[C@H]4C3)nc2n1		CHEMBL4453148	=	Inhibition	%	57.0	CHEMBL3650	Homo sapiens	INH	%	57.0
	19274873	CHEMBL4407572	Inhibition of recombinant human His-tagged FGFR1 cytoplasmic domain (308 to 731 residues) expressed in baculovirus expression system at 25 uM using FRET-labeled tyr 04 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	CC(C)COc1cccc(Cl)c1-c1cc2cnc(N)nc2nc1N1C[C@H]2[C@H](N)[C@H]2C1		CHEMBL4546703	=	Inhibition	%	60.0	CHEMBL3650	Homo sapiens	INH	%	60.0
	19276176	CHEMBL4408179	Inhibition of recombinant human FGFR1 (456 to 765 residues) at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	19295712	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CCN(C)CC4)c3)n[nH]c2c1		CHEMBL4437449	=	IC50	nM	10.1	CHEMBL3650	Homo sapiens	IC50	nM	10.1
	19295713	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CCCCO4)c3)n[nH]c2c1		CHEMBL4580357	=	IC50	nM	3.2	CHEMBL3650	Homo sapiens	IC50	nM	3.2
	19295714	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CCOC4)c3)n[nH]c2c1		CHEMBL4459160	=	IC50	nM	6.7	CHEMBL3650	Homo sapiens	IC50	nM	6.7
	19295715	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CCN4CCOCC4)c3)n[nH]c2c1		CHEMBL4559322	=	IC50	nM	11.5	CHEMBL3650	Homo sapiens	IC50	nM	11.5
	19295716	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CC(=O)N(C)C)c3)n[nH]c2c1		CHEMBL4460782	=	IC50	nM	11.7	CHEMBL3650	Homo sapiens	IC50	nM	11.7
	19295717	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CC(C)O)c3)n[nH]c2c1		CHEMBL4458216	=	IC50	nM	26.8	CHEMBL3650	Homo sapiens	IC50	nM	26.8
	19295718	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CCO)c3)n[nH]c2c1		CHEMBL4572126	=	IC50	nM	11.6	CHEMBL3650	Homo sapiens	IC50	nM	11.6
	19295719	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	IC50	nM	31.1	CHEMBL3650	Homo sapiens	IC50	nM	31.1
	19295720	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C(C)C)c3)n[nH]c2c1		CHEMBL4590244	=	IC50	nM	20.1	CHEMBL3650	Homo sapiens	IC50	nM	20.1
	19295721	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	CCCn1cc(-c2n[nH]c3cc(-c4cc(C(=O)Nc5cccc(C(F)(F)F)c5)ccc4C)ccc23)cn1		CHEMBL4449358	=	IC50	nM	12.9	CHEMBL3650	Homo sapiens	IC50	nM	12.9
	19295722	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	CCn1cc(-c2n[nH]c3cc(-c4cc(C(=O)Nc5cccc(C(F)(F)F)c5)ccc4C)ccc23)cn1		CHEMBL4535267	=	IC50	nM	6.7	CHEMBL3650	Homo sapiens	IC50	nM	6.7
	19295723	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C)c3)n[nH]c2c1		CHEMBL4524697	=	IC50	nM	6.4	CHEMBL3650	Homo sapiens	IC50	nM	6.4
	19295724	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cn[nH]c3)n[nH]c2c1		CHEMBL4534609	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	19295725	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(N4CCC(N5CCOCC5)CC4)cc3)n[nH]c2c1		CHEMBL4587973	=	IC50	nM	9.0	CHEMBL3650	Homo sapiens	IC50	nM	9.0
	19295726	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(N4CCOCC4)cc3)n[nH]c2c1		CHEMBL4454757	=	IC50	nM	55.4	CHEMBL3650	Homo sapiens	IC50	nM	55.4
	19295727	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(CN4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4467046	=	IC50	nM	20.7	CHEMBL3650	Homo sapiens	IC50	nM	20.7
	19295728	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(C(=O)N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4456231	=	IC50	nM	25.4	CHEMBL3650	Homo sapiens	IC50	nM	25.4
	19295729	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4549057	=	IC50	nM	19.3	CHEMBL3650	Homo sapiens	IC50	nM	19.3
	19295730	CHEMBL4412319	Inhibition of FGFR1 (unknown origin) at 10 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C4CCCC4)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4565181	=	Inhibition	%	19.4	CHEMBL3650	Homo sapiens	INH	%	19.4
	19295731	CHEMBL4412319	Inhibition of FGFR1 (unknown origin) at 10 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(CCO)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4538678	=	Inhibition	%	21.9	CHEMBL3650	Homo sapiens	INH	%	21.9
	19295732	CHEMBL4412319	Inhibition of FGFR1 (unknown origin) at 10 nM after 60 mins by ELISA relative to control	B	CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccc5cn[nH]c5c4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL4521671	=	Inhibition	%	13.9	CHEMBL3650	Homo sapiens	INH	%	13.9
	19295733	CHEMBL4412319	Inhibition of FGFR1 (unknown origin) at 10 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4569749	=	Inhibition	%	9.8	CHEMBL3650	Homo sapiens	INH	%	9.8
	19295734	CHEMBL4412319	Inhibition of FGFR1 (unknown origin) at 10 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C#N)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4525313	=	Inhibition	%	-2.7	CHEMBL3650	Homo sapiens	INH	%	-2.7
	19295735	CHEMBL4412319	Inhibition of FGFR1 (unknown origin) at 10 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4443643	=	Inhibition	%	2.1	CHEMBL3650	Homo sapiens	INH	%	2.1
	19295736	CHEMBL4412319	Inhibition of FGFR1 (unknown origin) at 10 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4448547	=	Inhibition	%	-1.4	CHEMBL3650	Homo sapiens	INH	%	-1.4
	19295737	CHEMBL4412318	Inhibition of FGFR1 (unknown origin) at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C4CCCC4)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4565181	=	Inhibition	%	35.7	CHEMBL3650	Homo sapiens	INH	%	35.7
	19295738	CHEMBL4412318	Inhibition of FGFR1 (unknown origin) at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(CCO)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4538678	=	Inhibition	%	46.7	CHEMBL3650	Homo sapiens	INH	%	46.7
	19295739	CHEMBL4412318	Inhibition of FGFR1 (unknown origin) at 100 nM after 60 mins by ELISA relative to control	B	CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccc5cn[nH]c5c4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL4521671	=	Inhibition	%	40.6	CHEMBL3650	Homo sapiens	INH	%	40.6
	19295740	CHEMBL4412318	Inhibition of FGFR1 (unknown origin) at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4569749	=	Inhibition	%	38.3	CHEMBL3650	Homo sapiens	INH	%	38.3
	19295741	CHEMBL4412318	Inhibition of FGFR1 (unknown origin) at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C#N)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4525313	=	Inhibition	%	-8.1	CHEMBL3650	Homo sapiens	INH	%	-8.1
	19295742	CHEMBL4412318	Inhibition of FGFR1 (unknown origin) at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4443643	=	Inhibition	%	3.0	CHEMBL3650	Homo sapiens	INH	%	3.0
	19295743	CHEMBL4412318	Inhibition of FGFR1 (unknown origin) at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4448547	=	Inhibition	%	0.3	CHEMBL3650	Homo sapiens	INH	%	0.3
	19295744	CHEMBL4412317	Inhibition of FGFR1 (unknown origin) at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C4CCCC4)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4565181	=	Inhibition	%	82.4	CHEMBL3650	Homo sapiens	INH	%	82.4
	19295745	CHEMBL4412317	Inhibition of FGFR1 (unknown origin) at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(CCO)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4538678	=	Inhibition	%	86.1	CHEMBL3650	Homo sapiens	INH	%	86.1
	19295746	CHEMBL4412317	Inhibition of FGFR1 (unknown origin) at 1000 nM after 60 mins by ELISA relative to control	B	CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccc5cn[nH]c5c4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL4521671	=	Inhibition	%	81.9	CHEMBL3650	Homo sapiens	INH	%	81.9
	19295747	CHEMBL4412317	Inhibition of FGFR1 (unknown origin) at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4569749	=	Inhibition	%	85.2	CHEMBL3650	Homo sapiens	INH	%	85.2
	19295748	CHEMBL4412317	Inhibition of FGFR1 (unknown origin) at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C#N)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4525313	=	Inhibition	%	30.3	CHEMBL3650	Homo sapiens	INH	%	30.3
	19295749	CHEMBL4412317	Inhibition of FGFR1 (unknown origin) at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4443643	=	Inhibition	%	57.7	CHEMBL3650	Homo sapiens	INH	%	57.7
	19295750	CHEMBL4412317	Inhibition of FGFR1 (unknown origin) at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4448547	=	Inhibition	%	18.9	CHEMBL3650	Homo sapiens	INH	%	18.9
	19295975	CHEMBL4412320	Inhibition of FGFR1 (unknown origin) after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
	19303782	CHEMBL4414234	Inhibition of FGFR1 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	97.0	CHEMBL3650	Homo sapiens	Activity	%	97.0
	19312946	CHEMBL4416501	Inhibition of recombinant human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using IGF-IRtide (12 to 527 residues) as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	>	Inhibition	%	75.0	CHEMBL3650	Homo sapiens	INH	%	75.0
	19319714	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc(OC)c1		CHEMBL4439933	=	Inhibition	%	74.2	CHEMBL3650	Homo sapiens	INH	%	74.2
	19319715	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	88.5	CHEMBL3650	Homo sapiens	INH	%	88.5
	19319716	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	Cc1cc(F)cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4537004	=	Inhibition	%	70.3	CHEMBL3650	Homo sapiens	INH	%	70.3
	19319717	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(C(F)(F)F)cc1Nc1cc(NC(=O)Nc2c(Cl)cccc2Cl)ncn1		CHEMBL4466011	=	Inhibition	%	55.4	CHEMBL3650	Homo sapiens	INH	%	55.4
	19319730	CHEMBL4417512	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay	B	COc1cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc(OC)c1		CHEMBL4439933	=	IC50	nM	1103.0	CHEMBL3650	Homo sapiens	IC50	nM	1103.0
	19319731	CHEMBL4417512	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	IC50	nM	808.0	CHEMBL3650	Homo sapiens	IC50	nM	808.0
	19319732	CHEMBL4417512	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay	B	Cc1cc(F)cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4537004	=	IC50	nM	1217.0	CHEMBL3650	Homo sapiens	IC50	nM	1217.0
	19319733	CHEMBL4417512	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	0.59	CHEMBL3650	Homo sapiens	IC50	nM	0.59
	19319921	CHEMBL4417526	Inhibition of N-terminal GST-tagged human FGFR1 expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	85.17	CHEMBL3650	Homo sapiens	INH	%	85.17
Active	19319934	CHEMBL4417534	Inhibition of FGF-induced FGFR1 phosphorylation in serum-starved human H520 cells upto 10 uM incubated for 1 hr by Western blot analysis	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19319936	CHEMBL4417535	Inhibition of FGFR in serum-starved human H520 cells assessed as reduction in FGFR-induced AKT phosphorylation upto 10 uM incubated for 1 hr by Western blot analysis	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19319939	CHEMBL4417536	Inhibition of FGF-induced FGFR1 phosphorylation in serum-starved human H520 cells at 10 uM incubated for 1 hr by Western blot analysis	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19319968	CHEMBL4417566	Inhibition of FGFR1 in gefitinib-insensitive human HCC827GR cells assessed as reduction in FGF-induced FGFR1 phosphorylation upto 10 uM measured after 2 hrs by western blot analysis	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19319975	CHEMBL4417537	Inhibition of FGFR in serum-starved human H520 cells assessed as reduction in FGFR-induced AKT phosphorylation at 10 uM incubated for 1 hr by Western blot analysis	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Active	19319983	CHEMBL4417577	Inhibition of FGFR1 in gefitinib-insensitive human HCC827GR cells assessed as reduction in FGF-induced Akt phosphorylation upto 10 uM measured after 2 hrs by western blot analysis	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	19320079	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cc(OC)cc(OC)c3)ncn2)cc(OC)c1		CHEMBL4554805	=	Inhibition	%	10.6	CHEMBL3650	Homo sapiens	INH	%	10.6
	19320080	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cc(OC)ccc3OC)ncn2)cc(OC)c1		CHEMBL4581382	=	Inhibition	%	3.4	CHEMBL3650	Homo sapiens	INH	%	3.4
	19320081	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cc(Br)ccc3OC)ncn2)cc(OC)c1		CHEMBL4564629	=	Inhibition	%	-1.5	CHEMBL3650	Homo sapiens	INH	%	-1.5
	19320082	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3ccc(Br)cc3OC)ncn2)cc(OC)c1		CHEMBL4585593	=	Inhibition	%	-0.7	CHEMBL3650	Homo sapiens	INH	%	-0.7
	19320083	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3ccc(OC)c(I)c3)ncn2)cc(OC)c1		CHEMBL4464852	=	Inhibition	%	10.3	CHEMBL3650	Homo sapiens	INH	%	10.3
	19320084	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cc(I)ccc3OC)ncn2)cc(OC)c1		CHEMBL4464085	=	Inhibition	%	-2.1	CHEMBL3650	Homo sapiens	INH	%	-2.1
	19320085	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3ccc(F)c(Cl)c3)ncn2)cc(OC)c1		CHEMBL4550747	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	19320086	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cc(F)ccc3OC)ncn2)cc(OC)c1		CHEMBL4591285	=	Inhibition	%	-1.6	CHEMBL3650	Homo sapiens	INH	%	-1.6
	19320087	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3ccc(C)c(F)c3)ncn2)cc(OC)c1		CHEMBL4581618	=	Inhibition	%	0.1	CHEMBL3650	Homo sapiens	INH	%	0.1
	19320088	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cc(C)cc(F)c3)ncn2)cc(OC)c1		CHEMBL4576543	=	Inhibition	%	1.1	CHEMBL3650	Homo sapiens	INH	%	1.1
	19320089	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3ccc(C)c(C)c3)ncn2)cc(OC)c1		CHEMBL4442961	=	Inhibition	%	21.3	CHEMBL3650	Homo sapiens	INH	%	21.3
	19320090	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3ccc(OC)c(C)c3)ncn2)cc(OC)c1		CHEMBL4474472	=	Inhibition	%	36.6	CHEMBL3650	Homo sapiens	INH	%	36.6
	19320091	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cc(C(F)(F)F)ccc3OC)ncn2)cc(OC)c1		CHEMBL4440779	=	Inhibition	%	11.0	CHEMBL3650	Homo sapiens	INH	%	11.0
	19320092	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cc(OC)cc(C(F)(F)F)c3)ncn2)cc(OC)c1		CHEMBL4453851	=	Inhibition	%	-1.7	CHEMBL3650	Homo sapiens	INH	%	-1.7
	19320093	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	CCc1cccc(Nc2cc(NC(=O)Nc3cc(OC)cc(OC)c3)ncn2)c1		CHEMBL4583403	=	Inhibition	%	1.1	CHEMBL3650	Homo sapiens	INH	%	1.1
	19320094	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	CCc1ccc(Nc2cc(NC(=O)Nc3cc(OC)cc(OC)c3)ncn2)cc1		CHEMBL4537590	=	Inhibition	%	6.1	CHEMBL3650	Homo sapiens	INH	%	6.1
	19320095	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3cccc(C(C)(C)C)c3)ncn2)cc(OC)c1		CHEMBL4542102	=	Inhibition	%	5.2	CHEMBL3650	Homo sapiens	INH	%	5.2
	19320096	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(NC(=O)Nc2cc(Nc3ccc(C(C)(C)C)cc3)ncn2)cc(OC)c1		CHEMBL4513702	=	Inhibition	%	-0.7	CHEMBL3650	Homo sapiens	INH	%	-0.7
	19320097	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(Br)cc1Nc1cc(NC(=O)Nc2c(Cl)cccc2Cl)ncn1		CHEMBL4553239	=	Inhibition	%	37.8	CHEMBL3650	Homo sapiens	INH	%	37.8
	19320098	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(Br)ccc1Nc1cc(NC(=O)Nc2c(Cl)cccc2Cl)ncn1		CHEMBL4436152	=	Inhibition	%	12.6	CHEMBL3650	Homo sapiens	INH	%	12.6
	19320099	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	O=C(Nc1cc(Nc2ccc(F)c(Cl)c2)ncn1)Nc1c(Cl)cccc1Cl		CHEMBL4470760	=	Inhibition	%	27.6	CHEMBL3650	Homo sapiens	INH	%	27.6
	19320100	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(F)cc1Nc1cc(NC(=O)Nc2c(Cl)cccc2Cl)ncn1		CHEMBL4535189	=	Inhibition	%	11.1	CHEMBL3650	Homo sapiens	INH	%	11.1
	19320101	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	Cc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1F		CHEMBL4443097	=	Inhibition	%	51.0	CHEMBL3650	Homo sapiens	INH	%	51.0
	19320102	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	Cc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1C		CHEMBL4447722	=	Inhibition	%	45.3	CHEMBL3650	Homo sapiens	INH	%	45.3
	19320103	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1C		CHEMBL4449667	=	Inhibition	%	50.4	CHEMBL3650	Homo sapiens	INH	%	50.4
	19320104	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc(C(F)(F)F)c1		CHEMBL4593223	=	Inhibition	%	0.9	CHEMBL3650	Homo sapiens	INH	%	0.9
	19320105	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	CCc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL4465610	=	Inhibition	%	47.3	CHEMBL3650	Homo sapiens	INH	%	47.3
	19320106	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	CC(C)(C)c1cccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4453960	=	Inhibition	%	10.7	CHEMBL3650	Homo sapiens	INH	%	10.7
	19320107	CHEMBL4417508	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	CC(C)(C)c1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL4583717	=	Inhibition	%	30.4	CHEMBL3650	Homo sapiens	INH	%	30.4
	19371125	CHEMBL4424843	Inhibition of human N-terminal GST-tagged FGFR1 (456 to 765 residues) expressed in baculovirus infected Sf21 insect cells using IGF-IRtide (12-527) as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	19406091	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c2)c1Cl		CHEMBL4562845	=	IC50	nM	3.3	CHEMBL3650	Homo sapiens	IC50	nM	3.3
	19406094	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4)n[nH]c3n2)c1		CHEMBL4437058	=	IC50	nM	3709.0	CHEMBL3650	Homo sapiens	IC50	nM	3709.0
	19406097	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4)nn(C)c3n2)c1Cl		CHEMBL4580145	>	IC50	nM	5000.0	CHEMBL3650	Homo sapiens	IC50	nM	5000.0
	19406100	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N)cc4)n[nH]c3n2)c1Cl		CHEMBL4464372	=	IC50	nM	8.8	CHEMBL3650	Homo sapiens	IC50	nM	8.8
	19406102	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCNCC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4466283	=	IC50	nM	11.7	CHEMBL3650	Homo sapiens	IC50	nM	11.7
	19406104	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(CCO)CC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4553127	=	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	19406116	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4469836	=	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	19406120	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCCCC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4569919	=	IC50	nM	8.8	CHEMBL3650	Homo sapiens	IC50	nM	8.8
	19406122	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCOCC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4445710	=	IC50	nM	7.7	CHEMBL3650	Homo sapiens	IC50	nM	7.7
	19406124	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(C5CCN(C)CC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4467102	=	IC50	nM	6.9	CHEMBL3650	Homo sapiens	IC50	nM	6.9
	19406126	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCCN(C)CC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4593639	=	IC50	nM	7.2	CHEMBL3650	Homo sapiens	IC50	nM	7.2
	19406138	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4567187	=	IC50	nM	0.5	CHEMBL3650	Homo sapiens	IC50	nM	0.5
	19406140	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C(C)C)CC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4576419	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
	19406142	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C6CCC6)CC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4557949	=	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
	19406144	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	C=CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4441872	=	IC50	nM	0.6	CHEMBL3650	Homo sapiens	IC50	nM	0.6
	19406146	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C(C)=O)CC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4447575	=	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
	19406148	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(S(C)(=O)=O)CC5)cc4)n[nH]c3n2)c1Cl		CHEMBL4542061	=	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
	19406150	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4Cl)n[nH]c3n2)c1Cl		CHEMBL4557543	=	IC50	nM	14.0	CHEMBL3650	Homo sapiens	IC50	nM	14.0
	19406152	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)c(Cl)c4)n[nH]c3n2)c1Cl		CHEMBL4440491	=	IC50	nM	14.5	CHEMBL3650	Homo sapiens	IC50	nM	14.5
	19406154	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2nc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc12		CHEMBL4527389	=	IC50	nM	74.4	CHEMBL3650	Homo sapiens	IC50	nM	74.4
	19406156	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(C(=O)Nc2n[nH]c3nc(-c4c(Cl)c(OC)cc(OC)c4Cl)ccc23)ccc1N1CCN(C)CC1		CHEMBL4571948	=	IC50	nM	14.2	CHEMBL3650	Homo sapiens	IC50	nM	14.2
	19406158	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)nc4)n[nH]c3n2)c1Cl		CHEMBL4533292	=	IC50	nM	6.2	CHEMBL3650	Homo sapiens	IC50	nM	6.2
	19406160	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cn4)n[nH]c3n2)c1Cl		CHEMBL4450368	=	IC50	nM	7.8	CHEMBL3650	Homo sapiens	IC50	nM	7.8
	19406162	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4cnc(N5CCN(C)CC5)cn4)n[nH]c3n2)c1Cl		CHEMBL4574280	=	IC50	nM	10.5	CHEMBL3650	Homo sapiens	IC50	nM	10.5
	19406164	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)s4)n[nH]c3n2)c1Cl		CHEMBL4561437	=	IC50	nM	4.1	CHEMBL3650	Homo sapiens	IC50	nM	4.1
	19406166	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccccc4)n[nH]c3n2)c1Cl		CHEMBL4535664	=	IC50	nM	42.4	CHEMBL3650	Homo sapiens	IC50	nM	42.4
	19406168	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N(C)C)cc4)n[nH]c3n2)c1Cl		CHEMBL4448605	=	IC50	nM	16.5	CHEMBL3650	Homo sapiens	IC50	nM	16.5
	19406170	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(Cl)c(-c2ccc3c(NC(=O)c4ccc(N(C)CCN(C)C)cc4)n[nH]c3n2)c1Cl		CHEMBL4559114	=	IC50	nM	3.9	CHEMBL3650	Homo sapiens	IC50	nM	3.9
	19406172	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359	=	IC50	nM	0.3	CHEMBL3650	Homo sapiens	IC50	nM	0.3
Dose-dependent effect	19406186	CHEMBL4426420	Inhibition of FGFR1 phosphorylation in human KG1 cells after 2 hrs by Western blot analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	19406187	CHEMBL4426421	Inhibition of FGFR1 in human KG1 cells assessed as suppression of PLCgamma phosphorylation after 2 hrs by Western blot analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
Dose-dependent effect	19406188	CHEMBL4426422	Inhibition of FGFR1 in human KG1 cells assessed as suppression of ERK phosphorylation after 2 hrs by Western blot analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	19406202	CHEMBL4426404	Inhibition of recombinant human FGFR1 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	19406223	CHEMBL4426438	Inhibition of human FGFR1	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
	19406229	CHEMBL4426437	Inhibition of full length human FGFR1 expressed in baculovirus system using poly (Glu,Tyr)4:1 as substrate incubated for 10 mins in presence of [gamma-32P]ATP by scintillation counting analysis	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	21.5	CHEMBL3650	Homo sapiens	IC50	nM	21.5
	19435818	CHEMBL4430388	Inhibition of human FGFR1 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	Inhibition	%	28.0	CHEMBL3650	Homo sapiens	INH	%	28.0
	19435819	CHEMBL4430388	Inhibition of human FGFR1 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	Inhibition	%	10.0	CHEMBL3650	Homo sapiens	INH	%	10.0
	19435820	CHEMBL4430388	Inhibition of human FGFR1 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL3353341	=	Inhibition	%	90.0	CHEMBL3650	Homo sapiens	INH	%	90.0
	19445443	CHEMBL4432480	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl		CHEMBL4582423	=	Inhibition	%	64.4	CHEMBL3650	Homo sapiens	INH	%	64.4
	19445465	CHEMBL4432480	Inhibition of recombinant FGFR1 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	74.8	CHEMBL3650	Homo sapiens	INH	%	74.8
	19475364	CHEMBL4479459	Inhibition of human FGFR1	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	>	IC50	nM	30000.0	CHEMBL3650	Homo sapiens	IC50	nM	30000.0
	20600528	CHEMBL4603480	Inhibition of recombinant His-tagged human FGFR1 cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3650	Homo sapiens	IC50	uM	100.0
	20609531	CHEMBL4605796	Inhibition of FGFR1 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	>	IC50	nM	5600.0	CHEMBL3650	Homo sapiens	IC50	uM	5.6
	20609532	CHEMBL4605796	Inhibition of FGFR1 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	10.0	CHEMBL3650	Homo sapiens	IC50	uM	0.01
	20609533	CHEMBL4605796	Inhibition of FGFR1 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	3100.0	CHEMBL3650	Homo sapiens	IC50	uM	3.1
	20631982	CHEMBL4610927	Inhibition of FGFR1 (unknown origin) at 1 uM after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	O=C(Nc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4643443	<	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	20631983	CHEMBL4610927	Inhibition of FGFR1 (unknown origin) at 1 uM after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	O=C(Cc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4646386	<	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	20639151	CHEMBL4612621	Inhibition of human FGFR1 cytoplasmic domain (398 to 822(end) residues) at 1 mM ATP relative to control	B	Cc1[nH]nc2[nH]c(=O)cc([C@H]3C[C@H]4C[C@@H]3C[C@@H]4CC#N)c12		CHEMBL4643061	=	Inhibition	%	32.0	CHEMBL3650	Homo sapiens	INH	%	32.0
	20681257	CHEMBL4623164	Inhibition of N-terminal GST fused human recombinant FGFR1 cytoplasmic domain (398 to 822 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4644718	=	IC50	nM	23.0	CHEMBL3650	Homo sapiens	IC50	nM	23.0
	20681258	CHEMBL4623164	Inhibition of N-terminal GST fused human recombinant FGFR1 cytoplasmic domain (398 to 822 (end) residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	99.0	CHEMBL3650	Homo sapiens	IC50	nM	99.0
	20683657	CHEMBL4623636	Inhibition of FGFR1 (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-7.0	CHEMBL3650	Homo sapiens	INH	%	-7.0
	20683658	CHEMBL4623637	Inhibition of FGFR1 (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-5.0	CHEMBL3650	Homo sapiens	INH	%	-5.0
	20711794	CHEMBL4629241	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)n1		CHEMBL4641667	=	IC50	nM	40.0	CHEMBL3650	Homo sapiens	IC50	nM	40.0
	20711817	CHEMBL4629241	Inhibition of N-terminal GST-tagged human FGFR1 cytoplasmic domain (398-822 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1cc(OC)cc(OC)c1		CHEMBL4642080	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
	22391788	CHEMBL4667002	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	-1.0	CHEMBL3650	Homo sapiens	INH	%	-1.0
	22391789	CHEMBL4667002	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	22391790	CHEMBL4667002	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	22392054	CHEMBL4667149	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	22423617	CHEMBL4674384	Inhibition of human FGFR1 using KKKSPGEYVNIEFG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	92.0	CHEMBL3650	Homo sapiens	Activity	%	92.0
	22423618	CHEMBL4674384	Inhibition of human FGFR1 using KKKSPGEYVNIEFG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	87.07	CHEMBL3650	Homo sapiens	Activity	%	87.07
	22425199	CHEMBL4674898	Inhibition of human FGFR1 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	Nc1nc2[nH]c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c2c(=O)[nH]1		CHEMBL4790677	=	Inhibition	%	-8.65	CHEMBL3650	Homo sapiens	INH	%	-8.65
	22425200	CHEMBL4674898	Inhibition of human FGFR1 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccc(F)cc4)CC3)c(CN3CCN(Cc4ccc(F)cc4)CC3)c2c(=O)[nH]1		CHEMBL4742745	=	Inhibition	%	50.52	CHEMBL3650	Homo sapiens	INH	%	50.52
	22425201	CHEMBL4674898	Inhibition of human FGFR1 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4cccc(F)c4)CC3)c(CN3CCN(Cc4cccc(F)c4)CC3)c2c(=O)[nH]1		CHEMBL4786524	=	Inhibition	%	54.45	CHEMBL3650	Homo sapiens	INH	%	54.45
	22425202	CHEMBL4674898	Inhibition of human FGFR1 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4F)CC3)c(CN3CCN(Cc4ccccc4F)CC3)c2c(=O)[nH]1		CHEMBL4788342	=	Inhibition	%	59.83	CHEMBL3650	Homo sapiens	INH	%	59.83
	22425203	CHEMBL4674898	Inhibition of human FGFR1 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4)CC3)c(CN3CCN(Cc4ccccc4)CC3)c2c(=O)[nH]1		CHEMBL4787439	=	Inhibition	%	47.1	CHEMBL3650	Homo sapiens	INH	%	47.1
	22446614	CHEMBL4679671	Inhibition of FGFR1 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4783926	=	GI50	nM	25.1	CHEMBL3650	Homo sapiens	GI50	nM	25.1
	22446615	CHEMBL4679671	Inhibition of FGFR1 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4776177	=	GI50	nM	0.3	CHEMBL3650	Homo sapiens	GI50	nM	0.3
	22766970	CHEMBL4703349	Inhibition of FGFR1 (unknown origin) at 100 nM	B	C=CC(=O)Nc1cccc(C)c1Nc1cc(-c2cccnc2Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL4744686	=	Inhibition	%	1.0	CHEMBL3650	Homo sapiens	INH	%	1.0
	22771684	CHEMBL4704544	Inhibition of GST-tagged recombinant FGFR1 (unknown origin) expressed in baculovirus expression system incubated for 15-45 mins in presence of [gamma32P]-ATP by radiometric assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	IC50	nM	750.0	CHEMBL3650	Homo sapiens	IC50	uM	0.75
	22771718	CHEMBL4704555	Inhibition of human recombinant FGFR1 (456 to 765 residues) at 100 nM in presence of [gamma33P]ATP by radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O		CHEMBL4752642	=	Inhibition	%	87.1	CHEMBL3650	Homo sapiens	INH	%	87.1
	22771719	CHEMBL4704555	Inhibition of human recombinant FGFR1 (456 to 765 residues) at 100 nM in presence of [gamma33P]ATP by radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(NCc4cccnc4N(C)S(C)(=O)=O)n3)cc2)c(=O)c1=O		CHEMBL4751164	=	Inhibition	%	32.5	CHEMBL3650	Homo sapiens	INH	%	32.5
	22771720	CHEMBL4704555	Inhibition of human recombinant FGFR1 (456 to 765 residues) at 100 nM in presence of [gamma33P]ATP by radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O		CHEMBL4777260	=	Inhibition	%	88.3	CHEMBL3650	Homo sapiens	INH	%	88.3
	22771721	CHEMBL4704555	Inhibition of human recombinant FGFR1 (456 to 765 residues) at 100 nM in presence of [gamma33P]ATP by radiometric assay relative to control	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C(C)C)c(=O)c3=O)cc2)ncc1Cl		CHEMBL4783568	=	Inhibition	%	83.5	CHEMBL3650	Homo sapiens	INH	%	83.5
	22809739	CHEMBL4713274	Inhibition of recombinant human FGFR1 (456 to 765 residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	34.0	CHEMBL3650	Homo sapiens	Activity	%	34.0
	22810001	CHEMBL4713438	Inhibition of FLT2 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	11.3	CHEMBL3650	Homo sapiens	IC50	nM	11.3
	22816198	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	C=CS(=O)(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4785949	=	IC50	nM	520.0	CHEMBL3650	Homo sapiens	IC50	uM	0.52
	22816199	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC#N)nc2)c1Cl		CHEMBL4750816	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816200	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NCC#N)nc2)c1Cl		CHEMBL4748301	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816201	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CC#N)nc2)c1Cl		CHEMBL4739914	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816202	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	C#CCNc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4799486	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816203	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CCl)nc2)c1Cl		CHEMBL4763652	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816204	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)C3CO3)nc2)c1Cl		CHEMBL4740775	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816205	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	C=C(F)C(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4757810	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816206	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NCC=O)nc2)c1Cl		CHEMBL4742889	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816207	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	C=C(C#N)C(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4796512	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816208	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22816209	CHEMBL4714829	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 01 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	A	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3908979	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	uM	10.0
	22820476	CHEMBL4716240	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	94.0	CHEMBL3650	Homo sapiens	Activity	%	94.0
	22820477	CHEMBL4716240	Inhibition of human FGFR1 assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	3.0	CHEMBL3650	Homo sapiens	Activity	%	3.0
	22826325	CHEMBL4717510	Inhibition of human FGFR1 assessed as residual activity at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Activity	%	60.0	CHEMBL3650	Homo sapiens	Activity	%	60.0
	22836210	CHEMBL4718857	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-4.0	CHEMBL3650	Homo sapiens	INH	%	-4.0
	22836211	CHEMBL4718857	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	0.0	CHEMBL3650	Homo sapiens	INH	%	0.0
	22836212	CHEMBL4718857	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	9.0	CHEMBL3650	Homo sapiens	INH	%	9.0
	22836213	CHEMBL4718857	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	3.0	CHEMBL3650	Homo sapiens	INH	%	3.0
	22836214	CHEMBL4718857	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	6.0	CHEMBL3650	Homo sapiens	INH	%	6.0
	22836215	CHEMBL4718857	Inhibition of recombinant human His-tagged FGFR1 (308 to 731 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	16.0	CHEMBL3650	Homo sapiens	INH	%	16.0
	22837417	CHEMBL4719091	Inhibition of recombinant His-tagged human FGFR1 (308 to 731 residues) expressed in baculovirus expression system at 10 uM by TR-FRET assay relative to control	B	C/C1=C\[C@H](OC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1		CHEMBL4756514	=	Inhibition	%	49.0	CHEMBL3650	Homo sapiens	INH	%	49.0
	22843745	CHEMBL4720731	Inhibition of human FGFR1 using KKKSPGEYVNIEFG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.42	CHEMBL3650	Homo sapiens	IC50	10^-9M	2.42
	22844097	CHEMBL4721083	Inhibition of human FGFR1 assessed as residual activity using KKKSPGEYVNIEFG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	87.93	CHEMBL3650	Homo sapiens	Activity	%	87.93
	22844709	CHEMBL4721384	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	90.68	CHEMBL3650	Homo sapiens	Activity	%	90.68
	22845488	CHEMBL4721769	Binding affinity to Nluc-tagged FGFR1 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	4.24	CHEMBL3650	Homo sapiens	deltaTm	degrees C	4.24
	22845508	CHEMBL4721789	Binding affinity to human FGFR1 using poly[Glu:Tyr] (4:1) as substrate by radiometric hotspot kinase assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	2.2	CHEMBL3650	Homo sapiens	IC50	nM	2.2
	22849869	CHEMBL4723271	Inhibition of FGFR1 kinase domain (407 to 822) (unknown origin) using 5-FluoAhx-EEPLYWSFPAKKKCO-NH2 peptide as substrate in presence of ATP measured after 60 mins by caliper microfluidic mobility shift assay	A	COCCOc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3973674	>	IC50	nM	10000.0	CHEMBL3650	Homo sapiens	IC50	nM	10000.0
	22854956	CHEMBL4724602	Inhibition of human N-terminal GST-tagged FGFR1 (398 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(Nc2ncc(CCc3c(F)c(OC)cc(OC)c3F)cn2)ccc1N1CCC(N2CCN(C)CC2)CC1		CHEMBL4763773	=	IC50	nM	1.7	CHEMBL3650	Homo sapiens	IC50	nM	1.7
Active	22906265	CHEMBL4733270	Inhibition of FGFR1 phosphorylation in human MDA-MB-31 cells at 3 to 6 uM incubated for 48 hrs in presence of bFGF by immunoblotting analysis	B	O=C(NCCCCC(c1ccc(F)cc1)c1ccc(F)cc1)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1		CHEMBL4779128		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	22930894	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cc(OC)cc(OC)c3)ccc12		CHEMBL4751903	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930895	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cccc(OC)c3)ccc12		CHEMBL4761494	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930896	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cc(C)cc(C)c3)ccc12		CHEMBL4765104	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930897	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3ccc(OC)cc3)ccc12		CHEMBL4760869	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930898	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3ccnc(OC)c3)ccc12		CHEMBL4740779	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930899	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cccs3)ccc12		CHEMBL4796363	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930900	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3ccsc3)ccc12		CHEMBL4784126	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930901	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3ccc4c(c3)CCO4)ccc12		CHEMBL4762574	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930902	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cccc(OC(F)(F)F)c3)ccc12		CHEMBL4800539	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930903	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cc(OC(F)(F)F)ccc3F)ccc12		CHEMBL4756999	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930904	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cccc(OC)c3F)ccc12		CHEMBL4795133	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930905	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3ccc(F)c(OC)c3)ccc12		CHEMBL4746506	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930906	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cc(F)cc(OC)c3)ccc12		CHEMBL4754648	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930907	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cc(OC)ccc3F)ccc12		CHEMBL4791462	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930908	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2nc(-c3cc(OC)cc(OC)c3)ccc12		CHEMBL4744134	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930909	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2nc(-c3cccc(OC)c3)ccc12		CHEMBL4751708	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930910	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2nc(-c3cc(F)cc(OC)c3)ccc12		CHEMBL4755247	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930911	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2nc(-c3ccc(F)c(OC)c3)ccc12		CHEMBL4747930	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930912	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2nc(-c3cc(OC)ccc3F)ccc12		CHEMBL4743257	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930913	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	CCC(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cc(OC)cc(OC)c3)ccc12		CHEMBL4785241	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930914	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4ccccc4NC(=O)CCl)n[nH]c3c2)c1		CHEMBL4795795	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930915	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4ccccc4NC(=O)C=C(C)C)n[nH]c3c2)c1		CHEMBL4746571	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930916	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=C(C)C(=O)Nc1ccccc1C(=O)Nc1n[nH]c2cc(-c3cc(OC)cc(OC)c3)ccc12		CHEMBL4764232	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930917	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4ccccc4NC(=O)C(C)C)n[nH]c3c2)c1		CHEMBL4751993	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930918	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4ccccc4NC(=O)C(C)(C)C)n[nH]c3c2)c1		CHEMBL4745994	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930919	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4ccccc4NC(=O)C(C)Cl)n[nH]c3c2)c1		CHEMBL4741627	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930920	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4ccccc4NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4751385	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930921	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1cccc(C(=O)Nc2n[nH]c3cc(-c4cc(OC)cc(OC)c4)ccc23)c1		CHEMBL4785890	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930922	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	CCC(=O)Nc1cccc(C(=O)Nc2n[nH]c3cc(-c4cc(OC)cc(OC)c4)ccc23)c1		CHEMBL4747265	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930923	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1		CHEMBL4757428	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930924	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4cccc(NC(=O)C(C)Cl)c4)n[nH]c3c2)c1		CHEMBL4793410	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930925	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4cccc(NC(=O)C=C(C)C)c4)n[nH]c3c2)c1		CHEMBL4747852	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930926	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	C=C(C)C(=O)Nc1cccc(C(=O)Nc2n[nH]c3cc(-c4cc(OC)cc(OC)c4)ccc23)c1		CHEMBL4758831	>	IC50	nM	1500.0	CHEMBL3650	Homo sapiens	IC50	nM	1500.0
	22930927	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	21.0	CHEMBL3650	Homo sapiens	IC50	nM	21.0
	22930928	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1cccc(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1F		CHEMBL4779598	=	IC50	nM	106.0	CHEMBL3650	Homo sapiens	IC50	nM	106.0
	22930929	CHEMBL4738758	Inhibition of FGFR1 (unknown origin)	A	COc1ccc(F)c(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1		CHEMBL4748343	=	IC50	nM	528.0	CHEMBL3650	Homo sapiens	IC50	nM	528.0
	22950595	CHEMBL4766162	Inhibition of human recombinant FGFR1 (456 to 765 residues) using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	7.0	CHEMBL3650	Homo sapiens	IC50	uM	0.006999999999999999
	22952838	CHEMBL4766775	Inhibition of recombinant human FGFR1 (456 to 765 residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	7.0	CHEMBL3650	Homo sapiens	Activity	%	7.0
	22953090	CHEMBL4767027	Inhibition of recombinant human FGFR1 (456 to 765 residues) using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	868.0	CHEMBL3650	Homo sapiens	IC50	uM	0.868
	22979768	CHEMBL4772650	Binding affinity to wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	=	Kd	nM	76.0	CHEMBL3650	Homo sapiens	Kd	nM	76.0
	22979802	CHEMBL4772684	Inhibition of wild-type human partial length FGFR1 (P357 to V669 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	>	Activity	%	90.0	CHEMBL3650	Homo sapiens	Activity	%	90.0
	22990701	CHEMBL4775142	Inhibition of FGFR1 (unknown origin)	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	23122571	CHEMBL4804922	Inhibition of human FGFR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	85.0	CHEMBL3650	Homo sapiens	Activity	%	85.0
	23123266	CHEMBL4805510	Inhibition of human FGFR1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL3650	Homo sapiens	Activity	%	100.0
	23123625	CHEMBL4805869	Inhibition of DNA-tagged human FGFR1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3650	Homo sapiens	Activity	%	100.0
	23124622	CHEMBL4806527	Inhibition of human FGFR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL3650	Homo sapiens	Activity	%	98.0
	23124623	CHEMBL4806527	Inhibition of human FGFR1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL3650	Homo sapiens	Activity	%	92.0
	23128104	CHEMBL4807843	Inhibition of FGFR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL3650	Homo sapiens	Activity	%	50.0
	23128105	CHEMBL4807843	Inhibition of FGFR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3650	Homo sapiens	Activity	%	75.0
	23128106	CHEMBL4807843	Inhibition of FGFR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	50.0	CHEMBL3650	Homo sapiens	Activity	%	50.0
	23149458	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc2nc(N3CCC(C(CC#N)n4cc(-c5ncnc6[nH]ccc56)cn4)CC3)sc2c1		CHEMBL4862283	=	IC50	nM	6.0	CHEMBL3650	Homo sapiens	IC50	nM	6.0
	23149459	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(CCc2cnc3[nH]ccc3c2)cc(OC)c1		CHEMBL4861534	=	IC50	nM	83.0	CHEMBL3650	Homo sapiens	IC50	nM	83.0
	23149460	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)cc(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4856613	=	IC50	nM	7.5	CHEMBL3650	Homo sapiens	IC50	nM	7.5
	23149461	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4847441	=	IC50	nM	1.9	CHEMBL3650	Homo sapiens	IC50	nM	1.9
	23149462	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1Cl		CHEMBL4863146	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
	23149463	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c(Cl)c(OC)c1Cl		CHEMBL4868291	=	IC50	nM	82.0	CHEMBL3650	Homo sapiens	IC50	nM	82.0
	23149464	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4863224	=	IC50	nM	1.1	CHEMBL3650	Homo sapiens	IC50	nM	1.1
	23149465	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1F		CHEMBL4870179	=	IC50	nM	0.12	CHEMBL3650	Homo sapiens	IC50	nM	0.12
	23149466	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1F		CHEMBL4862823	=	IC50	nM	0.17	CHEMBL3650	Homo sapiens	IC50	nM	0.17
	23149467	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4c(c3N(CCO)C2=O)CC(=O)N4)c1F		CHEMBL4874869	=	IC50	nM	4.4	CHEMBL3650	Homo sapiens	IC50	nM	4.4
	23149468	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4c(c3N(CCN3CCOCC3)C2=O)CC(=O)N4)c1F		CHEMBL4866178	=	IC50	nM	27.0	CHEMBL3650	Homo sapiens	IC50	nM	27.0
	23149469	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4c(c3N(c3cccc(F)c3F)C2=O)CC(=O)N4)c1F		CHEMBL4851637	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
	23149470	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4c(c3N(c3ccc(C#N)cc3)C2=O)CC(=O)N4)c1F		CHEMBL4871046	=	IC50	nM	9.2	CHEMBL3650	Homo sapiens	IC50	nM	9.2
	23149471	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3c(c21)C1(CC1)C(=O)N3		CHEMBL4848530	=	IC50	nM	20.0	CHEMBL3650	Homo sapiens	IC50	nM	20.0
	23149472	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4c(c3N(C)C2=O)C2(CC2)C(=O)N4)c1F		CHEMBL4846809	=	IC50	nM	0.79	CHEMBL3650	Homo sapiens	IC50	nM	0.79
	23149473	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4c(c3N(C)C2=O)C(C)(C)C(=O)N4)c1F		CHEMBL4858423	=	IC50	nM	9.8	CHEMBL3650	Homo sapiens	IC50	nM	9.8
	23149474	CHEMBL4810137	Inhibition of human FGFR1 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4c(c3N(C)C2=O)C2(CCN(C)CC2)C(=O)N4)c1F		CHEMBL4873003	=	IC50	nM	21.0	CHEMBL3650	Homo sapiens	IC50	nM	21.0
	23158836	CHEMBL4812088	Inhibition of FGFR1 (398 to 822 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	3.58	CHEMBL3650	Homo sapiens	INH	%	3.58
	23216084	CHEMBL4823599	Inhibition of recombinant human FGFR1 (456 to 765 residues) using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	23256916	CHEMBL4832284	Inhibition of FGFR1 (unknown origin) at 10 uM incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method relative to control	B	CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccccc4)c3)nc3sccn23)n1		CHEMBL4860202	=	Inhibition	%	3.33	CHEMBL3650	Homo sapiens	INH	%	3.33
	23256917	CHEMBL4832284	Inhibition of FGFR1 (unknown origin) at 10 uM incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method relative to control	B	CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccc(F)cc4)c3)nc3sccn23)n1		CHEMBL4873517	=	Inhibition	%	-0.04	CHEMBL3650	Homo sapiens	INH	%	-0.04
	23261786	CHEMBL4833167	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1cc(SC)ccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4879303	=	IC50	nM	39.0	CHEMBL3650	Homo sapiens	IC50	nM	39.0
	23261787	CHEMBL4833167	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1cc(S(C)(=O)=O)cc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4862742	=	IC50	nM	886.0	CHEMBL3650	Homo sapiens	IC50	nM	886.0
	23261788	CHEMBL4833167	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1cc(S(C)(=O)=O)ccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4877857	=	IC50	nM	28.0	CHEMBL3650	Homo sapiens	IC50	nM	28.0
	23261789	CHEMBL4833167	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1cc(S(N)(=O)=O)cc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4872856	=	IC50	nM	787.0	CHEMBL3650	Homo sapiens	IC50	nM	787.0
	23261790	CHEMBL4833167	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4514636	=	IC50	nM	624.0	CHEMBL3650	Homo sapiens	IC50	nM	624.0
	23261791	CHEMBL4833167	Inhibition of FGFR1 (unknown origin)	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	591.0	CHEMBL3650	Homo sapiens	IC50	nM	591.0
	23261869	CHEMBL4833200	Inhibition of FGFR1 (unknown origin) using poly-GT as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	320.0	CHEMBL3650	Homo sapiens	IC50	nM	320.0
	23265605	CHEMBL4834266	Inhibition of FGFR1 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	2100.0	CHEMBL3650	Homo sapiens	IC50	uM	2.1
	23265606	CHEMBL4834266	Inhibition of FGFR1 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	990.0	CHEMBL3650	Homo sapiens	IC50	uM	0.99
	23265607	CHEMBL4834266	Inhibition of FGFR1 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	>	IC50	nM	11000.0	CHEMBL3650	Homo sapiens	IC50	uM	11.0
Not Active	23270424	CHEMBL4835218	Inhibition of FGFR1 kinase (unknown origin) at 10 uM	B	C[C@H]1CN(C(=O)CC[C@@]2(C3CC3)NC(=O)NC2=O)CCN1c1cc(F)cc(F)c1		CHEMBL4650334		Inhibition	%		CHEMBL3650	Homo sapiens	INH		
	23284631	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(C4=CCN(C(=O)OC(C)(C)C)CC4)c(=O)n3c2)c1		CHEMBL4849708	=	IC50	nM	3.7	CHEMBL3650	Homo sapiens	IC50	nM	3.7
	23284632	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(OC4CCOCC4)c(=O)n3c2)c1		CHEMBL4849887	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	23284633	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(OCCN4CCOCC4)c(=O)n3c2)c1		CHEMBL4866831	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	23284634	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(OCCN(C)C)c(=O)n3c2)c1		CHEMBL4861296	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	23284635	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COCCOc1cnc2ccc(N(CCNC(C)C)c3cc(OC)cc(OC)c3)cn2c1=O		CHEMBL4856522	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	23284636	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(C4=CCNCC4)c(=O)n3c2)c1		CHEMBL4876974	=	IC50	nM	22.0	CHEMBL3650	Homo sapiens	IC50	nM	22.0
	23284637	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cccnc4)c(=O)n3c2)c1		CHEMBL4865722	=	IC50	nM	37.0	CHEMBL3650	Homo sapiens	IC50	nM	37.0
	23284638	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	=	IC50	nM	0.57	CHEMBL3650	Homo sapiens	IC50	nM	0.57
	23284639	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)c(=O)n3c2)c1		CHEMBL4876299	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	23284640	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn(C)nc4C)c(=O)n3c2)c1		CHEMBL4845750	=	IC50	nM	50.0	CHEMBL3650	Homo sapiens	IC50	nM	50.0
	23284641	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)c(=O)n3c2)c1		CHEMBL4852018	=	IC50	nM	2.1	CHEMBL3650	Homo sapiens	IC50	nM	2.1
	23284642	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	CCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cn3c2=O)cn1		CHEMBL4853985	=	IC50	nM	8.0	CHEMBL3650	Homo sapiens	IC50	nM	8.0
	23284643	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	CCCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cn3c2=O)cn1		CHEMBL4872440	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	23284644	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCF)c4)c(=O)n3c2)c1		CHEMBL4872664	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	23284645	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COCCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cn3c2=O)cn1		CHEMBL4852671	=	IC50	nM	2.0	CHEMBL3650	Homo sapiens	IC50	nM	2.0
	23284646	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCCCO5)c4)c(=O)n3c2)c1		CHEMBL4871676	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	23284647	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCOCC5)c4)c(=O)n3c2)c1		CHEMBL4850483	=	IC50	nM	1.5	CHEMBL3650	Homo sapiens	IC50	nM	1.5
	23284648	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCO)c4)c(=O)n3c2)c1		CHEMBL4862468	=	IC50	nM	2.7	CHEMBL3650	Homo sapiens	IC50	nM	2.7
	23284649	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)c(=O)n3c2)c1		CHEMBL4873997	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
	23284650	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCN(C)C)c4)c(=O)n3c2)c1		CHEMBL4863732	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	23284651	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCN5CCOCC5)c4)c(=O)n3c2)c1		CHEMBL4873837	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	23284652	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)c(=O)n3c2)c1		CHEMBL4848334	=	IC50	nM	0.65	CHEMBL3650	Homo sapiens	IC50	nM	0.65
	23284653	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)c(=O)n3c2)c1		CHEMBL4876247	=	IC50	nM	1.3	CHEMBL3650	Homo sapiens	IC50	nM	1.3
	23284654	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	CCN1CCC(n2cc(-c3cnc4ccc(N(CCNC(C)C)c5cc(OC)cc(OC)c5)cn4c3=O)cn2)CC1		CHEMBL4854151	=	IC50	nM	2.4	CHEMBL3650	Homo sapiens	IC50	nM	2.4
	23284655	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(C)=O)CC5)c4)c(=O)n3c2)c1		CHEMBL4849539	=	IC50	nM	0.82	CHEMBL3650	Homo sapiens	IC50	nM	0.82
	23284656	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(S(C)(=O)=O)CC5)c4)c(=O)n3c2)c1		CHEMBL4869917	=	IC50	nM	1.0	CHEMBL3650	Homo sapiens	IC50	nM	1.0
	23284657	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CNC5)c4)c(=O)n3c2)c1		CHEMBL4845884	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	23284658	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CN(C(C)=O)C5)c4)c(=O)n3c2)c1		CHEMBL4866204	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
	23284659	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CN(S(C)(=O)=O)C5)c4)c(=O)n3c2)c1		CHEMBL4867685	=	IC50	nM	1.6	CHEMBL3650	Homo sapiens	IC50	nM	1.6
	23284660	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4859203	=	IC50	nM	0.57	CHEMBL3650	Homo sapiens	IC50	nM	0.57
	23284661	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)c(=O)n2c1		CHEMBL4862302	>	IC50	nM	100.0	CHEMBL3650	Homo sapiens	IC50	nM	100.0
	23284662	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4849522	=	IC50	nM	1.9	CHEMBL3650	Homo sapiens	IC50	nM	1.9
	23284663	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC2CC2)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4860678	=	IC50	nM	1.4	CHEMBL3650	Homo sapiens	IC50	nM	1.4
	23284664	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC2COC2)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4856725	=	IC50	nM	85.0	CHEMBL3650	Homo sapiens	IC50	nM	85.0
	23284665	CHEMBL4838026	Inhibition of human N-terminal GST fusion tagged FGFR1 cytoplasmic domain (398 to 822 residues) expressed in baculovirus infected Sf21 insect cells in presence of ATP at Km concentration	B	COc1cc(OC)cc(N(CCNC2CCC(O)CC2)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4851029	=	IC50	nM	2.5	CHEMBL3650	Homo sapiens	IC50	nM	2.5
	23284763	CHEMBL4838073	Inhibition of recombinant human FGFR1 (456 to 765 residues) at 10 uM using KKKSPGEYVNIEF as substrate at 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis relative to control	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	>	Inhibition	%	90.0	CHEMBL3650	Homo sapiens	INH	%	90.0
	23284801	CHEMBL4838111	Inhibition of FGFR1 (unknown origin)	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	0.9	CHEMBL3650	Homo sapiens	IC50	nM	0.9
	23284802	CHEMBL4838111	Inhibition of FGFR1 (unknown origin)	B	C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828009	=	IC50	nM	2.8	CHEMBL3650	Homo sapiens	IC50	nM	2.8
	23284803	CHEMBL4838111	Inhibition of FGFR1 (unknown origin)	B	CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3[nH]c(CN4CCOCC4)cc3c21		CHEMBL4297522	=	IC50	nM	0.4	CHEMBL3650	Homo sapiens	IC50	nM	0.4
	23284804	CHEMBL4838111	Inhibition of FGFR1 (unknown origin)	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	1.2	CHEMBL3650	Homo sapiens	IC50	nM	1.2
	23284817	CHEMBL4838115	Inhibition of recombinant human FGFR1 in presence of ATP at Km concentration	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.2	CHEMBL3650	Homo sapiens	IC50	nM	0.2
	23289733	CHEMBL4839228	Inhibition of FGFR1 (unknown origin)	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	140.0	CHEMBL3650	Homo sapiens	IC50	nM	140.0
	23289734	CHEMBL4839228	Inhibition of FGFR1 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	17.5	CHEMBL3650	Homo sapiens	IC50	nM	17.5
	23295379	CHEMBL4840462	Inhibition of recombinant His-tagged human FGFR1 expressed in baculovirus expression system at 1 uM measured by select screen assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(Cc3cc(F)cc(F)c3)C4(C)C)cc2)CC1		CHEMBL4849505	=	Inhibition	%	60.0	CHEMBL3650	Homo sapiens	INH	%	60.0
	23297788	CHEMBL4841268	Inhibition of FGFR1 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL3650	Homo sapiens	IC50	nM	1000.0
	23299254	CHEMBL4841727	Inhibition of FGFR1 (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	17.0	CHEMBL3650	Homo sapiens	INH	%	17.0
	23299255	CHEMBL4841727	Inhibition of FGFR1 (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	75.0	CHEMBL3650	Homo sapiens	INH	%	75.0
Not Active	23317406	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23317874	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	57.0	CHEMBL3650	Homo sapiens	% Control	%	57.0
Not Active	23318543	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	62.0	CHEMBL3650	Homo sapiens	% Control	%	62.0
Not Active	23319024	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23319661	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	89.4	CHEMBL3650	Homo sapiens	% Control	%	89.4
Not Active	23320136	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23320814	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23321282	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23321912	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23322380	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23323069	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	90.0	CHEMBL3650	Homo sapiens	% Control	%	90.0
Not Active	23323537	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	87.0	CHEMBL3650	Homo sapiens	% Control	%	87.0
Not Active	23324009	CHEMBL4880628	FGFR1 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	23.0	CHEMBL3650	Homo sapiens	% inhibition	%	23.0
Not Active	23324391	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	86.6	CHEMBL3650	Homo sapiens	% Control	%	86.6
Not Active	23325026	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	98.0	CHEMBL3650	Homo sapiens	% Control	%	98.0
Not Active	23325494	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23326141	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23326609	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Slightly Active	23327309	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	49.0	CHEMBL3650	Homo sapiens	% Control	%	49.0
Not Active	23327777	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23328364	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23328832	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	93.0	CHEMBL3650	Homo sapiens	% Control	%	93.0
Not Active	23329343	CHEMBL4881050	FGFR1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	101.0	CHEMBL3650	Homo sapiens	% residual kinase activity	%	101.0
Not Active	23329778	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23330246	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23331002	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23331470	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23331881	CHEMBL4881421	Bayer in-house kinase assay with FGFR1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1	Non standard unit for type	CHEMBL3907057	>	IC50	µM	10.0	CHEMBL3650	Homo sapiens	IC50	µM	10.0
Not Active	23332057	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	85.5	CHEMBL3650	Homo sapiens	% Control	%	85.5
Not Active	23332523	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23333241	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23333880	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23334348	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23335327	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23335795	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23336422	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	90.0	CHEMBL3650	Homo sapiens	% Control	%	90.0
Not Active	23336890	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	91.0	CHEMBL3650	Homo sapiens	% Control	%	91.0
Not Active	23337594	CHEMBL4881965	FGFR1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	100.5	CHEMBL3650	Homo sapiens	% Ctrl	%	100.5
Not Active	23337971	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	95.0	CHEMBL3650	Homo sapiens	% Control	%	95.0
Not Active	23338439	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	72.0	CHEMBL3650	Homo sapiens	% Control	%	72.0
Not Active	23339051	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	94.0	CHEMBL3650	Homo sapiens	% Control	%	94.0
Not Active	23339519	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	95.0	CHEMBL3650	Homo sapiens	% Control	%	95.0
Not Active	23340156	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	95.0	CHEMBL3650	Homo sapiens	% Control	%	95.0
Not Active	23340624	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	87.0	CHEMBL3650	Homo sapiens	% Control	%	87.0
Not Active	23341281	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23341749	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23342365	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23342833	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	87.0	CHEMBL3650	Homo sapiens	% Control	%	87.0
Not Active	23343252	CHEMBL4882437	FGFR1 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	94.0	CHEMBL3650	Homo sapiens	% Ctrl	%	94.0
Not Active	23343463	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	86.0	CHEMBL3650	Homo sapiens	% Control	%	86.0
Not Active	23343931	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	84.0	CHEMBL3650	Homo sapiens	% Control	%	84.0
Not Active	23344569	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23345142	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	98.0	CHEMBL3650	Homo sapiens	% Control	%	98.0
Not Active	23345610	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23346187	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	82.0	CHEMBL3650	Homo sapiens	% Control	%	82.0
Not Active	23346656	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	92.4	CHEMBL3650	Homo sapiens	% Control	%	92.4
Not Active	23347261	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	94.1	CHEMBL3650	Homo sapiens	% Control	%	94.1
Not Active	23347747	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	78.0	CHEMBL3650	Homo sapiens	% Control	%	78.0
Not Active	23348326	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23348794	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	97.0	CHEMBL3650	Homo sapiens	% Control	%	97.0
Not Active	23349381	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23349999	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23350467	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	99.0	CHEMBL3650	Homo sapiens	% Control	%	99.0
Not Active	23351072	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23351540	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23352045	CHEMBL4882736	FGFR1 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.876	CHEMBL3650	Homo sapiens	% Inhibition	%	3.8764
Not Active	23352564	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23353032	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23353914	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23354382	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23355114	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23355582	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23356218	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23356686	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23357295	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23357942	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23358410	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23358996	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	86.5	CHEMBL3650	Homo sapiens	% Control	%	86.5
Not Active	23359594	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	95.0	CHEMBL3650	Homo sapiens	% Control	%	95.0
Not Active	23360062	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	91.0	CHEMBL3650	Homo sapiens	% Control	%	91.0
Not Active	23360647	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	99.0	CHEMBL3650	Homo sapiens	% Control	%	99.0
Not Active	23361115	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	88.0	CHEMBL3650	Homo sapiens	% Control	%	88.0
Not Active	23361688	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	90.0	CHEMBL3650	Homo sapiens	% Control	%	90.0
Not Active	23362224	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23362692	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	83.0	CHEMBL3650	Homo sapiens	% Control	%	83.0
Not Active	23363248	CHEMBL4883240	FGFR1 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	9.194	CHEMBL3650	Homo sapiens	% inhibition	%	9.1939
Not Active	23363249	CHEMBL4883240	FGFR1 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	4.257	CHEMBL3650	Homo sapiens	% inhibition	%	4.257
Not Active	23364334	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	68.0	CHEMBL3650	Homo sapiens	% Control	%	68.0
Not Active	23364802	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	91.0	CHEMBL3650	Homo sapiens	% Control	%	91.0
Not Active	23365541	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23366084	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL3650	Homo sapiens	% Control	%	95.0
Not Active	23366674	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	71.0	CHEMBL3650	Homo sapiens	% Control	%	71.0
Not Active	23367142	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23367570	CHEMBL4883923	FGF-R1 V561M ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	89.0	CHEMBL3650	Homo sapiens	% Residual activity with Skepinone-L	%	89.0
Not Active	23367571	CHEMBL4883924	FGF-R1 wt ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	117.0	CHEMBL3650	Homo sapiens	% Residual activity with Skepinone-L	%	117.0
Not Active	23368020	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	82.0	CHEMBL3650	Homo sapiens	% Control	%	82.0
Not Active	23368488	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23369087	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23369555	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23370065	CHEMBL4884309	FGFR1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	61.0	CHEMBL3650	Homo sapiens	% residual kinase activity	%	61.0
Not Active	23370523	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	97.0	CHEMBL3650	Homo sapiens	% Control	%	97.0
Not Active	23370991	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	97.0	CHEMBL3650	Homo sapiens	% Control	%	97.0
Not Active	23371800	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23372268	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	91.0	CHEMBL3650	Homo sapiens	% Control	%	91.0
	23373718	CHEMBL4885495	FGFR1(FGF1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3650	Homo sapiens	pIC50		6.0
Not Active	23374977	CHEMBL4885971	FGFR1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	5.5	CHEMBL3650	Homo sapiens	% Inhibition	%	5.5
Not Active	23375249	CHEMBL4886231	fibroblast growth factor receptor 1 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	8.0	CHEMBL3650	Homo sapiens	% inhibition	%	8.0
Not Active	23375695	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	93.0	CHEMBL3650	Homo sapiens	% Control	%	93.0
Not Active	23376163	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23376740	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23377209	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	85.0	CHEMBL3650	Homo sapiens	% Control	%	85.0
Not Active	23378068	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	82.0	CHEMBL3650	Homo sapiens	% Control	%	82.0
Not Active	23378536	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	84.0	CHEMBL3650	Homo sapiens	% Control	%	84.0
Not Active	23379703	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	98.0	CHEMBL3650	Homo sapiens	% Control	%	98.0
Not Active	23380171	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	93.0	CHEMBL3650	Homo sapiens	% Control	%	93.0
Not Active	23380865	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23381513	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23381981	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3650	Homo sapiens	% Control	%	100.0
Not Active	23382402	CHEMBL4887121	FGFR1 Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	64.0	CHEMBL3650	Homo sapiens	% inhibition	%	64.0
Not Active	23382605	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	89.0	CHEMBL3650	Homo sapiens	% Control	%	89.0
Not Active	23383073	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	82.0	CHEMBL3650	Homo sapiens	% Control	%	82.0
Not Active	23383789	CHEMBL4887427	FGFR1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	84.0	CHEMBL3650	Homo sapiens	% Ctrl	%	84.0
Not Active	23383790	CHEMBL4887427	FGFR1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	91.0	CHEMBL3650	Homo sapiens	% Ctrl	%	91.0
Not Active	23384274	CHEMBL4887869	FGFR1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	6.44	CHEMBL3650	Homo sapiens	% inhibition	%	6.44
Not Active	23384652	CHEMBL4888178	FGFR1 SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	25.0	CHEMBL3650	Homo sapiens	% Inhibition	%	25.0
Not Active	23384988	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	74.0	CHEMBL3650	Homo sapiens	% Control	%	74.0
Not Active	23385455	CHEMBL4879712	KinomeScan assay: inhibition of FGFR1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	91.0	CHEMBL3650	Homo sapiens	% Control	%	91.0
Not Active	23385879	CHEMBL4888352	FGFR1 Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	-2.0	CHEMBL3650	Homo sapiens	% inhibition	%	-2.0
